sampleId	hmfPatientId	hmfSampleId	tumorPurity	gender	birthYear	deathDate	primaryTumorLocation	primaryTumorSubLocation	primaryTumorType	primaryTumorSubType	primaryTumorExtraDetails	doids	biopsyDate	biopsySite	biopsyLocation	hasSystemicPreTreatment	hasRadiotherapyPreTreatment	treatmentGiven	treatmentStartDate	treatmentEndDate	treatment	consolidatedTreatmentType	responseDate	responseMeasured	firstResponse
ACTN01020001T	HMF005332	HMF005332A	0.26	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020002T	HMF005333	HMF005333A	0.5	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020003T	HMF005334	HMF005334A	0.87	null	null	null	Thyroid gland					1781	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020005T	HMF005336	HMF005336A	0.5	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020006T	HMF005337	HMF005337A	0.63	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020007T	HMF005338	HMF005338A	0.27	null	null	null	Ovary					2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020009T	HMF005339	HMF005339A	0.57	null	null	null	Colorectum					9256	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020010T	HMF005340	HMF005340A	0.24	null	null	null	Liver		Carcinoma	Hepatocellular carcinoma		684	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020011T	HMF005341	HMF005341A	0.58	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020012T	HMF005656	HMF005656A	0.58	null	null	null	Vulva					1245	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020016T	HMF005657	HMF005657A	0.36	null	null	null	Esophagus					5041	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020017T	HMF005658	HMF005658A	0.47	null	null	null	Prostate					10283	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020018T	HMF005659	HMF005659A	0.21	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020019T	HMF005660	HMF005660A	0.48	null	null	null	Pancreas		Neuroendocrine tumor			1793,169	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020020T	HMF005661	HMF005661A	0.45	null	null	null	Pancreas					1793	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020022T	HMF005741	HMF005741A	0.87	null	null	null	Ovary					2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020023T	HMF005663	HMF005663A	0.91	null	null	null	Uterus	Cervix	Neuroendocrine tumor			4362,169	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020024T	HMF005664	HMF005664A	0.48	null	null	null	Anus					14110	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020026T	HMF005666	HMF005666A	0.22	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020029T	HMF005742	HMF005742A	0.3	null	null	null	Colorectum	Rectum	Carcinoma			1993,305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020030T	HMF005743	HMF005743A	0.55	null	null	null	Prostate					10283	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020031T	HMF005744	HMF005744A	0.83	null	null	null	Eye		Melanoma			1752,1909	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020033T	HMF005746	HMF005746A	0.78	null	null	null	Head and neck	Nasal cavity	Carcinoma	Squamous cell carcinoma		5515,5520	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020036T	HMF005749	HMF005749A	0.77	null	null	null	Ovary					2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020037T	HMF005750	HMF005750A	0.9	null	null	null	Uterus		Carcinoma	Carcinosarcoma		6171,4236	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020038T	HMF005751	HMF005751A	0.63	null	null	null	Prostate					10283	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020039T	HMF005752	HMF005752A	0.81	null	null	null	Anus					14110	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020040T	HMF005753	HMF005753A	0.22	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020042T	HMF005754	HMF005754A	0.76	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020044T	HMF005845	HMF005845A	0.24	null	null	null	Gallbladder					3121	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020045T	HMF005846	HMF005846A	0.38	null	null	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020046T	HMF005847	HMF005847A	0.87	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020047T	HMF005848	HMF005848A	0.94	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020048T	HMF005849	HMF005849A	0.5	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020049T	HMF005850	HMF005850A	0.22	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020051T	HMF005852	HMF005852A	0.35	null	null	null	Uterus	Endometrium				1380	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020052T	HMF005853	HMF005853A	0.89	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020053T	HMF005960	HMF005960A	0.81	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020054T	HMF005941	HMF005941A	0.63	null	null	null	Ovary					2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020055T	HMF005908	HMF005908A	0.43	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020056T	HMF005909	HMF005909A	0.53	null	null	null	Anus					14110	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020057T	HMF005910	HMF005910A	0.58	null	null	null	Ovary					2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020060T	HMF005961	HMF005961A	0.76	null	null	null	Esophagus		Carcinoma			1107	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020061T	HMF005962	HMF005962A	0.33	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020062T	HMF006007	HMF006007A	0.4	null	null	null	Esophagus					5041	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020063T	HMF006008	HMF006008A	0.42	null	null	null	Colorectum					9256	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020064T	HMF006033	HMF006033A	0.96	null	null	null	Urothelial tract	Bladder	Carcinoma	Small cell neuroendocrine carcinoma		7132	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020066T	HMF006009	HMF006009A	0.34	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020069T	HMF006079	HMF006079A	0.66	null	null	null	Head and neck	Parotid gland	Carcinoma	Neuroendocrine carcinoma	Small cell	1542,1800	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020071T	HMF006072	HMF006072A	0.75	null	null	null	Head and neck	Nasal cavity and paranasal sinus				10811,0050619,11934	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020072T	HMF006055	HMF006055A	0.37	null	null	null	Thyroid gland					1781	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020078T	HMF006098	HMF006098A	0.52	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020079T	HMF006082	HMF006082A	0.75	null	null	null	Uterus	Endometrium	Carcinoma	Carcinosarcoma		6171,4236	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020080T	HMF006111	HMF006111A	0.61	null	null	null	Gallbladder		Carcinoma			4948	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020081T	HMF006099	HMF006099A	0.96	null	null	null	Pancreas		Neuroendocrine tumor			1793,169	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020084T	HMF006112	HMF006112A	0.57	null	null	null	Pancreas					1793	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020085T	HMF006151	HMF006151A	0.22	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020087T	HMF006113	HMF006113A	0.76	null	null	null	Uterus	Endometrium				1380	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020091T	HMF006115	HMF006115A	0.25	null	null	null	Kidney		Carcinoma	Renal cell carcinoma		4450	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020093T	HMF006180	HMF006180A	0.7	null	null	null	Eye	Choroid	Melanoma			6438,1909	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020095T	HMF006181	HMF006181A	0.56	null	null	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020098T	HMF006154	HMF006154A	0.27	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020101T	HMF006182	HMF006182A	0.62	null	null	null	Prostate					10283	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020102T2	HMF006183	HMF006183B	0.61	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020103T	HMF006184	HMF006184A	0.61	null	null	null	Esophagus					5041	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020104T	HMF006214	HMF006214A	0.48	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020105T	HMF006219	HMF006219A	0.89	null	null	null	Colorectum	Rectum	Neuroendocrine tumor			5777,169	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020106T	HMF006185	HMF006185A	0.66	null	null	null	Ovary					2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020108T	HMF006211	HMF006211A	0.33	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020109T	HMF006220	HMF006220A	0.67	null	null	null	Unknown	CUP				162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020110T	HMF006186	HMF006186A	0.31	null	null	null	Bile duct	Intrahepatic	Carcinoma			4928	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020111T	HMF006212	HMF006212A	0.63	null	null	null	Colorectum	Colon	Carcinoma	Neuroendocrine carcinoma		1520,1800	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020114T2	HMF006215	HMF006215B	0.29	null	null	null	Pancreas					1793	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020115T	HMF006221	HMF006221A	0.54	null	null	null	Kidney		Carcinoma	Renal cell carcinoma		4450	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020117T	HMF006223	HMF006223A	0.3	null	null	null	Bone/Soft tissue		Myxofibrosarcoma			0080534	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020120T	HMF006255	HMF006255A	0.48	null	null	null	Anus					14110	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020121T	HMF006273	HMF006273A	0.67	null	null	null	Head and neck	Sinonasal	Carcinoma	Squamous cell carcinoma		0050619,5520	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020122T	HMF006274	HMF006274A	0.22	null	null	null	Pancreas					1793	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020123T	HMF006275	HMF006275A	0.36	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020124T	HMF006276	HMF006276A	0.32	null	null	null	Ovary					2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020127T	HMF006264	HMF006264A	0.26	null	null	null	Vulva					1245	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020130T	HMF006278	HMF006278A	0.49	null	null	null	Anus					14110	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020131T	HMF006766	HMF006766A	0.59	null	null	null	Anus					14110	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020132T	HMF006279	HMF006279A	0.95	null	null	null	Colorectum					9256	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020134T	HMF006352	HMF006352A	0.87	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020136T	HMF006333	HMF006333A	0.73	null	null	null	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020137T	HMF006360	HMF006360A	0.48	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020138T	HMF006377	HMF006377A	0.68	null	null	null	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020141T	HMF006362	HMF006362A	0.39	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020142T	HMF006363	HMF006363A	0.73	null	null	null	Colorectum					9256	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020144T	HMF006364	HMF006364A	0.43	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020146T	HMF006404	HMF006404A	0.21	null	null	null	Lung		Carcinoma	Non-small cell carcinoma		3908	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020148T	HMF006405	HMF006405A	0.27	null	null	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020149T	HMF006430	HMF006430A	0.9	null	null	null	Pancreas		Carcinoma	Neuroendocrine carcinoma		1798,1800	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020150T	HMF006443	HMF006443A	0.48	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020151T	HMF006454	HMF006454A	0.22	null	null	null	Urothelial tract	Bladder				11054	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020153T	HMF006445	HMF006445A	0.89	null	null	null	Colorectum	Colon	Carcinoma	Neuroendocrine carcinoma		1520,1800	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020154T	HMF006446	HMF006446A	0.42	null	null	null	Thyroid gland					1781	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020155T	HMF006486	HMF006486A	0.42	null	null	null	Breast		Carcinoma	Triple negative		0060081	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020157T	HMF006501	HMF006501A	0.37	null	null	null	Lung		Carcinoma	Adenocarcinoma		3910,3908	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020159T	HMF006457	HMF006457A	0.24	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020162T	HMF006487	HMF006487A	0.68	null	null	null	Gastroesophageal	Esophago-gastric junction				0080374	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020164T	HMF006502	HMF006502A	0.37	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020165T	HMF006528	HMF006528A	0.39	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020167T	HMF006511	HMF006511A	0.3	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020168T	HMF006522	HMF006522A	0.79	null	null	null	Pancreas		Carcinoma	Acinar cell carcinoma		5742,3025	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020170T	HMF006503	HMF006503A	0.39	null	null	null	Skin		Carcinoma	Basal cell carcinoma		2513	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020171T2	HMF006534	HMF006534B	0.61	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020172T	HMF006571	HMF006571A	0.63	null	null	null	Esophagus		Neuroendocrine tumor			5784,169	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020175T	HMF006535	HMF006535A	0.41	null	null	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020176T	HMF006536	HMF006536A	0.2	null	null	null	Gallbladder		Carcinoma			4948	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020177T	HMF006606	HMF006606A	0.59	null	null	null	Esophagus					5041	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020179T	HMF006607	HMF006607A	0.25	null	null	null	Pancreas		Carcinoma	Adenocarcinoma		4074	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020180T	HMF006572	HMF006572A	0.9	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020189T	HMF006610	HMF006610A	0.7	null	null	null	Head and neck		Lacrimal 			292	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020191T	HMF006622	HMF006622A	0.25	null	null	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020197T	HMF006623	HMF006623A	0.71	null	null	null	Nervous system		Glioma	Astrocytoma	Low-grade	3069	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020201T	HMF006650	HMF006650A	0.6	null	null	null	Small intestine	Papilla of vater	Carcinoma			4932	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020202T	HMF006664	HMF006664A	0.89	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020203T	HMF006665	HMF006665A	0.68	null	null	null	Esophagus					5041	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020211T	HMF006698	HMF006698A	0.62	null	null	null	Colorectum	Colon sigmoideum				12192	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020212T	HMF006699	HMF006699A	0.38	null	null	null	Breast		Carcinoma	Triple negative		0060081	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020216T	HMF006767	HMF006767A	0.45	null	null	null	Ovary					2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020217T	HMF006735	HMF006735A	0.47	null	null	null	Urothelial tract	Bladder				11054	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020218T	HMF006736	HMF006736A	0.57	null	null	null	Uterus	Endometrium				1380	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020219T	HMF006700	HMF006700A	0.78	null	null	null	Unknown	CUP	Carcinoma			305	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020220T	HMF006737	HMF006737A	0.29	null	null	null	Breast		Carcinoma	Triple negative		0060081	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020223T	HMF006790	HMF006790A	0.86	null	null	null	Esophagus					5041	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020226T	HMF006769	HMF006769A	0.78	null	null	null	Small intestine		Neuroendocrine tumor			10154,169	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020227T	HMF006806	HMF006806A	0.21	null	null	null	Bile duct		Carcinoma			4947	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020228T	HMF006792	HMF006792A	0.73	null	null	null	Kidney		Carcinoma	Renal cell carcinoma		4450	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020229T	HMF006793	HMF006793A	0.44	null	null	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020234T	HMF006829	HMF006829A	0.53	null	null	null	Colorectum					9256	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020244T	HMF006850	HMF006850A	0.68	null	null	null	Colorectum	Colon sigmoideum	Carcinoma	Adenocarcinoma		12192,0050861	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020245T	HMF006874	HMF006874A	0.6	null	null	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020249T	HMF006897	HMF006897A	0.23	null	null	null	Biliary tract	null	Unknown	null		4606	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020252T	HMF006945	HMF006945A	0.83	null	null	null	Endometrium/uterus	null	Unknown	null		363,1380	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020254T	HMF006878	HMF006878A	0.68	null	null	null	Bladder	null	Unknown	null		11054	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020256T	HMF006911	HMF006911A	0.56	null	null	null	Colon	null	Unknown	null		9256,219	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020257T	HMF007049	HMF007049A	0.53	null	null	null	Breast	null	Unknown	null	ER-negative/Her2-negative (triple negative)	1612,0060076,0060080,0060081	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020258T	HMF006912	HMF006912A	0.3	null	null	null	Rectum	null	Unknown	null		9256,1993	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020259T	HMF006913	HMF006913A	0.9	null	null	null	Esophagus/gastroesophageal junction	null	Adenocarcinoma	null		4914,4944	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020261T	HMF006976	HMF006976A	0.64	null	null	null	Gallbladder	null	Unknown	null		3121	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020264T	HMF006916	HMF006916A	0.38	null	null	null	Colon	null	Other	null		9256,219	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020267T	HMF006977	HMF006977A	0.38	null	null	null	Unknown primary (e.g. CUP)	null	Unknown	null		162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020268T	HMF006918	HMF006918A	0.5	null	null	null	Ovary	null	Unknown	null		1964,2394	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020270T	HMF006919	HMF006919A	0.4	null	null	null	Prostate	null	Adenocarcinoma	null		2526	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020271T	HMF006947	HMF006947A	0.72	null	null	null	Colon	null	Unknown	null		9256,219	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020272T	HMF006920	HMF006920A	0.38	null	null	null	Breast	null	Unknown	null	ER-negative/Her2-negative (triple negative)	1612,0060076,0060080,0060081	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020274T	HMF006921	HMF006921A	0.39	null	null	null	Unknown primary (e.g. CUP)	null	Unknown	null		162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020275T	HMF006948	HMF006948A	0.67	null	null	null	Breast	null	Unknown	null	ER-negative/Her2-negative (triple negative)	1612,0060076,0060080,0060081	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020276T	HMF006978	HMF006978A	0.72	null	null	null	Nasal cavity	null	Other	null		10811,11934	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020279T	HMF006950	HMF006950A	0.68	null	null	null	Breast	null	Unknown	null	Unspecified	1612	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020284T	HMF006980	HMF006980A	0.77	null	null	null	Colon	null	Unknown	null		9256,219	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020285T2	HMF006981	HMF006981B	0.44	null	null	null	Anus	null	Unknown	null		14110	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020286T	HMF006982	HMF006982A	0.42	null	null	null	Soft tissue	null	Liposarcoma, not otherwise specified	null		3382,1115	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020289T	HMF006984	HMF006984A	0.59	null	null	null	Biliary tract	null	Unknown	null		4606	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020290T	HMF006985	HMF006985A	0.48	null	null	null	Breast	null	Unknown	null	Unspecified	1612	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020291T	HMF006986	HMF006986A	0.36	null	null	null	Unknown primary (e.g. CUP)	null	Unknown	null		162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020292T	HMF007033	HMF007033A	0.93	null	null	null	Rectum	null	Neuroendocrine tumor (NET)	null		9256,1993,5777,169	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020293T	HMF006987	HMF006987A	0.41	null	null	null	Unknown primary (e.g. CUP)	null	Unknown	null		162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020296T	HMF007013	HMF007013A	0.47	null	null	null	Stomach	null	Unknown	null		10534	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020298T	HMF007034	HMF007034A	0.5	null	null	null	Esophagus/gastroesophageal junction	null	Adenocarcinoma	null		4914,4944	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020300T	HMF007036	HMF007036A	0.57	null	null	null	Vagina	null	Squamous cell carcinoma	null		0050918	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020301T	HMF007073	HMF007073A	0.75	null	null	null	Small bowel/intestine	null	Unknown	null		10154	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020302T	HMF007074	HMF007074A	0.63	null	null	null	Esophagus/gastroesophageal junction	null	Adenocarcinoma	null		4914,4944	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020306T	HMF007076	HMF007076A	0.92	null	null	null	Rectum	null	Unknown	null		9256,1993	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020308T	HMF007051	HMF007051A	0.72	null	null	null	Lung	null	Neuroendocrine tumor (atypical carcinoid)	null		5410,169	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020311T	HMF007078	HMF007078A	0.65	null	null	null	Unknown primary (e.g. CUP)	null	Unknown	null		162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020312T	HMF007079	HMF007079A	0.54	null	null	null	Colon	null	Unknown	null		9256,219	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020314T	HMF007081	HMF007081A	0.2	null	null	null	Biliary tract	null	Other	null		4606	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020315T	HMF007082	HMF007082A	0.46	null	null	null	Colon	null	Unknown	null		9256,219	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020316T	HMF007083	HMF007083A	0.28	null	null	null	Pancreas	null	Unknown	null		1793	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020317T	HMF007084	HMF007084A	0.22	null	null	null	Colon	null	Unknown	null		9256,219	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020319T	HMF007086	HMF007086A	0.65	null	null	null	Esophagus/gastroesophageal junction	null	Unknown	null		5041,0080374	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020321T	HMF007087	HMF007087A	0.35	null	null	null	Unknown primary (e.g. CUP)	null	Unknown	null		162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020322T	HMF007088	HMF007088A	0.69	null	null	null	Rectum	null	Unknown	null		9256,1993	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020323T	HMF007089	HMF007089A	0.51	null	null	null	Ovary	null	High-grade serous carcinoma	null		5598,0050933	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020325T	HMF007091	HMF007091A	0.31	null	null	null	Bladder	null	Urothelial carcinoma	null		4006	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020326T	HMF007092	HMF007092A	0.31	null	null	null	Unknown primary (e.g. CUP)	null	Unknown	null		162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020328T	HMF007094	HMF007094A	0.31	null	null	null	Esophagus/gastroesophageal junction	null	Adenocarcinoma	null		4914,4944	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020329T	HMF007095	HMF007095A	0.5	null	null	null	Unknown primary (e.g. CUP)	null	Unknown	null		162	null	null	null	null	null	null	null	null	null	null	null	null	null
ACTN01020332T	HMF007097	HMF007097A	0.7	null	null	null	Skin	null	Merkel cell carcinoma	null		3965	null	null	null	null	null	null	null	null	null	null	null	null	null
CPCT02010255TII	HMF000812	HMF000812B	0.9	male	1952	null	Prostate					10283	2016-05-13	urinary bladder	NA	Yes	No	Yes	2015-09-24	2016-04-29	Enzalutamide	Hormonal therapy	2015-10-08	Yes	SD
CPCT02010256TII	HMF000615	HMF000615B	0.32	male	1963	null	Prostate					10283	2017-02-16	Lymph node	supraclavicular left	Yes	Yes	Yes	2015-08-04	2017-02-08	Enzalutamide	Hormonal therapy	2015-11-18	Yes	SD
CPCT02010267TII	HMF002852	HMF002852A	0.22	female	1977	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-11-23	Lymph node	axillar right	Yes	No	Yes	2015-11-27	2016-11-14	Tamoxifen	Hormonal therapy	2016-11-07	Yes	PD
CPCT02010267TIII	HMF002852	HMF002852B	0.5	female	1977	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-03-28	Primary	mamma/axilla right	Yes	No	Yes	2015-11-27	2016-11-14	Tamoxifen	Hormonal therapy	2016-11-07	Yes	PD
CPCT02010276TII	HMF002464	HMF002464B	0.73	female	1954	2019-04-12	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-30	Liver	segment L3	Yes	Yes	Yes	2015-12-18	2016-11-15	Letrozole	Hormonal therapy	null	null	null
CPCT02010291TII	HMF003050	HMF003050A	0.78	male	1942	null	Prostate					10283	2018-02-09	Adrenal gland	left	Yes	No	Yes	2016-01-11	2018-01-24	Enzalutamide	Hormonal therapy	2016-03-18	Yes	SD
CPCT02010292TII	HMF000200	HMF000200A	0.6	female	1954	2019-07-06	Bone/Soft tissue	Pelvis	Sarcoma			1115	2017-02-06	Liver	segment 3	Yes	No	Yes	2016-01-20	2016-05-18	Doxorubicin	Chemotherapy	2016-02-24	Yes	SD
CPCT02010325T	HMF003579	HMF003579A	0.94	male	1971	null	Bone/Soft tissue		Sarcoma			1115	2016-03-01	subcateneous	right buttocks	No	No	Yes	2016-03-18	2016-07-03	Doxorubicin/Ifosfamide	Chemotherapy	2016-04-21	Yes	SD
CPCT02010326TII	HMF002035	HMF002035A	0.78	female	1975	2017-04-10	Breast		Carcinoma	Triple negative		0060081	2017-03-31	Brain	frontoparietal	Yes	Yes	Yes	2016-03-04	2016-07-20	Gemcitabine/Carboplatin	Chemotherapy	2016-05-25	Yes	PR
CPCT02010329T	HMF002392	HMF002392A	0.3	female	1969	null	Breast		Carcinoma	Triple negative		0060081	2016-03-09	Lymph node	left axillary	Yes	Yes	Yes	2016-04-01	2016-07-27	Gemcitabine/Carboplatin/Paclitaxel	Chemotherapy	2016-06-08	Yes	SD
CPCT02010333TII	HMF000338	HMF000338A	0.55	female	1968	2016-12-27	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-10-28	Lymph node	axillar right	Yes	No	Yes	2016-03-22	2016-08-16	Afatinib	Targeted therapy	2016-05-03	Yes	SD
CPCT02010334T	HMF003136	HMF003136A	0.7	female	1956	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2016-03-11	Liver	segment 6	Yes	No	Yes	2016-03-16	2016-08-31	Masitinib	Targeted therapy	2016-06-01	Yes	PD
CPCT02010337TII	HMF000886	HMF000886B	0.91	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-17	cuntaneous	axilla right (PTB)	Yes	Yes	Yes	2016-04-19	2016-08-02	Doxorubicin	Chemotherapy	null	null	null
CPCT02010340T	HMF002687	HMF002687A	0.43	female	1944	2017-06-01	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-03-24	Kidney	right	No	No	Yes	2016-04-01	2017-01-01	Pazopanib	Targeted therapy	2016-08-09	Yes	SD
CPCT02010344TII	HMF003202	HMF003202A	0.81	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	Yes	No	Yes	2016-04-13	2016-06-01	Paclitaxel	Chemotherapy	null	null	null
CPCT02010347T	HMF000856	HMF000856A	0.9	male	1946	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-04-19	Liver	segment 8	No	No	Yes	2016-04-22	2016-06-01	Doxorubicin	Chemotherapy	2016-06-11	Yes	PD
CPCT02010347TII	HMF000856	HMF000856B	0.91	male	1946	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-06-28	Liver	segment 4	No	No	Yes	2016-04-22	2016-06-01	Doxorubicin	Chemotherapy	2016-06-11	Yes	PD
CPCT02010349T	HMF002684	HMF002684A	0.51	female	1950	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2016-04-21	intra-abdominal	left mesenterial	Yes	No	Yes	2016-05-30	2016-08-01	Imatinib	Targeted therapy	2016-07-06	Yes	SD
CPCT02010351T	HMF002764	HMF002764A	0.38	female	1952	2016-12-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-04-29	Lymph node	left axillary	Yes	Yes	Yes	2016-04-29	2016-07-26	Anastrozole	Hormonal therapy	null	null	null
CPCT02010352T	HMF003578	HMF003578A	0.56	male	1969	null	Small intestine		Neuroendocrine tumor			10154,169	2016-05-10	Liver	segment 2	No	No	Yes	2016-05-11	null	Octreotide/Lanreotide	Hormonal therapy	2016-09-06	Yes	SD
CPCT02010356T	HMF003787	HMF003787A	0.54	male	1960	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-05-24	subcutaneous	thoraxwall left	Yes	Yes	Yes	2016-06-02	2017-06-30	Nivolumab	Immunotherapy	2016-07-18	Yes	PD
CPCT02010359T	HMF001423	HMF001423C	0.43	female	1978	null	Breast		Carcinoma	Triple negative		0060081	2016-05-30	Primary	left mamma	No	No	Yes	2016-06-06	2017-02-15	Carboplatin/Capecitabine	Chemotherapy	2016-07-18	Yes	SD
CPCT02010361T	HMF000332	HMF000332A	0.29	male	1948	null	Prostate					10283	2018-07-04	Liver	segment 6	Yes	Yes	Yes	2016-06-06	2016-09-09	Enzalutamide	Hormonal therapy	null	null	null
CPCT02010362T	HMF003145	HMF003145A	0.68	female	1959	null	Small intestine		Neuroendocrine tumor			10154,169	2016-06-14	Primary	Ileum	No	No	Yes	2016-07-21	2021-08-01	Lanreotide	Hormonal therapy	2016-10-26	Yes	SD
CPCT02010366T	HMF001237	HMF001237A	1.0	female	1956	null	Small intestine		Neuroendocrine tumor			10154,169	2016-07-04	Peritoneum	transverse mesocolon	No	No	Yes	2016-08-22	null	Lanreotide	Hormonal therapy	2016-11-23	Yes	SD
CPCT02010369T	HMF002377	HMF002377A	0.79	male	1948	2016-09-30	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-06-16	cutaneous	left upper leg	Yes	Yes	Yes	2016-06-17	2016-08-17	Trabectedin	Chemotherapy	2016-08-31	Yes	PD
CPCT02010370T	HMF000256	HMF000256A	0.66	male	1976	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-06-17	Liver	segment 3	No	No	Yes	2016-07-13	2016-10-26	Doxorubicin	Chemotherapy	2016-09-06	Yes	PR
CPCT02010371T	HMF001013	HMF001013A	0.8	female	1961	null	Skin		Melanoma			8923	2016-06-22	subcutaneous	right lower arm	No	No	Yes	2016-06-23	2016-08-05	Pembrolizumab	Immunotherapy	2016-08-05	Yes	PD
CPCT02010373T	HMF002238	HMF002238A	0.67	male	1957	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-06-30	pleural lesion	right flank	Yes	No	Yes	2016-07-29	2018-07-13	Pembrolizumab	Immunotherapy	2016-09-30	Yes	PR
CPCT02010378T	HMF001842	HMF001842A	0.34	male	1952	null	Small intestine		Neuroendocrine tumor			10154,169	2016-07-01	Primary	small intestine and mestenterium	No	No	null	null	null	null	null	null	null	null
CPCT02010382TII	HMF000459	HMF000459A	0.21	female	1971	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-11	adnex	right	Yes	Yes	Yes	2016-07-07	2016-11-22	Anastrozole	Hormonal therapy	2016-09-14	Yes	SD
CPCT02010383T	HMF002455	HMF002455A	0.45	female	1955	null	Small intestine		Neuroendocrine tumor			10154,169	2016-07-06	Primary	terminal ileum	No	No	Yes	2016-07-25	null	Octreotide	Hormonal therapy	2016-11-02	Yes	SD
CPCT02010386T	HMF000662	HMF000662A	0.51	male	1954	2016-10-20	Bone/Soft tissue		Liposarcoma			3382,1115	2016-07-27	Bone	prepubis	Yes	No	Yes	2016-07-27	2016-09-07	GSK3174998	Experimental therapy	2016-09-14	Yes	PD
CPCT02010389T	HMF001024	HMF001024A	0.62	male	1953	null	Prostate					10283	2016-07-20	Liver	left liver lobe	Yes	Yes	Yes	2016-07-20	2016-10-26	Enzalutamide	Hormonal therapy	2016-10-19	Yes	PD
CPCT02010393T	HMF000299	HMF000299B	0.72	male	1955	null	Skin		Melanoma			8923	2016-07-28	Subcutaneous	right upper arm	Yes	Yes	Yes	2016-07-29	2018-07-20	Pembrolizumab	Immunotherapy	2016-10-07	Yes	SD
CPCT02010393TII	HMF000299	HMF000299A	0.43	male	1955	null	Skin		Melanoma			8923	2017-05-19	skin	shoulder right OTB	Yes	Yes	Yes	2016-07-29	2018-07-20	Pembrolizumab	Immunotherapy	2016-10-07	Yes	SD
CPCT02010397T	HMF002027	HMF002027A	0.48	male	1948	2018-01-09	Colorectum					9256	2016-08-08	Peritoneum	right	Yes	No	Yes	2016-08-10	2017-10-27	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2016-10-12	Yes	SD
CPCT02010398T	HMF002185	HMF002185A	0.54	female	1953	null	Bone/Soft tissue	Skin	Angiosarcoma			4159,0001816,1115	2016-08-02	skin	right mamma	No	No	Yes	2016-08-02	2016-12-07	Paclitaxel	Chemotherapy	2016-10-19	Yes	CR
CPCT02010399T	HMF001885	HMF001885A	0.45	male	1939	null	Prostate					10283	2016-08-16	Lymph node	para-iliacal left	Yes	No	Yes	2016-09-12	2016-12-14	Enzalutamide	Hormonal therapy	null	null	null
CPCT02010401T	HMF003422	HMF003422A	0.31	female	1975	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-09	Liver	segment 2	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010403T	HMF001977	HMF001977A	0.55	male	1951	2017-01-07	Skin		Melanoma			8923	2016-09-05	Liver	segment 8	No	No	Yes	2016-09-06	2016-11-09	Ipilimumab	Immunotherapy	null	null	null
CPCT02010403TII	HMF001977	HMF001977B	0.68	male	1951	2017-01-07	Skin		Melanoma			8923	2016-11-28	Liver	segment 6	No	No	Yes	2016-09-06	2016-11-09	Ipilimumab	Immunotherapy	null	null	null
CPCT02010406TII	HMF000301	HMF000301A	1.0	male	1935	null	Bone/Soft tissue		Low-grade myofibroblastic sarcoma			1115	2017-05-24	cutaneous	right leg	No	Yes	Yes	2016-08-23	2017-05-17	Pazopanib	Targeted therapy	2016-10-24	Yes	SD
CPCT02010408T	HMF003068	HMF003068A	0.76	female	1958	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-09-01	Lymph node	left inguinal	Yes	No	Yes	2016-09-05	2016-11-18	Pazopanib	Targeted therapy	null	null	null
CPCT02010408TII	HMF003068	HMF003068B	0.78	female	1958	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-11-24	Lymph node	left inguinal	Yes	No	Yes	2016-09-05	2016-11-18	Pazopanib	Targeted therapy	null	null	null
CPCT02010409T	HMF000059	HMF000059A	0.52	male	1953	2017-01-13	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-09-06	Lung	left upper lobe	Yes	No	Yes	2016-10-24	2017-01-13	Crizotinib	Targeted therapy	null	null	null
CPCT02010414T	HMF001965	HMF001965A	0.32	male	1949	null	Colorectum					9256	2016-09-16	Liver	segment 5/6	Yes	No	Yes	2016-09-19	2016-09-19	Irinotecan	Chemotherapy	2016-10-28	Yes	PD
CPCT02010419T	HMF001916	HMF001916C	0.41	female	1972	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-09-22	Liver	right lobe	Yes	Yes	Yes	2016-10-24	2017-05-31	Olaparib/Carboplatin	Multiple therapy	2016-11-29	Yes	SD
CPCT02010422T	HMF002324	HMF002324A	0.51	female	1952	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-09-30	Liver	segment 5	Yes	Yes	Yes	2016-10-12	2017-11-21	Capecitabine	Chemotherapy	2016-12-06	Yes	PR
CPCT02010424T	HMF002210	HMF002210A	0.83	female	1974	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-10-03	Liver	segment 3	Yes	No	Yes	2016-10-13	2017-01-18	Pazopanib	Targeted therapy	2017-01-11	Yes	PD
CPCT02010427T	HMF003684	HMF003684A	0.48	female	1969	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-10-14	Liver	segment 3	Yes	No	Yes	2016-10-20	2016-12-12	Everolimus	Targeted therapy	2016-12-13	Yes	PD
CPCT02010433T	HMF001401	HMF001401A	0.23	female	1988	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-10-26	Primary	mamma right	Yes	No	Yes	2017-01-02	2018-07-27	Fulvestrant/Palbociclib	Multiple therapy	null	null	null
CPCT02010434T	HMF001390	HMF001390A	0.84	female	1956	2016-12-04	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-10-26	Ascites	abdomen	Yes	Yes	Yes	2016-10-30	2016-11-14	Capecitabine	Chemotherapy	null	null	null
CPCT02010436T	HMF000880	HMF000880A	0.63	male	1974	null	Skin		Melanoma			8923	2016-10-31	Lymph node	left iliacal	Yes	Yes	Yes	2016-11-03	2018-11-05	Ipilimumab/Nivolumab	Immunotherapy	2017-01-19	Yes	PR
CPCT02010438T	HMF003561	HMF003561A	0.79	male	1945	null	Small intestine		Neuroendocrine tumor			10154,169	2016-11-08	Primary	colon	No	No	Yes	2016-11-08	2022-01-18	Octreotide	Hormonal therapy	2017-03-16	Yes	SD
CPCT02010440T	HMF002774	HMF002774A	0.67	female	1961	null	Skin		Melanoma			8923	2016-11-04	cutaneous	mamma right	Yes	No	Yes	2016-11-04	2017-01-19	Ipilimumab	Immunotherapy	2017-01-14	Yes	SD
CPCT02010447T	HMF002735	HMF002735A	0.47	female	1969	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-15	Subcutaneous	left mamma	Yes	Yes	Yes	2016-11-25	2017-04-03	Everolimus/Exemestane	Multiple therapy	2017-03-01	Yes	SD
CPCT02010450T	HMF000854	HMF000854A	0.23	male	1944	2017-07-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-11-25	Lymph node	supraclavicular	Yes	Yes	Yes	2017-01-10	2017-06-28	Pemetrexed/Cisplatin/Carboplatin	Chemotherapy	2017-02-21	Yes	SD
CPCT02010450TII	HMF000854	HMF000854B	0.38	male	1944	2017-07-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-07-14	Lymph node	neck left	Yes	Yes	Yes	2017-01-10	2017-06-28	Pemetrexed/Cisplatin/Carboplatin	Chemotherapy	2017-02-21	Yes	SD
CPCT02010451T	HMF003769	HMF003769A	0.69	male	1944	2017-01-15	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-11-29	subcutaneous	paravertebral	Yes	Yes	Yes	2016-12-20	2017-01-03	Nivolumab	Immunotherapy	2017-01-12	Yes	PD
CPCT02010452T	HMF003554	HMF003554A	0.42	female	1947	2017-03-23	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-12-02	Lung	left lower lobe	Yes	No	Yes	2017-02-08	2017-02-08	BMS 986148	Experimental therapy	2017-02-23	Yes	PD
CPCT02010453T	HMF000066	HMF000066A	0.99	male	1965	null	Lung		Carcinoma	Small cell carcinoma		5409	2016-12-02	Lymph node	supraclavicular	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010454T	HMF003482	HMF003482A	0.45	male	1955	null	Small intestine		Neuroendocrine tumor			10154,169	2016-12-02	Primary	Ileum	No	No	Yes	2016-12-03	null	Lanreotide	Hormonal therapy	2017-03-06	Yes	PD
CPCT02010455T	HMF003138	HMF003138A	0.23	male	1945	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-11-30	Lung	left upper lobe	Yes	No	Yes	2016-12-09	2017-01-05	Nivolumab	Immunotherapy	2017-01-07	Yes	PD
CPCT02010458T	HMF002394	HMF002394A	0.89	male	1957	2017-01-31	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-12-14	Kidney	right	Yes	No	Yes	2016-12-28	2017-01-31	Capecitabine/Temozolomide	Chemotherapy	null	null	null
CPCT02010461T	HMF000987	HMF000987A	0.68	female	1963	null	Breast		Carcinoma	Triple negative		0060081	2016-12-23	Liver	segment 5	Yes	Yes	Yes	2017-01-03	2017-03-30	Capecitabine	Chemotherapy	2017-02-11	Yes	SD
CPCT02010466T	HMF003041	HMF003041A	0.89	female	1950	2018-04-13	Small intestine		Neuroendocrine tumor			10154,169	2017-01-03	Ovarium	both sides	Yes	No	Yes	2017-02-16	2017-03-02	Capecitabine	Chemotherapy	2017-03-09	Yes	SD
CPCT02010468T	HMF003586	HMF003586A	0.47	female	1958	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-05	skin	left mamma	No	Yes	Yes	2017-01-11	2017-03-29	Doxorubicin/Cyclophosphamide	Chemotherapy	2017-02-20	Yes	SD
CPCT02010469T	HMF003112	HMF003112A	0.82	male	1962	null	Skin		Melanoma			8923	2017-01-05	skin	left upper leg	No	No	Yes	2017-01-09	2017-06-06	Pembrolizumab/Epacadostat or placebo	Multiple therapy	2017-03-28	Yes	SD
CPCT02010471T	HMF000957	HMF000957A	0.54	male	1942	null	Colorectum					9256	2017-01-17	Liver	segment 2	Yes	No	Yes	2017-01-17	2017-09-05	Panitumumab	Targeted therapy	2017-03-18	Yes	SD
CPCT02010473T	HMF002994	HMF002994A	0.36	male	1952	null	Colorectum					9256	2017-01-16	Liver	segment 8	Yes	No	Yes	2017-01-17	2017-06-20	Bevacizumab/Irinotecan	Multiple therapy	2017-03-14	Yes	SD
CPCT02010474T	HMF002776	HMF002776A	0.48	female	1953	null	Colorectum					9256	2017-01-10	Lung	right lower lobe	Yes	Yes	Yes	2017-01-11	2017-03-24	Irinotecan	Chemotherapy	2017-04-07	Yes	PD
CPCT02010477T	HMF002816	HMF002816A	0.27	female	1944	2018-07-16	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-01-12	Liver	segment 8	Yes	No	Yes	2017-02-01	2017-07-01	Trastuzumab/Paclitaxel	Multiple therapy	2017-03-31	Yes	SD
CPCT02010478T	HMF001288	HMF001288B	0.62	male	1959	2017-07-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-01-12	Lymph node	left inguinal	Yes	Yes	Yes	2017-02-16	2017-05-11	Carboplatin/Pemetrexed	Chemotherapy	2017-04-12	Yes	SD
CPCT02010478TII	HMF001288	HMF001288A	0.42	male	1959	2017-07-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-06-08	Lymph node	left upperleg	Yes	Yes	Yes	2017-02-16	2017-05-11	Carboplatin/Pemetrexed	Chemotherapy	2017-04-12	Yes	SD
CPCT02010481T	HMF001566	HMF001566A	0.25	female	1944	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-02-14	Lung	right lower lobe	Yes	No	Yes	2017-03-17	2017-12-12	Pemetrexed/Carboplatin	Chemotherapy	2017-04-20	Yes	PR
CPCT02010483T	HMF002800	HMF002800A	0.52	female	1947	2017-02-18	Colorectum					9256	2017-01-18	Peritoneum	ventral	Yes	No	Yes	2017-01-18	2017-02-18	Panitumumab	Targeted therapy	null	null	null
CPCT02010484T	HMF003080	HMF003080A	0.95	female	1959	2017-07-16	Lung		Carcinoma	Small cell carcinoma		5409	2017-01-19	pleural	paracardiaal	Yes	Yes	Yes	2017-01-30	2017-05-19	Topotecan	Chemotherapy	2017-04-11	Yes	PR
CPCT02010485T	HMF002273	HMF002273A	0.34	female	1982	null	Colorectum					9256	2017-01-19	rectum	NA	Yes	Yes	Yes	2017-01-20	2017-02-07	Capecitabine/Irinotecan	Chemotherapy	2017-03-23	Yes	SD
CPCT02010488T	HMF000882	HMF000882A	0.43	male	1941	null	Colorectum					9256	2017-01-30	Liver	segment 5/6	No	No	Yes	2017-02-09	2017-05-17	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-04-06	Yes	SD
CPCT02010490T	HMF001938	HMF001938A	0.74	male	1954	null	Prostate					10283	2017-02-13	Bone	rib 5	Yes	Yes	Yes	2017-02-03	2018-02-14	Enzalutamide	Hormonal therapy	null	null	null
CPCT02010492T	HMF002910	HMF002910A	0.7	male	1962	null	Lung		Neuroendocrine tumor			1324,169	2017-02-01	Liver	segment 2/3	Yes	No	Yes	2017-03-02	2017-05-29	Lanreotide	Hormonal therapy	2017-05-18	Yes	PD
CPCT02010494T	HMF002742	HMF002742A	0.82	male	1948	2017-06-10	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-01-26	Peritoneum	NA	Yes	No	Yes	2017-01-26	2017-03-21	Sunitinib	Targeted therapy	2017-03-14	Yes	PD
CPCT02010497T	HMF003298	HMF003298A	0.84	female	1968	null	Colorectum					9256	2017-02-01	Peritoneum	lower abdomen	Yes	Yes	Yes	2017-03-01	2017-06-01	Fluorouracil/Irinotecan/Panitumumab	Multiple therapy	2017-03-29	Yes	SD
CPCT02010498T	HMF003132	HMF003132B	0.92	male	1950	null	Lung		Carcinoma	Small cell carcinoma		5409	2017-02-02	subcutaneous	right flank	Yes	Yes	Yes	2017-02-01	2017-05-01	Etoposide/Cisplatin/Carboplatin	Chemotherapy	null	null	null
CPCT02010500T	HMF003897	HMF003897A	0.38	female	1964	2019-05-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-19	Lymph node	neck left	Yes	No	Yes	2019-04-05	2019-04-05	Paclitaxel/Bevacizumab	Multiple therapy	null	null	null
CPCT02010501T	HMF001114	HMF001114A	0.53	male	1949	null	Skin		Melanoma			8923	2017-02-01	subcatenous	chin	No	No	Yes	2017-02-01	2017-04-28	Pembrolizumab	Immunotherapy	2017-02-18	No	PD
CPCT02010503T	HMF001272	HMF001272A	0.32	female	1953	2018-03-16	Skin		Melanoma			8923	2017-02-10	skin	head	No	No	Yes	2017-02-10	2017-03-03	Ipilimumab/Nivolumab	Immunotherapy	2017-05-10	Yes	SD
CPCT02010503TII	HMF001272	HMF001272B	0.34	female	1953	2018-03-16	Skin		Melanoma			8923	2017-08-15	skin	head	No	No	Yes	2017-02-10	2017-03-03	Ipilimumab/Nivolumab	Immunotherapy	2017-05-10	Yes	SD
CPCT02010504T	HMF001774	HMF001774A	0.58	female	1969	2018-08-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-10	Liver	segment 3	Yes	No	Yes	2017-02-14	2017-07-04	Paclitaxel	Chemotherapy	2017-03-29	Yes	SD
CPCT02010505T	HMF000750	HMF000750A	0.64	female	1984	null	Skin		Melanoma			8923	2017-06-13	lesion subcutaneous	right groin	Yes	No	Yes	2017-02-10	2017-05-26	Ipilimumab/Nivolumab	Immunotherapy	2017-05-24	Yes	PD
CPCT02010506T	HMF001060	HMF001060A	0.32	female	1969	null	Colorectum					9256	2017-02-13	Liver	segment 6	Yes	No	Yes	2017-03-01	2017-08-29	Bevacizumab/Irinotecan	Multiple therapy	2017-04-28	Yes	SD
CPCT02010507T	HMF002855	HMF002855A	0.77	female	1946	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-08-23	Liver	segment 4	Yes	Yes	Yes	2017-09-22	2017-10-30	Pemetrexed/Carboplatin/Gemcitabine	Chemotherapy	2017-10-30	Yes	PD
CPCT02010508T	HMF003726	HMF003726A	0.55	female	1974	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-15	Primary	right mamma	No	No	Yes	2017-02-21	2018-04-09	Goserelin/Letrozole	Multiple therapy	2017-05-01	Yes	SD
CPCT02010509T	HMF000273	HMF000273A	0.74	female	1963	2017-11-27	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-22	Liver	segment 7	Yes	Yes	Yes	2017-03-02	2017-07-05	Capecitabine	Chemotherapy	2017-05-12	Yes	SD
CPCT02010512T	HMF000272	HMF000272A	0.65	female	1975	2017-10-08	Colorectum					9256	2017-02-20	Liver	right lobe	Yes	No	Yes	2017-02-21	2017-05-30	Panitumumab	Targeted therapy	2017-03-08	Yes	SD
CPCT02010514T	HMF001438	HMF001438A	0.21	male	1962	null	Colorectum					9256	2017-02-20	Subcutaneous	right lower abdomen	Yes	No	Yes	2017-02-21	2017-08-11	Capecitabine/Oxaliplatin	Chemotherapy	2017-04-18	Yes	SD
CPCT02010517T	HMF003399	HMF003399A	0.87	female	1965	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-27	Liver	segment 5	No	No	Yes	2017-03-08	2017-04-30	Fluorouracil/Epirubicin/Cyclophosphamide	Chemotherapy	2017-05-08	Yes	PD
CPCT02010518T	HMF000012	HMF000012A	0.46	female	1946	null	Bone/Soft tissue		Low-grade myofibroblastic sarcoma			1115	2017-03-01	skin	dorsum right foot (medial, ventral and lateral)	Yes	No	null	null	null	null	null	null	null	null
CPCT02010520T	HMF000922	HMF000922A	0.27	female	1956	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-09	skin	cutaneous metastasis under right mamma	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010521T	HMF002560	HMF002560A	0.92	female	1963	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-08	Liver	segment 6	Yes	Yes	Yes	2017-03-20	2018-06-28	Capecitabine	Chemotherapy	2017-05-31	Yes	SD
CPCT02010523T	HMF002270	HMF002270A	0.61	female	1956	2018-02-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-13	Liver	segment 3	Yes	Yes	Yes	2017-03-20	2017-06-20	Palbociclib	Targeted therapy	2017-06-13	Yes	PD
CPCT02010524T	HMF001784	HMF001784A	0.23	female	1958	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-03-13	Lymph node	right neck	Yes	Yes	Yes	2017-04-25	2019-04-02	Nivolumab	Immunotherapy	2017-05-22	Yes	PR
CPCT02010526T	HMF003714	HMF003714A	0.22	male	1993	2017-10-13	Skin		Melanoma			8923	2017-01-19	Lymph node	left neck	Yes	No	Yes	2017-03-21	2017-05-23	Ipilimumab/Nivolumab	Immunotherapy	2017-06-13	Yes	PD
CPCT02010528T	HMF000769	HMF000769A	0.7	female	1984	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-03-09	Liver	right lobe	No	No	Yes	2017-03-09	2017-06-22	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	null	null	null
CPCT02010530T	HMF002781	HMF002781A	0.44	male	1944	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-03-10	Bone	thorax wall	Yes	Yes	Yes	2017-03-28	2017-05-09	Nivolumab	Immunotherapy	2017-05-10	Yes	PD
CPCT02010531T	HMF000161	HMF000161A	0.67	female	1946	2017-09-11	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-03-23	Liver	right under lobe liver	Yes	No	null	null	null	null	null	null	null	null
CPCT02010532T	HMF000539	HMF000539A	0.72	female	1959	null	Skin		Melanoma			8923	2017-03-15	Lymph node	right axilla metastasis	No	No	Yes	2017-03-20	2018-06-13	Nivolumab/Ipilimumab	Immunotherapy	2017-06-02	Yes	PR
CPCT02010533T	HMF002369	HMF002369A	0.29	female	1963	null	Colorectum					9256	2017-03-15	skin	left upper lef	Yes	Yes	Yes	2017-03-17	2017-07-20	Capecitabine/Irinotecan	Chemotherapy	2017-05-17	Yes	PD
CPCT02010535T	HMF000710	HMF000710A	0.6	female	1950	2018-02-09	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-16	Liver	segment 3	Yes	Yes	Yes	2017-03-28	2017-12-01	Letrozole	Hormonal therapy	2017-12-14	Yes	SD
CPCT02010537T	HMF002094	HMF002094A	0.46	male	1948	null	Prostate					10283	2017-03-17	Lymph node	retroperitoneal left	Yes	No	Yes	2017-03-17	2017-08-31	Docetaxel	Chemotherapy	2017-06-20	Yes	PR
CPCT02010538T	HMF002928	HMF002928A	0.24	male	1950	null	Unknown	CUP	Neuroendocrine tumor			169	2017-03-24	Liver	segment 6	No	No	Yes	2017-03-30	2017-06-15	Everolimus	Targeted therapy	2017-05-30	Yes	PD
CPCT02010541T	HMF002302	HMF002302A	0.85	female	1960	null	Colorectum					9256	2017-03-27	Bone	right side ilium	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010545T	HMF001838	HMF001838A	0.38	male	1943	null	Colorectum					9256	2017-03-30	Liver	segment 4	Yes	No	Yes	2017-03-30	2017-07-26	Fluorouracil/Irinotecan/Leucovorin	Multiple therapy	2017-07-25	Yes	PD
CPCT02010547T	HMF003702	HMF003702A	0.86	female	1959	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-04-04	Subcutaneous	right paramedian abdominal wall	No	No	Yes	2017-04-10	2017-05-31	Imatinib	Targeted therapy	2017-05-27	Yes	PD
CPCT02010548T	HMF000647	HMF000647A	0.95	male	1956	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-04-06	Lung	right	Yes	No	null	null	null	null	null	null	null	null
CPCT02010550T	HMF002503	HMF002503A	0.3	male	1969	null	Skin		Melanoma			8923	2017-02-15	subcutaneous mass	left axilla	No	No	Yes	2017-02-17	2019-01-18	Ipilimumab/Nivolumab	Immunotherapy	2017-05-03	Yes	SD
CPCT02010555T	HMF001585	HMF001585A	0.65	female	1959	2017-05-27	Breast		Carcinoma	ER-positive/HER2-unknown		0060075	2017-04-12	skin	scalp	Yes	Yes	Yes	2017-04-25	2017-05-02	Vinorelbine	Chemotherapy	null	null	null
CPCT02010559T	HMF003017	HMF003017A	0.59	male	1959	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-04-25	Peritoneum	right lower abdomen	Yes	No	Yes	2017-04-25	null	Imatinib	Targeted therapy	2017-07-27	Yes	SD
CPCT02010560T	HMF001021	HMF001021A	0.87	female	1966	null	Small intestine		Neuroendocrine tumor			10154,169	2017-04-24	Liver	segment 5	No	No	Yes	2017-04-25	null	Octreotide/Lanreotide	Hormonal therapy	2017-05-12	Yes	SD
CPCT02010565T	HMF002879	HMF002879A	0.93	female	1956	null	Skin		Melanoma			8923	2017-05-03	skin	subcutaneous axilla right	Yes	No	Yes	2017-06-14	2017-12-20	Dabrafenib/Trametinib	Targeted therapy	null	null	null
CPCT02010567T	HMF003648	HMF003648A	0.28	male	1944	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-05-16	Lung	left lower lobe	Yes	No	Yes	2017-06-27	2018-05-28	Panitumumab	Targeted therapy	null	null	null
CPCT02010567TII	HMF003648	HMF003648B	0.6	male	1944	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-05	Lung	left lower lobe	Yes	No	Yes	2017-06-27	2018-05-28	Panitumumab	Targeted therapy	null	null	null
CPCT02010569T	HMF000732	HMF000732A	0.76	female	1967	null	Esophagus					5041	2017-05-22	Liver	segment 7	No	No	Yes	2017-05-23	2018-12-01	Capecitabine	Chemotherapy	2017-07-17	Yes	PR
CPCT02010571T	HMF003052	HMF003052A	0.7	male	1942	2019-10-15	Small intestine		Neuroendocrine tumor			10154,169	2017-05-17	Lymph node	left axilla	No	No	Yes	2017-05-29	2019-03-30	Lanreotide	Hormonal therapy	2017-08-10	Yes	SD
CPCT02010572T	HMF001764	HMF001764A	0.41	female	1946	null	Breast		Carcinoma	Triple negative		0060081	2017-05-24	Bone	os ilium left	Yes	Yes	Yes	2017-05-31	2020-09-29	Capecitabine	Chemotherapy	null	null	null
CPCT02010574T	HMF001282	HMF001282A	0.52	male	1965	null	Small intestine		Neuroendocrine tumor			10154,169	2017-05-26	Liver	segment 2	No	No	Yes	2017-05-31	2017-08-24	Lanreotide	Hormonal therapy	2017-08-15	Yes	PD
CPCT02010576T	HMF002627	HMF002627A	0.27	female	1960	null	Colorectum					9256	2017-05-29	peritoneal	omentum	Yes	No	null	null	null	null	null	null	null	null
CPCT02010577T	HMF001815	HMF001815A	0.86	male	1953	null	Pancreas		Neuroendocrine tumor			1793,169	2017-05-24	Liver	segment 4	Yes	No	Yes	2017-05-26	null	Everolimus	Targeted therapy	2017-08-03	Yes	SD
CPCT02010579T	HMF001704	HMF001704A	0.61	male	1945	2017-09-09	Colorectum					9256	2017-06-02	Liver	metastasis left lobe liver	Yes	No	null	null	null	null	null	null	null	null
CPCT02010585T	HMF000609	HMF000609A	0.91	male	1938	2017-10-08	Prostate					10283	2017-06-07	Lymph node	para aortal	Yes	Yes	Yes	2017-07-06	2017-10-08	Enzalutamide	Hormonal therapy	2017-09-11	Yes	PD
CPCT02010589T	HMF003111	HMF003111A	0.39	male	1954	2021-07-20	Pancreas		Neuroendocrine tumor			1793,169	2017-06-14	Liver	segment 4	No	No	Yes	2017-06-15	2019-10-03	Lanreotide	Hormonal therapy	2017-08-10	Yes	SD
CPCT02010590T	HMF000020	HMF000020B	0.72	male	1954	null	Colorectum					9256	2017-06-14	Liver	segment 6	Yes	No	Yes	2017-10-05	2017-11-23	Pembrolizumab	Immunotherapy	2017-12-05	Yes	PD
CPCT02010591T	HMF001007	HMF001007A	0.51	male	1971	null	Stomach					10534	2017-06-15	Liver	metastasis	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010593T	HMF000761	HMF000761A	0.22	female	1971	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-15	Liver	segment 4	Yes	Yes	Yes	2017-06-22	2018-11-23	Capecitabine	Chemotherapy	2017-08-21	Yes	SD
CPCT02010596T	HMF003107	HMF003107A	0.86	male	1958	null	Small intestine		Neuroendocrine tumor			10154,169	2017-08-08	Primary	ileum coecum	No	No	Yes	2017-08-28	null	Lanreotide	Hormonal therapy	2017-11-29	Yes	SD
CPCT02010600T	HMF000831	HMF000831A	0.88	female	1948	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-07-06	Subcutaneous	left upper abdominal wall	Yes	No	Yes	2017-07-25	null	Imatinib	Targeted therapy	2017-10-17	Yes	PR
CPCT02010603T	HMF003462	HMF003462A	0.88	female	1962	2017-08-17	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-07-03	subcutaneous	left dorsal back	Yes	Yes	Yes	2017-07-05	2017-07-21	Nivolumab	Immunotherapy	2017-07-28	Yes	PD
CPCT02010604T	HMF001287	HMF001287A	0.55	male	1959	null	Colorectum					9256	2017-07-04	Liver	segment 7	Yes	No	Yes	2017-07-05	2017-12-19	Fluorouracil/Irinotecan	Chemotherapy	null	null	null
CPCT02010605T	HMF001658	HMF001658A	0.44	female	1961	2017-12-24	Colorectum					9256	2017-07-10	Primary	colon	No	No	null	null	null	null	null	null	null	null
CPCT02010606T	HMF002136	HMF002136A	0.47	female	1949	2017-08-02	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-07-07	Liver	segment 5/6	Yes	No	Yes	2017-07-21	2017-07-21	Pemetrexed	Chemotherapy	null	null	null
CPCT02010607T	HMF003234	HMF003234A	0.51	male	1960	null	Colorectum					9256	2017-07-11	Liver	segment 2	Yes	No	Yes	2017-07-21	2017-08-30	Panitumumab/Irinotecan	Multiple therapy	2017-09-04	Yes	PD
CPCT02010608T	HMF000419	HMF000419A	0.85	female	1959	2022-11-24	Small intestine		Neuroendocrine tumor			10154,169	2017-07-13	Lymph node	subclavular left	No	No	Yes	2017-07-14	2022-11-23	Lanreotide	Hormonal therapy	2017-08-10	Yes	SD
CPCT02010611T	HMF003078	HMF003078A	0.46	female	1964	null	Small intestine		Neuroendocrine tumor			10154,169	2017-07-14	Primary	small intestine	No	No	Yes	2017-09-07	2017-12-14	Lanreotide	Hormonal therapy	null	null	null
CPCT02010612T	HMF002893	HMF002893A	0.26	female	1947	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-07-14	Lung	endobronchial	No	No	null	null	null	null	null	null	null	null
CPCT02010614T	HMF001303	HMF001303A	0.24	male	1965	null	Colorectum					9256	2017-07-28	Lymph node	left supraclavicular	No	No	Yes	2017-08-30	2017-12-05	Bevacizumab/Leucovorin/Fluorouracil/Oxaliplatin	Multiple therapy	2017-10-16	Yes	SD
CPCT02010618T	HMF000666	HMF000666B	0.39	female	1958	null	Lung		Carcinoma	Small cell carcinoma		5409	2017-08-04	Lung	right upper lobe	Yes	Yes	Yes	2017-08-11	2017-11-09	Cyclophosphamide/Doxorubicin/Vincristine	Chemotherapy	2017-09-11	Yes	SD
CPCT02010621T	HMF000094	HMF000094A	0.2	male	1943	2021-03-31	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-08-17	subcutaneous	right paramedian back	No	No	Yes	2017-08-18	null	Pembrolizumab	Immunotherapy	2017-09-16	Yes	SD
CPCT02010622T	HMF000610	HMF000610A	0.66	female	1962	null	Skin		Melanoma			8923	2017-08-15	subcutaneous	ventral median left abdominal wall	No	No	Yes	2017-08-15	2018-08-27	Ipilimumab/Nivolumab	Immunotherapy	2017-11-01	Yes	PR
CPCT02010624T	HMF000167	HMF000167A	0.54	male	1963	null	Colorectum					9256	2017-08-18	Liver	segment 3/4	Yes	Yes	Yes	2017-08-24	2017-10-14	Capecitabine/Irinotecan	Chemotherapy	2017-10-27	Yes	PD
CPCT02010625T	HMF002570	HMF002570A	0.89	female	1952	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-10-23	Primary	stomach	Yes	No	null	null	null	null	null	null	null	null
CPCT02010628T	HMF000577	HMF000577A	0.58	female	1955	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-24	Liver	segment 3	Yes	No	null	null	null	null	null	null	null	null
CPCT02010629T	HMF003638	HMF003638A	0.77	male	1960	2017-12-08	Prostate					10283	2017-09-01	Lymph node	supraclavicular left	Yes	Yes	Yes	2017-09-01	2017-11-13	Abiraterone	Hormonal therapy	2017-11-14	Yes	PD
CPCT02010632T	HMF001376	HMF001376A	0.44	male	1952	null	Mesothelium		Malignant mesothelioma			1790,0050686	2017-09-01	omentum	omentum	Yes	No	Yes	2017-09-21	2017-12-07	Pembrolizumab	Immunotherapy	2017-11-16	Yes	SD
CPCT02010633T	HMF001736	HMF001736A	0.25	female	1959	2018-03-30	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-28	subcutaneous	m. pectoralis	Yes	Yes	Yes	2017-07-05	2018-02-26	Fulvestrant/Vinorelbine	Multiple therapy	null	null	null
CPCT02010635T	HMF002109	HMF002109B	0.81	male	1954	null	Thymus		Carcinoma	Thymoma and Thymic carcinoma		3275,3284,305	2017-09-06	Subcutaneous	costa 6 left ventral Thorax wall	Yes	Yes	Yes	2017-11-09	2018-05-01	Sunitinib	Targeted therapy	2017-12-29	Yes	PR
CPCT02010639T	HMF000411	HMF000411B	0.83	female	1944	2018-01-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-05	Liver	Segment 6	Yes	Yes	Yes	2017-08-29	2017-11-28	Palbociclib/Fulvestrant	Multiple therapy	2017-11-23	Yes	PD
CPCT02010641TII	HMF001822	HMF001822B	0.44	male	1960	null	Skin		Melanoma			8923	2017-11-28	Subcutaneous	Left OTB Thorax wall	No	No	Yes	2017-09-06	2018-03-14	Pembrolizumab	Immunotherapy	2017-11-22	Yes	SD
CPCT02010643T	HMF000331	HMF000331A	0.51	female	1968	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-09-06	Liver	Segment 2/3	Yes	Yes	Yes	2017-09-06	null	Docetaxel/Pertuzumab/Trastuzumab	Multiple therapy	2017-09-29	Yes	PR
CPCT02010645T	HMF002991	HMF002991A	0.78	female	1962	null	Unknown	CUP	Neuroendocrine tumor			169	2017-09-08	Liver	segment 2/3	No	Yes	Yes	2017-09-18	2017-12-18	Capecitabine/Temozolomide	Chemotherapy	2017-12-11	Yes	SD
CPCT02010646T	HMF001462	HMF001462A	0.3	female	1965	2017-11-17	Ovary					2394	2017-09-15	Liver	Segment 6	Yes	Yes	Yes	2017-09-19	2017-10-13	Doxorubicin	Chemotherapy	2017-10-13	Yes	PD
CPCT02010647T	HMF003386	HMF003386A	0.57	female	1950	2018-11-10	Unknown	CUP	Carcinoma			305	2017-09-27	Liver	right lobe	No	No	Yes	2017-10-13	2018-02-02	Cisplatin/Gemcitabine	Chemotherapy	2017-12-07	Yes	SD
CPCT02010649T	HMF001749	HMF001749A	0.88	female	1943	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-08-29	Primary	Gastrointestinal	No	No	Yes	2017-09-11	2018-04-09	Imatinib	Targeted therapy	2017-12-05	Yes	PR
CPCT02010653T	HMF000322	HMF000322A	0.31	male	1951	null	Small intestine		Neuroendocrine tumor			10154,169	2017-10-09	Liver	segment 3	No	No	Yes	2017-10-09	2018-11-14	Lanreotide	Hormonal therapy	2018-01-09	Yes	PD
CPCT02010654T	HMF000445	HMF000445A	0.62	male	1959	null	Prostate					10283	2017-09-13	Lymph node	para aortal	No	Yes	Yes	2017-09-13	2018-01-17	Enzalutamide	Hormonal therapy	2017-12-08	Yes	PD
CPCT02010660T	HMF003411	HMF003411A	0.68	male	1950	2017-12-28	Lung		Carcinoma	Small cell carcinoma		5409	2017-10-04	Lymph node	level IV right neck	Yes	Yes	Yes	2017-12-06	2017-12-06	Cyclophosphamide/Doxorubicin/Vincristine	Chemotherapy	null	null	null
CPCT02010661T	HMF003113	HMF003113A	0.64	female	1959	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-26	Liver	left liver lobe	Yes	Yes	Yes	2017-09-27	2017-10-19	Vinorelbine	Chemotherapy	2017-10-19	Yes	PD
CPCT02010662T	HMF001562	HMF001562A	0.32	male	1966	2017-12-19	Esophagus					5041	2017-10-19	Liver	segment 4	Yes	No	Yes	2017-10-20	2017-11-03	Trastuzumab/Capecitabine	Multiple therapy	2017-11-20	Yes	PD
CPCT02010663T	HMF000531	HMF000531A	0.21	male	1945	2018-03-16	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-10-02	Lymph node	right groin	Yes	Yes	Yes	2017-10-03	2017-12-27	Pembrolizumab	Immunotherapy	2017-12-07	Yes	SD
CPCT02010665T	HMF002889	HMF002889A	0.33	male	1963	2018-02-20	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2017-10-04	Liver	central lesion	Yes	Yes	Yes	2017-10-05	2017-12-20	Pembrolizumab	Immunotherapy	2017-12-15	Yes	PD
CPCT02010666T	HMF003543	HMF003543A	0.47	female	1951	null	Colorectum					9256	2017-10-04	Lung	left lower lobe	Yes	Yes	Yes	2017-10-20	2018-04-30	Capecitabine/Bevacizumab	Multiple therapy	2018-03-07	Yes	SD
CPCT02010667T	HMF003085	HMF003085A	0.2	male	1973	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-10-05	subcutaneous	left thorax wall	No	Yes	Yes	2017-10-17	2018-06-04	Pembrolizumab	Immunotherapy	2017-11-27	Yes	PR
CPCT02010670T	HMF001742	HMF001742A	0.32	male	1947	null	Lung		Carcinoma	Small cell carcinoma		5409	2017-10-17	Lung	right lower lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02010676T	HMF000909	HMF000909A	0.74	male	1959	null	Lung		Carcinoma	Small cell carcinoma		5409	2017-10-24	Primary	lung right	Yes	Yes	Yes	2017-10-25	2018-01-05	Cyclophosphamide/Doxorubicin/Etoposide	Chemotherapy	2018-01-23	Yes	PR
CPCT02010678T	HMF001031	HMF001031A	0.75	female	1953	2020-04-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-30	Liver	segment 4A	Yes	No	Yes	2017-11-03	2018-07-25	Letrozole/Palbociclib	Multiple therapy	2018-01-12	Yes	PD
CPCT02010679T	HMF002838	HMF002838A	0.33	female	1975	null	Ovary					2394	2017-10-31	Peritoneum	ventral bladder	Yes	No	Yes	2017-11-07	2018-09-20	Tamoxifen	Hormonal therapy	2018-05-15	Yes	PD
CPCT02010680T	HMF001122	HMF001122A	0.72	female	1960	null	Bone/Soft tissue		Liposarcoma			3382,1115	2017-10-31	Bone	left supraclavicular	No	Yes	Yes	2017-11-02	2018-10-17	Doxorubicin/Olaratumab	Multiple therapy	2018-01-08	Yes	SD
CPCT02010682T	HMF000632	HMF000632A	0.82	female	1952	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-02	Liver	segment 5	Yes	Yes	Yes	2017-11-09	2018-07-11	Capecitabine	Chemotherapy	2018-01-17	Yes	PR
CPCT02010687T	HMF002080	HMF002080A	0.68	female	1966	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-14	Liver	Segment 4	Yes	Yes	Yes	2017-11-27	2018-03-20	Paclitaxel	Chemotherapy	2018-01-15	Yes	SD
CPCT02010690T	HMF000600	HMF000600A	0.48	male	1946	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-09	Liver	Segment 2	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010691T	HMF001244	HMF001244A	0.27	female	1966	2020-01-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-13	Liver	Segment 5/6	Yes	Yes	Yes	2017-11-23	2019-02-25	Fulvestrant/Palbociclib	Multiple therapy	null	null	null
CPCT02010692T	HMF001410	HMF001410A	0.69	male	1949	null	Prostate					10283	2017-11-16	Liver	segment 7	Yes	Yes	Yes	2017-11-16	2018-06-11	Enzalutamide	Hormonal therapy	2018-02-15	Yes	PD
CPCT02010692TII	HMF001410	HMF001410B	0.93	male	1949	null	Prostate					10283	2018-05-29	Liver	right	Yes	Yes	Yes	2017-11-16	2018-06-11	Enzalutamide	Hormonal therapy	2018-02-15	Yes	PD
CPCT02010694T	HMF001540	HMF001540A	0.73	female	1950	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-15	Primary	mamma right	Yes	No	Yes	2017-12-01	2020-09-23	Palbociclib/Fulvestrant	Multiple therapy	2018-05-25	Yes	SD
CPCT02010695T	HMF000079	HMF000079A	0.57	male	1953	null	Prostate					10283	2017-11-22	Bone	os ilium	Yes	Yes	Yes	2017-12-07	2018-06-07	Docetaxel	Chemotherapy	2018-01-29	Yes	SD
CPCT02010697T	HMF002365	HMF002365A	0.97	female	1968	null	Small intestine		Neuroendocrine tumor			10154,169	2017-11-17	Liver	segment 5	No	No	null	null	null	null	null	null	null	null
CPCT02010698T	HMF000972	HMF000972A	0.66	male	1973	null	Mesothelium		Malignant mesothelioma			1790,0050686	2017-11-20	subcutaneous	paravertebral	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010699T	HMF000835	HMF000835B	0.98	female	1946	null	Lung		Carcinoma	Small cell carcinoma		5409	2017-11-20	Lymph node	axilla leteral intramammair right	No	No	Yes	2017-12-11	2018-03-21	Carboplatin/Etoposide	Chemotherapy	2018-01-24	Yes	PR
CPCT02010704T	HMF001306	HMF001306A	0.63	female	1948	null	Small intestine		Neuroendocrine tumor			10154,169	2017-12-04	Liver	segment 3	Yes	Yes	Yes	2017-12-05	2018-12-25	Capecitabine/Temozolomide	Chemotherapy	2018-03-05	Yes	PD
CPCT02010705T	HMF003623	HMF003623A	0.9	male	1963	null	Small intestine		Neuroendocrine tumor			10154,169	2017-11-29	Liver	segment 5	Yes	No	null	null	null	null	null	null	null	null
CPCT02010706T	HMF001393	HMF001393A	0.27	female	1957	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-12-05	Lung	apex of right lower lobe	Yes	No	Yes	2018-03-01	2018-09-27	Gemcitabine	Chemotherapy	2018-10-05	Yes	PD
CPCT02010708T	HMF001851	HMF001851A	0.41	female	1974	null	Breast		Carcinoma	Triple negative		0060081	2017-11-30	Liver	Segment 2	Yes	Yes	Yes	2017-12-10	2018-02-23	Capecitabine	Chemotherapy	2018-02-14	Yes	PD
CPCT02010711T	HMF000983	HMF000983A	0.88	male	1943	null	Prostate					10283	2017-12-01	Liver	Segment 8	Yes	No	Yes	2017-12-01	2018-03-07	Enzalutamide	Hormonal therapy	2018-02-22	Yes	PD
CPCT02010712T	HMF000513	HMF000513A	0.48	male	1964	null	Urothelial tract	Urachus	Carcinoma	Urothelial carcinoma		7244	2018-01-08	Lung	lingula	Yes	Yes	Yes	2018-01-16	2018-07-24	Irinotecan	Chemotherapy	2018-03-21	Yes	SD
CPCT02010715T	HMF003485	HMF003485A	0.97	male	1969	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-12-05	Peritoneum	under liver	Yes	No	Yes	2017-12-05	null	Imatinib/Regorafenib	Targeted therapy	2018-01-30	Yes	SD
CPCT02010716T	HMF001100	HMF001100A	0.7	male	1957	null	Skin		Melanoma			8923	2017-12-07	subcutaneous	lower back	No	No	Yes	2017-12-08	2019-02-18	Pembrolizumab	Immunotherapy	2018-02-28	Yes	PR
CPCT02010718T	HMF000800	HMF000800A	0.88	female	1965	null	Unknown	CUP	Carcinoma			305	2017-12-11	Liver	segment 2/3	No	Yes	Yes	2017-12-13	2018-01-25	Gemcitabine/Carboplatin	Chemotherapy	2018-02-05	Yes	PD
CPCT02010720T	HMF002935	HMF002935A	0.34	female	1967	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-15	Primary	left lateral	No	No	Yes	2018-01-08	2018-05-23	Doxorubicin/Cyclophosphamide/Paclitaxel	Chemotherapy	2018-04-13	Yes	CR
CPCT02010721T	HMF003168	HMF003168A	0.74	female	1967	2018-09-29	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-13	Liver	segment 6	Yes	Yes	Yes	2018-01-15	null	Paclitaxel	Chemotherapy	2018-04-04	Yes	SD
CPCT02010722T	HMF000203	HMF000203B	0.6	male	1960	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-12-15	Liver	segment 2	No	No	Yes	2018-01-11	2018-03-01	Carboplatin/Gemcitabine	Chemotherapy	2018-02-24	Yes	SD
CPCT02010722TII	HMF000203	HMF000203A	0.34	male	1960	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-05	Liver	segment 4	No	No	Yes	2018-01-11	2018-03-01	Carboplatin/Gemcitabine	Chemotherapy	2018-02-24	Yes	SD
CPCT02010726T	HMF001428	HMF001428A	0.61	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-22	Liver	segment 8	Yes	No	Yes	2018-01-02	null	Letrozole	Hormonal therapy	2018-03-22	Yes	SD
CPCT02010727T	HMF000448	HMF000448A	0.68	female	1962	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-12-20	Lymph node	left axilla	No	Yes	Yes	2017-12-28	2018-06-07	Pembrolizumab	Immunotherapy	2018-01-15	Yes	SD
CPCT02010728T	HMF000293	HMF000293A	0.77	female	1950	2018-03-15	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-12-28	Adrenal gland	right	Yes	Yes	Yes	2017-12-29	2018-01-25	Topotecan	Chemotherapy	2018-02-05	Yes	PD
CPCT02010730T	HMF002811	HMF002811A	0.68	male	1952	null	Colorectum					9256	2017-12-28	Liver	segment 7/8	Yes	Yes	Yes	2018-01-16	2018-03-14	Trifluridine	Chemotherapy	2018-03-31	Yes	PD
CPCT02010735T	HMF001583	HMF001583A	0.47	female	1962	2019-05-08	Colorectum					9256	2018-01-02	Liver	segment 5	Yes	No	Yes	2018-01-16	2018-12-28	Bevacizumab/Leucovorin/Fluorouracil/Oxaliplatin	Multiple therapy	2018-03-14	Yes	SD
CPCT02010741T	HMF000128	HMF000128A	0.41	female	1949	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-16	Lung	intercostal 5-6	Yes	No	Yes	2018-02-08	2018-03-01	Pemetrexed	Chemotherapy	2018-03-22	Yes	PD
CPCT02010742T	HMF002865	HMF002865A	0.78	male	1939	null	Colorectum					9256	2018-01-11	Peritoneum	right lower abdomen	Yes	No	Yes	2018-01-16	2018-03-21	Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2018-03-27	Yes	SD
CPCT02010743T	HMF003669	HMF003669A	0.45	male	1978	null	Colorectum					9256	2018-01-11	subcutaneous	left abdomenal wall	Yes	No	Yes	2018-01-16	2018-09-05	Fluorouracil/Bevacizumab/Leucovorin/Irinotecan	Multiple therapy	2018-03-07	Yes	SD
CPCT02010746T	HMF001163	HMF001163A	0.75	female	1964	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-23	Liver	segment 5	Yes	Yes	Yes	2018-01-25	2018-03-01	Vinorelbine	Chemotherapy	2018-02-27	Yes	PD
CPCT02010750TII	HMF003653	HMF003653B	0.94	female	1960	2021-05-31	Colorectum					9256	2018-12-13	adnex	OTB	No	No	Yes	2018-02-01	2020-02-21	Oxaliplatin/Capecitabine/Bevacizumab	Multiple therapy	2018-03-30	Yes	SD
CPCT02010754TII	HMF002636	HMF002636B	0.45	male	1951	2019-10-24	Skin		Melanoma			8923	2018-12-17	Adrenal gland	left	No	No	Yes	2018-01-29	2018-07-18	Pembrolizumab	Immunotherapy	2018-04-19	Yes	PR
CPCT02010756T	HMF002351	HMF002351A	0.72	female	1954	null	Small intestine		Neuroendocrine tumor			10154,169	2018-01-26	Liver	unknown	No	No	Yes	2018-02-16	null	Octreotide	Hormonal therapy	2018-05-14	Yes	PR
CPCT02010757T	HMF000576	HMF000576A	0.69	male	1965	null	Bone/Soft tissue		Undifferentiated sarcoma			1115	2018-02-08	Lung	dorsal right lower lobe	Yes	Yes	Yes	2018-02-12	2018-04-08	Nintedanib	Targeted therapy	2018-03-26	Yes	PD
CPCT02010758T	HMF002552	HMF002552A	0.49	male	1941	null	Mesothelium		Malignant mesothelioma			1790,0050686	2018-01-30	subcutaneous	thorax wall	No	No	null	null	null	null	null	null	null	null
CPCT02010762T	HMF001697	HMF001697A	0.43	male	1957	null	Prostate					10283	2018-01-31	Lymph node	para aortal	Yes	Yes	Yes	2018-01-31	2018-04-18	Enzalutamide	Hormonal therapy	2018-03-14	Yes	PD
CPCT02010765T	HMF001654	HMF001654A	0.37	female	1981	2018-10-24	Breast		Carcinoma	Triple negative		0060081	2018-02-01	Lymph node	Armpit right	Yes	Yes	Yes	2018-02-05	2018-07-02	Capecitabine	Chemotherapy	2018-03-15	Yes	SD
CPCT02010768T	HMF000021	HMF000021A	0.71	female	1987	null	Breast		Carcinoma	Triple negative		0060081	2018-02-08	Subcutaneous	right thorax wall	Yes	No	Yes	2018-02-09	2018-07-02	Cisplatin/Etoposide/Carboplatin	Chemotherapy	2018-03-31	Yes	PR
CPCT02010769T	HMF003611	HMF003611A	0.39	male	1948	null	Stomach					10534	2018-02-23	Liver	Segment 6	Yes	Yes	Yes	2018-02-26	2018-02-26	Capecitabine/Oxaliplatin	Chemotherapy	null	null	null
CPCT02010774T	HMF004251	HMF004251A	0.38	female	1947	2020-12-06	Mesothelium		Malignant mesothelioma			1790,0050686	2019-04-23	Pleural abnormality	Left side	Yes	No	Yes	2019-05-07	2019-09-12	Nivolumab	Immunotherapy	2019-06-12	Yes	SD
CPCT02010776T	HMF000350	HMF000350A	0.25	male	1957	2018-10-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-02-14	Liver	segment 5	Yes	Yes	Yes	2018-04-03	2018-07-19	Pemetrexed/Carboplatin	Chemotherapy	2018-05-17	Yes	PD
CPCT02010776TII	HMF000350	HMF000350B	0.49	male	1957	2018-10-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-08-14	Liver	segment 5	Yes	Yes	Yes	2018-04-03	2018-07-19	Pemetrexed/Carboplatin	Chemotherapy	2018-05-17	Yes	PD
CPCT02010780T	HMF002689	HMF002689A	0.7	male	1957	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-02-21	Peritoneum	subcutaneous fatty tissue left upper abdomen	Yes	No	Yes	2018-03-20	2018-04-20	Nivolumab	Immunotherapy	2018-05-02	Yes	PD
CPCT02010781T	HMF001359	HMF001359A	0.64	male	1940	2018-03-10	Lung		Carcinoma	Small cell carcinoma		5409	2018-02-27	Liver	segment 4	Yes	No	Yes	2018-02-28	2018-02-28	Carboplatin/Paclitaxel	Chemotherapy	null	null	null
CPCT02010782T	HMF002955	HMF002955A	0.5	male	1965	null	Lung		Carcinoma	Small cell carcinoma		5409	2018-02-19	Lung	n/a	Yes	No	null	null	null	null	null	null	null	null
CPCT02010786T	HMF002144	HMF002144A	0.26	female	1948	null	Colorectum					9256	2018-02-23	Peritoneum	retroperitoneal	Yes	No	Yes	2018-03-01	2020-02-14	Pembrolizumab	Immunotherapy	2018-05-04	Yes	SD
CPCT02010790T	HMF003376	HMF003376A	0.44	female	1968	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-28	skin	not specified	No	No	Yes	2018-03-07	2018-06-19	Doxorubicin/Cyclophosphamide	Chemotherapy	2018-05-03	Yes	PR
CPCT02010791T	HMF001933	HMF001933A	0.66	female	1952	2020-03-30	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-01	Liver	segment 7	Yes	Yes	Yes	2018-03-08	2019-05-24	Fulvestrant/Palbociclib	Multiple therapy	2018-06-15	Yes	SD
CPCT02010794T	HMF000418	HMF000418A	0.77	male	1943	null	Skin		Melanoma			8923	2018-03-01	Lymph node	right groin	Yes	No	Yes	2018-03-02	2018-03-02	Ipilimumab/Nivolumab	Immunotherapy	2018-04-16	Yes	PD
CPCT02010797T	HMF000127	HMF000127A	0.62	male	1978	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-06	Lymph node	neck left lvl 5	Yes	No	null	null	null	null	null	null	null	null
CPCT02010801T	HMF000592	HMF000592A	0.88	female	1959	null	Skin		Melanoma			8923	2018-03-09	Peritoneum	Right	No	Yes	Yes	2018-03-15	2018-04-06	Ipilimumab/Nivolumab	Immunotherapy	2018-06-01	Yes	PR
CPCT02010802T	HMF001848	HMF001848A	0.49	female	1952	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-13	Lung	Perihilar right lower lobe	Yes	Yes	Yes	2018-04-04	2018-04-25	Cisplatin/Pemetrexed	Chemotherapy	2018-05-14	Yes	PD
CPCT02010807T	HMF002842	HMF002842A	0.4	male	1963	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-16	Lymph node	middle jugular	No	No	Yes	2018-03-20	2020-02-18	Pembrolizumab	Immunotherapy	2018-04-25	Yes	PR
CPCT02010810T	HMF001581	HMF001581A	0.48	male	1959	2020-09-24	Small intestine		Neuroendocrine tumor			10154,169	2018-03-21	Liver	segment 4/5	No	No	Yes	2018-04-01	2019-06-20	Lanreotide	Hormonal therapy	2019-01-14	Yes	PD
CPCT02010811T	HMF003622	HMF003622A	0.32	male	1951	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-22	Lymph node	right axilla	Yes	Yes	Yes	2018-03-29	2018-04-25	Nivolumab	Immunotherapy	2018-05-02	Yes	PD
CPCT02010813T	HMF001892	HMF001892A	0.32	male	1946	null	Esophagus					5041	2018-03-22	Liver	segment 5	No	Yes	Yes	2018-03-30	2018-07-20	Oxaliplatin/Capecitabine/Trastuzumab	Multiple therapy	null	null	null
CPCT02010815T	HMF000344	HMF000344A	0.46	male	1953	null	Esophagus					5041	2018-03-23	Adrenal gland	right	No	Yes	Yes	2018-03-30	2018-09-21	Oxaliplatin/Capecitabine	Chemotherapy	2018-05-04	Yes	SD
CPCT02010821T	HMF003167	HMF003167A	0.39	female	1949	null	Unknown					162	2018-03-28	Liver	segment 2	No	Yes	Yes	2018-04-17	2018-07-20	Cisplatin/Everolimus	Multiple therapy	2018-06-14	Yes	PR
CPCT02010824T	HMF002568	HMF002568A	0.68	female	1977	2021-01-07	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-29	Liver	segment 6	Yes	Yes	Yes	2018-04-04	2019-11-13	Letrozole/Leuprorelin	Multiple therapy	2018-06-18	Yes	SD
CPCT02010825T	HMF000415	HMF000415A	0.25	female	1963	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-30	Primary	right	No	No	Yes	2018-04-10	2018-05-23	Doxorubicin/Cyclophosphamide	Chemotherapy	null	null	null
CPCT02010828T	HMF001426	HMF001426A	0.91	female	1967	2019-02-21	Unknown	CUP	Carcinoma			305	2018-03-30	subcutaneous	right thorax wall	Yes	Yes	Yes	2018-04-23	2018-07-26	Etoposide/Carboplatin	Chemotherapy	2018-06-21	Yes	SD
CPCT02010831T	HMF000486	HMF000486A	0.84	female	1956	2018-05-18	Unknown	CUP	Carcinoma			305	2018-04-03	Lymph node	right inguinal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010835T	HMF003067	HMF003067A	0.51	male	1952	null	Colorectum					9256	2018-04-10	Liver	segment 8	Yes	Yes	Yes	2018-04-24	2018-05-02	Irinotecan	Chemotherapy	null	null	null
CPCT02010836T	HMF002323	HMF002323A	0.8	male	1947	null	Lung		Carcinoma	Small cell carcinoma		5409	2018-04-09	Liver	right point	Yes	Yes	Yes	2018-04-30	2018-07-03	Carboplatin/Etoposide	Chemotherapy	2018-06-08	Yes	SD
CPCT02010838T	HMF002655	HMF002655A	0.48	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-10	Primary	right breast	Yes	No	Yes	2018-04-10	2019-06-05	Palbociclib/Fulvestrant	Multiple therapy	null	null	null
CPCT02010839T	HMF000008	HMF000008B	0.55	female	1938	2019-02-05	Colorectum					9256	2018-04-11	Liver	segment 2	No	No	Yes	2018-04-13	2018-10-26	Oxaliplatin/Capecitabine	Chemotherapy	2018-06-07	Yes	SD
CPCT02010840T	HMF001925	HMF001925B	0.7	male	1941	null	Prostate					10283	2018-04-19	Liver	segment 5	Yes	No	Yes	2018-04-19	2018-07-04	Enzalutamide	Hormonal therapy	2018-05-22	Yes	SD
CPCT02010841T	HMF003786	HMF003786A	0.54	male	1965	null	Colorectum					9256	2018-04-12	Liver	segment 2/3	Yes	Yes	Yes	2018-04-19	2018-08-28	Capecitabine/Oxaliplatin	Chemotherapy	2018-06-15	Yes	SD
CPCT02010843T	HMF002886	HMF002886A	0.83	female	1957	2018-04-30	Mesothelium		Malignant mesothelioma			1790,0050686	2018-04-13	subcutaneous	pleural widening caudal of right breast	Yes	No	null	null	null	null	null	null	null	null
CPCT02010846T	HMF000624	HMF000624A	0.8	female	1951	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-16	Liver	segment 4	Yes	Yes	Yes	2018-05-22	2019-07-02	Niraparib	targeted therapy	2018-07-11	Yes	PR
CPCT02010847T	HMF001958	HMF001958A	0.68	female	1962	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-11	Lung	dorsobasal left	Yes	Yes	Yes	2018-06-18	2020-02-06	Nivolumab/Bevacizumab	Multiple therapy	2018-07-30	Yes	PR
CPCT02010849T	HMF003327	HMF003327A	0.21	female	1949	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-04-26	Lung	left lower lobe	Yes	No	Yes	2018-08-03	2019-03-22	Pemetrexed/Carboplatin	Chemotherapy	2018-09-13	Yes	SD
CPCT02010851T	HMF002338	HMF002338A	0.65	female	1958	2020-05-21	Small intestine		Neuroendocrine tumor			10154,169	2018-05-22	Primary	ilium	No	No	Yes	2018-06-18	2020-05-21	Lanreotide	Hormonal therapy	2018-11-19	Yes	PD
CPCT02010852T	HMF002512	HMF002512A	0.27	male	1961	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-04-20	Lymph node	left supraclavicular	Yes	Yes	Yes	2018-07-02	2018-10-30	Pembrolizumab/MK 5890	Multiple therapy	2018-09-03	Yes	SD
CPCT02010853T	HMF003441	HMF003441A	0.66	female	1946	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-04-20	Lymph node	right supraclavicular	Yes	No	null	null	null	null	null	null	null	null
CPCT02010856T	HMF001923	HMF001923A	0.51	female	1965	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2018-05-08	Lung	para aortal left lower lobe	Yes	No	Yes	2018-05-08	2018-07-04	Trabectedin	Chemotherapy	2018-07-02	Yes	PD
CPCT02010860T	HMF003334	HMF003334A	0.36	female	1946	null	Colorectum					9256	2018-05-07	Liver	segment 5	No	No	Yes	2018-05-25	2018-07-06	Capecitabine/Bevacizumab/Oxaliplatin	Multiple therapy	2018-07-05	Yes	SD
CPCT02010865T	HMF002911	HMF002911A	0.26	female	1965	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-04	subcutaneous	left upper shoulder	Yes	Yes	Yes	2018-05-07	2020-01-09	Dabrafenib/Trametinib	Targeted therapy	null	null	null
CPCT02010867T	HMF003604	HMF003604A	0.32	female	1963	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-08	intramuscular	Armpit right	No	No	Yes	2018-05-28	2018-06-21	Bevacizumab/Carboplatin/Paclitaxel	Multiple therapy	2018-07-12	Yes	SD
CPCT02010870T	HMF002939	HMF002939A	0.69	male	1946	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-09	Liver	Segment VI	No	Yes	null	null	null	null	null	null	null	null
CPCT02010872T	HMF003776	HMF003776A	0.85	male	1954	null	Small intestine		Neuroendocrine tumor			10154,169	2018-05-16	Liver	segment 6	No	No	Yes	2018-05-24	null	Octreotide	Hormonal therapy	2018-10-16	Yes	SD
CPCT02010873T	HMF003169	HMF003169A	0.69	female	1958	null	Colorectum					9256	2018-05-11	Liver	segment 8	No	No	Yes	2018-06-06	2018-07-17	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-08-01	Yes	PR
CPCT02010875T	HMF001039	HMF001039A	0.58	male	1938	null	Prostate					10283	2018-05-15	Lymph node	para-aortal left	Yes	No	Yes	2018-05-22	2019-01-29	Enzalutamide	Hormonal therapy	2018-08-15	Yes	SD
CPCT02010877T	HMF002337	HMF002337A	0.72	male	1945	2020-12-21	Prostate					10283	2018-05-16	Lymph node	right axilla	Yes	Yes	Yes	2018-05-17	2019-10-28	Enzalutamide	Hormonal therapy	2018-08-03	Yes	PR
CPCT02010878T	HMF002052	HMF002052A	0.7	male	1954	2020-07-13	Penis					11615	2018-05-16	subcutaneous	left groin	No	No	Yes	2018-05-16	2018-09-27	Carboplatin/Capecitabine	Chemotherapy	2018-07-13	Yes	SD
CPCT02010880T	HMF003048	HMF003048A	0.5	male	1953	null	Colorectum					9256	2018-05-22	Liver	segment 4/5	Yes	No	Yes	2018-05-25	2018-07-06	Irinotecan	Chemotherapy	2018-07-20	Yes	PD
CPCT02010882T	HMF002298	HMF002298A	0.7	male	1962	null	Small intestine	Ileum				10153	2018-05-22	colon	rectosigmoid	No	No	Yes	2018-06-20	2020-05-12	Pembrolizumab	Immunotherapy	2018-08-14	Yes	SD
CPCT02010884T	HMF002128	HMF002128A	0.32	female	1960	null	Colorectum					9256	2018-05-23	Liver	segment 3	Yes	No	Yes	2018-06-01	2018-07-13	Irinotecan	Chemotherapy	2018-08-01	Yes	PD
CPCT02010886T	HMF000701	HMF000701A	0.93	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-23	subcutaneous	Thorax wall	Yes	Yes	Yes	2018-05-31	2019-05-24	Capecitabine	Chemotherapy	2018-07-23	Yes	PR
CPCT02010889T	HMF000464	HMF000464A	0.78	male	1968	null	Prostate					10283	2018-05-28	Liver	Segment 3	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010890T	HMF002846	HMF002846A	0.2	female	1988	2019-04-11	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-05-29	Lymph node	Neck left	Yes	Yes	Yes	2018-06-18	2018-11-13	Vinorelbine/Trastuzumab	Multiple therapy	null	null	null
CPCT02010894T	HMF000028	HMF000028A	0.47	female	1957	2018-09-09	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-05	Liver	Segment 3	Yes	Yes	Yes	2018-06-15	2018-06-15	Pemetrexed	Chemotherapy	2018-07-04	Yes	PD
CPCT02010894TII	HMF000028	HMF000028B	0.79	female	1957	2018-09-09	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-08-23	Liver	segment 3	Yes	Yes	Yes	2018-06-15	2018-06-15	Pemetrexed	Chemotherapy	2018-07-04	Yes	PD
CPCT02010895T	HMF002944	HMF002944A	0.58	male	1964	2018-11-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-13	Adrenal gland	right	Yes	No	Yes	2018-08-21	2018-09-11	GSK3359609	Experimental therapy	null	null	null
CPCT02010896T	HMF001327	HMF001327A	0.48	female	1971	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-06-04	(sub)cutaneous	Thorax wall right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010897T	HMF000289	HMF000289A	0.95	female	1949	null	Lung		Carcinoma	Small cell carcinoma		5409	2018-06-07	subcutanous	left shoulder	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010898T	HMF002246	HMF002246A	0.85	male	1944	null	Colorectum					9256	2018-06-07	Liver	Segment 5	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010900T	HMF000727	HMF000727A	0.65	female	1978	null	Breast		Carcinoma	Triple negative		0060081	2018-06-08	Liver	Segment 2	Yes	Yes	Yes	2018-06-09	2018-07-01	Capecitabine	Chemotherapy	2018-07-18	Yes	PD
CPCT02010901T	HMF003231	HMF003231A	0.66	female	1971	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-11	Liver	Segment 6	Yes	Yes	Yes	2018-06-18	2018-07-26	Capecitabine	Chemotherapy	2018-07-20	Yes	PD
CPCT02010902T	HMF001561	HMF001561B	0.42	female	1981	null	Bile duct		Carcinoma			4947	2018-06-12	intra-abdominal	Omental cake	Yes	No	Yes	2018-06-29	2018-07-26	Irinotecan	Chemotherapy	null	null	null
CPCT02010903T	HMF003643	HMF003643A	0.41	male	1939	2018-06-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-14	pleural	right	No	No	null	null	null	null	null	null	null	null
CPCT02010904T	HMF000071	HMF000071A	0.63	male	1944	2018-09-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-15	Liver	segment 5	Yes	Yes	Yes	2018-06-15	2018-07-13	Nivolumab	Immunotherapy	2018-07-25	Yes	PD
CPCT02010911T	HMF002157	HMF002157A	0.31	male	1955	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-20	Lymph node	below adrenal gland left	Yes	Yes	Yes	2018-07-17	2018-10-11	Nivolumab	Immunotherapy	2018-08-23	Yes	PD
CPCT02010913T	HMF003644	HMF003644A	0.72	female	1955	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-20	subcutaneous	axilla right	No	Yes	Yes	2018-06-21	2020-02-24	Pembrolizumab	Immunotherapy	2018-08-01	Yes	SD
CPCT02010914T	HMF001703	HMF001703A	0.74	male	1967	null	Thymus		Carcinoma	Thymoma and Thymic carcinoma		3275,3284,305	2018-07-03	Lung	right dorsolateral	Yes	Yes	Yes	2018-08-08	2018-08-29	Carboplatin/Etoposide	Chemotherapy	2018-09-12	Yes	PD
CPCT02010915T	HMF001447	HMF001447A	0.83	female	1949	2019-02-20	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-22	Liver	segment 6	Yes	Yes	Yes	2018-07-10	2019-01-15	Everolimus/Exemestane	Multiple therapy	2018-11-13	Yes	PD
CPCT02010918T	HMF000018	HMF000018A	0.64	female	1951	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-29	Lymph node	neck right	Yes	Yes	Yes	2018-07-05	2018-11-08	Nivolumab	Immunotherapy	2018-08-15	Yes	SD
CPCT02010919T	HMF002345	HMF002345A	0.82	female	1974	null	Trachea					11920	2018-06-27	Liver	segment 2	No	No	null	null	null	null	null	null	null	null
CPCT02010920T	HMF000410	HMF000410A	0.4	female	1953	null	Skin		Carcinoma	Squamous cell carcinoma		3151	2018-06-27	skin	left lower leg	No	No	Yes	2018-10-18	2019-12-05	Anti-PD-1 (PDR001)	Immunotherapy	2018-12-13	Yes	SD
CPCT02010924T	HMF001919	HMF001919A	0.26	female	1942	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-07-02	Lung	bronchal	Yes	No	Yes	2018-07-10	2018-07-20	Nivolumab	Immunotherapy	2018-08-16	Yes	PD
CPCT02010926T	HMF000520	HMF000520A	0.62	female	1949	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-09	Liver	right OTB	null	null	Yes	2017-04-07	2019-04-05	null	null	null	null	null
CPCT02010927T	HMF004382	HMF004382A	0.55	male	1954	2019-08-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-18	Liver	Segment 6	Yes	Yes	Yes	2019-02-18	2019-03-12	Pemetrexed/Cisplatin	Chemotherapy	2019-03-26	Yes	PD
CPCT02010931T	HMF000690	HMF000690B	0.38	male	1940	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-07-19	Lung	left upper lobe	Yes	No	Yes	2018-07-19	2018-08-20	Durvalumab	Immunotherapy	2018-08-23	Yes	PD
CPCT02010933T	HMF000719	HMF000719A	0.59	female	1967	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-17	Primary	right lateral breast right	Yes	No	Yes	2018-07-24	2019-03-20	Vinorelbine	Chemotherapy	null	null	null
CPCT02010934T	HMF002195	HMF002195A	0.48	female	1965	null	Breast		Carcinoma	Triple negative		0060081	2018-07-25	Liver	segment 6	Yes	No	null	null	null	null	null	null	null	null
CPCT02010935T	HMF000319	HMF000319B	0.2	male	1950	2020-05-09	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-08-01	Peritoneum	para-iliacal	Yes	No	Yes	2018-08-07	2019-06-26	Pembrolizumab	Immunotherapy	2018-10-19	Yes	PD
CPCT02010936T	HMF001138	HMF001138A	0.43	female	1969	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-24	Bone	Right jaw	Yes	Yes	Yes	2018-08-17	2019-01-09	Palbociclib	Targeted therapy	2018-09-26	Yes	SD
CPCT02010938T	HMF003328	HMF003328A	0.74	female	1939	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-07-27	Lung	left	Yes	No	Yes	2018-08-04	2018-08-30	Carboplatin/Etoposide	Chemotherapy	2018-09-24	Yes	PD
CPCT02010939T	HMF003528	HMF003528A	0.77	female	1972	2018-12-25	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-07-27	Liver	segment 5/6	Yes	Yes	Yes	2018-08-02	2018-12-25	Palbociclib/Fulvestrant/Goserelin/Goserelin	Multiple therapy	2018-10-11	Yes	PD
CPCT02010941T	HMF003162	HMF003162A	0.28	female	1949	null	Skin		Melanoma			8923	2018-07-31	subcutaneous	Thorax wall	No	No	Yes	2018-07-31	2018-07-31	Pembrolizumab	Immunotherapy	2018-10-18	Yes	PR
CPCT02010942TII	HMF000703	HMF000703B	0.63	female	1951	2019-06-09	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-04-05	Liver	Segment 2	Yes	No	Yes	2018-11-29	2019-03-21	Paclitaxel/Bevacizumab	Multiple therapy	2019-01-13	Yes	SD
CPCT02010944T	HMF000061	HMF000061C	0.57	male	1946	2019-05-29	Urothelial tract	Bladder				11054	2018-08-08	Lymph node	neck level	Yes	Yes	Yes	2018-08-15	2019-03-12	Pembrolizumab	Immunotherapy	2018-11-08	Yes	PR
CPCT02010944TIII	HMF000061	HMF000061B	0.6	male	1946	2019-05-29	Urothelial tract	Bladder				11054	2018-09-07	Lymph node	neck level 4 OTB	Yes	Yes	Yes	2018-08-15	2019-03-12	Pembrolizumab	Immunotherapy	2018-11-08	Yes	PR
CPCT02010945T	HMF003024	HMF003024A	0.42	male	1969	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-08-13	Lymph node	supraclavicular right	No	Yes	null	null	null	null	null	null	null	null
CPCT02010947T	HMF000879	HMF000879A	0.64	male	1951	null	Prostate					10283	2018-08-17	Peritoneum	omentum	Yes	No	Yes	2018-08-17	2020-05-22	Enzalutamide	Hormonal therapy	null	null	null
CPCT02010953T	HMF001050	HMF001050A	0.8	female	1953	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-14	Lung	Central right	Yes	No	null	null	null	null	null	null	null	null
CPCT02010954T	HMF000593	HMF000593A	0.46	female	1943	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-14	Liver	segment 3	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02010958T	HMF003407	HMF003407A	0.89	male	1953	null	Prostate					10283	2018-09-11	Lymph node	left inguinal	Yes	No	null	null	null	null	null	null	null	null
CPCT02010963T	HMF001286	HMF001286A	0.92	male	1947	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-09-18	Psoas	Left	Yes	Yes	Yes	2018-09-26	2018-12-17	Pembrolizumab	Immunotherapy	2018-12-17	Yes	PD
CPCT02010963TII	HMF001286	HMF001286B	0.89	male	1947	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-11-07	intramuscular	psoas left OTB	Yes	Yes	Yes	2018-09-26	2018-12-17	Pembrolizumab	Immunotherapy	2018-12-17	Yes	PD
CPCT02010965T	HMF001567	HMF001567A	0.45	female	1942	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-02	Liver	segment 4/8	Yes	No	Yes	2018-12-06	2018-12-27	Pembrolizumab	Immunotherapy	2018-12-30	Yes	SD
CPCT02010966T	HMF001245	HMF001245A	0.37	female	1956	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-26	Lymph node	supraclavicular	Yes	Yes	Yes	2018-10-17	2019-04-10	Lorlatinib	Experimental therapy	2018-12-27	Yes	PR
CPCT02010966TII	HMF001245	HMF001245B	0.35	female	1956	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-04-10	Peritoneum	omentum majus right	Yes	Yes	Yes	2018-10-17	2019-04-10	Lorlatinib	Experimental therapy	2018-12-27	Yes	PR
CPCT02010969T	HMF001459	HMF001459A	0.93	female	1962	null	Breast		Carcinoma	Triple negative		0060081	2018-09-20	subcutaneous	abdominal wall	Yes	Yes	Yes	2018-10-08	2021-01-18	Palbociclib/Fulvestrant/Palbociclib	Multiple therapy	2019-01-24	Yes	PR
CPCT02010971T	HMF001398	HMF001398A	0.64	male	1957	null	Prostate					10283	2018-10-09	Lymph node	axilla	Yes	Yes	Yes	2018-10-09	2019-01-19	Enzalutamide	Hormonal therapy	null	null	null
CPCT02010972T	HMF000942	HMF000942A	0.37	male	1964	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-12	Kidney	right	Yes	Yes	Yes	2018-11-08	2019-04-11	Durvalumab	Immunotherapy	2018-12-06	Yes	SD
CPCT02010978T	HMF002964	HMF002964A	0.44	male	1948	null	Prostate					10283	2018-10-24	Lymph node	Retroperitoneal left	Yes	Yes	Yes	2018-10-25	2020-07-20	Enzalutamide/Docetaxel	Multiple therapy	2019-01-23	Yes	ND
CPCT02010980T	HMF000111	HMF000111A	0.53	male	1957	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-24	Lymph node	axilla left	No	No	Yes	2018-10-24	2018-12-27	Pembrolizumab	Immunotherapy	2018-11-29	Yes	PD
CPCT02010981T	HMF000307	HMF000307C	0.44	female	1969	2018-12-07	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-24	Lung	Left upper lobe	Yes	No	Yes	2018-10-25	2018-12-05	Crizotinib	Targeted therapy	null	null	null
CPCT02010982T	HMF002668	HMF002668A	0.78	female	1963	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-26	Lung	Right apical	Yes	No	Yes	2018-11-13	2020-08-17	Osimertinib	Targeted therapy	2019-01-07	Yes	PR
CPCT02010985T	HMF001091	HMF001091A	0.28	female	1948	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-29	Adrenal gland	Left adrenal gland	Yes	No	Yes	2019-01-04	2019-01-24	Pembrolizumab	Immunotherapy	2019-02-07	Yes	PD
CPCT02010988T	HMF000315	HMF000315A	0.53	male	1958	null	Thyroid gland					1781	2018-11-02	Lymph node	neck right 3	No	No	Yes	2018-11-02	2020-04-02	Lenvatinib	Targeted therapy	null	null	null
CPCT02010989T	HMF001737	HMF001737A	0.29	female	1949	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-09	Lung	right middle lobe	Yes	No	Yes	2018-12-20	2019-04-26	Pemetrexed/Carboplatin	Chemotherapy	null	null	null
CPCT02010990T	HMF001313	HMF001313A	0.41	male	1954	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-09	subcutaneous	supraclavicular	Yes	Yes	Yes	2018-11-29	2019-01-10	Lorlatinib	Experimental therapy	2019-01-13	Yes	PD
CPCT02010993T	HMF000407	HMF000407A	0.68	male	1954	null	Penis					11615	null	null	null	Yes	Yes	Yes	2018-11-13	2019-01-16	Atezolizumab	Immunotherapy	2019-01-30	Yes	PD
CPCT02010993TII	HMF000407	HMF000407B	0.7	male	1954	null	Penis					11615	null	null	null	Yes	Yes	Yes	2018-11-13	2019-01-16	Atezolizumab	Immunotherapy	2019-01-30	Yes	PD
CPCT02010994T	HMF002243	HMF002243A	0.32	male	1969	null	Skin		Melanoma			8923	2018-11-09	Liver	segment 8	No	No	Yes	2018-11-15	2019-02-06	Pembrolizumab	Immunotherapy	null	null	null
CPCT02010995T	HMF002472	HMF002472A	0.68	female	1950	null	Unknown	CUP	Carcinoma	Squamous cell carcinoma		1749	2018-11-13	Liver	segment 5	No	No	Yes	2018-11-28	2019-01-08	Gemcitabine/Carboplatin	Chemotherapy	2019-01-08	Yes	PD
CPCT02011000T	HMF000574	HMF000574A	0.46	male	1940	null	Prostate					10283	2018-11-21	Bone	Corpus L1 right side	Yes	Yes	Yes	2018-11-21	2019-07-10	Enzalutamide	Hormonal therapy	null	null	null
CPCT02011001T	HMF002264	HMF002264A	0.62	female	1935	2021-11-05	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-22	Lung	Left lower lobe	Yes	No	Yes	2018-12-10	2019-12-19	Crizotinib	Targeted therapy	2019-01-28	Yes	PR
CPCT02011002T	HMF002187	HMF002187A	0.9	male	1950	2019-09-05	Prostate					10283	2018-11-23	Lymph node	Para-aorthal left distal	Yes	Yes	Yes	2018-11-23	2019-03-05	Enzalutamide	Hormonal therapy	2019-02-21	Yes	PD
CPCT02011003T	HMF000384	HMF000384A	0.74	male	1951	null	Prostate					10283	2018-11-28	Lymph node	Lymph node para aortic	Yes	Yes	Yes	2018-11-28	2018-12-31	Abiraterone	Hormonal therapy	null	null	null
CPCT02011004T	HMF002425	HMF002425A	0.26	female	1969	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-29	Lung	Right upper lobe	No	Yes	Yes	2018-12-07	2019-09-24	Pembrolizumab	Immunotherapy	2019-01-12	Yes	SD
CPCT02011006T	HMF000340	HMF000340A	0.46	male	1980	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-30	Lung	Left upper lobe	Yes	Yes	Yes	2018-12-12	2019-03-28	Nivolumab	Immunotherapy	null	null	null
CPCT02011011T	HMF003192	HMF003192A	0.3	male	1947	null	Prostate					10283	2018-12-05	Lymph node	Left groin	No	Yes	Yes	2019-01-02	2019-03-13	Enzalutamide	Hormonal therapy	2019-03-08	Yes	PD
CPCT02011013T	HMF004170	HMF004170A	0.86	female	1947	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-12-06	Lung	Right lower lobe	Yes	Yes	Yes	2019-01-07	2019-01-09	Letrozole	Hormonal therapy	null	null	null
CPCT02011015T	HMF004359	HMF004359A	0.65	male	1963	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-11	Lung	Thoraciacal mass left	Yes	No	Yes	2018-12-18	2019-06-13	Atezolizumab/Bevacizumab/Paclitaxel/Carboplatin	Multiple therapy	2019-01-25	Yes	SD
CPCT02011017T	HMF004226	HMF004226A	0.28	male	1953	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-13	Adrenal gland	Left adrenal gland	Yes	Yes	Yes	2018-12-18	2018-12-18	Nivolumab	Immunotherapy	null	null	null
CPCT02011018T	HMF004388	HMF004388A	0.26	female	1947	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-12	subcutaneous	mamma right	Yes	No	Yes	2018-12-24	2019-08-29	Pembrolizumab	Immunotherapy	null	null	null
CPCT02011020T	HMF001746	HMF001746A	0.72	male	1946	null	Skin		Melanoma			8923	2018-12-18	subcutaneous	right flank	No	No	Yes	2018-12-28	2019-02-15	Ipilimumab/Nivolumab	Immunotherapy	2019-03-13	Yes	PR
CPCT02011022T	HMF004137	HMF004137B	0.37	female	1943	2020-02-05	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-20	Lung	Right upper lobe	Yes	No	Yes	2019-01-21	2019-04-11	Crizotinib	Targeted therapy	2019-04-05	Yes	PR
CPCT02011025T	HMF004011	HMF004011A	0.77	male	1957	2020-02-07	Skin		Melanoma			8923	2018-12-24	Primary	Right shoulder	No	No	Yes	2019-01-04	2019-01-24	Nivolumab/Ipilimumab	Immunotherapy	null	null	null
CPCT02011029T	HMF004134	HMF004134A	0.29	male	1956	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-03	Lung	right upper lobe	No	Yes	Yes	2019-01-15	2020-01-30	Ipilimumab/Nivolumab	Immunotherapy	2019-03-15	Yes	SD
CPCT02011032T	HMF004369	HMF004369A	0.25	female	1957	null	Lung		Carcinoma	Non-small cell carcinoma		3908	null	null	null	Yes	No	null	null	null	null	null	null	null	null
CPCT02011035T	HMF003916	HMF003916A	0.59	female	1958	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-16	Lung	subcutis left mamma	Yes	No	Yes	2019-01-18	2019-06-05	Pembrolizumab/Pemetrexed/Carboplatin	Multiple therapy	2019-03-04	Yes	PD
CPCT02011036T	HMF004370	HMF004370A	0.48	male	1946	2020-11-12	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-17	Lung	left	Yes	Yes	Yes	2019-01-25	2019-12-16	Nivolumab	Immunotherapy	null	null	null
CPCT02011038T	HMF003880	HMF003880B	0.94	female	1960	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-18	intra-abdominal	infra-umbilical	Yes	No	Yes	2019-01-19	2019-08-23	Afatinib	Targeted therapy	2019-03-08	Yes	SD
CPCT02011040T	HMF003827	HMF003827B	0.72	female	1956	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-24	Lung	left upper lobe	Yes	Yes	Yes	2019-01-25	2019-05-16	Osimertinib	Targeted therapy	2019-03-08	Yes	PR
CPCT02011040TII	HMF003827	HMF003827A	0.35	female	1956	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-21	Lung	Left upper lobe	Yes	Yes	Yes	2019-01-25	2019-05-16	Osimertinib	Targeted therapy	2019-03-08	Yes	PR
CPCT02011042T	HMF003844	HMF003844A	0.26	female	1937	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-01	Liver	segment 3	Yes	No	null	null	null	null	null	null	null	null
CPCT02011043T	HMF003830	HMF003830A	0.53	male	1953	null	Prostate					10283	2019-02-01	Bone	os ileum rechts	Yes	Yes	Yes	2019-02-02	2019-09-13	Enzalutamide	Hormonal therapy	null	null	null
CPCT02011045T	HMF004161	HMF004161B	0.5	male	1992	null	Skin		Melanoma			8923	2019-02-07	subcutaneous	left flank	No	Yes	Yes	2019-02-12	2019-02-12	Nivolumab	Immunotherapy	null	null	null
CPCT02011046T	HMF004190	HMF004190A	0.23	male	1939	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-07	Lymph node	level 5 (supraclavicular)	No	Yes	Yes	2019-02-14	2020-02-28	Pembrolizumab/Carboplatin/Pemetrexed	Multiple therapy	2019-03-22	Yes	SD
CPCT02011047T	HMF004058	HMF004058A	0.21	male	1941	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-21	Lung	right lower lobe	No	No	Yes	2018-12-31	2019-03-11	Carboplatin/Pembrolizumab/Pemetrexed	Multiple therapy	2019-02-08	Yes	PD
CPCT02011050T	HMF004149	HMF004149A	0.34	male	1957	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-15	Lymph node	neck, level 1 b	Yes	No	Yes	2019-02-15	2019-03-01	Afatinib	Targeted therapy	null	null	null
CPCT02011051T	HMF004159	HMF004159A	0.22	female	1957	2021-02-06	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-15	Lung	unknown	Yes	No	Yes	2019-02-21	2019-09-19	Crizotinib/Gefitinib	Targeted therapy	2019-03-20	Yes	SD
CPCT02011052T	HMF004320	HMF004320A	0.36	male	1956	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-22	Bone	os ilium left	Yes	Yes	Yes	2019-05-16	2020-06-26	Nivolumab	Immunotherapy	2019-09-10	Yes	SD
CPCT02011053T	HMF003966	HMF003966A	0.26	female	1954	2020-08-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-14	Lung	right lower lobe	Yes	No	Yes	2019-02-22	2019-03-14	Pembrolizumab	Immunotherapy	2019-03-28	Yes	PD
CPCT02011055T	HMF004139	HMF004139A	0.51	female	1961	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-18	subcutaneous	head right side	Yes	Yes	Yes	2019-03-06	2020-03-23	Nivolumab	Immunotherapy	2019-04-17	Yes	SD
CPCT02011056T	HMF003859	HMF003859A	0.55	female	1952	2019-03-31	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-22	Liver	Liver segment 5/8	Yes	Yes	Yes	2019-03-06	2019-03-28	Trastuzumab/Osimertinib	Targeted therapy	null	null	null
CPCT02011057T	HMF004275	HMF004275A	0.59	male	1953	2019-03-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-21	Subcutaneous	axilla left	Yes	Yes	Yes	2019-03-04	2019-03-26	HuMax-AXL-ADC	Targeted therapy	null	null	null
CPCT02011058T	HMF004039	HMF004039A	0.59	female	1965	2020-12-11	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-22	Lymph node	level 2 left	Yes	Yes	Yes	2019-04-09	2020-01-14	Palbociclib	Targeted therapy	2019-06-20	Yes	SD
CPCT02011059T	HMF004247	HMF004247A	0.48	male	1946	2019-08-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-25	Pleural fluid	right	Yes	No	Yes	2019-02-25	2019-03-18	Crizotinib	Targeted therapy	null	null	null
CPCT02011065T	HMF003813	HMF003813A	0.81	male	1945	2019-06-16	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-05	Lung	right dorsal thorax	Yes	Yes	Yes	2019-04-26	2019-06-16	Crizotinib	Targeted therapy	2019-06-03	Yes	SD
CPCT02011068T	HMF003973	HMF003973A	0.29	female	1945	2019-07-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-06-14	Lung	Right lower lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02011069T	HMF004008	HMF004008A	0.55	female	1959	2019-05-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-08	intramuscular	left leg	Yes	No	Yes	2019-04-02	2019-05-24	Pembrolizumab/Carboplatin/Paclitaxel	Multiple therapy	null	null	null
CPCT02011070T	HMF004103	HMF004103A	0.54	female	1969	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-04-29	Lung	left lower lobe	Yes	Yes	Yes	2019-04-30	2019-06-07	Crizotinib	Targeted therapy	2019-06-07	Yes	PD
CPCT02011071T	HMF003952	HMF003952A	0.24	female	1953	2020-10-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-11	Lung	thoracic wall left	Yes	No	Yes	2019-03-26	2020-10-29	Osimertinib/Pemetrexed/Carboplatin	Multiple therapy	2019-06-06	Yes	PR
CPCT02011073T	HMF003956	HMF003956A	0.73	female	1986	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-03-18	Liver	segment 4a	Yes	No	null	null	null	null	null	null	null	null
CPCT02011074T	HMF004153	HMF004153A	0.22	male	1953	2020-09-25	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-22	Lung	left upper lobe	Yes	No	Yes	2019-04-26	2020-06-09	Trastuzumab/Osimertinib	Targeted therapy	2019-06-24	Yes	SD
CPCT02011077T	HMF004299	HMF004299A	0.33	male	1952	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-15	Liver	segment 8	Yes	No	Yes	2019-04-16	2019-10-10	Pemetrexed/Carboplatin	Chemotherapy	2019-05-29	Yes	SD
CPCT02011079T	HMF003920	HMF003920A	0.56	female	1948	2019-12-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-12	Pleural fluid	pleural fluid	No	No	Yes	2019-05-24	2019-08-27	Pembrolizumab	Immunotherapy	2019-07-05	Yes	PR
CPCT02011080T	HMF004273	HMF004273A	0.3	female	1959	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-08	Primary	right side	No	No	Yes	2019-04-11	2021-02-19	Pembrolizumab/Carboplatin/Pemetrexed	Multiple therapy	2019-04-26	Yes	SD
CPCT02011082T	HMF003982	HMF003982A	0.55	male	1942	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-19	Kidney	left	No	Yes	null	null	null	null	null	null	null	null
CPCT02011086T	HMF004022	HMF004022A	0.38	male	1954	2019-04-11	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-27	Liver	segment 4	Yes	No	Yes	2019-04-09	2019-04-11	Durvalumab	Immunotherapy	null	null	null
CPCT02011087T	HMF004177	HMF004177B	0.27	male	1959	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-29	Spleen	Lateral	Yes	Yes	Yes	2019-04-11	2019-05-21	Nivolumab	Immunotherapy	2019-05-20	Yes	PD
CPCT02011088T	HMF004102	HMF004102A	0.35	male	1944	2019-11-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-29	Liver	segment 5	Yes	Yes	Yes	2019-04-30	2019-07-24	Pembrolizumab/Carboplatin/Paclitaxel	Multiple therapy	2019-06-11	Yes	PR
CPCT02011089T	HMF004133	HMF004133A	0.67	female	1940	2019-07-06	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-29	Liver	segment 2/3	Yes	Yes	Yes	2019-04-02	2019-05-14	Trastuzumab/Osimertinib	Targeted therapy	2019-05-14	Yes	PD
CPCT02011089TII	HMF004133	HMF004133B	0.33	female	1940	2019-07-06	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-23	Liver	segment 3	Yes	Yes	Yes	2019-04-02	2019-05-14	Trastuzumab/Osimertinib	Targeted therapy	2019-05-14	Yes	PD
CPCT02011090T	HMF004365	HMF004365A	0.83	male	1986	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2019-03-29	Peritoneum	right flank	Yes	No	Yes	2019-04-15	2019-07-22	Sunitinib	Targeted therapy	2019-07-08	Yes	SD
CPCT02011093T	HMF004168	HMF004168A	0.24	female	1961	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-04-09	Lung	middle lobe	Yes	No	Yes	2019-05-23	null	Osimertinib/Crizotinib	Targeted therapy	2019-07-26	Yes	SD
CPCT02011094T	HMF004079	HMF004079A	0.57	female	1951	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2019-04-03	Peritoneum	peritoneal metastases	Yes	No	Yes	2019-04-17	2020-10-30	Imatinib	Targeted therapy	2019-07-17	Yes	SD
CPCT02011098T	HMF004261	HMF004261A	0.71	male	1956	null	Thymus		Carcinoma	Thymoma and Thymic carcinoma		3275,3284,305	2019-04-23	subpleural mass	right dorsal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02011102T	HMF004319	HMF004319A	0.25	female	1952	2019-11-13	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-04-16	Lymph node	supraclavicular	Yes	Yes	Yes	2019-10-31	2019-11-03	Osimertinib	Targeted therapy	null	null	null
CPCT02011105T	HMF004282	HMF004282A	0.92	female	1962	2020-07-10	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-13	CNS	right frontal cerebrum	Yes	Yes	Yes	2019-05-31	2020-07-10	Crizotinib/Osimertinib/Bevacizumab/Capmatinib	Targeted therapy	2019-07-15	Yes	SD
CPCT02011107T	HMF003889	HMF003889A	0.31	female	1970	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-21	Lung	Lateral thoracic wall left	No	No	Yes	2019-05-22	2021-06-03	Pembrolizumab/Pemetrexed/Carboplatin	Multiple therapy	2019-06-27	Yes	PR
CPCT02011108T	HMF003912	HMF003912A	0.57	male	1982	null	Skin		Melanoma			8923	2019-05-28	Lymph node	right axillar	No	No	Yes	2019-06-04	2020-01-13	Pembrolizumab	Immunotherapy	2019-07-31	Yes	PR
CPCT02020105T	HMF001556	HMF001556A	0.67	female	1941	2018-08-01	Lung		Neuroendocrine tumor			1324,169	null	null	null	Yes	No	Yes	2014-02-18	2015-06-05	Everolimus/Everolimus/Everolimus	Targeted therapy	2014-04-11	Yes	SD
CPCT02020223TII	HMF003510	HMF003510A	0.47	female	1950	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-07-04	Liver	Segment 3	Yes	Yes	Yes	2015-10-09	2016-07-08	Tamoxifen	Hormonal therapy	2016-01-25	Yes	SD
CPCT02020232TII	HMF000288	HMF000288A	0.23	female	1945	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-05-02	Lymph node	right para-aortic	No	No	Yes	2015-12-02	2016-03-15	Pazopanib	Targeted therapy	2016-01-27	Yes	SD
CPCT02020245TII	HMF001089	HMF001089B	0.7	female	1968	2019-12-04	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-19	Lymph node	neck right	Yes	No	Yes	2015-12-30	2017-01-01	Fulvestrant	Hormonal therapy	2016-04-20	Yes	SD
CPCT02020246T	HMF001480	HMF001480A	0.69	female	1949	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	null	null	null	Yes	No	Yes	2016-03-24	2016-07-14	Doxorubicin	Chemotherapy	2016-05-23	Yes	SD
CPCT02020248TII	HMF001560	HMF001560A	0.59	female	1950	2018-02-02	Pancreas		Neuroendocrine tumor			1793,169	2017-07-18	Liver	segment 2/3	Yes	No	Yes	2016-01-27	2017-02-15	Everolimus	Targeted therapy	2016-04-06	Yes	SD
CPCT02020257TII	HMF000063	HMF000063A	0.73	female	1945	2017-01-31	Lung		Neuroendocrine tumor		Origin primary tumor not validated	1324,169	2016-05-26	Liver	Segment 4	No	No	Yes	2016-06-07	2016-10-26	Carboplatin	Chemotherapy	2016-08-17	Yes	SD
CPCT02020258T	HMF000016	HMF000016B	0.7	male	1942	2017-02-22	Prostate					10283	null	null	null	Yes	Yes	Yes	2016-02-17	2016-08-09	Cabazitaxel	Chemotherapy	null	null	null
CPCT02020258TII	HMF000016	HMF000016A	0.74	male	1942	2017-02-22	Prostate					10283	2016-10-18	Bone	os ileum	Yes	Yes	Yes	2016-02-17	2016-08-09	Cabazitaxel	Chemotherapy	null	null	null
CPCT02020267TIII	HMF000074	HMF000074C	0.31	male	1937	2017-07-01	Colorectum					9256	2017-03-21	Liver	unknown	Yes	Yes	Yes	2016-06-07	2017-02-01	Cetuximab	Targeted therapy	2016-07-29	Yes	SD
CPCT02020271T	HMF000304	HMF000304A	0.72	male	1943	2016-07-29	Skin		Melanoma			8923	2016-02-16	Lymph node	axilla right	No	No	Yes	2016-02-24	2016-04-26	Nivolumab	Immunotherapy	2016-05-06	Yes	PD
CPCT02020276T	HMF003677	HMF003677A	0.55	female	1952	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-23	Lymph node	neck (laterodorsal supraclavicular)	Yes	Yes	Yes	2016-02-19	2017-05-26	Letrozole	Hormonal therapy	2016-05-19	Yes	Non-CR/Non-PD
CPCT02020277TII	HMF000575	HMF000575A	0.91	male	1943	2018-10-31	Urothelial tract	Pyelum and Urethra	Carcinoma	Urothelial carcinoma		5974,734,2671	2017-09-22	Lymph node	subcarinal node	No	No	Yes	2016-04-08	2016-12-19	Pembrolizumab	Immunotherapy	2016-06-06	Yes	PR
CPCT02020283T	HMF003309	HMF003309A	0.61	male	1943	2017-08-06	Liver		Carcinoma	Hepatocellular carcinoma		684	2016-12-27	Liver	right lobe	No	No	Yes	2016-12-28	2017-01-05	VX-803	Targeted therapy	null	null	null
CPCT02020293T	HMF000904	HMF000904A	0.74	female	1951	2017-05-01	Colorectum					9256	2016-03-29	Lung	left lower lobe	Yes	No	Yes	2016-04-08	2016-07-19	Irinotecan	Chemotherapy	2016-05-31	Yes	SD
CPCT02020294T	HMF002248	HMF002248A	0.47	male	1945	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-04-11	Lung	supra lobe right	Yes	No	Yes	2016-05-06	2016-07-14	Nivolumab	Immunotherapy	2016-07-20	Yes	PD
CPCT02020298T	HMF002646	HMF002646A	0.85	female	1968	2016-10-07	Bone/Soft tissue		Sarcoma			1115	2016-04-19	Omentum	frontal abdominal wall	Yes	No	Yes	2016-04-21	2016-06-07	Doxorubicin	Chemotherapy	2016-06-02	Yes	PD
CPCT02020299T	HMF000529	HMF000529A	0.39	female	1946	2019-02-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-04-15	Thorax wall	Parasternal mass right	Yes	Yes	Yes	2016-04-21	2017-11-01	Letrozole	Hormonal therapy	2016-07-21	Yes	SD
CPCT02020307T	HMF001437	HMF001437A	0.87	female	1960	null	Ovary					2394	2016-05-02	Abdomen	omental cake left	No	No	Yes	2016-05-06	2016-09-30	Paclitaxel/Carboplatin/Paclitaxel/Carboplatin	Chemotherapy	2016-07-01	Yes	PR
CPCT02020310T	HMF002989	HMF002989A	0.61	male	1950	2018-07-12	Prostate					10283	2016-05-03	Bone	Os sacrum left	Yes	Yes	Yes	2016-05-04	2016-08-03	Docetaxel	Chemotherapy	2016-08-12	Yes	PD
CPCT02020313T	HMF001476	HMF001476A	0.54	male	1944	2017-12-31	Prostate					10283	2017-04-13	Liver	segment 6	Yes	Yes	Yes	2017-06-08	2017-09-25	Mitoxantrone	Chemotherapy	2017-08-09	Yes	PD
CPCT02020317T	HMF003153	HMF003153A	0.57	male	1958	2018-12-14	Small intestine		Neuroendocrine tumor			10154,169	2016-05-18	Liver	Segment 5	Yes	No	Yes	2016-07-01	2017-02-15	Pembrolizumab	Immunotherapy	2016-09-02	Yes	SD
CPCT02020320T	HMF001743	HMF001743A	0.71	male	1962	null	Skin		Melanoma			8923	2016-05-19	Lymph node	jugular gland left	No	No	Yes	2016-05-30	2016-08-09	Nivolumab	Immunotherapy	2016-08-16	Yes	PD
CPCT02020322T	HMF001443	HMF001443A	0.34	female	1959	2019-04-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-05-26	Bone	sacrum left	Yes	Yes	Yes	2016-06-16	2016-09-03	Exemestane/Everolimus	Multiple therapy	2016-09-02	Yes	PD
CPCT02020323T	HMF000995	HMF000995A	0.2	male	1946	2016-09-28	Prostate					10283	2016-05-17	Liver	segment 5	Yes	No	Yes	2016-06-08	2016-08-02	Apalutamide/Apalutamide	Hormonal therapy	2016-07-12	Yes	SD
CPCT02020325T	HMF001639	HMF001639A	0.91	male	1937	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2016-05-18	Rectum	proximal	No	No	Yes	2016-06-03	null	Imatinib	Targeted therapy	2016-08-22	Yes	PR
CPCT02020326T	HMF000700	HMF000700A	0.39	female	1960	2018-08-23	Liver		Carcinoma	Hepatocellular carcinoma		684	2016-06-07	Adrenal gland	left	No	No	Yes	2016-07-13	2016-08-10	Sorafenib/Sorafenib	Targeted therapy	null	null	null
CPCT02020333T	HMF001093	HMF001093A	0.7	female	1948	2017-10-01	Ovary					2394	2016-06-15	Peritoneum	ventralis	Yes	No	Yes	2016-06-16	2016-08-12	Carboplatin/Doxorubicin	Chemotherapy	2016-09-05	Yes	SD
CPCT02020340T	HMF003724	HMF003724A	0.57	male	1950	2017-06-17	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-07-07	Skin	subcutus right laterodorsaal	Yes	Yes	Yes	2016-07-07	2016-11-09	Sunitinib	Targeted therapy	2016-11-03	Yes	PD
CPCT02020341T	HMF000997	HMF000997A	0.52	female	1971	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-06-28	Liver	right lobe	Yes	No	Yes	2016-07-18	null	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02020342T	HMF003635	HMF003635A	0.75	male	1977	null	Skin		Melanoma			8923	2016-07-05	skin	subcutis right laterale femur	No	No	Yes	2016-07-14	2018-03-23	Nivolumab	Immunotherapy	2016-10-07	Yes	PR
CPCT02020343T	HMF002585	HMF002585A	0.71	female	1940	2016-10-25	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-07-07	Lymph node	mediastinum	No	No	Yes	2016-07-27	2016-08-24	Crizotinib	Targeted therapy	2016-08-30	Yes	SD
CPCT02020344T	HMF003072	HMF003072A	0.71	female	1953	2016-07-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-07-05	Subcutis	pre sternum	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020345T	HMF003062	HMF003062B	0.25	female	1956	2018-03-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-07-05	Liver	livertop	Yes	Yes	Yes	2017-03-22	2017-03-31	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02020345TII	HMF003062	HMF003062A	0.64	female	1956	2018-03-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-13	subcutis	presternal	Yes	Yes	Yes	2017-03-22	2017-03-31	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02020347T	HMF000085	HMF000085A	0.48	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-07-08	Lymph node	left axilla	No	No	Yes	2016-07-14	2017-06-06	Anastrozole	Hormonal therapy	2016-10-13	Yes	SD
CPCT02020351T	HMF000679	HMF000679A	0.42	male	1968	2018-07-27	Prostate					10283	2016-08-02	Bone	os ileum right	Yes	No	Yes	2016-08-17	2017-05-31	Enzalutamide	Hormonal therapy	2016-11-03	Yes	SD
CPCT02020351TII	HMF000679	HMF000679B	0.39	male	1968	2018-07-27	Prostate					10283	2017-06-15	Bone	os ileum right	Yes	No	Yes	2016-08-17	2017-05-31	Enzalutamide	Hormonal therapy	2016-11-03	Yes	SD
CPCT02020356T	HMF002046	HMF002046A	0.87	female	1947	2016-09-19	Head and neck	Tonsil	Carcinoma			8858,305,1542	2016-07-19	Bone	right os ileum	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020357T	HMF003733	HMF003733A	0.89	male	1949	2016-11-26	Prostate					10283	2016-08-03	Bone	occipitale	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020358T	HMF003659	HMF003659A	0.27	female	1957	null	Skin		Melanoma			8923	2016-08-04	Lymph node	right inguinal	No	No	Yes	2016-08-12	2017-02-17	Pembrolizumab/Pembrolizumab	Immunotherapy	2016-11-03	Yes	PD
CPCT02020362T	HMF001283	HMF001283A	0.82	male	1942	2018-11-06	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-12-01	Lung	left lower lobe	Yes	No	Yes	2017-12-04	2018-08-13	Pembrolizumab	Immunotherapy	2018-02-20	Yes	PD
CPCT02020369T	HMF002765	HMF002765B	0.77	female	1952	2017-06-09	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-18	subcutaneous	right mamma	Yes	Yes	Yes	2016-08-24	2017-01-18	Capecitabine	Chemotherapy	2016-10-18	Yes	SD
CPCT02020370T	HMF002110	HMF002110A	0.51	male	1949	2018-04-19	Prostate					10283	2016-08-24	Rectum	mesorectale fascie	Yes	Yes	Yes	2016-09-07	2017-01-11	Cabazitaxel	Chemotherapy	2016-11-02	Yes	SD
CPCT02020371T	HMF003771	HMF003771A	0.39	female	1964	2017-01-09	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-23	Liver	Segment 2	Yes	No	Yes	2016-09-02	2016-12-31	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02020373T	HMF000792	HMF000792A	0.5	female	1944	2017-02-23	Skin		Melanoma			8923	2016-08-31	skin	subcutane left knee	Yes	Yes	Yes	2016-08-31	2016-11-22	Pembrolizumab	Immunotherapy	2016-11-01	Yes	Non-CR/Non-PD
CPCT02020376T	HMF000425	HMF000425A	0.58	male	1948	2017-01-21	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-09-01	Kidney	tumormass right kidney	No	No	Yes	2016-09-05	2016-09-13	Pazopanib	Targeted therapy	null	null	null
CPCT02020377T	HMF003077	HMF003077A	0.44	female	1967	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-09-06	Lymph node	right-supraclaviculair	Yes	Yes	Yes	2016-09-17	2021-11-26	Anastrozole	Hormonal therapy	2017-02-21	Yes	Non-CR/Non-PD
CPCT02020378T	HMF003020	HMF003020A	0.63	male	1946	2017-01-31	Prostate					10283	2016-09-06	Bone	os ilium left	Yes	No	Yes	2016-10-12	2016-12-14	Pembrolizumab	Immunotherapy	2016-12-13	Yes	PD
CPCT02020380T	HMF000589	HMF000589A	0.37	male	1943	2017-12-26	Prostate					10283	2016-09-13	Lymph node	neck	Yes	Yes	Yes	2016-10-10	2016-11-30	Pembrolizumab	Immunotherapy	2016-11-23	Yes	PD
CPCT02020380TII	HMF000589	HMF000589B	0.44	male	1943	2017-12-26	Prostate					10283	2016-12-08	Adrenal gland	Adrenal gland	Yes	Yes	Yes	2016-10-10	2016-11-30	Pembrolizumab	Immunotherapy	2016-11-23	Yes	PD
CPCT02020382T	HMF002350	HMF002350B	0.46	female	1952	2019-01-27	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-10-04	Bone	costa 8 right	Yes	Yes	Yes	2016-10-18	2017-09-05	Anastrozole	Hormonal therapy	2017-08-23	Yes	PD
CPCT02020383T	HMF001724	HMF001724A	0.59	male	1951	null	Colorectum					9256	2016-10-06	Liver	segment 5	Yes	No	Yes	2016-10-21	2017-04-21	Cetuximab/Panitumumab	Targeted therapy	2017-01-06	Yes	PR
CPCT02020385T	HMF002775	HMF002775A	0.37	female	1948	2019-08-22	Breast		Carcinoma	Triple negative		0060081	2016-09-29	Lymph node	left axilla	Yes	No	Yes	2016-10-12	2017-02-09	Carboplatin	Chemotherapy	2016-12-20	Yes	PR
CPCT02020387T	HMF002029	HMF002029A	0.66	male	1946	2016-12-15	Prostate					10283	2016-10-04	Lymph node	para-aortal mass	Yes	No	null	null	null	null	null	null	null	null
CPCT02020388T	HMF003585	HMF003585A	0.61	male	1954	2018-10-10	Prostate					10283	2016-10-03	Lymph node	neck 3/4 left	Yes	No	Yes	2016-10-19	2017-05-17	Cabazitaxel	Chemotherapy	2017-01-03	Yes	PR
CPCT02020393T	HMF002496	HMF002496A	0.98	female	1950	2016-12-11	Ovary					2394	2016-10-05	Subcutus	tumormass near navel	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020394T	HMF002427	HMF002427A	0.68	male	1944	2017-10-04	Prostate					10283	2016-10-13	Bone	left iliacal	Yes	Yes	Yes	2016-10-19	2017-06-14	Enzalutamide	Hormonal therapy	2017-01-02	Yes	SD
CPCT02020398T	HMF001882	HMF001882A	0.29	female	1958	2017-02-18	Bone/Soft tissue		Rhabdomyosarcoma			3247,1115	2016-10-20	Bone	pelvis	No	No	null	null	null	null	null	null	null	null
CPCT02020399T	HMF001381	HMF001381A	0.66	female	1953	null	Unknown	CUP	Carcinoma	Neuroendocrine carcinoma		1800	2016-10-25	Liver	segment 5	Yes	No	null	null	null	null	null	null	null	null
CPCT02020403T	HMF000749	HMF000749A	0.43	male	1947	2017-11-11	Liver		Carcinoma	Hepatocellular carcinoma		684	2016-11-07	Liver	segment 5	No	No	Yes	2016-11-16	2017-04-03	Sorafenib	Targeted therapy	2017-01-10	Yes	SD
CPCT02020405T	HMF001750	HMF001750A	0.23	female	1973	2019-09-26	Gallbladder					3121	2016-11-14	Liver	segment 7/8	No	No	Yes	2016-11-23	2017-06-22	Gemcitabine/Cisplatin	Chemotherapy	2017-02-23	Yes	PR
CPCT02020406T	HMF000923	HMF000923A	0.34	male	1967	2017-09-17	Gallbladder					3121	2016-11-18	Liver	liver/paracholangio	No	No	Yes	2016-11-24	2017-04-28	Gemcitabine/Cisplatin	Chemotherapy	2017-01-20	Yes	SD
CPCT02020407T	HMF000295	HMF000295A	0.72	female	1944	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-11-29	Lymph node	axillair left	Yes	Yes	Yes	2016-12-01	2019-03-01	Everolimus/Exemestane	Multiple therapy	2017-04-28	Yes	SD
CPCT02020408T	HMF002661	HMF002661A	0.57	female	1967	null	Skin		Melanoma			8923	2016-11-18	Lymph node	right axillary	Yes	No	Yes	2016-11-30	2018-02-13	Pembrolizumab	Immunotherapy	2017-02-14	Yes	PR
CPCT02020409T	HMF003341	HMF003341A	0.61	male	1946	2017-02-12	Prostate					10283	2016-11-24	Lymph node	supraclavicular neck	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020410T	HMF002749	HMF002749A	0.24	male	1936	null	Skin		Melanoma			8923	2016-11-21	Lymph node	periclaviculair left	No	No	Yes	2016-11-24	2017-10-10	Nivolumab	Immunotherapy	2017-02-07	Yes	PR
CPCT02020412T	HMF003094	HMF003094A	0.32	male	1963	null	Skin		Melanoma			8923	2016-11-22	Primary	Neck right	No	No	Yes	2016-12-09	2017-08-18	Pembrolizumab	Immunotherapy	2017-02-24	Yes	SD
CPCT02020413T	HMF001811	HMF001811A	0.87	male	1963	2018-06-18	Pancreas		Neuroendocrine tumor			1793,169	2016-11-24	Liver	right liver lobe	Yes	No	Yes	2017-01-25	2017-06-07	Capecitabine/Temozolomide	Chemotherapy	2017-04-25	Yes	SD
CPCT02020413TII	HMF001811	HMF001811B	0.27	male	1963	2018-06-18	Pancreas		Neuroendocrine tumor			1793,169	2018-01-18	Liver	not specified	Yes	No	Yes	2017-01-25	2017-06-07	Capecitabine/Temozolomide	Chemotherapy	2017-04-25	Yes	SD
CPCT02020414T	HMF002471	HMF002471A	0.4	male	1958	2018-01-19	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-11-29	Kidney	Right kidney	Yes	Yes	Yes	2016-11-30	2017-03-07	Nivolumab	Immunotherapy	2017-02-06	Yes	SD
CPCT02020415T	HMF000091	HMF000091A	0.62	female	1982	2017-08-31	Lung		Neuroendocrine tumor			1324,169	2016-11-28	Lung	right mid lobe	No	Yes	null	null	null	null	null	null	null	null
CPCT02020417T	HMF003457	HMF003457A	0.7	male	1953	2017-09-20	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-12-01	Lymph node	supraclaviculair left	Yes	Yes	Yes	2016-12-19	2017-01-30	Pembrolizumab	Immunotherapy	2017-01-23	Yes	SD
CPCT02020419T	HMF000565	HMF000565A	0.32	male	1951	2017-08-07	Prostate					10283	2016-12-20	Lymph node	right iliac	Yes	Yes	Yes	2016-12-01	2017-07-27	Enzalutamide	Hormonal therapy	null	null	null
CPCT02020420T	HMF000280	HMF000280A	0.84	female	1947	2017-09-21	Ovary					2394	2016-12-13	Peritoneal	ventral abdomen	Yes	No	Yes	2016-12-14	2017-04-20	Pazopanib/Carboplatin/Paclitaxel	Multiple therapy	2017-02-13	Yes	SD
CPCT02020421T	HMF000484	HMF000484A	0.26	male	1946	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2016-12-05	Liver	right liverlobe	No	No	Yes	2016-12-05	2017-05-24	Sorafenib	Targeted therapy	2017-01-23	Yes	SD
CPCT02020422T	HMF003028	HMF003028A	0.41	male	1943	2017-03-25	Prostate					10283	2016-12-06	Liver	segment 5/6	Yes	No	Yes	2016-12-13	2017-01-25	Pembrolizumab	Immunotherapy	2017-02-10	Yes	PD
CPCT02020423T	HMF002815	HMF002815A	0.79	male	1982	null	Skin		Melanoma			8923	2016-12-08	subcutis	back dorsal	No	No	Yes	2016-12-23	2018-05-15	Pembrolizumab	Immunotherapy	2017-03-13	Yes	PR
CPCT02020424T	HMF000697	HMF000697A	0.54	male	1958	2017-04-14	Lung		Neuroendocrine tumor			1324,169	2016-12-19	Liver	right liver	Yes	No	Yes	2017-01-04	2017-01-20	Everolimus	Targeted therapy	2017-02-22	Yes	SD
CPCT02020426T	HMF003330	HMF003330A	0.55	female	1961	2017-03-15	Skin		Melanoma			8923	2016-12-12	Lymph node	left inguinal	No	No	Yes	2016-12-14	2017-02-03	Pembrolizumab	Immunotherapy	2017-02-01	Yes	PD
CPCT02020428T	HMF000712	HMF000712A	0.92	female	1993	null	Bone/Soft tissue		Desmoid type fibromatosis			0080366	2016-12-14	Peritoneum	mesenterium	Yes	No	Yes	2016-12-15	2017-02-06	Sorafenib	Targeted therapy	2017-02-01	Yes	PD
CPCT02020429T	HMF001629	HMF001629A	0.31	male	1946	2018-02-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-12-20	Lung	left upper lobe	Yes	Yes	Yes	2016-12-23	2017-05-26	Nivolumab	Immunotherapy	2017-03-13	Yes	SD
CPCT02020433T	HMF002629	HMF002629A	0.84	male	1943	null	Small intestine		Neuroendocrine tumor			10154,169	2016-12-27	Liver	segment 4	No	No	Yes	2017-02-06	2018-01-23	Octreotide	Hormonal therapy	2017-08-23	Yes	PD
CPCT02020434T	HMF001224	HMF001224A	0.88	female	1946	2018-10-14	Ovary					2394	2016-12-29	Liver	segment 6	Yes	No	Yes	2017-01-11	2017-05-10	Paclitaxel/Carboplatin/Doxorubicin	Chemotherapy	2017-03-13	Yes	SD
CPCT02020436T	HMF001656	HMF001656A	0.83	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-03	Liver	segment 4	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020438T	HMF001422	HMF001422A	0.37	female	1984	2018-11-13	Bone/Soft tissue		Follicular dendritic cell sarcoma			6262	2017-01-10	Liver	Segment 4	Yes	No	Yes	2017-02-14	2018-01-18	Vanucizumab/Selicrelumab	Unknown	2017-04-11	Yes	SD
CPCT02020441T	HMF003753	HMF003753A	0.34	female	1962	2020-07-08	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-10	Bone	Os ileum left	Yes	Yes	Yes	2017-02-02	2017-10-25	Everolimus/Exemestane	Multiple therapy	2017-04-20	Yes	Non-CR/Non-PD
CPCT02020442T	HMF002787	HMF002787A	0.83	female	1950	2017-11-07	Colorectum					9256	2017-01-12	Liver	right lobe	Yes	No	Yes	2017-02-27	2017-07-25	Trifluridine/Trifluridine	Chemotherapy	2017-04-19	Yes	SD
CPCT02020444T	HMF003032	HMF003032A	0.82	female	1947	2018-09-07	Pancreas		Neuroendocrine tumor			1793,169	2017-01-17	Liver	Segment 2/3	Yes	No	Yes	2017-01-30	2017-04-05	Everolimus/Sunitinib	Targeted therapy	2017-03-20	Yes	PD
CPCT02020445T	HMF002333	HMF002333A	0.49	female	1944	2018-02-22	Skin		Melanoma			8923	2017-01-13	Skin	unknown	No	No	Yes	2017-01-23	2017-06-21	Nivolumab	Immunotherapy	2017-04-19	Yes	PD
CPCT02020447T	HMF001936	HMF001936A	0.68	female	1963	2018-05-15	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-01-23	Kidney	right	No	Yes	Yes	2017-02-07	2017-10-05	Pazopanib	Targeted therapy	2017-06-30	Yes	SD
CPCT02020448T	HMF003373	HMF003373A	0.2	male	1963	2018-04-19	Liver		Carcinoma	Hepatocellular carcinoma		684	2017-01-19	Liver	liver	No	No	Yes	2017-01-25	2017-08-16	Sorafenib	Targeted therapy	2017-03-29	Yes	SD
CPCT02020449T	HMF003647	HMF003647A	0.45	male	1949	2017-04-19	Prostate					10283	2017-01-19	Liver	Segment 8	Yes	No	Yes	2017-02-01	2017-02-22	Cabazitaxel	Chemotherapy	2017-03-20	Yes	PD
CPCT02020452T	HMF003355	HMF003355A	0.77	female	1944	2017-02-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-01-24	Liver	Segment 2/3	Yes	No	Yes	2017-02-10	2017-02-23	Nivolumab	Immunotherapy	null	null	null
CPCT02020454T	HMF000756	HMF000756A	0.72	female	1964	2017-03-16	Colorectum					9256	2017-01-27	Liver	Segment 4	Yes	No	null	null	null	null	null	null	null	null
CPCT02020458T	HMF003603	HMF003603A	0.5	female	1946	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-01-30	Lung	right upper lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02020459T	HMF003335	HMF003335A	0.33	female	1957	null	Ovary					2394	2017-02-13	Peritoneum	Omentum	Yes	No	Yes	2017-03-13	2017-05-01	Olaparib	Targeted therapy	2017-04-07	Yes	SD
CPCT02020460T	HMF001876	HMF001876A	0.35	female	1966	2018-04-15	Bile duct		Carcinoma			4947	2017-02-07	Liver	liver	No	No	Yes	2017-02-22	2017-09-20	Cisplatin/Gemcitabine	Chemotherapy	2017-05-16	Yes	SD
CPCT02020465T	HMF000706	HMF000706A	0.64	female	1972	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-02-14	Liver	segment 6	No	No	Yes	2017-02-28	null	Imatinib	Targeted therapy	2017-05-16	Yes	PR
CPCT02020473T	HMF002061	HMF002061A	0.74	female	1956	null	Head and neck	Salivary gland				8850,11934	2017-02-24	Liver	Segment 2/3	Yes	No	null	null	null	null	null	null	null	null
CPCT02020474T	HMF003182	HMF003182A	0.54	female	1956	2018-09-29	Mesothelium		Malignant mesothelioma			1790,0050686	2017-02-27	Primary	left pleura	Yes	No	Yes	2017-04-21	2017-08-24	Pembrolizumab	Immunotherapy	2017-06-01	Yes	SD
CPCT02020475T	HMF003090	HMF003090A	0.73	female	1959	2017-05-29	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-28	Liver	Segment 2/3	Yes	Yes	Yes	2017-04-10	2017-05-12	Paclitaxel/Mucopolysaccharidosis I (MPS I) inhibitor	Multiple therapy	2017-05-11	Yes	PD
CPCT02020478T	HMF001418	HMF001418A	0.74	female	1964	null	Breast		Carcinoma	Triple negative		0060081	2017-03-06	Liver	liver	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020480T	HMF002469	HMF002469A	0.69	female	1934	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-03-07	Kidney	perirenal tissue	No	No	Yes	2017-03-28	2017-04-11	Sunitinib	Targeted therapy	null	null	null
CPCT02020482T	HMF003553	HMF003553A	0.26	female	1946	2017-10-07	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-03-07	Lymph node	supraclavicular left	Yes	No	Yes	2017-04-10	2017-07-25	Pembrolizumab	Immunotherapy	2017-06-30	Yes	SD
CPCT02020483T	HMF001874	HMF001874A	0.27	male	1937	2018-06-10	Pancreas					1793	2017-03-13	Liver	left lobe	No	No	Yes	2017-03-21	2018-03-22	Nab-paclitaxel/Gemcitabine	Chemotherapy	2017-05-08	Yes	PR
CPCT02020485T	HMF002419	HMF002419A	0.56	male	1963	2017-04-25	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-03-10	Lung	right lower lobe	Yes	Yes	Yes	2017-03-21	2017-04-04	Nivolumab	Immunotherapy	2017-04-11	Yes	PD
CPCT02020486T	HMF001856	HMF001856A	0.76	female	1981	2018-02-10	Colorectum					9256	2017-03-22	Abdomen subcutaneous	Ventral mass	Yes	No	Yes	2017-03-27	2017-07-17	LXH254	Experimental therapy	2017-05-15	Yes	SD
CPCT02020490T	HMF001940	HMF001940A	0.45	female	1973	2018-02-25	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-20	Liver	Segment 4b	Yes	Yes	Yes	2017-03-21	2018-02-08	Capecitabine	Chemotherapy	null	null	null
CPCT02020491T	HMF002762	HMF002762A	0.46	female	1957	null	Unknown	CUP	Carcinoma			305	2017-03-21	Kidney	peri renal tissue	No	No	Yes	2017-05-09	2017-10-02	Docetaxel	Chemotherapy	2017-06-14	Yes	SD
CPCT02020492T	HMF000343	HMF000343A	0.61	female	1967	2018-10-08	Uterus	Cervix				4362	2017-03-21	Peritoneum	Caudal of the liver	Yes	Yes	Yes	2017-03-24	2017-07-21	Carboplatin/Paclitaxel	Chemotherapy	2017-05-15	Yes	PR
CPCT02020493T	HMF000195	HMF000195B	0.46	female	1977	2019-06-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-23	Liver	liver	Yes	No	Yes	2017-03-24	2017-09-01	Paclitaxel	Chemotherapy	2017-06-16	Yes	PR
CPCT02020493TII	HMF000195	HMF000195A	0.58	female	1977	2019-06-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-26	Liver	unknown	Yes	No	Yes	2017-03-24	2017-09-01	Paclitaxel	Chemotherapy	2017-06-16	Yes	PR
CPCT02020497T	HMF002716	HMF002716A	0.33	male	1950	null	Colorectum					9256	2017-03-27	Lymph node	Supraclavicular right	Yes	No	null	null	null	null	null	null	null	null
CPCT02020501T	HMF001047	HMF001047A	0.67	male	1952	null	Prostate					10283	2017-04-04	Bone	L4	Yes	No	Yes	2017-04-10	2017-10-16	Cabazitaxel	Chemotherapy	null	null	null
CPCT02020502T	HMF002547	HMF002547A	0.69	male	1946	2018-03-29	Prostate					10283	2017-04-11	Lymph node	left inguinal	Yes	No	Yes	2017-05-09	2017-06-21	Docetaxel	Chemotherapy	2017-06-21	Yes	SD
CPCT02020505T	HMF001090	HMF001090A	0.94	female	1957	2018-01-23	Pancreas		Neuroendocrine tumor			1793,169	2017-04-20	Liver	liver	Yes	Yes	Yes	2017-07-20	2017-11-17	Lutetium (Lu) 177 DOTATATE	Nuclear therapy	2017-09-22	Yes	SD
CPCT02020506T	HMF002591	HMF002591B	0.61	male	1950	2017-09-22	Skin		Melanoma			8923	2017-04-26	Lymph node	left axilla	No	Yes	Yes	2017-05-02	2017-08-29	Vemurafenib/Cobimetinib	Targeted therapy	2017-07-24	Yes	SD
CPCT02020506TII	HMF002591	HMF002591A	0.57	male	1950	2017-09-22	Skin		Melanoma			8923	2017-09-11	Lymph node	left axilla	No	Yes	Yes	2017-05-02	2017-08-29	Vemurafenib/Cobimetinib	Targeted therapy	2017-07-24	Yes	SD
CPCT02020508T	HMF002985	HMF002985A	0.53	female	1952	2018-07-18	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-05-08	Liver	leftliverlobe	Yes	Yes	Yes	2017-05-18	2017-11-08	Pertuzumab/Paclitaxel/Trastuzumab	Multiple therapy	2017-07-11	Yes	PR
CPCT02020509T	HMF001898	HMF001898A	0.6	male	1988	null	Skin		Melanoma			8923	2017-05-01	subcutis	right shoulder	No	No	Yes	2017-05-02	2017-05-23	Nivolumab/Ipilimumab	Immunotherapy	2017-08-08	Yes	PR
CPCT02020511T	HMF002134	HMF002134A	0.86	female	1959	null	Skin		Melanoma			8923	2017-05-05	Subcutaneous	upper leg right	No	No	Yes	2017-05-11	2017-06-21	Nivolumab	Immunotherapy	2017-07-27	Yes	PR
CPCT02020513T	HMF002038	HMF002038A	0.62	female	1976	2018-03-13	Ovary					2394	2017-05-04	Peritoneum	lower abdomen lesion right	Yes	No	Yes	2017-05-04	2017-09-29	Letrozole	Hormonal therapy	2017-06-28	Yes	SD
CPCT02020514T	HMF002355	HMF002355A	0.66	female	1976	2020-08-25	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-05	Lymph node	right axillary	Yes	No	Yes	2017-05-11	2017-09-28	Paclitaxel	Chemotherapy	2017-07-14	Yes	PR
CPCT02020516T	HMF000613	HMF000613B	0.87	female	1951	null	Ovary					2394	2017-05-19	Peritoneum	pelvis	Yes	No	Yes	2017-05-26	2017-09-12	Carboplatin/Paclitaxel	Chemotherapy	2017-07-25	Yes	SD
CPCT02020517T	HMF000782	HMF000782A	0.27	male	1948	2017-05-26	Skin		Melanoma			8923	2017-05-16	Lymph node	Right axillary	No	No	null	null	null	null	null	null	null	null
CPCT02020519T	HMF000743	HMF000743A	0.46	male	1957	null	Skin		Melanoma			8923	2017-05-18	Primary	soft tissue right near scapula	No	No	Yes	2017-08-01	2018-05-24	Nivolumab	Immunotherapy	2017-10-10	Yes	SD
CPCT02020520T	HMF001748	HMF001748A	0.41	male	1952	2020-07-12	Skin		Melanoma			8923	2017-05-18	Subcutaneous	Left upper arm	No	No	Yes	2017-05-19	2017-10-10	Cobimetinib/Vemurafenib	Targeted therapy	null	null	null
CPCT02020521T	HMF001297	HMF001297A	0.37	male	1954	2019-02-21	Colorectum					9256	2017-05-29	Abdominal wall (Subcutaneous)	Abdominal wall	Yes	Yes	Yes	2017-05-30	2018-11-06	Trifluridine	Chemotherapy	2017-09-07	Yes	SD
CPCT02020523T	HMF003343	HMF003343A	0.84	male	1968	2017-09-18	Unknown	CUP	Carcinoma			305	2017-05-30	Lymph node	right	No	No	null	null	null	null	null	null	null	null
CPCT02020525T	HMF002630	HMF002630A	0.64	male	1939	2017-12-21	Prostate					10283	2017-06-12	Bone	right os sacrum	Yes	No	Yes	2017-06-29	2017-10-18	Radium-223	Nuclear therapy	null	null	null
CPCT02020526T	HMF001003	HMF001003A	0.63	female	1948	2018-02-13	Esophagus					5041	2017-05-30	Mamma	left	Yes	Yes	Yes	2017-05-31	2017-07-12	Carboplatin/Paclitaxel	Chemotherapy	2017-07-24	Yes	CR
CPCT02020533T	HMF003194	HMF003194A	0.37	female	1941	2017-07-28	Hepatobiliary system	Liver and Bile duct	Carcinoma	Combined hepatocellular carcinoma-cholangiocarcinoma		686,4947	2017-06-06	Liver	liver	No	No	Yes	2017-06-15	2017-06-24	Cisplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02020535T	HMF002946	HMF002946A	0.23	male	1951	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-06-07	Lung	bronchus mucous membrane	Yes	Yes	Yes	2017-06-16	2019-05-31	Nivolumab	Immunotherapy	2017-08-28	Yes	SD
CPCT02020536T	HMF002443	HMF002443B	0.43	male	1969	2018-03-22	Esophagus					5041	2017-06-08	Subcutaneous	Thoracic wall right (multiple)	Yes	Yes	Yes	2017-06-15	2017-11-01	Epirubicin/Oxaliplatin/Capecitabine	Chemotherapy	2017-08-09	Yes	SD
CPCT02020539T	HMF002086	HMF002086A	0.32	female	1974	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-06-16	Liver	right lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02020540T	HMF002832	HMF002832A	0.33	male	1949	2018-02-02	Unknown	CUP	Carcinoma			305	2017-06-20	Lymph node	Axillary right	No	No	Yes	2017-06-27	2017-09-12	Etoposide/Cisplatin/Carboplatin	Chemotherapy	2017-08-10	Yes	SD
CPCT02020541T	HMF002307	HMF002307A	0.48	female	1975	2019-07-31	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-20	Liver	right liver lesion	No	No	Yes	2017-07-05	2017-11-30	Paclitaxel	Chemotherapy	2017-09-21	Yes	SD
CPCT02020543T	HMF000050	HMF000050A	0.71	male	1965	2018-11-11	Prostate					10283	2017-07-19	Bone	hip	Yes	Yes	Yes	2017-07-27	2018-02-27	Enzalutamide	Hormonal therapy	null	null	null
CPCT02020544T	HMF000194	HMF000194A	0.63	female	1952	null	Ovary					2394	2017-06-28	Peritoneum	intra-abdominal mass	Yes	No	Yes	2017-06-29	2017-09-25	Doxorubicin/Carboplatin	Chemotherapy	2017-09-25	Yes	SD
CPCT02020545T	HMF000314	HMF000314A	0.74	female	1954	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-06-29	cutis	right thoracal wall	Yes	No	Yes	2017-07-04	null	Paclitaxel/Pertuzumab/Trastuzumab	Multiple therapy	null	null	null
CPCT02020546T	HMF000259	HMF000259A	0.24	male	1945	2017-11-06	Liver		Carcinoma	Hepatocellular carcinoma		684	2017-06-29	Liver	Right lobe	No	No	Yes	2017-07-11	2017-07-18	Sorafenib	Targeted therapy	null	null	null
CPCT02020554T	HMF002492	HMF002492A	0.38	male	1963	2018-04-05	Colorectum					9256	2017-07-20	Liver	segment 3	Yes	No	Yes	2017-07-25	2017-10-20	Trifluridine	Chemotherapy	2017-10-20	Yes	PD
CPCT02020559T	HMF002798	HMF002798A	0.46	male	1941	2018-03-08	Urothelial tract	Bladder	Carcinoma	Neuroendocrine carcinoma		4007,1800	2017-07-20	Liver	segment 8	No	No	Yes	2017-08-23	2017-12-13	Carboplatin/Etoposide	Chemotherapy	2017-10-12	Yes	PR
CPCT02020560T	HMF001189	HMF001189A	0.27	male	1958	null	Prostate					10283	2017-07-27	Bone	L4	Yes	No	Yes	2017-07-28	2018-10-22	Enzalutamide	Hormonal therapy	null	null	null
CPCT02020561T	HMF003456	HMF003456A	0.52	female	1954	2018-02-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-18	Liver	right lobe s8	Yes	No	Yes	2017-07-26	2017-12-15	Paclitaxel	Chemotherapy	2017-10-04	Yes	SD
CPCT02020565T	HMF000544	HMF000544A	0.79	female	1974	2018-03-31	Uterus	Cervix				4362	2017-07-14	Omentum	mass small pelvis	No	No	Yes	2017-07-28	2017-12-08	Cisplatin/Paclitaxel	Chemotherapy	2017-10-31	Yes	SD
CPCT02020566T	HMF001576	HMF001576A	0.21	male	1963	2020-04-29	Kidney		Carcinoma	Renal cell carcinoma		4450	null	null	null	No	No	Yes	2017-09-05	2018-03-06	Sunitinib	Targeted therapy	2017-12-19	Yes	PD
CPCT02020568T	HMF000763	HMF000763A	0.42	male	1945	2018-07-05	Mesothelium		Malignant mesothelioma			1790,0050686	2017-07-25	pleura	right paracardial	Yes	No	Yes	2017-08-14	2017-11-27	TAS-119	Experimental therapy	2017-09-27	Yes	PD
CPCT02020572T	HMF003668	HMF003668A	0.87	female	1954	2020-03-13	Ovary					2394	2017-08-30	Primary	ovarian (inside)	Yes	No	Yes	2017-10-23	2018-03-27	Carboplatin/Doxorubicin	Chemotherapy	2018-04-11	Yes	CR
CPCT02020573T	HMF001147	HMF001147A	0.58	female	1981	2018-03-17	Skin		Melanoma			8923	2017-07-31	Lymph node	left axillary	No	No	Yes	2017-08-23	2018-03-04	Vemurafenib/Cobimetinib	Targeted therapy	2017-11-08	Yes	PR
CPCT02020574T	HMF002868	HMF002868A	0.71	male	1992	2018-01-24	Skin		Melanoma			8923	2017-08-15	Liver	segment 6	No	No	Yes	2017-09-19	2017-12-12	Nivolumab	Immunotherapy	2017-12-07	Yes	PD
CPCT02020578T	HMF000253	HMF000253A	0.69	male	1937	2019-10-20	Skin		Melanoma			8923	2017-08-14	Primary	skin behind left ear	No	No	null	null	null	null	null	null	null	null
CPCT02020579T	HMF000739	HMF000739A	0.5	female	1962	2017-10-26	Pancreas		Neuroendocrine tumor			1793,169	2017-08-17	Liver	segment 6	Yes	No	Yes	2017-08-23	2017-09-13	Sunitinib	Targeted therapy	null	null	null
CPCT02020582T	HMF001240	HMF001240A	0.69	female	1947	null	Pancreas		Neuroendocrine tumor			1793,169	2017-08-29	Liver	dorsal right lobe	Yes	No	Yes	2017-09-05	2019-01-01	Lanreotide/Lanreotide	Hormonal therapy	2018-03-14	Yes	SD
CPCT02020583T	HMF002069	HMF002069A	0.62	male	1943	2018-05-31	Urothelial tract	Pyelum and Urethra	Carcinoma	Urothelial carcinoma		5974,734,2671	2017-08-21	Lymph node	right para-iliacal	Yes	No	Yes	2017-09-12	2018-02-06	Pembrolizumab	Immunotherapy	2017-11-29	Yes	SD
CPCT02020583TII	HMF002069	HMF002069B	0.42	male	1943	2018-05-31	Urothelial tract	Pyelum and Urethra	Carcinoma	Urothelial carcinoma		5974,734,2671	2017-12-15	Lymph node	Supraclavicular	Yes	No	Yes	2017-09-12	2018-02-06	Pembrolizumab	Immunotherapy	2017-11-29	Yes	SD
CPCT02020586T	HMF002597	HMF002597A	0.52	male	1968	2019-11-24	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-09-11	Lymph node	retro-peritoneal	Yes	No	Yes	2017-09-19	2018-08-08	Pembrolizumab	Immunotherapy	2017-12-11	Yes	PR
CPCT02020589T	HMF001889	HMF001889B	0.35	female	1981	null	Bile duct		Carcinoma			4947	2017-08-24	Liver	segment 4B	Yes	No	Yes	2017-09-13	2018-01-02	Cisplatin/Gemcitabine	Chemotherapy	2018-01-16	Yes	SD
CPCT02020591T	HMF001820	HMF001820A	0.67	female	1963	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-24	Liver	segment 4A	Yes	No	Yes	2017-08-22	null	Letrozole	Hormonal therapy	2017-12-21	Yes	PR
CPCT02020592T	HMF001554	HMF001554A	0.24	male	1951	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-08-29	Kidney	left	No	No	Yes	2017-09-26	null	Avelumab/Axitinib	Multiple therapy	2017-12-12	Yes	SD
CPCT02020593T	HMF000243	HMF000243A	0.62	female	1957	2018-08-23	Ovary					2394	2017-08-28	Subcutaneous	Retroperitoneal lesion right	Yes	No	Yes	2017-09-01	2018-01-05	Doxorubicin/Carboplatin	Chemotherapy	2018-01-26	Yes	SD
CPCT02020597T	HMF000718	HMF000718A	0.36	female	1951	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-04	Lymph node	neck right	Yes	Yes	Yes	2017-09-20	2018-07-27	Exemestane	Hormonal therapy	2017-12-15	Yes	SD
CPCT02020598T	HMF000250	HMF000250A	0.51	female	1954	2018-07-10	Uterus	Endometrium				1380	2017-09-04	Peritoneum	omental cake left	No	No	Yes	2017-09-05	2018-01-23	Carboplatin/Paclitaxel	Chemotherapy	2017-10-31	Yes	PR
CPCT02020599T	HMF000713	HMF000713A	0.58	female	1969	2018-07-31	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-11	subcutaneous	right shoulder	Yes	Yes	Yes	2017-09-01	2017-10-01	Capecitabine	Chemotherapy	null	null	null
CPCT02020600T	HMF000999	HMF000999A	0.6	female	1962	2017-11-25	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-09-08	Liver	segment 6	Yes	Yes	Yes	2017-09-19	2017-10-10	Pembrolizumab	Immunotherapy	null	null	null
CPCT02020608T	HMF000029	HMF000029A	0.63	male	1963	null	Small intestine		Neuroendocrine tumor			10154,169	2017-09-14	Liver	segment 8	Yes	No	Yes	2017-10-12	2018-03-29	Lutetium (Lu) 177 DOTATATE	Nuclear therapy	2018-01-16	Yes	SD
CPCT02020609T	HMF002866	HMF002866A	0.26	male	1928	null	Skin		Melanoma			8923	2017-09-14	skin	subcutis frontal	No	No	Yes	2017-09-19	2018-01-09	Nivolumab	Immunotherapy	2018-01-11	Yes	PD
CPCT02020610T	HMF002260	HMF002260A	0.94	male	1939	2018-03-26	Prostate					10283	2017-10-04	Bone	sacroiliac joint	Yes	Yes	Yes	2017-10-18	2017-12-13	Radium-223	Nuclear therapy	2018-01-15	Yes	PD
CPCT02020611T	HMF001832	HMF001832B	0.48	male	1946	2018-01-26	Colorectum					9256	2017-09-25	Liver	not specified	Yes	No	Yes	2017-10-03	2017-11-08	Irinotecan	Chemotherapy	2017-11-08	Yes	PD
CPCT02020613T	HMF002403	HMF002403A	0.49	male	1939	2018-10-22	Unknown	CUP	Neuroendocrine tumor			169	2017-10-09	Liver	left liver lobe	No	No	Yes	2017-11-30	2018-06-08	Lutetium (Lu) 177 DOTATATE	Nuclear therapy	2018-02-27	Yes	PR
CPCT02020614T	HMF001523	HMF001523A	0.71	male	1946	2018-08-19	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-10-12	Liver	Segment 4a/8	No	No	Yes	2017-10-25	2018-02-14	Carboplatin/Gemcitabine	Chemotherapy	2017-12-18	Yes	PR
CPCT02020615T	HMF001120	HMF001120A	0.65	male	1980	null	Skin		Melanoma			8923	2017-10-03	Lymph node	supraclavicular	No	No	Yes	2017-10-31	2018-06-26	Nivolumab	Immunotherapy	2018-01-17	Yes	PD
CPCT02020617T	HMF003392	HMF003392A	0.39	female	1949	2018-04-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-03	skin	subcutaneous back	Yes	Yes	Yes	2017-10-10	2017-11-17	Letrozole	Hormonal therapy	2017-11-15	Yes	PD
CPCT02020619T	HMF003160	HMF003160A	0.53	male	1958	2017-11-05	Urothelial tract		Carcinoma	Urothelial carcinoma		3996,2671	2017-10-17	Liver	segment 6	Yes	Yes	Yes	2017-10-17	2017-11-05	Pembrolizumab	Immunotherapy	null	null	null
CPCT02020620T	HMF002518	HMF002518A	0.56	male	1952	2018-11-24	Prostate					10283	2017-10-17	Lymph node	para-iliacal	Yes	No	Yes	2017-11-02	2017-12-14	Cabazitaxel	Chemotherapy	2017-12-28	Yes	PD
CPCT02020621TII	HMF000516	HMF000516B	0.24	male	1960	2019-09-09	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-09-13	omental lesion	cranomedial	Yes	Yes	Yes	2017-10-11	2018-05-01	Pembrolizumab	Immunotherapy	2017-12-28	Yes	PR
CPCT02020622T	HMF001397	HMF001397A	0.74	male	1949	2017-11-21	Esophagus					5041	2017-10-16	Liver	not specified	No	No	null	null	null	null	null	null	null	null
CPCT02020623T	HMF001705	HMF001705A	0.86	female	1972	2018-03-20	Uterus	Cervix				4362	2017-10-12	Lymph node	retroperitoneal	Yes	No	Yes	2018-01-11	2018-01-11	Pembrolizumab	Immunotherapy	2018-01-25	Yes	PD
CPCT02020626T	HMF000844	HMF000844A	0.52	female	1958	null	Skin		Melanoma			8923	2017-10-10	skin	subcutis	No	No	Yes	2017-10-17	2018-05-09	Nivolumab	Immunotherapy	2018-01-05	Yes	PR
CPCT02020628T	HMF001129	HMF001129A	0.74	male	1955	2019-10-03	Prostate					10283	2017-10-24	Liver	segment 4	Yes	No	Yes	2017-10-25	2018-02-12	Enzalutamide	Hormonal therapy	null	null	null
CPCT02020629T	HMF000129	HMF000129A	0.2	male	1941	2017-11-02	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2017-10-31	Liver	segment 6	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020630T	HMF002829	HMF002829A	0.94	male	1953	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-10-12	Liver	segment 4B/5	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020632T	HMF003499	HMF003499A	0.36	male	1947	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-10-24	Liver	segment 2	Yes	No	Yes	2017-10-25	2017-12-07	Pembrolizumab	Immunotherapy	2017-12-07	Yes	PD
CPCT02020633T	HMF003280	HMF003280A	0.51	male	1949	2019-05-02	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-10-16	Lymph node	para iliac left	No	No	Yes	2017-10-18	2017-12-27	Methotrexate/Vinblastine/Doxorubicin/Cisplatin	Chemotherapy	2017-11-22	Yes	SD
CPCT02020633TII	HMF003280	HMF003280B	0.45	male	1949	2019-05-02	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-08-29	Lymph node	para-iliac left	No	No	Yes	2017-10-18	2017-12-27	Methotrexate/Vinblastine/Doxorubicin/Cisplatin	Chemotherapy	2017-11-22	Yes	SD
CPCT02020635T	HMF002099	HMF002099A	0.72	female	1964	2017-11-15	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-20	Peritoneum	not specified	Yes	Yes	Yes	2017-10-28	2017-10-28	Eribulin	Chemotherapy	null	null	null
CPCT02020636T	HMF003040	HMF003040A	0.94	female	1987	2018-05-12	Uterus	Cervix				4362	2017-10-25	Lymph node	presacral	Yes	Yes	Yes	2017-11-03	2018-01-26	Carboplatin/Paclitaxel	Chemotherapy	2018-01-18	Yes	PD
CPCT02020637T	HMF001969	HMF001969A	0.35	female	1957	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-30	Liver	segment 2	Yes	Yes	Yes	2017-11-01	2018-04-01	Paclitaxel/Bevacizumab	Multiple therapy	2018-01-19	Yes	SD
CPCT02020641T	HMF000353	HMF000353A	0.78	male	1951	2018-05-01	Mesothelium		Malignant mesothelioma			1790,0050686	2017-11-14	Lung	pleura	Yes	No	null	null	null	null	null	null	null	null
CPCT02020642TII	HMF002909	HMF002909B	0.29	male	1947	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-05-17	Lymph node	Supraclavicular left	No	No	Yes	2019-05-21	2021-05-05	Pembrolizumab	Immunotherapy	2019-08-05	Yes	PR
CPCT02020643T	HMF001605	HMF001605B	0.47	male	1944	2018-09-17	Skin		Melanoma			8923	2017-11-17	skin	cranium	No	No	Yes	2017-11-24	2018-04-17	Cobimetinib/Vemurafenib/Nivolumab	Multiple therapy	null	null	null
CPCT02020646T	HMF003737	HMF003737A	0.2	male	1944	null	Mesothelium		Malignant mesothelioma			1790,0050686	2017-11-20	Lung	left upper lobe	Yes	No	Yes	2018-01-04	2018-06-21	Pembrolizumab	Immunotherapy	2018-03-20	Yes	SD
CPCT02020648T	HMF000227	HMF000227A	0.34	male	1946	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-11-27	Liver	segment 8	Yes	No	Yes	2017-11-28	2019-12-10	Pembrolizumab	Immunotherapy	2018-02-20	Yes	SD
CPCT02020650T	HMF001715	HMF001715A	0.63	female	1957	2019-01-01	Bone/Soft tissue	Uterus	Uterine stromal sarcoma			5165,1115	2017-12-05	Psoas left	abdominal mass	Yes	Yes	Yes	2017-12-05	2018-03-27	Pazopanib	Targeted therapy	2018-03-06	Yes	SD
CPCT02020651T	HMF001951	HMF001951A	0.44	male	1941	2018-04-13	Colorectum					9256	2017-11-28	Liver	segment 5	Yes	No	Yes	2017-12-07	2018-02-07	Trifluridine	Chemotherapy	null	null	null
CPCT02020653T	HMF003476	HMF003476A	0.72	male	1947	2020-03-06	Mesothelium		Malignant mesothelioma			1790,0050686	2017-12-04	Subcutaneous	thorax wall right	Yes	No	Yes	2018-03-20	2018-05-22	Pembrolizumab	Immunotherapy	2018-04-26	Yes	SD
CPCT02020656T	HMF001682	HMF001682A	0.84	male	1935	2019-11-27	Prostate					10283	2018-01-04	Lymph node	left axillary	Yes	Yes	Yes	2018-02-06	2018-07-03	Docetaxel	Chemotherapy	2018-04-09	Yes	SD
CPCT02020656TII	HMF001682	HMF001682B	0.77	male	1935	2019-11-27	Prostate					10283	2018-10-29	Lymph node	left axilla	Yes	Yes	Yes	2018-02-06	2018-07-03	Docetaxel	Chemotherapy	2018-04-09	Yes	SD
CPCT02020658T	HMF000114	HMF000114A	0.64	male	1941	2019-08-18	Prostate					10283	2018-01-11	Bone	rib left 8	Yes	Yes	Yes	2018-01-18	2018-04-12	Docetaxel	Chemotherapy	null	null	null
CPCT02020662T	HMF001914	HMF001914A	0.4	male	1961	null	Skin		Melanoma			8923	2017-12-18	Lymph node	Right inguinal	No	No	Yes	2018-01-03	2018-05-14	Vemurafenib/Cobimetinib	Targeted therapy	2018-04-06	Yes	PR
CPCT02020665T	HMF000725	HMF000725A	0.64	male	1951	2018-02-21	Skin		Melanoma			8923	2018-01-05	Skin/subcutaneous	Melanoma left chest	No	Yes	Yes	2018-01-05	2018-02-21	Vemurafenib/Cobimetinib	Targeted therapy	null	null	null
CPCT02020666T	HMF000374	HMF000374A	0.93	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-04	Bone	Metastasis os ileum right	Yes	No	Yes	2018-02-02	2018-03-08	Capecitabine	Chemotherapy	null	null	null
CPCT02020667T	HMF001827	HMF001827A	0.23	male	1947	2019-01-07	Bile duct		Carcinoma			4947	2017-12-28	Primary	intrahepatic cholangiocarcinoma	No	No	Yes	2018-01-31	2018-02-28	Irinotecan	Chemotherapy	2018-03-13	Yes	SD
CPCT02020670T	HMF002506	HMF002506A	0.51	male	1949	2018-11-05	Skin		Melanoma			8923	2018-01-18	Lymph node	Axilla right	No	No	Yes	2018-01-18	2018-04-10	Pembrolizumab	Immunotherapy	2018-04-10	Yes	PD
CPCT02020670TII	HMF002506	HMF002506B	0.62	male	1949	2018-11-05	Skin		Melanoma			8923	2018-04-16	Lymph node	Axilla right	No	No	Yes	2018-01-18	2018-04-10	Pembrolizumab	Immunotherapy	2018-04-10	Yes	PD
CPCT02020671T	HMF000519	HMF000519A	0.31	female	1958	2018-11-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-09	Lymph node	Supraclavicula	Yes	Yes	Yes	2018-01-18	2018-11-07	Nivolumab	Immunotherapy	2018-02-19	Yes	PR
CPCT02020672T	HMF003657	HMF003657A	0.9	male	1960	null	Skin		Melanoma			8923	2018-01-15	Skin/subcutaneous	left inguinal	No	Yes	Yes	2018-02-01	2018-02-28	Ipilimumab/Nivolumab	Immunotherapy	2018-04-18	Yes	SD
CPCT02020673T	HMF002434	HMF002434A	0.49	male	1952	2020-09-02	Prostate					10283	2018-01-30	Bone	Dorsal left os ilium	Yes	Yes	Yes	2018-01-31	2018-08-07	Cabazitaxel	Chemotherapy	2018-04-20	Yes	PR
CPCT02020678TII	HMF002663	HMF002663B	0.77	male	1964	2018-11-25	Prostate					10283	2018-10-24	Subcutaneous	Left coeur	Yes	No	Yes	2018-03-05	2018-10-12	Enzalutamide	Hormonal therapy	null	null	null
CPCT02020680T	HMF002272	HMF002272A	0.72	male	1952	2018-02-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-25	Liver	right	Yes	Yes	Yes	2018-02-02	2018-02-14	Letrozole	Hormonal therapy	null	null	null
CPCT02020682T	HMF002300	HMF002300A	0.48	female	1950	2019-07-03	Uterus	Endometrium				1380	2018-01-24	Lymph node	Inguinal right	Yes	No	Yes	2018-01-25	2018-07-12	Carboplatin/Paclitaxel/Pazopanib	Multiple therapy	2018-03-13	Yes	SD
CPCT02020683T	HMF001675	HMF001675A	0.5	male	1954	2019-12-31	Bone/Soft tissue		Myxofibrosarcoma			0080534	2018-02-01	Muscle tissue	Right groin; M. rectus femoris	Yes	Yes	Yes	2018-02-01	2019-01-18	Pazopanib	Targeted therapy	2018-06-11	Yes	SD
CPCT02020684T	HMF003770	HMF003770A	0.82	male	1954	2019-03-23	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-02-06	Muscle tissue	Left shoulder blade	Yes	No	Yes	2018-02-08	2018-05-15	Pembrolizumab	Immunotherapy	2018-05-11	Yes	SD
CPCT02020685T	HMF002813	HMF002813A	0.81	female	1966	2019-12-30	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-26	Lymph node	Subclavicular right	Yes	Yes	Yes	2018-02-02	2018-04-30	Palbociclib/Fulvestrant	Multiple therapy	2018-04-09	Yes	PD
CPCT02020686T	HMF002690	HMF002690A	0.61	male	1949	null	Prostate					10283	2018-03-02	Lymph node	obturatorloge	Yes	Yes	Yes	2018-03-15	2018-04-26	Pembrolizumab	Immunotherapy	2018-05-17	Yes	PD
CPCT02020687T	HMF001344	HMF001344A	0.23	male	1948	2020-08-15	Prostate					10283	2018-02-16	Bone	Dorsal right ilac crest	Yes	No	Yes	2018-03-06	2019-01-08	Cabazitaxel	Chemotherapy	2018-04-30	Yes	SD
CPCT02020688T	HMF001641	HMF001641A	0.76	female	1974	2018-06-09	Breast		Carcinoma	Triple negative		0060081	2018-02-02	Lymph node	Right axilla	Yes	No	Yes	2018-02-02	2018-03-16	Paclitaxel/Carboplatin	Chemotherapy	2018-03-20	Yes	PD
CPCT02020689T	HMF001030	HMF001030A	0.59	male	1942	null	Mesothelium		Malignant mesothelioma			1790,0050686	2018-02-02	Pulmonary pleurae	dorsolateral, between ribs	Yes	Yes	Yes	2018-03-07	2020-01-09	Pembrolizumab	Immunotherapy	2018-05-30	Yes	SD
CPCT02020690T	HMF002635	HMF002635A	0.71	male	1941	2018-05-28	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-02-13	Liver	Segment 6	No	Yes	Yes	2018-02-20	2018-04-25	Sorafenib	Targeted therapy	2018-04-23	Yes	PD
CPCT02020691T	HMF000827	HMF000827A	0.77	male	1966	2018-04-15	Bone/Soft tissue		Undifferentiated sarcoma	Pleomorphic sarcoma		1115	2018-02-05	Primary	Musculus deltoideus	Yes	Yes	Yes	2018-02-05	2018-04-06	Pazopanib	Targeted therapy	2018-03-27	Yes	PD
CPCT02020692T	HMF002796	HMF002796A	0.96	female	1952	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-02-09	Peritoneum	Omentum	Yes	Yes	Yes	2018-02-26	2019-02-01	Capecitabine	Chemotherapy	null	null	null
CPCT02020693T	HMF002743	HMF002743A	0.43	female	1981	2018-06-25	Breast		Carcinoma	Triple negative		0060081	2018-02-07	Mamma	Right	Yes	No	Yes	2018-02-09	2018-04-17	Paclitaxel	Chemotherapy	2018-04-20	Yes	PD
CPCT02020694T	HMF003281	HMF003281A	0.31	male	1969	null	Skin		Melanoma			8923	2018-02-07	Lymph node	Right inguinal nodes	No	No	Yes	2018-02-09	2020-02-05	Nivolumab/Ipilimumab	Immunotherapy	2018-04-19	Yes	PR
CPCT02020695T	HMF003805	HMF003805A	0.48	male	1953	2018-04-25	Colorectum					9256	2018-02-06	Lung	Left lower lobe	Yes	Yes	Yes	2018-03-14	2018-04-04	Trifluridine	Chemotherapy	2018-04-03	Yes	SD
CPCT02020696T	HMF000404	HMF000404A	0.47	male	1947	2018-09-08	Mesothelium		Malignant mesothelioma			1790,0050686	2018-02-19	Lung	Pleura left	Yes	No	Yes	2018-03-22	2018-05-24	Pembrolizumab	Immunotherapy	2018-05-03	Yes	SD
CPCT02020700T	HMF002566	HMF002566A	0.77	male	1972	2018-08-10	Skin		Melanoma			8923	2018-02-13	Lymph node	Inguinal nodes left	No	No	Yes	2018-02-16	2018-05-14	Ipilimumab/Nivolumab	Immunotherapy	2018-05-04	Yes	SD
CPCT02020703T	HMF003356	HMF003356A	0.4	male	1955	2019-08-17	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-02-22	Liver	Right	No	No	Yes	2018-03-28	2018-07-25	Gemcitabine/Carboplatin	Chemotherapy	2018-05-04	Yes	PR
CPCT02020704T	HMF003074	HMF003074A	0.92	male	1953	2019-03-21	Prostate					10283	2018-03-05	Bone	Rib left	Yes	No	Yes	2018-03-07	2018-06-21	Cabazitaxel	Chemotherapy	2018-05-23	Yes	PD
CPCT02020704TII	HMF003074	HMF003074B	0.86	male	1953	2019-03-21	Prostate					10283	2019-01-16	Lymph node	Left axilla	Yes	No	Yes	2018-03-07	2018-06-21	Cabazitaxel	Chemotherapy	2018-05-23	Yes	PD
CPCT02020706T	HMF003469	HMF003469A	0.9	male	1976	2019-10-27	Bone/Soft tissue		Clear cell sarcoma			4233	2018-03-01	Lymph node	Retroperitoneal, para aortal left	No	No	Yes	2018-03-02	2018-04-12	Ipilimumab/Nivolumab	Immunotherapy	2018-04-04	Yes	SD
CPCT02020711T	HMF002025	HMF002025A	0.71	female	1946	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-22	Lymph node	Supraclavicular left	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020712T	HMF000481	HMF000481A	0.51	female	1961	2018-05-18	Esophagus					5041	2018-02-27	Subcutaneous	mons pubis	Yes	Yes	Yes	2018-03-01	2018-03-06	Oxaliplatin/Capecitabine	Chemotherapy	null	null	null
CPCT02020714T	HMF002015	HMF002015A	0.68	female	1993	null	Skin		Melanoma			8923	2018-02-28	Subcutaneous	Laesion next to patella, right	Yes	No	Yes	2018-03-09	2018-06-22	Nivolumab/Vemurafenib/Cobimetinib/Trametinib/Dabrafenib/Trametinib/Dabrafenib	Multiple therapy	2018-06-15	Yes	SD
CPCT02020715T	HMF001913	HMF001913A	0.87	male	1937	2018-07-06	Prostate					10283	2018-03-20	Bone	os ileum right	Yes	Yes	Yes	2018-04-18	2018-05-16	Radium-223	Nuclear therapy	null	null	null
CPCT02020716T	HMF003612	HMF003612A	0.55	female	1986	2018-09-22	Uterus	Cervix				4362	2018-03-07	Peritoneum	Omentum	No	Yes	Yes	2018-03-15	2018-05-04	Paclitaxel/Cisplatin/Carboplatin	Chemotherapy	2018-05-07	Yes	SD
CPCT02020717T	HMF002912	HMF002912A	0.69	female	1950	2019-01-20	Urothelial tract	Bladder				11054	2018-03-21	Primary	Bladder	Yes	No	Yes	2018-03-27	2018-05-31	Pembrolizumab	Immunotherapy	2018-06-13	Yes	PD
CPCT02020718T	HMF002531	HMF002531A	0.26	male	1943	2019-11-10	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-03-12	Lymph node	Axilla left	Yes	Yes	Yes	2018-03-14	2019-04-03	Nivolumab	Immunotherapy	2018-05-08	Yes	SD
CPCT02020719T	HMF003518	HMF003518A	0.63	female	1968	2018-06-08	Breast		Carcinoma	Triple negative		0060081	2018-03-05	Skin/subcutaneous	Pre-sternal	Yes	Yes	Yes	2018-03-06	2018-03-06	Cisplatin	Chemotherapy	2018-03-20	Yes	PD
CPCT02020721T	HMF000668	HMF000668A	0.55	female	1964	2019-02-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-08	Lymph node	Axilla/thoracic wall, left	Yes	Yes	Yes	2018-03-26	2018-05-07	Palbociclib/Fulvestrant	Multiple therapy	2018-05-07	Yes	PD
CPCT02020723T	HMF001809	HMF001809A	0.67	male	1966	null	Skin		Melanoma			8923	2018-03-19	Lymph node	para aortal	No	No	Yes	2018-03-22	2018-04-12	Nivolumab/Ipilimumab	Immunotherapy	2018-05-25	Yes	PR
CPCT02020730T	HMF000198	HMF000198A	0.77	male	1951	null	Unknown				Paraganglioma or Neuroendocrine tumor, possibly lung	162	2018-03-13	Lymph node	Para aortal left	Yes	Yes	Yes	2018-03-21	2018-08-14	Dacarbazine/Cyclophosphamide/Vincristine	Chemotherapy	2018-05-16	Yes	SD
CPCT02020731T	HMF001623	HMF001623A	0.45	male	1947	2019-03-03	Prostate					10283	2018-03-27	Lymph node	Para-iliacal left	Yes	Yes	Yes	2018-03-29	2018-08-30	Cabazitaxel	Chemotherapy	2018-07-26	Yes	SD
CPCT02020734T	HMF003532	HMF003532A	0.94	female	1965	null	Uterus	Cervix				4362	2018-03-20	Primary	Cervix	No	No	Yes	2018-03-21	2020-02-13	Bevacizumab/Paclitaxel/Cisplatin	Multiple therapy	2018-05-16	Yes	PR
CPCT02020739T	HMF002849	HMF002849A	0.83	male	1943	2018-07-06	Skin		Melanoma			8923	2018-04-09	Subcutaneous	Right lateral	No	No	Yes	2018-05-25	2018-06-08	Cobimetinib/Atezolizumab/Nivolumab/Ipilimumab	Multiple therapy	null	null	null
CPCT02020740T	HMF000884	HMF000884A	0.52	female	1966	null	Ovary					2394	2018-04-05	Peritoneum	Epigastrio	Yes	No	Yes	2018-04-06	2020-06-04	Doxorubicin (liposomal)/Carboplatin/Olaparib	Multiple therapy	2018-06-29	Yes	PR
CPCT02020741T	HMF001208	HMF001208A	0.9	female	1951	2019-02-19	Ovary					2394	2018-04-09	Liver	Segment VI	Yes	No	Yes	2018-04-11	2018-08-30	Carboplatin/Paclitaxel/Pazopanib	Multiple therapy	2018-06-11	Yes	SD
CPCT02020743T	HMF001441	HMF001441A	0.74	male	1944	null	Skin		Melanoma			8923	2018-04-04	Lymph node	Axilla right	No	No	Yes	2018-04-10	2018-11-23	Nivolumab	Immunotherapy	2018-06-26	Yes	PR
CPCT02020744T	HMF000785	HMF000785A	0.28	female	1954	2018-12-09	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-04-11	Primary	Mamma left	Yes	Yes	Yes	2018-05-28	2018-07-17	Vinorelbine/Trastuzumab	Multiple therapy	2018-07-27	Yes	PD
CPCT02020750T	HMF000252	HMF000252A	0.52	male	1971	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-04-09	Abdominal	right	No	No	Yes	2018-04-17	2018-06-18	Imatinib	Targeted therapy	2018-06-15	Yes	SD
CPCT02020752T	HMF000047	HMF000047A	0.21	male	1954	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-04-16	Lung	Right upper lobe	Yes	No	Yes	2018-04-18	2018-09-19	Nivolumab	Immunotherapy	2018-07-06	Yes	SD
CPCT02020756T	HMF001034	HMF001034A	0.76	female	1951	2019-03-28	Small intestine		Neuroendocrine tumor			10154,169	2018-04-11	Liver	right lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02020757T	HMF003289	HMF003289A	0.44	female	1961	2019-03-22	Colorectum					9256	2018-04-17	Liver	Right lobe	Yes	No	Yes	2018-05-03	2018-08-16	Irinotecan	Chemotherapy	2018-07-05	Yes	PD
CPCT02020758T	HMF003177	HMF003177A	0.3	female	1958	2019-10-14	Appendix		Carcinoma	Pseudomyxoma peritonei		4902	2018-04-12	Peritoneum	Ventral stomach wall	No	No	Yes	2018-04-18	2018-06-11	Capecitabine/Oxaliplatin	Chemotherapy	2018-06-13	Yes	PD
CPCT02020759T	HMF002190	HMF002190A	0.67	male	1954	2018-06-20	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-04-24	Liver	not specified	Yes	Yes	Yes	2018-05-02	2018-05-28	Regorafenib	Targeted therapy	null	null	null
CPCT02020760T	HMF002699	HMF002699A	0.67	male	1951	null	Prostate					10283	2018-05-14	Lymph node	Retroperitoneal	Yes	Yes	Yes	2018-05-16	2018-10-17	Docetaxel	Chemotherapy	2018-07-16	Yes	PD
CPCT02020762T	HMF003076	HMF003076A	0.47	male	1950	2019-01-03	Bile duct		Carcinoma			4947	2018-04-16	Liver	Segment IVb	No	No	Yes	2018-04-18	2018-08-08	Gemcitabine/Cisplatin	Chemotherapy	null	null	null
CPCT02020764T	HMF002486	HMF002486A	0.42	female	1959	2018-09-18	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-04-17	Liver	Segment 6	No	No	Yes	2018-04-24	2018-09-18	Sunitinib	Targeted therapy	2018-07-05	Yes	PR
CPCT02020765T	HMF002511	HMF002511A	0.63	female	1963	2019-02-20	Mesothelium		Malignant mesothelioma			1790,0050686	2018-04-17	Lung	Pleura, right basal	Yes	No	Yes	2018-05-17	2018-09-06	Nivolumab	Immunotherapy	2018-08-09	Yes	SD
CPCT02020767T	HMF002737	HMF002737A	0.26	male	1945	null	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2018-04-26	Lymph node	Para-iliac right	Yes	No	Yes	2018-05-08	2020-03-31	Pembrolizumab	Immunotherapy	2018-07-24	Yes	PR
CPCT02020770T	HMF003093	HMF003093A	0.63	female	1944	2019-05-03	Skin		Melanoma			8923	2018-04-23	Skin/subcutaneous	Chin	Yes	No	Yes	2018-04-25	2018-12-18	Nivolumab	Immunotherapy	2018-07-03	Yes	SD
CPCT02020773T	HMF003712	HMF003712A	0.73	female	1945	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-01	Cutaneous	Thorax right (scar mamma)	Yes	Yes	Yes	2018-05-17	2019-06-25	Letrozole/Palbociclib	Multiple therapy	2019-02-26	Yes	PR
CPCT02020778T	HMF003524	HMF003524A	0.56	female	1958	2018-10-05	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-05-07	CNS	Right frontal brain	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020780T	HMF000599	HMF000599A	0.48	male	1935	null	Prostate					10283	2018-05-22	Bone	Th12	Yes	Yes	Yes	2018-05-24	2021-03-01	Enzalutamide	Hormonal therapy	null	null	null
CPCT02020781T	HMF002288	HMF002288A	0.44	female	1980	2018-08-17	Stomach					10534	2018-05-08	Liver	Segment 7	Yes	No	Yes	2018-05-11	2018-06-29	Ramucirumab/Paclitaxel	Multiple therapy	2018-07-02	Yes	PD
CPCT02020785T	HMF000083	HMF000083A	0.52	male	1931	null	Skin		Melanoma			8923	2018-05-16	Subcutaneous	Abdominal wall, below belly button	No	No	Yes	2018-05-16	2019-05-15	Nivolumab	Immunotherapy	2018-08-03	Yes	PR
CPCT02020787T	HMF000324	HMF000324A	0.94	male	1957	2019-09-27	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2018-05-17	Liver	Segment 5	No	No	Yes	2018-06-29	2018-11-07	Gemcitabine/Carboplatin	Chemotherapy	2018-08-29	Yes	PR
CPCT02020789T	HMF000804	HMF000804A	0.46	male	1967	null	Skin		Melanoma			8923	2018-05-22	Liver	Right lobe	No	No	Yes	2018-06-04	2018-07-13	Ipilimumab/Nivolumab	Immunotherapy	2018-08-15	Yes	PR
CPCT02020790T	HMF002162	HMF002162A	0.92	female	1952	2018-08-01	Bone/Soft tissue		Synovial sarcoma			5485,1115	2018-05-22	Primary	Left lung	Yes	No	Yes	2018-05-24	2018-07-12	Pazopanib	Targeted therapy	2018-07-12	Yes	PD
CPCT02020795T	HMF000988	HMF000988A	0.47	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-29	Liver	Left lobe	Yes	No	Yes	2018-06-11	2019-09-26	Palbociclib/Fulvestrant	Multiple therapy	2018-08-27	Yes	SD
CPCT02020796T	HMF003357	HMF003357A	0.28	male	1950	null	Skin		Carcinoma	Basal cell carcinoma		2513	2018-05-29	Primary	Lower abdomen	No	No	Yes	2018-05-29	2019-03-22	Vismodegib	Targeted therapy	2018-08-14	Yes	SD
CPCT02020797T	HMF000538	HMF000538A	0.86	male	1942	2019-05-19	Unknown	CUP	Neuroendocrine tumor			169	2018-06-12	Lymph node	Supraclavicular left	Yes	No	Yes	2018-08-09	2019-05-15	Sunitinib/Sunitinib	Targeted therapy	2018-10-30	Yes	PR
CPCT02020800T	HMF000711	HMF000711A	0.27	male	1946	2020-01-14	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-06-07	Lymph node	Inguinal left	No	No	Yes	2018-06-22	2018-10-12	Gemcitabine/Cisplatin	Chemotherapy	2018-08-23	No	PR
CPCT02020801T	HMF002359	HMF002359A	0.43	female	1960	2019-10-12	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-18	Liver	ventral	Yes	No	Yes	2018-06-25	2018-11-01	Palbociclib/Letrozole	Multiple therapy	2018-09-26	Yes	PD
CPCT02020802T	HMF000231	HMF000231A	0.63	male	1942	2018-12-06	Colorectum					9256	2018-06-04	Liver	1	Yes	No	Yes	2018-06-12	2018-07-17	Trifluridine/Trifluridine	Chemotherapy	2018-08-06	Yes	PD
CPCT02020804T	HMF000279	HMF000279A	0.55	male	1941	null	Prostate					10283	2018-06-11	mass mesorectum	pelvis	Yes	No	null	null	null	null	null	null	null	null
CPCT02020807T	HMF002196	HMF002196A	0.35	female	1963	2019-05-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-28	Liver	Segment 2	Yes	Yes	Yes	2018-07-05	2018-08-21	Palbociclib/Fulvestrant	Multiple therapy	null	null	null
CPCT02020808T	HMF002150	HMF002150A	0.47	male	1965	2019-06-12	Stomach					10534	2018-06-15	Lymph node	Supraclavicular left	No	No	Yes	2018-06-26	2018-10-30	Epirubicin/Oxaliplatin/Capecitabine	Chemotherapy	2018-08-21	Yes	PR
CPCT02020810T	HMF003680	HMF003680A	0.52	female	1969	null	Skin		Melanoma			8923	2018-06-25	Subcutaneous	Hip left	No	No	Yes	2018-06-26	2019-03-29	Vemurafenib/Cobimetinib	Targeted therapy	2018-09-20	Yes	PR
CPCT02020812T	HMF002303	HMF002303A	0.92	male	1980	2018-10-10	Bone/Soft tissue		Synovial sarcoma			5485,1115	2018-06-15	Primary	Right knee	Yes	No	Yes	2018-06-23	2018-10-01	Pazopanib	Targeted therapy	null	null	null
CPCT02020813T	HMF003762	HMF003762A	0.64	male	1964	null	Skin		Melanoma			8923	2018-06-26	Skin/subcutaneous	Abdominal wall, right	No	No	Yes	2018-07-03	2019-01-29	Pembrolizumab	Immunotherapy	2018-10-16	Yes	PD
CPCT02020815T	HMF001416	HMF001416A	0.3	female	1970	2019-10-28	Unknown	CUP	Carcinoma			305	2018-06-25	Lymph node	Supraclavicular right	Yes	No	Yes	2018-07-25	2018-09-05	Erlotinib	Targeted therapy	2018-09-05	Yes	SD
CPCT02020817T	HMF003571	HMF003571A	0.52	male	1940	2018-09-18	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-06-28	Peritoneum	Pelvis, right	No	No	Yes	2018-07-03	2018-08-14	Pembrolizumab	Immunotherapy	2018-09-05	Yes	PD
CPCT02020819T	HMF001449	HMF001449A	0.95	male	1975	2019-03-02	Skin		Melanoma			8923	2018-07-05	(Sub)cutaneous	Thoracic wall	No	No	Yes	2018-07-09	2018-09-19	Nivolumab	Immunotherapy	2018-09-28	Yes	PD
CPCT02020821T	HMF001308	HMF001308A	0.59	female	1942	null	Skin		Melanoma			8923	2018-07-05	Lung	Left lower lobe	No	No	Yes	2018-07-18	2018-09-26	Nivolumab	Immunotherapy	2018-10-02	Yes	PD
CPCT02020822T	HMF001445	HMF001445A	0.36	female	1940	null	Skin		Melanoma			8923	2018-07-05	(Sub)cutaneous	medial malleolus left	Yes	No	Yes	2018-07-05	2019-01-03	Nivolumab	Immunotherapy	2018-09-13	Yes	SD
CPCT02020824T	HMF003701	HMF003701A	0.32	female	1985	2019-10-20	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-09	Liver	Left	Yes	No	Yes	2018-07-10	2019-06-28	Capecitabine	Chemotherapy	2018-09-20	Yes	PR
CPCT02020827T	HMF001866	HMF001866A	0.43	male	1954	null	Prostate					10283	2018-07-16	Lymph node	Para-aortal	Yes	No	Yes	2018-08-15	2019-01-09	Abiraterone	Hormonal therapy	2018-11-14	Yes	SD
CPCT02020828T	HMF002142	HMF002142A	0.39	male	1959	null	Skin		Melanoma			8923	2018-07-20	Lymph node	Inguinal left	Yes	No	Yes	2018-07-24	2019-02-19	Nivolumab	Immunotherapy	2018-10-16	Yes	SD
CPCT02020829T	HMF003519	HMF003519A	0.49	female	1952	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-12	Peritoneum	Omentum	Yes	No	Yes	2018-07-23	2019-10-08	Palbociclib/Fulvestrant	Multiple therapy	2018-11-06	Yes	SD
CPCT02020830T	HMF003236	HMF003236A	0.25	female	1966	2019-01-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-13	Subcutaneous	Thoracic wall left lateral	Yes	Yes	Yes	2018-08-16	2018-10-04	Fulvestrant/Palbociclib	Multiple therapy	2018-10-17	Yes	PD
CPCT02020832T	HMF000172	HMF000172A	0.5	female	1948	2019-04-28	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-08-13	Peritoneum	Small pelvis left	Yes	No	Yes	2018-08-14	2018-10-16	Pembrolizumab	Immunotherapy	2018-11-08	Yes	PD
CPCT02020837T	HMF001253	HMF001253A	0.84	male	1942	null	Skin		Melanoma			8923	2018-07-30	Lymph node	Inguinal left	No	Yes	Yes	2018-08-02	2019-01-29	Nivolumab	Immunotherapy	2018-10-16	Yes	SD
CPCT02020837TII	HMF001253	HMF001253B	0.89	male	1942	null	Skin		Melanoma			8923	2019-03-04	Lymph node	iliac left	No	Yes	Yes	2018-08-02	2019-01-29	Nivolumab	Immunotherapy	2018-10-16	Yes	SD
CPCT02020839T	HMF003516	HMF003516A	0.26	female	1937	2018-10-11	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-08-31	Liver	Right lobe	No	No	Yes	2018-09-18	2018-10-01	Sorafenib	Targeted therapy	null	null	null
CPCT02020840T	HMF003223	HMF003223A	0.29	male	1952	2019-05-11	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-08-21	Lymph node	Inguinal left	No	Yes	Yes	2018-10-08	2019-01-22	Gemcitabine/Cisplatin/Carboplatin	Chemotherapy	2018-11-19	Yes	PR
CPCT02020847T	HMF001412	HMF001412A	0.66	male	1942	2020-01-21	Prostate					10283	2018-09-05	Bone	Os ilium left	Yes	No	Yes	2018-09-27	2019-01-03	Abiraterone	Hormonal therapy	null	null	null
CPCT02020848T	HMF002278	HMF002278A	0.28	female	1990	null	Bone/Soft tissue		Desmoid type fibromatosis		Familial Adenomatous Polyposis	0080366	2018-08-30	Desmoid	Abdominal wall	Yes	No	Yes	2018-08-30	2019-01-04	Sorafenib	Targeted therapy	2018-12-03	Yes	SD
CPCT02020852T	HMF002920	HMF002920A	0.39	male	1942	2019-11-04	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-09-17	Liver	segment 4	Yes	No	Yes	2018-09-20	2019-06-18	Sorafenib/Sorafenib	Targeted therapy	2018-11-23	Yes	SD
CPCT02020853T	HMF000027	HMF000027A	0.23	male	1951	null	Skin		Melanoma			8923	2018-09-28	skin left back	skin left back	No	Yes	Yes	2018-10-12	2019-03-28	Nivolumab	Immunotherapy	2018-12-27	Yes	SD
CPCT02020854T	HMF000183	HMF000183A	0.55	male	1955	2019-03-24	Skin		Melanoma			8923	2018-09-28	Lymph node	left axilla	No	No	Yes	2018-10-08	2019-03-12	Nivolumab/Ipilimumab/Cobimetinib/Vemurafenib	Multiple therapy	2019-01-15	Yes	SD
CPCT02020857T	HMF000734	HMF000734A	0.69	female	1963	2020-08-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-09-27	Liver	Left	Yes	Yes	Yes	2018-09-28	2020-03-09	Palbociclib/Fulvestrant	Multiple therapy	2019-02-15	Yes	SD
CPCT02020859T	HMF001887	HMF001887A	0.21	male	1946	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-10-05	Lymph node	Para-iliac	Yes	No	Yes	2018-10-09	2020-10-13	Pembrolizumab	Immunotherapy	2018-12-27	Yes	PR
CPCT02020861T	HMF001565	HMF001565A	0.66	male	1949	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-10-16	Primary	HCC	Yes	No	Yes	2018-10-29	2022-09-26	Regorafenib	Targeted therapy	2019-01-07	Yes	SD
CPCT02020863T	HMF000878	HMF000878A	0.89	male	1944	null	Skin		Melanoma			8923	2018-11-06	Lymph node	Axilla left	No	No	Yes	2018-11-09	2019-08-16	Nivolumab	Immunotherapy	2019-01-25	Yes	SD
CPCT02020865T	HMF003715	HMF003715A	0.6	male	1948	2020-09-04	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-10-30	Lymph node	Para-aortal	No	No	Yes	2018-11-07	2020-02-18	Pazopanib	Targeted therapy	2019-01-02	Yes	SD
CPCT02020866T	HMF003525	HMF003525A	0.72	male	1941	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-11-09	Kidney	Left	No	No	Yes	2018-11-30	2019-10-15	Sunitinib	Targeted therapy	2019-03-07	Yes	SD
CPCT02020867T	HMF001638	HMF001638A	0.27	male	1950	2019-03-04	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-10-30	Lymph node	Supraclavicular left	Yes	No	Yes	2018-10-31	2019-01-23	Pembrolizumab	Immunotherapy	2019-01-15	Yes	PD
CPCT02020868T	HMF000846	HMF000846A	0.83	male	1952	2019-07-15	Skin		Melanoma			8923	2018-11-15	Lymph node	Inguinal right	No	No	Yes	2018-11-16	2018-12-28	Nivolumab	Immunotherapy	2019-01-07	Yes	PD
CPCT02020872T	HMF000815	HMF000815A	0.98	female	1941	2020-01-13	Lung		Carcinoma	Small cell carcinoma		5409	2018-11-21	Liver	not specified	No	No	Yes	2018-11-24	2019-05-28	Carboplatin/Etoposide/Atezolizumab	Multiple therapy	2019-03-06	Yes	PR
CPCT02020876T	HMF004187	HMF004187A	0.26	male	1969	null	Mesothelium		Malignant mesothelioma			1790,0050686	2018-11-27	Subcutaneous	Extrathoracic left	Yes	No	Yes	2018-11-27	2021-01-19	Nivolumab	Immunotherapy	2019-02-19	Yes	PR
CPCT02020879T	HMF000550	HMF000550A	0.81	male	1938	2019-09-29	Mesothelium		Malignant mesothelioma			1790,0050686	2018-11-27	Primary	Left lung	Yes	No	Yes	2018-11-27	2019-03-19	Nivolumab	Immunotherapy	2019-02-19	Yes	SD
CPCT02020886T	HMF004024	HMF004024A	0.3	male	1948	2019-09-24	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-12-06	Liver	Segment 2/3	No	No	Yes	2019-01-09	2019-05-27	Sorafenib	Targeted therapy	2019-05-24	Yes	PD
CPCT02020887T	HMF004310	HMF004310A	0.41	female	1938	2019-03-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-10	Liver	Segment 2	Yes	Yes	Yes	2018-12-17	2019-01-28	Afatinib	Targeted therapy	2019-01-28	Yes	PD
CPCT02020888T	HMF004001	HMF004001A	0.65	male	1947	2020-01-18	Prostate					10283	2018-12-12	Bone	os ileum left	Yes	No	Yes	2018-12-18	2019-10-10	Enzalutamide	Hormonal therapy	null	null	null
CPCT02020894T	HMF004385	HMF004385A	0.59	female	1961	2019-10-17	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2019-01-08	Lymph node	Supraclavicular	Yes	No	Yes	2019-01-16	2019-03-20	Pembrolizumab	Immunotherapy	2019-04-02	Yes	PD
CPCT02020895T	HMF003967	HMF003967B	0.7	female	1951	2020-07-31	Skin		Melanoma			8923	2019-01-09	Skin/subcutaeous	Right upper leg	No	No	Yes	2019-02-05	2019-04-30	Nivolumab	Immunotherapy	2019-04-23	Yes	PD
CPCT02020896T	HMF003958	HMF003958A	0.25	male	1951	2021-03-17	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2019-01-15	Primary	Right kidney	No	No	Yes	2019-02-06	2019-03-14	Sunitinib	Targeted therapy	2019-03-06	Yes	SD
CPCT02020897T	HMF004332	HMF004332A	0.31	female	1948	null	Skin		Melanoma			8923	2019-01-22	Lymph node	Left supraclavicular	No	No	Yes	2019-01-30	2019-04-10	Nivolumab	Immunotherapy	2019-04-17	Yes	PR
CPCT02020898T	HMF004042	HMF004042A	0.56	female	1949	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-01-14	Mamma	Right	Yes	No	Yes	2019-01-29	null	Palbociclib/Fulvestrant	Multiple therapy	2019-04-26	Yes	SD
CPCT02020901T	HMF004167	HMF004167A	0.88	female	1965	null	Skin		Melanoma			8923	2019-01-21	Skin/subcutaneous	Abdominal wall	No	No	Yes	2019-01-25	2019-11-08	Nivolumab	Immunotherapy	2019-04-12	Yes	PD
CPCT02020902T	HMF003863	HMF003863A	0.49	male	1946	2020-01-01	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-01-31	Liver	Not specified	Yes	No	Yes	2019-02-05	2019-09-26	Pembrolizumab	Immunotherapy	2019-04-30	Yes	PR
CPCT02020903T	HMF003994	HMF003994A	0.91	male	1987	2019-07-22	Bone/Soft tissue		Malignant peripheral nerve sheath tumor			5940,1115	2019-01-22	Lung	Left dorsal	Yes	Yes	Yes	2019-01-25	2019-06-21	Pazopanib	Targeted therapy	2019-04-18	Yes	SD
CPCT02020906T	HMF004281	HMF004281A	0.52	male	1956	2019-03-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-29	Intramuscular	Right flank	Yes	Yes	Yes	2019-02-26	2019-02-26	Carboplatin/Pemetrexed	Chemotherapy	null	null	null
CPCT02020910T	HMF003852	HMF003852A	0.78	female	1950	2020-01-19	Skin		Melanoma			8923	2019-02-04	Subcutaneous	Pre-sternal	Yes	No	Yes	2019-02-21	2019-02-21	Nivolumab/Ipilimumab	Immunotherapy	2019-04-03	Yes	PD
CPCT02020912T	HMF004243	HMF004243A	0.29	female	1960	2019-07-09	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-07	Liver	Right lobe	Yes	Yes	Yes	2019-02-28	2019-06-19	Pembrolizumab	Immunotherapy	2019-04-26	Yes	SD
CPCT02020914T	HMF003894	HMF003894A	0.37	male	1948	null	Skin		Melanoma			8923	2019-02-08	Subcutaneous	Right scapula	No	No	Yes	2019-02-18	2019-11-25	Nivolumab	Immunotherapy	2019-05-06	Yes	SD
CPCT02020916T	HMF004337	HMF004337A	0.26	male	1952	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-02-12	Bone	Os pubis left	Yes	No	Yes	2019-02-19	2020-07-07	Pembrolizumab	Immunotherapy	2019-05-09	Yes	SD
CPCT02020918T	HMF004373	HMF004373A	0.81	male	1948	null	Prostate					10283	2019-02-25	Bone	Os ileum	Yes	No	Yes	2019-03-05	2020-05-14	Abiraterone	Hormonal therapy	null	null	null
CPCT02020918TII	HMF004373	HMF004373B	0.68	male	1948	null	Prostate					10283	2020-06-17	Bone	Right ileum, dorsal	Yes	No	Yes	2019-03-05	2020-05-14	Abiraterone	Hormonal therapy	null	null	null
CPCT02020919T	HMF003886	HMF003886A	0.21	male	1970	2019-12-07	Skin		Melanoma			8923	2019-02-19	(Sub)cutaneous	Occipital	No	Yes	Yes	2019-02-19	2019-08-07	Vemurafenib/Cobimetinib	Targeted therapy	null	null	null
CPCT02020920T	HMF003986	HMF003986A	0.3	male	1946	2019-08-19	Mesothelium		Malignant mesothelioma			1790,0050686	2019-02-18	Primary	Pleura right	Yes	No	Yes	2019-02-20	2019-05-29	Nivolumab	Immunotherapy	2019-04-03	Yes	PD
CPCT02020922T	HMF003931	HMF003931A	0.46	male	1947	2020-10-11	Mesothelium		Malignant mesothelioma			1790,0050686	2019-03-11	Lung	Pleural mass next to the liver	Yes	No	Yes	2019-03-13	2019-05-22	Nivolumab	Immunotherapy	2019-05-31	Yes	PD
CPCT02020924T	HMF004047	HMF004047A	0.51	male	1957	2020-01-14	Prostate					10283	2019-03-19	Lymph node	Right inguinal	Yes	No	Yes	2019-03-25	2019-08-14	Abiraterone	Hormonal therapy	2019-06-13	Yes	PR
CPCT02020925T	HMF004304	HMF004304A	0.36	female	1971	2019-03-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-22	Lymph node	Supraclavicular left	Yes	No	Yes	2019-02-19	2019-03-19	Nivolumab	Immunotherapy	null	null	null
CPCT02020931T	HMF004113	HMF004113A	0.64	male	1934	2019-05-04	Prostate					10283	2019-03-11	Lymph node	Iliac right	Yes	No	Yes	2019-03-18	2019-04-17	Abiraterone	Hormonal therapy	2019-04-25	Yes	PD
CPCT02020933T	HMF004392	HMF004392A	0.35	male	1955	2019-05-13	Skin		Melanoma			8923	2019-03-04	Lymph node	Supraclavicular right	No	No	Yes	2019-03-02	2019-04-09	Nivolumab/Ipilimumab	Immunotherapy	2019-04-05	Yes	PD
CPCT02020934T	HMF004108	HMF004108A	0.73	male	1950	2020-04-09	Skin		Melanoma			8923	2019-03-11	Lymph node	Cervical, level 5 left	No	No	Yes	2019-03-14	2019-11-01	Nivolumab/Nivolumab	Immunotherapy	null	null	null
CPCT02020937T	HMF004014	HMF004014A	0.95	female	1983	2020-04-06	Bone/Soft tissue		Synovial sarcoma			5485,1115	2019-03-13	Lung	Pleura	No	Yes	null	null	null	null	null	null	null	null
CPCT02020938T	HMF004221	HMF004221A	0.96	male	1956	2021-01-10	Prostate					10283	2019-03-21	Lung	Pleura para-mediastinal right	Yes	Yes	Yes	2019-04-03	2019-12-03	Abiraterone	Hormonal therapy	2019-05-29	Yes	SD
CPCT02020939T	HMF004274	HMF004274A	0.2	male	1951	null	Skin		Melanoma			8923	2019-03-15	Lymph node	Cervical left	No	No	Yes	2019-03-18	2019-10-21	Nivolumab	Immunotherapy	null	null	null
CPCT02020942T	HMF003885	HMF003885A	0.49	male	1949	2020-07-23	Prostate					10283	2019-04-03	Lymph node	Inguinal left	Yes	No	Yes	2019-04-17	2020-06-09	Abiraterone	Hormonal therapy	2019-07-08	Yes	PR
CPCT02020947T	HMF003900	HMF003900A	0.54	male	1948	2020-08-20	Mesothelium		Malignant mesothelioma			1790,0050686	2019-04-19	Lung	Pleura, right	Yes	No	Yes	2019-04-24	2020-08-13	Nivolumab	Immunotherapy	2019-06-06	Yes	SD
CPCT02020949T	HMF003093	HMF003093B	0.34	female	1944	2019-05-03	Skin		Melanoma			8923	2019-04-11	Lung	Not specified	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020951T	HMF004314	HMF004314A	0.27	male	1961	2020-01-07	Skin		Melanoma			8923	2019-04-19	Lymph node	Inguinal left	No	No	Yes	2019-04-26	2019-04-26	Ipilimumab/Nivolumab	Immunotherapy	null	null	null
CPCT02020952T	HMF003884	HMF003884A	0.43	female	1947	2019-10-17	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2019-04-25	Liver	Segment 4	Yes	No	Yes	2019-04-30	2019-07-02	Pembrolizumab	Immunotherapy	2019-07-15	Yes	PD
CPCT02020955T	HMF003976	HMF003976A	0.23	male	1944	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-05-02	Lung	LLL	No	No	Yes	2019-05-21	2019-10-22	Nivolumab/Ipilimumab	Immunotherapy	2019-08-01	Yes	PR
CPCT02020956T	HMF004171	HMF004171A	0.24	male	1949	2020-10-27	Mesothelium		Malignant mesothelioma			1790,0050686	2019-04-23	Lung	Apical left	Yes	No	Yes	2019-04-30	2019-10-29	Nivolumab	Immunotherapy	2019-06-07	Yes	SD
CPCT02020958T	HMF003915	HMF003915A	0.78	male	1977	2020-07-03	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-05-06	Lymph node	Obturatorloge left	Yes	No	Yes	2019-05-06	2019-05-06	Pembrolizumab	Immunotherapy	null	null	null
CPCT02020959T	HMF004291	HMF004291A	0.66	female	1960	2021-03-06	Skin		Melanoma			8923	2019-04-29	CNS	brain metastasis	No	No	Yes	2019-05-28	2019-07-30	Dabrafenib/Trametinib/Dabrafenib/Trametinib	Targeted therapy	2019-08-02	Yes	PR
CPCT02020960T	HMF004146	HMF004146A	0.94	male	1965	2020-03-27	Skin		Melanoma			8923	2019-05-02	Adrenal gland	Left	No	Yes	Yes	2019-06-07	2019-09-21	Dabrafenib/Trametinib	Targeted therapy	2019-08-30	Yes	SD
CPCT02020964T	HMF004124	HMF004124A	0.74	male	1952	2019-07-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-08	Lung	Right central	Yes	Yes	Yes	2019-05-28	2019-06-11	Nivolumab	Immunotherapy	null	null	null
CPCT02020966T	HMF004172	HMF004172A	0.84	female	1967	2021-07-31	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-05-16	Primary	Proximal medial	Yes	No	Yes	2019-06-06	2019-08-15	Doxorubicin/Fluorouracil/Cyclophosphamide	Chemotherapy	2019-07-15	Yes	SD
CPCT02020968T	HMF004100	HMF004100A	0.54	male	1937	null	Prostate					10283	2019-06-06	Lymph node	Retroperitoneal	Yes	Yes	Yes	2019-06-11	null	Abiraterone	Hormonal therapy	2019-09-10	Yes	PR
CPCT02020969T	HMF003992	HMF003992A	0.79	female	1970	2020-01-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-05-24	Bone	Os ileum left	Yes	No	null	null	null	null	null	null	null	null
CPCT02020970T	HMF001344	HMF001344B	0.66	male	1948	2020-08-15	Prostate					10283	2019-06-18	Bone	Ileum right	Yes	No	Yes	2019-06-18	2020-01-07	Abiraterone	Hormonal therapy	2019-09-16	Yes	PR
CPCT02020971T	HMF004013	HMF004013A	0.54	male	1948	2019-08-05	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-07-08	Lung	Metastasis	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020975T	HMF004443	HMF004443A	0.91	male	1947	null	Prostate					10283	2019-07-24	Lymph node	Para-iliac right	Yes	Yes	Yes	2019-07-31	2021-11-23	Abiraterone	Hormonal therapy	2020-01-24	Yes	PR
CPCT02020977T	HMF003862	HMF003862A	0.51	male	1948	2020-07-31	Prostate					10283	2019-08-09	Primary	Prostate	Yes	Yes	Yes	2019-08-10	2019-10-29	Abiraterone	Hormonal therapy	2019-10-01	Yes	PD
CPCT02020979T	HMF003908	HMF003908A	0.28	female	1954	2020-01-04	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-08-22	Lymph node	Para-iliac right	Yes	No	Yes	2019-08-27	2019-09-17	Pembrolizumab	Immunotherapy	2019-10-02	Yes	PD
CPCT02020982T	HMF004441	HMF004441A	0.21	male	1961	2019-12-16	Prostate					10283	2019-09-12	Lymph node	Mesenteric	Yes	No	Yes	2019-09-19	2019-12-12	Abiraterone	Hormonal therapy	2019-10-10	Yes	SD
CPCT02020983T	HMF004325	HMF004325A	0.35	male	1954	2020-02-24	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-09-10	Lymph node	Supraclavicular	Yes	No	Yes	2019-09-17	2019-12-10	Pembrolizumab	Immunotherapy	2019-11-05	Yes	SD
CPCT02020984T	HMF004422	HMF004422A	0.46	male	1947	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-09-16	Abdominal wall (intramuscular)	M. rectus abdominis right	No	No	Yes	2019-09-17	2021-09-24	Pembrolizumab	Immunotherapy	2019-12-09	Yes	PR
CPCT02020986T	HMF004529	HMF004529A	0.76	male	1972	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-10-16	Lymph node	Para-iliac right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020988T	HMF004723	HMF004723A	0.43	male	1948	2020-01-17	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-10-31	Liver	NS	Yes	Yes	Yes	2019-11-05	2019-11-26	Pembrolizumab	Immunotherapy	2019-12-11	Yes	PD
CPCT02020989T	HMF004710	HMF004710A	0.26	female	1961	2019-12-15	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-11-11	Liver	Segment 8	Yes	Yes	Yes	2019-11-13	2019-11-13	Pembrolizumab	Immunotherapy	2019-11-26	Yes	PD
CPCT02020991T	HMF004400	HMF004400A	0.78	male	1952	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-12-27	Lymph node	Para-iliac right	Yes	No	Yes	2019-12-31	2020-05-06	Pembrolizumab	Immunotherapy	2020-03-17	Yes	PR
CPCT02020993T	HMF004531	HMF004531A	0.34	male	1949	2020-04-22	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2020-02-19	Lymph node	Para-aortic	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02020996T	HMF004975	HMF004975A	0.59	female	1949	2020-10-29	Pancreas					1793	2020-06-15	Liver	Segment 6	No	No	Yes	2020-06-19	2020-10-09	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2020-08-10	Yes	SD
CPCT02020997T	HMF005176	HMF005176A	0.48	male	1965	2021-06-24	Pancreas					1793	2020-10-12	Liver	Left lobe	No	No	Yes	2020-10-16	2021-03-23	Fluorouracil/Oxaliplatin/Leucovorin/Irinotecan	Multiple therapy	2020-12-10	Yes	SD
CPCT02021002T	HMF005619	HMF005619A	0.41	male	1950	null	Pancreas					1793	2021-06-11	Liver	Segment 4	Yes	Yes	Yes	2021-06-23	2022-02-02	Fluorouracil/Oxaliplatin/Irinotecan/Leucovorin	Multiple therapy	2021-07-07	Yes	PD
CPCT02021008T	HMF006001	HMF006001A	0.57	male	1940	2022-05-24	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2022-02-14	Lung	right lower lobe	Yes	No	Yes	2022-02-17	2022-03-09	Pembrolizumab	Immunotherapy	2022-03-31	Yes	PD
CPCT02021009T	HMF006142	HMF006142A	0.84	male	1967	2022-09-06	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2022-06-02	Liver	Segment 8	Yes	No	Yes	2022-06-03	2022-07-13	Pembrolizumab	Immunotherapy	2022-08-02	No	PD
CPCT02021011T	HMF006548	HMF006548A	0.79	male	1942	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2022-11-22	Lung	Apical left	Yes	No	Yes	2022-11-25	null	Pembrolizumab	Immunotherapy	2023-02-07	Yes	SD
CPCT02030218TII	HMF001046	HMF001046A	0.53	female	1964	2018-06-15	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-17	Liver	right liver lobe	Yes	Yes	Yes	2015-02-24	2016-08-03	Exemestane/Everolimus	Multiple therapy	null	null	null
CPCT02030218TIII	HMF001046	HMF001046B	0.44	female	1964	2018-06-15	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-02	Liver	right lobe lesion segment 5	Yes	Yes	Yes	2015-02-24	2016-08-03	Exemestane/Everolimus	Multiple therapy	null	null	null
CPCT02030233T	HMF001614	HMF001614A	0.58	female	1961	2020-10-08	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-03-31	Lymph node	Supraclavicular left	Yes	Yes	Yes	2017-04-24	2018-11-13	Trastuzumab	Targeted therapy	2017-06-20	Yes	Non-CR/Non-PD
CPCT02030242T	HMF003527	HMF003527A	0.81	female	1957	2022-01-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-04-11	Liver	Most ventral left liver lobe	Yes	Yes	Yes	2016-04-18	2016-10-03	Cyclophosphamide/Fluorouracil/Methotrexate	Chemotherapy	2016-06-07	Yes	SD
CPCT02030243T	HMF001439	HMF001439A	0.52	male	1949	2016-09-09	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-05-02	Skin	subcutaneous part of the cutaneous lesion	Yes	Yes	Yes	2016-06-01	2016-08-04	Nivolumab	Immunotherapy	2016-06-17	Yes	SD
CPCT02030245T	HMF000357	HMF000357A	0.66	female	1949	null	Esophagus					5041	2016-05-10	esophagus - small intestine	unknown	No	No	Yes	2016-05-13	2016-06-26	Cisplatin/Etoposide	Chemotherapy	2016-07-07	Yes	PD
CPCT02030246T	HMF000714	HMF000714B	0.57	female	1948	2017-05-21	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-05-19	Lung	right lung dorsal	No	No	Yes	2016-05-26	2016-07-07	Doxorubicin	Chemotherapy	2016-07-28	Yes	PD
CPCT02030246TII	HMF000714	HMF000714A	0.54	female	1948	2017-05-21	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-08-18	intra abdominal	left side abdominal wall	No	No	Yes	2016-05-26	2016-07-07	Doxorubicin	Chemotherapy	2016-07-28	Yes	PD
CPCT02030247T	HMF002314	HMF002314A	0.82	male	1948	2016-09-09	Skin		Melanoma			8923	2016-05-20	Liver	left lobe	No	No	Yes	2016-05-27	2016-08-31	Vemurafenib	Targeted therapy	2016-07-15	Yes	PD
CPCT02030250T	HMF000684	HMF000684A	0.96	female	1943	2016-10-25	Ovary					2394	2016-05-31	Liver	right lobe	Yes	No	Yes	2016-06-14	2016-08-23	Bevacizumab/Carboplatin/Gemcitabine	Multiple therapy	2016-08-11	Yes	PD
CPCT02030256T	HMF001368	HMF001368A	0.24	female	1953	null	Skin		Melanoma			8923	2016-06-30	Lymph node	Level 5 right	No	No	Yes	2016-07-28	2017-11-30	Pembrolizumab	Immunotherapy	2016-10-07	Yes	PR
CPCT02030257T	HMF003385	HMF003385A	0.64	female	1955	2017-01-18	Esophagus					5041	2016-07-08	Liver	rigth liver lobe	Yes	Yes	Yes	2016-07-28	2016-10-17	Capecitabine/Oxaliplatin	Chemotherapy	2016-09-05	Yes	SD
CPCT02030258T	HMF000817	HMF000817A	0.73	female	1977	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-25	Bone	left ileum	Yes	Yes	Yes	2018-05-16	2020-07-01	Fulvestrant/Palbociclib/Ribociclib	Multiple therapy	2020-06-25	Yes	PD
CPCT02030259TII	HMF001102	HMF001102A	0.62	female	1956	2020-07-21	Ovary					2394	2016-07-18	Lymph node	Supraclavicular leven 4/5 left	Yes	No	Yes	2016-07-20	2017-06-06	Carboplatin/Gemcitabine/Bevacizumab	Multiple therapy	2016-09-28	Yes	PR
CPCT02030259TIII	HMF001102	HMF001102B	0.47	female	1956	2020-07-21	Ovary					2394	2018-02-19	Lymph node	supra clav left side	Yes	No	Yes	2016-07-20	2017-06-06	Carboplatin/Gemcitabine/Bevacizumab	Multiple therapy	2016-09-28	Yes	PR
CPCT02030262T	HMF002336	HMF002336A	0.48	male	1958	2016-10-12	Pancreas					1793	2016-07-20	Liver	right	Yes	No	null	null	null	null	null	null	null	null
CPCT02030264T	HMF002360	HMF002360A	0.25	female	1953	2017-04-04	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-17	Skin	skin lesion between mammae	No	No	Yes	2016-08-29	2016-12-01	Fulvestrant/Anastrozole	Hormonal therapy	2016-11-16	Yes	PD
CPCT02030265T	HMF002573	HMF002573B	0.34	female	1953	2018-04-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-18	Lymph node	axilla right	No	No	Yes	2016-09-02	2017-06-28	Anastrozole	Hormonal therapy	2017-01-31	Yes	Non-CR/Non-PD
CPCT02030265TII	HMF002573	HMF002573A	0.26	female	1953	2018-04-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-22	Muscle back	musculus erector spinae and gluteus minimus	No	No	Yes	2016-09-02	2017-06-28	Anastrozole	Hormonal therapy	2017-01-31	Yes	Non-CR/Non-PD
CPCT02030269T	HMF000361	HMF000361A	0.48	female	1956	null	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2016-09-07	Liver	Segment 2	No	No	Yes	2016-09-27	2017-01-20	Carboplatin/Gemcitabine	Chemotherapy	2016-11-21	Yes	SD
CPCT02030270T	HMF001387	HMF001387A	0.84	female	1966	2016-12-01	Skin		Melanoma			8923	2016-09-08	Lymph node	Left groin	No	No	Yes	2016-09-30	2016-11-10	Pembrolizumab	Immunotherapy	2016-10-25	Yes	PD
CPCT02030271T	HMF000309	HMF000309A	0.56	female	1958	2017-03-29	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-09-08	subcutis	left ventral of the manubrium sterni	Yes	No	Yes	2016-09-13	2016-12-28	Trastuzumab/Pertuzumab	Targeted therapy	2016-11-28	Yes	PR
CPCT02030272T	HMF000897	HMF000897A	0.86	female	1948	2017-09-17	Skin		Melanoma			8923	2016-09-09	Lymph node	lymfe node supraclaviculair left	No	No	Yes	2016-09-20	2017-08-29	Dabrafenib/Trametinib	Targeted therapy	2016-11-22	Yes	PR
CPCT02030274T	HMF000515	HMF000515A	0.38	female	1965	2016-11-15	Breast		Carcinoma	Triple negative		0060081	2016-09-20	Liver	subcapsular	Yes	Yes	Yes	2016-09-30	2016-10-21	Paclitaxel	Chemotherapy	null	null	null
CPCT02030275T	HMF003022	HMF003022A	0.87	male	1965	null	Head and neck	Oropharynx				8557,11934	2016-10-03	Lymph node	neck right	Yes	Yes	Yes	2016-10-14	2017-02-07	Cetuximab/Cisplatin/Fluorouracil	Multiple therapy	2016-12-13	Yes	PR
CPCT02030276T	HMF003368	HMF003368A	0.52	female	1973	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-10-03	Lung	middle lobe of right lung	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02030277T	HMF000774	HMF000774A	0.65	male	1949	2017-11-14	Esophagus					5041	2017-05-18	Liver	superficial lesion	Yes	Yes	Yes	2017-06-09	2017-07-28	Paclitaxel	Chemotherapy	2017-08-09	Yes	SD
CPCT02030278T	HMF002251	HMF002251A	0.75	female	1954	null	Ovary					2394	2016-10-10	Lymph node	supraclaviculair left	Yes	No	Yes	2016-10-12	2017-02-02	Gemcitabine/Carboplatin	Chemotherapy	2017-02-13	Yes	PR
CPCT02030279T	HMF000274	HMF000274A	0.72	female	1961	2022-03-04	Skin		Melanoma			8923	2016-10-10	subcutaneous	supra-clavicular right	No	No	Yes	2016-10-11	2017-02-14	Pembrolizumab	Immunotherapy	2017-01-03	Yes	PD
CPCT02030280T	HMF003430	HMF003430A	0.34	female	1950	2017-02-10	Ovary					2394	2016-10-10	Lymph node	Axilla right	Yes	Yes	Yes	2016-10-13	2017-01-03	Anastrozole	Hormonal therapy	2016-12-28	Yes	PD
CPCT02030284T	HMF003258	HMF003258A	0.69	male	1948	2017-08-12	Skin		Melanoma			8923	2016-10-28	Below left nipple	subcutaneous	No	No	Yes	2016-11-03	2017-07-08	Dabrafenib/Trametinib/Trametinib	Targeted therapy	2017-01-19	Yes	PR
CPCT02030285T	HMF003598	HMF003598A	0.2	male	1961	2018-10-05	Prostate					10283	2016-11-07	Lymph node	right groin	Yes	No	Yes	2016-12-14	2017-06-28	Docetaxel	Chemotherapy	2017-06-09	Yes	PR
CPCT02030286T	HMF002948	HMF002948A	0.48	male	1943	2017-01-25	Esophagus					5041	2016-11-07	Lymph node	supra-clavicular right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02030289T	HMF000889	HMF000889B	0.47	female	1952	2019-03-09	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-11	Lymph node	left axillair conglomerate	Yes	Yes	Yes	2016-11-23	2018-01-10	Trastuzumab	Targeted therapy	2017-01-19	Yes	PR
CPCT02030291T	HMF001154	HMF001154A	0.63	male	1948	2018-12-09	Skin		Melanoma			8923	2016-11-16	Lymph node	left axillair	No	No	Yes	2016-12-01	2017-09-07	Pembrolizumab	Immunotherapy	2017-02-17	Yes	PR
CPCT02030292T	HMF000278	HMF000278A	0.31	null	1956	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null	null
CPCT02030293T	HMF003365	HMF003365A	0.82	female	1959	2017-04-17	Anus					14110	2016-11-22	Liver	caudal right liver lobe	No	No	Yes	2016-11-26	2016-11-26	Capecitabine/Cisplatin	Chemotherapy	2017-01-09	Yes	SD
CPCT02030294T	HMF000316	HMF000316B	0.39	female	1964	2017-06-22	Head and neck	Lip and oral cavity				8564,11934	2016-11-23	skinlesion	neck low left	Yes	Yes	Yes	2016-12-09	2017-03-05	Pembrolizumab/Carboplatin/Fluorouracil	Multiple therapy	2017-02-09	Yes	PD
CPCT02030296T	HMF002413	HMF002413A	0.75	female	1954	2022-11-01	Ovary					2394	2016-11-25	omentum	paramedian peritoneal	No	No	Yes	2016-12-15	2017-01-25	Carboplatin/Paclitaxel	Chemotherapy	2017-01-18	Yes	PR
CPCT02030299T	HMF003260	HMF003260A	0.63	female	1958	2017-06-30	Ovary					2394	2016-11-30	Liver	ventral right lobe	Yes	No	Yes	2016-12-06	2017-02-21	Carboplatin	Chemotherapy	2017-03-20	Yes	PD
CPCT02030303T	HMF000508	HMF000508A	0.44	female	1955	2019-01-12	Ovary					2394	2016-12-14	Omentum	omental deposition	No	No	Yes	2016-12-30	2017-06-07	Carboplatin/Paclitaxel	Chemotherapy	2017-02-02	Yes	SD
CPCT02030304T	HMF002490	HMF002490A	0.71	female	1952	null	Esophagus					5041	2016-12-20	oesophagus	mid oesophageal	No	No	Yes	2017-01-02	2017-01-30	Paclitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02030305T	HMF002267	HMF002267A	0.83	female	1971	2020-02-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-15	Liver	segment 6	Yes	Yes	Yes	2016-12-22	2017-12-15	Anastrozole	Hormonal therapy	2017-02-02	Yes	SD
CPCT02030306T	HMF002606	HMF002606A	0.45	female	1935	2017-02-18	Colorectum					9256	2016-12-15	Liver	central	Yes	Yes	Yes	2016-12-19	2017-01-17	Trifluridine	Chemotherapy	2017-01-28	Yes	PD
CPCT02030307T	HMF003491	HMF003491A	0.34	male	1946	2017-08-06	Esophagus					5041	2016-12-22	gastric mucosa	gastro-oesophagal area	No	No	Yes	2017-01-02	2017-01-30	Paclitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02030314T	HMF002874	HMF002874A	0.75	male	1955	null	Small intestine		Neuroendocrine tumor			10154,169	2017-01-25	Lymph node	ileum	No	No	null	null	null	null	null	null	null	null
CPCT02030315T	HMF001588	HMF001588A	0.29	male	1977	2018-05-06	Hepatobiliary system					0080355	2017-02-01	Liver	segment 6	Yes	Yes	Yes	2017-02-03	2018-02-16	Oxaliplatin/Irinotecan/Fluorouracil	Chemotherapy	2017-04-03	Yes	SD
CPCT02030318T	HMF002880	HMF002880A	0.46	male	1974	2017-05-29	Stomach		Carcinoma	Adenocarcinoma		3717	2017-02-24	Liver	left liverlobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02030319T	HMF002555	HMF002555A	0.85	male	1975	2017-10-30	Colorectum	Colon sigmoideum	Carcinoma	Adenocarcinoma		12192,0050861	2017-02-27	Lymph node	iliacal right side	Yes	Yes	Yes	2017-02-28	2017-04-18	Fluorouracil/Irinotecan	Chemotherapy	2017-05-05	Yes	PD
CPCT02030320T	HMF002482	HMF002482A	0.63	female	1961	2017-10-25	Uterus	Cervix				4362	2017-02-28	Primary	viginal top	Yes	No	Yes	2017-03-16	2017-03-16	Paclitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02030323T	HMF001871	HMF001871A	0.65	female	1960	2017-10-18	Colorectum					9256	2017-03-09	Liver	left liver lobe	Yes	No	Yes	2017-03-20	2017-05-02	Irinotecan/Fluorouracil	Chemotherapy	2017-05-10	Yes	PD
CPCT02030324T	HMF003381	HMF003381A	0.29	female	1957	2018-03-14	Head and neck	Lip and oral cavity	Carcinoma	Squamous cell carcinoma		0050866,5520	2017-03-10	Lymph node	just above arteria subclavia left side	No	Yes	Yes	2017-03-15	2017-05-22	Cetuximab/Cisplatin/Capecitabine	Multiple therapy	null	null	null
CPCT02030325T	HMF002131	HMF002131A	0.84	female	1965	2017-08-03	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2017-03-13	Adnex	right	Yes	No	Yes	2017-03-15	2017-07-05	Gemcitabine/Docetaxel	Chemotherapy	2017-05-09	Yes	PR
CPCT02030329T	HMF000857	HMF000857A	0.49	female	1975	2019-02-08	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-31	Bone	Th 6	Yes	Yes	Yes	2017-04-07	2017-10-03	Fulvestrant	Hormonal therapy	2017-06-21	Yes	SD
CPCT02030330T	HMF000557	HMF000557A	0.5	male	1952	2017-07-18	Head and neck	Larynx	Carcinoma			2600,1542	2017-03-24	Lymph node	Supraclavicular left	Yes	Yes	Yes	2017-03-30	2017-07-07	Carboplatin/Capecitabine/Cetuximab	Multiple therapy	2017-05-29	Yes	SD
CPCT02030331T	HMF001142	HMF001142A	0.44	male	1955	2021-05-14	Colorectum					9256	2017-04-21	Liver	cranio-dorsal	No	Yes	Yes	2017-05-19	2018-12-27	Bevacizumab/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2017-07-21	Yes	SD
CPCT02030332T	HMF001722	HMF001722A	0.49	male	1950	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-04-24	muscle	right upper leg	No	No	Yes	2017-04-24	2018-07-04	Pazopanib	Targeted therapy	2017-07-31	Yes	SD
CPCT02030336T	HMF002675	HMF002675A	0.4	female	1946	2017-07-09	Liver		Carcinoma	Hepatocellular carcinoma		684	2017-05-02	Adrenal gland	left side	No	No	null	null	null	null	null	null	null	null
CPCT02030339T	HMF002603	HMF002603B	0.29	female	1949	2018-05-12	Skin		Melanoma			8923	2017-05-09	Left maximus gluteus	Subcutaneous	Yes	Yes	Yes	2017-05-24	2017-07-26	Pembrolizumab	Immunotherapy	2017-08-09	Yes	PD
CPCT02030339TII	HMF002603	HMF002603A	0.57	female	1949	2018-05-12	Skin		Melanoma			8923	2017-08-18	subcutaneous	subcutaneous lesion left side, dorsal iliacal	Yes	Yes	Yes	2017-05-24	2017-07-26	Pembrolizumab	Immunotherapy	2017-08-09	Yes	PD
CPCT02030340T	HMF003670	HMF003670A	0.77	female	1962	2017-10-12	Breast		Carcinoma	ER-positive/HER2-negative	Ductal adenocarcinoma	0060075,0060080	2017-05-12	Lymph node	upper arm/chest. not difined left or right	Yes	Yes	Yes	2017-05-22	2017-10-12	Vinorelbine/Exemestane/Everolimus	Multiple therapy	2017-07-11	Yes	PD
CPCT02030343T	HMF002777	HMF002777A	0.39	male	1966	2017-06-06	Colorectum					9256	2017-05-19	Omental cake	Omental cake	Yes	No	null	null	null	null	null	null	null	null
CPCT02030347T	HMF001981	HMF001981A	0.34	male	1936	2017-10-17	Stomach					10534	2017-05-31	Stomach	Angulus	No	No	Yes	2017-06-19	2017-07-02	Capecitabine/Oxaliplatin	Chemotherapy	null	null	null
CPCT02030349T	HMF000498	HMF000498B	0.31	female	1967	2019-02-10	Unknown	CUP	Carcinoma			305	2017-06-21	Lymph node	Axillair	Yes	Yes	Yes	2017-06-27	2017-10-17	Doxorubicin (liposomal)	Chemotherapy	2017-09-12	Yes	SD
CPCT02030350T	HMF001795	HMF001795A	0.59	male	1948	null	Skin		Melanoma			8923	2017-06-29	Bone	right side	No	No	Yes	2017-06-29	2018-01-24	Pembrolizumab	Immunotherapy	2017-09-14	Yes	PR
CPCT02030351T	HMF000633	HMF000633A	0.5	male	1981	2018-01-03	Head and neck	Tongue	Carcinoma			0080641,1542	2017-07-11	Lymph node	Neck, right side	No	Yes	Yes	2017-07-14	2017-12-07	Cetuximab/Cisplatin/Fluorouracil	Multiple therapy	2017-09-11	Yes	SD
CPCT02030353T	HMF000839	HMF000839A	0.82	male	1949	2017-11-11	Small intestine		Carcinoma	Neuroendocrine carcinoma		0050925,1800	2017-07-10	Primary	jejunum	Yes	No	Yes	2017-08-23	2017-09-28	Capecitabine/Temozolomide	Chemotherapy	2017-09-22	Yes	PD
CPCT02030354T	HMF000457	HMF000457A	0.25	female	1951	null	Uterus	Endometrium				1380	2017-07-12	Vagina	Subepithelial	No	No	Yes	2017-07-26	2017-11-28	Paclitaxel/Carboplatin	Chemotherapy	2017-09-19	Yes	PR
CPCT02030355T	HMF003329	HMF003329A	0.54	female	1953	2019-10-22	Ovary					2394	2017-07-13	Lymph node	supraclavicular left	Yes	No	Yes	2017-07-19	2017-10-17	Paclitaxel	Chemotherapy	2017-09-06	Yes	PR
CPCT02030357T	HMF001107	HMF001107B	0.56	male	1953	2019-06-30	Colorectum					9256	2017-07-19	Liver	Left lobe	Yes	No	Yes	2017-07-20	2018-02-27	Trifluridine	Chemotherapy	2018-03-22	Yes	PD
CPCT02030361T	HMF002612	HMF002612A	0.73	male	1958	2018-08-29	Colorectum					9256	2017-08-04	Liver	Segment 4B	Yes	Yes	Yes	2017-08-30	2018-03-21	Panitumumab	Targeted therapy	2017-11-06	Yes	SD
CPCT02030363T	HMF003608	HMF003608A	0.23	male	1950	2018-09-19	Esophagus					5041	2017-08-08	Muscle	Gluteus maximus right	Yes	Yes	Yes	2017-08-25	2018-05-04	Capecitabine/Oxaliplatin	Chemotherapy	2017-10-27	Yes	SD
CPCT02030364T	HMF003685	HMF003685A	0.73	male	1941	null	Small intestine	Duodenum	Neuroendocrine tumor			10021,169	2017-08-09	Liver	segment 2	No	No	Yes	2017-08-17	2018-06-14	Lanreotide	Hormonal therapy	2017-12-04	Yes	SD
CPCT02030365T	HMF002561	HMF002561A	0.87	male	1980	null	Small intestine		Neuroendocrine tumor			10154,169	2017-08-15	Liver	segment 6	No	No	Yes	2017-08-24	2022-03-18	Lanreotide	Hormonal therapy	2017-11-24	Yes	SD
CPCT02030366T	HMF001814	HMF001814A	0.35	male	1951	2017-11-16	Pancreas					1793	2017-08-16	Peritoneum	peritoneum	No	No	Yes	2017-08-25	2017-09-29	Oxaliplatin/Irinotecan/Fluorouracil	Chemotherapy	2017-10-08	Yes	SD
CPCT02030368T	HMF001611	HMF001611A	0.88	male	1958	2019-11-25	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-08-01	CNS	brain	No	No	Yes	2017-08-28	2017-11-03	Temozolomide	Chemotherapy	null	null	null
CPCT02030369T	HMF003616	HMF003616A	0.78	male	1966	null	Nervous system	Brain	Glioma	Glioblastoma multiforme		3068	2017-08-09	CNS	brain	No	No	Yes	2017-09-18	2018-09-03	Temozolomide/Temozolomide/ABT-414 or placebo	Multiple therapy	null	null	null
CPCT02030370T	HMF002254	HMF002254A	0.42	female	1946	2017-11-23	Skin		Melanoma			8923	2017-08-21	skin	noduli on the scalp	No	No	Yes	2017-08-23	2017-09-13	Pembrolizumab	Immunotherapy	2017-10-26	Yes	PD
CPCT02030371T	HMF003627	HMF003627A	0.42	female	1962	2017-11-18	Colorectum					9256	2017-08-22	Liver	left lobe	Yes	No	Yes	2017-09-11	2017-10-17	Trifluridine	Chemotherapy	null	null	null
CPCT02030373T	HMF000148	HMF000148A	0.39	female	1940	2018-01-05	Gallbladder					3121	2017-08-28	Lymph node	neck level 4 right side	Yes	No	Yes	2017-09-29	2017-11-17	Cisplatin/Gemcitabine	Chemotherapy	2017-11-24	Yes	PD
CPCT02030374T	HMF003686	HMF003686A	0.33	male	1949	2018-05-06	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-08-14	CNS	brain right side temporal	No	No	Yes	2017-09-22	2018-04-10	Temozolomide	Chemotherapy	null	null	null
CPCT02030375T	HMF001855	HMF001855A	0.66	female	1954	2018-05-27	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-08-15	CNS	Brain, right temporal	No	No	Yes	2017-09-25	2018-04-07	Temozolomide	Chemotherapy	null	null	null
CPCT02030377T	HMF003415	HMF003415A	0.9	female	1953	2021-04-08	Bone/Soft tissue	Meninges	Solitary fibrous tumor			3565,264,1115	2017-09-07	muscle tissue	glut. max left side	Yes	Yes	Yes	2017-09-12	2018-01-29	Pazopanib	Targeted therapy	2017-11-15	Yes	SD
CPCT02030380T	HMF003379	HMF003379B	0.48	male	1949	2018-07-28	Prostate					10283	2017-09-15	Bone	os ilium right side	Yes	Yes	Yes	2017-10-03	2018-03-08	Lutetium (Lu) 177 - Prostate-specific membrane antigen (PSMA)	Nuclear therapy	2017-12-11	Yes	PR
CPCT02030380TII	HMF003379	HMF003379A	0.62	male	1949	2018-07-28	Prostate					10283	2018-04-17	Bone	perlvis (bone)	Yes	Yes	Yes	2017-10-03	2018-03-08	Lutetium (Lu) 177 - Prostate-specific membrane antigen (PSMA)	Nuclear therapy	2017-12-11	Yes	PR
CPCT02030381T	HMF000199	HMF000199A	0.91	female	1963	2019-04-09	Uterus	Endometrium				1380	2017-09-19	Vagina	Vagina top	Yes	Yes	Yes	2017-10-03	2018-03-06	Paclitaxel	Chemotherapy	2017-12-19	Yes	SD
CPCT02030382T	HMF002194	HMF002194A	0.31	male	1983	2017-11-17	Colorectum					9256	2017-09-27	Primary	Sigmoid	No	No	Yes	2017-09-28	2017-11-14	Oxaliplatin/Leucovorin/Fluorouracil/Panitumumab	Multiple therapy	2017-11-06	Yes	PD
CPCT02030383T	HMF001478	HMF001478A	0.64	female	1963	2020-03-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-31	omentum	omentum right side	Yes	No	Yes	2018-06-05	2019-02-19	Paclitaxel	Chemotherapy	null	null	null
CPCT02030385T	HMF000925	HMF000925A	0.85	male	1946	2017-11-06	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-09-22	CNS	Brain right temporal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02030386T	HMF003406	HMF003406A	0.5	female	1978	2017-10-07	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-09-20	CNS	Brain left temporo-medial	No	No	null	null	null	null	null	null	null	null
CPCT02030387T	HMF002371	HMF002371A	0.87	female	1947	2019-01-13	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-09-13	CNS	Brain, right parasagital	No	No	Yes	2017-10-16	2017-10-30	Temozolomide	Chemotherapy	null	null	null
CPCT02030392T	HMF003589	HMF003589A	0.88	male	1962	2018-02-04	Nervous system	Brain	Glioma	Glioblastoma multiforme		3068	2017-09-27	CNS	Brain	No	No	Yes	2017-10-27	2018-01-15	Temozolomide	Chemotherapy	null	null	null
CPCT02030394T	HMF001725	HMF001725A	0.9	female	1955	2018-06-06	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-27	Lymph node	Axilla right	Yes	No	Yes	2017-10-15	2018-01-22	Tamoxifen	Hormonal therapy	2018-01-19	Yes	PD
CPCT02030396T	HMF002478	HMF002478A	0.92	male	1955	2018-02-20	Nervous system	Brain	Glioma	Glioblastoma multiforme		3068	2017-10-09	CNS	left side temporo-pari?to-occipitaal	No	No	Yes	2017-11-15	2018-01-29	Temozolomide	Chemotherapy	null	null	null
CPCT02030397T	HMF002821	HMF002821A	0.71	male	1962	2019-06-01	Nervous system		Glioma	Anaplastic astrocytoma-like glioma		3070	2017-10-09	CNS	Brain	No	No	Yes	2017-11-13	2018-04-22	Temozolomide	Chemotherapy	null	null	null
CPCT02030399T	HMF002651	HMF002651A	0.44	male	1964	2019-07-04	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-10-19	CNS	Brain right temporoparietal	Yes	Yes	Yes	2017-11-08	2018-06-07	Temozolomide	Chemotherapy	null	null	null
CPCT02030400T	HMF003405	HMF003405A	0.82	female	1946	2019-09-25	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-10-06	CNS	braintumor left frontal	No	No	Yes	2017-10-31	2018-05-22	Temozolomide	Chemotherapy	null	null	null
CPCT02030408T	HMF003217	HMF003217A	0.69	female	1961	2020-04-15	Ovary					2394	2017-10-13	ovary	left ovary	No	No	Yes	2017-10-20	2018-03-28	Carboplatin/Paclitaxel	Chemotherapy	2017-12-04	Yes	SD
CPCT02030410T	HMF002266	HMF002266A	0.36	male	1951	2020-02-28	Nervous system	Brain	Glioma	Glioblastoma multiforme		3068	2017-11-01	Glioblastoma	Brain	No	No	Yes	2017-12-14	2018-07-07	Temozolomide	Chemotherapy	null	null	null
CPCT02030414T	HMF003204	HMF003204A	0.73	female	1964	2018-01-16	Appendix		Carcinoma			4902	2017-10-23	Lymph node	Supraclavicular lymph nodes left	Yes	No	Yes	2017-11-15	2018-01-03	Capecitabine/Oxaliplatin	Chemotherapy	2018-01-09	Yes	PD
CPCT02030415T	HMF002993	HMF002993A	0.62	male	1960	2019-08-23	Bone/Soft tissue	Nose	Angiosarcoma			0001816,1115	2017-10-24	Primary	nose	No	No	Yes	2017-10-24	2018-03-27	Paclitaxel	Chemotherapy	2018-01-09	Yes	CR
CPCT02030416T	HMF003026	HMF003026A	0.76	female	1973	null	Nervous system	Brain	Glioma	Glioblastoma multiforme		3068	2017-11-16	brain left temporal GBM	left side temporal	No	No	null	null	null	null	null	null	null	null
CPCT02030417T	HMF001624	HMF001624A	0.52	female	1967	2018-07-23	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-10-30	CNS	Brain	No	No	Yes	2017-11-28	2018-04-03	Temozolomide	Chemotherapy	null	null	null
CPCT02030421T	HMF000649	HMF000649A	0.89	male	1944	2019-02-09	Nervous system	Brain	Glioma	Glioblastoma multiforme		3068	2017-11-09	CNS	frontal right	No	No	Yes	2017-12-11	2018-07-11	Temozolomide	Chemotherapy	null	null	null
CPCT02030422T	HMF002633	HMF002633A	0.84	female	1968	2022-12-16	Bone/Soft tissue	Uterus	Leiomyosarcoma			363,1967,1115	2017-11-10	intramuscular (soft tissue, mass)	sinistra pleura left	No	No	Yes	2017-11-13	2018-09-05	Doxorubicin/Olaratumab	Multiple therapy	2018-01-10	Yes	SD
CPCT02030425T	HMF001000	HMF001000A	0.85	male	1961	2018-05-11	Unknown	CUP	Carcinoma	Neuroendocrine carcinoma		1800	2017-11-15	Lymph node	Neck level 3 left	No	No	Yes	2017-11-20	2018-02-22	Carboplatin/Etoposide	Chemotherapy	2018-01-10	Yes	PR
CPCT02030428T	HMF002756	HMF002756A	0.58	female	1962	2019-05-01	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-04	breast left	left breast	Yes	No	Yes	2017-12-07	2018-06-26	Tamoxifen	Hormonal therapy	2018-03-01	Yes	SD
CPCT02030430T	HMF003436	HMF003436A	0.86	female	1945	2018-09-29	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-11-22	ovarium	ovarium	No	No	Yes	2017-12-22	2018-06-19	Temozolomide	Chemotherapy	null	null	null
CPCT02030435T	HMF001444	HMF001444A	0.65	male	1945	2019-09-16	Colorectum					9256	2017-11-29	Liver	Right lobe	Yes	Yes	Yes	2017-12-01	2018-10-23	Capecitabine/Bevacizumab/Fluorouracil	Multiple therapy	2018-01-26	Yes	PR
CPCT02030437T	HMF003718	HMF003718A	0.33	male	1977	null	Skin		Melanoma			8923	2017-12-01	skin, medial left upper leg	medial left upper leg	No	No	Yes	2017-12-08	2017-12-29	Nivolumab/Ipilimumab	Immunotherapy	2018-01-26	Yes	PR
CPCT02030440T	HMF003496	HMF003496A	0.39	female	1946	2018-09-05	Ovary					2394	2017-12-04	Lymph node	right groin	Yes	No	Yes	2017-12-05	2018-01-24	Gemcitabine	Chemotherapy	2018-02-07	Yes	PD
CPCT02030441T	HMF000329	HMF000329A	0.94	female	1962	2019-07-21	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-12-06	Primary	Brain	No	No	Yes	2018-01-09	2018-08-12	Temozolomide	Chemotherapy	null	null	null
CPCT02030442T	HMF002429	HMF002429A	0.59	male	1952	2018-04-03	Colorectum	Colon	Carcinoma			219	2018-01-17	Liver	segment 6	Yes	No	Yes	2018-02-23	2018-03-09	Capecitabine/Oxaliplatin	Chemotherapy	null	null	null
CPCT02030443T	HMF002679	HMF002679A	0.6	female	1972	2018-07-06	Colorectum					9256	2017-12-13	Liver	right lobe	Yes	Yes	Yes	2017-12-19	2018-02-27	Trifluridine	Chemotherapy	2018-02-26	Yes	PD
CPCT02030447T	HMF003783	HMF003783A	0.87	female	1972	2018-04-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-20	Liver	right lobe	Yes	Yes	Yes	2017-12-22	2018-02-06	Palbociclib/Fulvestrant	Multiple therapy	2018-02-22	Yes	PD
CPCT02030448T	HMF002244	HMF002244A	0.67	female	1978	2019-10-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-21	Bone	femur right	Yes	No	Yes	2018-01-11	2018-12-13	Capecitabine	Chemotherapy	2018-03-07	Yes	SD
CPCT02030453T	HMF003044	HMF003044A	0.89	male	1955	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-01-19	Primary	brain left frontal	No	No	null	null	null	null	null	null	null	null
CPCT02030454T	HMF000037	HMF000037A	0.26	female	1964	2018-07-02	Colorectum					9256	2018-01-18	Liver	unk	Yes	No	Yes	2018-01-22	2018-04-30	Leucovorin/Fluorouracil/Irinotecan	Multiple therapy	2018-03-14	Yes	SD
CPCT02030455T	HMF000509	HMF000509A	0.45	female	1971	2020-05-22	Ovary					2394	2018-01-22	mamma	right lateral	Yes	No	Yes	2018-02-27	2018-09-11	Gemcitabine/Bevacizumab	Multiple therapy	2018-05-15	Yes	SD
CPCT02030458T	HMF002945	HMF002945A	0.8	male	1953	2019-08-23	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-01-24	pancreas	pancreas	Yes	No	Yes	2018-01-24	2018-10-01	Regorafenib	Targeted therapy	2018-05-24	Yes	SD
CPCT02030459T	HMF001414	HMF001414B	0.52	female	1957	2019-10-24	Skin		Carcinoma	Basal cell carcinoma		2513	2018-01-25	Primary	scalp	No	No	Yes	2018-02-07	2019-02-27	Vismodegib	Targeted therapy	2018-02-09	Yes	SD
CPCT02030461T	HMF000214	HMF000214A	0.89	male	1944	2019-04-11	Skin		Melanoma			8923	2018-01-30	Lung	left upperlobe	No	Yes	Yes	2018-03-14	2019-03-08	Pembrolizumab	Immunotherapy	2018-05-18	Yes	SD
CPCT02030463T	HMF003754	HMF003754A	0.4	female	1972	2018-05-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-05	Liver	segment 5	Yes	Yes	Yes	2018-02-09	2018-04-04	Carboplatin	Chemotherapy	2018-04-18	Yes	PD
CPCT02030464T	HMF003449	HMF003449A	0.77	female	1940	2018-05-24	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2018-02-08	Lymph node	axilla left	Yes	No	Yes	2018-02-21	2018-03-13	Trastuzumab/Ado-trastuzumab emtansine (T-DM1)	Multiple therapy	2018-03-21	Yes	PD
CPCT02030465T	HMF000921	HMF000921A	0.87	male	1956	2019-01-24	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-02-09	Primary	right temporal	No	No	Yes	2018-03-05	2018-04-10	Temozolomide	Chemotherapy	null	null	null
CPCT02030466T	HMF003001	HMF003001A	0.22	female	1962	2019-10-31	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-02-12	Primary	brain	No	Yes	null	null	null	null	null	null	null	null
CPCT02030467T	HMF001070	HMF001070A	0.82	female	1953	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-02-16	Primary	brain (frontal right)	No	No	Yes	2018-03-20	2018-06-15	Temozolomide	Chemotherapy	null	null	null
CPCT02030468T	HMF002768	HMF002768A	0.38	female	1944	2018-11-12	Skin		Melanoma			8923	2018-02-16	Lymph node	inguinal left	No	No	Yes	2018-02-22	2018-06-28	Pembrolizumab	Immunotherapy	2018-05-09	Yes	SD
CPCT02030471T	HMF002758	HMF002758A	0.62	female	1948	null	Pancreas		Neuroendocrine tumor			1793,169	2018-02-20	Liver	left lobe	No	No	Yes	2018-02-27	2018-05-24	Lutetium (Lu) 177 DOTATATE	Nuclear therapy	null	null	null
CPCT02030472T	HMF003374	HMF003374A	0.65	female	1940	2018-07-17	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-21	Liver	left lobe	Yes	Yes	Yes	2018-03-28	2018-05-16	Cyclophosphamide/Doxorubicin	Chemotherapy	2018-06-11	Yes	PD
CPCT02030476T	HMF003504	HMF003504A	0.54	male	1953	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-03-21	Primary	right	No	No	null	null	null	null	null	null	null	null
CPCT02030477T	HMF000524	HMF000524A	0.79	female	1975	null	Ovary					2394	2018-03-21	between liver and kiney	right side	No	No	Yes	2018-04-05	2018-08-21	Carboplatin/Paclitaxel	Chemotherapy	2018-05-29	Yes	SD
CPCT02030478T	HMF000941	HMF000941A	0.38	female	1965	2020-07-01	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-03-22	Bone	Th7 right	Yes	Yes	Yes	2018-03-28	2018-06-22	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	2018-05-22	Yes	PR
CPCT02030479T	HMF002379	HMF002379A	0.61	female	1955	null	Skin		Melanoma			8923	2018-03-26	subcutaan lower leg right	subcutaan lower leg right	No	No	Yes	2018-04-04	2019-02-13	Pembrolizumab	Immunotherapy	2018-06-21	Yes	PR
CPCT02030483T	HMF002343	HMF002343A	0.57	male	1943	2019-01-28	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-04-06	Primary	brain	No	No	Yes	2018-05-07	2018-12-08	Temozolomide/Temozolomide	Chemotherapy	null	null	null
CPCT02030484T	HMF002073	HMF002073A	0.35	female	1967	2022-01-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-06	Liver	segment 5/6	No	No	Yes	2018-04-11	2018-07-25	Doxorubicin/Cyclophosphamide	Chemotherapy	null	null	null
CPCT02030487T	HMF001235	HMF001235A	0.79	male	1971	2019-12-08	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-04-19	Primary	brain	No	No	Yes	2018-05-22	2018-08-31	Temozolomide	Chemotherapy	null	null	null
CPCT02030490T	HMF003196	HMF003196A	0.87	male	1959	null	Skin		Melanoma			8923	2018-04-19	soft tissue	left flank	No	No	Yes	2018-04-26	2021-03-08	Ipilimumab/Nivolumab/Nivolumab	Immunotherapy	2018-06-11	Yes	SD
CPCT02030492T	HMF002954	HMF002954A	0.67	female	1942	2022-04-26	Ovary					2394	2018-04-24	Lymph node	axilla right	No	No	Yes	2018-05-01	2019-03-20	Bevacizumab/Gemcitabine/Carboplatin	Multiple therapy	2018-07-05	Yes	CR
CPCT02030493T	HMF000852	HMF000852A	0.29	male	1964	2019-02-23	Colorectum					9256	2018-04-24	Liver	segment 3	Yes	Yes	Yes	2018-05-01	2018-08-07	Bevacizumab/Tegafur, Gimeracil, Oteracil (S1)/Fluorouracil	Multiple therapy	2018-08-30	Yes	PD
CPCT02030495T	HMF001136	HMF001136A	0.38	female	1949	2019-01-22	Ovary					2394	2018-04-26	omental cake	right	No	No	Yes	2018-05-17	2018-07-27	Carboplatin/Paclitaxel	Chemotherapy	2018-06-14	Yes	SD
CPCT02030497T	HMF000493	HMF000493A	0.4	male	1947	2018-06-16	Unknown	CUP	Carcinoma	Neuroendocrine carcinoma		1800	2018-04-26	retroperitoneal mass	left	No	No	null	null	null	null	null	null	null	null
CPCT02030499T	HMF000535	HMF000535A	0.45	male	1962	2020-02-27	Skin		Melanoma			8923	2018-05-02	Lymph node	groin right	No	No	Yes	2018-05-07	2018-07-11	Nivolumab/Ipilimumab	Immunotherapy	2018-07-26	Yes	PR
CPCT02030500T	HMF003005	HMF003005A	0.33	female	1950	2018-07-16	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-05-03	subcutane	back	Yes	Yes	Yes	2018-05-18	2018-05-18	Doxorubicin/Cyclophosphamide	Chemotherapy	2018-05-28	Yes	SD
CPCT02030501T	HMF003547	HMF003547A	0.36	female	1954	2018-06-17	Pancreas					1793	2018-05-03	Liver	segment 4b	No	No	null	null	null	null	null	null	null	null
CPCT02030502T	HMF003038	HMF003038A	0.46	female	1954	2018-06-18	Adrenal gland	Adrenal cortex	Carcinoma			3948	2018-05-07	Liver	left	No	No	Yes	2018-05-14	2018-06-14	Etoposide/Cisplatin/Doxorubicin/Mitotane	Chemotherapy	null	null	null
CPCT02030505T	HMF001312	HMF001312A	0.65	female	1962	2020-02-26	Ovary					2394	2018-05-16	Lymph node	axilla right	Yes	No	Yes	2018-05-22	2019-04-24	Gemcitabine/Carboplatin/Niraparib	Multiple therapy	2018-10-02	Yes	PR
CPCT02030506T	HMF001888	HMF001888A	0.62	male	1960	2018-11-27	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-05-24	Primary	left frontoparietal	No	No	Yes	2018-06-20	2018-11-09	Temozolomide/Bevacizumab	Multiple therapy	null	null	null
CPCT02030507T	HMF003774	HMF003774A	0.44	female	1966	2019-03-16	Vulva					1245	2018-05-24	Lymph node	lesion inguinal right	No	Yes	Yes	2018-05-31	2018-07-10	Carboplatin/Paclitaxel	Chemotherapy	2018-07-26	Yes	PD
CPCT02030508T	HMF003301	HMF003301A	0.92	female	1952	2018-09-02	Lung		Carcinoma	Small cell carcinoma		5409	2018-05-25	Lymph node	supra-claviculair right	Yes	Yes	Yes	2018-06-05	2018-08-09	Carboplatin/Cisplatin	Chemotherapy	2018-07-13	Yes	SD
CPCT02030509T	HMF002825	HMF002825A	0.28	female	1953	null	Ovary					2394	2018-05-29	omental cake	omental cake	No	No	Yes	2018-06-07	2018-10-24	Carboplatin/Paclitaxel/Docetaxel	Chemotherapy	2018-07-11	Yes	PR
CPCT02030510T	HMF002152	HMF002152A	0.51	male	1944	2019-02-24	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-06-01	Primary	brain	No	No	Yes	2018-06-26	2018-12-04	Temozolomide	Chemotherapy	null	null	null
CPCT02030513T	HMF001810	HMF001810A	0.87	female	1951	2019-05-09	Bone/Soft tissue		Undifferentiated sarcoma			1115	2018-06-04	Peritoneum	peritoneal mass right flank	Yes	No	Yes	2018-06-20	2018-11-28	Doxorubicin/Olaratumab	Multiple therapy	2018-08-15	Yes	PR
CPCT02030514T	HMF002281	HMF002281A	0.7	female	1955	2020-06-04	Colorectum					9256	2018-06-05	Liver	S2	Yes	No	Yes	2018-06-12	2018-07-31	Fluorouracil/Bevacizumab	Multiple therapy	2018-08-09	Yes	PD
CPCT02030516T	HMF001434	HMF001434A	0.87	male	1950	2018-11-12	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-06-08	Primary	brain	No	No	Yes	2018-07-10	2018-08-20	Temozolomide	Chemotherapy	null	null	null
CPCT02030517T	HMF001177	HMF001177A	0.6	female	1958	2018-07-23	Ovary					2394	2018-06-07	Lymph node	inguinal left	Yes	Yes	Yes	2018-06-15	2018-06-15	Doxorubicin (liposomal)	Chemotherapy	null	null	null
CPCT02030519T	HMF000177	HMF000177A	0.57	male	1958	2019-05-17	Esophagus					5041	2018-06-08	Liver	liver left	No	No	Yes	2018-06-15	2018-12-21	Trastuzumab/Oxaliplatin/Capecitabine	Multiple therapy	2018-08-10	Yes	SD
CPCT02030520T	HMF000447	HMF000447A	0.66	male	1956	2018-10-07	Prostate		Neuroendocrine tumor			2992,169	2018-06-11	Liver	Left lobe	Yes	Yes	Yes	2018-06-13	2018-08-10	Etoposide/Carboplatin	Chemotherapy	2018-08-01	Yes	SD
CPCT02030521T	HMF002657	HMF002657A	0.25	female	1955	null	Breast		Carcinoma	Triple negative		0060081	2018-06-11	Lymph node	supraclaviculair right	No	Yes	null	null	null	null	null	null	null	null
CPCT02030522T	HMF003362	HMF003362A	0.63	female	1980	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-12	Liver	S 5/6	Yes	Yes	Yes	2018-06-14	2018-09-27	Cyclophosphamide/Doxorubicin/Bevacizumab	Multiple therapy	2018-08-06	Yes	SD
CPCT02030528T	HMF002532	HMF002532A	0.79	male	1965	2019-03-15	Colorectum					9256	2018-06-20	Liver	S7/8	Yes	Yes	Yes	2018-06-26	2018-08-08	Trifluridine	Chemotherapy	2018-08-16	Yes	PD
CPCT02030529T	HMF000842	HMF000842A	0.53	female	1964	2020-08-07	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-06-22	CNS	right occipital	No	No	Yes	2018-09-24	2019-03-01	Temozolomide	Chemotherapy	null	null	null
CPCT02030531T	HMF001369	HMF001369A	0.46	male	1947	2019-11-27	Lung		Carcinoma	Small cell carcinoma		5409	2018-07-02	CNS	left frontal brain	Yes	Yes	Yes	2018-07-20	2018-08-27	Etoposide/Carboplatin	Chemotherapy	2018-09-11	Yes	SD
CPCT02030532T	HMF002509	HMF002509A	0.73	female	1973	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-06-27	Primary	brain	Yes	Yes	Yes	2018-08-07	2018-09-17	Temozolomide	Chemotherapy	null	null	null
CPCT02030537T	HMF000294	HMF000294A	0.81	male	1956	2019-09-07	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-06-29	CNS	brain right parietal	No	No	Yes	2018-07-31	2019-03-25	Temozolomide/Temozolomide	Chemotherapy	null	null	null
CPCT02030543T	HMF001853	HMF001853A	0.65	male	1946	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-07-19	Lung	pleura	Yes	No	Yes	2018-07-20	2018-12-19	Cabozantinib	Targeted therapy	2018-10-12	Yes	SD
CPCT02030545T	HMF002730	HMF002730A	0.43	male	1943	2019-03-17	Prostate					10283	2018-08-15	Bone	os ileum right	Yes	Yes	Yes	2018-08-31	2018-12-27	Docetaxel	Chemotherapy	2019-01-11	Yes	PD
CPCT02030546T	HMF002548	HMF002548A	0.54	female	1964	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-21	brain	parietaal right	No	No	Yes	2018-11-13	2020-05-01	Pembrolizumab/Carboplatin/Pemetrexed	Multiple therapy	2018-12-20	Yes	SD
CPCT02030547T	HMF001067	HMF001067A	0.34	male	1979	2020-06-21	Skin		Melanoma			8923	2018-09-17	subcutaneous fat	right thigh	No	No	Yes	2018-09-21	2019-02-14	Pembrolizumab	Immunotherapy	2018-12-06	Yes	SD
CPCT02030548T	HMF003740	HMF003740A	0.83	male	1983	null	Skin		Melanoma			8923	2018-10-17	Lymph node	inguinal left	No	No	Yes	2018-10-26	2018-12-06	Ipilimumab/Nivolumab	Immunotherapy	2019-01-10	Yes	PR
CPCT02030549T	HMF002432	HMF002432A	0.52	female	1962	2021-12-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-10-19	Liver	segment 6	Yes	Yes	Yes	2018-10-24	2019-03-11	Everolimus/Exemestane	Multiple therapy	2018-12-12	Yes	PD
CPCT02030550T	HMF002179	HMF002179A	0.57	female	1956	2021-10-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-10-19	pleural lesion	near rib 8 right side	Yes	Yes	Yes	2018-10-20	2019-01-10	Everolimus/Exemestane	Multiple therapy	2019-01-03	Yes	PD
CPCT02030552T	HMF002808	HMF002808A	0.47	female	1960	null	Skin		Melanoma			8923	2018-11-07	subcutane	subcutane meta left thorax	No	No	Yes	2018-11-13	2019-05-02	Nivolumab	Immunotherapy	2019-01-31	Yes	PR
CPCT02030553T	HMF002956	HMF002956A	0.77	female	1939	2019-12-29	Skin		Melanoma			8923	2018-11-26	skin	right arm	No	No	Yes	2018-11-27	2019-02-19	Nivolumab	Immunotherapy	null	null	null
CPCT02030555T	HMF004169	HMF004169A	0.44	male	1957	2019-02-13	Skin		Melanoma			8923	2019-01-15	Liver	liver	No	No	Yes	2019-01-17	2019-02-08	Ipilimumab/Nivolumab	Immunotherapy	2019-02-12	Yes	PD
CPCT02030556T	HMF004331	HMF004331A	0.73	male	1957	2020-05-22	Head and neck	Nasopharynx				9261,11934	2019-03-26	Lymph node	neck left ,level 2	Yes	Yes	Yes	2019-04-10	2019-06-19	Nivolumab	Immunotherapy	null	null	null
CPCT02030560T	HMF005620	HMF005620A	0.42	male	1970	2021-11-21	Pancreas					1793	2021-04-15	Liver	left liver lobe (biggest lesion)	No	No	Yes	2021-04-23	2021-06-24	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2021-07-05	Yes	PD
CPCT02030562T	HMF006051	HMF006051A	0.48	male	1960	2023-02-21	Pancreas					1793	2022-03-02	abdominal wall left	metastasis	No	No	Yes	2022-02-28	2022-09-21	Fluorouracil/Oxaliplatin/Irinotecan/Leucovorin/Olaparib	Multiple therapy	null	null	null
CPCT02040020T	HMF002645	HMF002645A	0.6	male	1951	2017-05-08	Liver		Carcinoma	Hepatocellular carcinoma		684	2016-04-18	Bone	os ilium right	No	No	Yes	2016-04-19	2016-05-20	Sorafenib	Targeted therapy	2016-07-05	Yes	SD
CPCT02040021T	HMF000753	HMF000753A	0.56	male	1953	2017-02-04	Colorectum					9256	2016-04-25	Liver	segment 8	No	No	Yes	2016-04-28	2016-10-19	Capecitabine/Irinotecan/Oxaliplatin	Chemotherapy	2016-06-22	Yes	SD
CPCT02040021TII	HMF000753	HMF000753B	0.46	male	1953	2017-02-04	Colorectum					9256	2016-11-01	Liver	left hepatic lobe	No	No	Yes	2016-04-28	2016-10-19	Capecitabine/Irinotecan/Oxaliplatin	Chemotherapy	2016-06-22	Yes	SD
CPCT02040027T	HMF000760	HMF000760A	0.29	female	1936	2017-02-05	Colorectum					9256	2016-06-06	Liver	left liver lobe	No	No	Yes	2016-06-15	2016-09-28	Bevacizumab/Capecitabine	Multiple therapy	2016-08-08	Yes	SD
CPCT02040031T	HMF001533	HMF001533A	0.44	female	1968	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2016-06-28	Liver	segment 6	Yes	No	Yes	2016-07-07	2018-10-12	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	null	null	null
CPCT02040035T	HMF002744	HMF002744A	0.76	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-02	Liver	liver	Yes	Yes	Yes	2016-08-11	2018-10-16	Doxorubicin/Cyclophosphamide/Anastrozole/Fulvestrant/Palbociclib	Multiple therapy	2016-10-07	Yes	PR
CPCT02040036T	HMF000558	HMF000558A	0.7	female	1943	2016-12-01	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-18	Peritoneum	peritoneum	Yes	Yes	Yes	2016-08-23	2016-10-17	Megestrol	Hormonal therapy	null	null	null
CPCT02040037T	HMF000001	HMF000001A	0.77	male	1951	null	Unknown	CUP	Carcinoma	Neuroendocrine carcinoma		1800	2016-08-25	Liver	left liver lobe	No	No	Yes	2016-08-31	2016-09-29	Carboplatin/Etoposide	Chemotherapy	null	null	null
CPCT02040038T	HMF000223	HMF000223A	0.25	female	1956	2018-04-02	Ovary					2394	2016-08-31	Lymph node	para aortal	Yes	Yes	Yes	2016-09-05	2017-01-21	Carboplatin/Gemcitabine	Chemotherapy	2016-11-14	Yes	PR
CPCT02040039T	HMF002164	HMF002164A	0.46	female	1962	2017-10-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-09-06	Bone	os ilium right	No	No	Yes	2016-09-20	2017-02-15	Pemetrexed/Cisplatin	Chemotherapy	2016-11-29	Yes	PD
CPCT02040040T	HMF000036	HMF000036A	0.66	female	1960	2016-11-15	Colorectum					9256	2016-09-05	Liver	lobus caudatus	No	No	Yes	2016-09-08	2016-09-29	Capecitabine/Bevacizumab/Oxaliplatin	Multiple therapy	2016-11-01	Yes	SD
CPCT02040045T	HMF000024	HMF000024A	0.46	female	1951	2016-11-08	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-10-10	Lymph node	low cervical left	No	No	null	null	null	null	null	null	null	null
CPCT02040046T	HMF001477	HMF001477A	0.57	male	1953	null	Prostate					10283	2016-10-05	Liver	segment 4	Yes	No	null	null	null	null	null	null	null	null
CPCT02040047T	HMF003509	HMF003509A	0.57	female	1941	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2016-10-13	Liver	segment 4	No	No	Yes	2016-11-02	2017-11-22	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	2017-01-31	Yes	PR
CPCT02040051T	HMF001290	HMF001290A	0.73	female	1973	2017-10-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-10-25	Lung	dorsal paravertebraal left lower lobe	No	No	Yes	2016-11-17	2016-12-29	Pemetrexed/Cisplatin	Chemotherapy	2017-01-25	Yes	SD
CPCT02040054T	HMF002958	HMF002958A	0.5	female	1952	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-11-01	Lung	between left atrium and aorta	No	No	Yes	2016-11-19	2017-01-31	Pemetrexed/Cisplatin/Carboplatin	Chemotherapy	2017-02-13	Yes	PR
CPCT02040055T	HMF002461	HMF002461A	0.4	female	1975	2017-06-12	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-03	Liver	right lower lobe	Yes	Yes	Yes	2016-11-09	2017-02-23	Cisplatin	Chemotherapy	2017-01-05	Yes	SD
CPCT02040058T	HMF000869	HMF000869A	0.56	female	1958	2017-09-24	Colorectum					9256	2016-11-15	Liver	segment 2	No	No	Yes	2016-12-28	2017-09-21	Oxaliplatin/Capecitabine	Chemotherapy	2017-02-20	Yes	SD
CPCT02040062T	HMF001022	HMF001022A	0.39	male	1939	2018-01-22	Colorectum					9256	2016-11-24	Liver	segment VII	No	No	Yes	2017-03-25	2017-04-19	Capecitabine	Chemotherapy	2017-06-01	Yes	SD
CPCT02040063T	HMF000217	HMF000217A	0.4	male	1949	2017-01-02	Liver		Carcinoma	Hepatocellular carcinoma		684	2016-11-25	Liver	left liver lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040064T	HMF001151	HMF001151A	0.66	female	1940	2017-06-23	Ovary					2394	2016-12-02	Peritoneum	omentum cake	No	No	Yes	2016-12-09	2017-02-02	Carboplatin	Chemotherapy	2017-02-16	Yes	PR
CPCT02040067T	HMF000011	HMF000011A	0.73	male	1943	2017-04-29	Colorectum					9256	2016-12-06	Liver	segment 8	Yes	Yes	Yes	2016-12-09	2017-04-28	Panitumumab	Targeted therapy	2017-02-07	Yes	PR
CPCT02040068T	HMF000166	HMF000166A	0.61	male	1960	null	Colorectum					9256	2016-12-15	Liver	segment 3 left lobe	Yes	No	Yes	2016-12-19	2017-02-22	Irinotecan/Panitumumab	Multiple therapy	2017-01-02	Yes	SD
CPCT02040069T	HMF001061	HMF001061A	0.33	female	1948	2017-03-10	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-12-19	Bone	rib 6 right ventral	Yes	No	Yes	2016-12-28	2017-02-27	Trastuzumab/Paclitaxel	Multiple therapy	2017-01-30	Yes	PD
CPCT02040070T	HMF003252	HMF003252A	0.34	female	1946	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-20	Liver	lateral right	Yes	Yes	Yes	2017-01-03	2017-07-04	Paclitaxel	Chemotherapy	2017-04-11	Yes	SD
CPCT02040071T	HMF001902	HMF001902B	0.76	female	1956	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-19	Lymph node	left axilla	No	No	Yes	2016-12-20	2017-07-29	Anastrozole	Hormonal therapy	null	null	null
CPCT02040071TII	HMF001902	HMF001902A	0.52	female	1956	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-22	Lung	left dorsobasal	No	No	Yes	2016-12-20	2017-07-29	Anastrozole	Hormonal therapy	null	null	null
CPCT02040072T	HMF003723	HMF003723A	0.94	female	1969	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-12-19	Liver	segment 2/3	No	No	Yes	2017-01-03	2017-05-10	Doxorubicin	Chemotherapy	2017-02-22	Yes	SD
CPCT02040075T	HMF001205	HMF001205A	0.87	male	1941	2018-11-06	Colorectum					9256	2017-01-19	Liver	right in liver	Yes	No	Yes	2017-01-23	2017-08-24	Capecitabine/Irinotecan	Chemotherapy	2017-03-16	Yes	SD
CPCT02040077T	HMF000617	HMF000617A	0.99	male	1949	2017-09-15	Lung		Carcinoma	Small cell carcinoma		5409	2017-02-02	Lymph node	right pretracheaal	No	No	Yes	2017-02-16	2017-04-21	Carboplatin/Etoposide	Chemotherapy	2017-04-24	Yes	PR
CPCT02040078T	HMF000818	HMF000818A	0.53	female	1967	2018-06-01	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-02-06	Liver	segment 8	Yes	No	Yes	2017-02-20	2018-01-02	Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	2017-04-12	Yes	SD
CPCT02040083T	HMF001934	HMF001934A	0.6	male	1944	null	Pancreas					1793	2017-02-14	Liver	right liver lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040086T	HMF000144	HMF000144A	0.78	female	1946	2017-03-04	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-02-17	Liver	left lobe	No	No	Yes	2017-02-22	2017-02-23	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	null	null	null
CPCT02040089T	HMF002970	HMF002970A	0.97	female	1962	2017-03-08	Uterus	Endometrium				1380	2017-03-03	Liver	ventral in liver	Yes	No	null	null	null	null	null	null	null	null
CPCT02040091T	HMF000207	HMF000207A	0.77	female	1967	2019-01-31	Colorectum					9256	2017-03-09	Lung	left lower lobe	Yes	No	Yes	2017-03-15	2017-09-11	Bevacizumab/Capecitabine	Multiple therapy	2017-05-17	Yes	PR
CPCT02040092T	HMF000225	HMF000225A	0.26	female	1946	2017-05-07	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-03-14	Lung	left upper lobe	Yes	Yes	Yes	2017-04-05	2017-04-19	Nivolumab	Immunotherapy	null	null	null
CPCT02040093T	HMF003224	HMF003224A	0.82	male	1947	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-03-22	trachea	dorsal in trachea	No	No	Yes	2017-03-29	2017-05-31	Gemcitabine/Cisplatin/Etoposide	Chemotherapy	2017-06-22	Yes	PR
CPCT02040095T	HMF003172	HMF003172A	0.31	female	1944	null	Fallopian tube		Carcinoma	Serous adenocarcinoma	Extra-ovarian, lacking further location details	5598	2017-03-28	Peritoneum	central in stomach	No	No	Yes	2017-04-10	2017-09-07	Carboplatin/Paclitaxel	Chemotherapy	2017-05-16	Yes	PR
CPCT02040097T	HMF003446	HMF003446A	0.53	female	1935	2018-07-27	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-03-28	Liver	left lobe	No	No	Yes	2017-04-13	2018-01-08	Trastuzumab/Paclitaxel	Multiple therapy	2017-06-27	Yes	PR
CPCT02040100T	HMF001869	HMF001869A	0.71	female	1945	2020-01-02	Colorectum					9256	2017-04-07	vagina	vagina	No	No	Yes	2017-04-11	2018-02-21	Capecitabine/Oxaliplatin	Chemotherapy	2017-06-01	Yes	SD
CPCT02040102T	HMF000348	HMF000348A	0.49	male	1949	null	Colorectum					9256	2017-04-11	Lung	right lower lobe	Yes	Yes	Yes	2017-04-21	2017-06-05	Capecitabine/Irinotecan	Chemotherapy	2017-05-31	Yes	SD
CPCT02040104T	HMF003609	HMF003609A	0.57	male	1952	2017-05-31	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-04-25	Liver	left lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02040105T	HMF000060	HMF000060A	0.28	male	1940	2017-05-11	Urothelial tract	Bladder				11054	2017-04-20	Liver	segment 8	No	No	null	null	null	null	null	null	null	null
CPCT02040106T	HMF000208	HMF000208A	0.33	male	1969	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-04-18	Lung	left upper lobe	No	No	Yes	2017-07-03	2017-10-02	Gemcitabine/Carboplatin	Chemotherapy	2017-07-27	Yes	PR
CPCT02040107T	HMF002065	HMF002065A	0.69	male	1960	2017-05-22	Prostate					10283	2017-04-25	Lung	right lower lobe	Yes	No	Yes	2017-05-17	2017-05-18	Cabazitaxel	Chemotherapy	null	null	null
CPCT02040108T	HMF001831	HMF001831A	0.42	male	1943	null	Esophagus					5041	2017-04-25	Liver	segment 2	No	No	Yes	2017-05-22	2017-09-19	Capecitabine/Oxaliplatin	Chemotherapy	2017-07-17	Yes	PR
CPCT02040113T	HMF000873	HMF000873A	0.89	female	1939	2018-07-31	Lung		Carcinoma	Small cell carcinoma		5409	2017-05-23	Lymph node	supraclaviculair right	No	No	Yes	2017-06-12	2017-08-16	Etoposide/Carboplatin	Chemotherapy	2017-08-10	Yes	PR
CPCT02040115T	HMF002763	HMF002763B	0.28	male	1956	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-05-26	Lymph node	right hilair	No	No	Yes	2017-06-28	2018-11-15	Pemetrexed/Cisplatin	Chemotherapy	2017-09-14	Yes	SD
CPCT02040117T	HMF001738	HMF001738A	0.38	female	1947	2020-10-08	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-07-04	Lung	left upper lobe	No	No	Yes	2017-07-24	2017-09-11	Cisplatin/Gemcitabine	Chemotherapy	2017-10-03	Yes	SD
CPCT02040119T	HMF002001	HMF002001A	0.52	male	1953	null	Esophagus					5041	2017-06-01	Liver	transcostal	No	No	Yes	2017-06-14	2022-02-14	Capecitabine/Oxaliplatin/Trastuzumab	Multiple therapy	2017-08-10	Yes	PR
CPCT02040121T	HMF003219	HMF003219A	0.56	male	1954	2017-08-23	Lung		Carcinoma	Small cell carcinoma		5409	2017-06-22	Liver	left lobe	No	No	Yes	2017-06-30	2017-08-11	Etoposide/Carboplatin	Chemotherapy	2017-08-08	Yes	SD
CPCT02040122T	HMF001026	HMF001026A	0.26	female	1948	2019-07-15	Colorectum					9256	2018-03-27	Liver	segment 6/7	Yes	No	Yes	2018-04-05	2019-01-20	Trifluridine	Chemotherapy	2018-06-29	Yes	SD
CPCT02040123T	HMF000077	HMF000077A	0.54	female	1962	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-06-20	Lymph node	right axilla	Yes	No	Yes	2017-06-21	2018-04-22	Docetaxel/Pertuzumab/Trastuzumab	Multiple therapy	2017-08-17	Yes	SD
CPCT02040134T	HMF000119	HMF000119A	0.62	female	1931	null	Breast		Carcinoma	Triple negative		0060081	2017-07-18	Liver	segment 2	No	Yes	null	null	null	null	null	null	null	null
CPCT02040136T	HMF002447	HMF002447A	0.92	male	1949	2018-11-25	Lung		Carcinoma	Small cell carcinoma		5409	2017-07-25	Kidney	left kidney	Yes	Yes	Yes	2017-07-26	2017-10-01	Cyclophosphamide/Doxorubicin/Etoposide	Chemotherapy	2017-10-05	Yes	PR
CPCT02040138T	HMF002311	HMF002311A	0.61	female	1957	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-28	Bone	os ileum left	Yes	Yes	Yes	2017-08-09	2017-09-20	Anastrozole	Hormonal therapy	2017-09-27	Yes	SD
CPCT02040140T	HMF001653	HMF001653A	0.28	male	1966	2018-06-06	Colorectum					9256	2017-08-03	Liver	left lobe liver	No	No	Yes	2017-08-21	2017-11-20	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-10-19	Yes	PR
CPCT02040141T	HMF000139	HMF000139A	0.72	male	1946	2017-11-12	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-08-08	Peritoneum	Tumor right abdomen	Yes	No	Yes	2017-08-08	2017-08-28	Imatinib	Targeted therapy	2017-08-28	Yes	SD
CPCT02040142T	HMF000608	HMF000608A	0.9	female	1953	2018-04-10	Skin		Melanoma			8923	2017-08-10	Liver	left lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040143T	HMF002158	HMF002158A	0.36	female	1956	null	Ovary					2394	2017-08-15	Lymph node	supraclaviculair left	Yes	No	null	null	null	null	null	null	null	null
CPCT02040144T	HMF002905	HMF002905A	0.68	female	1943	2018-01-30	Ovary					2394	2017-08-22	Liver	segment 5	Yes	No	Yes	2017-09-11	2017-09-12	Paclitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02040145T	HMF002554	HMF002554A	0.51	female	1948	2018-02-06	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-22	Liver	right lobe	Yes	Yes	Yes	2017-09-05	2017-11-28	Doxorubicin/Cyclophosphamide	Chemotherapy	2017-11-04	Yes	ND
CPCT02040148T	HMF000853	HMF000853A	0.82	male	1930	null	Colorectum					9256	2017-08-24	Liver	right lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040149T	HMF002901	HMF002901A	0.58	male	1955	null	Lung		Carcinoma	Small cell carcinoma		5409	2017-08-29	Lung	right upper lobe	No	No	Yes	2017-09-18	2017-12-13	Carboplatin/Etoposide	Chemotherapy	2017-10-31	Yes	PR
CPCT02040151T	HMF002005	HMF002005A	0.35	male	1943	null	Colorectum					9256	2017-08-29	Liver	left lobe	Yes	No	Yes	2017-10-13	2017-12-18	Capecitabine	Chemotherapy	2017-12-13	Yes	PD
CPCT02040152T	HMF003188	HMF003188A	0.34	female	1955	2018-04-13	Colorectum					9256	2017-09-05	Liver	right lobe	Yes	No	Yes	2017-09-11	2017-10-23	Fluorouracil/Irinotecan	Chemotherapy	2017-10-30	Yes	PD
CPCT02040154T	HMF002626	HMF002626A	0.46	male	1951	null	Bile duct		Carcinoma			4947	2017-09-01	Liver	left lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040156T	HMF000103	HMF000103A	0.39	male	1965	2018-05-27	Esophagus					5041	2017-09-07	Liver	liver	No	Yes	Yes	2017-09-12	2017-12-05	Oxaliplatin/Capecitabine	Chemotherapy	2017-11-07	Yes	PD
CPCT02040160T	HMF001190	HMF001190A	0.56	female	1971	2022-05-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-06	Primary	right mamma	Yes	No	Yes	2017-09-18	2020-08-05	Anastrozole	Hormonal therapy	null	null	null
CPCT02040164T	HMF001488	HMF001488A	0.4	male	1962	2017-10-21	Urothelial tract	Bladder				11054	2017-09-28	Liver	left lobe	No	No	Yes	2017-10-06	2017-10-11	Gemcitabine/Cisplatin	Chemotherapy	null	null	null
CPCT02040165T	HMF003267	HMF003267A	0.37	male	1940	null	Colorectum					9256	2017-09-19	Liver	right liver lobe	Yes	Yes	Yes	2017-09-26	2017-10-15	Oxaliplatin/Bevacizumab/Capecitabine	Multiple therapy	2017-10-20	Yes	SD
CPCT02040169T	HMF002854	HMF002854A	0.39	female	1960	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-10-03	Liver	segment 5	No	No	Yes	2017-10-16	2017-10-23	Gemcitabine/Cisplatin	Chemotherapy	null	null	null
CPCT02040174T	HMF001637	HMF001637A	0.35	female	1955	2017-11-22	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-10-03	Bone	os ilium right	No	No	null	null	null	null	null	null	null	null
CPCT02040181T	HMF003166	HMF003166A	0.36	male	1940	2018-04-03	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-10-19	Lung	dorsal in left under lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040183T	HMF000741	HMF000741A	0.52	male	1946	2018-01-06	Colorectum					9256	2017-10-26	Liver	segment 8	Yes	No	null	null	null	null	null	null	null	null
CPCT02040186T	HMF000507	HMF000507A	0.67	female	1957	2017-11-20	Lung		Carcinoma	Small cell carcinoma		5409	2017-11-02	Lymph node	supraclaviculair	No	No	Yes	2017-11-09	2017-11-11	Carboplatin/Etoposide	Chemotherapy	null	null	null
CPCT02040191T	HMF001341	HMF001341A	0.75	female	1979	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-11-09	Liver	left lobe	No	No	Yes	2017-11-13	2023-03-07	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	2018-01-17	Yes	PR
CPCT02040192T	HMF002173	HMF002173A	0.66	female	1953	null	Ovary					2394	2017-11-07	Peritoneum	para umbilicaal left omentum	No	No	Yes	2017-11-16	2018-04-17	Paclitaxel/Carboplatin	Chemotherapy	2017-12-19	Yes	PR
CPCT02040194T	HMF003736	HMF003736A	0.88	female	1940	2018-05-21	Lung		Carcinoma	Small cell carcinoma		5409	2017-11-10	Liver	right lobe	No	No	Yes	2017-11-16	2018-01-19	Etoposide/Carboplatin	Chemotherapy	2018-01-30	Yes	PR
CPCT02040196T	HMF003681	HMF003681A	0.78	male	1936	2017-11-30	Esophagus					5041	2017-11-16	Liver	left lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040198T	HMF002631	HMF002631A	0.38	female	1949	2018-07-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-16	Lung	left upper lobe	Yes	No	Yes	2017-12-07	2018-02-15	Pemetrexed/Carboplatin	Chemotherapy	2018-01-11	Yes	SD
CPCT02040201T	HMF000789	HMF000789A	0.59	male	1940	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-21	Bone	L4	No	No	Yes	2017-12-01	2018-01-10	Gefitinib	Targeted therapy	2018-01-08	Yes	SD
CPCT02040202T	HMF000786	HMF000786A	0.52	male	1953	2018-03-02	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-23	Lung	left lower lobe	Yes	Yes	Yes	2017-12-15	2018-02-07	Gemcitabine/Carboplatin	Chemotherapy	2018-02-05	Yes	SD
CPCT02040204T	HMF000401	HMF000401A	0.28	male	1960	null	Colorectum					9256	2017-11-28	Peritoneum	intra abdominal against diafragma	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02040215T	HMF000307	HMF000307A	0.3	female	1969	2018-12-07	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-12-28	Liver	segment 5	No	No	Yes	2017-12-30	2018-05-06	Carboplatin/Pemetrexed/Crizotinib	Multiple therapy	2018-04-23	Yes	ND
CPCT02040215TII	HMF000307	HMF000307B	0.49	female	1969	2018-12-07	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-08	Liver	segment 8	No	No	Yes	2017-12-30	2018-05-06	Carboplatin/Pemetrexed/Crizotinib	Multiple therapy	2018-04-23	Yes	ND
CPCT02040216T	HMF000866	HMF000866A	0.43	female	1948	2018-09-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-02	Adrenal gland	left	No	No	Yes	2018-01-29	2018-07-31	Cisplatin/Pemetrexed/Atezolizumab	Multiple therapy	2018-04-23	Yes	PD
CPCT02040219T	HMF002862	HMF002862A	0.25	female	1955	2018-12-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-23	Bone	acetabulum right	Yes	No	Yes	2018-03-05	2018-10-25	Anastrozole/Palbociclib	Multiple therapy	2018-06-13	Yes	SD
CPCT02040220T	HMF003570	HMF003570A	0.75	male	1950	2019-04-29	Mesothelium		Malignant mesothelioma			1790,0050686	2018-01-30	Lung	right	No	No	Yes	2018-02-22	2018-04-27	Cisplatin/Pemetrexed	Chemotherapy	2018-05-07	Yes	PD
CPCT02040221T	HMF003660	HMF003660A	0.68	male	1941	2018-02-15	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-26	Lymph node	supraclaviculair right	No	No	null	null	null	null	null	null	null	null
CPCT02040223T	HMF000654	HMF000654A	0.41	female	1941	null	Ovary					2394	2018-02-01	Peritoneum	paracolisch left	No	No	Yes	2018-02-13	2018-07-25	Paclitaxel/Carboplatin	Chemotherapy	2018-03-13	Yes	PR
CPCT02040225T	HMF000929	HMF000929A	0.71	female	1960	2018-05-18	Lung		Carcinoma	Small cell carcinoma		5409	2018-02-06	Kidney	mass left kidney	Yes	No	Yes	2018-02-19	2018-02-23	Cyclophosphamide/Doxorubicin/Etoposide	Chemotherapy	null	null	null
CPCT02040226T	HMF002748	HMF002748A	0.59	male	1945	2018-05-15	Colorectum					9256	2018-02-06	Lung	left lower lobe	Yes	Yes	Yes	2018-04-12	2018-05-01	Panitumumab	Targeted therapy	null	null	null
CPCT02040228T	HMF003590	HMF003590A	0.73	female	1961	null	Pancreas		Neuroendocrine tumor			1793,169	2018-02-23	Liver	segment 7	No	No	Yes	2018-04-12	2018-06-30	Capecitabine/Temozolomide	Chemotherapy	2018-06-15	Yes	SD
CPCT02040230T	HMF002747	HMF002747A	0.52	female	1947	2020-02-04	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-06	Bone	sacrum left	Yes	Yes	Yes	2018-03-16	2019-12-25	Anastrozole	Hormonal therapy	2018-06-18	Yes	SD
CPCT02040235T	HMF001391	HMF001391A	0.77	female	1968	2018-08-20	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-07	Primary	right mamma	Yes	No	Yes	2018-03-16	2018-06-16	Capecitabine	Chemotherapy	null	null	null
CPCT02040242T	HMF002117	HMF002117A	0.38	male	1959	2018-04-29	Esophagus					5041	2018-03-20	Liver	segment 6	No	Yes	null	null	null	null	null	null	null	null
CPCT02040245T	HMF003424	HMF003424A	0.44	female	1952	2018-06-05	Bile duct		Carcinoma			4947	2018-03-27	Liver	segment 6	No	No	Yes	2018-05-15	2018-05-16	Cisplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02040246T	HMF000090	HMF000090A	0.22	male	1952	null	Skin		Melanoma			8923	2018-03-22	Lymph node	axillair right	No	No	null	null	null	null	null	null	null	null
CPCT02040248T	HMF002860	HMF002860A	0.78	male	1949	2018-07-22	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-03-22	Lung	fissura major right	No	No	Yes	2018-03-28	2018-05-02	Pazopanib	Targeted therapy	2018-05-15	Yes	PD
CPCT02040249T	HMF000414	HMF000414A	0.79	male	1943	2018-05-03	Prostate					10283	2018-03-29	Bone	sacrum	No	No	null	null	null	null	null	null	null	null
CPCT02040250T	HMF003046	HMF003046A	0.26	male	1951	2018-09-17	Mesothelium		Malignant mesothelioma			1790,0050686	2018-03-30	Pleural fluid	pleural right, pleuritis carcinomatosa	No	No	Yes	2018-04-20	2018-06-02	Cisplatin/Pemetrexed	Chemotherapy	2018-06-28	Yes	PD
CPCT02040254T	HMF002995	HMF002995A	0.68	female	1964	2019-12-06	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-12	Liver	left lobe	Yes	Yes	Yes	2018-04-25	2019-03-25	Capecitabine	Chemotherapy	2018-06-12	Yes	SD
CPCT02040255T	HMF003602	HMF003602A	0.51	male	1960	2019-01-13	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-04-10	Liver	segment 4	Yes	Yes	Yes	2018-04-26	2018-06-28	Pembrolizumab	Immunotherapy	2018-06-04	Yes	SD
CPCT02040257T	HMF001671	HMF001671A	0.66	female	1944	2018-12-01	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-12	Lymph node	axillair left	No	No	Yes	2018-04-19	2018-10-10	Anastrozole	Hormonal therapy	2018-07-23	Yes	SD
CPCT02040258T	HMF003146	HMF003146A	0.34	male	1954	null	Colorectum					9256	2018-05-03	Peritoneum	left subdiafragmal	Yes	No	Yes	2018-05-07	2019-01-02	Fluorouracil/Irinotecan/Bevacizumab	Multiple therapy	2018-06-25	Yes	PR
CPCT02040264T	HMF003533	HMF003533A	0.71	female	1982	2020-11-18	Colorectum					9256	2018-05-11	Lung	right lower lobe	No	Yes	null	null	null	null	null	null	null	null
CPCT02040266T	HMF002414	HMF002414A	0.39	female	1961	2021-01-19	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-05-17	Lymph node	axillair left	Yes	Yes	Yes	2018-05-18	2018-06-08	Trastuzumab	Targeted therapy	2018-07-23	Yes	PR
CPCT02040269T	HMF002998	HMF002998A	0.49	female	1935	2019-10-18	Colorectum					9256	2018-05-22	Peritoneum	retroperitoneal right	Yes	No	Yes	2018-06-01	2018-09-21	Capecitabine/Bevacizumab/Oxaliplatin	Multiple therapy	2018-07-27	Yes	SD
CPCT02040271T	HMF001825	HMF001825A	0.34	male	1944	2018-12-29	Mesothelium		Malignant mesothelioma			1790,0050686	2018-05-22	scin	subcentrimetisch subpleural	Yes	No	Yes	2018-08-21	2018-10-04	Pemetrexed/Carboplatin	Chemotherapy	2018-10-22	Yes	SD
CPCT02040273T	HMF003033	HMF003033A	0.74	male	1960	2018-09-01	Mesothelium		Malignant mesothelioma			1790,0050686	2018-05-24	Bone	rib 9	Yes	No	Yes	2018-07-24	2018-08-23	Pemetrexed/Carboplatin	Chemotherapy	null	null	null
CPCT02040278T	HMF003656	HMF003656A	0.59	female	1946	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-05-29	Liver	right liver lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02040280T	HMF001442	HMF001442A	0.66	male	1942	2019-04-28	Prostate					10283	2018-06-05	Bone	corpus L1	No	No	null	null	null	null	null	null	null	null
CPCT02040280TII	HMF001442	HMF001442B	0.74	male	1942	2019-04-28	Prostate					10283	2018-11-21	Lymph node	station 4 left	No	No	null	null	null	null	null	null	null	null
CPCT02040283T	HMF003130	HMF003130A	0.58	male	1929	2018-10-29	Prostate					10283	2018-06-07	Primary	prostate right	No	No	Yes	2018-06-13	2018-08-22	Goserelin	Androgen/estrogen deprivation therapy	null	null	null
CPCT02040286T	HMF002894	HMF002894A	0.43	female	1971	2019-01-23	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-14	Lymph node	subraclaviculair right	Yes	No	Yes	2018-06-27	2018-10-23	Bevacizumab/Paclitaxel/Carboplatin	Multiple therapy	2018-09-17	Yes	SD
CPCT02040290T	HMF002494	HMF002494A	0.62	female	1942	2018-12-30	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-28	Bone	left sacrum	No	Yes	Yes	2018-07-07	2018-10-18	Anastrozole	Hormonal therapy	null	null	null
CPCT02040291T	HMF003382	HMF003382A	0.37	female	1958	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-28	Bone	th10	No	No	Yes	2018-07-04	2019-11-08	Anastrozole	Hormonal therapy	2018-10-03	Yes	SD
CPCT02040292T	HMF003271	HMF003271A	0.42	female	1947	2019-06-18	Bile duct		Carcinoma			4947	2018-07-26	Bone	between costa 11 -12	No	No	Yes	2018-08-09	2018-11-15	Cisplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02040294T	HMF000755	HMF000755A	0.51	male	1972	null	Prostate					10283	2018-08-30	Lymph node	para-iliacal left	Yes	Yes	Yes	2018-09-03	2019-02-01	Enzalutamide	Hormonal therapy	2018-12-04	Yes	PR
CPCT02040295T	HMF000875	HMF000875A	0.62	male	1944	2019-07-01	Prostate					10283	2018-11-06	Bone	ascetabulum left	Yes	No	Yes	2018-11-20	2019-01-25	Cabazitaxel	Chemotherapy	null	null	null
CPCT02040298T	HMF001578	HMF001578A	0.77	female	1963	2019-07-02	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-23	subcutis	left back	Yes	Yes	Yes	2018-11-29	2019-01-03	Pembrolizumab	Immunotherapy	2019-01-21	Yes	PD
CPCT02040299T	HMF000271	HMF000271A	0.45	male	1956	2020-04-10	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-23	rectum	rectum	Yes	No	Yes	2018-11-09	2019-03-12	Pembrolizumab/Carboplatin/Pemetrexed	Multiple therapy	2018-12-20	Yes	SD
CPCT02040301T	HMF000126	HMF000126A	0.93	male	1963	2020-01-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-02	Lymph node	supraclaviculair right	No	No	null	null	null	null	null	null	null	null
CPCT02040305T	HMF003763	HMF003763A	0.91	female	1971	2020-02-20	Lung		Carcinoma	Small cell carcinoma		5409	2018-11-13	Lung	bronchus	No	No	null	null	null	null	null	null	null	null
CPCT02040306T	HMF003545	HMF003545A	0.53	female	1948	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-11-22	Lymph node	supraclaviculair right	Yes	Yes	Yes	2018-11-29	2021-12-15	Anastrozole/Palbociclib	Multiple therapy	2019-03-12	Yes	PR
CPCT02040307T	HMF004121	HMF004121A	0.55	female	1950	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-11-27	Bone	costa10 right	Yes	No	Yes	2018-12-04	2021-11-15	Anastrozole	Hormonal therapy	null	null	null
CPCT02040312T	HMF003963	HMF003963A	0.46	female	1944	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-18	Lung	left lower lobe	No	No	Yes	2019-01-10	2021-02-04	Pembrolizumab/Pemetrexed/Cisplatin/Carboplatin	Multiple therapy	2019-03-11	Yes	PR
CPCT02040313T	HMF004086	HMF004086A	0.64	male	1952	null	Lung		Carcinoma	Small cell carcinoma		5409	2018-12-21	Liver	left hemiliver	No	No	null	null	null	null	null	null	null	null
CPCT02040315T	HMF004115	HMF004115A	0.35	female	1944	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-10	Lung	right upper lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040316T	HMF003969	HMF003969A	0.55	male	1961	2020-11-18	Prostate					10283	2019-01-29	Bone	corpus L4 right	Yes	Yes	Yes	2019-01-29	2019-08-01	Enzalutamide	Hormonal therapy	null	null	null
CPCT02040317T	HMF003831	HMF003831A	0.94	female	1941	null	Lung		Carcinoma	Small cell carcinoma		5409	2019-01-24	Lymph node	supraclaviculair right	No	No	null	null	null	null	null	null	null	null
CPCT02040320T	HMF004342	HMF004342A	0.72	male	1963	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-19	Lung	left upper lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040321T	HMF004071	HMF004071A	0.5	female	1979	2021-02-15	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	Yes	Yes	Yes	2019-03-14	2019-09-12	Anastrozole	Hormonal therapy	2019-06-03	Yes	SD
CPCT02040323T	HMF003871	HMF003871A	0.41	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-03-07	Lymph node	subcutis left back	Yes	Yes	Yes	2019-03-19	2021-02-17	Anastrozole	Hormonal therapy	null	null	null
CPCT02040329T	HMF004280	HMF004280A	0.31	female	1936	null	Breast		Carcinoma			3459	2019-05-16	Lung	left upper lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040330T	HMF003980	HMF003980A	0.9	female	1969	null	Lung		Carcinoma	Small cell carcinoma		5409	2019-04-19	Lung	mediastinum	No	No	null	null	null	null	null	null	null	null
CPCT02040331T	HMF004098	HMF004098A	0.6	female	1950	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-04-25	Lung	mediastinal	Yes	Yes	Yes	2019-04-30	2020-07-21	Anastrozole	Hormonal therapy	2019-07-12	Yes	SD
CPCT02040334T	HMF004355	HMF004355A	0.67	male	1950	null	Prostate					10283	2019-05-07	Bone	acetabulum left	Yes	Yes	Yes	2019-05-07	2021-01-15	Enzalutamide	Hormonal therapy	2019-07-03	Yes	PR
CPCT02040337T	HMF004277	HMF004277A	0.83	female	1952	2021-08-07	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-05-16	Lymph node	axillair right	No	Yes	Yes	2019-05-29	2021-04-21	Anastrozole/Palbociclib	Multiple therapy	2019-08-16	Yes	PR
CPCT02040338T	HMF004350	HMF004350A	0.23	female	1951	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-23	Lung	right upper lobe	No	No	Yes	2019-06-13	2020-01-14	Erlotinib	Targeted therapy	2019-07-12	Yes	SD
CPCT02040340T	HMF003833	HMF003833A	0.69	female	1945	2019-06-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-23	Lung	right lower lobe	No	No	null	null	null	null	null	null	null	null
CPCT02040342T	HMF003899	HMF003899A	0.47	male	1946	2019-10-13	Prostate					10283	2019-07-04	Bone	pelvis right	Yes	No	Yes	2019-07-05	2019-08-31	Abiraterone	Hormonal therapy	null	null	null
CPCT02040343T	HMF004160	HMF004160A	0.91	male	1951	2020-05-06	Prostate					10283	2019-07-16	Liver	Segment 7	Yes	No	Yes	2019-07-18	2019-11-28	Abiraterone	Hormonal therapy	2019-11-22	Yes	PD
CPCT02040349T	HMF005621	HMF005621A	0.56	male	1993	null	Pancreas					1793	2021-03-25	Liver	segment VIII	No	No	Yes	2021-04-07	2021-10-27	Irinotecan/Oxaliplatin/Fluorouracil/Leucovorin	Multiple therapy	2021-06-07	Yes	PR
CPCT02040351T	HMF005830	HMF005830A	0.56	male	1948	2021-12-30	Urothelial tract	Bladder				11054	2021-11-19	Bone	os pubis	Yes	Yes	Yes	2021-11-22	2021-12-13	Pembrolizumab	Immunotherapy	2021-12-08	Yes	PD
CPCT02040353T	HMF006024	HMF006024A	0.39	male	1949	2023-01-27	Pancreas					1793	2022-02-15	Lung	ventral right upper lobe	No	No	Yes	2022-03-02	2022-09-14	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2022-05-04	Yes	SD
CPCT02050037T	HMF002969	HMF002969A	0.78	female	1966	null	Skin		Melanoma			8923	2016-04-06	breast/mamma	Cranial of the left mamma nipple	No	No	Yes	2016-04-06	2017-06-01	Pembrolizumab	Immunotherapy	2016-07-01	Yes	SD
CPCT02050038T	HMF003494	HMF003494A	0.27	male	1943	2016-10-30	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-04-07	Liver	liver	No	No	Yes	2016-04-18	2016-09-02	Sunitinib	Targeted therapy	2016-07-13	Yes	SD
CPCT02050039T	HMF003803	HMF003803A	0.62	female	1956	2018-03-29	Unknown	CUP	Neuroendocrine tumor			169	2016-04-14	Liver	metastases	No	No	Yes	2016-06-17	2016-09-21	Octreotide	Hormonal therapy	2016-09-13	Yes	PD
CPCT02050040T	HMF002182	HMF002182A	0.41	male	1962	2016-09-18	Skin		Melanoma			8923	2016-04-15	subcutaneous lesion	right groin	No	No	Yes	2016-04-15	2016-08-31	Dabrafenib/Trametinib	Targeted therapy	2016-06-10	Yes	PR
CPCT02050041T	HMF001257	HMF001257A	0.85	male	1945	2016-06-27	Esophagus					5041	2016-05-20	Liver	Segment 2	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02050045T	HMF003261	HMF003261A	0.86	male	1946	null	Skin		Melanoma			8923	2016-06-30	Lymph node	Right axilla	Yes	No	Yes	2016-07-15	2016-09-16	Ipilimumab	Immunotherapy	2016-10-07	Yes	PR
CPCT02050046T	HMF002587	HMF002587A	0.54	male	1952	2020-05-30	Skin		Melanoma			8923	2018-02-07	Muscle	m erector spinae right	No	No	Yes	2016-07-20	2016-10-14	Pembrolizumab	Immunotherapy	2016-10-13	Yes	PR
CPCT02050047T	HMF000744	HMF000744A	0.32	male	1943	null	Skin		Melanoma			8923	2016-07-21	Liver	segment IVb	No	Yes	Yes	2016-07-29	2016-09-30	Ipilimumab	Immunotherapy	null	null	null
CPCT02050048T	HMF003061	HMF003061A	0.75	male	1948	2017-07-05	Colorectum					9256	2016-07-22	Liver	right lobe	No	No	Yes	2016-08-09	2016-12-27	Panitumumab/Fluorouracil/Oxaliplatin	Multiple therapy	2016-09-30	Yes	SD
CPCT02050049T	HMF001248	HMF001248A	0.57	female	1960	2018-02-01	Unknown	CUP	Carcinoma			305	2016-07-29	Liver	Segment 4b	Yes	Yes	Yes	2016-07-29	2016-09-07	Everolimus	Targeted therapy	2016-10-17	Yes	SD
CPCT02050052T	HMF000078	HMF000078A	0.48	male	1950	2017-07-07	Skin		Melanoma			8923	2016-08-17	subcutaneous	subcutaneous lesion neck	No	No	Yes	2016-08-17	2017-03-17	Dabrafenib/Trametinib	Targeted therapy	2016-11-11	Yes	PR
CPCT02050053T	HMF002063	HMF002063A	0.63	female	1955	2018-04-19	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-08-23	Liver	right liver lobe	Yes	No	Yes	2016-08-31	2017-07-13	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	2016-10-31	Yes	PR
CPCT02050055T	HMF000004	HMF000004B	0.55	male	1952	2017-04-02	Skin		Melanoma			8923	2016-08-30	paravertebral subcutaneous lesion	left thoraric wall	No	Yes	Yes	2016-08-30	2016-12-31	Dabrafenib/Trametinib	Targeted therapy	2016-10-25	Yes	PR
CPCT02050055TII	HMF000004	HMF000004A	0.81	male	1952	2017-04-02	Skin		Melanoma			8923	2017-01-10	Subcutaneous lesion thorax wall	Dorsal against 12th costa left	No	Yes	Yes	2016-08-30	2016-12-31	Dabrafenib/Trametinib	Targeted therapy	2016-10-25	Yes	PR
CPCT02050056T	HMF003079	HMF003079A	0.9	female	1950	2017-04-09	Skin		Melanoma			8923	2016-09-05	Lymph node	axillary left	Yes	No	Yes	2016-10-25	2017-02-14	Dabrafenib	Targeted therapy	2016-12-20	Yes	SD
CPCT02050057T	HMF003322	HMF003322A	0.54	female	1942	2017-02-12	Colorectum					9256	2016-09-05	Liver	cranial segment VIII	No	No	Yes	2016-09-07	2017-01-09	Bevacizumab/Oxaliplatin/Capecitabine	Multiple therapy	2016-11-10	Yes	PR
CPCT02050058T	HMF001509	HMF001509A	0.73	female	1940	2017-01-24	Ovary					2394	2016-09-07	Peritoneum	right lower abdomen superficiality of the ilium	Yes	No	Yes	2016-09-08	2016-10-20	MSC2490484A	Experimental therapy	2016-10-18	Yes	PD
CPCT02050060T	HMF001546	HMF001546A	0.23	female	1964	2017-08-31	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2016-09-07	Lymph node	Axilla right	Yes	No	Yes	2016-10-07	2017-06-29	Trastuzumab/Ado-trastuzumab emtansine (T-DM1)	Multiple therapy	2017-01-11	Yes	SD
CPCT02050061T	HMF000559	HMF000559A	0.43	male	1957	2016-12-13	Colorectum					9256	2016-09-12	Liver	beneath the diaphragm, right back side	Yes	No	null	null	null	null	null	null	null	null
CPCT02050063T	HMF003520	HMF003520A	0.86	male	1958	null	Head and neck	Salivary gland				8850,11934	2016-09-20	Bone	submandibular mass	No	Yes	Yes	2016-09-20	2016-11-22	Cisplatin/Doxorubicin/Cyclophosphamide	Chemotherapy	2016-11-22	Yes	PD
CPCT02050068T	HMF003675	HMF003675A	0.34	male	1956	2017-11-11	Colorectum					9256	2016-10-04	Liver	segment VI	No	No	Yes	2016-10-06	2017-05-10	Bevacizumab/Capecitabine/Oxaliplatin	Multiple therapy	2016-12-01	Yes	SD
CPCT02050071T	HMF002290	HMF002290A	0.79	female	1952	2018-06-04	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-10-14	Liver	segment II	No	No	Yes	2016-10-19	2017-04-29	Trastuzumab/Letrozole	Multiple therapy	2016-12-15	Yes	PR
CPCT02050073T	HMF000300	HMF000300A	0.9	female	1954	2018-03-09	Skin		Melanoma			8923	2016-10-12	Lymph node	gland in the neck left	No	Yes	Yes	2016-10-21	2017-04-07	Pembrolizumab	Immunotherapy	2016-12-15	Yes	PD
CPCT02050073TII	HMF000300	HMF000300B	0.82	female	1954	2018-03-09	Skin		Melanoma			8923	2017-05-16	Lymph node	neck, left side	No	Yes	Yes	2016-10-21	2017-04-07	Pembrolizumab	Immunotherapy	2016-12-15	Yes	PD
CPCT02050074T	HMF000806	HMF000806A	0.71	female	1966	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-10-24	Lymph node	left axilla	No	No	Yes	2016-11-14	2018-02-20	Anastrozole	Hormonal therapy	null	null	null
CPCT02050075T	HMF001590	HMF001590A	0.59	female	1948	2018-03-08	Colorectum					9256	2016-10-20	thoracic wall subcutaneous	left	Yes	No	Yes	2016-11-03	2017-05-04	Cetuximab	Targeted therapy	2016-12-23	Yes	SD
CPCT02050076TII	HMF003743	HMF003743A	0.83	male	1949	2017-05-02	Gallbladder					3121	2017-01-30	Liver	liver	No	No	Yes	2017-01-31	2017-03-22	Sunitinib	Targeted therapy	2017-03-22	Yes	PD
CPCT02050077T	HMF002487	HMF002487A	0.65	male	1946	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-10-25	Lymph node	supraclavicular lymph node	No	No	Yes	2016-11-01	2017-04-10	Sunitinib	Targeted therapy	2017-01-17	Yes	PD
CPCT02050079T	HMF002681	HMF002681B	0.84	male	1952	2018-05-16	Skin		Melanoma			8923	2016-11-01	Primary	Subcutaneous nodules arm	Yes	Yes	Yes	2016-11-01	2017-04-11	Pembrolizumab	Immunotherapy	2017-01-24	Yes	SD
CPCT02050079TII	HMF002681	HMF002681A	0.79	male	1952	2018-05-16	Skin		Melanoma			8923	2017-05-16	Subcutane	close to left shoulder joint	Yes	Yes	Yes	2016-11-01	2017-04-11	Pembrolizumab	Immunotherapy	2017-01-24	Yes	SD
CPCT02050082T	HMF002199	HMF002199A	0.93	female	1952	2019-12-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-22	Lymph node	Axilla right	Yes	No	Yes	2016-11-16	2017-08-08	Letrozole	Hormonal therapy	2017-08-01	Yes	PD
CPCT02050085T	HMF003218	HMF003218A	0.35	female	1967	2017-01-13	Colorectum					9256	2016-11-28	Liver	right liver lobe	Yes	Yes	Yes	2016-11-28	2016-12-02	Sorafenib	Targeted therapy	null	null	null
CPCT02050086T	HMF003452	HMF003452A	0.31	male	1960	2017-03-31	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2016-11-25	Liver	segment V	Yes	No	Yes	2016-12-07	2017-01-30	Tremelimumab	Immunotherapy	2017-01-26	Yes	PD
CPCT02050088T	HMF001323	HMF001323A	0.58	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-05	Lymph node	axilla left	No	Yes	Yes	2016-12-12	2018-03-08	Letrozole	Hormonal therapy	2017-02-06	Yes	SD
CPCT02050091T	HMF003572	HMF003572A	0.25	female	1946	2017-01-27	Bile duct		Carcinoma			4947	2016-12-06	Liver	Segment III	Yes	No	Yes	2016-12-07	2016-12-28	Sunitinib	Targeted therapy	null	null	null
CPCT02050093T	HMF001505	HMF001505A	0.79	male	1948	2017-05-06	Colorectum					9256	2016-12-09	Liver	Left lobe	Yes	No	Yes	2016-12-15	2017-04-06	Cetuximab	Targeted therapy	2017-02-02	Yes	PR
CPCT02050095T	HMF002441	HMF002441B	0.66	female	1971	2018-05-26	Colorectum					9256	2016-12-09	Liver	Left lobe	No	No	Yes	2016-12-09	2017-08-05	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-02-08	Yes	SD
CPCT02050096T	HMF003241	HMF003241A	0.87	female	1951	null	Breast		Carcinoma	Triple negative		0060081	2016-12-16	Liver	liver N.O.S.	Yes	Yes	Yes	2017-01-09	2017-02-27	Carboplatin/Gemcitabine	Chemotherapy	2017-03-06	Yes	PD
CPCT02050097T	HMF000032	HMF000032A	0.48	female	1940	2018-01-19	Colorectum					9256	2016-12-19	Liver	No specified location	Yes	No	Yes	2016-12-20	2017-07-07	Irinotecan	Chemotherapy	2017-02-08	Yes	SD
CPCT02050100T	HMF002054	HMF002054A	0.51	male	1966	2017-02-18	Esophagus					5041	2016-12-23	Primary	Esophagus	Yes	No	Yes	2016-12-28	2017-01-22	Paclitaxel	Chemotherapy	null	null	null
CPCT02050103T	HMF001080	HMF001080A	0.42	female	1962	2017-12-08	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2017-01-04	Bone	Lesion os frontale left paramedian frontal	No	No	Yes	2017-01-09	2017-05-10	Gemcitabine/Carboplatin	Chemotherapy	2017-03-09	Yes	PR
CPCT02050104T	HMF001804	HMF001804A	0.57	male	1963	2017-03-06	Colorectum					9256	2017-01-05	Liver	Left lobe	Yes	Yes	Yes	2017-01-11	2017-01-31	Human Vascular Endothelial Growth Factor (hVEGF) vaccine	Experimental therapy	null	null	null
CPCT02050105T	HMF000499	HMF000499A	0.39	male	1946	2017-02-06	Skin		Carcinoma	Squamous cell carcinoma		3151	2017-01-06	Cutaneous lesion	left cervical	Yes	Yes	Yes	2017-01-09	2017-01-24	Paclitaxel	Chemotherapy	null	null	null
CPCT02050106T	HMF002978	HMF002978A	0.44	female	1962	2017-02-16	Thyroid gland					1781	2017-01-26	Lymph node	left cervical	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02050107T	HMF003576	HMF003576A	0.27	male	1960	2017-03-28	Colorectum					9256	2017-01-10	Liver	segment V	Yes	No	null	null	null	null	null	null	null	null
CPCT02050109T	HMF000196	HMF000196A	0.42	female	1950	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-12	Liver	segment 5/6 OR segment 4a/8	Yes	Yes	Yes	2017-01-27	2017-03-24	Capecitabine	Chemotherapy	2017-03-24	Yes	SD
CPCT02050113T	HMF002719	HMF002719A	0.34	male	1938	null	Colorectum					9256	2017-01-19	Liver	lateral right	Yes	No	Yes	2017-01-20	2017-08-02	Leucovorin/Fluorouracil/Oxaliplatin/Bevacizumab	Multiple therapy	2017-04-26	Yes	SD
CPCT02050115T	HMF003324	HMF003324A	0.49	male	1967	2017-03-23	Colorectum					9256	2017-01-23	Liver	left lobe	Yes	No	Yes	2017-01-25	2017-02-08	Sunitinib	Targeted therapy	null	null	null
CPCT02050117T	HMF002932	HMF002932A	0.64	female	1945	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-01-25	Lymph node	axilla right	No	No	Yes	2017-02-06	2017-07-04	Letrozole	Hormonal therapy	2017-04-07	Yes	SD
CPCT02050118T	HMF002057	HMF002057A	0.68	male	1940	2018-02-10	Colorectum					9256	2017-01-31	Liver	segment 4-5	Yes	No	Yes	2017-02-08	2017-09-27	Cetuximab	Targeted therapy	2017-03-31	Yes	SD
CPCT02050120T	HMF000323	HMF000323C	0.22	female	1955	2018-09-25	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-02-08	Lung	middle lob	Yes	No	Yes	2017-02-22	2017-04-26	Docetaxel/Trastuzumab	Multiple therapy	2017-04-19	Yes	PD
CPCT02050124T	HMF000819	HMF000819A	0.43	male	1936	2017-04-26	Urothelial tract	Bladder				11054	2017-02-14	Lymph node	left axilla	No	No	Yes	2017-02-28	2017-02-28	Carboplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02050127T	HMF003507	HMF003507A	0.3	female	1943	2019-12-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-15	Lymph node	Left axilla	No	No	Yes	2017-03-01	2019-01-16	Letrozole	Hormonal therapy	2017-04-24	Yes	SD
CPCT02050128T	HMF001783	HMF001783A	0.64	male	1947	null	Colorectum					9256	2017-02-16	Liver	Unknown	No	No	Yes	2017-02-17	2017-04-06	Fluorouracil/Leucovorin/Oxaliplatin	Multiple therapy	2017-02-23	Yes	SD
CPCT02050133T	HMF002440	HMF002440A	0.41	male	1961	2018-02-03	Bile duct		Carcinoma			4947	2017-03-06	Liver	Right liver lobe	Yes	No	Yes	2017-03-07	2017-04-18	Sunitinib	Targeted therapy	2017-04-25	Yes	PD
CPCT02050135T	HMF003175	HMF003175A	0.29	male	1954	2017-12-09	Pancreas					1793	2017-03-03	Liver	Unknown	No	No	Yes	2017-03-04	2017-08-23	Fluorouracil/Irinotecan/Oxaliplatin/Leucovorin	Multiple therapy	2017-06-12	Yes	SD
CPCT02050136T	HMF001957	HMF001957A	0.76	male	1955	2017-11-03	Small intestine	Duodenum	Carcinoma	Adenocarcinoma		10816	2017-03-06	Liver	Right lobe	No	No	null	null	null	null	null	null	null	null
CPCT02050138T	HMF000492	HMF000492A	0.69	female	1975	2018-04-08	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-03-15	Lymph node	Axilla left	Yes	Yes	Yes	2017-03-27	2017-07-03	Trastuzumab	Targeted therapy	2017-06-26	Yes	PD
CPCT02050139T	HMF001498	HMF001498A	0.84	male	1956	2017-10-04	Colorectum	Rectum				1993	2017-03-17	Liver	Unknown	Yes	Yes	Yes	2017-03-31	2017-06-29	Trifluridine	Chemotherapy	2017-06-21	Yes	PD
CPCT02050141T	HMF002130	HMF002130A	0.55	male	1948	null	Skin		Melanoma			8923	2017-03-21	Lymph node	axillary left	Yes	No	Yes	2017-03-24	2017-11-17	Pembrolizumab	Immunotherapy	2017-06-16	Yes	PD
CPCT02050142T	HMF001409	HMF001409A	0.45	male	1988	2018-06-11	Small intestine		Neuroendocrine tumor			10154,169	2017-03-22	Liver	segment 2	Yes	Yes	Yes	2017-03-27	2018-02-19	Pazopanib	Targeted therapy	2017-05-18	Yes	SD
CPCT02050143T	HMF001466	HMF001466A	0.69	female	1954	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-22	Intramuscular	hypo-echogenic mass chest wall left	Yes	Yes	Yes	2017-04-04	2019-04-23	Anastrozole	Hormonal therapy	2017-06-06	Yes	Non-CR/Non-PD
CPCT02050144T	HMF001264	HMF001264A	0.62	male	1943	2017-06-19	Gallbladder					3121	2017-03-24	Liver	segment 7/8	No	No	null	null	null	null	null	null	null	null
CPCT02050146T	HMF003206	HMF003206A	0.76	female	1952	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-27	Lymph node	right axilla	No	No	Yes	2017-04-03	2018-05-28	Letrozole	Hormonal therapy	2017-05-29	Yes	SD
CPCT02050147T	HMF001527	HMF001527A	0.75	male	1950	2017-06-15	null	null	null	null	null	null	2017-03-31	Liver	segment VI	Yes	No	Yes	2017-04-06	2017-05-04	Oxaliplatin/Epirubicin/Capecitabine	Chemotherapy	2017-05-26	Yes	PD
CPCT02050148T	HMF001277	HMF001277A	0.63	female	1953	2018-05-01	Colorectum	Rectum				1993	2017-03-29	Liver	Segment VI	Yes	No	Yes	2017-04-25	2017-10-19	Irinotecan	Chemotherapy	2017-06-20	Yes	SD
CPCT02050149T	HMF000855	HMF000855A	0.42	male	1959	2018-02-17	Skin		Melanoma			8923	2017-04-03	Lymph node	Inguinal left	Yes	Yes	Yes	2017-04-04	2017-07-10	Ipilimumab	Immunotherapy	2017-07-04	Yes	PD
CPCT02050151T	HMF000138	HMF000138A	0.76	male	1951	2017-06-14	Head and neck	Tonsil	Carcinoma			8858,305,1542	2017-04-07	Lymph node	neck right	Yes	No	Yes	2017-05-16	2017-06-14	Paclitaxel	Chemotherapy	null	null	null
CPCT02050156T	HMF002501	HMF002501A	0.62	female	1953	null	Breast		Carcinoma			3459	2017-04-19	Liver	segment 5	Yes	No	Yes	2017-04-20	2017-04-27	Eribulin	Chemotherapy	null	null	null
CPCT02050157T	HMF003096	HMF003096A	0.47	female	1973	2017-08-29	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-01	Liver	right	Yes	Yes	Yes	2017-05-01	2017-07-17	Epirubicin/Cyclophosphamide	Chemotherapy	2017-07-06	Yes	PD
CPCT02050158T	HMF000173	HMF000173A	0.37	male	1946	2018-09-30	Skin		Melanoma			8923	2017-04-21	Lymph node	Inguinal region right	No	No	Yes	2017-07-21	2017-09-21	Trametinib	Targeted therapy	2017-09-14	Yes	SD
CPCT02050159T	HMF002234	HMF002234A	0.33	male	1949	null	Skin		Melanoma			8923	2017-04-24	Lymph node	left inguinal	No	Yes	Yes	2017-04-24	2017-11-13	Cobimetinib/Vemurafenib	Targeted therapy	2017-05-09	Yes	SD
CPCT02050160T	HMF000982	HMF000982A	0.75	female	1952	2018-05-03	Breast		Carcinoma	Triple negative		0060081	2017-04-25	Skin	Thorax and scalp	Yes	Yes	Yes	2017-05-04	2017-08-07	Doxorubicin	Chemotherapy	2017-06-09	Yes	SD
CPCT02050161T	HMF001268	HMF001268B	0.4	female	1973	2017-12-31	Head and neck	Nasal cavity and paranasal sinus				10811,0050619,11934	2017-04-26	Endonasal	Left	Yes	Yes	Yes	2017-05-02	2017-06-22	Sorafenib	Targeted therapy	2017-07-03	Yes	PD
CPCT02050164T	HMF002135	HMF002135A	0.51	female	1948	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-03	Bone	Sternum left	Yes	No	Yes	2017-05-11	2019-01-29	Tamoxifen	Hormonal therapy	2017-10-02	Yes	PR
CPCT02050166T	HMF002759	HMF002759A	0.56	female	1943	2022-05-27	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-05	Liver	Left lobe	Yes	Yes	Yes	2017-05-05	2017-06-28	Capecitabine	Chemotherapy	2017-06-29	Yes	PD
CPCT02050167T	HMF000932	HMF000932A	0.25	male	1958	null	Unknown	CUP				162	2017-05-05	Bone	Laesie level costa 9 left	No	Yes	Yes	2017-05-15	2017-09-01	Gemcitabine/Cisplatin	Chemotherapy	2017-07-14	Yes	PR
CPCT02050168T	HMF002791	HMF002791A	0.81	male	1985	null	Skin		Melanoma			8923	2017-05-09	Lymph node	Para-iliacal Left	No	No	Yes	2017-05-18	2018-01-26	Pembrolizumab	Immunotherapy	2017-08-03	Yes	PR
CPCT02050170T	HMF001534	HMF001534A	0.88	female	1948	null	Skin		Melanoma			8923	2017-05-10	Subcutane metastasis.	paravertebraal right side	No	No	Yes	2017-05-10	2018-12-18	Pembrolizumab	Immunotherapy	2017-07-25	Yes	PD
CPCT02050172T	HMF002066	HMF002066B	0.8	female	1946	null	Head and neck	Nasal cavity and paranasal sinus			Palatum durum	10811,0050619,11934	2017-05-12	Primary	palatum durum	Yes	Yes	Yes	2017-05-18	2017-09-14	Methotrexate	Chemotherapy	null	null	null
CPCT02050174T	HMF002076	HMF002076A	0.55	female	1932	2019-02-23	Head and neck	Larynx				2596,11934	2017-05-15	Subcutaneous	Metastasis	No	Yes	Yes	2017-06-01	2017-08-11	Octreotide	Hormonal therapy	2017-10-19	Yes	PD
CPCT02050175T	HMF002361	HMF002361B	0.56	female	1970	2018-04-19	Colorectum					9256	2017-05-16	Intra-abdominal	Abdominal metastatic	Yes	No	Yes	2017-11-01	2017-11-20	Olaparib	Targeted therapy	null	null	null
CPCT02050176T	HMF003339	HMF003339A	0.71	male	1981	2018-02-21	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-05-15	Brain	frontal left	Yes	Yes	Yes	2017-06-05	2017-10-24	Temozolomide	Chemotherapy	null	null	null
CPCT02050179T	HMF003257	HMF003257A	0.83	male	1942	2017-07-08	Stomach					10534	2017-05-31	abdominal wall (intramuscular)	stomach	Yes	No	Yes	2017-06-30	2017-07-08	Fluorouracil/Oxaliplatin	Chemotherapy	null	null	null
CPCT02050181T	HMF000553	HMF000553A	0.21	male	1966	null	Skin		Melanoma			8923	2017-05-23	Lung	inguinal left	No	No	Yes	2017-05-23	2018-03-13	Pembrolizumab	Immunotherapy	2017-08-14	Yes	CR
CPCT02050182T	HMF001035	HMF001035A	0.38	male	1949	null	Bile duct		Carcinoma			4947	2017-05-24	Liver	right lobe	No	No	Yes	2017-06-03	2017-08-02	Gemcitabine/Cisplatin	Chemotherapy	2017-07-27	Yes	PD
CPCT02050183T	HMF002578	HMF002578A	0.52	female	1956	2018-03-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-24	Cutane lesion	Skin lesion on back	Yes	No	Yes	2017-05-29	2017-10-04	Everolimus/Exemestane	Multiple therapy	2017-09-26	Yes	PD
CPCT02050184T	HMF000628	HMF000628C	0.5	male	1944	2019-02-28	Colorectum					9256	2017-05-30	Lung	right side	Yes	No	Yes	2017-05-31	2018-01-09	Irinotecan	Chemotherapy	2017-07-25	Yes	SD
CPCT02050186T	HMF003259	HMF003259A	0.45	male	1954	2018-06-23	Head and neck	Hypopharynx				8533,11934	2017-06-06	Lung	Right upper lobe	Yes	Yes	Yes	2017-06-13	2017-10-24	Carboplatin/Fluorouracil/Cetuximab	Multiple therapy	2017-08-23	Yes	PR
CPCT02050187T	HMF003759	HMF003759A	0.84	male	1992	2017-07-09	Colorectum					9256	2017-06-06	Liver	diffuse lesions	Yes	No	Yes	2017-06-06	2017-07-09	Irinotecan	Chemotherapy	null	null	null
CPCT02050192T	HMF003144	HMF003144A	0.81	female	1948	null	Small intestine		Neuroendocrine tumor			10154,169	2017-06-20	Liver	diffuse lesions	No	No	Yes	2017-09-25	2017-11-18	Everolimus	Targeted therapy	null	null	null
CPCT02050193T	HMF003755	HMF003755A	0.75	female	1947	2017-09-23	Bone marrow		Multiple myeloma			9538	2017-06-27	Primary	melanoma right scapula point	Yes	No	Yes	2017-06-27	2017-08-15	Pembrolizumab	Immunotherapy	null	null	null
CPCT02050194T	HMF002006	HMF002006A	0.86	male	1935	2018-05-03	Skin		Melanoma			8923	2017-06-29	Primary	melanoma right scapula	No	No	Yes	2017-06-29	2018-05-01	Pembrolizumab	Immunotherapy	2017-09-19	Yes	PR
CPCT02050195T	HMF002322	HMF002322A	0.46	female	1964	2018-02-22	Pancreas					1793	2017-06-30	Peritoneum	Peritoneal deposition	No	No	Yes	2017-06-30	2017-11-29	Fluorouracil/Oxaliplatin/Irinotecan	Chemotherapy	2017-09-28	Yes	SD
CPCT02050199T	HMF000630	HMF000630A	0.23	female	1952	null	Colorectum					9256	2017-07-03	Liver	metastasis	No	No	Yes	2017-08-29	2017-12-12	Capecitabine/Oxaliplatin	Chemotherapy	2017-10-18	Yes	SD
CPCT02050209T	HMF002692	HMF002692A	0.45	female	1950	2018-05-10	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-20	Liver	Metastasis segment V	Yes	Yes	Yes	2017-08-10	2017-10-23	Vinorelbine	Chemotherapy	2017-10-12	Yes	PD
CPCT02050210T	HMF000781	HMF000781A	0.68	female	1966	2019-10-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-21	Ovary	right	Yes	Yes	Yes	2017-08-04	2018-04-16	Palbociclib/Letrozole	Multiple therapy	2018-01-02	Yes	PD
CPCT02050212T	HMF000346	HMF000346A	0.92	male	1946	null	Skin		Melanoma			8923	2017-07-21	Primary	Lower back	No	No	Yes	2017-07-21	2018-06-19	Dabrafenib/Trametinib	Targeted therapy	2017-09-12	Yes	PR
CPCT02050213T	HMF002678	HMF002678A	0.43	male	1952	null	Thyroid gland					1781	2017-07-25	Lymph node	Metastasis	Yes	Yes	Yes	2017-08-07	2017-08-24	Cabozantinib	Targeted therapy	null	null	null
CPCT02050214T	HMF001828	HMF001828A	0.57	male	1959	2017-10-31	Skin		Melanoma			8923	2017-07-25	Lymph node	Metastasis	No	No	Yes	2017-07-25	2017-10-09	Nivolumab/Ipilimumab	Immunotherapy	2017-10-04	Yes	PD
CPCT02050215T	HMF001384	HMF001384A	0.81	female	1970	2017-08-20	Breast		Carcinoma	Triple negative		0060081	2017-07-28	Liver	Metastasis	Yes	Yes	Yes	2017-08-09	2017-08-17	Capecitabine	Chemotherapy	null	null	null
CPCT02050216T	HMF002305	HMF002305A	0.54	male	1941	2017-09-11	Urothelial tract	Bladder				11054	2017-08-02	Peritoneum	Caracolic left	No	No	Yes	2017-08-09	2017-08-23	Cisplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02050217T	HMF001846	HMF001846A	0.33	female	1952	2020-03-08	Skin		Melanoma			8923	2017-08-04	Lymph node	left inguinal	No	No	Yes	2017-08-04	2019-12-20	Vemurafenib/Cobimetinib/Nivolumab/Ipilimumab	Multiple therapy	2017-08-18	Yes	PR
CPCT02050218T	HMF002093	HMF002093A	0.82	female	1946	2018-07-16	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-07	Liver	Metastasis	Yes	No	Yes	2017-08-09	2017-11-09	Vinorelbine	Chemotherapy	2017-10-26	Yes	SD
CPCT02050220T	HMF000369	HMF000369A	0.59	male	1969	2018-01-24	Colorectum					9256	2017-08-09	Liver	Metastasis	Yes	Yes	Yes	2017-08-09	2017-10-18	Irinotecan	Chemotherapy	2017-10-12	Yes	PD
CPCT02050223T	HMF002700	HMF002700A	0.53	male	1964	null	Pancreas					1793	2017-08-11	Liver	metastasis	No	No	null	null	null	null	null	null	null	null
CPCT02050224T	HMF000048	HMF000048A	0.73	male	1945	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2017-08-14	Liver	Segement 5	Yes	No	Yes	2017-08-15	2018-03-20	Sunitinib	Targeted therapy	2017-10-03	Yes	SD
CPCT02050225T	HMF002023	HMF002023B	0.81	female	1952	2019-04-14	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-08-14	Peritoneum	para-umbilicaal right side	Yes	No	Yes	2017-08-22	2018-06-08	Imatinib/Imatinib	Targeted therapy	2017-10-30	Yes	SD
CPCT02050225TII	HMF002023	HMF002023A	0.59	female	1952	2019-04-14	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-12-14	Small pelvic	small pelvic tumor	Yes	No	Yes	2017-08-22	2018-06-08	Imatinib/Imatinib	Targeted therapy	2017-10-30	Yes	SD
CPCT02050227T	HMF002213	HMF002213A	0.64	female	1964	null	Colorectum					9256	2017-08-17	Peritoneum	Omentum craniolateral umbilicus	No	No	Yes	2017-08-22	2018-05-08	Oxaliplatin/Capecitabine/Bevacizumab	Multiple therapy	2017-10-12	Yes	SD
CPCT02050229T	HMF003354	HMF003354A	0.57	male	1963	2019-01-31	Adrenal gland	Adrenal medulla	Pheochromocytoma			5719	2017-04-12	Primary	Adrenal gland	No	Yes	null	null	null	null	null	null	null	null
CPCT02050232T	HMF000640	HMF000640A	0.73	male	1962	null	Skin		Melanoma			8923	2017-08-29	Lymph node	Left inguinal	No	No	Yes	2017-08-29	2019-02-01	Vemurafenib/Cobimetinib	Targeted therapy	2017-09-12	Yes	SD
CPCT02050236T	HMF000367	HMF000367A	0.73	male	1961	null	Skin		Melanoma			8923	2017-08-31	Lymph node	left groin	No	Yes	Yes	2017-09-22	2017-11-07	Ipilimumab/Nivolumab	Immunotherapy	2017-12-11	Yes	SD
CPCT02050238T	HMF002082	HMF002082A	0.44	male	1962	null	Colorectum					9256	2017-09-01	Abdominal wall right intramuscular	suspect lesion	Yes	No	Yes	2017-09-01	2018-05-16	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-10-20	Yes	SD
CPCT02050239T	HMF002572	HMF002572A	0.46	male	1967	2018-01-08	Pancreas					1793	2017-09-04	Liver	Segment IV	Yes	No	Yes	2017-09-05	2017-10-31	Sunitinib	Targeted therapy	2017-10-24	Yes	PD
CPCT02050241T	HMF000285	HMF000285A	0.7	male	1944	null	Colorectum					9256	2017-09-06	Liver	Metastasis left lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02050244T	HMF003613	HMF003613A	0.37	male	1970	2017-10-05	Pancreas					1793	2017-09-14	Liver	Segment 4	Yes	No	Yes	2017-09-14	2017-09-17	Gemcitabine	Chemotherapy	null	null	null
CPCT02050245T	HMF001353	HMF001353A	0.62	male	1942	null	Skin		Melanoma			8923	2017-09-14	Lymph node	axilla	No	No	Yes	2017-09-14	2018-07-05	Pembrolizumab	Immunotherapy	2017-12-04	Yes	PR
CPCT02050246T	HMF003693	HMF003693A	0.79	male	1948	2017-11-14	Pancreas					1793	2017-09-18	Liver	segment 3	Yes	No	Yes	2017-09-19	2017-10-26	Sorafenib	Targeted therapy	2017-10-26	Yes	PD
CPCT02050249T	HMF002545	HMF002545A	0.4	female	1936	null	Skin		Melanoma			8923	2017-09-25	Lymph node	Inguinal	No	No	Yes	2017-09-25	2017-11-30	Pembrolizumab	Immunotherapy	2017-12-14	Yes	SD
CPCT02050251T	HMF002992	HMF002992A	0.64	female	1949	null	Bile duct		Carcinoma			4947	2017-09-27	Liver	Bilary duct	No	No	Yes	2017-09-27	2018-06-04	Cisplatin/Gemcitabine	Chemotherapy	2017-11-22	Yes	SD
CPCT02050252T	HMF001833	HMF001833A	0.65	male	1933	2019-09-25	Small intestine		Carcinoma	Adenocarcinoma		4906	2017-09-25	Liver	Metastasis	No	No	Yes	2017-10-23	2018-06-19	Oxaliplatin/Capecitabine	Chemotherapy	2017-12-20	Yes	PR
CPCT02050256T	HMF001270	HMF001270A	0.31	male	1978	2018-05-15	Colorectum					9256	2017-10-04	Liver	Segment 5-6	Yes	Yes	Yes	2017-10-04	2017-12-19	Cetuximab	Targeted therapy	2017-11-22	Yes	PD
CPCT02050258T	HMF003610	HMF003610A	0.52	female	1962	null	Colorectum					9256	2017-10-04	Liver	Metastasis segment 3-4	No	No	Yes	2017-10-04	2018-05-08	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-11-24	Yes	SD
CPCT02050259T	HMF001830	HMF001830A	0.8	male	1946	2018-09-06	Colorectum					9256	2017-10-04	Liver	left side	Yes	Yes	Yes	2017-11-29	2018-03-28	Cetuximab	Targeted therapy	2018-01-31	Yes	SD
CPCT02050260T	HMF001408	HMF001408A	0.46	female	1949	null	Colorectum					9256	2017-10-04	Bone	Presacral lesion	No	No	Yes	2017-10-10	2018-03-13	Capecitabine	Chemotherapy	2018-01-15	Yes	SD
CPCT02050261T	HMF002750	HMF002750A	0.57	male	1987	2019-02-19	Colorectum					9256	2018-07-26	Liver	-	Yes	No	Yes	2017-10-06	2018-03-21	Capecitabine	Chemotherapy	2017-12-06	Yes	SD
CPCT02050263T	HMF001759	HMF001759A	0.39	male	1962	2017-11-28	Bile duct		Carcinoma			4947	2017-10-09	Peritoneum	metastasis	Yes	No	null	null	null	null	null	null	null	null
CPCT02050264T	HMF001069	HMF001069A	0.46	male	1945	2018-09-26	Unknown	CUP	Neuroendocrine tumor			169	2017-10-10	Liver	segm 4	No	No	Yes	2017-11-14	2018-08-06	Etoposide/Carboplatin	Chemotherapy	2018-01-25	Yes	PR
CPCT02050268T	HMF000376	HMF000376B	0.54	male	1947	2018-10-09	Prostate					10283	2017-10-11	Kidney	Anteromedial right kidney	Yes	Yes	Yes	2017-10-12	2018-01-08	Abiraterone	Hormonal therapy	2017-12-28	Yes	PD
CPCT02050269T	HMF003305	HMF003305A	0.39	male	1960	2021-01-30	Colorectum					9256	2017-10-11	Liver	Lesion	Yes	Yes	Yes	2017-10-20	2019-03-29	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-12-12	Yes	PR
CPCT02050276T	HMF002383	HMF002383B	0.55	female	1959	null	Skin		Melanoma			8923	2017-10-19	Lymph node	Right side para- iliacale	No	No	Yes	2017-10-19	2018-06-28	Pembrolizumab	Immunotherapy	2018-01-04	Yes	PR
CPCT02050276TII	HMF002383	HMF002383A	0.52	female	1959	null	Skin		Melanoma			8923	2018-10-05	Lymph node	para-ilical	No	No	Yes	2017-10-19	2018-06-28	Pembrolizumab	Immunotherapy	2018-01-04	Yes	PR
CPCT02050279T	HMF000512	HMF000512B	0.26	male	1942	null	Colorectum					9256	2017-10-25	Liver	central lesion	No	No	Yes	2017-11-09	2018-02-20	Capecitabine/Oxaliplatin	Chemotherapy	2018-02-06	Yes	PD
CPCT02050280T	HMF000642	HMF000642A	0.33	female	1962	2018-03-10	Colorectum					9256	2017-10-27	Liver	Segment IV	No	No	Yes	2017-10-30	2018-03-10	Capecitabine/Oxaliplatin	Chemotherapy	2017-12-27	Yes	SD
CPCT02050281T	HMF003109	HMF003109A	0.4	male	1944	2017-12-02	Skin		Melanoma			8923	2017-11-02	skin	re couer melanoom	No	Yes	Yes	2017-11-02	2017-12-02	Ipilimumab/Nivolumab	Immunotherapy	null	null	null
CPCT02050282T	HMF002291	HMF002291A	0.54	female	1950	2018-06-22	Small intestine		Carcinoma	Neuroendocrine carcinoma		0050925,1800	2017-10-31	Liver	Segment V	No	No	Yes	2017-11-01	2018-06-04	Cisplatin/Etoposide/Carboplatin	Chemotherapy	2018-01-11	Yes	SD
CPCT02050283T	HMF003336	HMF003336A	0.6	female	1953	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-10-31	Lung	lesion	Yes	No	Yes	2017-12-01	2018-05-03	Pemetrexed	Chemotherapy	2018-01-09	Yes	PR
CPCT02050285T	HMF003181	HMF003181A	0.4	female	1957	2019-02-19	Breast		Carcinoma	Triple negative		0060081	2017-11-07	Bone	left os ileum	Yes	Yes	Yes	2017-11-21	2018-03-06	Eribulin	Chemotherapy	2018-01-15	Yes	Non-CR/Non-PD
CPCT02050286T	HMF002507	HMF002507A	0.8	female	1956	2019-03-17	Bile duct		Carcinoma			4947	2017-11-08	Liver	segment VII	No	No	Yes	2017-11-09	2018-10-03	Gemcitabine/Cisplatin	Chemotherapy	2018-01-02	Yes	PR
CPCT02050287T	HMF001374	HMF001374A	0.53	male	1955	null	Esophagus					5041	2017-11-13	Liver	segment II	Yes	No	Yes	2017-11-14	2018-01-24	Sunitinib	Targeted therapy	2018-01-17	Yes	PD
CPCT02050288T	HMF000901	HMF000901A	0.41	female	1955	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-09	Liver	segment VI	Yes	Yes	Yes	2017-11-09	2019-05-30	Capecitabine	Chemotherapy	2018-07-05	Yes	PR
CPCT02050289T	HMF002728	HMF002728A	0.31	male	1964	2018-05-09	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-11-14	Lymph node	Axillair right	Yes	Yes	Yes	2017-11-14	2018-04-04	Pembrolizumab	Immunotherapy	2018-01-25	Yes	SD
CPCT02050291T	HMF002458	HMF002458A	0.46	male	1951	null	Skin		Melanoma			8923	2017-11-17	Lymph node	Left subclavicular	No	No	Yes	2017-11-17	2018-05-11	Dabrafenib/Trametinib	Targeted therapy	2018-01-12	Yes	PR
CPCT02050292T	HMF001677	HMF001677A	0.58	male	1962	2018-01-05	Gastroesophageal	Esophago-gastric junction				0080374	2017-11-17	Liver	Right liver lobe	No	No	Yes	2017-11-18	2017-12-27	Epirubicin/Oxaliplatin/Capecitabine	Chemotherapy	null	null	null
CPCT02050294T	HMF000791	HMF000791A	0.26	female	1961	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-22	Lymph node	Neck	No	No	Yes	2018-01-05	2019-12-12	Pembrolizumab	Immunotherapy	2018-02-16	Yes	PR
CPCT02050295T	HMF003672	HMF003672A	0.74	male	1965	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2017-11-23	Liver	liver	Yes	No	Yes	2017-11-23	2018-01-24	Sorafenib	Targeted therapy	null	null	null
CPCT02050296T	HMF002949	HMF002949A	0.52	female	1973	2018-12-07	Colorectum					9256	2017-11-24	Liver	Metastasis	No	No	Yes	2017-11-29	2018-02-14	Capecitabine/Oxaliplatin	Chemotherapy	2018-02-13	Yes	PD
CPCT02050297T	HMF002163	HMF002163B	0.38	male	1966	2018-06-18	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-11-27	Peritoneum	Abdomen metastsis	Yes	Yes	Yes	2017-12-05	2018-02-13	Carboplatin/Gemcitabine	Chemotherapy	2018-02-05	Yes	PD
CPCT02050299T	HMF003802	HMF003802A	0.22	female	1943	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-01	Liver	hilus	Yes	Yes	Yes	2017-11-28	2018-05-29	Capecitabine	Chemotherapy	2018-01-31	Yes	PR
CPCT02050300T	HMF002897	HMF002897A	0.75	female	1955	2019-10-26	Colorectum					9256	2017-11-29	Lymph node	neck	Yes	No	Yes	2017-11-30	2018-09-06	Irinotecan	Chemotherapy	2018-02-01	Yes	SD
CPCT02050301T	HMF002856	HMF002856A	0.84	female	1944	null	Skin		Melanoma			8923	2017-11-30	Primary	Melanoma right lower leg	No	No	Yes	2017-11-30	2018-05-21	Dabrafenib/Trametinib	Targeted therapy	2018-01-22	Yes	PR
CPCT02050304T	HMF002219	HMF002219A	0.36	male	1938	null	Skin		Melanoma			8923	2017-12-19	Primary	Lesion head	No	No	Yes	2017-12-19	2018-07-17	Pembrolizumab	Immunotherapy	2018-03-05	Yes	CR
CPCT02050307T	HMF000527	HMF000527A	0.73	male	1944	null	Colorectum					9256	2018-01-03	Lymph node	Neck	Yes	No	Yes	2018-01-03	2018-07-13	Capecitabine/Bevacizumab/Oxaliplatin	Multiple therapy	2018-02-28	Yes	SD
CPCT02050308T	HMF000525	HMF000525A	0.9	male	1956	2018-06-19	Skin		Melanoma			8923	2018-01-04	Lymph node	Inguinal	Yes	No	Yes	2018-01-04	2018-03-08	Nivolumab	Immunotherapy	2018-03-08	Yes	PD
CPCT02050310T	HMF002997	HMF002997A	0.66	female	1938	2018-08-28	Skin		Melanoma			8923	2018-01-09	Bone	Costa 10/11	No	Yes	Yes	2018-01-19	2018-06-19	Pembrolizumab	Immunotherapy	2018-03-22	Yes	PD
CPCT02050312T	HMF000102	HMF000102A	0.31	male	1950	2018-04-08	Pancreas					1793	2018-01-15	Liver	Metastasis segment 3	No	No	null	null	null	null	null	null	null	null
CPCT02050314T	HMF002634	HMF002634B	0.22	male	1959	2018-07-09	Esophagus					5041	2018-01-17	Lung	Lesion	No	No	Yes	2018-02-02	2018-06-01	Gemcitabine/Cisplatin	Chemotherapy	2018-03-09	Yes	SD
CPCT02050315T	HMF001435	HMF001435A	0.86	female	1951	2018-12-26	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-01-18	Lymph node	Supraclavicular left	Yes	No	Yes	2018-01-22	2018-09-07	Pembrolizumab	Immunotherapy	2018-03-19	Yes	PD
CPCT02050317T	HMF003170	HMF003170A	0.4	female	1942	2018-03-01	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-01-23	Kidney	Cranial side left kdiney	No	No	Yes	2018-01-30	2018-02-06	Sunitinib	Targeted therapy	null	null	null
CPCT02050319T	HMF002671	HMF002671A	0.46	male	1970	null	Testis					2998	2018-01-26	Peritoneum	para-aortic massa	Yes	No	Yes	2018-02-02	2018-04-10	Cisplatin/Ifosfamide/Paclitaxel	Chemotherapy	2018-04-24	Yes	PR
CPCT02050321T	HMF001917	HMF001917A	0.52	male	1946	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-30	Lung	Lesion right lower lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02050322T	HMF001978	HMF001978A	0.64	female	1939	null	Skin		Melanoma			8923	2018-01-30	Subcutaneous	Lesion left upper arm lateral side	No	No	Yes	2018-01-31	2018-07-24	Pembrolizumab	Immunotherapy	2018-04-24	Yes	PR
CPCT02050325T	HMF003125	HMF003125A	0.39	male	1958	2018-09-11	Colorectum					9256	2018-02-06	Peritoneum	abdominal wall	Yes	Yes	Yes	2018-02-14	2018-04-18	Trifluridine	Chemotherapy	2018-05-08	Yes	SD
CPCT02050327T	HMF000566	HMF000566A	0.54	male	1943	null	Colorectum					9256	2018-02-08	Liver	segment 6	Yes	No	Yes	2018-02-08	2018-08-15	Bevacizumab/Oxaliplatin/Capecitabine	Multiple therapy	2018-04-04	Yes	SD
CPCT02050329T	HMF000752	HMF000752A	0.68	female	1965	2019-05-14	Colorectum					9256	2018-02-13	Peritoneum	lesion metastasis	Yes	No	null	null	null	null	null	null	null	null
CPCT02050330T	HMF000811	HMF000811B	0.61	male	1946	2020-01-25	Esophagus					5041	2018-02-14	Lymph node	level VI left side	No	No	Yes	2018-03-06	2018-07-02	Capecitabine/Oxaliplatin	Chemotherapy	2018-05-04	Yes	PR
CPCT02050331T	HMF001324	HMF001324A	0.2	female	1952	2020-07-09	Skin		Melanoma			8923	2018-02-19	Lymph node	Right inguinal	Yes	No	Yes	2018-03-02	2019-04-25	Pembrolizumab	Immunotherapy	2018-05-17	Yes	SD
CPCT02050332T	HMF001230	HMF001230A	0.23	male	1970	2020-02-21	Bile duct		Carcinoma			4947	2018-03-23	Peritoneum	gastrojejunostomie mass	Yes	No	Yes	2018-04-20	2018-06-12	Gemcitabine/Cisplatin	Chemotherapy	2018-06-12	Yes	PD
CPCT02050333T	HMF001405	HMF001405A	0.23	female	1956	2018-07-21	Breast		Carcinoma	Triple negative		0060081	2018-02-21	Lymph node	neck left side	Yes	No	Yes	2018-04-27	2018-07-11	Paclitaxel	Chemotherapy	2018-06-27	Yes	PD
CPCT02050337T	HMF003666	HMF003666A	0.36	female	1964	2018-06-26	Breast		Carcinoma	Triple negative		0060081	2018-02-26	Lymph node	Right axilla	Yes	Yes	Yes	2018-03-02	2018-06-14	Eribulin	Chemotherapy	2018-04-30	Yes	SD
CPCT02050338T	HMF001066	HMF001066A	0.68	female	1971	2018-11-15	Breast		Carcinoma	Triple negative		0060081	2018-02-27	Primary	Left mamma	No	Yes	Yes	2018-02-22	2018-05-22	Capecitabine	Chemotherapy	2018-05-22	Yes	PD
CPCT02050339T	HMF000356	HMF000356A	0.9	male	1945	2018-11-01	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-01	Lymph node	Left groin	Yes	Yes	Yes	2018-03-02	2018-05-18	Carboplatin/Etoposide	Chemotherapy	2018-04-11	Yes	SD
CPCT02050341T	HMF001683	HMF001683A	0.38	male	1950	2019-03-30	Head and neck	Nasopharynx				9261,11934	2018-03-05	Liver	Metastasis	No	No	Yes	2018-03-06	2018-09-17	Cisplatin/Gemcitabine	Chemotherapy	2018-05-08	Yes	PR
CPCT02050342T	HMF002229	HMF002229A	0.89	male	1953	2018-10-31	Gallbladder					3121	2018-03-06	Liver	Metastasis	No	No	Yes	2018-03-07	2018-05-01	Cisplatin/Gemcitabine	Chemotherapy	2018-05-01	Yes	PD
CPCT02050343T	HMF003402	HMF003402A	0.78	female	1954	2018-06-05	Esophagus					5041	2018-03-07	Liver	Lesion right lobe	Yes	Yes	Yes	2018-03-14	2018-05-29	Irinotecan	Chemotherapy	2018-05-29	Yes	PD
CPCT02050346T	HMF002983	HMF002983A	0.89	female	1951	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-08	Liver	Metastasis	No	No	null	null	null	null	null	null	null	null
CPCT02050347T	HMF001920	HMF001920A	0.31	male	1985	null	Skin		Melanoma			8923	2018-03-12	Lymph node	Right axilla	No	No	Yes	2018-03-15	2018-05-15	Ipilimumab/Nivolumab	Immunotherapy	2018-05-29	Yes	PR
CPCT02050348T	HMF001894	HMF001894A	0.33	male	1939	2018-10-26	Thyroid gland					1781	2018-03-15	Lymph node	Neck left side	No	No	Yes	2018-03-16	2018-04-30	Doxorubicin/Docetaxel	Chemotherapy	2018-04-18	Yes	SD
CPCT02050349T	HMF001895	HMF001895A	0.24	male	1952	2018-06-05	Esophagus					5041	2018-03-16	Psoas	Mass left	No	No	null	null	null	null	null	null	null	null
CPCT02050351T	HMF001719	HMF001719A	0.29	male	1946	2019-04-24	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-03-20	Subcutaneous	Small pelvis left side	Yes	No	Yes	2018-03-27	2018-08-06	Pembrolizumab	Immunotherapy	2018-06-12	Yes	SD
CPCT02050351TII	HMF001719	HMF001719B	0.41	male	1946	2019-04-24	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-08-21	Subcutaneous	small pelvis	Yes	No	Yes	2018-03-27	2018-08-06	Pembrolizumab	Immunotherapy	2018-06-12	Yes	SD
CPCT02050352T	HMF003445	HMF003445A	0.28	female	1971	2018-06-22	Colorectum					9256	2018-03-20	Peritoneum	Abdominal wall right side	Yes	Yes	Yes	2018-04-10	2018-05-30	Tipiracil	Chemotherapy	2018-05-30	No	Clinical progression
CPCT02050354T	HMF003690	HMF003690A	0.64	female	1936	2018-12-17	Colorectum					9256	2018-03-28	Liver	Left lobe	Yes	No	Yes	2018-03-29	2018-07-25	Cetuximab	Targeted therapy	2018-05-17	Yes	SD
CPCT02050355T	HMF002847	HMF002847A	0.46	male	1943	2018-07-28	Colorectum					9256	2018-04-09	Liver	segm IV B	Yes	No	Yes	2018-04-09	2018-05-29	Sunitinib	Targeted therapy	2018-05-29	Yes	PD
CPCT02050356T	HMF000877	HMF000877A	0.7	male	1963	2018-05-03	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2018-04-03	Peritoneum	Abdominal	Yes	No	Yes	2018-04-03	2018-04-30	Pembrolizumab	Immunotherapy	null	null	null
CPCT02050357T	HMF001937	HMF001937A	0.68	male	1943	2018-04-14	Esophagus					5041	2018-03-29	Liver	Right liver lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02050358T	HMF000845	HMF000845A	0.69	male	1944	null	Colorectum					9256	2018-04-04	Subcutaneous	Cranial in scar on back-side	Yes	No	Yes	2018-04-05	2019-01-04	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-06-04	Yes	PR
CPCT02050359T	HMF001191	HMF001191A	0.52	female	1963	2019-08-23	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-04-06	Subcutaneous	Lesion	Yes	Yes	Yes	2018-04-06	2018-08-01	Trastuzumab	Targeted therapy	2018-06-13	Yes	PR
CPCT02050360T	HMF000757	HMF000757A	0.71	male	1948	2018-07-21	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-04-11	Liver	segm 5	Yes	Yes	Yes	2018-04-11	2018-04-14	Regorafenib	Targeted therapy	null	null	null
CPCT02050362T	HMF001365	HMF001365A	0.42	male	1950	2018-08-25	Esophagus					5041	2018-04-13	Liver	segm 6	No	No	Yes	2018-06-07	2018-07-02	Capecitabine/Epirubicin/Oxaliplatin	Chemotherapy	2018-07-31	Yes	SD
CPCT02050363T	HMF001777	HMF001777A	0.87	female	1956	2018-05-08	Vulva					1245	2018-04-13	Liver	Segment III	No	No	Yes	2018-04-16	2018-05-05	Ipilimumab/Nivolumab	Immunotherapy	null	null	null
CPCT02050364T	HMF003429	HMF003429A	0.63	female	1949	2018-05-17	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-23	Liver	Right liverlobe	Yes	Yes	Yes	2018-04-25	2018-05-09	Carboplatin	Chemotherapy	2018-05-09	No	Clinical progression
CPCT02050365T	HMF002996	HMF002996A	0.5	female	1951	null	Skin		Melanoma			8923	2018-04-17	Lymph node	Neck supraclavicular left	No	No	Yes	2018-04-17	2019-04-09	Pembrolizumab	Immunotherapy	null	null	null
CPCT02050370T	HMF000389	HMF000389A	0.44	female	1961	2018-09-01	Skin		Melanoma			8923	2018-04-25	Lymph node	Neck right level 4	No	No	Yes	2018-05-01	2018-06-19	Ipilimumab/Nivolumab	Immunotherapy	2018-08-08	Yes	SD
CPCT02050371T	HMF003185	HMF003185A	0.6	male	1961	2018-05-25	Urothelial tract	Bladder				11054	2018-04-30	Thoracic wall (subcutaneous mass)	Right side	Yes	Yes	Yes	2018-04-30	2018-05-22	Pembrolizumab	Immunotherapy	2018-05-22	No	Clinical progression
CPCT02050373T	HMF001014	HMF001014A	0.54	female	1956	2018-05-29	Skin		Melanoma			8923	2018-05-07	Liver	Near gallbladder	No	No	null	null	null	null	null	null	null	null
CPCT02050375T	HMF002332	HMF002332A	0.68	female	1950	2019-04-23	Colorectum					9256	2018-05-14	Liver	segm II	Yes	No	Yes	2018-05-24	2018-07-26	Irinotecan	Chemotherapy	2018-07-25	Yes	PD
CPCT02050376T	HMF002188	HMF002188A	0.91	male	1936	2018-12-03	Skin		Melanoma			8923	2018-05-16	Lymph node	Left axilla	No	No	Yes	2018-05-16	2018-11-14	Dabrafenib/Trametinib	Targeted therapy	2018-07-04	Yes	SD
CPCT02050380T	HMF002024	HMF002024A	0.62	male	1954	null	Esophagus					5041	2018-05-09	Liver	metastatic lesion	Yes	Yes	Yes	2018-05-23	2018-05-31	Epirubicin/Oxaliplatin/Capecitabine	Chemotherapy	null	null	null
CPCT02050383T	HMF001708	HMF001708A	0.36	female	1950	2020-07-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-29	Bone	left os ilium	Yes	Yes	Yes	2018-06-12	2019-05-21	Letrozole	Hormonal therapy	2018-09-24	Yes	SD
CPCT02050384T	HMF000704	HMF000704A	0.52	male	1951	2018-06-18	Esophagus					5041	2018-06-01	Liver	segment III	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02050386T	HMF003117	HMF003117A	0.82	male	1963	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-06-06	Lung	right lower lobe	No	No	Yes	2018-09-05	2019-07-31	Sorafenib	Targeted therapy	2018-11-14	Yes	SD
CPCT02050390T	HMF003795	HMF003795A	0.5	female	1965	2018-12-28	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-06-18	Primary	Brain right temporal	Yes	Yes	Yes	2018-07-19	2018-08-31	Lomustine	Chemotherapy	null	null	null
CPCT02050392T	HMF002415	HMF002415A	0.82	male	1954	null	Bone/Soft tissue		Solitary fibrous tumor			264,1115	2018-06-20	Peritoneum	metastasis	No	No	Yes	2018-06-20	2018-11-28	Sunitinib	Targeted therapy	null	null	null
CPCT02050395T	HMF000188	HMF000188A	0.7	male	1968	2018-09-14	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-06-25	Abdominal mass intra-abdominal	Soft tissue small pelvis	Yes	No	Yes	2018-07-10	2018-08-21	Pembrolizumab	Immunotherapy	2018-08-24	Yes	PD
CPCT02050396T	HMF000672	HMF000672A	0.92	female	1982	2018-08-26	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-06-26	Primary	Brain	No	No	null	null	null	null	null	null	null	null
CPCT02050398T	HMF002848	HMF002848A	0.62	male	1962	2020-06-17	Colorectum					9256	2018-07-05	Liver	segment 6-7	No	No	Yes	2018-07-05	2019-04-16	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-09-20	Yes	SD
CPCT02050399T	HMF002231	HMF002231A	0.6	male	1961	2019-09-09	Skin		Melanoma			8923	2018-07-03	Skin	Metastasis	No	No	Yes	2018-07-03	2018-12-18	Nivolumab/Ipilimumab	Immunotherapy	2018-09-17	Yes	SD
CPCT02050402T	HMF003760	HMF003760A	0.63	male	1985	2019-04-29	Skin		Melanoma			8923	2018-07-06	Lymph node	right axilla metastasis	No	No	Yes	2018-07-06	2019-03-13	Vemurafenib/Cabozantinib	Targeted therapy	2018-08-24	Yes	SD
CPCT02050403T	HMF003226	HMF003226A	0.24	male	1961	2018-11-18	Esophagus					5041	2018-07-11	Bone	L2	No	No	Yes	2018-08-28	2018-10-02	Capecitabine/Oxaliplatin	Chemotherapy	2018-10-18	Yes	PD
CPCT02050404T	HMF001057	HMF001057A	0.83	male	1935	2018-09-30	Skin		Melanoma			8923	2018-07-12	Lymph node	inguinal	No	No	Yes	2018-07-12	2018-08-23	Pembrolizumab	Immunotherapy	null	null	null
CPCT02050405T	HMF002683	HMF002683A	0.63	female	1936	null	Skin		Melanoma			8923	2018-08-03	Subcutaneous	lesion right lower leg	No	No	Yes	2018-08-03	2019-08-27	Pembrolizumab	Immunotherapy	2018-10-23	Yes	PR
CPCT02050407T	HMF003395	HMF003395A	0.3	male	1950	2019-11-18	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-08-08	Abdominal wall intra-abdominal	Right side abdomen	Yes	No	Yes	2018-08-28	2019-05-07	Sunitinib	Targeted therapy	2018-11-14	Yes	SD
CPCT02050409T	HMF001575	HMF001575A	0.8	female	1969	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-08-28	Primary	Right mamma (skin/ subcutaneous lesion)	Yes	Yes	Yes	2018-09-06	2018-11-22	Palbociclib/Fulvestrant	Multiple therapy	2018-11-09	Yes	PD
CPCT02050411T	HMF003184	HMF003184A	0.53	female	1939	2019-04-14	Skin		Melanoma			8923	2018-09-28	Subcutaneous lesion	left upper leg	No	No	Yes	2018-10-01	2019-02-14	Dabrafenib/Trametinib	Targeted therapy	2018-11-14	Yes	PR
CPCT02050412T	HMF002249	HMF002249A	0.44	female	1964	2018-11-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-01	Liver	Segment 5	Yes	Yes	Yes	2018-11-06	2018-11-11	Bevacizumab/Paclitaxel/Carboplatin/Osimertinib	Multiple therapy	null	null	null
CPCT02050414T	HMF000455	HMF000455A	0.44	male	1954	2019-06-24	Stomach					10534	2018-10-08	Liver	Lesions right part of the liver	Yes	No	Yes	2018-10-09	2018-12-04	Medi0562/Tremelimumab	Immunotherapy	2018-12-04	Yes	PD
CPCT02050415T	HMF000107	HMF000107A	0.88	female	1955	null	Skin		Melanoma			8923	2018-10-17	Subcutaneous	left lower back	No	Yes	Yes	2018-10-17	2018-12-19	Pembrolizumab	Immunotherapy	2018-12-18	Yes	PD
CPCT02050418T	HMF004216	HMF004216A	0.65	male	1949	null	Prostate					10283	2018-11-26	Liver	Segment V	Yes	No	Yes	2018-12-01	2019-01-18	Abiraterone	Hormonal therapy	null	null	null
CPCT02050421T	HMF001173	HMF001173A	0.61	female	1953	null	Skin		Melanoma			8923	2018-12-13	Lymph node	Mamma left	No	Yes	Yes	2018-12-24	2019-04-30	Dabrafenib/Trametinib	Targeted therapy	2019-03-19	Yes	SD
CPCT02050424T	HMF003930	HMF003930A	0.44	male	1943	null	Skin		Melanoma			8923	2019-01-21	Skin	Right shoulder	No	No	Yes	2019-01-21	2019-10-04	Nivolumab	Immunotherapy	2019-04-02	Yes	PR
CPCT02050427T	HMF004191	HMF004191A	0.3	female	1956	2020-09-15	Head and neck	Oropharynx				8557,11934	2019-01-30	Lymph node	lymphnodes level 2 left side	Yes	No	Yes	2019-02-05	2019-11-26	Nivolumab	Immunotherapy	2019-05-06	Yes	PR
CPCT02050431T	HMF004386	HMF004386A	0.28	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-03-21	Mamma	right	Yes	Yes	Yes	2019-03-20	2020-03-26	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02050432T	HMF004250	HMF004250A	0.68	female	1951	2019-09-23	Skin		Melanoma			8923	2019-03-29	subcutaneous mass	right lower back	No	No	Yes	2019-03-29	2019-05-03	Dabrafenib/Trametinib	Targeted therapy	2019-05-17	Yes	SD
CPCT02050434T	HMF003921	HMF003921A	0.41	female	1967	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-04-09	Liver	-	Yes	No	Yes	2019-04-08	2019-06-04	Everolimus	Targeted therapy	2019-06-12	Yes	SD
CPCT02050439T	HMF003964	HMF003964A	0.48	female	1964	2019-07-17	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-26	Liver	Right lobe	Yes	Yes	Yes	2019-03-13	2019-03-28	Lorlatinib	Experimental therapy	2019-04-11	Yes	PD
CPCT02050440T	HMF004207	HMF004207A	0.74	female	1978	2020-03-23	Skin		Melanoma			8923	2019-04-30	Lymph node	Right axilla	No	No	Yes	2019-05-10	2019-12-01	Dabrafenib/Trametinib	Targeted therapy	2019-08-02	Yes	PR
CPCT02050442T	HMF003936	HMF003936A	0.7	male	1956	2019-11-02	Prostate					10283	2019-04-26	Lymph node	right para-iliac	Yes	No	Yes	2019-04-15	2019-07-29	Enzalutamide	Hormonal therapy	2019-07-19	Yes	PD
CPCT02050443T	HMF004300	HMF004300A	0.97	male	1957	2020-10-04	Prostate					10283	2019-04-30	Lymph node	supraclavicular left	Yes	No	Yes	2019-04-23	2019-08-28	Enzalutamide	Hormonal therapy	2019-09-10	Yes	SD
CPCT02050445T	HMF004506	HMF004506A	0.31	male	1952	2020-02-14	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-10-30	Lymph node	Groin left	Yes	No	Yes	2019-10-30	2020-01-02	Pembrolizumab	Immunotherapy	2019-11-08	Yes	SD
CPCT02050447T	HMF004548	HMF004548A	0.52	female	1950	2021-07-08	Pancreas					1793	2020-01-27	Liver	Segment V / VI	No	No	Yes	2020-02-13	2021-02-24	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	2020-05-13	Yes	PR
CPCT02050451T	HMF005218	HMF005218A	0.49	female	1946	2021-07-26	Pancreas					1793	2020-12-15	Liver	Segment II	Yes	No	Yes	2020-12-16	2021-01-13	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	2021-01-19	Yes	PD
CPCT02050453T	HMF005831	HMF005831A	0.23	male	1959	2022-04-20	Pancreas					1793	2021-08-16	Liver	S4	No	No	Yes	2021-11-26	2022-01-24	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2022-02-09	Yes	PD
CPCT02050462T	HMF005898	HMF005898A	0.23	male	1947	null	Pancreas					1793	2021-12-02	Liver	segment 7	No	No	Yes	2021-12-24	2022-08-22	Irinotecan/Oxaliplatin/Fluorouracil/Leucovorin	Multiple therapy	2022-02-10	Yes	SD
CPCT02060006T	HMF003212	HMF003212A	0.87	male	1950	2016-05-14	Skin		Melanoma			8923	2016-04-12	skin	right flank	Yes	Yes	Yes	2016-04-18	2016-04-25	Dacarbazine	Chemotherapy	null	null	null
CPCT02060010T	HMF003593	HMF003593A	0.83	male	1981	2017-01-23	Testis					2998	2016-05-25	Peritoneum	peritonial left abdomen	Yes	No	Yes	2016-05-25	2016-10-11	Carboplatin/Paclitaxel	Chemotherapy	2016-07-29	Yes	SD
CPCT02060011T	HMF000807	HMF000807A	0.52	female	1963	2019-09-05	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	null	null	null	Yes	No	Yes	2016-09-28	2017-02-22	Atezolizumab	Immunotherapy	2016-11-04	Yes	PR
CPCT02060013T	HMF001201	HMF001201A	0.7	female	1950	2016-07-10	Urothelial tract	Bladder				11054	2016-06-10	Liver	segment 6	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060015T	HMF001085	HMF001085A	0.46	male	1968	2017-04-12	Colorectum					9256	2016-06-10	Liver	left lobe liver	No	No	Yes	2016-06-13	2016-12-05	Capecitabine/Oxaliplatin/Fluorouracil	Chemotherapy	2016-08-08	Yes	SD
CPCT02060017T	HMF000528	HMF000528A	0.67	male	1952	2017-09-07	Gallbladder					3121	2016-07-05	Liver	right lobe	Yes	No	Yes	2016-07-01	2016-10-14	Chloroquine	Other	2016-08-09	Yes	PD
CPCT02060018T	HMF000330	HMF000330A	0.61	female	1959	2017-05-31	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-07-07	Lung	right pleural lesion	No	No	Yes	2016-07-13	2016-11-07	Doxorubicin	Chemotherapy	2016-07-21	Yes	ND
CPCT02060022T	HMF001976	HMF001976A	0.82	female	1944	2016-11-24	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2016-07-28	Lymph node	left retroperitoneal	No	No	Yes	2016-08-05	2016-10-14	Anastrozole	Hormonal therapy	2016-11-03	Yes	PD
CPCT02060023T	HMF000049	HMF000049A	0.63	male	1954	2017-04-08	Anus					14110	2016-08-08	Liver	right lobe	Yes	Yes	Yes	2016-08-18	2016-11-21	Capecitabine	Chemotherapy	2016-10-17	Yes	SD
CPCT02060029T	HMF000673	HMF000673A	0.55	male	1951	2017-06-19	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-09-15	Calf muscle left	muscle left leg	No	Yes	Yes	2016-12-27	2017-01-20	Pazopanib	Targeted therapy	2017-01-02	Yes	SD
CPCT02060033T	HMF001396	HMF001396B	0.9	female	1978	2018-03-01	Adrenal gland		Germ cell tumor			3953,4717	2016-09-16	Bone	sacrum left	No	No	Yes	2016-09-29	2016-12-06	Bleomycin/Etoposide/Cisplatin	Chemotherapy	2016-12-27	Yes	SD
CPCT02060034T	HMF003210	HMF003210A	0.84	female	1969	null	Unknown		Carcinoma	Adenoid cystic carcinoma		0080202	2016-10-05	Liver	segment 4B	No	Yes	null	null	null	null	null	null	null	null
CPCT02060035T	HMF000810	HMF000810A	0.54	female	1971	2017-06-07	Uterus	Cervix				4362	null	null	null	Yes	No	null	null	null	null	null	null	null	null
CPCT02060037T	HMF000939	HMF000939A	0.93	male	1971	2017-05-03	Skin		Carcinoma	Merkel cell carcinoma		3965	2016-09-27	retro peritoneal left	caudal of kidneys para-aortal left	No	Yes	Yes	2016-09-28	2017-02-16	Cisplatin/Carboplatin/Etoposide	Chemotherapy	2016-12-20	Yes	SD
CPCT02060039T	HMF001771	HMF001771A	0.48	male	1957	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-10-14	Adrenal	left	Yes	No	null	null	null	null	null	null	null	null
CPCT02060041T	HMF002124	HMF002124A	0.37	male	1964	null	Skin		Carcinoma	Squamous cell carcinoma		3151	2016-10-04	skin	nose bridge	Yes	No	Yes	2016-10-01	2018-04-30	Vismodegib/Vismodegib	Targeted therapy	null	null	null
CPCT02060042T	HMF001135	HMF001135A	0.48	male	1965	2017-11-16	Stomach		Neuroendocrine tumor			10534,169	2017-10-20	Liver	Right lobe	Yes	Yes	Yes	2016-10-25	2017-11-04	Everolimus	Targeted therapy	null	null	null
CPCT02060043T	HMF000220	HMF000220B	0.87	female	1953	null	Skin		Carcinoma	Basal cell carcinoma		2513	2016-10-12	skin	skin	No	No	Yes	2016-11-14	2017-06-13	Vismodegib	Targeted therapy	null	null	null
CPCT02060044T	HMF003124	HMF003124A	0.88	female	1948	null	Skin		Melanoma			8923	2016-10-14	Lymph node	left armpit	No	No	Yes	2016-10-31	2017-02-13	Pembrolizumab	Immunotherapy	2017-01-19	Yes	PD
CPCT02060045T	HMF003801	HMF003801A	0.57	male	1947	null	Prostate					10283	2016-10-25	Liver	right lobe	Yes	No	Yes	2016-10-28	2017-02-08	Docetaxel	Chemotherapy	2017-02-20	Yes	PR
CPCT02060046T	HMF001921	HMF001921A	0.72	female	1960	2018-11-13	Ovary					2394	2016-11-29	Peritoneum	peritoneum left	Yes	No	Yes	2016-12-05	2017-04-26	Letrozole	Hormonal therapy	2017-04-07	Yes	SD
CPCT02060050T	HMF002139	HMF002139A	0.61	male	1954	2017-04-27	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-11-14	Lymph node	left level V	No	No	Yes	2016-11-22	2017-04-07	Pazopanib/Nivolumab	Multiple therapy	2017-02-24	Yes	SD
CPCT02060054T	HMF000142	HMF000142A	0.62	male	1960	2017-04-22	Liver		Carcinoma	Hepatocellular carcinoma		684	2016-12-02	Liver	left lobe	No	No	Yes	2016-12-05	2017-01-31	Sorafenib	Targeted therapy	null	null	null
CPCT02060056T	HMF000776	HMF000776A	0.83	female	1954	null	Ovary					2394	2016-12-07	intraperitoneal deposition	intraperitoneal deposition left	Yes	No	null	null	null	null	null	null	null	null
CPCT02060058T	HMF001394	HMF001394A	0.25	female	1958	null	Pancreas					1793	2016-12-08	Liver	right lobe	No	No	Yes	2016-12-20	2017-02-20	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2017-02-13	No	PD
CPCT02060059T	HMF000372	HMF000372B	0.35	female	1971	2018-04-12	Breast		Carcinoma	Triple negative		0060081	2016-12-07	Subcutaneous	Abdomenal wall	Yes	Yes	Yes	2016-12-13	2017-04-03	Carboplatin/Paclitaxel	Chemotherapy	2016-12-16	Yes	ND
CPCT02060061T	HMF003211	HMF003211A	0.44	male	1970	2018-05-14	Bone/Soft tissue		Undifferentiated sarcoma			1115	2016-12-08	Skin	occipital right	No	Yes	null	null	null	null	null	null	null	null
CPCT02060063T	HMF001714	HMF001714A	0.6	female	1965	2017-06-07	Gallbladder					3121	2016-12-20	null	gall bladder	No	No	Yes	2016-12-29	2017-04-19	Gemcitabine/Cisplatin	Chemotherapy	2017-01-09	Yes	ND
CPCT02060066T	HMF002112	HMF002112A	0.46	male	1957	null	Bone/Soft tissue		Solitary fibrous tumor			264,1115	2017-01-09	Liver	liver	No	Yes	null	null	null	null	null	null	null	null
CPCT02060067T	HMF001356	HMF001356A	0.76	male	1975	2019-04-17	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-12-29	Bone	skull - Left pariatal	Yes	Yes	Yes	2017-01-13	2017-02-24	Nivolumab	Immunotherapy	2017-02-28	Yes	ND
CPCT02060070T	HMF001930	HMF001930A	0.6	female	1956	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-02-07	Liver	liver	Yes	No	Yes	2017-02-14	2017-06-01	Carboplatin	Chemotherapy	null	null	null
CPCT02060071T	HMF000276	HMF000276A	0.65	female	1946	2017-07-20	Bone/Soft tissue	Breast	Osteosarcoma			7787,3347	2017-02-21	Lung	lung	No	No	null	null	null	null	null	null	null	null
CPCT02060072T	HMF003208	HMF003208A	0.45	female	1954	2017-07-30	Colorectum					9256	2017-02-21	Liver	liver	Yes	No	null	null	null	null	null	null	null	null
CPCT02060073T	HMF000244	HMF000244A	0.22	female	1952	null	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2017-02-22	Lymph node	lymph node neck	No	Yes	Yes	2017-03-01	2017-06-14	Gemcitabine/Carboplatin	Chemotherapy	null	null	null
CPCT02060075T	HMF002386	HMF002386A	0.41	female	1958	2017-08-30	Breast		Carcinoma	Triple negative		0060081	2017-03-06	Pectoralis major	Left medial from left musculus pectoralis	Yes	Yes	Yes	2017-03-15	2017-07-17	Carboplatin/Capecitabine	Chemotherapy	2017-03-21	Yes	ND
CPCT02060077T	HMF003620	HMF003620A	0.53	male	1967	2018-03-06	Unknown	CUP	Carcinoma			305	2017-03-15	Liver	left lobe	No	No	Yes	2017-03-21	2017-06-13	Capecitabine/Oxaliplatin	Chemotherapy	2017-05-12	Yes	SD
CPCT02060081T	HMF000424	HMF000424A	0.26	male	1953	2017-07-21	Penis					11615	null	null	null	No	No	null	null	null	null	null	null	null	null
CPCT02060082T	HMF001692	HMF001692A	0.8	male	1963	2018-05-23	Urothelial tract	Bladder				11054	2017-03-29	sigmoid	sigmoid	Yes	No	Yes	2017-06-12	2018-01-30	Atezolizumab	Immunotherapy	2017-08-09	Yes	SD
CPCT02060088T	HMF002520	HMF002520B	0.54	female	1965	2018-09-11	Ovary					2394	2017-04-12	Lymph node	axilla left	Yes	No	Yes	2017-11-08	2018-05-28	Pertuzumab/Trastuzumab	Targeted therapy	2018-01-12	Yes	SD
CPCT02060089T	HMF003458	HMF003458A	0.33	female	1967	2018-08-14	Ovary					2394	2017-04-19	Lymph node	level II neck	Yes	No	Yes	2017-06-21	2018-02-01	Carboplatin/Gemcitabine/Bevacizumab	Multiple therapy	2017-08-29	Yes	PR
CPCT02060092T	HMF001182	HMF001182A	0.41	female	1970	2018-06-23	Skin		Melanoma			8923	2017-05-15	Skin/subcutaneous	right flanc	Yes	No	Yes	2017-05-15	2018-05-07	Dacarbazine/Pembrolizumab	Multiple therapy	2017-07-18	Yes	PD
CPCT02060093T	HMF001454	HMF001454A	0.59	female	1963	2019-03-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-11	Liver	Segment 4	Yes	Yes	Yes	2017-05-16	2019-03-05	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02060094T	HMF001292	HMF001292A	0.71	female	1956	2018-07-05	Ovary					2394	2017-05-19	Abdomen	Right, lateral	Yes	No	Yes	2017-08-01	2017-12-11	Carboplatin/Paclitaxel	Chemotherapy	2017-10-20	Yes	SD
CPCT02060096T	HMF000015	HMF000015A	0.4	female	1966	2017-10-07	Colorectum					9256	2017-05-23	Liver	unknown	Yes	No	Yes	2017-05-31	2017-06-26	Capecitabine/Oxaliplatin	Chemotherapy	2017-09-07	Yes	PD
CPCT02060103T	HMF001176	HMF001176A	0.5	female	1964	2018-12-04	Colorectum	Colon	Carcinoma			1520	2017-06-23	Abdomen	Lower right	Yes	No	Yes	2017-06-29	2018-03-23	Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2017-09-28	Yes	SD
CPCT02060104T	HMF000571	HMF000571B	0.24	female	1945	2018-06-19	Bone/Soft tissue	Retroperitoneal	Liposarcoma			3382,1115	2017-07-05	Abdomen	intra-abdominal right, lateral	No	No	Yes	2017-07-17	2018-01-01	Olaratumab/Doxorubicin	Multiple therapy	2017-09-25	Yes	PD
CPCT02060105T	HMF002751	HMF002751A	0.59	female	1962	null	Ovary				Extra-ovarian	2394	2017-06-30	Vaginal	Unknown	Yes	No	Yes	2017-09-07	2017-12-21	Carboplatin/Paclitaxel	Chemotherapy	2017-09-08	Yes	SD
CPCT02060107T	HMF003536	HMF003536A	0.57	female	1947	2018-03-14	Pancreas					1793	2017-07-11	Liver	Left lobe	No	No	Yes	2017-08-17	2018-01-04	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2017-11-28	Yes	PR
CPCT02060112T	HMF002367	HMF002367A	0.52	female	1962	null	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2017-07-19	Lymph node	Para-iliacaal left	No	No	Yes	2017-08-10	2017-12-27	Gemcitabine/Cisplatin	Chemotherapy	2017-10-05	Yes	SD
CPCT02060114T	HMF001311	HMF001311B	0.24	female	1980	2018-02-10	Uterus	Cervix				4362	2017-07-20	Lymph node	Iliac communis right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060116T	HMF002445	HMF002445A	0.21	female	1969	2017-12-20	Pancreas					1793	2017-07-21	Liver	Segment II	No	No	Yes	2017-08-15	2017-11-01	Leucovorin/Oxaliplatin/Irinotecan/Fluorouracil	Multiple therapy	null	null	null
CPCT02060117T	HMF002632	HMF002632A	0.86	female	1980	2019-06-27	Uterus	Cervix				4362	2017-07-28	mesentery	meso ileum, 10 cm from ileocoecal angle	No	No	Yes	2017-10-01	2018-02-26	Carboplatin/Paclitaxel/ISA101 vaccine/Bevacizumab	Multiple therapy	2017-12-27	Yes	PR
CPCT02060118T	HMF002595	HMF002595A	0.69	female	1959	2017-10-19	Uterus	Endometrium				1380	2017-08-09	Abdomen	Omental cake	Yes	No	Yes	2017-09-01	2017-09-01	Doxorubicin (liposomal)	Chemotherapy	null	null	null
CPCT02060119T	HMF000981	HMF000981A	0.92	female	1958	2017-12-18	Head and neck	Sublingual gland				8849,11934	2017-08-11	Liver	Left liver lobe	No	Yes	Yes	2017-09-01	2017-10-12	Doxorubicin/Cyclophosphamide/Cisplatin	Chemotherapy	2017-11-03	Yes	PD
CPCT02060120T	HMF002316	HMF002316A	0.73	female	1970	2017-10-01	Ovary					2394	2017-08-17	Skin/ subcutaneous	Right site scapula	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060121T	HMF000758	HMF000758A	0.32	female	1950	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-08-21	Lung	Left lower lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060125T	HMF001424	HMF001424A	0.91	female	1964	2018-02-25	Anus					14110	2017-08-22	Perineal	Woundbed necrotic cavity	Yes	Yes	Yes	2017-10-06	2017-10-16	Capecitabine	Chemotherapy	2017-11-20	Yes	ND
CPCT02060126T	HMF003423	HMF003423A	0.69	male	1954	null	Skin		Melanoma			8923	2017-08-24	skin/subcutaneous	Ventral side abdomen/omentum/peritoneum	No	No	Yes	2017-08-24	2019-03-01	Pembrolizumab	Immunotherapy	2017-11-14	Yes	SD
CPCT02060128T	HMF002484	HMF002484A	0.65	female	1951	2018-08-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-29	Liver	Segment IV	Yes	Yes	Yes	2017-09-06	2018-04-25	Everolimus/Exemestane/Palbociclib/Fulvestrant/Epirubicin	Multiple therapy	null	null	null
CPCT02060129T	HMF001615	HMF001615A	0.68	female	1959	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-08-30	Bone	Sacrum right (from posterior)	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060133T	HMF001645	HMF001645A	0.69	female	1947	null	Eye		Melanoma			1752,1909	2017-09-13	Liver	Segment 5/6	No	No	null	null	null	null	null	null	null	null
CPCT02060136T	HMF000169	HMF000169A	0.7	female	1961	null	Colorectum					9256	2017-10-04	Liver	right lobe	Yes	No	Yes	2018-06-27	2018-10-16	Bevacizumab/Capecitabine/Irinotecan	Multiple therapy	2018-08-24	Yes	SD
CPCT02060140T	HMF003569	HMF003569A	0.67	male	1961	null	Small intestine		Neuroendocrine tumor			10154,169	2018-05-01	Abdominal wall paramedian	under the abdominal wall para-umbilical	Yes	No	Yes	2017-10-11	2019-06-26	Octreotide	Hormonal therapy	null	null	null
CPCT02060142T	HMF000070	HMF000070A	0.86	female	1973	null	Ovary					2394	2017-09-22	Mass	Near to left side bladder	Yes	No	Yes	2017-10-03	2018-03-06	Mutant p53 reactivating compound APR-246 (PRIMA-1Met)/Doxorubicin (liposomal)/Carboplatin	Multiple therapy	2017-11-24	Yes	SD
CPCT02060146T	HMF000809	HMF000809C	0.39	male	1975	null	Skin		Carcinoma	Hidradenocarcinoma	Skin adnex	5667	2017-09-29	Lymph node	Right axillar	No	Yes	null	null	null	null	null	null	null	null
CPCT02060147T	HMF002085	HMF002085A	0.62	male	1953	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-10-02	CNS	Brain; Left parietal	Yes	Yes	Yes	2017-11-01	2018-05-22	Temozolomide	Chemotherapy	null	null	null
CPCT02060149T	HMF001709	HMF001709A	0.24	male	1965	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-10-03	Adrenal gland	right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060150T	HMF002725	HMF002725A	0.32	female	1962	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-10-05	CNS	Left frontal brain	Yes	Yes	Yes	2017-10-05	2018-10-29	Trastuzumab/Anastrozole	Multiple therapy	null	null	null
CPCT02060155T	HMF001946	HMF001946A	0.62	female	1959	2019-02-01	Colorectum					9256	2017-10-05	Vagina	Top of vagina	Yes	Yes	Yes	2017-11-27	2017-12-04	Oxaliplatin/Capecitabine	Chemotherapy	2018-03-01	Yes	PR
CPCT02060160T	HMF003349	HMF003349A	0.51	male	1950	2018-09-13	Colorectum					9256	2017-10-30	Lymph node	left inguinal	Yes	Yes	Yes	2017-11-07	2018-04-24	Fluorouracil	Chemotherapy	2018-02-20	Yes	SD
CPCT02060161T	HMF001701	HMF001701A	0.3	male	1963	2018-07-22	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-10-24	Brain	right temperal	Yes	Yes	Yes	2017-11-17	2018-01-16	Lomustine	Chemotherapy	null	null	null
CPCT02060163T	HMF000564	HMF000564A	0.6	female	1965	2018-02-15	Skin		Melanoma			8923	2017-10-31	Liver	right lobe	No	No	null	null	null	null	null	null	null	null
CPCT02060167T	HMF002008	HMF002008A	0.49	male	1950	2018-01-11	Pancreas					1793	2017-11-08	Liver	Segment VI	No	No	Yes	2017-11-22	2017-12-28	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	null	null	null
CPCT02060168T	HMF002416	HMF002416A	0.5	female	1953	2019-03-30	Ovary					2394	2017-11-22	Intra peritoneal	Right lower abdomen	Yes	No	Yes	2017-11-22	2018-04-26	Letrozole	Hormonal therapy	2018-04-20	Yes	PD
CPCT02060179T	HMF002342	HMF002342A	0.59	female	1956	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-29	Liver	left lobe	Yes	Yes	Yes	2017-11-30	2018-09-12	Palbociclib/Letrozole	Multiple therapy	2018-01-25	Yes	SD
CPCT02060181T	HMF003122	HMF003122A	0.91	female	1950	2018-09-01	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2017-12-04	Chest wall	ventral right thorax wall	Yes	Yes	Yes	2018-01-17	2018-03-08	Ifosfamide	Chemotherapy	2018-03-19	Yes	SD
CPCT02060199T	HMF002953	HMF002953A	0.23	male	1963	null	Esophagus					5041	2018-01-18	Lymph node	Lymph node right supravicular	No	No	Yes	2018-03-14	2018-06-18	Oxaliplatin/Capecitabine	Chemotherapy	2018-06-11	Yes	PD
CPCT02060201T	HMF000386	HMF000386A	0.38	male	1976	2018-04-17	Stomach					10534	2018-01-18	Lymph node	supraclavicular left	No	No	Yes	2018-01-29	2018-03-28	Oxaliplatin/Fluorouracil/Leucovorin	Multiple therapy	null	null	null
CPCT02060206T	HMF002783	HMF002783A	0.47	female	1972	null	Unknown	CUP	Carcinoma			305	2018-01-30	Mass right mamma	in the m. pectoralis	No	No	Yes	2018-02-01	2018-05-16	Paclitaxel/Carboplatin	Chemotherapy	2018-03-26	Yes	SD
CPCT02060210T	HMF000868	HMF000868A	0.24	male	1944	2018-10-07	Pancreas					1793	2018-01-30	Liver	left lobe	No	null	null	null	null	null	null	null	null	null
CPCT02060211T	HMF001032	HMF001032A	0.82	male	1954	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2018-02-05	Liver	left lobe	No	No	Yes	2018-02-13	2018-06-06	Doxorubicin/Olaratumab	Multiple therapy	2018-04-24	Yes	SD
CPCT02060213T	HMF000824	HMF000824A	0.25	male	1953	2018-04-22	Esophagus					5041	2018-02-08	Lymph node	right supraclavicular LN	No	Yes	null	null	null	null	null	null	null	null
CPCT02060214T	HMF001392	HMF001392A	0.62	female	1943	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-02-21	Liver	left side	Yes	Yes	Yes	2018-03-01	2018-05-22	Capecitabine	Chemotherapy	2018-04-26	Yes	PR
CPCT02060220T	HMF000317	HMF000317A	0.51	female	1957	null	Bile duct		Carcinoma			4947	2018-02-26	Liver	segment V/VIII	No	No	null	null	null	null	null	null	null	null
CPCT02060221T	HMF001729	HMF001729A	0.78	female	1967	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-26	Ovarium	unknown	Yes	Yes	Yes	2018-03-20	null	Fulvestrant	Hormonal therapy	null	null	null
CPCT02060224T	HMF001837	HMF001837A	0.71	male	1952	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-03-05	Primary	right frontal near motor cortex	No	Yes	null	null	null	null	null	null	null	null
CPCT02060225T	HMF002830	HMF002830A	0.67	male	1952	2018-09-20	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-03-20	CNS	Brain parieto-occipitaal	No	No	null	null	null	null	null	null	null	null
CPCT02060226T	HMF001389	HMF001389A	0.63	female	1952	null	Ovary					2394	2018-02-18	Ovarium	Ovarium	Yes	No	Yes	2017-11-20	2018-03-12	Carboplatin	Chemotherapy	2018-01-08	Yes	PR
CPCT02060228T	HMF000232	HMF000232A	0.47	female	1983	null	Skin		Melanoma			8923	2018-03-15	Brain	left temporal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060230T	HMF002102	HMF002102A	0.95	female	1945	null	Bone/Soft tissue		Ewing sarcoma			3369	2018-03-08	Peritoneum	at location sigmoid	No	No	null	null	null	null	null	null	null	null
CPCT02060231T	HMF002450	HMF002450A	0.2	female	1962	2018-11-29	Colorectum					9256	2018-03-23	Liver	segment VIII	Yes	No	Yes	2018-03-29	2018-09-13	Irinotecan	Chemotherapy	2018-06-14	Yes	SD
CPCT02060235T	HMF000532	HMF000532A	0.93	male	1954	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-09-06	Liver	Right side	Yes	No	Yes	2018-03-14	2018-05-23	Imatinib	Targeted therapy	null	null	null
CPCT02060236T	HMF003239	HMF003239A	0.59	male	1958	null	Pancreas		Neuroendocrine tumor			1793,169	2018-04-03	Liver	segment VI	No	No	Yes	2018-03-30	2020-07-18	Octreotide	Hormonal therapy	null	null	null
CPCT02060237T	HMF001262	HMF001262A	0.64	female	1991	null	Bone/Soft tissue		Malignant peripheral nerve sheath tumor			5940,1115	2018-04-03	Lung	Posterior left lower lobe	No	Yes	Yes	2018-04-05	2018-09-21	Vindesine/Epirubicin/Ifosfamide	Chemotherapy	2018-06-25	Yes	SD
CPCT02060239T	HMF001023	HMF001023A	0.37	female	1949	null	Colorectum					9256	2018-04-16	Lymph node	left inguinal	Yes	Yes	Yes	2018-06-15	2018-10-10	Oxaliplatin/Capecitabine	Chemotherapy	2018-08-22	Yes	PD
CPCT02060241T	HMF000124	HMF000124A	0.81	male	1998	2019-04-10	Bone/Soft tissue		Rhabdomyosarcoma			3247,1115	2018-04-18	Bladder	bladder neck ventral and right	Yes	No	Yes	2018-04-19	2018-11-10	Vindesine/Epirubicin/Ifosfamide	Chemotherapy	2018-06-14	Yes	CR
CPCT02060242T	HMF003209	HMF003209A	0.86	male	1941	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-05-09	Primary	left liver lobe	No	No	Yes	2018-06-11	2019-04-01	Sorafenib	Targeted therapy	2018-08-30	Yes	PD
CPCT02060245T	HMF001568	HMF001568A	0.45	male	1944	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2018-03-02	Abdominal	Mesenterium small intestine	No	No	Yes	2018-04-18	2018-10-29	Doxorubicin/Olaratumab	Multiple therapy	2018-06-11	Yes	PD
CPCT02060246T	HMF003773	HMF003773A	0.76	male	1978	2019-05-30	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-06-19	Primary	left frontal brain	No	Yes	Yes	2018-07-03	2018-09-25	Temozolomide	Chemotherapy	null	null	null
CPCT02060247T	HMF000224	HMF000224A	0.89	male	1965	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-05-17	CNS	right parietaal	No	No	Yes	2018-06-25	2018-11-20	Temozolomide	Chemotherapy	null	null	null
CPCT02060248T	HMF003148	HMF003148A	0.67	male	1960	null	Esophagus					5041	2018-05-18	Liver	left lobe	No	No	Yes	2018-06-05	2018-08-13	Etoposide/Cisplatin	Chemotherapy	2018-07-09	Yes	SD
CPCT02060249T	HMF003159	HMF003159A	0.3	male	1947	2020-01-29	Prostate					10283	2018-05-29	Lymph node	right inguinal	Yes	No	Yes	2018-06-27	2018-09-01	Docetaxel	Chemotherapy	null	null	null
CPCT02060251T	HMF001077	HMF001077A	0.84	female	1976	null	Ovary		Sex-cord stromal tumor	Granulosa cell tumor		2999,2394	2018-05-30	Liver	left lobe	No	No	null	null	null	null	null	null	null	null
CPCT02060253T	HMF001192	HMF001192A	0.9	male	1947	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-05-30	Soft tissue mass	central in abdomen	No	No	null	null	null	null	null	null	null	null
CPCT02060254T	HMF001854	HMF001854A	0.95	female	1969	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2018-05-31	Lymph node	right axilla	No	Yes	Yes	2018-06-25	2018-07-16	Doxorubicin/Olaratumab	Multiple therapy	null	null	null
CPCT02060255T	HMF000406	HMF000406A	0.29	male	1969	2018-09-05	Esophagus					5041	2018-06-01	gluteus maximus	lateral right leg	Yes	Yes	Yes	2018-06-06	2018-06-21	Leucovorin/Fluorouracil/Oxaliplatin	Multiple therapy	2018-07-09	Yes	PD
CPCT02060257T	HMF001062	HMF001062A	0.98	male	1996	null	Nervous system	Brain	Blastoma	Medulloblastoma		0050902	2018-06-04	CNS	L5-S1	Yes	Yes	Yes	2018-08-02	2018-10-23	Cisplatin/Ifosfamide/Etoposide	Chemotherapy	null	null	null
CPCT02060259T	HMF003873	HMF003873A	0.48	female	1967	null	Colorectum					9256	2019-04-02	Lung	left upper lobe	Yes	No	Yes	2019-04-08	2020-02-10	Fluorouracil	Chemotherapy	2019-05-28	Yes	SD
CPCT02060261T	HMF002576	HMF002576A	0.23	male	1953	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-19	Lung	left upper lobe	Yes	Yes	Yes	2018-06-22	2018-09-14	Carboplatin/Pemetrexed	Chemotherapy	2018-12-18	Yes	PD
CPCT02060264T	HMF000788	HMF000788A	0.44	female	1967	2019-04-17	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-07-03	CNS	left frontal brain	Yes	Yes	Yes	2018-11-06	2018-11-24	Lomustine	Chemotherapy	null	null	null
CPCT02060272T	HMF002119	HMF002119A	0.69	female	1960	2019-01-16	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-08-15	Liver	Segment 2	Yes	No	Yes	2018-08-15	2018-09-03	Fulvestrant	Hormonal therapy	2018-08-29	Yes	PD
CPCT02060275T	HMF001772	HMF001772A	0.85	male	1991	null	Bone/Soft tissue		Sclerosing epithelioid fibrosarcoma			3355,1115	2018-11-01	Lung	left lower lobe	No	Yes	Yes	2019-01-28	2019-05-20	Doxorubicin	Chemotherapy	2019-04-19	Yes	SD
CPCT02060276T	HMF003601	HMF003601A	0.37	male	1946	2019-01-20	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-08-29	Liver	right	No	No	Yes	2018-09-05	2018-11-13	Sorafenib	Targeted therapy	null	null	null
CPCT02060277T	HMF001966	HMF001966A	0.71	female	1973	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-09-05	Liver	right	No	No	Yes	2018-09-20	2019-05-01	Paclitaxel/Eftilagimod alpha or placebo	Multiple therapy	2018-11-13	Yes	SD
CPCT02060278T	HMF002125	HMF002125A	0.42	female	1969	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-09-06	mamma	left mamma	Yes	No	Yes	2018-09-06	null	Fulvestrant/Palbociclib	Multiple therapy	null	null	null
CPCT02060279T	HMF004381	HMF004381A	0.41	female	1965	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-11-29	Liver	S4	Yes	Yes	Yes	2018-11-27	2018-12-24	Bicalutamide	Androgen/estrogen deprivation therapy	null	null	null
CPCT02060282T	HMF004111	HMF004111A	0.4	male	1992	null	Bone/Soft tissue		Alveolar soft part sarcoma			4239,1115	2019-02-07	Skin, subcutaneous	Calf left	No	No	null	null	null	null	null	null	null	null
CPCT02060285T	HMF004094	HMF004094A	0.22	female	1946	2019-05-25	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-15	Liver	Segment IV	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060286T	HMF003864	HMF003864A	0.89	female	1948	null	Skin		Melanoma			8923	2019-03-14	Lymph node	station 4	No	No	null	null	null	null	null	null	null	null
CPCT02060288T	HMF004235	HMF004235A	0.53	female	1960	null	Skin		Melanoma			8923	2019-03-28	Skin	Upper back right	Yes	Yes	Yes	2019-03-28	2019-06-03	Nivolumab	Immunotherapy	2019-06-06	Yes	PD
CPCT02060289T	HMF003825	HMF003825A	0.39	female	1973	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-04-29	Liver	liver metastasis	Yes	Yes	Yes	2019-05-02	2019-06-24	Bicalutamide	Androgen/estrogen deprivation therapy	2019-06-18	Yes	PD
CPCT02060290T	HMF003828	HMF003828A	0.91	male	2000	null	Bone/Soft tissue		Desmoplastic small round cell tumor			6785	2019-04-29	Liver	liver metastasis	Yes	No	Yes	2019-05-24	2019-08-01	Vincristine/Dactinomycin/Ifosfamide	Chemotherapy	2019-08-05	Yes	PD
CPCT02060291T	HMF003856	HMF003856A	0.29	female	1953	null	Skin		Melanoma			8923	2019-05-16	subcutaneous	dorsal abdominal wall level of Th3	No	No	Yes	2019-05-20	2019-11-25	Nivolumab	Immunotherapy	2019-07-15	Yes	PR
CPCT02060292T	HMF003955	HMF003955A	0.31	male	1977	2019-06-12	Bone/Soft tissue		Low-grade myofibroblastic sarcoma			1115	2019-05-23	subcutaneous	left intercostal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02060294T	HMF003903	HMF003903A	0.87	male	1951	null	Prostate					10283	2019-05-28	Peritoneum	omentum	Yes	No	Yes	2019-07-02	2019-10-22	Docetaxel	Chemotherapy	2019-10-31	Yes	PD
CPCT02070009T	HMF001044	HMF001044B	0.88	male	1974	2017-07-18	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2016-05-01	gastro intestinal	resection GIST retroperitoneal	Yes	No	Yes	2016-05-02	2016-10-14	Regorafenib	Targeted therapy	2016-07-15	Yes	SD
CPCT02070013T	HMF001009	HMF001009A	0.54	male	1996	2017-01-25	Bone/Soft tissue		Ewing sarcoma			3369	2016-08-02	Bone	Amputated upper leg	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070015T	HMF000334	HMF000334A	0.46	male	1960	null	Esophagus					5041	2016-08-16	Liver	segment 2	No	No	null	null	null	null	null	null	null	null
CPCT02070018T	HMF003744	HMF003744A	0.56	male	1945	2017-02-18	Penis					11615	2016-09-20	bladder	bladder wall	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070020T	HMF000108	HMF000108A	0.45	male	1940	2017-03-09	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2016-09-20	Lymph node	parailliacal	Yes	Yes	Yes	2016-10-19	2017-01-25	Docetaxel	Chemotherapy	2016-12-05	Yes	Clinical progression
CPCT02070021T	HMF002537	HMF002537A	0.64	male	1954	2017-01-06	Prostate					10283	2016-09-21	Lymph node	Right side of neck	Yes	Yes	Yes	2016-09-21	2016-12-28	Cabazitaxel/Cyproterone/Degarelix	Multiple therapy	2016-12-28	Yes	PD
CPCT02070023T	HMF000458	HMF000458C	0.95	male	1958	null	Prostate					10283	2016-09-22	subcutaneous lesion	Upper thoracic wall, left	Yes	Yes	Yes	2016-10-26	2017-01-04	Cabazitaxel	Chemotherapy	2017-01-13	Yes	PD
CPCT02070023TII	HMF000458	HMF000458B	0.85	male	1958	null	Prostate					10283	2017-11-30	Adrenal gland	resection	Yes	Yes	Yes	2016-10-26	2017-01-04	Cabazitaxel	Chemotherapy	2017-01-13	Yes	PD
CPCT02070025T	HMF003735	HMF003735A	0.84	male	1961	2021-09-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-09-27	muscle, pectoralis major right	Pectoralis major right	No	Yes	Yes	2017-12-13	2018-05-02	Cyclophosphamide/Cisplatin/Doxorubicin	Chemotherapy	2018-02-16	Yes	SD
CPCT02070027T	HMF002092	HMF002092A	0.83	male	1958	2017-09-21	Prostate					10283	2017-08-03	Lymph node	para-aortal	Yes	No	Yes	2016-11-17	2017-04-07	Radium-223	Nuclear therapy	2017-01-25	Yes	SD
CPCT02070030T	HMF003009	HMF003009A	0.22	male	1963	2019-12-23	Head and neck	Salivary gland				8850,11934	2017-10-04	Liver	Location not specified	No	Yes	Yes	2017-11-09	2018-03-22	Doxorubicin/Cyclophosphamide/Cisplatin	Chemotherapy	2018-01-10	Yes	SD
CPCT02070032T	HMF000551	HMF000551B	0.79	male	1950	2020-10-25	Prostate					10283	2016-10-11	Lymph node	abdominal	Yes	No	Yes	2016-10-25	2017-12-20	Pembrolizumab	Immunotherapy	2016-12-21	Yes	PR
CPCT02070034T	HMF001078	HMF001078A	0.31	male	1964	2018-12-14	Esophagus					5041	2017-07-26	Liver	segment 5	No	No	Yes	2017-08-14	2018-04-01	Paclitaxel/Ramucirumab	Multiple therapy	2017-10-10	Yes	PR
CPCT02070036T	HMF000312	HMF000312A	0.62	male	1943	null	Prostate					10283	2016-10-18	Kidney	pararenal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070037T	HMF000002	HMF000002A	0.72	male	1961	2017-10-20	Prostate					10283	2016-11-17	Bladder	bladder wall right dorsal	Yes	No	Yes	2017-02-02	2017-05-19	Prostate-specific membrane antigen (PSMA) - Actinium-225 (Ac-225)	Nuclear therapy	null	null	null
CPCT02070038T	HMF001158	HMF001158A	0.81	male	1959	2017-07-28	Head and neck	Salivary gland				8850,11934	2016-11-24	Muscle	Gluteus	Yes	Yes	Yes	2017-02-02	2017-04-19	Crizotinib	Targeted therapy	2017-03-20	Yes	SD
CPCT02070039T	HMF000748	HMF000748A	0.27	male	1961	2017-12-15	Head and neck	Oropharynx				8557,11934	2016-12-01	soft tissue costa	rib 11	No	Yes	Yes	2017-01-10	2017-04-18	Nivolumab	Immunotherapy	2017-02-20	Yes	PD
CPCT02070040T	HMF001603	HMF001603A	0.41	male	1956	2016-12-02	Pancreas		Neuroendocrine tumor			1793,169	2016-11-24	Liver	left lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02070041T	HMF000394	HMF000394A	0.8	male	1966	2017-06-27	Urothelial tract	Bladder				11054	2016-11-25	Bone	Iliac crest	Yes	No	null	null	null	null	null	null	null	null
CPCT02070043T	HMF001716	HMF001716A	0.69	female	1948	2016-12-25	Urothelial tract	Bladder				11054	2016-12-06	Liver	Left lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070044T	HMF000917	HMF000917A	0.25	male	1961	null	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2016-12-08	Kidney	Kidney right	No	No	Yes	2016-12-28	2017-04-19	Gemcitabine/Cisplatin	Chemotherapy	2017-02-23	Yes	PR
CPCT02070046T	HMF001539	HMF001539A	0.29	male	1946	2017-06-27	Prostate					10283	2016-12-08	Liver	left lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070049T	HMF002207	HMF002207A	0.58	male	1954	2017-03-17	Prostate					10283	2016-12-08	Lymph node	Axilla left	Yes	Yes	Yes	2016-12-21	2017-02-22	Abiraterone	Hormonal therapy	null	null	null
CPCT02070050T	HMF000075	HMF000075A	0.55	female	1961	null	Colorectum					9256	2016-12-08	Bone	Os ilium	Yes	Yes	Yes	2016-12-17	2017-04-19	Trifluridine/Trifluridine	Chemotherapy	2017-04-12	Yes	PD
CPCT02070051T	HMF001553	HMF001553A	0.78	male	1965	2018-01-17	Bone/Soft tissue		Liposarcoma			3382,1115	2016-12-09	Salivary gland	Left parotid gland	Yes	Yes	Yes	2016-12-23	2017-08-01	Eribulin/HDM201	Multiple therapy	2017-02-21	Yes	PD
CPCT02070052T	HMF002072	HMF002072A	0.46	male	1945	null	Gallbladder					3121	2016-12-20	Liver	Right lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02070053T	HMF003631	HMF003631A	0.79	female	1977	2017-06-07	Unknown	CUP	Carcinoma	Neuroendocrine carcinoma		1800	2016-12-15	Liver	left lobe	Yes	Yes	Yes	2017-01-23	2017-04-29	Everolimus	Targeted therapy	2017-04-06	Yes	SD
CPCT02070055T	HMF000222	HMF000222A	0.6	male	1966	2019-07-09	Prostate					10283	2016-12-30	bladder wall	Bladder wall	Yes	No	Yes	2017-01-10	2019-03-21	Abiraterone/Cabazitaxel/Carboplatin/Olaparib/Cabazitaxel/Carboplatin	Multiple therapy	2017-03-15	Yes	PD
CPCT02070055TII	HMF000222	HMF000222B	0.8	male	1966	2019-07-09	Prostate					10283	2019-04-04	Liver	right lobe, segment 5	Yes	No	Yes	2017-01-10	2019-03-21	Abiraterone/Cabazitaxel/Carboplatin/Olaparib/Cabazitaxel/Carboplatin	Multiple therapy	2017-03-15	Yes	PD
CPCT02070057T	HMF003054	HMF003054A	0.43	male	1952	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-01-03	Bone	xiphoid process	Yes	No	Yes	2017-04-12	2019-02-19	Nivolumab	Immunotherapy	2017-06-08	Yes	PR
CPCT02070058T	HMF001728	HMF001728A	0.66	female	1955	2018-08-01	Ovary					2394	2016-12-27	Vagina	Upper wall	Yes	No	Yes	2017-03-14	2017-08-22	Paclitaxel	Chemotherapy	2017-05-31	Yes	PR
CPCT02070060T	HMF001789	HMF001789A	0.84	female	1959	2018-04-20	Uterus	Cervix				4362	2017-02-16	soft tissue	Soft tissue ramus inferior os pubis	Yes	Yes	Yes	2017-06-12	2017-09-26	Pembrolizumab	Immunotherapy	2017-08-14	Yes	PD
CPCT02070064T	HMF001867	HMF001867C	0.45	male	1954	2020-01-17	Prostate					10283	2016-12-30	Lymph node	Low para iliac left	Yes	No	Yes	2017-01-04	2017-04-19	Docetaxel	Chemotherapy	2017-05-02	Yes	SD
CPCT02070064TII	HMF001867	HMF001867B	0.65	male	1954	2020-01-17	Prostate					10283	2018-03-23	Bone	sacral	Yes	No	Yes	2017-01-04	2017-04-19	Docetaxel	Chemotherapy	2017-05-02	Yes	SD
CPCT02070064TIII	HMF001867	HMF001867A	0.29	male	1954	2020-01-17	Prostate					10283	2018-10-09	Bone	os pubis right	Yes	No	Yes	2017-01-04	2017-04-19	Docetaxel	Chemotherapy	2017-05-02	Yes	SD
CPCT02070065T	HMF003716	HMF003716A	0.95	male	1959	2020-09-17	Head and neck	Lip and oral cavity				8564,11934	2017-01-19	Lung	Pleural mass dorsal base right	No	No	Yes	2017-08-14	2017-11-14	Vinorelbine	Chemotherapy	2017-11-06	Yes	PD
CPCT02070066T	HMF002810	HMF002810B	0.3	female	1954	2017-11-03	Colorectum					9256	2017-01-03	Liver	liver meta	Yes	No	Yes	2017-01-01	2017-05-01	Panitumumab	Targeted therapy	2017-01-18	Yes	null
CPCT02070068T	HMF001720	HMF001720A	0.62	male	1960	2017-07-06	Prostate					10283	2017-01-05	Lymph node	Left side neck	Yes	Yes	Yes	2017-01-06	2017-05-02	Cabazitaxel/Enzalutamide	Multiple therapy	2017-03-30	Yes	CR
CPCT02070069T	HMF001636	HMF001636A	0.45	male	1950	2018-12-31	Prostate					10283	null	null	null	No	No	Yes	2017-05-10	2018-10-24	Docetaxel/Abiraterone	Multiple therapy	null	null	null
CPCT02070069TII	HMF001636	HMF001636B	0.8	male	1950	2018-12-31	Prostate					10283	null	null	null	No	No	Yes	2017-05-10	2018-10-24	Docetaxel/Abiraterone	Multiple therapy	null	null	null
CPCT02070070T	HMF001773	HMF001773A	0.7	male	1938	2017-08-03	Colorectum					9256	2017-01-31	Liver	Liver	Yes	Yes	Yes	2017-02-06	2017-03-28	Irinotecan	Chemotherapy	2017-04-06	Yes	PD
CPCT02070074T	HMF000421	HMF000421A	0.9	male	1946	2021-05-13	Prostate					10283	2017-01-13	Lymph node	Paraclavicular left	Yes	Yes	Yes	2017-01-27	2017-05-23	Prostate-specific membrane antigen (PSMA) - Actinium-225 (Ac-225)	Nuclear therapy	2017-05-31	Yes	PR
CPCT02070078T	HMF001455	HMF001455A	0.82	female	1972	2017-04-29	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-01-27	subcutaneous	musculus obliquus externus	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070082T	HMF000351	HMF000351A	0.34	male	1956	2018-05-29	Prostate					10283	2017-03-06	Bone	vertebra th4	Yes	Yes	Yes	2017-03-08	2017-08-01	Docetaxel	Chemotherapy	2017-05-26	Yes	PR
CPCT02070086T	HMF000268	HMF000268A	0.97	female	1942	2017-08-02	Mesothelium		Malignant mesothelioma			1790,0050686	2017-02-09	Peritoneum	peritoneum	Yes	No	null	null	null	null	null	null	null	null
CPCT02070087T	HMF003597	HMF003597A	0.75	male	1937	2017-10-28	Prostate					10283	2017-02-07	Lymph node	para-iliacal right	Yes	Yes	Yes	2017-05-17	2017-06-27	Pembrolizumab	Immunotherapy	2017-08-02	Yes	SD
CPCT02070091T	HMF001239	HMF001239A	0.2	male	1968	2019-10-15	Prostate					10283	2017-03-07	Bone	acetabulum right	Yes	No	Yes	2017-05-01	2017-08-22	Docetaxel	Chemotherapy	null	null	null
CPCT02070092T	HMF000960	HMF000960A	0.79	male	1961	2019-05-13	Prostate					10283	2018-02-08	Adrenal gland	right	Yes	No	Yes	2018-02-08	2018-10-01	Docetaxel/Carboplatin	Chemotherapy	2018-11-06	Yes	PD
CPCT02070094T	HMF003434	HMF003434A	0.33	male	1944	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-02-16	Lymph node	inguinal	No	No	Yes	2017-03-09	2017-12-20	Pembrolizumab	Immunotherapy	2017-05-29	Yes	PR
CPCT02070095T	HMF002926	HMF002926A	0.61	female	1982	2018-09-23	Bone/Soft tissue	Bone	Osteosarcoma			3376	2017-02-17	Bone	crista	Yes	No	Yes	2017-09-01	2017-11-04	Ifosfamide	Chemotherapy	null	null	null
CPCT02070096T	HMF003751	HMF003751A	0.62	male	1948	2017-09-17	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-02-20	bladder	bladder	Yes	Yes	Yes	2017-05-08	2017-08-22	Pembrolizumab	Immunotherapy	2017-08-01	Yes	PD
CPCT02070098T	HMF002018	HMF002018A	0.87	male	1952	null	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2017-03-23	Liver	segment VIII	No	No	null	null	null	null	null	null	null	null
CPCT02070099T	HMF002410	HMF002410A	0.8	female	1960	2021-10-01	Unknown		Carcinoma	Adenoid cystic carcinoma		0080202	2017-03-07	lacrimal sac	lacrimal sac, oculus sinistra	No	No	Yes	2017-03-24	2017-07-14	Cyclophosphamide/Doxorubicin/Cisplatin	Chemotherapy	2017-05-17	Yes	SD
CPCT02070101T	HMF001378	HMF001378B	0.58	male	1945	2020-12-11	Prostate					10283	2017-03-16	Lymph node	right axilla	Yes	Yes	Yes	2017-04-01	2018-09-07	Enzalutamide	Hormonal therapy	null	null	null
CPCT02070102T	HMF002465	HMF002465A	0.38	male	1961	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-03-14	Lymph node	retroclavicular left	Yes	No	Yes	2017-05-03	2018-05-01	Pembrolizumab	Immunotherapy	2017-07-05	Yes	PR
CPCT02070106T	HMF002299	HMF002299A	0.9	male	1949	2018-08-09	Prostate					10283	2018-01-30	Lymph node	iliacal left	Yes	Yes	Yes	2017-04-19	2018-01-25	Enzalutamide	Hormonal therapy	2018-01-04	Yes	null
CPCT02070107T	HMF000790	HMF000790A	0.61	male	1956	2021-01-28	Prostate					10283	2017-06-15	Lymph node	neck left	Yes	Yes	Yes	2017-06-16	2018-08-29	Abiraterone	Hormonal therapy	2017-09-12	Yes	SD
CPCT02070107TII	HMF000790	HMF000790B	0.89	male	1956	2021-01-28	Prostate					10283	2018-09-11	Lymph node	supra claviculair left	Yes	Yes	Yes	2017-06-16	2018-08-29	Abiraterone	Hormonal therapy	2017-09-12	Yes	SD
CPCT02070108T	HMF000416	HMF000416A	0.83	female	1950	2018-01-13	Bone/Soft tissue		Undifferentiated sarcoma			1115	2017-03-21	intra-abdominal	ventral/cranial of pancreas	Yes	No	Yes	2017-03-24	2017-09-25	Doxorubicin/Olaratumab/Carboplatin/Etoposide/Carboplatin/Etoposide	Multiple therapy	2017-05-19	Yes	PD
CPCT02070110T	HMF001101	HMF001101B	0.61	female	1963	2019-02-06	Uterus	Cervix				4362	2017-03-23	solide lesion cranial of right scapula	solide lesion cranial of right scapula	Yes	Yes	Yes	2017-04-01	2017-09-01	Paclitaxel/Carboplatin	Chemotherapy	2017-09-12	Yes	SD
CPCT02070111T	HMF003480	HMF003480A	1.0	female	1976	2017-12-12	Bone/Soft tissue		Solitary fibrous tumor			264,1115	2017-03-23	Primary	lower abdomen right	No	No	Yes	2017-03-24	2017-10-09	Doxorubicin/Olaratumab/Trabectedin/Dacarbazine	Multiple therapy	2017-05-17	Yes	PD
CPCT02070117T	HMF002155	HMF002155A	0.78	male	1954	null	Prostate					10283	2017-04-03	Lymph node	lymph node neck right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070120T	HMF001609	HMF001609A	0.44	male	1962	2018-03-19	Esophagus					5041	2017-04-06	Liver	segment 2	No	No	Yes	2017-04-24	2017-08-03	Trastuzumab/Cisplatin/Fluorouracil/Leucovorin/Oxaliplatin	Multiple therapy	2017-08-18	Yes	SD
CPCT02070122T	HMF000364	HMF000364A	0.47	female	1955	2017-07-04	Colorectum					9256	2017-04-25	Liver	left lobe	Yes	No	Yes	2017-05-01	2017-05-17	Trifluridine	Chemotherapy	2017-05-17	Yes	PD
CPCT02070125T	HMF002127	HMF002127A	0.49	male	1951	2019-07-16	Prostate					10283	2017-10-11	Lymph node	right inguinal	Yes	No	Yes	2017-04-13	2017-10-03	Abiraterone/Radium-223	Multiple therapy	null	null	null
CPCT02070130TII	HMF000162	HMF000162A	0.86	male	1953	2018-10-02	Prostate					10283	2018-09-20	Liver	liver segment 3	No	No	Yes	2017-06-01	null	Goserelin/Goserelin	Androgen/estrogen deprivation therapy	null	null	null
CPCT02070131T	HMF001186	HMF001186A	0.33	male	1955	2017-10-03	Prostate					10283	2017-05-03	Lymph node	Neck left side	Yes	Yes	Yes	2017-05-03	2017-07-18	Enzalutamide	Hormonal therapy	null	null	null
CPCT02070132T	HMF000607	HMF000607A	0.29	male	1962	2017-06-22	Pancreas					1793	2017-05-18	Liver	right liverlobe	No	No	null	null	null	null	null	null	null	null
CPCT02070133T	HMF003178	HMF003178A	0.79	male	1937	2018-01-09	Prostate					10283	2017-05-12	Bone	crista iliaca	Yes	Yes	Yes	2017-05-23	2017-07-17	Prostate-specific membrane antigen (PSMA) - Actinium-225 (Ac-225)	Nuclear therapy	null	null	null
CPCT02070135T	HMF002421	HMF002421A	0.85	male	1957	2019-03-05	Prostate					10283	2017-05-10	Lymph node	supraclavicular right	Yes	Yes	Yes	2017-08-03	2018-11-30	Olaparib/Olaparib	Targeted therapy	2017-09-05	Yes	SD
CPCT02070139T	HMF003006	HMF003006A	0.66	male	1967	2019-05-21	Prostate					10283	2018-04-17	Lymph node	lilical left	Yes	Yes	Yes	2017-06-22	2018-05-08	Enzalutamide	Hormonal therapy	null	null	null
CPCT02070140T	HMF001596	HMF001596B	0.82	male	1947	2018-05-27	Prostate					10283	2017-05-30	Lymph node	retroperitoneal lymph node	Yes	Yes	Yes	2017-07-13	2017-11-01	Docetaxel	Chemotherapy	2017-11-01	Yes	PD
CPCT02070141T	HMF000377	HMF000377A	0.77	male	1949	2020-09-16	Prostate					10283	2017-05-23	Lymph node	iliacale lymph node	Yes	No	Yes	2017-07-25	2019-02-20	Abiraterone	Hormonal therapy	2018-02-05	Yes	SD
CPCT02070145T	HMF002771	HMF002771A	0.48	male	1948	2018-03-29	Urothelial tract	Bladder				11054	2017-05-16	Lymph node	Supraclavicular	Yes	No	Yes	2017-07-04	2018-01-17	Nivolumab/Gemcitabine	Multiple therapy	2017-07-25	Yes	PD
CPCT02070147TII	HMF000996	HMF000996B	0.69	male	1956	2018-11-25	Prostate					10283	2018-04-10	Lymph node	supraclavicular left	Yes	Yes	Yes	2017-09-30	2018-01-17	Abiraterone	Hormonal therapy	2017-11-22	Yes	SD
CPCT02070148T	HMF002536	HMF002536A	0.7	male	1937	2017-07-03	Prostate					10283	2017-05-18	Lymph node	at kidney level	Yes	No	null	null	null	null	null	null	null	null
CPCT02070149T	HMF003667	HMF003667A	0.61	male	1944	2018-08-07	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-07-06	Liver	Left side	Yes	No	Yes	2017-07-06	2017-10-19	Pembrolizumab	Immunotherapy	2017-09-21	Yes	PD
CPCT02070154T	HMF002211	HMF002211B	0.52	female	1944	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-06-08	Subcutaneous mass	femur	Yes	No	Yes	2017-07-19	2019-09-19	Nivolumab	Immunotherapy	2017-09-20	Yes	PR
CPCT02070154TII	HMF002211	HMF002211A	0.47	female	1944	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-03-27	lesion in right upper leg	soft tissue around femur right	Yes	No	Yes	2017-07-19	2019-09-19	Nivolumab	Immunotherapy	2017-09-20	Yes	PR
CPCT02070156T	HMF003110	HMF003110A	0.23	male	1949	2020-05-21	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-06-08	Bone	os ileum	Yes	Yes	Yes	2017-07-19	2017-12-14	Nivolumab/Gemcitabine/Carboplatin	Multiple therapy	null	null	null
CPCT02070158T	HMF001526	HMF001526A	0.54	male	1938	2020-05-24	Prostate					10283	2017-06-09	Bone	left crista iliaca	Yes	Yes	Yes	2017-06-14	2017-06-14	Cabazitaxel	Chemotherapy	2018-01-22	Yes	SD
CPCT02070159T	HMF002941	HMF002941A	0.75	female	1969	2019-01-17	Uterus	Cervix				4362	2017-06-22	Liver	segment 3	Yes	Yes	Yes	2017-07-04	2018-04-02	Tisotumab vedotin/Paclitaxel/Carboplatin/Bevacizumab	Multiple therapy	null	null	null
CPCT02070161T	HMF001112	HMF001112A	0.8	male	1952	2018-04-27	Prostate					10283	2017-06-22	Liver	segment 4	Yes	Yes	Yes	2017-06-26	2017-12-27	Docetaxel/Cabazitaxel/Carboplatin	Chemotherapy	2017-10-04	Yes	PD
CPCT02070162T	HMF001687	HMF001687A	0.41	male	1973	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-06-29	metastatic lesion	pelvis area	No	No	Yes	2017-07-24	2018-08-14	Gemcitabine/Carboplatin/Cisplatin/Nivolumab	Multiple therapy	2017-09-18	Yes	PD
CPCT02070164T	HMF000881	HMF000881C	0.76	male	1949	2019-04-02	Prostate					10283	2017-06-20	Liver	left lobe	Yes	Yes	Yes	2017-06-21	2017-08-23	Cabazitaxel/Carboplatin	Chemotherapy	2017-08-23	Yes	PD
CPCT02070167T	HMF003139	HMF003139A	0.22	female	1987	2018-04-26	Colorectum					9256	2017-06-20	Liver	segment 6	Yes	No	Yes	2017-07-12	2017-12-06	Bevacizumab/Oxaliplatin/Capecitabine	Multiple therapy	2017-09-28	Yes	PD
CPCT02070168T	HMF001160	HMF001160A	0.73	female	1951	2017-12-27	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-04	Liver	Liver	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070169T	HMF000895	HMF000895A	0.26	female	1951	2020-12-16	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-07-07	Liver	segment 5	No	No	Yes	2017-07-16	2017-11-23	Pazopanib	Targeted therapy	2017-10-09	Yes	PR
CPCT02070171T	HMF001307	HMF001307B	0.61	male	1957	2018-12-07	Colorectum					9256	2017-07-13	Liver	left liverlobe	No	No	Yes	2017-07-17	2018-03-01	Oxaliplatin/Capecitabine/Bevacizumab	Multiple therapy	2017-09-15	Yes	PR
CPCT02070172T	HMF000764	HMF000764A	0.31	female	1978	2017-11-12	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-07-11	abdominal wall (intramuscular)	right kwadrant of lower abdomen	Yes	No	Yes	2017-07-12	2017-08-23	Nivolumab	Immunotherapy	2017-08-23	Yes	PD
CPCT02070174T	HMF002145	HMF002145A	0.56	male	1953	2018-08-13	Prostate					10283	2017-07-04	Lymph node	left obturatorius loge	Yes	No	Yes	2017-07-12	2018-07-18	Enzalutamide	Hormonal therapy	2017-12-12	Yes	SD
CPCT02070176T	HMF001106	HMF001106A	0.81	male	1969	2017-11-11	Prostate					10283	2017-07-13	Liver	left lobe of the liver	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070177T	HMF000796	HMF000796A	0.31	male	1962	2017-09-08	Pancreas					1793	2017-07-04	Liver	right live lobe	No	No	Yes	2017-07-25	2017-07-25	Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2017-08-07	Yes	PD
CPCT02070187T	HMF003687	HMF003687A	0.69	female	1962	null	Bile duct		Carcinoma			4947	2017-08-15	Liver	left lobe	No	No	Yes	2017-09-15	null	Cisplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02070190T	HMF002439	HMF002439A	0.22	female	1948	2017-09-21	Ovary					2394	2017-07-27	Liver	liver	Yes	Yes	Yes	2017-07-31	2017-08-21	Topotecan	Chemotherapy	null	null	null
CPCT02070193T	HMF003642	HMF003642A	0.71	male	1946	2017-12-20	Prostate					10283	2017-08-03	Bone	Left ilium	No	Yes	Yes	2017-08-08	2017-12-20	Leuprorelin	Androgen/estrogen deprivation therapy	2017-09-11	Yes	PD
CPCT02070194T	HMF002732	HMF002732B	0.21	male	1968	2018-08-15	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-08-15	Lymph node	parailiacal	No	No	Yes	2017-08-25	2018-01-18	Gemcitabine/Carboplatin	Chemotherapy	2017-11-02	Yes	PR
CPCT02070195T	HMF002106	HMF002106A	0.84	male	1949	2018-04-28	Prostate					10283	2017-08-08	Lymph node	retropertional para-aortal left	Yes	No	Yes	2017-10-09	2017-11-16	Olaparib	Targeted therapy	2017-11-21	Yes	PD
CPCT02070196T	HMF000677	HMF000677A	0.78	male	1949	2020-04-25	Prostate					10283	2017-09-14	Lymph node	para-iliacal (right)	Yes	Yes	Yes	2017-11-01	2018-09-26	Docetaxel	Chemotherapy	2017-11-27	Yes	SD
CPCT02070198T	HMF003444	HMF003444A	0.26	male	1975	2017-11-12	Colorectum					9256	2017-08-24	Liver	left lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02070200T	HMF003537	HMF003537A	0.79	male	1947	2018-09-26	Prostate					10283	2017-08-29	Lymph node	right inguinal	Yes	Yes	Yes	2017-10-04	2018-02-20	Docetaxel	Chemotherapy	2018-01-16	Yes	PD
CPCT02070202T	HMF003268	HMF003268A	0.77	male	1957	null	Prostate					10283	2017-08-31	Lymph node	para-iliac lymph node right	Yes	No	null	null	null	null	null	null	null	null
CPCT02070204T	HMF003275	HMF003275A	0.85	female	1972	2018-01-05	Urothelial tract	Bladder				11054	2017-08-25	Liver	left lobe	Yes	Yes	Yes	2017-09-01	2017-09-29	Nivolumab	Immunotherapy	2017-10-16	Yes	PD
CPCT02070206T	HMF003088	HMF003088A	0.76	male	1952	2020-02-27	Prostate					10283	2017-10-03	Bone	right dorsal ilium	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070208T	HMF000007	HMF000007A	0.4	male	1953	2018-06-14	Prostate					10283	2018-03-27	Primary	prostate	Yes	No	Yes	2018-04-11	2018-06-12	Abiraterone	Hormonal therapy	2018-05-24	Yes	PD
CPCT02070210T	HMF001243	HMF001243A	0.62	female	1979	2017-12-28	Ovary					2394	2017-08-28	left retroperitoneal lesion	left retroperitoneal lesion	Yes	No	null	null	null	null	null	null	null	null
CPCT02070217T	HMF003114	HMF003114A	0.88	male	1956	2018-06-28	Prostate					10283	2017-09-19	Lymph node	lymph nodes pelvis	No	No	Yes	2017-09-21	2018-03-14	Cisplatin/Etoposide	Chemotherapy	2017-11-27	Yes	PR
CPCT02070218T	HMF001220	HMF001220A	0.6	male	1938	2019-01-30	Prostate					10283	2017-09-26	Lymph node	para-iliacal left	Yes	Yes	Yes	2017-09-26	2017-12-21	Pembrolizumab	Immunotherapy	2017-12-12	Yes	PD
CPCT02070222T	HMF002582	HMF002582A	0.33	female	1949	2019-08-12	Ovary					2394	2017-09-21	omentum	omentum	Yes	No	null	null	null	null	null	null	null	null
CPCT02070223T	HMF002390	HMF002390A	0.78	male	1947	2018-05-14	Prostate					10283	2017-09-29	Bone	right crista	Yes	No	Yes	2017-11-01	2018-05-01	Docetaxel	Chemotherapy	2018-03-09	Yes	SD
CPCT02070225T	HMF002605	HMF002605A	0.82	female	1955	2017-11-13	Head and neck	Salivary gland				8850,11934	2017-09-26	Primary	right parotis	No	No	null	null	null	null	null	null	null	null
CPCT02070229T	HMF003707	HMF003707A	0.85	male	1944	2019-10-17	Prostate					10283	2017-10-03	Lymph node	para-iliacal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070230T	HMF000825	HMF000825A	0.95	male	1958	2018-01-09	Bone/Soft tissue		Rhabdomyosarcoma			3247,1115	2017-10-03	sinus right posterior paranasal	right posterior paranasal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070231T	HMF000363	HMF000363A	0.3	male	1948	2018-01-31	Pancreas					1793	2017-10-05	Liver	segment 8	No	No	Yes	2017-10-23	2017-11-27	Pegylated recombinant human hyaluronidase 20 (PEGPH20)/Paclitaxel/Gemcitabine	Multiple therapy	2017-12-05	Yes	SD
CPCT02070232T	HMF002660	HMF002660A	0.46	male	1952	null	Colorectum					9256	2016-05-18	Lung	right lower lobe	Yes	Yes	Yes	2017-10-09	2018-02-20	Leucovorin/Fluorouracil/Irinotecan/Bevacizumab	Multiple therapy	2017-11-29	Yes	SD
CPCT02070233T	HMF002189	HMF002189A	0.52	male	1938	null	Prostate					10283	2017-10-10	Lymph node	right para-iliacal	Yes	Yes	Yes	2017-10-31	2019-12-30	Abiraterone	Hormonal therapy	2018-06-04	Yes	PR
CPCT02070234T	HMF002802	HMF002802A	0.77	male	1946	2018-01-01	Prostate					10283	2017-10-12	Lymph node	right iliacal	Yes	No	null	null	null	null	null	null	null	null
CPCT02070235T	HMF003152	HMF003152A	0.34	male	1957	2018-06-17	Prostate					10283	2017-10-31	Lymph node	left inguinal	Yes	No	Yes	2017-12-19	2018-03-14	Abiraterone	Hormonal therapy	2018-03-14	Yes	PD
CPCT02070236T	HMF002564	HMF002564A	0.67	male	1946	null	Prostate					10283	2017-10-13	Lymph node	left axillar	Yes	Yes	Yes	2017-10-13	2023-03-13	Abiraterone	Hormonal therapy	2017-12-27	Yes	SD
CPCT02070237T	HMF003655	HMF003655A	0.26	male	1960	2018-01-03	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-10-17	Lymph node	para-aortal	Yes	No	Yes	2017-10-18	2017-12-21	Pembrolizumab	Immunotherapy	2017-12-11	Yes	PD
CPCT02070241T	HMF002279	HMF002279A	0.44	male	1952	null	Prostate					10283	2017-10-31	Lymph node	neck	Yes	No	Yes	2017-11-09	2018-01-14	Abiraterone	Hormonal therapy	2018-02-13	Yes	PD
CPCT02070243T	HMF000109	HMF000109A	0.43	male	1932	2018-05-11	Skin		Melanoma			8923	2017-11-07	Lymph node	axillar left	No	Yes	Yes	2017-11-07	2018-03-21	Pembrolizumab	Immunotherapy	2018-01-23	Yes	PD
CPCT02070244T	HMF002206	HMF002206A	0.44	male	1943	2017-12-04	Urothelial tract	Bladder				11054	2017-10-31	Lymph node	para-aortal	No	No	null	null	null	null	null	null	null	null
CPCT02070245T	HMF000803	HMF000803A	0.69	male	1954	2019-08-05	Prostate					10283	2017-11-09	Lymph node	para-aortal left	Yes	No	Yes	2017-12-20	2018-06-01	Cabazitaxel	Chemotherapy	2017-12-29	Yes	SD
CPCT02070247T	HMF000894	HMF000894A	0.97	male	1962	2018-01-24	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-11-08	Primary	stomach	Yes	No	null	null	null	null	null	null	null	null
CPCT02070249T	HMF002083	HMF002083A	0.84	female	1998	null	Bone/Soft tissue		Ewing sarcoma			3369	2017-11-10	Bone	os pubis	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070250T	HMF003244	HMF003244A	0.92	male	1961	2018-01-17	Prostate					10283	2017-11-14	intraperitoneal mass	paramedian left	Yes	No	null	null	null	null	null	null	null	null
CPCT02070252T	HMF003551	HMF003551A	0.74	male	1953	2019-07-29	Prostate					10283	2017-11-14	Lymph node	subpectoral left	Yes	No	Yes	2017-12-27	2018-08-27	Enzalutamide	Hormonal therapy	2018-06-12	Yes	PD
CPCT02070253T	HMF000652	HMF000652A	0.54	male	1962	null	Prostate					10283	2017-11-14	Lymph node	periclavicular	Yes	No	Yes	2018-01-10	2020-10-16	Abiraterone	Hormonal therapy	null	null	null
CPCT02070256T	HMF001985	HMF001985A	0.44	male	1946	2018-07-11	Prostate					10283	2017-12-12	Bone	crista iliaca right	Yes	No	Yes	2017-12-20	2018-04-11	Radium-223	Nuclear therapy	2018-03-26	Yes	PD
CPCT02070257T	HMF003120	HMF003120A	0.71	female	1960	2018-04-10	Uterus		Carcinoma	Carcinosarcoma		6171	2017-11-30	Lymph node	mass para iliacal left abdomen	Yes	No	Yes	2017-12-07	2017-12-07	Doxorubicin	Chemotherapy	null	null	null
CPCT02070262T	HMF003515	HMF003515A	0.84	male	1952	2020-01-27	Colorectum					9256	2017-12-05	Liver	right lobe	Yes	No	Yes	2017-12-08	2018-11-01	Oxaliplatin/Capecitabine/Bevacizumab	Multiple therapy	2018-01-31	Yes	PR
CPCT02070263T	HMF000115	HMF000115A	0.27	male	1938	2018-05-22	Prostate					10283	2018-01-23	Bone	right os ileum	Yes	No	Yes	2018-01-25	2018-04-10	Lutetium (Lu) 177 - Prostate-specific membrane antigen (PSMA)	Nuclear therapy	null	null	null
CPCT02070264T	HMF001758	HMF001758A	0.48	male	1953	2018-03-17	Prostate					10283	2017-12-14	Bone	right os ilium	Yes	Yes	Yes	2017-12-15	2018-03-17	Abiraterone	Hormonal therapy	2018-03-07	Yes	PD
CPCT02070265T	HMF000490	HMF000490A	0.48	female	1964	2018-08-10	Head and neck	Salivary gland				8850,11934	2017-11-30	Liver	4b/5	No	No	Yes	2017-12-01	2018-01-29	Goserelin	Androgen/estrogen deprivation therapy	2018-01-23	Yes	PD
CPCT02070269T	HMF000822	HMF000822A	0.7	male	1956	null	Prostate					10283	2017-12-08	Bone	L4	Yes	Yes	Yes	2018-01-30	2018-08-30	Enzalutamide	Hormonal therapy	2018-07-26	Yes	PD
CPCT02070272T	HMF002594	HMF002594A	0.48	male	1938	2020-06-04	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-12-14	Liver	segment 4A	Yes	Yes	Yes	2017-12-14	2018-03-19	Pembrolizumab	Immunotherapy	2018-03-19	Yes	PD
CPCT02070275T	HMF002214	HMF002214A	0.73	female	1957	2018-06-02	Unknown	CUP	Carcinoma	Squamous cell carcinoma		1749	2017-12-19	Liver	left lobe	Yes	Yes	Yes	2018-02-08	2018-05-01	Nivolumab	Immunotherapy	2018-03-22	Yes	SD
CPCT02070276T	HMF001175	HMF001175A	0.26	male	1951	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-12-22	Lymph node	left subclavicular	Yes	No	Yes	2017-12-22	2019-12-06	Pembrolizumab	Immunotherapy	2018-01-26	Yes	PR
CPCT02070278T	HMF002230	HMF002230A	0.98	male	1993	null	Bone/Soft tissue		Ewing sarcoma			3369	2018-01-03	Lung	right lower lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070280T	HMF002177	HMF002177A	0.93	male	1943	null	Prostate					10283	2018-01-09	Lymph node	iliaca externa	Yes	Yes	Yes	2018-01-31	2018-04-17	Abiraterone	Hormonal therapy	2018-03-14	Yes	SD
CPCT02070282T	HMF000473	HMF000473A	0.37	female	1964	2018-09-27	Stomach					10534	2018-01-12	esophagus/stomach	cardia	Yes	No	Yes	2018-01-19	2018-04-13	Paclitaxel/Ramucirumab	Multiple therapy	2018-04-05	Yes	PD
CPCT02070289T	HMF002674	HMF002674A	0.64	male	1953	2019-07-09	Prostate					10283	2018-01-30	Lymph node	iliac gland right	Yes	No	Yes	2018-01-30	2018-10-22	Abiraterone	Hormonal therapy	null	null	null
CPCT02070290T	HMF003179	HMF003179A	0.95	female	1961	2018-07-04	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2018-01-23	deep subcutaneous	under right rib cage	No	Yes	Yes	2018-02-06	2018-03-04	Pazopanib	Targeted therapy	null	null	null
CPCT02070292T	HMF002313	HMF002313A	0.44	male	1950	2021-01-07	Prostate					10283	2018-02-01	Bone	Os ilium	Yes	No	null	null	null	null	null	null	null	null
CPCT02070293T	HMF003299	HMF003299A	0.71	male	1952	null	Prostate					10283	2018-01-25	Liver	segment 5	Yes	Yes	Yes	2018-01-01	2018-08-23	Cabazitaxel	Chemotherapy	2018-01-19	Yes	SD
CPCT02070294T	HMF001668	HMF001668B	0.93	female	1960	2019-05-22	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2018-01-29	Lymph node	Uterus	No	Yes	Yes	2018-01-19	2018-07-10	Paclitaxel/Carboplatin	Chemotherapy	2018-03-19	Yes	SD
CPCT02070295T	HMF001098	HMF001098A	0.56	male	1946	2018-10-23	Prostate					10283	2018-02-01	Bone	Os ilium	Yes	Yes	Yes	2018-04-01	2018-07-01	Abiraterone	Hormonal therapy	2018-04-26	Yes	PD
CPCT02070298T	HMF000762	HMF000762A	0.36	male	1952	2018-09-13	Pancreas		Neuroendocrine tumor			1793,169	2018-02-22	Liver	segment 4	No	No	null	null	null	null	null	null	null	null
CPCT02070299T	HMF001399	HMF001399A	0.58	male	1945	null	Urothelial tract	Bladder				11054	2018-02-07	Lymph node	lymph node neck	Yes	No	Yes	2018-02-08	2019-01-08	Pembrolizumab	Immunotherapy	2018-04-26	Yes	PR
CPCT02070300T	HMF000174	HMF000174A	0.54	male	1941	null	Prostate					10283	2018-02-09	Bone	local Lidocaine, transpedicular left	Yes	No	Yes	2017-11-01	2019-01-11	Radium-223	Nuclear therapy	2018-04-19	Yes	SD
CPCT02070301T	HMF003732	HMF003732A	0.83	male	1945	2019-06-16	Prostate					10283	2018-02-15	Lymph node	para-iliacal left	Yes	Yes	Yes	2018-04-01	2018-11-01	Cabazitaxel	Chemotherapy	null	null	null
CPCT02070304T	HMF002007	HMF002007A	0.83	female	1955	2018-06-07	Gallbladder					3121	2018-02-22	Liver	null	No	No	null	null	null	null	null	null	null	null
CPCT02070306T	HMF001627	HMF001627A	0.56	male	1953	2019-08-30	Prostate					10283	2018-03-06	Lymph node	left inguinal	Yes	No	Yes	2018-04-17	2018-10-30	Lutetium (Lu) 177 - Prostate-specific membrane antigen (PSMA)	Nuclear therapy	2018-07-09	Yes	SD
CPCT02070307T	HMF000902	HMF000902B	0.65	male	1968	2019-05-21	Prostate					10283	2018-02-28	soft tissue lesion	mass around os ilium	Yes	Yes	Yes	2018-06-13	2018-12-27	Docetaxel/Carboplatin	Chemotherapy	2018-08-06	Yes	PD
CPCT02070307TII	HMF000902	HMF000902A	0.59	male	1968	2019-05-21	Prostate					10283	2018-05-17	skin/subcutaneous	buttock right	Yes	Yes	Yes	2018-06-13	2018-12-27	Docetaxel/Carboplatin	Chemotherapy	2018-08-06	Yes	PD
CPCT02070309T	HMF001470	HMF001470A	0.84	male	1951	null	Mesothelium		Malignant mesothelioma			1790,0050686	2018-03-08	Lung	null	Yes	No	null	null	null	null	null	null	null	null
CPCT02070310T	HMF000687	HMF000687A	0.95	male	1963	2018-07-10	Unknown				Probably near rectum	162	2018-03-13	brain	cerebrum	No	No	Yes	2018-05-07	2018-05-28	Etoposide/Cisplatin	Chemotherapy	2018-06-18	Yes	PD
CPCT02070311T	HMF003488	HMF003488A	0.63	female	1967	null	Nervous system	Choroid plexus	Papilloma			2626	2018-03-20	brain	cerebrum	No	Yes	null	null	null	null	null	null	null	null
CPCT02070312T	HMF002476	HMF002476A	0.86	male	1949	null	Prostate					10283	2018-03-13	Lymph node	para-aortal	Yes	Yes	Yes	2018-03-26	2018-09-23	Abiraterone	Hormonal therapy	2019-09-19	Yes	PR
CPCT02070313T	HMF001402	HMF001402A	0.9	female	1974	2018-07-02	Bone/Soft tissue		Rhabdomyosarcoma			3247,1115	2018-03-13	Lymph node	neck	Yes	No	Yes	2018-03-08	2018-04-01	Doxorubicin/Olaratumab	Multiple therapy	2018-05-08	Yes	PD
CPCT02070317T	HMF002176	HMF002176A	0.73	male	1992	null	Bone/Soft tissue	Humerus bone	Chondrosarcoma			3371	2018-03-19	Lung	lower right lobe	No	No	null	null	null	null	null	null	null	null
CPCT02070318T	HMF000430	HMF000430A	0.71	male	1940	2019-06-27	Prostate					10283	2018-03-23	abdominal wall (subcutaneous)	scar abdominal wall	Yes	Yes	Yes	2018-04-01	2018-10-09	Etoposide/Carboplatin	Chemotherapy	2018-05-24	Yes	SD
CPCT02070319T	HMF001929	HMF001929A	0.75	female	1939	2019-08-21	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2018-05-09	skull skin	skull skin	No	No	Yes	2018-08-01	2018-08-24	Pazopanib	Targeted therapy	null	null	null
CPCT02070320T	HMF003290	HMF003290A	0.41	male	1963	2018-11-05	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-19	Lymph node	supraclaviculair left	No	No	Yes	2018-04-24	2018-09-12	Pemetrexed	Chemotherapy	2018-04-30	Yes	null
CPCT02070323T	HMF003694	HMF003694A	0.33	male	1945	null	Head and neck	Salivary gland	Carcinoma			0050904,1542	2018-03-22	Liver	segment 4a	No	No	Yes	2018-04-11	2020-02-10	Goserelin/Goserelin	Androgen/estrogen deprivation therapy	2018-06-27	Yes	PD
CPCT02070324T	HMF001673	HMF001673A	0.94	female	1954	2019-09-02	Ovary		Sex-cord stromal tumor	Granulosa cell tumor		2999,2394	2018-04-10	Abdominal wall (intramuscular)	Abdominal wall right	No	No	Yes	2018-06-18	2019-03-20	Cabazitaxel/Bevacizumab/Paclitaxel	Multiple therapy	2018-10-18	Yes	SD
CPCT02070335T	HMF001897	HMF001897A	0.67	male	1960	2020-06-30	Prostate					10283	2018-04-04	Bone	femoral head	Yes	No	Yes	2018-04-10	2018-05-01	Cabazitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02070336T	HMF001054	HMF001054A	0.39	female	1956	2019-09-03	Urothelial tract	Bladder				11054	2018-04-06	Lymph node	para-illical	Yes	No	Yes	2018-04-12	2018-08-03	Gemcitabine/Carboplatin	Chemotherapy	2018-05-11	Yes	SD
CPCT02070337T	HMF002649	HMF002649A	0.93	male	1976	2020-01-24	Adrenal gland	Adrenal cortex	Carcinoma			3948	2018-03-09	Adrenal gland	left	No	No	Yes	2018-04-05	2018-06-11	Mitotane	Chemotherapy	2018-04-10	Yes	SD
CPCT02070338T	HMF002217	HMF002217A	0.84	male	1953	2019-08-28	Prostate					10283	2018-04-26	Lymph node	small pelvis	Yes	Yes	Yes	2018-05-09	2018-11-29	Docetaxel	Chemotherapy	2018-12-12	Yes	PD
CPCT02070339T	HMF002930	HMF002930A	0.21	male	1943	2018-10-28	Prostate					10283	2018-04-12	Lymph node	pelvis	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070341T	HMF001322	HMF001322A	0.96	female	1981	2018-12-19	Nervous system	Brain	Glioma	Anaplastic oligodendroma-like glioma		3070	2018-04-12	glioma	glioma	Yes	Yes	Yes	2018-06-20	2018-07-17	Temozolomide	Chemotherapy	null	null	null
CPCT02070342T	HMF000993	HMF000993A	0.26	male	1955	2019-03-27	Esophagus					5041	2018-04-13	Liver	liver	Yes	No	Yes	2018-04-20	2018-07-13	Capecitabine/Oxaliplatin	Chemotherapy	2018-07-19	Yes	SD
CPCT02070345T	HMF000391	HMF000391B	0.44	male	1938	2020-04-16	Prostate					10283	2018-05-08	Lymph node	iliacal left	Yes	Yes	Yes	2018-05-29	2018-07-30	Cabazitaxel	Chemotherapy	2018-08-10	Yes	PR
CPCT02070347T	HMF003380	HMF003380A	0.54	female	1939	2019-02-01	Vulva					1245	null	null	null	No	Yes	Yes	2018-06-01	2018-08-10	Paclitaxel	Chemotherapy	null	null	null
CPCT02070348T	HMF001229	HMF001229A	0.88	female	1946	2018-07-30	Ovary					2394	2018-05-03	Peritoneum	peritoneum	Yes	No	Yes	2018-05-08	2018-07-09	Bevacizumab/Atezolizumab	Multiple therapy	2018-07-03	Yes	PD
CPCT02070349T	HMF003004	HMF003004A	0.6	female	1981	null	Ovary					2394	2018-05-02	thorax wall intramuscular	thorax wall	Yes	Yes	Yes	2018-09-01	2019-04-01	Letrozole	Hormonal therapy	2018-09-06	Yes	SD
CPCT02070350T	HMF000975	HMF000975A	0.72	male	1939	2018-08-28	Prostate					10283	2018-05-15	Lymph node	para-aortal	Yes	Yes	Yes	2018-06-06	2018-08-28	Pembrolizumab	Immunotherapy	2018-08-01	Yes	PD
CPCT02070351T	HMF002438	HMF002438A	0.81	male	1979	null	Nervous system	Brain	Glioma			3070	2018-05-08	CNS	brain	No	No	Yes	2018-05-30	2019-01-30	Temozolomide	Chemotherapy	null	null	null
CPCT02070352T	HMF002680	HMF002680A	0.81	female	1951	2019-12-10	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-05-08	Lymph node	supraclaviculair	Yes	Yes	Yes	2018-05-22	2019-03-22	Trastuzumab/Pertuzumab/Docetaxel	Multiple therapy	2018-08-07	Yes	SD
CPCT02070353T	HMF001593	HMF001593A	0.68	male	1964	null	Nervous system		Glioma			3070	2018-05-08	brain	precuneus right	No	No	Yes	2018-06-01	2019-02-01	Temozolomide	Chemotherapy	null	null	null
CPCT02070355T	HMF001939	HMF001939A	0.48	male	1970	null	Thyroid gland					1781	2018-05-11	Lymph node	neck	Yes	Yes	Yes	2018-07-08	2021-03-21	Cabozantinib	Targeted therapy	2018-10-04	Yes	SD
CPCT02070357T	HMF001291	HMF001291A	0.58	male	1982	2019-07-11	Bone/Soft tissue		Fibrosarcoma			3355	2018-05-18	occipital subcutaneous	right	Yes	Yes	Yes	2018-04-10	2018-12-01	Paclitaxel	Chemotherapy	2018-05-02	Yes	null
CPCT02070358T	HMF000892	HMF000892A	0.38	female	1940	2018-09-10	Ovary					2394	2018-05-22	Lymph node	abdominal wall	Yes	No	Yes	2018-05-28	2018-09-04	Bevacizumab/Atezolizumab	Multiple therapy	2018-07-26	Yes	SD
CPCT02070359T	HMF002580	HMF002580A	0.96	male	1942	2018-08-09	Prostate					10283	2018-05-24	Adrenal gland	adrenal	Yes	Yes	Yes	2018-05-24	2018-06-26	Abiraterone	Hormonal therapy	null	null	null
CPCT02070360T	HMF002625	HMF002625A	0.44	female	1964	2020-02-05	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-05-29	thyroid gland	mass thyroid gland	No	Yes	Yes	2018-07-13	2018-09-12	Letrozole	Hormonal therapy	2018-09-06	Yes	PD
CPCT02070361T	HMF001137	HMF001137A	0.22	male	1949	null	Prostate					10283	2018-06-01	Bone	os sacrum	Yes	No	Yes	2018-08-15	2020-03-03	Olaparib	Targeted therapy	2018-10-03	Yes	SD
CPCT02070363T	HMF003711	HMF003711A	0.35	male	1956	2019-07-11	Head and neck	Salivary gland	Carcinoma	Salivary duct carcinoma		0050904,1542	2018-05-30	Liver	liver	Yes	Yes	Yes	2018-06-24	2019-01-02	Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	2018-08-20	Yes	PD
CPCT02070365T	HMF000099	HMF000099A	0.77	male	1953	2020-05-15	Bone/Soft tissue		Myxofibrosarcoma			0080534	2018-06-07	Bone	bone	Yes	Yes	Yes	2018-06-11	2018-07-23	Gemcitabine	Chemotherapy	2018-08-06	Yes	SD
CPCT02070367T	HMF002235	HMF002235A	0.47	male	1952	null	Prostate					10283	2018-06-12	Lymph node	para-aortal	Yes	Yes	Yes	2018-07-01	2019-07-22	Pembrolizumab	Immunotherapy	2018-09-05	Yes	SD
CPCT02070370T	HMF000429	HMF000429A	0.21	male	1963	2020-07-16	Prostate					10283	2018-06-19	Lymph node	groin	Yes	No	Yes	2018-06-20	2018-11-27	Enzalutamide	Hormonal therapy	2018-11-27	Yes	Clinical progression
CPCT02070371T	HMF002452	HMF002452A	0.64	male	1966	2019-03-08	Bone/Soft tissue		Rhabdomyosarcoma			3247,1115	2018-06-21	subcutaneously	pelvis left	No	Yes	Yes	2018-07-16	2018-12-03	Vincristine/Cyclophosphamide/Dactinomycin	Chemotherapy	2018-10-11	Yes	PR
CPCT02070372T	HMF002396	HMF002396A	0.23	male	1960	null	Mesothelium		Malignant mesothelioma			1790,0050686	2018-07-10	Lung	right	No	No	null	null	null	null	null	null	null	null
CPCT02070373T	HMF001194	HMF001194A	0.82	female	1994	2018-09-10	Nervous system		Glioma	Oligodendroglioma	Low-grade	3181	2018-06-25	CNS	brain right frontal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070379T	HMF001241	HMF001241A	0.46	male	1938	null	Prostate					10283	2018-06-28	Liver	null	Yes	No	null	null	null	null	null	null	null	null
CPCT02070380T	HMF003132	HMF003132A	0.93	male	1950	2018-08-02	Lung		Carcinoma	Small cell carcinoma		5409	2018-06-28	skin/subcutaneous	subcutaneous thorax	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070381T	HMF001168	HMF001168B	0.47	female	1961	null	Bone/Soft tissue	Lung	PEComa			1324,2643,1115	2018-07-10	Lung	pleural lesion	No	No	Yes	2018-07-10	2018-09-28	Everolimus	Targeted therapy	2018-09-26	Yes	PD
CPCT02070383T	HMF003541	HMF003541A	0.52	male	1949	2019-05-06	Prostate					10283	2018-07-03	Liver	liver	Yes	No	Yes	2018-08-01	2019-02-06	Cabazitaxel	Chemotherapy	2019-03-22	Yes	PD
CPCT02070384T	HMF000039	HMF000039A	0.75	male	1948	null	Skin	External auditory canal	Carcinoma	Ceruminous adenocarcinoma	Skin adnex	6446,4159	2018-06-29	Bone	bone	No	Yes	Yes	2018-09-05	2018-12-07	Everolimus	Targeted therapy	2018-11-30	Yes	PD
CPCT02070386T	HMF000823	HMF000823A	0.86	female	1962	null	Head and neck	Salivary gland	Carcinoma	Salivary duct carcinoma		0050904,1542	2018-07-05	Lymph node	left axillar	Yes	Yes	Yes	2018-07-12	2019-02-18	Cisplatin/Cyclophosphamide/Doxorubicin	Chemotherapy	2018-09-06	Yes	PR
CPCT02070388T	HMF001691	HMF001691A	0.4	male	1949	2019-03-08	Prostate					10283	2018-07-17	Lymph node	axillary left	Yes	Yes	Yes	2018-07-18	2018-11-07	Enzalutamide	Hormonal therapy	2018-10-26	Yes	SD
CPCT02070389T	HMF000918	HMF000918A	0.61	male	1951	2019-06-16	Prostate					10283	2018-07-19	Lymph node	small pelvis	Yes	No	Yes	2018-07-19	2018-11-06	Enzalutamide	Hormonal therapy	2018-10-22	Yes	PD
CPCT02070391T	HMF000740	HMF000740A	0.6	male	1944	2018-11-23	Prostate					10283	2018-08-09	Lymph node	para-aortal left	Yes	No	Yes	2018-08-29	2018-10-11	Pembrolizumab/Enzalutamide	Multiple therapy	null	null	null
CPCT02070392T	HMF000017	HMF000017A	0.85	male	1939	2019-11-14	Prostate					10283	2018-09-06	Lymph node	para-iliacal left	Yes	No	Yes	2018-09-06	2018-12-18	Abiraterone	Hormonal therapy	2018-12-13	Yes	PD
CPCT02070393T	HMF002940	HMF002940A	0.29	male	1951	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-04	pleural	left ventral	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070394T	HMF001980	HMF001980A	0.61	female	1994	2021-04-06	Skin		Carcinoma	Squamous cell carcinoma		3151	2018-09-04	intramuscular	The left upper arm	Yes	Yes	Yes	2018-09-13	2019-09-05	Pembrolizumab	Immunotherapy	2018-10-23	Yes	PR
CPCT02070395T	HMF003036	HMF003036A	0.73	male	1936	null	Prostate					10283	2018-09-11	Lymph node	lymph gland left retroperitoneal dorsal of the kidney vein	Yes	Yes	Yes	2018-11-14	2019-05-01	Abiraterone	Hormonal therapy	2019-01-02	Yes	SD
CPCT02070396T	HMF002610	HMF002610A	0.67	male	1964	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-18	Liver	segment	Yes	Yes	Yes	2018-04-01	2018-12-12	Osimertinib	Targeted therapy	null	null	null
CPCT02070397T	HMF002717	HMF002717A	0.52	female	1965	2019-09-18	Ovary					2394	2018-09-27	Lymph node	inguinal left	Yes	Yes	Yes	2018-10-02	2018-12-31	Atezolizumab/Bevacizumab	Multiple therapy	null	null	null
CPCT02070398T	HMF002198	HMF002198A	0.46	male	1943	2019-02-08	Prostate					10283	2018-09-27	Liver	liver	Yes	Yes	Yes	2018-10-10	2019-02-08	Abiraterone	Hormonal therapy	2018-12-12	Yes	PD
CPCT02070399T	HMF000446	HMF000446A	0.61	female	1959	2019-06-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-11	Lung	lung	Yes	Yes	Yes	2018-10-15	2019-03-08	Gefitinib	Targeted therapy	2018-12-18	Yes	SD
CPCT02070401T	HMF002326	HMF002326A	0.3	female	1957	2019-02-03	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2018-10-23	Liver	liver	Yes	No	Yes	2018-10-29	2018-12-05	Atezolizumab/Cabozantinib	Multiple therapy	2018-12-05	Yes	PD
CPCT02070402T	HMF002262	HMF002262A	0.44	male	1973	null	Prostate					10283	2018-11-01	Lymph node	inguinal	Yes	No	null	null	null	null	null	null	null	null
CPCT02070403T	HMF000978	HMF000978A	0.37	male	1970	2021-08-13	Mesothelium		Malignant mesothelioma			1790,0050686	2018-10-25	skin/subcutaneous	subcutaneous mass	Yes	No	Yes	2019-01-24	2020-05-15	Nivolumab	Immunotherapy	2019-03-01	Yes	SD
CPCT02070404T	HMF003126	HMF003126A	0.34	male	1967	2019-02-27	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-25	Lung	pleural	Yes	No	Yes	2018-11-08	2019-01-29	Cabozantinib/Atezolizumab	Multiple therapy	2018-12-17	Yes	SD
CPCT02070405T	HMF003489	HMF003489A	0.57	female	1961	2019-07-22	Colorectum	Colon	Carcinoma			1520	2018-10-30	Liver	metastasis	Yes	No	Yes	2018-10-31	2019-02-27	Cetuximab	Targeted therapy	2018-12-19	Yes	SD
CPCT02070406T	HMF001744	HMF001744A	0.66	female	1958	2019-08-23	Bone/Soft tissue	Endometrium	Endometrial stromal sarcoma			4226,1115	2018-11-13	abdominal wall (intramuscular)	biggest lesion (22mm)	Yes	No	Yes	2019-01-16	2019-01-28	Pazopanib	Targeted therapy	null	null	null
CPCT02070409T	HMF003789	HMF003789A	0.65	male	1959	null	Prostate					10283	2018-11-22	Lymph node	para iliacal left	Yes	No	Yes	2018-11-27	2021-02-24	Abiraterone	Hormonal therapy	null	null	null
CPCT02070410T	HMF000678	HMF000678A	0.64	male	1946	2019-03-29	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-11-22	Lymph node	inguinal left	Yes	Yes	Yes	2018-11-26	2019-01-10	Pembrolizumab	Immunotherapy	2019-01-22	Yes	PD
CPCT02070415T	HMF000986	HMF000986A	0.56	male	1961	null	Prostate					10283	2018-12-04	Bone	bone	Yes	Yes	Yes	2018-12-04	2021-04-29	Enzalutamide	Hormonal therapy	null	null	null
CPCT02070418T	HMF000123	HMF000123A	0.65	female	1958	2019-05-07	Ovary					2394	2018-12-18	Lymph node	retroclavicular left	Yes	No	Yes	2018-12-20	2019-02-20	Bevacizumab/Atezolizumab	Multiple therapy	2019-02-11	Yes	SD
CPCT02070420T	HMF004351	HMF004351A	0.22	male	1936	null	Prostate					10283	2019-01-10	Lymph node	para aortal	Yes	No	Yes	2019-01-10	2019-04-03	Abiraterone	Hormonal therapy	2019-05-01	Yes	SD
CPCT02070422T	HMF003416	HMF003416A	0.47	female	1941	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-13	Lymph node	right supraclavicular	Yes	No	Yes	2019-02-07	2019-07-25	Lenvatinib	Targeted therapy	2019-04-04	Yes	SD
CPCT02070424T	HMF003850	HMF003850A	0.65	female	1968	2021-03-27	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-12-27	Primary	mama left	Yes	No	null	null	null	null	null	null	null	null
CPCT02070425T	HMF003826	HMF003826A	0.75	male	1952	2020-04-27	Prostate					10283	2018-12-18	Lymph node	para iliacal left	Yes	No	Yes	2019-01-01	2019-07-22	Abiraterone	Hormonal therapy	2019-03-19	Yes	SD
CPCT02070426T	HMF003948	HMF003948A	0.82	male	1953	2020-07-12	Prostate					10283	2018-12-20	Lymph node	para caval	Yes	No	Yes	2018-12-20	2019-04-10	Atezolizumab	Immunotherapy	2019-02-18	Yes	SD
CPCT02070430T	HMF004057	HMF004057A	0.83	male	1939	null	Prostate					10283	2018-12-13	Bone	Th12	Yes	Yes	Yes	2018-12-18	2022-03-31	Abiraterone	Hormonal therapy	2019-03-08	Yes	SD
CPCT02070433T	HMF003918	HMF003918A	0.54	male	1950	null	Prostate					10283	2019-01-10	Bone	right ilium wing	Yes	Yes	Yes	2019-01-10	2019-03-01	Abiraterone	Hormonal therapy	null	null	null
CPCT02070434T	HMF004396	HMF004396A	0.92	female	1955	null	Ovary					2394	2019-01-11	vagina	top of vagina	Yes	Yes	Yes	2019-01-28	2020-08-17	Bevacizumab	Targeted therapy	2019-03-15	Yes	PR
CPCT02070441T	HMF004237	HMF004237A	0.89	female	1948	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2019-01-31	omental	on level of bellybutton	Yes	No	Yes	2019-02-01	null	Imatinib	Targeted therapy	2019-05-02	Yes	SD
CPCT02070443T	HMF003939	HMF003939A	0.62	male	1942	null	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2019-02-14	Primary	soft tissue abdomen	Yes	No	Yes	2019-02-14	2021-01-13	Pembrolizumab	Immunotherapy	2019-04-11	Yes	SD
CPCT02070444T	HMF004295	HMF004295A	0.29	male	1966	2020-10-24	Prostate					10283	2019-01-29	Primary	Prostate	Yes	No	Yes	2019-02-04	2019-11-27	Enzalutamide	Hormonal therapy	2019-11-14	Yes	PD
CPCT02070444TII	HMF004295	HMF004295B	0.86	male	1966	2020-10-24	Prostate					10283	2019-12-17	Primary	prostate	Yes	No	Yes	2019-02-04	2019-11-27	Enzalutamide	Hormonal therapy	2019-11-14	Yes	PD
CPCT02070445T	HMF003925	HMF003925A	0.44	male	1951	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-01-29	Lymph node	unknown	Yes	No	Yes	2019-01-29	2020-10-09	Pembrolizumab	Immunotherapy	2019-04-17	Yes	SD
CPCT02070446T	HMF004049	HMF004049A	0.37	male	1961	null	Prostate					10283	2019-01-29	Primary	prostate	Yes	No	Yes	2019-03-01	null	Enzalutamide	Hormonal therapy	2019-05-14	No	PD
CPCT02070447T	HMF004048	HMF004048A	0.88	female	1967	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-29	Liver	segment 6	Yes	No	Yes	2019-02-15	2019-07-20	Alectinib	Targeted therapy	2019-04-10	Yes	PR
CPCT02070449T	HMF004070	HMF004070A	0.78	male	1943	null	Prostate					10283	2019-02-05	Lymph node	para-aortal left	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02070450T	HMF004363	HMF004363A	0.59	male	1940	null	Prostate					10283	2019-02-13	Bone	th 7 right	Yes	Yes	Yes	2019-02-21	null	Abiraterone	Hormonal therapy	null	null	null
CPCT02070452T	HMF003822	HMF003822A	0.55	male	1938	2020-10-01	Prostate					10283	2019-02-19	Primary	prostate	Yes	No	Yes	2019-03-01	2019-05-01	Abiraterone	Hormonal therapy	2019-04-29	Yes	PD
CPCT02070459T	HMF004189	HMF004189A	0.77	male	1956	null	Prostate					10283	2019-03-19	Lymph node	retroperitoneal left	Yes	Yes	Yes	2019-03-19	2019-05-14	Abiraterone	Hormonal therapy	2019-05-28	Yes	PD
CPCT02070463T	HMF004322	HMF004322A	0.46	male	1954	2019-08-14	Bone/Soft tissue		Myxofibrosarcoma			0080534	2019-04-09	Peritoneum	left upper abdomen	Yes	Yes	Yes	2019-04-10	2019-08-14	Pazopanib	Targeted therapy	2019-06-21	Yes	SD
CPCT02070465T	HMF004105	HMF004105A	0.71	female	1953	2020-09-05	Ovary					2394	2019-04-16	Lung	right lower lobe	Yes	No	Yes	2019-04-03	2019-07-03	Tamoxifen	Hormonal therapy	2019-06-27	Yes	PD
CPCT02070466TII	HMF004050	HMF004050A	0.9	male	1948	2020-11-21	Prostate					10283	2019-09-02	Bone	femur	Yes	Yes	Yes	2019-05-14	2019-09-24	Abiraterone	Hormonal therapy	2019-08-22	Yes	PD
CPCT02070468T	HMF004228	HMF004228A	0.75	male	1943	2020-08-13	Prostate					10283	2019-04-16	Primary	prostate	No	No	Yes	2019-06-13	2020-08-13	Abiraterone	Hormonal therapy	null	null	null
CPCT02070474T	HMF003914	HMF003914A	0.62	male	1953	null	Prostate					10283	2019-05-16	Lymph node	para iliacal left	Yes	Yes	Yes	2019-05-16	2022-09-06	Enzalutamide	Hormonal therapy	null	null	null
CPCT02070478T	HMF003944	HMF003944A	0.4	male	1945	null	Prostate					10283	2019-06-27	Peritoneum	left abdomen	No	Yes	null	null	null	null	null	null	null	null
CPCT02070480T	HMF003853	HMF003853A	0.25	male	1949	null	Urothelial tract	Bladder				11054	2019-07-26	Lymph node	para iliacal	Yes	No	Yes	2019-07-10	2020-06-26	Pembrolizumab	Immunotherapy	2019-09-19	Yes	PR
CPCT02070484T	HMF003887	HMF003887A	0.36	male	1955	2020-07-17	Prostate					10283	2019-08-13	prostate	left side	Yes	Yes	Yes	2019-08-13	2019-10-09	Abiraterone	Hormonal therapy	2019-10-01	Yes	PD
CPCT02070485T	HMF004208	HMF004208A	0.34	male	1953	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-08-13	Lymph node	fossa obturatorius left	Yes	No	Yes	2019-08-14	null	Pembrolizumab	Immunotherapy	2019-10-10	Yes	Non-CR/Non-PD
CPCT02070486T	HMF004109	HMF004109A	0.79	male	1951	2020-09-11	Prostate					10283	2019-08-15	Lymph node	inguinal right	Yes	Yes	Yes	2019-09-04	2019-11-21	Abiraterone	Hormonal therapy	null	null	null
CPCT02070487T	HMF004002	HMF004002A	0.2	male	1948	2019-12-17	Prostate					10283	2019-08-27	Liver	segment 6	Yes	Yes	Yes	2019-09-08	2019-10-03	Abiraterone	Hormonal therapy	null	null	null
CPCT02070490T	HMF003942	HMF003942A	0.34	male	1961	null	Prostate					10283	2019-09-19	Lymph node	supraclavicular left	Yes	Yes	Yes	2019-10-15	null	Abiraterone/Olaparib or placebo	Multiple therapy	null	null	null
CPCT02080001TII	HMF003479	HMF003479A	0.66	female	1959	2017-07-25	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-05	Primary	Breast left	Yes	No	Yes	2015-06-10	2017-05-03	Exemestane/Everolimus	Multiple therapy	2015-09-07	Yes	SD
CPCT02080014TII	HMF000771	HMF000771B	0.64	female	1967	2017-07-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-24	Mamma right	Superolateral	Yes	Yes	Yes	2016-03-21	2017-02-20	Vinorelbine/Cyclophosphamide/Methotrexate/Fluorouracil/Eribulin	Chemotherapy	2017-02-07	Yes	ND
CPCT02080016T	HMF001293	HMF001293A	0.38	female	1948	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-06-03	Lymph node	Axilla left	Yes	No	Yes	2016-06-04	2018-01-04	Anastrozole	Hormonal therapy	2017-04-26	No	Non-CR/Non-PD
CPCT02080019T	HMF000656	HMF000656A	0.23	female	1948	2019-09-10	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-03-21	Primary	Breast right	Yes	No	Yes	2017-03-21	2018-11-20	Cyclophosphamide/Methotrexate/Fluorouracil/Trastuzumab	Multiple therapy	2017-06-02	Yes	SD
CPCT02080022T	HMF002529	HMF002529A	0.37	female	1956	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	No	No	Yes	2016-07-15	2016-11-17	Docetaxel/Carboplatin/Trastuzumab/Trastuzumab	Multiple therapy	2016-09-03	Yes	PR
CPCT02080024T	HMF002184	HMF002184A	0.64	female	1950	2019-09-06	Ovary					2394	2016-07-06	Lymph node	left axilla	Yes	No	Yes	2016-07-07	2016-12-22	Carboplatin/Doxorubicin	Chemotherapy	2016-09-15	Yes	Non-CR/Non-PD
CPCT02080025T	HMF002397	HMF002397A	0.46	female	1953	2018-01-12	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-07-05	Skin	Satellite nodule in skin of primary breast	Yes	Yes	Yes	2016-07-06	2017-04-10	Capecitabine	Chemotherapy	2016-12-13	Yes	SD
CPCT02080027T	HMF001962	HMF001962A	0.4	female	1956	2018-08-22	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-07-22	Liver	segment 7	Yes	Yes	Yes	2016-08-02	2016-09-13	Docetaxel	Chemotherapy	2016-09-13	Yes	SD
CPCT02080029T	HMF000476	HMF000476A	0.73	female	1960	2018-11-12	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-29	Liver	Caudal right liver lobe	Yes	No	Yes	2017-10-06	2018-02-08	Capecitabine/Vinorelbine	Chemotherapy	2017-11-29	Yes	PD
CPCT02080029TII	HMF000476	HMF000476B	0.55	female	1960	2018-11-12	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-27	Liver	Segment 5	Yes	No	Yes	2017-10-06	2018-02-08	Capecitabine/Vinorelbine	Chemotherapy	2017-11-29	Yes	PD
CPCT02080030T	HMF000549	HMF000549A	0.37	female	1956	2016-12-09	Unknown	CUP	Carcinoma			305	null	null	null	No	No	Yes	2016-10-06	2016-11-24	Cisplatin/Gemcitabine	Chemotherapy	2016-11-30	Yes	PD
CPCT02080031T	HMF000145	HMF000145A	0.25	female	1940	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-24	Primary	right breast	No	No	Yes	2016-09-09	2016-11-24	Doxorubicin/Cyclophosphamide	Chemotherapy	2016-11-19	Yes	SD
CPCT02080036T	HMF001718	HMF001718A	0.63	female	1961	2017-02-15	Breast		Carcinoma	Triple negative		0060081	2016-09-20	Lymph node	Inguinal right	Yes	Yes	Yes	2016-09-20	2016-12-13	Cyclophosphamide/Methotrexate/Fluorouracil/Cyclophosphamide	Chemotherapy	2016-12-06	Yes	PD
CPCT02080039T	HMF003703	HMF003703A	0.56	female	1944	2017-06-08	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	Yes	No	Yes	2016-10-20	2017-01-19	Fulvestrant/Palbociclib	Multiple therapy	2017-01-10	Yes	PD
CPCT02080040T	HMF002031	HMF002031A	0.63	male	1947	2016-12-13	Head and neck	Nasal cavity and paranasal sinus				10811,0050619,11934	2016-10-05	Mouth	Region 13	No	No	null	null	null	null	null	null	null	null
CPCT02080041T	HMF003351	HMF003351A	0.29	female	1954	null	Pancreas		Neuroendocrine tumor			1793,169	2016-10-11	Liver	Right lobe liver	Yes	No	Yes	2016-11-22	2017-02-09	Peptide Receptor Radionuclide Therapy (PRRT)/Lutetium (Lu) 177 DOTATATE	Nuclear therapy	2017-04-25	Yes	SD
CPCT02080042T	HMF000745	HMF000745A	0.52	male	1965	2017-10-20	Colorectum					9256	2017-08-17	Peritoneum	Abdominal wall at side of laparotomy scar	Yes	No	Yes	2017-08-23	2017-10-02	Irinotecan/Leucovorin/Fluorouracil/Fluorouracil	Multiple therapy	2017-10-11	Yes	SD
CPCT02080045T	HMF001343	HMF001343B	0.73	female	1962	2018-06-04	Bone/Soft tissue		Rhabdomyosarcoma			3247,1115	2016-10-21	Subcutaneous	Soft tissue near left scapula	No	Yes	Yes	2016-10-24	2017-02-10	Doxorubicin	Chemotherapy	2016-11-29	Yes	SD
CPCT02080047T	HMF000693	HMF000693B	0.62	female	1963	2018-11-06	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-10-20	Lymph node	axilla left	Yes	Yes	Yes	2016-10-21	2017-10-25	Palbociclib/Fulvestrant	Multiple therapy	2016-12-05	Yes	PR
CPCT02080048T	HMF003323	HMF003323A	0.71	male	1959	2017-05-24	Colorectum					9256	2016-11-08	Abdominal wall (subcutaneous)	Abdomen (right side of the umbilicus)	Yes	No	Yes	2016-11-18	2017-05-05	Trifluridine	Chemotherapy	2017-03-09	Yes	SD
CPCT02080049T	HMF000919	HMF000919A	0.91	female	1960	2020-01-10	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2016-11-03	Lymph node	Supraclavicular left	Yes	Yes	Yes	2016-11-14	2017-02-27	Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	2017-03-01	Yes	Non-CR/Non-PD
CPCT02080050T	HMF002650	HMF002650A	0.82	male	1960	null	Thyroid gland					1781	2016-11-14	Lymph node	lymf node neck left side	No	No	null	null	null	null	null	null	null	null
CPCT02080053T	HMF001094	HMF001094A	0.23	female	1941	2017-09-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-30	Lymph node	right axilla	Yes	No	Yes	2016-12-13	2017-01-16	Paclitaxel	Chemotherapy	2017-01-26	Yes	SD
CPCT02080054T	HMF001143	HMF001143A	0.88	male	1947	2017-02-06	Liver		Carcinoma	Hepatocellular carcinoma		684	2016-12-06	Liver	Liver caudal	No	No	null	null	null	null	null	null	null	null
CPCT02080055T	HMF001689	HMF001689A	0.22	female	1978	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-02	Primary	Mamma left	No	No	Yes	2016-12-15	2017-05-10	Doxorubicin/Cyclophosphamide/Docetaxel	Chemotherapy	2017-02-25	Yes	SD
CPCT02080056T	HMF000579	HMF000579B	0.68	female	1952	2018-03-11	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-12-06	skin	subcutis right upper arm	Yes	Yes	Yes	2016-12-06	2017-01-18	Eribulin/Trastuzumab	Multiple therapy	2017-02-01	Yes	PD
CPCT02080060T	HMF001204	HMF001204A	0.59	female	1947	2021-08-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-21	Primary	Breast left	No	No	Yes	2016-12-22	2017-10-13	Fulvestrant	Hormonal therapy	2017-09-26	Yes	PD
CPCT02080062T	HMF003197	HMF003197A	0.71	male	1950	2017-10-15	Colorectum					9256	2017-07-25	Liver	Liver	Yes	No	null	null	null	null	null	null	null	null
CPCT02080063T	HMF000950	HMF000950A	0.59	female	1975	2017-08-28	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-10	Liver	Liver segment 4B	Yes	Yes	Yes	2017-01-11	2017-01-24	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02080064T	HMF001780	HMF001780A	0.91	female	1947	2017-02-10	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-06	Liver	Liver	Yes	Yes	Yes	2017-01-19	2017-02-07	Capecitabine	Chemotherapy	null	null	null
CPCT02080066T	HMF000175	HMF000175A	0.22	male	1964	2019-01-09	Gallbladder					3121	2017-01-30	Abdominal wall (intramuscular)	Abdominal wall	No	No	Yes	2017-02-09	2017-08-16	Cisplatin/Gemcitabine	Chemotherapy	2017-05-01	Yes	PR
CPCT02080067T	HMF002312	HMF002312A	0.57	female	1960	2018-04-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-20	Liver	Liver segment 3	Yes	No	Yes	2017-02-08	2017-07-26	Letrozole/Palbociclib	Multiple therapy	2017-06-07	Yes	PD
CPCT02080069T	HMF000397	HMF000397A	0.56	female	1958	2019-03-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-20	Peritoneum	Epigastric region	Yes	Yes	Yes	2017-01-25	2017-12-20	Capecitabine	Chemotherapy	2017-07-25	Yes	Non-CR/Non-PD
CPCT02080070T	HMF000403	HMF000403A	0.26	female	1961	2019-05-07	Breast		Carcinoma	Triple negative		0060081	2017-01-26	Lymph node	Axilla right	Yes	Yes	Yes	2017-01-31	2017-06-13	Capecitabine/Vinorelbine	Chemotherapy	2017-03-30	Yes	PR
CPCT02080070TII	HMF000403	HMF000403B	0.37	female	1961	2019-05-07	Breast		Carcinoma	Triple negative		0060081	2017-09-20	Skin/Subcutaneous	Right chest wall	Yes	Yes	Yes	2017-01-31	2017-06-13	Capecitabine/Vinorelbine	Chemotherapy	2017-03-30	Yes	PR
CPCT02080071T	HMF000650	HMF000650A	0.55	male	1947	2017-08-31	Unknown	CUP	Carcinoma			305	2017-04-18	Liver	Right hemi-liver	Yes	No	Yes	2017-04-24	2017-07-20	Trifluridine/Trifluridine	Chemotherapy	2017-07-13	Yes	PD
CPCT02080072T	HMF002965	HMF002965A	0.52	female	1965	2021-09-14	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-02-03	Lymph node	Axilla right	Yes	Yes	Yes	2017-02-06	2017-06-12	Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	2017-04-04	Yes	PR
CPCT02080073T	HMF001905	HMF001905A	0.6	female	1942	2017-05-09	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-09	Liver	Liver segment 3	Yes	Yes	Yes	2017-02-09	2017-03-22	Capecitabine	Chemotherapy	null	null	null
CPCT02080075T	HMF001942	HMF001942A	0.73	male	1938	2017-08-13	Colorectum					9256	2017-02-08	Abdominal wall (intramuscular)	Abdominal wall	No	No	Yes	2017-06-09	2017-06-14	Capecitabine/Oxaliplatin	Chemotherapy	null	null	null
CPCT02080076T	HMF001516	HMF001516A	0.6	female	1965	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-14	Lymph node	Left axilla	No	No	Yes	2017-02-23	2017-07-19	Doxorubicin/Cyclophosphamide/Docetaxel	Chemotherapy	2017-05-01	Yes	SD
CPCT02080078T	HMF001450	HMF001450B	0.63	male	1943	2019-11-02	Prostate					10283	2017-02-23	Liver	Liver left lobe	Yes	No	Yes	2017-02-23	2018-08-13	Docetaxel/Docetaxel/Cabazitaxel	Chemotherapy	2017-05-09	Yes	SD
CPCT02080078TII	HMF001450	HMF001450A	0.72	male	1943	2019-11-02	Prostate					10283	2018-09-14	Liver	Right hemiliver	Yes	No	Yes	2017-02-23	2018-08-13	Docetaxel/Docetaxel/Cabazitaxel	Chemotherapy	2017-05-09	Yes	SD
CPCT02080079T	HMF001879	HMF001879A	0.65	female	1944	null	Skin		Melanoma			8923	2017-03-14	Lung	Left lung	Yes	Yes	Yes	2017-04-04	2018-04-03	Pembrolizumab	Immunotherapy	2017-08-15	Yes	PD
CPCT02080080T	HMF002204	HMF002204A	0.55	male	1971	2017-07-29	Colorectum					9256	2017-02-21	Liver	Liver segment 7	Yes	Yes	Yes	2017-04-20	2017-05-12	Olaparib	Targeted therapy	2017-05-15	Yes	SD
CPCT02080084T	HMF002957	HMF002957A	0.56	female	1952	2018-01-04	Colorectum					9256	2017-03-01	Lung	Right lower lobe	Yes	Yes	Yes	2017-03-02	2017-10-04	Trifluridine/Trifluridine	Chemotherapy	2017-05-10	Yes	SD
CPCT02080086T	HMF000154	HMF000154B	0.93	male	1957	2018-01-01	Pancreas		Carcinoma	Neuroendocrine carcinoma		1798,1800	2017-02-24	Liver	Caudal in liver	No	No	Yes	2017-03-09	2017-04-18	Cisplatin/Etoposide	Chemotherapy	2017-04-04	Yes	SD
CPCT02080088T	HMF002698	HMF002698A	0.59	female	1957	2017-05-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-03-10	Primary	Lung	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02080091T	HMF000645	HMF000645A	0.67	male	1947	2017-05-14	Pancreas					1793	2017-04-25	Liver	Segment 3	No	No	Yes	2017-05-09	2017-05-12	Nab-paclitaxel/Gemcitabine	Chemotherapy	null	null	null
CPCT02080092T	HMF000686	HMF000686A	0.29	female	1953	2017-08-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-04-10	Lung	Soft tissue near 7th dorsal rib left	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02080093T	HMF002839	HMF002839A	0.23	female	1978	2017-11-08	Ovary					2394	2017-04-05	Skin	Belly	Yes	No	Yes	2017-05-31	2017-11-02	Trametinib	Targeted therapy	2017-08-25	Yes	SD
CPCT02080095T	HMF001019	HMF001019A	0.59	female	1961	2018-06-29	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-04-20	Liver	liver	Yes	Yes	Yes	2017-04-20	2017-06-15	Palbociclib/Letrozole	Multiple therapy	2017-06-19	Yes	PD
CPCT02080099T	HMF000040	HMF000040A	0.55	male	1968	2017-10-12	Head and neck	Lip and oral cavity				8564,11934	2017-04-21	Primary	Mouth, submandibular	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02080102T	HMF001362	HMF001362B	0.39	female	1947	2018-03-14	Uterus	Endometrium	Carcinoma	Carcinosarcoma		6171,4236	2017-05-10	Lung	Right upper lobe	Yes	Yes	Yes	2017-05-15	2017-09-07	Carboplatin/Paclitaxel	Chemotherapy	2017-07-24	Yes	PR
CPCT02080103T	HMF002596	HMF002596A	0.38	male	1953	2018-05-10	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-05-12	Bone	Left os ilium	Yes	Yes	Yes	2017-07-07	2018-02-23	Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	2017-09-21	Yes	PR
CPCT02080105T	HMF001864	HMF001864A	0.74	male	1952	2017-11-05	Unknown	CUP	Carcinoma			305	2017-05-16	Lung	anterior mediastinum	No	No	Yes	2017-05-19	2017-10-01	Cisplatin/Etoposide/Carboplatin	Chemotherapy	2017-07-10	Yes	SD
CPCT02080106T	HMF000887	HMF000887A	0.47	female	1970	2018-12-05	Breast		Carcinoma	Triple negative		0060081	2017-05-18	Primary	Lateral upper quadrant	No	No	Yes	2017-05-24	2017-11-01	Doxorubicin/Cyclophosphamide/Paclitaxel	Chemotherapy	2017-08-07	Yes	SD
CPCT02080110T	HMF001337	HMF001337A	0.3	male	1949	2017-10-13	Prostate					10283	2017-06-16	Lung	Left upper lobe	Yes	Yes	Yes	2017-06-22	2017-08-03	Abiraterone	Hormonal therapy	2017-08-07	Yes	PD
CPCT02080111T	HMF001431	HMF001431A	0.42	male	1951	2018-08-05	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-06-21	Lymph node	Paravertebral left	No	No	Yes	2017-07-10	2017-10-01	Sunitinib	Targeted therapy	2017-08-16	Yes	PD
CPCT02080112T	HMF002600	HMF002600A	0.34	female	1951	null	Breast		Carcinoma	Triple negative		0060081	2017-06-16	Primary	Right breast	No	No	Yes	2017-06-26	2017-12-06	Doxorubicin/Cyclophosphamide/Paclitaxel	Chemotherapy	2017-09-09	Yes	CR
CPCT02080113T	HMF003121	HMF003121A	0.46	female	1968	null	Skin		Melanoma			8923	2017-06-22	Mamma	Right breast (cutaneously)	Yes	No	Yes	2017-07-11	2017-10-09	Ipilimumab/Nivolumab	Immunotherapy	2017-11-02	Yes	PR
CPCT02080114T	HMF003550	HMF003550A	0.43	male	1949	2017-09-05	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-06-19	Lung	Basal in left lower lobe	Yes	Yes	Yes	2017-07-14	2017-08-15	Docetaxel/Erlotinib	Multiple therapy	null	null	null
CPCT02080116T	HMF003171	HMF003171A	0.8	male	1962	2018-01-24	Skin		Melanoma			8923	2017-06-23	Lung	Pleura dorsobasal right	No	Yes	Yes	2017-07-10	2017-12-24	Vemurafenib/Cobimetinib	Targeted therapy	2017-07-14	Yes	ND
CPCT02080118T	HMF003220	HMF003220A	0.37	female	1941	2017-07-29	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-23	Lymph node	Right axilla	No	Yes	Yes	2017-07-03	2017-07-29	Letrozole	Hormonal therapy	null	null	null
CPCT02080119T	HMF000140	HMF000140A	0.4	male	1943	2017-09-12	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-06-30	Liver	Liver parenchyma right ventral	Yes	Yes	Yes	2017-07-04	2017-09-01	Atezolizumab	Immunotherapy	2017-08-29	Yes	PD
CPCT02080120T	HMF002030	HMF002030A	0.47	male	1957	2018-01-18	Head and neck	Hypopharynx				8533,11934	2017-07-03	Primary	Hypopharynx	No	No	null	null	null	null	null	null	null	null
CPCT02080122T	HMF003599	HMF003599A	0.33	female	1964	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-06	Primary	Breast right	No	No	Yes	2017-07-13	2017-12-21	Doxorubicin/Cyclophosphamide/Docetaxel/Paclitaxel	Chemotherapy	2017-09-30	Yes	PR
CPCT02080123T	HMF000597	HMF000597A	0.87	female	1933	2018-11-03	Skin		Melanoma			8923	2017-07-13	Lymph node	Corner of left jaw	No	No	Yes	2017-08-18	2018-02-05	Pembrolizumab	Immunotherapy	2017-11-27	Yes	PD
CPCT02080125T	HMF001280	HMF001280A	0.53	female	1970	2020-04-15	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-07-18	Liver	Segment 6 or 4B	Yes	No	Yes	2017-08-04	2017-12-20	Capecitabine/Vinorelbine	Chemotherapy	2017-09-26	Yes	SD
CPCT02080126T	HMF001655	HMF001655A	0.66	male	1968	2018-03-29	Colorectum					9256	2017-11-02	Liver	Right liver lobe	Yes	Yes	Yes	2017-11-13	2017-11-27	Trifluridine	Chemotherapy	null	null	null
CPCT02080127T	HMF000395	HMF000395A	0.59	female	1977	2018-03-18	Breast		Carcinoma	Triple negative		0060081	2017-07-27	Primary	Breast left	Yes	No	Yes	2017-08-05	2017-10-24	Capecitabine/Vinorelbine	Chemotherapy	2017-10-17	Yes	PD
CPCT02080128T	HMF000937	HMF000937A	0.81	female	1954	2018-06-16	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-01	Liver	Segment 6	Yes	Yes	Yes	2017-08-08	2017-11-29	Eribulin	Chemotherapy	null	null	null
CPCT02080130T	HMF001845	HMF001845A	0.63	male	1951	2018-01-16	Esophagus					5041	2017-08-24	Muscle	Right gluteal muscle	No	Yes	Yes	2017-08-22	2017-12-27	Oxaliplatin/Capecitabine	Chemotherapy	2017-10-16	Yes	SD
CPCT02080131T	HMF000930	HMF000930A	0.23	female	1950	2018-09-19	Colorectum					9256	2017-08-08	Liver	subxyphoidal	No	No	Yes	2017-08-16	2018-03-06	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-10-10	Yes	SD
CPCT02080135T	HMF003358	HMF003358A	0.38	male	1951	2018-06-14	Unknown	CUP	Carcinoma			305	2017-08-30	Cutaneous tissue	Tumor near clavicula medial left	No	Yes	null	null	null	null	null	null	null	null
CPCT02080136T	HMF001950	HMF001950A	0.35	male	1939	2017-12-20	Head and neck	Tongue	Carcinoma	Squamous cell carcinoma		0050865,5520	2017-08-30	Skin	Neck left	No	Yes	Yes	2017-09-15	2017-10-27	Methotrexate	Chemotherapy	2017-10-23	Yes	PD
CPCT02080137T	HMF001643	HMF001643A	0.36	male	1967	2017-10-27	Head and neck	Nasal cavity and paranasal sinus				10811,0050619,11934	2017-09-18	Lymph node	axilla	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02080138T	HMF003118	HMF003118A	0.28	male	1952	2021-07-16	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-09-08	Lung	right upper lobe	Yes	No	Yes	2017-10-11	2019-07-10	Nivolumab	Immunotherapy	2018-01-02	Yes	PR
CPCT02080141T	HMF003490	HMF003490A	0.35	male	1961	2018-02-19	Gastroesophageal					0080374	2017-09-21	Primary	stomach	No	No	Yes	2017-09-25	2018-02-10	Epirubicin/Oxaliplatin/Capecitabine	Chemotherapy	2017-11-21	Yes	PR
CPCT02080143T	HMF000545	HMF000545A	0.55	female	1955	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-09-27	Primary	right breast	No	No	Yes	2017-09-27	2018-02-21	Doxorubicin/Cyclophosphamide/Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	2017-12-09	Yes	SD
CPCT02080152T	HMF003240	HMF003240B	0.8	female	1949	2018-06-02	Uterus	Endometrium				1380	2017-10-12	Primary	endometrium	Yes	No	Yes	2017-10-26	2018-03-01	Etoposide/Carboplatin	Chemotherapy	2018-03-20	Yes	PD
CPCT02080156T	HMF000621	HMF000621A	0.54	female	1948	2018-02-01	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-10-19	Liver	left part of liver	Yes	No	Yes	2017-10-24	2017-12-01	Docetaxel	Chemotherapy	null	null	null
CPCT02080158T	HMF003396	HMF003396A	0.94	male	1948	2019-10-17	Thyroid gland					1781	2017-11-09	Lymph node	Neck left	No	No	Yes	2017-11-18	2018-12-26	Vandetanib	Targeted therapy	2018-02-06	Yes	SD
CPCT02080160T	HMF001973	HMF001973A	0.67	female	1951	2020-05-15	Ovary					2394	2017-10-27	Peritoneum	Peritoneal implant	Yes	No	Yes	2018-01-30	2018-06-19	Doxorubicin (liposomal)/Carboplatin	Chemotherapy	null	null	null
CPCT02080163T	HMF002101	HMF002101A	0.74	male	1942	2017-12-01	Skin		Melanoma			8923	2017-11-07	Liver	Left hemiliver	Yes	Yes	Yes	2017-11-24	2017-12-01	Pembrolizumab	Immunotherapy	null	null	null
CPCT02080164T	HMF000352	HMF000352A	0.57	male	1953	2019-01-08	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2017-11-17	Lymph node	supraclavicular	No	No	Yes	2017-12-22	2018-11-05	Pembrolizumab/Gemcitabine/Cisplatin	Multiple therapy	2018-02-15	Yes	SD
CPCT02080168T	HMF001733	HMF001733A	0.28	male	1941	2018-09-11	Mesothelium		Malignant mesothelioma			1790,0050686	2017-11-21	Primary	left thorax wall	Yes	No	Yes	2018-01-16	2018-08-14	Pembrolizumab	Immunotherapy	2018-02-21	Yes	SD
CPCT02080169T	HMF000339	HMF000339A	0.39	male	1958	2018-03-23	Bile duct		Carcinoma			4947	2017-11-23	Subcutaneous	Right hemiabdomen	No	No	Yes	2017-11-30	2017-11-30	Cisplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02080170T	HMF001982	HMF001982A	0.3	female	1983	2020-03-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-23	Liver	left liver lobe	Yes	Yes	Yes	2017-11-29	2018-09-12	Ribociclib/Letrozole/Goserelin	Multiple therapy	2018-02-28	Yes	PR
CPCT02080174T	HMF002045	HMF002045A	0.68	male	1962	2019-02-18	Colorectum					9256	2017-12-06	Liver	superficial lesion accessible via right intercostal space	No	No	Yes	2018-01-05	2018-07-05	Capecitabine/Oxaliplatin	Chemotherapy	2018-04-13	Yes	PR
CPCT02080179T	HMF001119	HMF001119A	0.52	male	1962	2018-05-10	Head and neck	Salivary gland				8850,11934	2017-12-15	Lymph node	left supraclavicular	No	Yes	Yes	2018-01-15	2018-03-30	Goserelin	Androgen/estrogen deprivation therapy	2018-04-11	Yes	PD
CPCT02080180T	HMF003628	HMF003628A	0.88	male	1948	2018-03-02	Prostate					10283	2018-01-02	Lymph node	left para aortic	Yes	Yes	Yes	2018-01-08	2018-01-23	Enzalutamide	Hormonal therapy	null	null	null
CPCT02080181TII	HMF003295	HMF003295B	0.76	female	1947	2019-03-01	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2019-02-14	Lung	Right lung	No	No	Yes	2017-12-22	2019-01-25	Doxorubicin/Olaratumab	Multiple therapy	2018-02-16	Yes	SD
CPCT02080183T	HMF003003	HMF003003A	0.75	female	1972	2018-07-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-02	Liver	Segment IV	Yes	No	Yes	2018-01-22	2018-06-25	Paclitaxel	Chemotherapy	2018-04-10	Yes	SD
CPCT02080184T	HMF001711	HMF001711A	0.27	female	1982	2020-11-28	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-04	Bone	Right pubic bone	Yes	Yes	Yes	2018-01-04	2018-08-01	Ribociclib/Letrozole	Multiple therapy	null	null	null
CPCT02080185T	HMF003709	HMF003709A	0.2	female	1948	2018-03-28	Uterus	Cervix				4362	2018-01-04	Lymph node	Supraclavicular	Yes	Yes	Yes	2018-01-10	2018-02-22	Carboplatin/Paclitaxel	Chemotherapy	2018-03-13	Yes	PD
CPCT02080188T	HMF000491	HMF000491A	0.43	male	1952	2019-12-15	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-12	Lymph node	left, subcutaneous, at the transition point between station 2 and station 5	No	No	Yes	2018-02-08	2018-03-07	Cisplatin/Pemetrexed	Chemotherapy	2018-03-19	Yes	PD
CPCT02080191T	HMF003688	HMF003688A	0.7	female	1940	null	Ovary					2394	2018-01-17	Peritoneum	Right lower abdomen	Yes	No	Yes	2018-01-25	2018-06-13	Carboplatin/Doxorubicin (liposomal)/Doxorubicin (liposomal)	Chemotherapy	null	null	null
CPCT02080192T	HMF003650	HMF003650A	0.56	male	1958	2018-05-07	Unknown	CUP	Carcinoma			305	2018-01-23	Liver	segment 6	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02080193T	HMF003410	HMF003410A	0.67	male	1955	null	Head and neck	Hypopharynx				8533,11934	2018-01-24	Lymph node	Neck left	No	No	Yes	2018-01-25	2019-05-08	Cisplatin/Cetuximab/Fluorouracil/Carboplatin	Multiple therapy	2018-04-16	Yes	PR
CPCT02080196T	HMF002147	HMF002147A	0.71	female	1963	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-26	Liver	Inferior segment(s)	No	No	Yes	2018-02-01	null	Letrozole/Goserelin/Palbociclib	Multiple therapy	2018-05-02	Yes	PR
CPCT02080197T	HMF001140	HMF001140A	0.51	male	1958	2018-06-17	Colorectum					9256	2018-01-31	Lymph node	left neck	Yes	Yes	Yes	2018-02-05	2018-03-13	Trifluridine	Chemotherapy	2018-04-05	Yes	PD
CPCT02080198T	HMF000643	HMF000643A	0.75	female	1986	2018-04-30	Ovary					2394	2018-02-01	breast	Right breast	Yes	No	null	null	null	null	null	null	null	null
CPCT02080200T	HMF002562	HMF002562A	0.77	female	1959	2018-10-28	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-20	Cutaneous lesions	Skin of the head: left occipital-parietal	Yes	Yes	Yes	2018-02-20	2018-06-11	Eribulin	Chemotherapy	2018-05-04	Yes	PD
CPCT02080204T	HMF000653	HMF000653A	0.59	male	1946	2019-04-06	Thyroid gland					1781	2018-02-20	Lung	Subpleural nodus dorsobasal	Yes	Yes	Yes	2018-02-23	2018-04-17	Lenvatinib	Targeted therapy	null	null	null
CPCT02080205T	HMF000594	HMF000594B	0.42	female	1943	2021-05-13	Skin		Carcinoma	Basal cell carcinoma		2513	2018-03-06	Lung	Right lower lobe	Yes	No	Yes	2018-03-12	2018-09-04	Vismodegib	Targeted therapy	2018-05-24	Yes	SD
CPCT02080206T	HMF001878	HMF001878A	0.79	female	1981	2023-04-30	Bone/Soft tissue		Liposarcoma			3382,1115	2018-02-23	Intra-abdominal	left flank	No	Yes	Yes	2018-03-02	2019-04-05	Doxorubicin/Olaratumab	Multiple therapy	2018-05-03	Yes	SD
CPCT02080207T	HMF001620	HMF001620A	0.23	male	1943	null	Skin		Melanoma			8923	2018-03-02	Lymph node	pararenal	No	No	Yes	2018-03-13	2018-06-25	Dabrafenib/Trametinib	Targeted therapy	2018-03-22	Yes	null
CPCT02080208T	HMF002727	HMF002727A	0.34	male	1942	2020-05-08	Bile duct		Carcinoma			4947	2018-03-02	Primary	right hemiliver	No	No	Yes	2018-03-07	2018-07-04	Cisplatin/Gemcitabine	Chemotherapy	2018-05-01	Yes	SD
CPCT02080215T	HMF003662	HMF003662A	0.72	female	1964	2022-08-07	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-03-20	Liver	segment 5/6	Yes	No	Yes	2018-03-28	2019-07-08	Regorafenib	Targeted therapy	2018-06-19	Yes	SD
CPCT02080216T	HMF003370	HMF003370A	0.33	female	1974	2021-12-04	Breast		Carcinoma	Triple negative		0060081	2018-03-23	Lymph node	parasternal	Yes	No	Yes	2018-04-04	2018-08-27	Carboplatin/Paclitaxel	Chemotherapy	2018-07-12	Yes	PR
CPCT02080218T	HMF001407	HMF001407A	0.5	female	1941	2018-05-25	Bile duct		Carcinoma			4947	2018-03-29	Liver	segments 4A and 4B	No	No	null	null	null	null	null	null	null	null
CPCT02080220T	HMF000440	HMF000440A	0.69	female	1946	2021-07-04	Uterus	Cervix				4362	2018-04-05	cutaneous	Sister Mary Joseph Nodule	No	No	Yes	2018-04-23	2018-08-09	Carboplatin/Paclitaxel	Chemotherapy	2018-09-05	Yes	PR
CPCT02080221T	HMF003176	HMF003176A	0.78	female	1952	2019-07-23	Skin		Melanoma			8923	2018-04-10	Lung	Right lower lobe	No	No	Yes	2018-04-24	2018-04-24	Nivolumab/Ipilimumab	Immunotherapy	2018-08-02	Yes	SD
CPCT02080223T	HMF001355	HMF001355A	0.85	male	1950	2019-05-08	Pancreas		Neuroendocrine tumor			1793,169	2018-04-10	Liver	segment 3/4	No	No	Yes	2018-04-18	2018-09-08	Cisplatin/Etoposide	Chemotherapy	2018-09-11	Yes	PR
CPCT02080224T	HMF002705	HMF002705A	0.42	female	1937	2018-09-15	Bile duct		Carcinoma			4947	2018-04-13	Liver	segment 8	No	No	Yes	2018-05-04	2018-05-31	Gemcitabine	Chemotherapy	null	null	null
CPCT02080225T	HMF001799	HMF001799A	0.62	male	1961	2019-10-12	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-04-11	CNS	right temporal lobe	Yes	Yes	Yes	2018-05-14	2018-07-11	Temozolomide	Chemotherapy	null	null	null
CPCT02080226T	HMF001564	HMF001564A	0.62	female	1949	2019-02-14	Uterus	Cervix				4362	2018-04-17	Lung	right upper lobe	Yes	Yes	Yes	2018-05-03	2018-08-23	Carboplatin/Paclitaxel	Chemotherapy	2018-06-25	Yes	PR
CPCT02080227T	HMF002304	HMF002304A	0.69	male	1965	2020-07-04	Bone/Soft tissue		Liposarcoma			3382,1115	2018-04-19	Liver	segment 8	No	Yes	Yes	2018-04-26	2018-06-15	Doxorubicin/Olaratumab	Multiple therapy	2018-06-26	Yes	PD
CPCT02080228T	HMF000735	HMF000735A	0.57	female	1953	2020-11-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-20	Liver	Right hemi liver	Yes	Yes	Yes	2018-04-23	2019-07-30	Palbociclib/Letrozole	Multiple therapy	2018-07-09	Yes	SD
CPCT02080229T	HMF001400	HMF001400A	0.54	female	1949	2018-05-23	Lung		Carcinoma	Neuroendocrine carcinoma		3905,1800	2018-04-20	Liver	segment 3	No	No	null	null	null	null	null	null	null	null
CPCT02080230T	HMF003297	HMF003297A	0.89	female	1946	null	Thymus		Carcinoma	Thymoma and Thymic carcinoma		3275,3284,305	2018-04-20	Bone	soft tissue component right ilium	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02080232T	HMF001613	HMF001613A	0.44	male	1940	null	Lymphoid tissue		Non-Hodgkin lymphoma	Diffuse large B-cell lymphoma		0050745	2018-04-26	Liver	segment 5	No	No	Yes	2018-05-11	2018-10-05	Cyclophosphamide/Doxorubicin/Vincristine/Paclitaxel/Rituximab	Multiple therapy	2018-07-09	Yes	PR
CPCT02080234T	HMF001195	HMF001195B	0.51	male	1946	2022-07-15	Skin		Carcinoma	Squamous cell carcinoma		3151	2018-05-11	Lymph node	right supraclavicular	No	Yes	Yes	2018-05-12	2018-11-09	Carboplatin/Fluorouracil/Cetuximab	Multiple therapy	2018-06-29	Yes	SD
CPCT02080236T	HMF000543	HMF000543A	0.58	female	1942	2020-03-11	Ovary					2394	2018-05-08	Peritoneum	middle line	Yes	No	Yes	2018-07-10	2018-09-07	Olaparib/Bevacizumab/Durvalumab	Multiple therapy	2018-08-29	Yes	SD
CPCT02080238T	HMF001865	HMF001865A	0.5	male	1960	2018-06-29	Pancreas					1793	2018-05-11	Liver	segment 3	No	No	null	null	null	null	null	null	null	null
CPCT02080239T	HMF002095	HMF002095A	0.76	male	1952	2019-09-22	Skin		Melanoma			8923	2018-05-15	Bone	Acetabulum right	No	null	null	null	null	null	null	null	null	null
CPCT02080240T	HMF003255	HMF003255A	0.2	male	1957	2019-02-18	Unknown	CUP	Carcinoma			305	2018-05-17	Liver	segment 6	No	No	Yes	2018-05-18	2019-01-04	Gemcitabine	Chemotherapy	2018-07-26	Yes	SD
CPCT02080242T	HMF001448	HMF001448A	0.49	female	1991	2018-06-26	Skin		Melanoma			8923	2018-05-22	duodenum	duodenum	Yes	No	Yes	2018-05-22	2018-05-22	Dacarbazine	Chemotherapy	null	null	null
CPCT02080243T	HMF003581	HMF003581A	0.54	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-25	Subcutaneous lesion on the back	Laterodorsal left	Yes	No	Yes	2018-06-05	2018-10-31	Trastuzumab/Pertuzumab/Docetaxel	Multiple therapy	2018-09-11	Yes	PR
CPCT02080244T	HMF003215	HMF003215A	0.34	male	1966	2018-08-23	Colorectum					9256	2018-05-29	Liver	segment 3	Yes	Yes	Yes	2018-06-01	2018-06-05	Trifluridine	Chemotherapy	null	null	null
CPCT02080247T	HMF003466	HMF003466A	0.72	male	1960	2018-10-20	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-06-05	Primary	Abdominal mass left	Yes	No	Yes	2018-06-05	2018-08-15	Imatinib	Targeted therapy	2018-08-17	Yes	SD
CPCT02080248T	HMF000928	HMF000928A	0.29	male	1957	2019-10-16	Bone/Soft tissue		Sarcoma			1115	2018-06-19	Liver	right liver lobe	No	No	Yes	2018-07-02	2019-02-21	Doxorubicin/Olaratumab	Multiple therapy	2018-08-29	Yes	SD
CPCT02080250T	HMF000133	HMF000133A	0.47	female	1970	2018-12-10	Breast		Carcinoma	Triple negative		0060081	2018-06-15	Lymph node	Left supraclavicular	Yes	Yes	Yes	2018-06-21	2018-10-03	Capecitabine	Chemotherapy	null	null	null
CPCT02080251T	HMF001582	HMF001582A	0.53	male	1959	2018-08-03	Head and neck	Lip and oral cavity				8564,11934	2018-06-19	Primary	Base of tongue	Yes	Yes	Yes	2018-06-27	2018-07-05	Carboplatin/Fluorouracil/Cetuximab	Multiple therapy	null	null	null
CPCT02080253T	HMF001263	HMF001263A	0.7	female	1963	2018-07-22	Breast		Carcinoma	Triple negative		0060081	2018-06-22	Lung	Left lower lobe	Yes	Yes	Yes	2018-06-27	2018-06-27	Eribulin	Chemotherapy	null	null	null
CPCT02080254T	HMF001970	HMF001970A	0.7	female	1968	2019-03-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-27	Primary	Left breast	Yes	No	Yes	2018-07-12	2018-08-13	Everolimus/Exemestane	Multiple therapy	2018-08-13	Yes	PD
CPCT02080255T	HMF000157	HMF000157A	0.45	male	1943	2018-11-28	Esophagus					5041	2018-06-28	Abdominal wall (subcutaneous)	Abdominal wall, near umbilicus	Yes	No	Yes	2018-07-11	2018-10-17	Ramucirumab/Paclitaxel	Multiple therapy	2018-09-26	Yes	PD
CPCT02080256T	HMF003390	HMF003390A	0.69	male	1945	2018-08-26	Unknown	CUP	Carcinoma			305	2018-06-29	Liver	Right hemiliver	No	No	Yes	2018-07-27	2018-08-03	Gemcitabine/Carboplatin	Chemotherapy	null	null	null
CPCT02080257T	HMF002754	HMF002754A	0.38	male	1982	2019-01-26	Thyroid gland					1781	2018-06-27	Lymph node	Neck right	Yes	No	Yes	2018-07-18	2019-01-04	Lenvatinib	Targeted therapy	2018-10-01	Yes	SD
CPCT02080259T	HMF000979	HMF000979A	0.33	female	1954	null	Skin		Melanoma			8923	2018-07-13	Lymph node	Inguinal left	Yes	No	Yes	2018-07-27	2018-09-28	Ipilimumab	Immunotherapy	2018-10-12	Yes	PD
CPCT02080261T	HMF000502	HMF000502A	0.59	female	1962	2021-06-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-06	Bone	TH10	Yes	Yes	Yes	2018-08-01	2018-11-26	Palbociclib/Letrozole	Multiple therapy	null	null	null
CPCT02080263T	HMF000385	HMF000385A	0.43	male	1942	2018-07-30	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2018-07-19	Kidney	Renal space left (local recurrence after nephrectomy)	No	No	null	null	null	null	null	null	null	null
CPCT02080266T	HMF000876	HMF000876A	0.92	male	1947	2019-07-10	Skin		Melanoma			8923	2018-07-27	Bone	Right ilium	No	No	Yes	2018-08-02	2018-12-24	Pembrolizumab	Immunotherapy	2018-09-11	Yes	PD
CPCT02080266TII	HMF000876	HMF000876B	0.9	male	1947	2019-07-10	Skin		Melanoma			8923	2019-01-29	Kidney	Right kidney (upper pole)	No	No	Yes	2018-08-02	2018-12-24	Pembrolizumab	Immunotherapy	2018-09-11	Yes	PD
CPCT02080269T	HMF002321	HMF002321A	0.74	female	1943	2019-02-21	Skin		Melanoma			8923	2018-09-13	Lymph node	Right inguinal lymph node	No	No	Yes	2018-09-17	2018-12-10	Nivolumab	Immunotherapy	2018-11-26	Yes	PD
CPCT02080270T	HMF000097	HMF000097A	0.63	male	1956	2019-07-19	Skin		Melanoma			8923	2018-10-02	Soft tissue (muscle)	Right forearm	Yes	Yes	Yes	2018-10-02	2018-12-28	Nivolumab	Immunotherapy	2018-12-19	Yes	PD
CPCT02080271T	HMF001162	HMF001162A	0.95	female	1965	2019-03-12	Skin		Melanoma			8923	2018-10-12	subcutaneous lesion	epigastrium	No	No	Yes	2018-10-19	2019-02-17	Dabrafenib/Trametinib	Targeted therapy	2018-11-28	Yes	PR
CPCT02080273T	HMF002132	HMF002132A	0.91	male	1956	null	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2018-11-15	Lymph node	right parailiac lymph node	No	Yes	Yes	2018-11-19	2019-11-12	Pembrolizumab	Immunotherapy	2019-02-06	Yes	SD
CPCT02080275T	HMF003421	HMF003421A	0.44	female	1938	2019-02-07	Skin		Melanoma			8923	2018-11-20	Lymph node	right axilla	No	No	Yes	2018-11-28	2019-01-30	Nivolumab/Ipilimumab	Immunotherapy	null	null	null
CPCT02080280T	HMF004329	HMF004329A	0.28	female	1959	2019-01-02	Skin		Melanoma			8923	2018-12-28	Lymph node	Inguinal right	No	No	null	null	null	null	null	null	null	null
CPCT02080281T	HMF004242	HMF004242A	0.79	male	1955	null	Prostate					10283	2018-12-28	Primary	prostate	Yes	Yes	Yes	2019-01-08	2020-02-04	Enzalutamide	Hormonal therapy	2019-04-26	Yes	PR
CPCT02080282T	HMF003806	HMF003806A	0.72	male	1940	2020-04-19	Skin		Melanoma			8923	2019-01-02	Lymph node	Axilla right	No	No	Yes	2019-01-03	2019-12-04	Nivolumab	Immunotherapy	2019-03-19	Yes	SD
CPCT02080283T	HMF004206	HMF004206A	0.51	male	1956	2019-08-24	Colorectum					9256	2019-01-11	Liver	segment 8	Yes	No	Yes	2019-01-21	2019-05-21	Panitumumab	Targeted therapy	2019-04-08	Yes	PR
CPCT02080286T	HMF004095	HMF004095A	0.23	male	1938	2019-10-16	Unknown	CUP	Carcinoma			305	2019-01-16	Liver	Right hemiliver	No	No	null	null	null	null	null	null	null	null
CPCT02080287T	HMF004080	HMF004080A	0.41	male	1946	2019-06-02	Skin		Melanoma			8923	2019-01-21	Lymph node	Left axilla	No	No	Yes	2019-01-31	2019-05-13	Nivolumab	Immunotherapy	null	null	null
CPCT02080288T	HMF004030	HMF004030A	0.24	female	1955	2023-01-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-01-18	Liver	Segment 4	Yes	Yes	Yes	2019-01-24	2020-06-16	Palbociclib/Letrozole	Multiple therapy	2019-03-12	Yes	SD
CPCT02080290T	HMF001982	HMF001982B	0.5	female	1983	2020-03-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-01-25	Bone	Iliac wing right	Yes	Yes	Yes	2019-01-26	2019-03-20	Everolimus/Exemestane	Multiple therapy	2019-03-22	Yes	PD
CPCT02080292T	HMF004140	HMF004140A	0.91	female	1935	2019-11-03	Skin		Carcinoma	Merkel cell carcinoma		3965	2019-02-08	(Sub)cutaneous lesion	Left upper arm	No	Yes	Yes	2019-02-08	2019-06-04	Avelumab	Immunotherapy	2019-04-23	Yes	PD
CPCT02080294T	HMF003922	HMF003922A	0.89	male	1962	2019-10-09	Skin		Melanoma			8923	2019-02-18	Lung	Dorsal in right lower lobe	No	No	Yes	2019-02-19	2019-07-09	Nivolumab/Ipilimumab	Immunotherapy	2019-04-18	Yes	SD
CPCT02080295T	HMF004084	HMF004084A	0.74	female	1941	2020-03-25	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-02-26	Lymph node	Right inguinal lymph node	Yes	No	Yes	2019-02-26	2019-11-05	Pembrolizumab	Immunotherapy	2019-05-15	Yes	SD
CPCT02080296T	HMF003849	HMF003849A	0.59	male	1948	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-25	Lymph node	Axilla left	Yes	No	Yes	2019-03-01	2020-06-30	Palbociclib/Letrozole/Goserelin/Goserelin	Multiple therapy	2019-05-21	Yes	SD
CPCT02080297T	HMF004335	HMF004335A	0.34	male	1947	2020-02-16	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2019-03-07	Liver	Segment 5	No	No	null	null	null	null	null	null	null	null
CPCT02080302T	HMF003947	HMF003947A	0.73	male	1941	2020-08-25	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-04-23	Bone	Sternum left	No	No	Yes	2019-05-07	2019-09-10	Nivolumab/Ipilimumab	Immunotherapy	2019-05-17	Yes	ND
CPCT02080304T	HMF004204	HMF004204A	0.42	female	1935	2020-05-05	Skin		Melanoma			8923	2019-04-26	Lymph node	Iliacal left	No	No	Yes	2019-04-29	2019-09-17	Nivolumab	Immunotherapy	2019-07-15	Yes	PD
CPCT02080307T	HMF003924	HMF003924A	0.5	female	1953	null	Skin		Melanoma			8923	2019-04-30	Lymph node	Neck left	No	No	Yes	2019-05-06	2020-08-04	Nivolumab	Immunotherapy	2019-07-22	Yes	PD
CPCT02080308T	HMF003840	HMF003840A	0.58	male	1953	2020-01-02	Skin		Melanoma			8923	2019-05-14	Adrenal gland	Left adrenal gland	Yes	No	Yes	2019-06-04	2019-07-02	Nivolumab	Immunotherapy	2019-07-17	Yes	PD
CPCT02080311T	HMF003860	HMF003860A	0.72	male	1961	null	Skin		Melanoma			8923	2019-05-29	subcutaneous tissue	Left axilla	Yes	No	Yes	2019-05-14	2020-07-06	Nivolumab	Immunotherapy	2019-08-05	Yes	PD
CPCT02080313T	HMF004125	HMF004125A	0.28	male	1940	2019-10-18	Skin		Melanoma			8923	2019-05-31	Lymph node	Axilla left	No	No	Yes	2019-06-06	2019-08-27	Nivolumab	Immunotherapy	2019-08-29	Yes	PD
CPCT02080314T	HMF003890	HMF003890A	0.76	male	1984	2021-08-08	Skin		Melanoma			8923	2019-05-31	Lymph node	Lymph node station 4R	Yes	Yes	Yes	2019-06-11	2019-10-28	Nivolumab	Immunotherapy	2019-08-26	Yes	SD
CPCT02080315T	HMF004255	HMF004255A	0.63	female	1946	2021-12-07	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-09-05	Bladder	left anterior bladder wall	Yes	No	Yes	2019-09-06	2020-08-05	Pembrolizumab	Immunotherapy	2019-11-20	Yes	CR
CPCT02080317T	HMF005219	HMF005219A	0.39	male	1951	2021-02-09	Pancreas					1793	2020-12-10	Liver	Segment 3	No	No	Yes	2020-12-14	2021-01-08	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	null	null	null
CPCT02080321T	HMF005622	HMF005622A	0.48	male	1956	2022-04-15	Pancreas					1793	2021-04-01	Liver	Segment VI	No	No	Yes	2021-04-09	2021-07-22	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2021-04-16	Yes	ND
CPCT02080322T	HMF005623	HMF005623A	0.28	female	1953	2023-01-04	Pancreas					1793	2021-07-22	Liver	Segment 4/5	No	No	Yes	2021-08-04	2021-12-01	Oxaliplatin/Leucovorin/Fluorouracil/Irinotecan	Multiple therapy	2021-09-29	Yes	PR
CPCT02080323T	HMF005733	HMF005733A	0.44	male	1947	2021-10-13	Pancreas					1793	2021-09-24	Liver	Segment II	No	No	Yes	2021-10-01	2021-10-13	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	null	null	null
CPCT02080326T	HMF006052	HMF006052A	0.64	male	1964	null	Pancreas					1793	2022-03-11	Liver	Liver (not specified)	No	No	Yes	2022-03-21	2022-12-06	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2022-06-08	Yes	PR
CPCT02090002T	HMF002328	HMF002328A	0.73	male	1942	null	Skin		Melanoma			8923	2016-09-12	Lymph node	right flank	No	No	Yes	2016-09-19	2017-08-23	Pembrolizumab	Immunotherapy	2016-12-05	Yes	PR
CPCT02090003T	HMF002979	HMF002979A	0.93	female	1970	2018-02-22	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2016-11-11	lesion ventral of bladder	ventral of bladder	Yes	No	Yes	2016-11-11	2017-12-22	Regorafenib	Targeted therapy	2017-01-26	No	PR
CPCT02090004T	HMF001212	HMF001212A	0.34	female	1963	2017-09-18	Colorectum					9256	2016-11-28	Liver	segment 3	Yes	Yes	Yes	2016-11-28	2017-02-06	Irinotecan	Chemotherapy	2017-01-30	No	PD
CPCT02090005T	HMF002178	HMF002178A	0.93	male	1949	2017-05-06	Skin		Melanoma			8923	2016-12-05	Lymph node	right flank	No	No	Yes	2017-01-26	2017-03-08	Pembrolizumab	Immunotherapy	2017-03-14	Yes	PD
CPCT02090006T	HMF002753	HMF002753A	0.54	male	1958	2018-01-01	Thyroid gland					1781	2017-01-31	Liver	liver right part	Yes	No	Yes	2017-03-09	2017-11-14	Cabozantinib	Targeted therapy	2017-04-12	Yes	SD
CPCT02090011T	HMF001377	HMF001377A	0.73	female	1998	2018-02-12	Bone/Soft tissue	Bone	Osteosarcoma			3376	2017-03-15	Bone	femur left	Yes	No	null	null	null	null	null	null	null	null
CPCT02090012T	HMF002872	HMF002872A	0.6	female	1959	2018-10-10	Bone/Soft tissue	Uterus	Leiomyosarcoma			363,1967,1115	2017-04-11	skin	right flank	Yes	No	Yes	2017-04-28	2017-08-17	Gemcitabine/Docetaxel	Chemotherapy	2017-06-22	Yes	SD
CPCT02090014T	HMF002726	HMF002726A	0.77	female	1966	null	Bone/Soft tissue	Bone	Osteosarcoma			3376	2017-04-24	intramusculaire leasion	m. gluteus medius left	Yes	No	Yes	2017-04-26	2017-06-16	Gemcitabine/Docetaxel	Chemotherapy	null	null	null
CPCT02090018T	HMF001584	HMF001584A	0.57	female	1947	2017-12-22	Ovary					2394	2017-06-20	subcutane left abdominal	left abdominal	Yes	No	Yes	2017-06-23	2017-09-19	Paclitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02090019T	HMF003205	HMF003205A	0.7	female	1953	null	Ovary					2394	2017-07-04	right paracolisch right paracolisch	right paracolisch, caudal from liver	Yes	No	Yes	2017-07-05	2018-04-16	Tamoxifen	Hormonal therapy	2017-09-25	Yes	SD
CPCT02090020T	HMF002534	HMF002534A	0.52	female	1986	2018-07-20	Ovary					2394	2017-07-31	m. rectus abdominus	left	Yes	No	Yes	2017-08-10	2017-09-22	Tim-3 blocker	Targeted therapy	2017-09-29	Yes	PD
CPCT02090021T	HMF000843	HMF000843A	0.69	male	1955	2020-02-07	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-08-08	Kidney	right	No	No	Yes	2017-08-23	2018-12-29	Pazopanib	Targeted therapy	2017-11-24	Yes	SD
CPCT02090026T	HMF000924	HMF000924A	0.31	male	1971	2018-10-14	Stomach		Carcinoma			5517	2017-11-27	Liver	front	Yes	Yes	Yes	2017-11-27	2018-03-08	Paclitaxel/Regorafenib	Multiple therapy	2018-01-19	Yes	PR
CPCT02090027T	HMF002981	HMF002981A	0.25	female	1972	2018-09-07	Pancreas					1793	2017-11-28	Liver	left side	No	No	Yes	2018-01-08	2018-06-11	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2018-02-20	Yes	SD
CPCT02090028T	HMF002942	HMF002942A	0.72	male	1939	2018-01-22	Colorectum					9256	2017-11-28	Liver	right lobe	Yes	Yes	Yes	2017-11-30	2017-11-30	Irinotecan	Chemotherapy	null	null	null
CPCT02090030T	HMF000147	HMF000147A	0.27	female	1956	2018-02-13	Vulva					1245	2017-12-01	Liver	leasion right lobe	No	Yes	Yes	2017-12-08	2017-12-29	Paclitaxel/Carboplatin	Chemotherapy	2018-01-11	No	PD
CPCT02090031T	HMF000488	HMF000488A	0.29	male	1972	null	Pancreas					1793	2017-12-12	Liver	front	No	No	Yes	2018-01-09	2018-07-17	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2018-02-23	Yes	SD
CPCT02090033T	HMF001111	HMF001111A	0.65	male	1948	2018-06-25	Prostate					10283	2018-01-08	Bone	os pubis	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02090034T	HMF002081	HMF002081A	0.76	female	1968	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-08	Bone	left os ilium	Yes	Yes	Yes	2018-01-10	2018-01-14	Capecitabine	Chemotherapy	null	null	null
CPCT02090035T	HMF002040	HMF002040A	0.65	male	1950	null	Skin		Melanoma			8923	2018-01-22	Lymph node	retroperitoneaal	Yes	No	Yes	2018-02-02	2018-04-06	Ipilimumab	Immunotherapy	2018-04-04	Yes	PD
CPCT02090036T	HMF001826	HMF001826A	0.46	female	1997	2018-05-20	Bone/Soft tissue		Angiosarcoma			0001816,1115	2018-04-10	Liver	liver	No	No	Yes	2018-01-23	2018-04-10	Doxorubicin/Ifosfamide/Pazopanib	Multiple therapy	null	null	null
CPCT02090037T	HMF001315	HMF001315A	0.73	male	1951	2018-04-22	Esophagus					5041	2018-01-23	Liver	liver	Yes	Yes	Yes	2018-01-23	2018-04-05	Paclitaxel	Chemotherapy	2018-04-09	Yes	PD
CPCT02090038T	HMF003799	HMF003799A	0.92	male	1975	null	Bone/Soft tissue	Meninges	Solitary fibrous tumor			3565,264,1115	2018-01-26	skin	upper leg left	Yes	Yes	Yes	2018-01-29	2018-10-08	Dacarbazine	Chemotherapy	2018-03-29	Yes	SD
CPCT02090039T	HMF000603	HMF000603A	0.49	male	1945	2018-06-08	Pancreas					1793	2018-02-06	Liver	right lobe	No	No	Yes	2018-02-20	2018-03-05	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	null	null	null
CPCT02090042T	HMF002417	HMF002417A	0.78	male	1947	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-02-19	Peritoneum	right abdomen	No	No	Yes	2018-02-21	null	Imatinib	Targeted therapy	2018-06-28	Yes	PR
CPCT02090043T	HMF000375	HMF000375A	0.83	female	1956	null	Ovary					2394	2018-02-20	vagina	cuff	Yes	No	Yes	2018-02-21	2018-04-20	Carboplatin/Doxorubicin (liposomal)	Chemotherapy	2018-05-04	Yes	PD
CPCT02090044T	HMF001915	HMF001915A	0.38	male	1939	null	Bone/Soft tissue	Skin	Undifferentiated sarcoma	Pleomorphic dermal sarcoma		4159,1115	2018-02-28	Lung	left	No	No	null	null	null	null	null	null	null	null
CPCT02090047T	HMF003150	HMF003150A	0.36	female	1949	null	Pancreas					1793	2018-04-18	Liver	liver	No	No	Yes	2018-05-14	2018-08-20	Fluorouracil/Oxaliplatin/Irinotecan/Leucovorin	Multiple therapy	2018-05-25	Yes	ND
CPCT02090049T	HMF001606	HMF001606A	0.46	male	1957	2018-05-15	Head and neck	Nasal cavity and paranasal sinus			Palatum durum	10811,0050619,11934	2018-04-25	cavum nasi	left	No	Yes	Yes	2018-04-25	2018-05-02	Imatinib	Targeted therapy	null	null	null
CPCT02090052T	HMF000951	HMF000951A	0.97	female	1979	null	Bone/Soft tissue		Mesenchymal chondrosarcoma			4545	2018-05-14	leasion abdomen intra peritoneal	right side	Yes	Yes	Yes	2018-05-21	null	Cyclophosphamide/Sirolimus	Multiple therapy	2018-07-12	Yes	SD
CPCT02090053T	HMF000345	HMF000345A	0.93	male	1999	null	Bone/Soft tissue		Mesenchymal chondrosarcoma			4545	2018-05-15	Lung	leasion	Yes	Yes	Yes	2018-10-29	2019-01-07	Olaratumab/Doxorubicin	Multiple therapy	null	null	null
CPCT02090054T	HMF002209	HMF002209A	0.45	female	1947	2018-07-15	Colorectum	Rectum	Carcinoma			1993,305	2018-05-22	Liver	right lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02090058T	HMF000010	HMF000010A	0.77	male	1956	2018-08-08	Prostate					10283	2018-05-28	Bone	os ilieum	Yes	No	null	null	null	null	null	null	null	null
CPCT02090059T	HMF001520	HMF001520A	0.81	female	1953	2018-08-03	Colorectum					9256	2018-06-05	Liver	liver	Yes	Yes	Yes	2018-06-06	2018-07-07	Trifluridine	Chemotherapy	null	null	null
CPCT02090060T	HMF000636	HMF000636A	0.63	female	1952	2019-03-03	Pancreas					1793	2018-06-19	Liver	liver	No	No	Yes	2018-06-26	2018-12-07	Leucovorin/Oxaliplatin/Fluorouracil	Multiple therapy	2018-08-13	Yes	SD
CPCT02090062T	HMF000251	HMF000251A	0.35	female	1963	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-10-17	Bone	ileum right	Yes	Yes	Yes	2018-11-08	2019-04-08	Capecitabine	Chemotherapy	null	null	null
CPCT02090063T	HMF000013	HMF000013A	0.78	female	1978	null	Bone/Soft tissue		Sarcoma			1115	2018-11-28	Lung	right	Yes	Yes	Yes	2018-11-29	2019-05-17	Pazopanib	Targeted therapy	2019-01-16	Yes	SD
CPCT02090064T	HMF003896	HMF003896A	0.77	male	1992	null	Bone/Soft tissue		Alveolar soft part sarcoma			4239,1115	2019-03-22	Bone	right	Yes	No	Yes	2019-03-27	2019-10-31	Cediranib	Targeted therapy	2019-05-16	Yes	SD
CPCT02090065T	HMF004056	HMF004056A	0.9	male	1956	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2019-04-02	intra abdominal	left upper quadrant	Yes	No	Yes	2019-04-10	2020-08-03	Sunitinib	Targeted therapy	2019-06-26	Yes	SD
CPCT02100001TII	HMF001646	HMF001646C	0.71	female	1949	2018-11-10	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-05-26	Primary	R retro-areolair	Yes	No	Yes	2015-09-28	2016-04-20	Everolimus/Exemestane	Multiple therapy	2015-11-23	Yes	SD
CPCT02100007T	HMF001678	HMF001678A	0.3	female	1957	2017-03-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	null	null	null	null	null	null	null	null	null	null
CPCT02100009T	HMF003595	HMF003595A	0.55	male	1939	2016-12-17	Esophagus					5041	2016-04-01	Primary	Prox stomach carcinoma	No	No	Yes	2016-04-21	2016-12-01	Oxaliplatin/Capecitabine	Chemotherapy	2016-06-16	Yes	PR
CPCT02100011T	HMF003531	HMF003531A	0.3	female	1965	2018-06-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-05-11	Bone	os ileum left	Yes	Yes	Yes	2016-06-06	2016-08-29	Carboplatin/Cyclophosphamide	Chemotherapy	2016-07-25	Yes	SD
CPCT02100013T	HMF000152	HMF000152A	0.79	female	1955	2017-05-13	Colorectum					9256	2016-05-24	Mamma	Left mamma	Yes	Yes	Yes	2016-05-27	2016-11-28	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2016-07-25	Yes	SD
CPCT02100013TII	HMF000152	HMF000152B	0.54	female	1955	2017-05-13	Colorectum					9256	2017-01-24	Breast	Left breast	Yes	Yes	Yes	2016-05-27	2016-11-28	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2016-07-25	Yes	SD
CPCT02100017T	HMF002559	HMF002559A	0.63	female	1947	2016-11-10	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-06-24	subcutaneous	Shoulder left flank	Yes	Yes	Yes	2016-06-27	2016-10-27	Fulvestrant	Hormonal therapy	2016-10-25	Yes	PD
CPCT02100019T	HMF000318	HMF000318A	0.62	male	1949	2017-09-21	Colorectum					9256	2017-04-11	Omentum	mesenterial mass right	Yes	No	Yes	2017-04-24	2017-06-08	Trifluridine	Chemotherapy	2017-06-13	Yes	PD
CPCT02100020T	HMF002391	HMF002391A	0.81	female	1949	2016-07-28	Breast		Carcinoma	Triple negative		0060081	2016-06-27	Lymph node	Supraclaviculair	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02100021T	HMF000228	HMF000228A	0.71	female	1959	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-07-07	Lymph node	Neck left	Yes	Yes	Yes	2016-07-12	2017-10-25	Letrozole	Hormonal therapy	2016-10-10	Yes	SD
CPCT02100023T	HMF000408	HMF000408A	0.51	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-07-15	Liver	Ventral liverlobe	Yes	No	Yes	2016-07-28	2016-11-01	Capecitabine	Chemotherapy	2016-11-29	Yes	PD
CPCT02100024T	HMF001607	HMF001607A	0.6	female	1942	2018-12-11	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-07-15	Lymph node	Right Axilla	Yes	No	Yes	2016-07-19	2016-08-30	Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	2016-09-12	Yes	SD
CPCT02100026T	HMF000969	HMF000969A	0.24	male	1934	2018-03-27	Urothelial tract	Bladder				11054	2016-07-22	Lymph node	Axillair Left	No	No	Yes	2016-08-10	2016-11-30	Carboplatin/Gemcitabine	Chemotherapy	2016-10-06	Yes	PR
CPCT02100027T	HMF001219	HMF001219A	0.28	female	1951	2017-02-18	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-08-02	Lymph node	Neck	Yes	Yes	Yes	2016-08-09	2017-01-10	Trastuzumab	Targeted therapy	2016-09-12	Yes	SD
CPCT02100029T	HMF001157	HMF001157A	0.7	female	1937	2017-01-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-08-26	Liver	Subcapsulair	Yes	Yes	Yes	2016-11-18	2016-12-29	Vinorelbine	Chemotherapy	null	null	null
CPCT02100030T	HMF000242	HMF000242A	0.84	female	1952	2017-05-16	Ovary					2394	2016-09-09	small pelvis	Para iliacal mass left	Yes	No	null	null	null	null	null	null	null	null
CPCT02100032T	HMF002192	HMF002192A	0.37	female	1947	2016-11-04	Esophagus					5041	2016-09-15	Lymph node	Subclaviculair right/ Neck	Yes	Yes	Yes	2016-10-10	2016-10-24	Paclitaxel/Carboplatin	Chemotherapy	2016-11-02	Yes	PD
CPCT02100033T	HMF003350	HMF003350A	0.25	male	1940	2017-12-27	Skin		Melanoma			8923	2016-09-30	Lymph node	supraclaviculair left	No	No	Yes	2016-10-31	2017-03-22	Nivolumab	Immunotherapy	2017-01-18	Yes	PD
CPCT02100035T	HMF000381	HMF000381A	0.26	female	1936	2018-01-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-10-31	Lymph node	Supraclaviculair right	No	No	Yes	2016-11-08	2017-07-05	Anastrozole	Hormonal therapy	2017-01-24	Yes	PD
CPCT02100036T	HMF001210	HMF001210A	0.26	male	1959	2017-11-09	Colorectum					9256	2017-01-24	Peritoneum	caudal from spleen in peritoneum	Yes	No	Yes	2017-02-06	2017-03-21	Trifluridine	Chemotherapy	2017-03-31	Yes	PD
CPCT02100037T	HMF001860	HMF001860A	0.52	female	1953	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-09	Lymph node	Neck right	No	No	Yes	2016-11-14	2019-04-24	Letrozole	Hormonal therapy	2017-01-30	Yes	PR
CPCT02100039T	HMF001798	HMF001798A	0.67	male	1944	2017-05-02	Unknown	CUP	Carcinoma			305	2016-11-11	Liver	Right liverlobe	No	No	Yes	2016-11-23	2017-03-08	Paclitaxel/Carboplatin/Etoposide	Chemotherapy	2017-02-06	Yes	SD
CPCT02100041T	HMF003756	HMF003756A	0.61	male	1951	2019-06-28	Prostate					10283	2016-11-30	Lymph node	Obturator right	Yes	No	Yes	2016-12-01	2017-09-25	Enzalutamide	Hormonal therapy	2017-01-10	Yes	PR
CPCT02100042T	HMF001388	HMF001388A	0.69	male	1956	null	Colorectum					9256	2016-11-29	Liver	Caudal right	Yes	No	null	null	null	null	null	null	null	null
CPCT02100043T	HMF002201	HMF002201A	0.64	female	1955	2022-02-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-30	Musculus Pectoralis Major	Right lesion	Yes	Yes	Yes	2016-12-12	2018-05-08	Palbociclib/Fulvestrant	Multiple therapy	2017-02-17	Yes	SD
CPCT02100044T	HMF003091	HMF003091A	0.34	male	1956	2017-07-18	Esophagus					5041	2016-12-05	Lymph node	Left Axillair	No	No	Yes	2016-12-14	2017-04-05	Carboplatin/Paclitaxel	Chemotherapy	null	null	null
CPCT02100048T	HMF001430	HMF001430A	0.47	female	1950	null	Breast		Carcinoma	Triple negative		0060081	2016-12-16	Lymph node	Axillair right	No	No	Yes	2016-12-29	2017-06-06	Paclitaxel	Chemotherapy	2017-03-01	Yes	SD
CPCT02100049T	HMF002589	HMF002589A	0.72	female	1963	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-12-12	Liver	Lesion	Yes	Yes	Yes	2016-12-20	2017-11-17	Paclitaxel/Trastuzumab/Pertuzumab/Letrozole	Multiple therapy	2017-02-16	Yes	SD
CPCT02100050T	HMF003264	HMF003264A	0.79	female	1962	2017-07-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-21	Lymph node	Right axillair	Yes	No	Yes	2017-02-15	2017-05-02	Palbociclib/Fulvestrant	Multiple therapy	2017-05-04	Yes	PD
CPCT02100051T	HMF003417	HMF003417A	0.69	female	1958	2018-08-01	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-20	mediastinale mass	Mediastinale mass	Yes	No	Yes	2017-02-03	2017-03-27	Vinorelbine	Chemotherapy	2017-04-03	Yes	Clinical progression
CPCT02100056T	HMF002898	HMF002898A	0.22	male	1969	null	Stomach					10534	2017-02-01	Bone	Subclaviculair left	Yes	Yes	Yes	2017-02-08	2017-06-14	Paclitaxel/Ramucirumab	Multiple therapy	2017-04-03	Yes	PR
CPCT02100057T	HMF002703	HMF002703A	0.76	female	1932	2019-03-04	Colorectum					9256	2017-02-15	small pelvic	Small pelvic	Yes	No	Yes	2017-02-24	2017-04-11	Panitumumab	Targeted therapy	2017-04-19	Yes	SD
CPCT02100058T	HMF002619	HMF002619A	0.58	male	1951	null	Colorectum	Colon sigmoideum				12192	2017-02-22	Lymph node	Axillary left	Yes	No	Yes	2017-03-15	2017-08-24	Oxaliplatin/Fluorouracil	Chemotherapy	2017-05-04	Yes	SD
CPCT02100061T	HMF003173	HMF003173A	0.55	male	1943	null	Gastroesophageal	Esophago-gastric junction				0080374	2017-03-03	Liver	Ventral segment 4B	No	No	Yes	2017-03-23	null	Oxaliplatin/Trastuzumab/Capecitabine	Multiple therapy	2017-05-22	Yes	PR
CPCT02100064T	HMF003778	HMF003778A	0.2	female	1940	2017-08-10	Esophagus					5041	2017-03-23	Cutane metastasis abdomen	Left flank	Yes	No	Yes	2017-04-07	2017-05-19	Carboplatin/Paclitaxel	Chemotherapy	2017-05-29	Yes	SD
CPCT02100066T	HMF002329	HMF002329A	0.63	female	1948	2021-11-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-04-10	Lymph node	Axilla left	Yes	Yes	Yes	2017-05-08	2019-04-03	Palbociclib/Fulvestrant	Multiple therapy	2017-06-29	Yes	SD
CPCT02100067T	HMF001145	HMF001145A	0.7	female	1950	2017-10-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-04-11	Liver	Liver right central	Yes	No	Yes	2017-04-19	2017-06-14	Exemestane/Everolimus	Multiple therapy	2017-06-13	Yes	PD
CPCT02100067TII	HMF001145	HMF001145B	0.62	female	1950	2017-10-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-18	Liver	Segment VIII	Yes	No	Yes	2017-04-19	2017-06-14	Exemestane/Everolimus	Multiple therapy	2017-06-13	Yes	PD
CPCT02100072T	HMF002704	HMF002704A	0.3	male	1955	null	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2017-05-19	Liver	Segment 7 + 8	No	No	Yes	2017-05-23	2017-09-19	Carboplatin/Gemcitabine	Chemotherapy	2017-07-14	Yes	SD
CPCT02100074T	HMF001935	HMF001935A	0.62	female	1946	2017-06-11	Unknown	CUP	Carcinoma			305	2017-05-16	omentum	Right lower abomen	No	No	null	null	null	null	null	null	null	null
CPCT02100075T	HMF003227	HMF003227A	0.31	female	1965	2018-03-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-17	Primary	Lateral lower quadrant	No	No	Yes	2017-05-19	2017-10-01	Tamoxifen/Leuprorelin	Multiple therapy	2017-08-21	Yes	PD
CPCT02100076T	HMF003083	HMF003083A	0.62	male	1951	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-04-26	Lymph node	Left inguinalis	Yes	Yes	Yes	2017-05-24	2017-08-16	Carboplatin/Gemcitabine	Chemotherapy	2017-07-27	Yes	SD
CPCT02100077T	HMF002041	HMF002041A	0.2	male	1952	2017-06-18	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-05-29	Liver	right liver lobe lateral	No	No	null	null	null	null	null	null	null	null
CPCT02100079T	HMF003562	HMF003562A	0.59	female	1952	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-30	Liver	Liver metastasis	Yes	Yes	Yes	2017-06-15	2017-07-27	Docetaxel	Chemotherapy	2017-08-08	Yes	PR
CPCT02100081T	HMF003793	HMF003793A	0.71	male	1943	2017-09-01	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-05-30	mass Brain	Temporal left	No	No	null	null	null	null	null	null	null	null
CPCT02100084T	HMF002335	HMF002335A	0.96	male	1949	2018-01-21	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-05-31	Brain	supratentiorieel left	No	No	Yes	2017-07-10	2017-10-27	Temozolomide	Chemotherapy	null	null	null
CPCT02100085T	HMF001333	HMF001333A	0.64	female	1957	2017-08-31	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-06-06	Primary	Brain left temporal	No	No	null	null	null	null	null	null	null	null
CPCT02100086T	HMF003029	HMF003029A	0.65	male	1953	null	Colorectum					9256	2017-06-13	Lymph node	Iliacal right	Yes	No	Yes	2017-06-19	2017-09-27	Fluorouracil/Oxaliplatin	Chemotherapy	2017-08-07	Yes	SD
CPCT02100089T	HMF003015	HMF003015A	0.73	male	1964	null	Nervous system		Glioma	Oligodendroglioma	Low-grade	3181	2017-06-23	Primary	Supratentorial left	No	No	null	null	null	null	null	null	null	null
CPCT02100090T	HMF003517	HMF003517A	0.7	male	1954	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-06-26	Primary	suprotentorial right	No	No	Yes	2017-07-25	2017-11-25	Temozolomide	Chemotherapy	null	null	null
CPCT02100091T	HMF000977	HMF000977B	0.72	female	1972	2018-07-02	Bone/Soft tissue		Leiomyosarcoma			1967,1115	2017-06-30	subcutaneous leiomyosarcoma occipital	metastasis	No	No	Yes	2017-07-04	2017-11-01	Letrozole	Hormonal therapy	2017-10-30	Yes	PD
CPCT02100092T	HMF001338	HMF001338A	0.88	male	1967	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-06-30	Primary	Supratentorial left	No	No	Yes	2017-08-07	2018-03-10	Temozolomide	Chemotherapy	null	null	null
CPCT02100093T	HMF000239	HMF000239A	0.71	female	1938	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-04	subcuteanous	at the level of the processus xiphoideus	Yes	Yes	Yes	2017-07-11	2017-10-03	Letrozole	Hormonal therapy	2017-08-09	Yes	Clinical progression
CPCT02100094T	HMF001602	HMF001602A	0.69	female	1957	null	Nervous system		Glioma	Astrocytoma	Low-grade	3069	2017-07-04	Primary	Supratentiorial right	No	No	Yes	2017-08-08	2018-03-05	Temozolomide	Chemotherapy	null	null	null
CPCT02100098T	HMF000420	HMF000420A	0.65	male	1951	2017-09-07	Esophagus					5041	2017-07-13	Lymph node	lymph node neck	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02100101T	HMF001910	HMF001910A	0.93	female	1998	2018-03-23	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-07-21	Primary	brain supratentiorial right	No	No	Yes	2017-08-28	2018-01-12	Temozolomide	Chemotherapy	null	null	null
CPCT02100102T	HMF000184	HMF000184A	0.43	female	1950	2021-01-16	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-26	Liver	lesion left lever	Yes	Yes	Yes	2017-08-06	2019-10-29	Palbociclib/Tamoxifen	Multiple therapy	2017-10-09	Yes	SD
CPCT02100104T	HMF003049	HMF003049A	0.83	female	1981	2020-08-17	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-23	Primary	Cranial Right mamma	Yes	Yes	Yes	2017-08-28	2019-03-21	Capecitabine	Chemotherapy	2017-10-24	Yes	SD
CPCT02100105T	HMF003473	HMF003473A	0.79	female	1964	2020-05-10	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-22	Bone	Frontal subcutis	Yes	No	Yes	2017-08-29	2017-11-24	Letrozole	Hormonal therapy	2017-11-20	Yes	PD
CPCT02100106T	HMF002549	HMF002549A	0.54	male	1953	2017-11-13	Colorectum					9256	2017-08-29	Omentum	Left ventral	Yes	No	Yes	2017-10-02	2017-11-13	Trifluridine	Chemotherapy	null	null	null
CPCT02100107T	HMF002113	HMF002113A	0.7	male	1954	2018-02-20	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-09-04	Bone	os pubic right	No	No	Yes	2017-10-05	2018-01-18	Sunitinib	Targeted therapy	2017-11-10	Yes	SD
CPCT02100108T	HMF003232	HMF003232A	0.9	male	1979	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-09-04	Primary	Supratentorial left	No	No	null	null	null	null	null	null	null	null
CPCT02100110T	HMF002122	HMF002122A	0.73	female	1962	2018-09-01	Breast		Carcinoma	Triple negative		0060081	2017-09-19	Liver	lobe	Yes	No	Yes	2017-09-20	2018-02-05	Carboplatin	Chemotherapy	null	null	null
CPCT02100112T	HMF002670	HMF002670A	0.42	female	1940	2020-02-08	Ovary					2394	2017-09-25	intra-abdominal	mass omentum paramedian left	Yes	No	Yes	2017-10-10	2019-05-17	Carboplatin/Gemcitabine/Bevacizumab	Multiple therapy	2017-12-14	Yes	PR
CPCT02100115T	HMF000255	HMF000255A	0.95	female	1969	2019-01-10	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-28	Abdominal wall cutaneous	skin abdomen	Yes	No	Yes	2017-10-05	2018-09-09	Capecitabine	Chemotherapy	2017-11-30	Yes	PR
CPCT02100116T	HMF000655	HMF000655A	0.59	female	1960	2018-03-07	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-09-25	Primary	supratentorial right	Yes	Yes	Yes	2017-10-30	2017-12-29	Temozolomide	Chemotherapy	null	null	null
CPCT02100119T	HMF002648	HMF002648A	0.45	female	1942	2022-12-17	Ovary					2394	2017-10-12	Peritoneum	omentum	Yes	No	Yes	2017-10-26	2020-12-24	Bevacizumab/Carboplatin/Gemcitabine	Multiple therapy	2017-12-18	Yes	PR
CPCT02100120T	HMF002696	HMF002696A	0.63	female	1941	2018-05-24	Colorectum					9256	2017-10-10	Lymph node	Mesenterial/ colon transversum	No	No	null	null	null	null	null	null	null	null
CPCT02100121T	HMF002784	HMF002784A	0.76	female	1957	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-10-06	Primary	supratentorial right temporal	No	No	Yes	2017-11-14	2018-06-01	Temozolomide	Chemotherapy	null	null	null
CPCT02100127T	HMF001975	HMF001975A	0.76	female	1950	2018-01-30	Esophagus					5041	2017-11-09	Liver	ventral	No	No	Yes	2017-11-23	2018-01-24	Capecitabine/Oxaliplatin/Trastuzumab/Fluorouracil/Leucovorin	Multiple therapy	2018-01-17	Yes	PR
CPCT02100130T	HMF003468	HMF003468A	0.44	male	1948	2017-12-01	Colorectum					9256	2017-11-14	Liver	left liverlobe	No	No	null	null	null	null	null	null	null	null
CPCT02100131T	HMF003634	HMF003634A	0.85	female	1946	null	Colorectum					9256	2017-11-17	Liver	left liver lobe	Yes	No	Yes	2017-11-21	2017-12-04	Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2017-12-15	Yes	PD
CPCT02100132T	HMF003303	HMF003303A	0.85	female	1959	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-20	Lymph node	Axillair right	Yes	Yes	Yes	2017-11-20	2018-02-01	Vinorelbine	Chemotherapy	2018-02-08	Yes	PD
CPCT02100133T	HMF003256	HMF003256A	0.56	female	1948	null	Esophagus					5041	2017-11-22	Liver	left liverlobe ventral	No	No	null	null	null	null	null	null	null	null
CPCT02100135T	HMF000120	HMF000120A	0.4	female	1956	2018-04-25	Pancreas					1793	2017-11-27	Primary	pancreas	No	No	Yes	2017-12-20	2017-12-20	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	null	null	null
CPCT02100137T	HMF000238	HMF000238A	0.93	male	1959	null	Prostate					10283	2017-11-29	Lymph node	mass small pelvis	No	No	Yes	2018-02-13	2020-06-02	Docetaxel/Darolutamide	Multiple therapy	2018-06-20	Yes	PR
CPCT02100140T	HMF002772	HMF002772A	0.38	female	1949	2018-02-04	Esophagus					5041	2017-12-15	Lymph node	paratracheal right	No	No	Yes	2017-12-22	2018-01-12	Capecitabine/Oxaliplatin/Trastuzumab	Multiple therapy	2018-01-29	Yes	PR
CPCT02100141T	HMF001847	HMF001847A	0.53	male	1955	2018-08-15	Esophagus					5041	2017-12-19	Lymph node	left neck	No	No	Yes	2017-12-22	2018-01-04	Capecitabine/Oxaliplatin	Chemotherapy	null	null	null
CPCT02100144T	HMF001131	HMF001131B	0.39	female	1963	2018-07-31	Colorectum					9256	2018-01-12	Liver	metastasis segm 03-04	Yes	No	Yes	2018-01-22	2018-04-11	Trifluridine	Chemotherapy	2018-04-05	Yes	PD
CPCT02100145T	HMF001278	HMF001278A	0.31	male	1947	2018-05-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-17	Primary	left dorsobasal	Yes	Yes	Yes	2018-02-15	2018-03-26	Docetaxel	Chemotherapy	2018-03-22	Yes	PD
CPCT02100149T	HMF002459	HMF002459A	0.31	female	1944	2018-10-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-02-14	Bone	os ilium right	Yes	Yes	Yes	2018-03-09	2018-09-21	Pembrolizumab	Immunotherapy	2018-07-26	Yes	PD
CPCT02100151T	HMF003157	HMF003157A	0.86	male	1960	2019-07-26	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-01-29	brain	glioma supratentorial resection	No	No	Yes	2018-03-05	2019-01-06	Temozolomide	Chemotherapy	null	null	null
CPCT02100152T	HMF002598	HMF002598A	0.8	female	1942	2020-07-04	Ovary					2394	2018-02-01	omentum	metastasis	Yes	No	Yes	2018-02-13	2019-06-04	Bevacizumab/Carboplatin/Gemcitabine	Multiple therapy	2018-04-04	Yes	CR
CPCT02100156T	HMF000681	HMF000681A	0.24	female	1967	2018-04-17	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-02-12	Bone	left dorsal of the shoulder blade	No	No	Yes	2018-02-27	2018-04-11	Pembrolizumab	Immunotherapy	2018-03-20	Yes	PD
CPCT02100157T	HMF003321	HMF003321B	0.8	female	1947	2019-02-11	Vagina		Carcinoma	Squamous cell carcinoma		0050918,1749	2018-02-06	vagina	squamous cell carcinoma	No	No	Yes	2018-02-07	2018-06-11	Paclitaxel/Carboplatin	Chemotherapy	2018-04-05	Yes	PR
CPCT02100159T	HMF001331	HMF001331A	0.74	male	1973	2019-06-30	Nervous system		Glioma	Glioblastoma multiforme		3068	2018-02-06	brain	right in temporal point	No	No	Yes	2018-03-12	2018-11-09	Temozolomide	Chemotherapy	null	null	null
CPCT02100161T	HMF000373	HMF000373A	0.84	male	1956	2019-06-16	Bone/Soft tissue		Sarcoma			1115	2018-03-09	Bone	hemipelvis left	No	Yes	Yes	2018-03-14	2018-04-12	Pazopanib	Targeted therapy	null	null	null
CPCT02100163T	HMF000426	HMF000426A	0.51	male	1944	2019-06-17	Esophagus					5041	2018-02-23	Liver	metastasis	No	No	Yes	2018-03-07	2018-09-11	Capecitabine/Oxaliplatin/Trastuzumab	Multiple therapy	2018-06-07	Yes	SD
CPCT02100164T	HMF003800	HMF003800A	0.53	female	1959	2019-04-25	Breast		Carcinoma	Triple negative		0060081	2018-03-02	Liver	lesion left liverlob	Yes	Yes	Yes	2018-03-09	2018-07-16	Capecitabine	Chemotherapy	2018-05-14	Yes	SD
CPCT02100165T	HMF003727	HMF003727A	0.49	female	1965	2020-04-09	Colorectum					9256	2018-03-06	skin	subcutaneous abdominal wall	Yes	No	Yes	2018-03-09	2018-12-27	Bevacizumab/Capecitabine	Multiple therapy	2018-05-03	Yes	SD
CPCT02100166T	HMF003433	HMF003433A	0.34	male	1954	2018-08-28	Nervous system		Glioma	Anaplastic astrocytoma-like glioma		3070	2018-03-01	brain	supratentorial	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02100170T	HMF002721	HMF002721A	0.48	female	1955	2018-08-31	Breast		Carcinoma	Triple negative		0060081	2018-03-06	Lymph node	axillar	Yes	Yes	Yes	2018-03-16	2018-06-27	Capecitabine	Chemotherapy	null	null	null
CPCT02100172T	HMF002623	HMF002623A	0.2	male	1966	2018-04-03	Bile duct		Carcinoma			4947	2018-03-13	Liver	mass left liverlob	No	No	null	null	null	null	null	null	null	null
CPCT02100173T	HMF000813	HMF000813A	0.32	male	1958	2018-05-07	Colorectum					9256	2018-03-14	omentum	omentum	No	No	null	null	null	null	null	null	null	null
CPCT02100176T	HMF003095	HMF003095A	0.64	female	1950	2018-08-05	Esophagus					5041	2018-03-28	Liver	metastasis adenocarcinoma	Yes	Yes	Yes	2018-04-19	2018-07-13	Capecitabine/Oxaliplatin/Fluorouracil	Chemotherapy	2018-07-11	Yes	PD
CPCT02100182T	HMF001538	HMF001538A	0.25	male	1959	2018-11-14	Colorectum					9256	2018-06-08	Liver	segment 2	No	No	Yes	2018-06-13	2018-08-23	Capecitabine/Bevacizumab/Oxaliplatin/Irinotecan	Multiple therapy	2018-09-05	Yes	SD
CPCT02100184T	HMF001793	HMF001793A	0.39	female	1945	2018-11-01	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-12	Bone	Thoracic VIII (soft tissue)	No	Yes	Yes	2018-06-15	2018-07-21	Gemcitabine/Cisplatin/Carboplatin	Chemotherapy	2018-07-27	Yes	PD
CPCT02100186T	HMF001115	HMF001115A	0.38	male	1951	2018-12-19	Esophagus					5041	2018-07-04	Liver	liver	Yes	Yes	Yes	2018-07-27	2018-11-28	Carboplatin/Paclitaxel	Chemotherapy	2018-09-25	Yes	SD
CPCT02100187T	HMF002368	HMF002368A	0.49	female	1973	2020-01-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-26	Liver	mild omental thickening ventromedial of the left liver lobe	Yes	Yes	Yes	2018-07-06	2018-10-05	Palbociclib/Tamoxifen	Multiple therapy	2018-10-02	Yes	PD
CPCT02100188T	HMF002767	HMF002767A	0.28	female	1942	null	null	null	null	null	null	null	2018-09-06	Liver	metastasis	No	No	Yes	2018-11-05	null	Lanreotide	Hormonal therapy	null	null	null
CPCT02100189T	HMF003764	HMF003764A	0.91	male	1961	2019-03-27	Prostate					10283	2018-09-18	Liver	segment 6	Yes	No	Yes	2018-10-01	2019-02-11	Carboplatin/Etoposide	Chemotherapy	2018-12-20	Yes	PR
CPCT02100190T	HMF001464	HMF001464A	0.67	male	1952	2018-10-30	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-09-25	pectoralis	metastases	No	No	Yes	2018-10-02	2018-10-15	Sunitinib	Targeted therapy	null	null	null
CPCT02100194T	HMF004387	HMF004387A	0.2	male	1953	2020-01-15	Prostate					10283	2019-01-30	Lymph node	Right inguinal	Yes	No	Yes	2019-02-07	2019-08-23	Enzalutamide	Hormonal therapy	2019-04-24	Yes	SD
CPCT02100195T	HMF004062	HMF004062A	0.49	female	1956	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-04	mammae	Lesion	Yes	Yes	Yes	2019-02-18	null	Fulvestrant/Palbociclib	Multiple therapy	2019-05-09	Yes	SD
CPCT02100200T	HMF004179	HMF004179A	0.44	female	1940	2019-12-25	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-05-10	Mamma/axilla	left	Yes	Yes	Yes	2019-07-30	2019-10-10	Nivolumab	Immunotherapy	2019-10-18	Yes	PD
CPCT02100203T	HMF003923	HMF003923A	0.44	male	1951	2021-01-08	Prostate					10283	2019-08-30	Lymph node	neck gland left supraclavicular	Yes	No	Yes	2019-09-05	2020-02-18	Enzalutamide	Hormonal therapy	2019-11-19	Yes	PR
CPCT02100205T	HMF005023	HMF005023A	0.59	male	1944	2020-10-18	Pancreas					1793	2020-07-17	Liver	metastasis segm 4	No	No	Yes	2020-07-22	2020-08-03	Fluorouracil/Oxaliplatin/Irinotecan/Leucovorin	Multiple therapy	2020-08-18	Yes	PD
CPCT02100206T	HMF005624	HMF005624A	0.43	male	1966	2022-01-17	Pancreas					1793	2021-06-25	Liver	lesion segment 4	No	No	Yes	2021-07-14	2021-09-29	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2021-09-10	Yes	SD
CPCT02100207T	HMF005625	HMF005625A	0.31	female	1974	2021-08-17	Pancreas					1793	2021-07-09	Lymph node	axilla left	No	No	Yes	2021-07-14	2021-08-06	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	null	null	null
CPCT02100209T	HMF006003	HMF006003A	0.31	female	1955	2022-06-28	Pancreas					1793	2022-01-28	Lymph node	supraclavicular left	No	No	Yes	2022-02-23	2022-04-06	Irinotecan/Oxaliplatin/Fluorouracil/Leucovorin	Multiple therapy	2022-04-14	Yes	PD
CPCT02110002T	HMF001372	HMF001372A	0.62	male	1967	2016-11-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-05-17	Lymph node	chest	No	No	Yes	2016-09-09	2016-09-30	Pemetrexed/Cisplatin	Chemotherapy	2016-10-18	Yes	PD
CPCT02110003T	HMF003782	HMF003782A	0.27	female	1961	2018-07-25	Colorectum					9256	2016-06-16	Lymph node	supraclavicular lymphnode	No	No	Yes	2016-06-17	2016-10-13	Capecitabine/Bevacizumab	Multiple therapy	2016-08-12	Yes	SD
CPCT02110004T	HMF003720	HMF003720A	0.36	female	1978	2020-06-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-06-21	Bone	vertebrae L5	Yes	Yes	Yes	2016-06-22	2018-10-10	Anastrozole/Leuprorelin/Tamoxifen	Multiple therapy	2016-07-21	Yes	SD
CPCT02110007T	HMF002068	HMF002068A	0.61	male	1938	2017-11-28	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-08-11	Primary	R kidney	No	No	Yes	2016-08-18	2017-07-12	Pazopanib	Targeted therapy	2016-10-25	Yes	SD
CPCT02110008T	HMF002239	HMF002239A	0.8	male	1948	2017-04-26	Colorectum	Colon ascendens				218	2016-08-19	Primary	colon ascendens	No	No	Yes	2016-09-22	2017-04-06	Oxaliplatin/Fluorouracil/Leucovorin/Bevacizumab	Multiple therapy	2016-11-08	Yes	Clinical progression
CPCT02110010T	HMF000893	HMF000893A	0.92	female	1952	2017-07-14	Lung		Carcinoma	Small cell carcinoma		5409	2016-09-23	Liver	NOS	No	No	Yes	2016-10-01	2016-12-15	Etoposide/Cisplatin	Chemotherapy	2016-11-14	Yes	PR
CPCT02110011T	HMF000098	HMF000098A	0.29	female	1940	2017-04-16	Colorectum					9256	2016-10-03	Primary	coecum	No	No	Yes	2016-10-31	2017-02-02	Capecitabine	Chemotherapy	2017-02-02	Yes	PD
CPCT02110012T	HMF000067	HMF000067A	0.22	female	1959	2019-06-27	Colorectum					9256	2016-10-12	Primary	sigmoid	No	No	Yes	2017-05-30	2017-11-15	Fluorouracil/Leucovorin/Bevacizumab/Oxaliplatin	Multiple therapy	null	null	null
CPCT02110015T	HMF000258	HMF000258A	0.53	male	1949	2017-10-30	Lung		Carcinoma	Small cell carcinoma		5409	2017-01-31	Liver	not specified	No	No	Yes	2017-02-08	2017-05-26	Cisplatin/Etoposide/Carboplatin	Chemotherapy	2017-03-17	Yes	PR
CPCT02110016T	HMF003018	HMF003018A	0.22	female	1958	2018-08-21	Ovary					2394	2017-02-16	Liver	Right lobe	No	No	Yes	2017-03-10	2017-09-15	Carboplatin/Paclitaxel	Chemotherapy	2017-04-14	Yes	PR
CPCT02110017T	HMF001857	HMF001857A	0.25	male	1957	2017-11-01	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-02-16	Liver	left lobe	No	No	Yes	2017-04-01	2017-07-01	Cisplatin/Pemetrexed	Chemotherapy	2017-05-18	Yes	SD
CPCT02110018T	HMF003214	HMF003214A	0.26	male	1962	2017-03-10	Esophagus					5041	2017-02-24	Liver	left lobe	No	No	Yes	2017-03-07	2017-03-08	Oxaliplatin/Fluorouracil	Chemotherapy	null	null	null
CPCT02110020T	HMF003460	HMF003460A	0.71	female	1956	2019-05-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-08	Primary	mamma left	Yes	Yes	Yes	2017-05-31	2018-12-21	Palbociclib/Fulvestrant	Multiple therapy	2018-10-26	Yes	PD
CPCT02110023T	HMF000583	HMF000583A	0.45	female	1939	2019-03-15	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-03-31	Liver	segment VI	No	No	Yes	2017-04-20	2019-01-23	Docetaxel/Pertuzumab/Trastuzumab/Anastrozole	Multiple therapy	2017-08-23	Yes	PR
CPCT02110024T	HMF002773	HMF002773A	0.6	female	1962	2017-07-31	Skin		Melanoma			8923	2017-04-05	Adrenal gland	R. adrenal	No	No	Yes	2017-04-15	null	Dabrafenib/Trametinib	Targeted therapy	null	null	null
CPCT02110028T	HMF002831	HMF002831A	0.47	female	1975	2017-10-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-04-13	soft tissue mass near sternum	pre-sternal	Yes	Yes	Yes	2017-05-10	2017-08-23	Carboplatin	Chemotherapy	2017-06-20	Yes	PD
CPCT02110029T	HMF001535	HMF001535A	0.53	female	1980	2019-01-23	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-04-14	Liver	central segm II	Yes	Yes	Yes	2017-04-26	2018-01-08	Docetaxel/Pertuzumab/Trastuzumab/Anastrozole/Goserelin	Multiple therapy	2017-06-20	Yes	PR
CPCT02110030T	HMF002364	HMF002364A	0.36	female	1966	2017-05-16	Breast		Carcinoma	Triple negative		0060081	2017-04-21	Lymph node	supraclavicular Left	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02110032T	HMF001803	HMF001803A	0.43	female	1958	2018-09-09	Esophagus					5041	2017-05-30	Lymph node	supraclavicular	No	No	Yes	2017-06-01	2017-12-04	Oxaliplatin/Capecitabine	Chemotherapy	2017-08-03	Yes	SD
CPCT02110033T	HMF000398	HMF000398A	0.85	male	1971	2017-07-01	Colorectum					9256	2017-06-06	Liver	segment IVb	Yes	No	null	null	null	null	null	null	null	null
CPCT02110035T	HMF002533	HMF002533A	0.89	male	1959	2023-04-17	Pancreas		Neuroendocrine tumor			1793,169	2017-06-09	Liver	segment 6	No	No	Yes	2017-07-15	null	Lanreotide	Hormonal therapy	null	null	null
CPCT02110036T	HMF000368	HMF000368B	0.92	male	1953	2019-01-06	Bone/Soft tissue		Ewing sarcoma			3369	2017-06-14	Muscle	M. erector spinae L.	No	No	Yes	2017-06-27	2018-01-10	Etoposide/Doxorubicin/Ifosfamide/Vincristine/Dactinomycin	Chemotherapy	2017-08-29	Yes	SD
CPCT02110039T	HMF001497	HMF001497A	0.85	female	1955	2017-08-26	Anus					14110	2017-06-27	Liver	R. Lobe	Yes	Yes	Yes	2017-08-01	2017-08-15	Paclitaxel	Chemotherapy	2017-08-24	Yes	PD
CPCT02110041T	HMF002924	HMF002924A	0.53	male	1950	2018-09-12	Urothelial tract	Bladder				11054	2017-07-27	Lymph node	left groin	No	No	Yes	2017-07-31	2017-11-06	Gemcitabine/Cisplatin	Chemotherapy	2017-09-21	Yes	PR
CPCT02110042T	HMF001698	HMF001698A	0.67	female	1973	2019-05-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-03	Liver	R lobe	Yes	Yes	Yes	2017-08-10	2018-03-22	Paclitaxel	Chemotherapy	2017-11-22	Yes	PR
CPCT02110046T	HMF001723	HMF001723A	0.72	female	1976	null	Colorectum					9256	2017-10-16	Liver	segment 7	Yes	No	null	null	null	null	null	null	null	null
CPCT02110047T	HMF002984	HMF002984A	0.58	female	1972	2018-01-02	Unknown	CUP	Carcinoma			305	2017-11-06	Liver	R lobe	No	No	Yes	2017-11-15	2017-12-13	Fluorouracil/Oxaliplatin/Leucovorin	Multiple therapy	2017-12-15	No	Clinical progression
CPCT02110049T	HMF002878	HMF002878A	0.41	female	1958	2019-04-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-14	Liver	segment 4	Yes	No	null	null	null	null	null	null	null	null
CPCT02110050T	HMF000984	HMF000984B	0.79	female	1960	2018-06-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-20	Liver	Right lobe	Yes	Yes	Yes	2018-01-04	2018-03-14	Vinorelbine	Chemotherapy	2018-03-21	Yes	PD
CPCT02110056T	HMF001172	HMF001172A	0.56	female	1959	2018-03-04	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-18	skin	R shoulder	Yes	Yes	Yes	2018-02-06	2018-02-12	Vinorelbine	Chemotherapy	2018-02-20	Yes	PD
CPCT02110057T	HMF003034	HMF003034A	0.58	female	1964	2019-04-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-23	Liver	segment 8	Yes	Yes	Yes	2018-01-24	2018-02-22	Vinorelbine	Chemotherapy	2018-02-23	Yes	PD
CPCT02110059T	HMF001104	HMF001104A	0.26	male	1960	2018-11-16	Colorectum					9256	2018-02-05	Liver	R lobe	Yes	No	Yes	2018-02-09	2018-03-23	Irinotecan	Chemotherapy	2018-03-21	Yes	SD
CPCT02110060T	HMF001197	HMF001197A	0.32	female	1969	2018-04-16	Pancreas					1793	2018-02-05	Liver	segment IV	Yes	No	null	null	null	null	null	null	null	null
CPCT02110061T	HMF001858	HMF001858A	0.94	male	1955	2020-04-05	Esophagus					5041	2018-02-07	Liver	liver NOS	No	Yes	Yes	2018-02-09	2018-08-05	Fluorouracil/Oxaliplatin	Chemotherapy	2018-03-28	Yes	SD
CPCT02110062T	HMF001522	HMF001522A	0.55	female	1946	2019-04-10	Colorectum					9256	2018-02-12	Liver	not specified	Yes	Yes	Yes	2018-04-16	2019-01-07	Panitumumab	Targeted therapy	2018-07-02	Yes	PR
CPCT02110063T	HMF001690	HMF001690A	0.41	female	1961	2020-12-28	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-13	Bone	L5, lumbal corpus	Yes	No	Yes	2018-02-21	2018-11-02	Fulvestrant/Palbociclib	Multiple therapy	2018-06-06	No	SD
CPCT02110064T	HMF000303	HMF000303A	0.22	male	1943	2018-08-04	Colorectum					9256	2018-02-15	Liver	left lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02110069T	HMF002569	HMF002569A	0.39	female	1949	2020-02-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-20	Liver	R lobe	Yes	Yes	Yes	2018-04-01	2018-09-26	Capecitabine	Chemotherapy	2018-06-06	Yes	PD
CPCT02110071T	HMF001429	HMF001429A	0.64	male	1956	2018-10-22	Colorectum	Rectosigmoid				2781	2018-05-17	Liver	right liver	Yes	No	Yes	2018-05-26	2018-06-30	Trifluridine	Chemotherapy	2018-07-26	Yes	PD
CPCT02110073T	HMF001688	HMF001688A	0.36	female	1947	null	Colorectum					9256	2018-06-04	Liver	null	No	No	Yes	2018-06-29	2018-09-13	Bevacizumab/Capecitabine	Multiple therapy	2018-08-22	Yes	SD
CPCT02110074T	HMF002691	HMF002691A	0.73	female	1967	2019-03-03	Ovary					2394	2018-06-06	Lymph node	supra clavicular left site	Yes	No	Yes	2018-06-14	2018-07-26	Bevacizumab/Doxorubicin (liposomal)	Multiple therapy	null	null	null
CPCT02110075T	HMF001598	HMF001598A	0.73	male	1961	2018-06-29	Colorectum	Rectosigmoid	Neuroendocrine tumor			2781,169	2018-06-14	Primary	colon	No	No	null	null	null	null	null	null	null	null
CPCT02110076T	HMF001041	HMF001041A	0.43	female	1981	2019-07-19	Breast		Carcinoma	Triple negative		0060081	2018-06-18	Liver	liver nos	Yes	Yes	Yes	2018-06-26	2019-02-05	Paclitaxel	Chemotherapy	2018-08-27	Yes	SD
CPCT02110077T	HMF001148	HMF001148A	0.84	female	1963	2018-07-30	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-22	Lymph node	right axilla	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02110078T	HMF000125	HMF000125A	0.62	female	1956	2019-03-04	Fallopian tube		Carcinoma			1963	2018-06-29	Lymph node	neck right site, supraclavicular	Yes	Yes	Yes	2018-07-10	2018-11-05	Paclitaxel/Carboplatin	Chemotherapy	2018-09-12	Yes	SD
CPCT02110079T	HMF004078	HMF004078A	0.58	female	1972	2020-07-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-03-25	Bone	Pelvis	Yes	Yes	Yes	2019-03-26	null	Exemestane/Everolimus/Goserelin	Multiple therapy	null	null	null
CPCT02110080T	HMF003720	HMF003720B	0.39	female	1978	2020-06-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-04-03	Bone	Os ilium	Yes	Yes	Yes	2019-03-26	2019-07-05	Exemestane/Everolimus/Everolimus	Multiple therapy	2019-07-01	Yes	PD
CPCT02110088T	HMF004865	HMF004865A	0.27	male	1959	2021-06-07	Pancreas					1793	2020-04-30	Liver	Left lobe	Yes	No	Yes	2020-05-26	2020-06-30	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2020-07-14	Yes	PD
CPCT02110089T	HMF004961	HMF004961A	0.88	female	1966	2020-10-26	Pancreas					1793	2020-07-07	Liver	segment 3	No	No	Yes	2020-07-24	2020-09-29	Fluorouracil/Oxaliplatin/Irinotecan/Leucovorin	Multiple therapy	2020-09-10	Yes	PD
CPCT02110090T	HMF004888	HMF004888A	0.45	male	1952	2022-11-15	Pancreas					1793	2020-07-22	Primary	between stomach, spleen and pancreas	No	No	Yes	2020-07-29	2020-09-30	Fluorouracil/Oxaliplatin/Irinotecan/Leucovorin	Multiple therapy	2020-09-16	Yes	SD
CPCT02110091T	HMF005049	HMF005049A	0.51	male	1951	2021-11-15	Pancreas					1793	2020-08-11	Peritoneum	lateral of navel	Yes	Yes	Yes	2020-09-02	2021-02-17	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	2020-10-22	Yes	SD
CPCT02110092T	HMF005220	HMF005220A	0.23	male	1976	null	Pancreas					1793	2020-10-22	Liver	segment 6	Yes	No	Yes	2020-10-28	2021-02-17	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	2020-12-24	Yes	SD
CPCT02110099T	HMF005833	HMF005833A	0.36	male	1949	null	Pancreas					1793	2021-10-21	Liver	left lobe, segment II	Yes	No	Yes	2021-10-25	2022-03-29	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2021-12-20	Yes	PR
CPCT02110102T	HMF005834	HMF005834A	0.52	male	1981	2022-09-03	Pancreas					1793	2021-11-19	Liver	segm II/III	No	No	Yes	2021-11-29	2022-06-07	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	2022-01-24	Yes	SD
CPCT02110103T	HMF005900	HMF005900A	0.25	male	1955	2022-11-28	Urothelial tract	Bladder				11054	2021-12-03	Primary	Urinary bladder	Yes	No	Yes	2021-12-07	2022-01-26	Pembrolizumab	Immunotherapy	2021-12-28	Yes	PD
CPCT02110104T	HMF006144	HMF006144A	0.24	male	1959	2022-05-28	Urothelial tract	Bladder				11054	2022-03-21	Peritoneum	omentum near gallbladder	Yes	Yes	Yes	2022-04-05	2022-04-05	Pembrolizumab	Immunotherapy	2022-04-13	Yes	PD
CPCT02120001T	HMF001461	HMF001461B	0.63	female	1956	2019-04-14	Breast		Carcinoma	Triple negative		0060081	2018-03-29	Liver	medial left	Yes	Yes	Yes	2018-04-17	2018-06-12	Doxorubicin	Chemotherapy	2018-06-12	Yes	PD
CPCT02120002T	HMF003272	HMF003272A	0.22	male	1942	2017-06-02	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-03-21	Liver	RIGHT	No	No	Yes	2017-03-27	2017-06-02	Sunitinib	Targeted therapy	null	null	null
CPCT02120005T	HMF000870	HMF000870A	0.52	male	1945	2017-12-29	Colorectum	Rectum				1993	2017-03-31	Liver	LEFT	Yes	No	Yes	2017-04-21	2017-10-30	Panitumumab	Targeted therapy	2017-07-26	Yes	SD
CPCT02120007T	HMF001808	HMF001808A	0.43	male	1963	2018-02-02	Stomach					10534	2017-04-03	Liver	SEGMENT 4	No	No	Yes	2017-04-21	2017-06-21	Oxaliplatin/Capecitabine	Chemotherapy	2017-06-19	Yes	PD
CPCT02120008T	HMF000014	HMF000014A	0.74	female	1946	2017-09-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-16	Liver	distal	Yes	Yes	Yes	2017-04-07	2017-06-23	Bevacizumab/Anastrozole	Multiple therapy	null	null	null
CPCT02120011T	HMF001984	HMF001984A	0.72	male	1950	2017-12-05	Esophagus					5041	2017-04-20	muscle	right gluteal	Yes	Yes	Yes	2017-05-01	2017-08-21	Carboplatin/Paclitaxel	Chemotherapy	2017-06-30	Yes	SD
CPCT02120014T	HMF001484	HMF001484A	0.55	female	1942	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-05-02	Kidney	left	No	No	Yes	2017-05-12	2017-05-29	Pazopanib	Targeted therapy	2018-01-15	Yes	PD
CPCT02120016T	HMF002327	HMF002327A	0.42	female	1967	2017-06-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-03	Liver	liver	Yes	Yes	Yes	2017-05-04	2017-05-04	Paclitaxel	Chemotherapy	null	null	null
CPCT02120018T	HMF003454	HMF003454A	0.89	female	1939	2017-09-05	Adrenal gland	Adrenal cortex	Carcinoma			3948	2017-05-10	Liver	right lobe	No	No	null	null	null	null	null	null	null	null
CPCT02120020T	HMF002711	HMF002711A	0.87	male	1952	2018-01-31	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2017-08-11	Liver	left	Yes	No	Yes	2017-05-24	2017-07-26	Topotecan	Chemotherapy	null	null	null
CPCT02120021T	HMF003051	HMF003051A	0.37	female	1952	2018-04-17	Colorectum					9256	2017-06-02	Lymph node	neck	No	No	Yes	2017-06-08	2018-01-19	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-07-31	Yes	PR
CPCT02120022T	HMF002356	HMF002356A	0.34	female	1939	null	Ovary					2394	2017-06-02	Liver	right, cranial	Yes	No	Yes	2017-06-08	2017-12-06	Bevacizumab/Carboplatin/Gemcitabine	Multiple therapy	2017-08-10	Yes	CR
CPCT02120023T	HMF003058	HMF003058A	0.31	male	1959	2017-07-25	Colorectum					9256	2017-06-06	abdominal wall (intramuscular)	abdominal wall abdominal wall (intramuscular)	Yes	No	null	null	null	null	null	null	null	null
CPCT02120024T	HMF000366	HMF000366A	0.44	female	1945	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-13	Bone	acetabulum	Yes	Yes	Yes	2017-06-30	2018-06-08	Letrozole	Hormonal therapy	2018-03-16	Yes	CR
CPCT02120027T	HMF002890	HMF002890A	0.61	female	1946	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-06-07	intra-abdominal	ventral right	No	No	Yes	2017-06-09	2019-10-29	Pazopanib	Targeted therapy	2017-08-30	Yes	SD
CPCT02120028T	HMF002168	HMF002168A	0.34	female	1960	2018-04-28	Ovary					2394	2017-06-13	Lymph node	retrocaval	Yes	No	Yes	2017-06-16	2017-11-17	Bevacizumab/Carboplatin/Gemcitabine	Multiple therapy	null	null	null
CPCT02120029T	HMF001225	HMF001225A	0.65	female	1963	2018-02-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-19	Liver	left	Yes	Yes	Yes	2017-06-26	2017-08-11	Carboplatin/Gemcitabine	Chemotherapy	2017-07-31	Yes	PD
CPCT02120030T	HMF002319	HMF002319A	0.45	male	1961	null	Colorectum					9256	2017-06-13	Liver	ventral , right liver lobe	No	No	Yes	2017-07-11	2017-12-12	Bevacizumab/Fluorouracil/Oxaliplatin	Multiple therapy	2017-08-31	Yes	PR
CPCT02120031T	HMF001319	HMF001319A	0.42	male	1955	2018-03-07	Colorectum					9256	2017-06-15	Liver	right	Yes	No	Yes	2017-07-07	2017-08-28	Trifluridine	Chemotherapy	2017-10-31	Yes	PD
CPCT02120032T	HMF000073	HMF000073A	0.52	male	1970	null	Lymphoid tissue		Non-Hodgkin lymphoma	Diffuse large B-cell lymphoma		0050745	2017-06-15	Liver	right	No	No	Yes	2017-06-29	2017-12-07	Rituximab/Doxorubicin/Vincristine	Multiple therapy	2017-08-22	Yes	PR
CPCT02120033T	HMF003025	HMF003025A	0.54	female	1962	2019-06-08	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-06-27	soft tissue surrounding os ilium	right	Yes	Yes	Yes	2017-07-06	2018-01-25	Trastuzumab/Tamoxifen	Multiple therapy	2017-09-13	Yes	SD
CPCT02120037T	HMF002153	HMF002153A	0.6	male	1952	2017-08-23	Skin		Melanoma			8923	2017-07-04	Liver	left	No	No	Yes	2017-08-17	2017-08-17	Pembrolizumab	Immunotherapy	null	null	null
CPCT02120040T	HMF002049	HMF002049A	0.47	female	1974	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-07-14	Lymph node	axilla	Yes	Yes	Yes	2017-08-02	2019-07-10	Nivolumab	Immunotherapy	2017-10-20	Yes	SD
CPCT02120041T	HMF002205	HMF002205A	0.55	female	1948	2018-03-12	Colorectum					9256	2017-07-13	intramuscular	abdominal wall right	No	No	Yes	2017-08-08	2017-09-19	Oxaliplatin	Chemotherapy	2017-09-25	Yes	PD
CPCT02120050T	HMF001053	HMF001053A	0.73	male	1961	null	Mesothelium		Malignant mesothelioma			1790,0050686	2017-08-29	Peritoneum	left paracolic	No	No	null	null	null	null	null	null	null	null
CPCT02120051T	HMF002599	HMF002599A	0.39	female	1944	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-29	Bone	pelvis left	No	No	Yes	2017-10-16	2019-05-28	Palbociclib	Targeted therapy	2017-12-18	Yes	SD
CPCT02120053T	HMF001751	HMF001751A	0.64	male	1947	2018-02-23	Skin		Melanoma			8923	2017-09-05	subcutis	medial proximal left upper leg	No	Yes	Yes	2017-09-11	2018-01-25	Dabrafenib/Trametinib	Targeted therapy	2017-12-13	Yes	PR
CPCT02120054T	HMF001016	HMF001016A	0.58	male	1962	2018-02-06	Colorectum					9256	2017-09-06	Liver	high dorsal right lobe	Yes	No	Yes	2017-09-14	2017-09-14	Irinotecan	Chemotherapy	2017-10-25	Yes	PD
CPCT02120055T	HMF001770	HMF001770A	0.29	male	1965	null	Skin		Melanoma			8923	2017-09-19	Lymph node	axillary left	No	No	Yes	2017-10-06	2017-10-27	Ipilimumab/Nivolumab	Immunotherapy	2017-10-17	Yes	SD
CPCT02120056T	HMF000634	HMF000634A	0.54	male	1939	2018-01-28	Urothelial tract	Bladder				11054	2017-09-14	Liver	right	No	No	Yes	2017-10-31	2017-11-07	Gemcitabine/Carboplatin	Chemotherapy	2017-12-12	Yes	PD
CPCT02120058T	HMF001254	HMF001254A	0.72	female	1969	2017-11-07	Skin		Melanoma			8923	2017-09-26	Lymph node	left axillary	No	No	Yes	2017-10-06	2017-10-26	Pembrolizumab	Immunotherapy	null	null	null
CPCT02120059T	HMF001457	HMF001457A	0.59	female	1951	2018-06-28	Bile duct		Carcinoma			4947	2017-09-20	Lymph node	neck, low cervical	No	No	null	null	null	null	null	null	null	null
CPCT02120061T	HMF002540	HMF002540A	0.47	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-29	Liver	left	Yes	Yes	Yes	2017-11-13	2018-01-10	Gemcitabine/Carboplatin	Chemotherapy	null	null	null
CPCT02120062T	HMF002227	HMF002227A	0.47	male	1969	2020-11-07	Skin		Melanoma			8923	2017-10-03	Lymph node	right axilla	No	No	Yes	2017-10-05	2019-09-19	Pembrolizumab	Immunotherapy	2017-12-20	Yes	Non-CR/Non-PD
CPCT02120066T	HMF002967	HMF002967A	0.74	female	1958	2017-12-29	Colorectum					9256	2017-10-09	Liver	right central	Yes	Yes	Yes	2017-10-17	2017-11-24	Fluorouracil/Oxaliplatin	Chemotherapy	2017-12-18	Yes	PD
CPCT02120069T	HMF001926	HMF001926A	0.68	female	1946	2018-07-31	Esophagus					5041	2017-10-24	Liver	left ventral	Yes	Yes	Yes	2017-11-20	2018-01-10	Fluorouracil/Oxaliplatin	Chemotherapy	2018-01-17	Yes	PD
CPCT02120070T	HMF002934	HMF002934A	0.91	female	1950	2018-08-25	Lung		Carcinoma	Small cell carcinoma		5409	2017-10-18	skin leasion	front thorax side	Yes	No	Yes	2017-10-30	2018-02-01	Paclitaxel/Carboplatin	Chemotherapy	2018-01-31	Yes	PR
CPCT02120073T	HMF000086	HMF000086A	0.34	female	1948	2018-09-29	Breast		Carcinoma	Triple negative		0060081	2017-10-26	Liver	right	Yes	Yes	Yes	2017-11-15	2018-06-05	Carboplatin/Cyclophosphamide	Chemotherapy	2017-12-22	Yes	SD
CPCT02120074T	HMF001805	HMF001805A	0.45	male	1953	null	Prostate					10283	2017-10-31	Lymph node	SUPRACLAVICULAR	Yes	Yes	Yes	2017-10-30	2020-08-22	Enzalutamide	Hormonal therapy	2018-07-02	Yes	SD
CPCT02120077T	HMF003495	HMF003495A	0.47	female	1956	null	Skin		Melanoma			8923	2017-11-09	Liver	high	No	No	Yes	2017-11-16	2018-09-27	Pembrolizumab	Immunotherapy	2018-02-02	Yes	PD
CPCT02120078T	HMF002301	HMF002301A	0.54	male	1949	2018-08-11	Colorectum					9256	2017-11-10	Liver	ventral left	Yes	Yes	Yes	2017-11-13	2017-12-27	Bevacizumab/Fluorouracil/Irinotecan	Multiple therapy	2018-01-03	Yes	PD
CPCT02120079T	HMF003483	HMF003483A	0.5	female	1943	2018-07-29	Colorectum					9256	2017-11-10	Liver	segment 3-4	No	No	Yes	2017-12-06	2018-01-26	Fluorouracil/Oxaliplatin/Panitumumab	Multiple therapy	2018-01-31	Yes	PR
CPCT02120080T	HMF002613	HMF002613A	0.52	male	1948	2018-06-27	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2017-11-21	Lung	left	No	No	Yes	2017-12-04	2018-03-28	Cisplatin/Gemcitabine	Chemotherapy	2018-02-23	Yes	PR
CPCT02120085T	HMF002565	HMF002565A	0.43	male	1959	2018-06-16	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-11-23	Bone	right ilium	No	No	Yes	2017-12-01	2018-05-16	Pazopanib	Targeted therapy	2018-02-16	Yes	SD
CPCT02120087T	HMF001076	HMF001076A	0.45	female	1953	2019-08-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-29	Liver	right	Yes	Yes	Yes	2018-01-06	2018-10-25	Paclitaxel/Bevacizumab/Fulvestrant	Multiple therapy	2018-03-29	Yes	SD
CPCT02120088T	HMF002525	HMF002525A	0.24	male	1955	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-28	Lung	left upper lung	No	No	Yes	2017-12-12	2019-07-05	Erlotinib	Targeted therapy	2018-01-19	Yes	PR
CPCT02120090T	HMF003741	HMF003741A	0.24	female	1943	2018-05-03	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-11-30	Primary	right kidney	No	No	Yes	2017-12-20	2018-03-09	Pazopanib	Targeted therapy	2018-02-02	Yes	SD
CPCT02120096T	HMF001660	HMF001660A	0.39	female	1950	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-12-19	Adrenal gland	ADRENAL LEFT	No	No	Yes	2017-12-27	2018-08-15	Pazopanib	Targeted therapy	2018-03-05	Yes	PR
CPCT02120097T	HMF002423	HMF002423A	0.44	female	1962	2019-03-18	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-12-15	Lymph node	left axilla	Yes	Yes	Yes	2017-12-18	2018-07-11	Nivolumab	Immunotherapy	2018-03-07	Yes	PD
CPCT02120098T	HMF002218	HMF002218A	0.49	male	1959	null	Skin		Melanoma			8923	2018-01-05	Primary	left lower leg	No	No	Yes	2018-01-17	2019-02-02	Anti-PD-1 (PDR001) or placebo/Dabrafenib/Trametinib	Multiple therapy	2018-04-04	Yes	PR
CPCT02120100T	HMF000933	HMF000933A	0.45	female	1941	2018-11-22	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-12-29	Primary	lung	Yes	Yes	Yes	2018-01-15	2018-02-21	Pembrolizumab	Immunotherapy	2018-02-21	Yes	PD
CPCT02120101T	HMF000336	HMF000336A	0.56	female	1941	2018-04-25	Skin		Melanoma			8923	2018-01-02	Primary	skin left lower leg	No	No	Yes	2018-01-18	2018-03-22	Pembrolizumab	Immunotherapy	2018-04-03	Yes	PD
CPCT02120103T	HMF000105	HMF000105A	0.79	male	1937	null	Unknown	CUP	Carcinoma			305	2018-01-09	Liver	multiple	No	No	null	null	null	null	null	null	null	null
CPCT02120105T	HMF002707	HMF002707A	0.9	male	1967	2018-04-22	Skin		Melanoma			8923	2018-01-11	abdominal wall (subcutaneous)	abdominal wall (subcutaneous)	No	No	Yes	2018-01-10	2018-01-23	Dabrafenib/Trametinib	Targeted therapy	null	null	null
CPCT02120107T	HMF002519	HMF002519A	0.24	male	1960	2019-09-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-31	Lymph node	LN neck left	Yes	Yes	Yes	2018-04-16	2018-06-18	Docetaxel	Chemotherapy	2018-05-23	Yes	SD
CPCT02120108T	HMF001597	HMF001597A	0.79	female	1954	2018-04-03	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-02-01	Peritoneum	left paramedian	Yes	Yes	Yes	2018-02-21	2018-03-07	Carboplatin	Chemotherapy	null	null	null
CPCT02120110T	HMF001261	HMF001261A	0.41	male	1949	null	Skin		Melanoma			8923	2018-02-07	Lymph node	right axillary	No	No	Yes	2018-03-08	2018-03-29	Pembrolizumab	Immunotherapy	2018-05-09	Yes	PD
CPCT02120111T	HMF003035	HMF003035A	0.94	female	1991	null	Head and neck	Salivary gland				8850,11934	2018-02-13	Bone	L3	No	Yes	null	null	null	null	null	null	null	null
CPCT02120112T	HMF001508	HMF001508A	0.62	male	1944	2020-04-16	Colorectum					9256	2018-02-22	Primary	coecum	No	No	Yes	2018-03-15	2019-08-28	Oxaliplatin/Bevacizumab/Capecitabine	Multiple therapy	2018-05-15	Yes	PR
CPCT02120114T	HMF002809	HMF002809A	0.37	female	1974	2018-05-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-22	Lymph node	left axillary	Yes	Yes	Yes	2018-02-22	2018-04-30	Capecitabine	Chemotherapy	2018-03-30	Yes	PD
CPCT02120117T	HMF000497	HMF000497A	0.58	female	1971	2018-04-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-01	skin	shoulder left	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02120118T	HMF002212	HMF002212A	0.75	female	1974	2019-07-26	Ovary					2394	2018-03-13	skin	chest wall	Yes	No	Yes	2018-04-17	2019-01-22	Bevacizumab/Carboplatin/Gemcitabine	Multiple therapy	2018-06-12	Yes	PR
CPCT02120119T	HMF003619	HMF003619A	0.56	female	1945	null	Colorectum					9256	2018-03-01	Liver	left	No	No	Yes	2018-04-09	2018-04-17	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	null	null	null
CPCT02120120T	HMF000080	HMF000080A	0.55	female	1981	2018-12-07	Ovary					2394	2018-02-27	Peritoneum	left	No	No	Yes	2018-03-01	2018-06-28	Carboplatin/Paclitaxel	Chemotherapy	2018-04-30	Yes	PR
CPCT02120121T	HMF003645	HMF003645A	0.55	female	1959	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-06	Liver	right	Yes	Yes	Yes	2018-03-13	2018-06-27	Cyclophosphamide/Doxorubicin	Chemotherapy	2018-05-09	Yes	PR
CPCT02120124T	HMF002616	HMF002616A	0.48	male	1975	null	Colorectum					9256	2018-03-13	Liver	intercostal right	No	No	Yes	2018-03-19	2018-06-12	Oxaliplatin/Capecitabine	Chemotherapy	2018-05-22	Yes	PR
CPCT02120125T	HMF002070	HMF002070A	0.41	female	1967	2018-09-16	Unknown	CUP	Carcinoma			305	2018-03-22	musculus gluteus	left	No	No	null	null	null	null	null	null	null	null
CPCT02120131T	HMF003594	HMF003594A	0.25	female	1969	2019-03-14	Pancreas					1793	2018-04-17	Liver	segment 6	Yes	No	Yes	2018-05-12	2018-08-28	Fluorouracil/Oxaliplatin/Irinotecan	Chemotherapy	2018-07-04	Yes	PR
CPCT02120132T	HMF000926	HMF000926A	0.41	female	1955	2018-07-30	Ovary					2394	2018-04-17	Lymph node	left inguinal	Yes	Yes	Yes	2018-04-20	2018-07-20	Bevacizumab/Carboplatin/Gemcitabine	Multiple therapy	2018-06-18	Yes	SD
CPCT02120136T	HMF002053	HMF002053A	0.37	male	1949	2018-11-21	Colorectum					9256	2018-04-12	Liver	right	Yes	Yes	Yes	2018-04-19	2018-06-15	Cisplatin/Fluorouracil	Chemotherapy	2018-06-26	Yes	SD
CPCT02120137T	HMF002801	HMF002801A	0.62	female	1965	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-17	Liver	left	Yes	Yes	Yes	2018-05-02	2019-04-11	Capecitabine	Chemotherapy	2018-06-28	Yes	PR
CPCT02120138T	HMF002084	HMF002084A	0.28	female	1951	2018-05-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-04-25	Lymph node	mesenteriale lymphnode	Yes	Yes	Yes	2018-05-01	2018-05-17	Cisplatin/Pemetrexed	Chemotherapy	null	null	null
CPCT02120140T	HMF001170	HMF001170A	0.38	male	1961	2018-05-06	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-04-20	Lymph node	right neck	Yes	Yes	Yes	2018-04-30	2018-04-30	Pembrolizumab	Immunotherapy	null	null	null
CPCT02120144T	HMF003474	HMF003474A	0.54	male	1947	2019-01-15	Mesothelium		Malignant mesothelioma			1790,0050686	2018-05-07	advance to subcutaneous left flank	advance to subcutaneous left flank	Yes	No	Yes	2018-05-29	2018-07-31	Carboplatin/Pemetrexed	Chemotherapy	2018-07-04	Yes	SD
CPCT02120147T	HMF000478	HMF000478A	0.52	female	1950	2018-06-08	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-08	metastasis right leg	metastasis right leg	Yes	No	Yes	2018-05-08	2018-05-22	Nivolumab	Immunotherapy	2018-05-29	Yes	PD
CPCT02120148T	HMF003283	HMF003283A	0.7	female	1940	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-15	Liver	left	Yes	Yes	Yes	2018-05-23	2019-02-26	Palbociclib	Targeted therapy	2018-08-20	Yes	SD
CPCT02120149T	HMF003253	HMF003253A	0.39	female	1940	null	Ovary					2394	2018-05-22	Lymph node	supraclavicular left	Yes	No	null	null	null	null	null	null	null	null
CPCT02120150T	HMF001670	HMF001670A	0.26	male	1939	2018-09-16	Esophagus					5041	2018-05-17	Lymph node	supraclavicular	Yes	No	Yes	2018-06-05	2018-08-02	Oxaliplatin/Capecitabine	Chemotherapy	2018-08-02	Yes	PD
CPCT02120152T	HMF001309	HMF001309A	0.54	male	1949	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-12	Lung	right upper lobe	Yes	No	Yes	2018-08-13	2019-05-13	Pemetrexed/Carboplatin	Chemotherapy	2018-11-09	Yes	SD
CPCT02120153T	HMF003556	HMF003556A	0.71	female	1948	null	Ovary					2394	2018-05-31	omentum	left ventral	Yes	No	Yes	2018-06-12	2019-12-10	Bevacizumab/Gemcitabine/Carboplatin	Multiple therapy	2018-08-14	Yes	PR
CPCT02120154T	HMF003363	HMF003363A	0.73	female	1958	2021-04-12	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-31	Liver	right, ventrolateral	Yes	Yes	Yes	2018-06-11	2018-12-07	Palbociclib/Fulvestrant	Multiple therapy	2018-09-17	Yes	SD
CPCT02120158T	HMF002652	HMF002652A	0.81	female	1976	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-12	Primary	left mamma lateral upper quadrant	No	No	Yes	2018-06-29	2019-01-29	Bevacizumab/Paclitaxel	Multiple therapy	2018-09-17	Yes	SD
CPCT02120160T	HMF003263	HMF003263A	0.73	male	1951	2020-10-07	Colorectum					9256	2018-06-20	Liver	right	No	No	Yes	2018-07-05	2018-11-01	Capecitabine/Oxaliplatin	Chemotherapy	2018-08-21	Yes	SD
CPCT02120161T	HMF002914	HMF002914A	0.44	female	1975	2019-08-08	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-26	Lung	right upper lung	Yes	No	Yes	2018-07-12	2018-10-25	Pembrolizumab	Immunotherapy	2018-07-16	Yes	ND
CPCT02120162T	HMF003057	HMF003057A	0.91	male	1951	null	Colorectum					9256	2018-07-05	Liver	left	No	No	Yes	2018-08-21	2019-01-19	Bevacizumab/Capecitabine/Oxaliplatin	Multiple therapy	2018-10-17	Yes	PR
CPCT02120165T	HMF001269	HMF001269A	0.78	female	1970	2018-09-25	Breast		Carcinoma	Triple negative		0060081	2018-07-18	Lung	right	Yes	Yes	Yes	2018-07-24	2018-09-10	Carboplatin/Gemcitabine	Chemotherapy	2018-09-12	Yes	PD
CPCT02120167T	HMF000113	HMF000113A	0.89	male	1953	2019-05-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-08-08	Lung	brochus	Yes	No	Yes	2018-12-19	2019-04-08	Nivolumab	Immunotherapy	2019-01-24	Yes	SD
CPCT02120168T	HMF002840	HMF002840A	0.84	male	1948	null	Urothelial tract	Bladder				11054	2018-08-16	Liver	left	Yes	No	Yes	2018-09-04	2018-09-04	Pembrolizumab	Immunotherapy	2018-10-06	Yes	PD
CPCT02120171T	HMF001213	HMF001213A	0.27	female	1954	2019-05-20	Colorectum					9256	2018-10-10	Liver	left	Yes	No	Yes	2018-11-22	2019-01-16	Bermekimab	Experimental therapy	null	null	null
CPCT02120172T	HMF000723	HMF000723A	0.26	female	1959	2019-02-20	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-12	Lymph node	supraclavicular right	Yes	No	Yes	2018-10-30	2018-12-28	Pemetrexed/Pertuzumab/Trastuzumab	Multiple therapy	2018-12-04	Yes	PD
CPCT02120176T	HMF004389	HMF004389A	0.47	male	1957	2019-10-29	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-12-11	Lymph node	left axillar	No	No	Yes	2019-01-12	2019-06-30	Sunitinib	Targeted therapy	2019-01-25	Yes	ND
CPCT02120179T	HMF004136	HMF004136A	0.6	female	1964	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-01-24	Primary	left mamma	Yes	No	Yes	2019-02-26	2019-07-25	Gemcitabine/Carboplatin	Chemotherapy	2019-05-06	Yes	PD
CPCT02120180T	HMF004088	HMF004088A	0.4	male	1934	2019-04-20	Skin		Melanoma			8923	2019-01-22	Primary	skin, pectoral	No	No	Yes	2019-01-23	2019-03-27	Pembrolizumab	Immunotherapy	2019-04-08	Yes	PD
CPCT02120183T	HMF004215	HMF004215A	0.21	female	1951	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2019-03-07	skin	left shoulder	Yes	Yes	Yes	2019-03-26	2019-10-16	Trastuzumab/Trastuzumab/Vinorelbine	Multiple therapy	2019-05-22	Yes	Non-CR/Non-PD
CPCT02120184T	HMF004375	HMF004375A	0.36	male	1944	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-02-07	Primary	dorsolateral to bladder	Yes	Yes	Yes	2019-02-11	2019-07-08	Pembrolizumab	Immunotherapy	2019-04-23	Yes	SD
CPCT02120187T	HMF004345	HMF004345A	0.82	male	1945	2020-11-23	Skin		Melanoma			8923	2019-03-28	Lymph node	groin	No	No	Yes	2019-04-09	2019-05-22	Ipilimumab/Nivolumab	Immunotherapy	2019-06-26	Yes	SD
CPCT02120189T	HMF004294	HMF004294A	0.45	male	1946	null	Skin		Melanoma			8923	2019-04-09	Primary	back	Yes	No	Yes	2019-04-10	2022-08-16	Binimetinib/Encorafenib	Targeted therapy	2019-07-01	Yes	CR
CPCT02120191T	HMF004265	HMF004265A	0.6	male	1951	null	Skin		Melanoma			8923	2019-04-16	Lymph node	left axillary	No	No	Yes	2019-04-18	2019-06-28	Ipilimumab/Nivolumab	Immunotherapy	2019-05-28	Yes	Non-CR/Non-PD
CPCT02120193T	HMF004383	HMF004383A	0.86	female	1957	null	Skin		Melanoma			8923	2019-04-19	skin	ventral left upper leg	No	No	Yes	2019-04-25	2019-06-27	Pembrolizumab	Immunotherapy	2019-07-10	Yes	PD
CPCT02120195T	HMF003898	HMF003898A	0.2	male	1949	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-04-18	abdominal wall (subcutaneous)	left	No	No	Yes	2019-04-26	2019-05-17	Ipilimumab/Nivolumab	Immunotherapy	2019-07-01	Yes	PD
CPCT02120198T	HMF004347	HMF004347A	0.64	male	1945	2020-04-21	Skin		Melanoma			8923	2019-05-21	Lymph node	left axilla	Yes	Yes	Yes	2019-05-24	2019-06-14	Pembrolizumab	Immunotherapy	2019-09-03	Yes	PD
CPCT02120199T	HMF003943	HMF003943A	0.9	female	1970	null	Skin		Melanoma			8923	2019-05-28	Lymph node	groin, right	No	No	Yes	2019-06-12	2019-07-24	Pembrolizumab	Immunotherapy	2019-08-27	Yes	PR
CPCT02120200T	HMF004063	HMF004063A	0.31	male	1955	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-05-31	Liver	right	No	No	Yes	2019-06-26	2020-08-10	Ipilimumab/Nivolumab	Immunotherapy	2019-10-03	Yes	SD
CPCT02120203T	HMF004184	HMF004184A	0.84	male	1940	2021-06-22	Urothelial tract	Bladder				11054	2019-09-04	Primary	bladder left	Yes	Yes	Yes	2019-10-29	2019-12-10	Pembrolizumab	Immunotherapy	2019-12-27	Yes	PD
CPCT02120204T	HMF004574	HMF004574A	0.26	male	1945	2020-01-09	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-12-09	Bone	os pubis left	Yes	No	null	null	null	null	null	null	null	null
CPCT02120206T	HMF004426	HMF004426A	0.68	male	1946	null	Urothelial tract	Bladder				11054	2019-12-20	subcutaneous lesion	left ventral	Yes	No	Yes	2019-12-17	2021-12-02	Pembrolizumab	Immunotherapy	2020-03-04	Yes	PR
CPCT02120207T	HMF005626	HMF005626A	0.35	male	1947	null	Pancreas					1793	2021-07-05	Primary	pancreas tail	Yes	No	Yes	2021-07-27	2021-11-24	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2021-09-15	Yes	PR
CPCT02130006T	HMF001040	HMF001040A	0.37	male	1947	2017-12-14	Bile duct		Carcinoma			4947	2017-11-07	Peritoneum	ventral medial	Yes	No	null	null	null	null	null	null	null	null
CPCT02130010T	HMF001231	HMF001231A	0.4	male	1955	2018-01-18	Pancreas					1793	2017-11-15	Peritoneum	left	Yes	No	Yes	2017-11-23	2017-11-30	Gemcitabine/Paclitaxel	Chemotherapy	2017-12-01	Yes	PD
CPCT02130013T	HMF000328	HMF000328A	0.63	female	1988	2019-06-03	Uterus	Cervix				4362	2017-11-15	cervix	cervix	Yes	Yes	Yes	2017-11-20	2018-03-05	Bevacizumab/Cisplatin/Paclitaxel	Multiple therapy	2018-01-16	Yes	PR
CPCT02130014T	HMF003530	HMF003530A	0.36	male	1955	null	Pancreas					1793	2017-11-16	Liver	segment unknown	No	No	Yes	2017-11-30	2019-07-01	Capecitabine/Oxaliplatin	Chemotherapy	2018-01-23	Yes	SD
CPCT02130019T	HMF001573	HMF001573A	0.45	male	1946	2019-03-21	Small intestine	Duodenum	Carcinoma	Mixed neuroendocrine non-neurendocrine carcinoma	Duodenal papilla	4932	2017-11-30	Liver	right	No	No	Yes	2018-01-02	2018-09-11	Capecitabine/Streptozocin	Chemotherapy	null	null	null
CPCT02130025T	HMF002640	HMF002640A	0.35	male	1950	2018-11-26	Pancreas					1793	2017-12-14	Liver	segment 4	No	No	null	null	null	null	null	null	null	null
CPCT02130027T	HMF001911	HMF001911A	0.69	male	1966	2018-01-26	Gastroesophageal	Esophago-gastric junction				0080374	2017-12-28	Lymph node	para aortic ventral upper abdomen, cranial of pancreas	No	No	null	null	null	null	null	null	null	null
CPCT02130030T	HMF001406	HMF001406A	0.53	male	1952	2018-04-29	Gastroesophageal	Esophago-gastric junction				0080374	2018-01-10	Liver	right side	Yes	Yes	Yes	2018-01-19	2018-04-23	Oxaliplatin/Capecitabine	Chemotherapy	2018-03-09	Yes	SD
CPCT02130031T	HMF001922	HMF001922A	0.81	female	1944	2018-10-18	Colorectum					9256	2018-01-11	Liver	left	Yes	No	Yes	2018-01-24	2018-05-22	Oxaliplatin/Capecitabine	Chemotherapy	2018-03-20	Yes	SD
CPCT02130032T	HMF001990	HMF001990A	0.41	female	1934	2019-07-20	Thyroid gland					1781	2018-01-16	skin	head	Yes	Yes	Yes	2018-03-19	2018-03-21	Sorafenib	Targeted therapy	null	null	null
CPCT02130033T	HMF000722	HMF000722A	0.4	male	1958	2018-10-18	Esophagus					5041	2018-01-17	Bone	os pubis left side	No	No	Yes	2018-01-24	null	Capecitabine/Oxaliplatin/Trastuzumab	Multiple therapy	null	null	null
CPCT02130034T	HMF002245	HMF002245A	0.75	female	1972	2018-02-28	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-01-17	Liver	left side	No	Yes	Yes	2018-01-26	2018-02-23	Cyclophosphamide	Chemotherapy	null	null	null
CPCT02130035T	HMF000132	HMF000132A	0.62	female	1949	2018-07-07	Bile duct		Carcinoma			4947	2018-01-25	Liver	segment 4b/5	No	No	null	null	null	null	null	null	null	null
CPCT02130041T	HMF003286	HMF003286A	0.69	male	1946	2018-09-10	Esophagus					5041	2018-01-31	Lung	right pleura basoventral	Yes	Yes	Yes	2018-02-22	2018-04-18	Oxaliplatin/Capecitabine	Chemotherapy	2018-04-23	Yes	SD
CPCT02130044T	HMF002881	HMF002881A	0.31	female	1957	2018-10-31	Pancreas					1793	2018-02-09	subcutaneous	abdomen lower quadrant	Yes	No	Yes	2018-02-26	2018-08-31	Gemcitabine	Chemotherapy	2018-06-04	Yes	PD
CPCT02130046T	HMF002406	HMF002406A	0.23	female	1961	2018-06-26	Stomach					10534	2018-02-13	Liver	right lobe	Yes	No	Yes	2018-03-05	2018-04-17	Ramucirumab/Paclitaxel	Multiple therapy	2018-04-19	Yes	PD
CPCT02130047T	HMF003400	HMF003400A	0.4	female	1962	2018-07-09	Pancreas					1793	2018-02-13	ovarium	adnex right side	Yes	No	Yes	2018-02-16	2018-03-30	Gemcitabine/Paclitaxel	Chemotherapy	2018-04-05	Yes	PD
CPCT02130049T	HMF002105	HMF002105A	0.77	male	1955	null	Esophagus					5041	2018-02-15	Peritoneum	omental fat ventral of left liver lobe	Yes	Yes	Yes	2018-02-21	2019-01-01	Oxaliplatin/Trastuzumab/Capecitabine	Multiple therapy	2018-06-05	Yes	PR
CPCT02130050T	HMF000471	HMF000471A	0.53	female	1976	2018-08-02	Uterus	Cervix				4362	2018-02-20	Peritoneum	left upper quadrant	Yes	Yes	Yes	2018-02-20	2018-03-30	Etoposide	Chemotherapy	2018-04-17	Yes	PD
CPCT02130051T	HMF000069	HMF000069A	0.69	female	1963	2018-04-19	Ovary					2394	2018-02-23	Peritoneum	para colic right	Yes	No	Yes	2018-02-23	2018-04-06	Paclitaxel	Chemotherapy	null	null	null
CPCT02130054T	HMF002098	HMF002098A	0.92	male	1940	2019-06-21	Stomach		Neuroendocrine tumor	Gastrinoma		10534,5577	2018-02-26	Liver	metastasis	Yes	No	null	null	null	null	null	null	null	null
CPCT02130056T	HMF002902	HMF002902A	0.65	female	1957	2018-08-28	Ovary					2394	2018-02-27	rectum	along sacrum/os coccygys	Yes	Yes	Yes	2018-03-02	2018-05-04	Carboplatin	Chemotherapy	2018-05-16	Yes	PD
CPCT02130057T	HMF002009	HMF002009A	0.33	female	1956	2018-10-16	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-02-27	Lung	wig excision left	No	No	Yes	2018-03-19	2018-05-11	Sorafenib	Targeted therapy	2018-05-07	Yes	PD
CPCT02130059T	HMF002643	HMF002643B	0.65	female	1973	2018-07-06	Uterus	Cervix				4362	2018-03-02	Liver	segment 4	Yes	Yes	Yes	2018-03-05	2018-04-30	Etoposide	Chemotherapy	2018-04-25	Yes	PD
CPCT02130062T	HMF003673	HMF003673A	0.66	male	1986	2018-05-14	Bone/Soft tissue	Bone	Osteosarcoma			3376	2018-03-05	Lung	para mediastinal left lower lobe	Yes	Yes	Yes	2018-04-24	2018-05-09	Palbociclib	Targeted therapy	null	null	null
CPCT02130064T	HMF002695	HMF002695A	0.46	female	1955	null	Bile duct		Carcinoma			4947	2018-03-07	Liver	liver segment 3	No	No	Yes	2018-03-14	2018-09-03	Cisplatin/Gemcitabine	Chemotherapy	2018-05-30	Yes	SD
CPCT02130065T	HMF002348	HMF002348A	0.65	male	1963	null	Small intestine	Ileum	Neuroendocrine tumor			10153,169	2018-03-09	Liver	segment 5	Yes	No	Yes	2018-03-09	2019-02-19	Lanreotide/Octreotide	Hormonal therapy	2018-03-27	Yes	PD
CPCT02130066T	HMF000412	HMF000412A	0.36	female	1957	2018-06-21	Bile duct		Carcinoma			4947	2018-03-13	abdominal wall (subcutaneous)	right side	Yes	No	null	null	null	null	null	null	null	null
CPCT02130067T	HMF002048	HMF002048A	0.63	female	1956	null	Bile duct		Carcinoma			4947	2018-03-13	Liver	right	Yes	No	Yes	2018-05-18	2018-05-29	Trastuzumab/Pertuzumab	Targeted therapy	2018-05-29	Yes	PD
CPCT02130069T	HMF002100	HMF002100A	0.49	female	1956	2020-08-31	Colorectum					9256	2018-03-13	Liver	right side	Yes	Yes	Yes	2018-04-19	2018-08-22	Capecitabine/Oxaliplatin	Chemotherapy	2018-06-19	Yes	PR
CPCT02130070T	HMF003742	HMF003742A	0.9	female	1942	2018-05-14	Esophagus					5041	2018-03-14	Primary	esophagus	Yes	Yes	Yes	2017-03-16	2018-04-17	Capecitabine/Oxaliplatin	Chemotherapy	null	null	null
CPCT02130071T	HMF003587	HMF003587A	0.21	male	1948	null	Esophagus					5041	2018-03-14	Liver	segment 4	No	No	Yes	2018-03-16	2018-06-20	Capecitabine/Oxaliplatin	Chemotherapy	2018-06-25	Yes	PD
CPCT02130079T	HMF001518	HMF001518A	0.22	female	1943	null	Pancreas					1793	2018-03-20	Liver	right lobe	No	No	Yes	2018-04-05	2018-07-11	Gemcitabine/Paclitaxel	Chemotherapy	2018-06-18	Yes	PD
CPCT02130084T	HMF002294	HMF002294A	0.46	male	1953	2019-01-29	Bile duct		Carcinoma			4947	2018-03-22	Liver	segment 1	No	No	Yes	2018-05-29	2018-05-29	Gemcitabine	Chemotherapy	null	null	null
CPCT02130085T	HMF002544	HMF002544A	0.51	female	1946	2018-05-21	Ovary					2394	2018-03-22	Liver	segment 4	Yes	No	Yes	2018-03-23	2018-05-04	Carboplatin/Gemcitabine	Chemotherapy	2018-05-08	Yes	PD
CPCT02130087T	HMF002586	HMF002586A	0.52	female	1942	null	Ovary		Germ cell tumor			2155	2018-03-23	Lymph node	para-iliacal	Yes	No	Yes	2018-03-28	2018-10-08	Carboplatin/Gemcitabine	Chemotherapy	2018-05-25	Yes	SD
CPCT02130093T	HMF001159	HMF001159A	0.72	female	1972	2020-08-24	Ovary					2394	2018-03-28	Peritoneum	abdomen, right upper quadrant	Yes	Yes	Yes	2018-04-03	2018-09-25	Fulvestrant	Hormonal therapy	null	null	null
CPCT02130094T	HMF003661	HMF003661A	0.57	female	1963	null	Vulva					1245	2018-03-29	vulva	in resection area	No	No	Yes	2018-04-05	2018-05-14	Carboplatin/Paclitaxel	Chemotherapy	null	null	null
CPCT02130095T	HMF002089	HMF002089A	0.23	male	1949	2018-04-10	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-04-03	Liver	known metastase	No	Yes	null	null	null	null	null	null	null	null
CPCT02130096T	HMF002466	HMF002466A	0.68	male	1935	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-04-04	Primary	liver	No	No	Yes	2018-04-11	2018-04-19	Sorafenib	Targeted therapy	null	null	null
CPCT02130103T	HMF001273	HMF001273A	0.59	male	1960	null	Unknown	CUP	Carcinoma			305	2018-04-12	Lymph node	supraclaviculair	Yes	Yes	Yes	2018-06-21	2018-09-11	Carboplatin/Gemcitabine	Chemotherapy	2018-09-04	Yes	PR
CPCT02130105T	HMF000605	HMF000605A	0.25	male	1941	2019-02-20	Esophagus					5041	2018-04-13	Lymph node	inguinal right side	Yes	Yes	Yes	2018-04-23	2018-06-04	Irinotecan/Oxaliplatin/Paclitaxel	Chemotherapy	2018-06-11	Yes	PD
CPCT02130116T	HMF000638	HMF000638A	0.48	female	1969	null	Bile duct		Carcinoma			4947	2018-05-03	Liver	segment 5	No	No	Yes	2018-05-25	2018-08-12	Gemcitabine/Carboplatin	Chemotherapy	2018-08-20	Yes	PD
CPCT02130118T	HMF000163	HMF000163A	0.28	female	1973	null	Pancreas					1793	2018-05-11	Liver	metastasis	No	No	Yes	2018-05-11	2018-10-22	Fluorouracil/Oxaliplatin/Irinotecan	Chemotherapy	null	null	null
CPCT02130120T	HMF003501	HMF003501A	0.42	female	1945	2018-05-27	Pancreas					1793	2018-05-08	Liver	left liver lobe	No	No	Yes	2018-04-26	2018-05-20	Fluorouracil/Oxaliplatin/Irinotecan	Chemotherapy	null	null	null
CPCT02130122T	HMF000095	HMF000095A	0.61	male	1966	2018-08-11	Stomach					10534	2018-05-07	Primary	cardia stomach	No	Yes	null	null	null	null	null	null	null	null
CPCT02130125T	HMF001472	HMF001472A	0.71	female	1979	2018-11-08	Uterus	Cervix	Carcinoma	Neuroendocrine carcinoma		2893,1800	2018-05-22	Lymph node	Neck	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02130127T	HMF003615	HMF003615A	0.81	female	1948	2018-08-07	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-05-29	Primary	Liver	No	Yes	null	null	null	null	null	null	null	null
CPCT02130129T	HMF001717	HMF001717A	0.27	female	1969	null	Pancreas					1793	2018-06-01	Liver	liver	No	No	Yes	2018-06-05	2018-07-26	Fluorouracil/Oxaliplatin/Irinotecan/Leucovorin	Multiple therapy	null	null	null
CPCT02130131T	HMF000546	HMF000546A	0.42	female	1972	2020-01-10	Uterus	Cervix				4362	2018-06-05	Lymph node	neck, left	Yes	Yes	Yes	2018-06-12	2018-09-27	Bevacizumab/Paclitaxel/Topotecan	Multiple therapy	2018-08-08	Yes	PR
CPCT02130132T	HMF001861	HMF001861A	0.49	male	1956	null	Bile duct		Carcinoma			4947	null	null	null	Yes	No	null	null	null	null	null	null	null	null
CPCT02130134T	HMF001776	HMF001776A	0.86	female	1951	2018-07-24	Uterus	Endometrium	Carcinoma	Carcinosarcoma	Multifocal	6171,4236	2018-06-08	Liver	liver	No	Yes	null	null	null	null	null	null	null	null
CPCT02130137T	HMF001307	HMF001307A	0.66	male	1957	2018-12-07	Colorectum	Rectum	Carcinoma			1993,305	2018-06-19	Liver	liver	Yes	Yes	Yes	2018-07-05	2018-08-28	Fluorouracil/Cetuximab/Irinotecan	Multiple therapy	2018-08-22	Yes	SD
CPCT02130138T	HMF001904	HMF001904A	0.69	male	1956	2019-02-23	Bile duct		Carcinoma			4947	2018-06-20	Liver	Liver	No	No	Yes	2018-07-01	2018-12-07	Gemcitabine/Cisplatin	Chemotherapy	2018-10-23	Yes	SD
CPCT02130139T	HMF000358	HMF000358A	0.72	female	1954	2018-10-02	Bile duct		Carcinoma			4947	2018-06-20	Liver	liver	No	No	Yes	2018-06-27	2018-08-22	Cisplatin/Gemcitabine	Chemotherapy	2018-08-22	Yes	PD
CPCT02130140T	HMF000863	HMF000863A	0.36	male	1941	2018-10-01	Esophagus					5041	2018-06-21	abdominal wall (subcutaneous)	abdominal wall	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02130142T	HMF002609	HMF002609A	0.57	male	1941	2018-07-18	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-06-21	Liver	Liver	No	No	null	null	null	null	null	null	null	null
CPCT02130148T	HMF000327	HMF000327A	0.55	female	1951	2018-12-11	Uterus	Cervix				4362	2018-06-29	Liver	left lobe	No	No	Yes	2018-06-29	2018-10-14	Carboplatin/Etoposide	Chemotherapy	2018-08-20	Yes	PR
CPCT02130152T	HMF002929	HMF002929A	0.27	male	1965	null	Bile duct		Carcinoma			4947	2018-07-11	Liver	left lobe	No	Yes	Yes	2018-08-17	2018-10-21	Gemcitabine/Cisplatin	Chemotherapy	null	null	null
CPCT02130155T	HMF001420	HMF001420A	0.57	male	1944	2018-11-11	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-07-24	Liver	liver	No	No	Yes	2018-07-30	2018-11-11	Sorafenib	Targeted therapy	2018-09-10	Yes	SD
CPCT02130156T	HMF001768	HMF001768A	0.31	male	1942	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-08-08	Adrenal gland	left adrenal gland	No	No	Yes	2018-08-17	2018-10-15	Sorafenib	Targeted therapy	2018-10-12	Yes	SD
CPCT02130157T	HMF002320	HMF002320A	0.52	male	1977	2018-11-01	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-08-09	Liver	liver	No	No	Yes	2018-08-09	2018-09-08	Sorafenib	Targeted therapy	2018-09-20	Yes	PD
CPCT02130158T	HMF000392	HMF000392A	0.81	female	1955	2018-12-29	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-08-17	Liver	liver	No	No	Yes	2018-08-17	2018-10-16	Sorafenib	Targeted therapy	2018-10-15	Yes	PD
CPCT02130159T	HMF003251	HMF003251A	0.55	male	1966	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-08-23	abdominal wall (subcutaneous)	cranial side scar	Yes	No	Yes	2018-08-24	2018-12-21	Regorafenib	Targeted therapy	2018-10-18	Yes	SD
CPCT02130163T	HMF002075	HMF002075A	0.72	female	1968	2021-08-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-09-06	Liver	segment 6/7	Yes	Yes	Yes	2018-09-06	2021-07-24	Letrozole/Palbociclib	Multiple therapy	2018-11-19	Yes	SD
CPCT02130164T	HMF002508	HMF002508A	0.47	male	1956	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-10-02	Primary	kidney	No	No	Yes	2018-10-09	2019-03-01	Sunitinib	Targeted therapy	2019-01-22	Yes	SD
CPCT02130167T	HMF003987	HMF003987A	0.77	female	1948	2020-04-26	Liver		Carcinoma	Hepatocellular carcinoma		684	2019-01-10	Liver	segment 7	No	No	Yes	2019-01-26	2019-02-22	Sorafenib	Targeted therapy	2019-04-02	Yes	SD
CPCT02130169T	HMF004348	HMF004348A	0.92	male	1947	2019-08-19	Prostate					10283	2019-02-21	Kidney	right side	No	No	Yes	2019-03-19	2019-06-24	Abiraterone	Hormonal therapy	2019-06-24	Yes	PD
CPCT02130170T	HMF003991	HMF003991A	0.28	male	1935	2019-09-04	Thyroid gland					1781	2019-02-21	pleura	lung, right side	No	Yes	Yes	2019-02-25	2019-04-15	Lenvatinib	Targeted therapy	2019-04-25	Yes	PD
CPCT02130172T	HMF004306	HMF004306A	0.45	male	1967	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2019-03-06	Lung	right	No	No	Yes	2019-03-07	2019-05-20	Sorafenib	Targeted therapy	2019-05-09	Yes	SD
CPCT02130173T	HMF004132	HMF004132A	0.71	female	1963	2020-11-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-03-08	Brain	leasion frontal lobe	Yes	Yes	Yes	2019-03-29	2020-11-30	Osimertinib	Targeted therapy	2019-05-03	Yes	SD
CPCT02130180T	HMF003993	HMF003993A	0.59	female	1942	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2019-04-05	Liver	segment 7	No	No	Yes	2019-04-16	2019-05-06	Sorafenib	Targeted therapy	null	null	null
CPCT02130184T	HMF004324	HMF004324A	0.78	male	1954	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2019-06-21	Liver	segment 2/3	No	No	Yes	2019-06-23	2020-02-01	Lenvatinib/Regorafenib	Targeted therapy	2019-08-12	Yes	SD
CPCT02130186T	HMF004040	HMF004040A	0.48	male	1955	null	Liver		Carcinoma	Hepatocellular carcinoma		684	2019-06-11	Liver	right liver side	No	No	Yes	2019-06-12	2020-06-10	Sorafenib	Targeted therapy	2019-08-12	Yes	SD
CPCT02130189T	HMF004958	HMF004958A	0.48	male	1950	2020-10-10	Pancreas					1793	2020-06-16	Liver	segment 3	No	No	Yes	2020-06-22	2020-10-01	Leucovorin/Fluorouracil/Irinotecan/Oxaliplatin	Multiple therapy	2020-08-24	Yes	SD
CPCT02130190T	HMF005038	HMF005038A	0.25	male	1965	null	Pancreas					1793	2020-07-14	Liver	Segment 6	No	No	Yes	2020-07-22	2020-10-08	Leucovorin/Fluorouracil/Irinotecan/Oxaliplatin	Multiple therapy	null	null	null
CPCT02130195T	HMF005221	HMF005221A	0.61	male	1949	2021-05-15	Pancreas					1793	2020-11-11	Liver	segment 4	No	No	Yes	2021-01-13	2021-03-04	Leucovorin/Fluorouracil/Irinotecan/Oxaliplatin	Multiple therapy	2021-03-02	Yes	PD
CPCT02130200T	HMF005627	HMF005627A	0.41	male	1947	null	Pancreas					1793	2021-02-23	Liver	Segment 2/3	No	No	Yes	2021-03-24	null	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	null	null	null
CPCT02130203T	HMF005628	HMF005628A	0.33	male	1986	null	Pancreas					1793	2021-03-11	Liver	unknown	No	No	Yes	2021-03-23	null	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	null	null	null
CPCT02140003T	HMF001011	HMF001011B	0.51	male	1954	2017-06-08	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-03-24	Lymph node	para-aortal	No	No	Yes	2016-03-26	2017-03-13	Pazopanib	Targeted therapy	2016-06-08	Yes	SD
CPCT02140004T	HMF000914	HMF000914A	0.51	female	1957	2017-10-13	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-03-23	Skin/ cutaneous	Scalp	Yes	Yes	Yes	2017-02-15	2017-09-13	Fluorouracil/Epirubicin/Cyclophosphamide	Chemotherapy	2017-04-10	Yes	PR
CPCT02140004TII	HMF000914	HMF000914B	0.68	female	1957	2017-10-13	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-02-08	Subcutaneous	Back of the head	Yes	Yes	Yes	2017-02-15	2017-09-13	Fluorouracil/Epirubicin/Cyclophosphamide	Chemotherapy	2017-04-10	Yes	PR
CPCT02140006T	HMF002071	HMF002071A	0.75	male	1938	2016-12-07	Prostate					10283	2016-04-20	Liver	Right liver lobe	Yes	No	Yes	2016-04-25	2016-07-18	Cabazitaxel	Chemotherapy	2016-07-04	Yes	PD
CPCT02140007T	HMF003190	HMF003190A	0.4	male	1948	2018-07-24	Prostate					10283	2016-06-02	Primary	Prostate (Tur-p)	Yes	No	Yes	2016-06-10	2017-04-24	Enzalutamide	Hormonal therapy	2016-09-02	Yes	Non-CR/Non-PD
CPCT02140010T	HMF002108	HMF002108A	0.26	male	1950	2016-07-12	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-06-23	Bone	Os ileum lesion left	Yes	Yes	Yes	2016-07-06	2016-07-12	Nivolumab	Immunotherapy	null	null	null
CPCT02140011T	HMF002517	HMF002517A	0.87	male	1959	2017-12-31	Prostate					10283	2016-06-23	Lymph node	Para aortal left (intra abdominal)	Yes	Yes	Yes	2016-07-04	2016-11-21	Radium-223	Nuclear therapy	2016-09-12	Yes	Non-CR/Non-PD
CPCT02140012T	HMF001652	HMF001652A	0.38	male	1942	2018-07-23	Colorectum					9256	2016-06-30	Colon	Rectum	No	No	Yes	2016-07-07	2018-01-24	Capecitabine/Capecitabine/Oxaliplatin/Oxaliplatin/Bevacizumab	Multiple therapy	2016-08-30	Yes	SD
CPCT02140015T	HMF002362	HMF002362A	0.63	male	1939	2016-10-14	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-08-03	Subcutaneous	Para-vertebral right	Yes	No	Yes	2016-09-07	2016-09-29	Nivolumab	Immunotherapy	null	null	null
CPCT02140017T	HMF000213	HMF000213B	0.93	male	1947	2019-01-13	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-08-16	Kidney	Lymph node mediastinum	No	No	Yes	2016-08-17	2018-03-13	Pazopanib	Targeted therapy	2016-11-01	Yes	SD
CPCT02140018T	HMF003544	HMF003544A	0.33	female	1935	2018-08-10	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-08-25	Lung	Left upper lobe	Yes	No	Yes	2016-10-11	2016-12-14	Pemetrexed/Carboplatin	Chemotherapy	2016-12-28	Yes	SD
CPCT02140020T	HMF001440	HMF001440A	0.9	male	1941	2018-08-30	Prostate					10283	2016-08-29	Lymph node	Lymph glands throat left	Yes	Yes	Yes	2016-09-19	2017-07-28	Enzalutamide	Hormonal therapy	2016-11-16	Yes	SD
CPCT02140021T	HMF001694	HMF001694A	0.22	female	1936	2019-03-19	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-09-05	Lung	Pulmonary lesion left basal	Yes	No	Yes	2016-09-28	2019-02-08	Osimertinib	Targeted therapy	2016-12-28	Yes	SD
CPCT02140022T	HMF000826	HMF000826B	0.63	male	1957	2017-01-26	Prostate					10283	2016-09-06	Lymph node	Para-aortal	Yes	Yes	Yes	2016-09-09	2016-11-11	Cabazitaxel	Chemotherapy	2016-11-22	Yes	SD
CPCT02140023T	HMF003266	HMF003266A	0.93	male	1948	2016-10-12	Prostate					10283	2016-09-08	Liver	Liver intercostal	Yes	Yes	Yes	2016-09-10	2016-09-10	Docetaxel	Chemotherapy	null	null	null
CPCT02140024T	HMF003699	HMF003699A	0.35	female	1947	2017-03-19	Mesothelium		Malignant mesothelioma			1790,0050686	2016-10-17	Pleura	Enlargement right	Yes	No	null	null	null	null	null	null	null	null
CPCT02140025T	HMF000249	HMF000249A	0.58	male	1951	2017-11-16	Prostate					10283	2017-05-09	Lymph node	Para aortal	Yes	Yes	Yes	2016-11-03	2017-03-23	Radium-223	Nuclear therapy	2017-04-12	Yes	ND
CPCT02140026T	HMF001972	HMF001972A	0.4	male	1953	2016-12-27	Prostate					10283	2016-11-03	Lymph node	Supraclavicular left	Yes	No	Yes	2016-11-04	2016-12-06	Enzalutamide	Hormonal therapy	null	null	null
CPCT02140028T	HMF003233	HMF003233A	0.74	female	1946	2017-04-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-11-14	Lung	Sub-pleural lesion dorsal right	Yes	Yes	Yes	2016-12-01	2017-02-17	Osimertinib	Targeted therapy	2017-01-16	Yes	SD
CPCT02140029T	HMF000938	HMF000938A	0.61	male	1960	2017-03-06	Prostate					10283	2016-11-14	Bone	Os ilium left	Yes	No	Yes	2016-11-15	2017-01-17	Enzalutamide	Hormonal therapy	2017-01-05	No	PD
CPCT02140030T	HMF001592	HMF001592B	0.91	male	1960	2017-06-01	Prostate					10283	2016-11-14	Lymph node	Sub-clavicular right	Yes	No	Yes	2016-11-21	2017-01-30	Cabazitaxel	Chemotherapy	2017-01-02	Yes	SD
CPCT02140034T	HMF003467	HMF003467A	0.29	male	1964	2020-04-10	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-03-09	Liver	Left lobe	No	No	Yes	2016-12-16	2018-03-05	Sunitinib/Pazopanib	Targeted therapy	null	null	null
CPCT02140036T	HMF001544	HMF001544A	0.5	male	1968	2017-11-13	Colorectum					9256	2017-01-12	Liver	Left lobe	Yes	Yes	Yes	2017-01-16	2017-05-01	Irinotecan	Chemotherapy	2017-03-21	Yes	SD
CPCT02140037T	HMF002844	HMF002844A	0.42	male	1956	2017-08-24	Urothelial tract	Bladder				11054	2017-01-12	Liver	Segment 5	No	No	Yes	2017-01-17	2017-05-16	Gemcitabine/Cisplatin	Chemotherapy	2017-03-14	Yes	PR
CPCT02140038T	HMF001909	HMF001909A	0.44	male	1947	2018-01-20	Prostate					10283	2017-01-26	Liver	Right lobe dorsocranial	Yes	Yes	Yes	2017-02-01	2017-04-26	Abiraterone	Hormonal therapy	2017-04-21	Yes	PD
CPCT02140040T	HMF000663	HMF000663A	0.3	male	1941	2018-03-15	Prostate					10283	2017-02-23	Bone	Os ilium right	Yes	Yes	Yes	2017-03-13	2017-09-04	Cabazitaxel	Chemotherapy	2017-05-24	Yes	Non-CR/Non-PD
CPCT02140041T	HMF001806	HMF001806A	0.33	male	1955	2019-03-12	Prostate					10283	2017-03-30	Lymph node	Para-aortal left	Yes	Yes	Yes	2017-03-31	2017-08-21	Enzalutamide	Hormonal therapy	2017-06-19	Yes	SD
CPCT02140041TII	HMF001806	HMF001806C	0.79	male	1955	2019-03-12	Prostate					10283	2017-09-06	Lymph node	Para-aortal left	Yes	Yes	Yes	2017-03-31	2017-08-21	Enzalutamide	Hormonal therapy	2017-06-19	Yes	SD
CPCT02140041TIII	HMF001806	HMF001806B	0.85	male	1955	2019-03-12	Prostate					10283	2018-06-14	Lymph node	Para-aortal left	Yes	Yes	Yes	2017-03-31	2017-08-21	Enzalutamide	Hormonal therapy	2017-06-19	Yes	SD
CPCT02140041TIV	HMF001806	HMF001806E	0.86	male	1955	2019-03-12	Prostate					10283	2018-09-27	Lymph node	Para-aortal left	Yes	Yes	Yes	2017-03-31	2017-08-21	Enzalutamide	Hormonal therapy	2017-06-19	Yes	SD
CPCT02140042T	HMF002388	HMF002388A	0.5	male	1955	2017-08-24	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-04-05	Bone	Mass retro-sternal	No	No	Yes	2017-04-18	2017-06-30	Pazopanib	Targeted therapy	2017-06-30	Yes	PD
CPCT02140044T	HMF000171	HMF000171A	0.41	female	1968	2018-05-17	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-15	Liver	left lobe	Yes	Yes	Yes	2017-11-20	2018-05-04	Everolimus/Everolimus/Exemestane	Multiple therapy	2018-01-30	Yes	SD
CPCT02140045T	HMF000840	HMF000840B	0.57	male	1950	2018-03-02	Prostate				Also possible rectum cancer	10283	2017-06-15	Lymph node	Para-aortic	Yes	Yes	Yes	2017-06-26	2017-11-21	Cabazitaxel	Chemotherapy	2017-09-08	Yes	SD
CPCT02140046T	HMF001943	HMF001943A	0.4	male	1959	2020-05-03	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-06-16	Lung	Pleural lesion thoracic wall right side	No	No	Yes	2017-06-27	2019-02-19	Avelumab/Avelumab/Axitinib	Multiple therapy	2017-08-01	Yes	SD
CPCT02140050T	HMF000141	HMF000141A	0.75	male	1950	2017-10-11	Prostate					10283	2017-09-01	Lymph node	Neck	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02140052T	HMF001217	HMF001217A	0.4	male	1947	2018-11-23	Prostate					10283	2017-10-27	Lymph node	Para aortal mass	Yes	Yes	Yes	2017-10-30	2018-03-19	Docetaxel	Chemotherapy	2018-01-15	Yes	SD
CPCT02140053T	HMF003443	HMF003443A	0.28	female	1976	2017-11-25	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-26	Liver	|Lesion centre in liver	Yes	Yes	Yes	2017-10-27	2017-11-04	Vinorelbine	Chemotherapy	null	null	null
CPCT02140054T	HMF003063	HMF003063A	0.42	male	1950	2018-08-22	Prostate					10283	2017-11-01	Bone	Os ileum right	Yes	Yes	Yes	2017-11-03	2018-05-15	Docetaxel	Chemotherapy	2017-12-13	Yes	PR
CPCT02140055T	HMF002593	HMF002593A	0.23	male	1939	2018-02-14	Prostate					10283	2017-11-08	Liver	Left lobe	Yes	No	Yes	2017-12-01	2018-01-19	Cabazitaxel	Chemotherapy	2018-01-03	Yes	SD
CPCT02140057T	HMF000296	HMF000296B	0.99	female	1956	2018-08-12	Lung		Carcinoma	Small cell carcinoma		5409	2017-11-28	Subcutaneous	Epigastrium	Yes	No	Yes	2017-12-07	2017-12-28	Cyclophosphamide/Doxorubicin/Etoposide	Chemotherapy	null	null	null
CPCT02140059T	HMF001616	HMF001616A	0.42	male	1954	2018-05-11	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-12-21	Lymph node	intra abdominal	No	No	Yes	2017-12-23	2018-04-20	Pazopanib	Targeted therapy	2018-03-09	Yes	SD
CPCT02140060T	HMF000212	HMF000212A	0.63	male	1953	2019-05-01	Prostate					10283	2018-01-17	Bone	os ileum left	Yes	Yes	Yes	2018-01-17	2018-05-01	Cabazitaxel	Chemotherapy	null	null	null
CPCT02140061T	HMF000062	HMF000062A	0.57	male	1977	2018-09-15	Colorectum					9256	2018-01-24	Liver	left lobe	Yes	No	Yes	2018-02-01	2018-04-26	Irinotecan	Chemotherapy	2018-03-26	Yes	SD
CPCT02140065T	HMF002079	HMF002079A	0.46	male	1945	2018-08-15	Prostate					10283	2018-02-21	Bone	os ileum right	Yes	Yes	Yes	2018-02-27	2018-05-22	Radium-223	Nuclear therapy	null	null	null
CPCT02140067T	HMF001357	HMF001357A	0.87	male	1968	2021-01-26	Prostate					10283	2018-03-13	Lymph node	Lyphome right para iliac	Yes	No	Yes	2018-03-01	2019-07-09	Enzalutamide	Hormonal therapy	2018-09-14	Yes	SD
CPCT02140070T	HMF002837	HMF002837A	0.43	female	1951	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-03-26	Lymph node	lymph node left retroperitoneal	Yes	No	Yes	2018-03-27	2019-04-23	Nivolumab	Immunotherapy	2018-06-12	Yes	SD
CPCT02140071T	HMF000934	HMF000934A	0.47	male	1963	2022-05-21	Kidney		Carcinoma	Renal cell carcinoma		4450	null	null	null	No	No	Yes	2018-04-10	2020-06-29	Pazopanib	Targeted therapy	2018-06-26	Yes	SD
CPCT02140074T	HMF003633	HMF003633A	0.41	male	1953	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-05-04	pleural mass	right	No	No	Yes	2018-06-01	2020-11-23	Pazopanib	Targeted therapy	2018-07-13	Yes	SD
CPCT02140075T	HMF001821	HMF001821A	0.87	male	1946	2018-09-30	Prostate					10283	2018-05-18	Lymph node	left groin	Yes	No	Yes	2018-05-25	2018-09-28	Docetaxel	Chemotherapy	2018-08-06	Yes	SD
CPCT02140080T	HMF001928	HMF001928A	0.22	male	1966	2019-07-12	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-06-06	Intra abdominal mass (fatty tissue)	close to spleen	Yes	No	Yes	2018-06-08	2019-05-22	Nivolumab	Immunotherapy	2018-08-24	Yes	PR
CPCT02140081T	HMF001260	HMF001260A	0.6	male	1940	2019-03-29	Prostate					10283	2018-06-19	Lymph node	left inguinal	Yes	No	Yes	2018-06-22	2018-10-26	Docetaxel	Chemotherapy	2018-08-14	Yes	SD
CPCT02140083T	HMF002363	HMF002363A	0.45	female	1936	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-27	Skin	left breast	Yes	Yes	Yes	2018-07-03	2018-11-21	Fulvestrant/Palbociclib	Multiple therapy	2018-09-17	Yes	PD
CPCT02140086T	HMF003728	HMF003728A	0.84	male	1955	null	Prostate					10283	2018-07-24	Lymph node	Para-aortal	Yes	Yes	Yes	2018-07-25	null	Enzalutamide	Hormonal therapy	2018-10-22	Yes	PR
CPCT02140087T	HMF001207	HMF001207A	0.34	male	1939	2018-12-26	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-08-13	Primary	Left kidney	No	No	Yes	2018-08-16	2018-08-31	Pazopanib	Targeted therapy	null	null	null
CPCT02140093T	HMF001029	HMF001029A	0.28	male	1950	2019-07-08	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-10-11	Liver	Left	Yes	Yes	Yes	2018-10-15	2018-10-15	Nivolumab	Immunotherapy	null	null	null
CPCT02140095T	HMF001967	HMF001967B	0.33	male	1958	2019-10-25	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-11-01	Primary	Right kidney	Yes	No	Yes	2018-11-02	2019-09-30	Cabozantinib	Targeted therapy	2019-01-15	Yes	SD
CPCT02140098T	HMF004284	HMF004284A	0.6	male	1956	2021-10-06	Prostate					10283	2018-12-27	Lymph node	Lateral of V. Iliaca externa	Yes	Yes	Yes	2019-03-05	2019-06-25	Apalutamide/JNJ-63723283	Multiple therapy	2019-04-23	Yes	SD
CPCT02140101T	HMF003933	HMF003933A	0.5	male	1958	2019-04-18	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-01-28	Liver	Right lobe	Yes	No	Yes	2019-02-05	2019-03-19	Pembrolizumab	Immunotherapy	2019-04-01	Yes	PD
CPCT02140104T	HMF004353	HMF004353A	0.36	female	1972	2020-04-24	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-02-26	Lymph node	Left jugular	No	No	Yes	2019-03-14	2019-04-03	Ipilimumab/Nivolumab	Immunotherapy	null	null	null
CPCT02140105T	HMF004308	HMF004308A	0.26	male	1968	2019-12-23	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-03-08	Skin	Cheek	No	Yes	Yes	2019-03-13	2019-05-07	Pazopanib	Targeted therapy	2019-05-03	Yes	PD
CPCT02140110T	HMF004771	HMF004771A	0.41	male	1936	2019-10-29	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2019-08-14	Lung	RLL	Yes	No	Yes	2019-08-19	2019-08-19	Pembrolizumab	Immunotherapy	2019-09-06	Yes	PD
CPCT02150002T	HMF002151	HMF002151A	0.53	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-11	Liver	Segment 6	No	No	Yes	2017-08-30	2019-12-23	Letrozole/Ribociclib	Multiple therapy	2017-12-20	Yes	SD
CPCT02150005T	HMF001354	HMF001354A	0.55	male	1953	2018-08-29	Bile duct		Carcinoma			4947	2017-12-05	Liver	left lobe	No	No	Yes	2017-12-19	2018-04-05	Gemcitabine/Cisplatin	Chemotherapy	2018-03-06	Yes	SD
CPCT02150006T	HMF001218	HMF001218A	0.77	male	1947	2018-03-19	Skin		Melanoma			8923	2017-12-07	Lymph node	lymph node left axilla	No	No	null	null	null	null	null	null	null	null
CPCT02150008T	HMF001537	HMF001537A	0.81	male	1951	2018-09-05	Prostate					10283	2018-03-08	Bone	Os Ileum	Yes	Yes	Yes	2018-03-15	2018-04-24	Enzalutamide	Hormonal therapy	null	null	null
CPCT02150012T	HMF002913	HMF002913A	0.74	male	1952	2018-09-01	Esophagus					5041	2018-04-05	Liver	right liver lobe	Yes	Yes	Yes	2018-04-16	2018-06-11	Paclitaxel/Carboplatin	Chemotherapy	2018-06-27	Yes	SD
CPCT02150013T	HMF002541	HMF002541A	0.59	male	1972	2018-09-30	Stomach					10534	2018-04-17	Liver	not specified	No	No	Yes	2018-04-19	2018-07-26	Cisplatin/Trastuzumab/Capecitabine/Oxaliplatin	Multiple therapy	2018-06-14	Yes	PR
CPCT02150014T	HMF002524	HMF002524A	0.65	female	1983	2018-09-29	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-18	Liver	Left lobe	Yes	Yes	Yes	2018-04-24	2018-05-11	Paclitaxel	Chemotherapy	null	null	null
CPCT02150016T	HMF001559	HMF001559A	0.83	female	1955	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-24	Mammae	upper right quarter	No	No	Yes	2018-04-30	2020-02-04	Palbociclib/Anastrozole	Multiple therapy	null	null	null
CPCT02150018T	HMF001349	HMF001349A	0.59	female	1961	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-05-24	Liver	Segment 3	No	No	Yes	2018-06-06	2019-06-05	Carboplatin/Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	null	null	null
CPCT02150019T	HMF001790	HMF001790A	0.72	male	1960	2019-03-31	Prostate					10283	2018-06-01	Liver	Not specified	Yes	No	Yes	2018-06-05	2018-08-28	Docetaxel	Chemotherapy	2018-09-04	Yes	PD
CPCT02150021T	HMF002020	HMF002020A	0.67	male	1958	2018-07-25	Esophagus					5041	2018-06-22	Subcutaneous	Near the musculus gluteus, right	No	No	Yes	2018-07-17	2018-07-17	Carboplatin/Paclitaxel	Chemotherapy	null	null	null
CPCT02150022T	HMF001417	HMF001417A	0.24	female	1950	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-06-20	Lymph node	Neck left	No	No	null	null	null	null	null	null	null	null
CPCT02150025T	HMF000916	HMF000916A	0.85	female	1966	2018-07-28	Colorectum					9256	2018-07-02	Peritoneum	Omentum	No	No	Yes	2018-07-03	2018-07-07	Trifluridine	Chemotherapy	null	null	null
CPCT02150026T	HMF001475	HMF001475A	0.63	male	1939	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-07-17	Lymph node	Inguinal left	No	No	Yes	2018-08-06	2019-01-07	Cyclophosphamide/Doxorubicin/Rituximab/Vincristine	Multiple therapy	2018-10-25	Yes	PR
CPCT02150027T	HMF001425	HMF001425A	0.7	female	1953	null	Breast		Carcinoma	Triple negative		0060081	2018-07-18	Liver	Left lobe	No	No	Yes	2018-07-24	2018-11-06	Cyclophosphamide/Doxorubicin/Fluorouracil	Chemotherapy	2018-09-19	Yes	PR
CPCT02150030T	HMF001545	HMF001545A	0.73	male	1950	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-08-14	Lymph node	Supraclavicular, right	No	No	Yes	2018-09-27	2020-04-09	Rituximab/Ibrutinib or placebo	Multiple therapy	2019-01-21	Yes	PR
CPCT02150031T	HMF002374	HMF002374A	0.83	male	1955	2019-04-11	Prostate					10283	2018-08-21	Liver	Segment 5/8	Yes	No	Yes	2018-09-17	2019-01-24	Cisplatin/Etoposide/Etoposide	Chemotherapy	2018-11-20	Yes	SD
CPCT02150033T	HMF000215	HMF000215A	0.9	male	1955	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-09-25	Lymph node	Cervical left	No	No	Yes	2018-10-16	2019-02-11	Cyclophosphamide/Methotrexate/Doxorubicin/Vincristine/Rituximab/Cytarabine/Etoposide/Ifosfamide/Rituximab/Cytarabine	Multiple therapy	null	null	null
CPCT02150034T	HMF000110	HMF000110A	0.58	male	1954	2018-11-04	Bone/Soft tissue		Undifferentiated sarcoma			1115	2018-10-01	Peritoneum	mesenteric	No	No	null	null	null	null	null	null	null	null
CPCT02150038T	HMF004267	HMF004267A	0.61	male	1967	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2019-01-09	Buttock (musculair)	Lateral top edge left	Yes	No	Yes	2019-01-29	null	Bendamustine/Rituximab/Lenalidomide	Multiple therapy	2019-04-19	Yes	PR
CPCT02150040T	HMF004315	HMF004315A	0.86	female	1979	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-01-23	Lymph node	Axilla right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02150043T	HMF004091	HMF004091A	0.57	male	1967	2020-04-15	Prostate					10283	null	null	null	No	No	Yes	2019-03-22	2019-06-14	Docetaxel	Chemotherapy	2019-07-08	Yes	PD
CPCT02150044T	HMF004186	HMF004186A	0.86	female	1948	2019-02-26	Unknown	CUP	Carcinoma			305	2019-02-14	Liver	segment 5/7	No	No	null	null	null	null	null	null	null	null
CPCT02150046T	HMF004286	HMF004286A	0.79	female	1965	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2019-02-19	Liver	right liver lobe, segment 5	No	No	Yes	2019-02-25	2019-05-21	Docetaxel/Pertuzumab/Trastuzumab/Paclitaxel	Multiple therapy	2019-05-03	Yes	PR
CPCT02150048T	HMF003819	HMF003819A	0.71	male	1965	null	Colorectum					9256	2019-04-05	Liver	Segment 5/6	Yes	No	Yes	2019-04-12	2019-08-23	Irinotecan	Chemotherapy	2019-06-14	Yes	SD
CPCT02150051T	HMF004004	HMF004004A	0.52	female	1977	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2019-04-30	Liver	left lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02150052T	HMF004229	HMF004229A	0.85	male	1943	null	Prostate					10283	2019-05-29	Peritoneum	sacral	Yes	Yes	Yes	2019-05-30	2019-07-30	Abiraterone	Hormonal therapy	null	null	null
CPCT02160001T	HMF001868	HMF001868A	0.78	female	1944	2017-02-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-05-02	Primary	Mamma	No	Yes	Yes	2016-05-10	2017-02-10	Letrozole	Hormonal therapy	2016-07-25	Yes	SD
CPCT02160004T	HMF001502	HMF001502A	0.62	female	1951	2018-02-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-05-20	Lymph node	supraclaviculair	Yes	Yes	Yes	2016-05-30	2016-10-28	Fulvestrant	Hormonal therapy	2016-08-02	Yes	SD
CPCT02160007T	HMF003311	HMF003311A	0.26	male	1964	2018-01-13	Esophagus					5041	2016-10-13	soft tissue	Neck left	Yes	Yes	Yes	2016-11-25	null	Gemcitabine	Chemotherapy	null	null	null
CPCT02160008T	HMF003174	HMF003174A	0.2	female	1986	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2016-10-13	Lymph node	Axillair	No	No	Yes	2016-10-18	2017-11-27	Fluorouracil/Epirubicin/Cyclophosphamide/Trastuzumab/Pertuzumab/Paclitaxel/Carboplatin	Multiple therapy	2016-12-12	Yes	SD
CPCT02160009T	HMF002448	HMF002448A	0.76	female	1964	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-01	Lymph node	Axillair	No	No	Yes	2016-11-04	null	Doxorubicin/Cyclophosphamide/Docetaxel/Tamoxifen/Letrozole	Multiple therapy	2017-04-12	Yes	SD
CPCT02160010T	HMF000092	HMF000092A	0.82	male	1952	2017-03-25	Pancreas					1793	2016-10-25	Liver	right liver lob	No	No	Yes	2016-11-15	2017-01-03	Oxaliplatin/Irinotecan/Fluorouracil	Chemotherapy	2017-01-11	Yes	PD
CPCT02160012T	HMF000087	HMF000087A	0.31	female	1969	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2016-10-27	Primary	Breast	No	No	Yes	2016-10-28	2017-12-22	Doxorubicin/Cyclophosphamide/Docetaxel/Pertuzumab/Trastuzumab	Multiple therapy	2017-01-10	Yes	CR
CPCT02160013T	HMF001468	HMF001468A	0.32	female	1967	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-11-11	Primary	Breast	No	No	Yes	2016-11-18	2022-06-01	Doxorubicin/Cyclophosphamide/Tamoxifen	Multiple therapy	2017-02-07	Yes	SD
CPCT02160014T	HMF001801	HMF001801A	0.44	female	1980	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2016-11-23	Primary	Breast	No	No	Yes	2016-11-25	null	Doxorubicin/Cyclophosphamide/Docetaxel/Pertuzumab/Trastuzumab/Tamoxifen/Letrozole	Multiple therapy	2017-02-07	Yes	CR
CPCT02160015T	HMF003427	HMF003427A	0.72	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-30	Liver	left liverlob	Yes	Yes	Yes	2017-01-06	2017-03-05	Palbociclib/Fulvestrant	Multiple therapy	2017-03-01	Yes	PD
CPCT02160017T	HMF002200	HMF002200A	0.81	female	1932	2017-03-15	Ovary					2394	2017-01-18	Central in abdomen	Peritoneals lesion	Yes	No	null	null	null	null	null	null	null	null
CPCT02160018T	HMF002233	HMF002233A	0.29	female	1964	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-03	Primary	Breast left	No	No	Yes	2017-03-10	2022-07-22	Doxorubicin/Cyclophosphamide/Docetaxel/Tamoxifen/Letrozole	Multiple therapy	2017-08-11	Yes	CR
CPCT02160019T	HMF002463	HMF002463A	0.21	female	1953	2017-04-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-03	Liver	Right liverlob	Yes	Yes	Yes	2017-03-10	2017-04-10	Letrozole	Hormonal therapy	2017-04-11	Yes	PD
CPCT02160020T	HMF000833	HMF000833A	0.35	female	1942	2018-07-01	Colorectum					9256	2017-03-31	Lymph node	Neck	No	Yes	Yes	2017-04-04	2017-12-05	Capecitabine/Bevacizumab	Multiple therapy	2017-05-29	Yes	SD
CPCT02160021T	HMF003682	HMF003682A	0.65	male	1956	2017-08-21	Colorectum					9256	2017-03-31	Liver	Right liver lob	No	No	null	null	null	null	null	null	null	null
CPCT02160022T	HMF002873	HMF002873A	0.74	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-04-21	Primary	Mamma left	No	No	Yes	2017-04-25	null	Doxorubicin/Cyclophosphamide/Docetaxel/Tamoxifen/Letrozole/Tamoxifen	Multiple therapy	2017-07-04	Yes	PR
CPCT02160024T	HMF001886	HMF001886A	0.34	male	1958	2019-11-05	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-07-10	Lymph node	Abdomen	No	No	Yes	2017-07-20	2018-03-13	Sunitinib	Targeted therapy	2017-10-05	Yes	SD
CPCT02160026T	HMF003021	HMF003021A	0.78	male	1941	2018-05-08	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-07-14	Lymph node	Axilla	Yes	Yes	Yes	2017-07-20	2017-10-19	Carboplatin/Gemcitabine	Chemotherapy	2017-09-25	Yes	SD
CPCT02160027T	HMF002521	HMF002521A	0.7	female	1972	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-20	Primary	Mamma left	No	No	Yes	2017-07-24	null	Doxorubicin/Cyclophosphamide/Docetaxel/Tamoxifen	Multiple therapy	2017-10-09	Yes	PR
CPCT02160028T	HMF003187	HMF003187A	0.49	female	1943	2017-12-11	Colorectum					9256	2017-07-17	Lymph node	Mesenterium	Yes	No	Yes	2017-07-21	2017-12-08	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-10-19	Yes	SD
CPCT02160029T	HMF002412	HMF002412A	0.65	female	1967	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-24	Liver	Left liver lob	Yes	No	Yes	2017-08-24	2018-03-07	Palbociclib/Fulvestrant	Multiple therapy	2017-11-30	Yes	SD
CPCT02160030T	HMF002258	HMF002258A	0.26	female	1960	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-09-19	Primary	Right mamma	No	No	Yes	2017-09-28	null	Doxorubicin/Cyclophosphamide/Docetaxel/Pertuzumab/Trastuzumab/Tamoxifen	Multiple therapy	2018-02-27	Yes	CR
CPCT02160034T	HMF000041	HMF000041A	0.56	female	1961	null	Colorectum					9256	2017-10-20	Lymph node	parasternaal	Yes	Yes	Yes	2017-10-27	2018-09-05	Capecitabine/Bevacizumab/Oxaliplatin	Multiple therapy	2017-12-21	Yes	PR
CPCT02160035T	HMF001052	HMF001052A	0.29	male	1949	2018-11-29	Skin		Melanoma			8923	2017-11-09	Liver	Segment 2/3	No	No	Yes	2017-12-08	2018-04-17	Dabrafenib/Trametinib	Targeted therapy	2018-03-16	Yes	PR
CPCT02160036T	HMF000849	HMF000849A	0.71	female	1960	2019-04-16	Urothelial tract	Bladder				11054	2017-12-01	Lymph node	Supraclaviculair	No	No	Yes	2018-01-30	null	Cisplatin/Gemcitabine/Pembrolizumab	Multiple therapy	2018-03-09	Yes	SD
CPCT02160037T	HMF000435	HMF000435A	0.54	female	1967	null	Breast		Carcinoma	Triple negative		0060081	2018-01-16	Primary	Mamma	No	No	Yes	2018-01-24	2018-03-28	Cyclophosphamide/Doxorubicin	Chemotherapy	2018-04-09	Yes	CR
CPCT02160038T	HMF001284	HMF001284A	0.43	male	1941	2018-05-12	Colorectum					9256	2018-01-23	Lung	Right under lob	Yes	Yes	Yes	2018-02-13	2018-03-07	Trifluridine/Trifluridine	Chemotherapy	null	null	null
CPCT02160039T	HMF003730	HMF003730A	0.94	female	1952	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-09	Liver	Right liverlob	No	Yes	Yes	2018-02-20	2018-11-27	Letrozole/Palbociclib	Multiple therapy	2018-05-07	Yes	SD
CPCT02160040T	HMF001379	HMF001379B	0.67	male	1957	null	Colorectum					9256	2018-02-27	Soft tissue	Sacrum	Yes	Yes	Yes	2018-02-27	2018-07-05	Trifluridine	Chemotherapy	2018-05-07	Yes	SD
CPCT02160041T	HMF003291	HMF003291A	0.53	female	1974	2019-10-24	Breast		Carcinoma	Triple negative		0060081	2018-03-02	Primary	left mamma	No	No	Yes	2018-03-06	2018-04-17	Doxorubicin/Cyclophosphamide	Chemotherapy	2018-05-08	Yes	PD
CPCT02160042T	HMF003414	HMF003414A	0.29	female	1967	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2018-03-05	Primary	Right mamma	No	No	Yes	2018-03-07	2018-10-30	Doxorubicin/Cyclophosphamide/Docetaxel/Trastuzumab/Pertuzumab	Multiple therapy	2018-08-06	Yes	SD
CPCT02160047T	HMF001174	HMF001174A	0.42	female	1956	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-03-29	Lymph node	Lymph nodes in Pelvis	Yes	No	Yes	2018-07-13	2019-02-11	Eribulin	Chemotherapy	2018-09-06	Yes	SD
CPCT02160049T	HMF002138	HMF002138A	0.7	male	1939	2018-07-12	Colorectum					9256	2018-04-11	Liver	Left liver lob	Yes	No	Yes	2018-04-12	2018-05-06	Trifluridine	Chemotherapy	null	null	null
CPCT02160051T	HMF001161	HMF001161A	0.37	female	1969	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-25	Primary	Left mamma	No	No	Yes	2018-05-03	2018-09-27	Cyclophosphamide/Doxorubicin/Docetaxel	Chemotherapy	2018-07-17	Yes	PR
CPCT02160052T	HMF002624	HMF002624A	0.34	male	1946	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-06-05	Bone	Left hip	Yes	Yes	Yes	2018-06-11	2019-08-06	Nivolumab	Immunotherapy	2018-08-24	Yes	SD
CPCT02160055T	HMF001836	HMF001836A	0.59	female	1969	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-12	Primary	mamma left	No	No	Yes	2018-06-13	2018-11-07	Doxorubicin/Cyclophosphamide/Docetaxel	Chemotherapy	2018-08-21	Yes	SD
CPCT02160057T	HMF002515	HMF002515A	0.63	male	1966	2019-06-18	Colorectum					9256	2018-10-10	Liver	Segment 5	Yes	Yes	Yes	2018-10-18	2018-11-29	Panitumumab/Irinotecan	Multiple therapy	2018-12-11	Yes	PD
CPCT02160058T	HMF003337	HMF003337A	0.74	female	1942	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-12-19	Lung	Right side thorax	No	No	Yes	2018-12-27	2019-10-01	Letrozole/Palbociclib	Multiple therapy	2019-03-21	Yes	SD
CPCT02160059T	HMF004138	HMF004138A	0.49	male	1941	null	Colorectum					9256	2019-01-11	Liver	Segment 4	Yes	No	Yes	2019-01-23	2019-08-21	Panitumumab	Targeted therapy	2019-03-13	Yes	SD
CPCT02160060T	HMF004110	HMF004110A	0.24	male	1948	2019-06-23	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-02-22	Lymph node	Groin Right	No	No	Yes	2019-03-01	2019-05-14	Pazopanib	Targeted therapy	2019-05-08	Yes	PD
CPCT02160061T	HMF004083	HMF004083A	0.47	male	1943	2019-10-29	Prostate					10283	2019-03-20	Liver	Right liverlob	No	Yes	Yes	2019-03-26	2019-05-01	Enzalutamide	Hormonal therapy	null	null	null
CPCT02160062T	HMF004044	HMF004044A	0.46	male	1966	null	Prostate					10283	2019-05-06	Primary	prostate	Yes	No	Yes	2019-05-13	2020-04-09	Enzalutamide	Hormonal therapy	null	null	null
CPCT02170001T	HMF001116	HMF001116A	0.45	female	1938	null	Small intestine	Duodenum	Neuroendocrine tumor			10021,169	2017-03-02	Liver	liver	No	No	Yes	2017-03-01	2017-08-23	Everolimus	Targeted therapy	null	null	null
CPCT02170002T	HMF000837	HMF000837A	0.43	male	1959	2017-05-08	Pancreas		Carcinoma	Neuroendocrine carcinoma		1798,1800	2017-03-09	Liver	liver	No	No	Yes	2017-03-14	2017-04-18	Cisplatin/Etoposide	Chemotherapy	null	null	null
CPCT02170003T	HMF000510	HMF000510A	0.79	female	1949	2018-05-23	Small intestine		Neuroendocrine tumor			10154,169	2017-04-21	Liver	right liver lab	Yes	No	Yes	2017-04-24	2017-06-12	Everolimus	Targeted therapy	null	null	null
CPCT02170006T	HMF001469	HMF001469A	0.32	male	1956	null	Skin		Melanoma			8923	2017-07-13	Lymph node	left groin	No	No	Yes	2017-07-21	2018-05-25	Pembrolizumab/Pembrolizumab	Immunotherapy	null	null	null
CPCT02170007T	HMF000155	HMF000155A	0.63	male	1951	null	Stomach					10534	2017-07-18	Liver	left liver lobe	Yes	No	Yes	2017-07-21	2017-10-06	Paclitaxel/Ramucirumab	Multiple therapy	2017-10-12	Yes	PD
CPCT02170009T	HMF000569	HMF000569A	0.66	male	1950	null	Small intestine		Neuroendocrine tumor			10154,169	2017-08-29	Liver	left liver lab	No	No	Yes	2017-10-30	2018-01-08	Capecitabine/Temozolomide	Chemotherapy	2018-01-09	Yes	PD
CPCT02170010T	HMF002685	HMF002685A	0.52	female	1936	2018-04-03	Bile duct		Carcinoma			4947	2017-08-29	Liver	left liver lobe	No	No	null	null	null	null	null	null	null	null
CPCT02170012T	HMF002788	HMF002788B	0.39	male	1972	null	Thymus		Neuroendocrine tumor			3277,169	2017-09-04	pleural	left pleural intercostal	Yes	Yes	Yes	2017-09-12	2018-01-05	Carboplatin/Etoposide	Chemotherapy	2017-11-06	Yes	SD
CPCT02170013T	HMF002757	HMF002757A	0.28	male	1976	2018-03-17	Unknown	CUP	Carcinoma	Neuroendocrine carcinoma		1800	2017-09-07	cardia	cardia	Yes	No	Yes	2017-09-12	2018-01-02	Paclitaxel	Chemotherapy	2017-12-04	Yes	PR
CPCT02170014T	HMF000452	HMF000452A	0.46	female	1970	2018-09-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-26	Liver	liver capsula	Yes	Yes	Yes	2017-10-09	2018-01-02	Everolimus/Exemestane	Multiple therapy	2017-12-21	Yes	PD
CPCT02170016T	HMF003558	HMF003558A	0.38	male	1948	null	Colorectum					9256	2017-10-02	Lymph node	neck	Yes	No	Yes	2017-10-05	2019-02-26	Capecitabine/Bevacizumab/Tegafur, Gimeracil, Oteracil (S1)/Bevacizumab/Tegafur, Gimeracil, Oteracil (S1)	Multiple therapy	2017-11-22	Yes	SD
CPCT02170017T	HMF003607	HMF003607A	0.71	male	1951	2017-11-13	Skin		Melanoma			8923	2017-10-13	Lymph node	abdomen	Yes	No	Yes	2017-10-16	2017-10-16	Nivolumab/Ipilimumab	Immunotherapy	null	null	null
CPCT02170018T	HMF003691	HMF003691A	0.53	female	1953	2017-12-15	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-17	skin	under left breast	Yes	Yes	Yes	2017-11-02	2017-12-15	Palbociclib/Fulvestrant	Multiple therapy	null	null	null
CPCT02170019T	HMF001586	HMF001586A	0.31	male	1958	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-07	Lung	,transthoracaal, right basal from dorsal	Yes	No	Yes	2017-11-14	2018-01-23	Gemcitabine	Chemotherapy	2018-01-26	Yes	SD
CPCT02170020T	HMF002016	HMF002016A	0.52	female	1947	2019-01-15	Ovary					2394	2017-11-06	intra-abdominal	abdominal wall	Yes	No	Yes	2017-11-09	2018-04-16	Carboplatin/Doxorubicin (liposomal)	Chemotherapy	2018-05-02	Yes	PR
CPCT02170022T	HMF002961	HMF002961A	0.34	female	1953	2018-03-16	Pancreas		Neuroendocrine tumor			1793,169	2018-01-08	Liver	caudal right liver lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02170024T	HMF002826	HMF002826A	0.89	male	1979	null	Bile duct		Carcinoma			4947	2018-02-22	intra-abdominaal	left lower abdomen	Yes	No	Yes	2018-03-01	2018-06-07	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	2018-04-20	Yes	SD
CPCT02170027T	HMF003331	HMF003331A	0.6	female	1965	2018-09-17	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-15	skin	skin	Yes	Yes	Yes	2018-03-28	2018-04-18	Trastuzumab	Targeted therapy	2018-05-15	Yes	PD
CPCT02170032T	HMF003463	HMF003463A	0.8	female	1970	2018-10-05	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2018-05-29	Lung	left underlab	Yes	No	Yes	2018-06-05	2018-08-10	Pembrolizumab	Immunotherapy	2018-09-07	Yes	PD
CPCT02170033T	HMF001005	HMF001005A	0.68	male	1989	2019-02-09	Colorectum					9256	2018-05-31	sigmoid	sigmoid	Yes	Yes	Yes	2018-06-07	2018-07-18	Fluorouracil/Oxaliplatin/Irinotecan/Leucovorin	Multiple therapy	2018-08-23	Yes	SD
CPCT02170035T	HMF000264	HMF000264A	0.52	male	1960	null	Colorectum					9256	2018-06-06	Liver	right liver lobe	No	No	Yes	2018-06-14	2022-06-08	Bevacizumab/Oxaliplatin/Fluorouracil/Leucovorin	Multiple therapy	2018-08-01	Yes	PR
CPCT02170036T	HMF000134	HMF000134A	0.35	male	1943	2019-10-19	Kidney		Carcinoma	Squamous cell carcinoma		4451	2018-06-05	Liver	Segment VI of liver	No	Yes	Yes	2018-06-15	2018-11-23	Gemcitabine/Cisplatin	Chemotherapy	2018-08-31	Yes	PR
CPCT02170037T	HMF001872	HMF001872A	0.46	male	1955	2018-11-04	Colorectum					9256	2018-06-13	Liver	caudal right liver lobe	No	No	Yes	2018-07-10	2018-08-21	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-08-30	Yes	PR
CPCT02170039T	HMF004165	HMF004165A	0.22	male	1963	null	Skin		Melanoma			8923	2018-12-31	Lymph node	left axilla	Yes	No	Yes	2019-01-04	2019-07-09	Nivolumab/Ipilimumab	Immunotherapy	2019-02-27	Yes	SD
CPCT02180001T	HMF002745	HMF002745A	0.52	male	1934	2016-11-18	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2016-09-27	Omentum	omentum right	No	No	Yes	2016-10-14	2016-10-14	Rituximab	Targeted therapy	null	null	null
CPCT02180002T	HMF003372	HMF003372A	0.9	male	1948	2016-11-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-10-12	Lymph node	supraclavicular lymph node	No	No	null	null	null	null	null	null	null	null
CPCT02180003T	HMF003506	HMF003506A	0.74	male	1960	2020-12-05	Kidney		Carcinoma	Renal cell carcinoma		4450	2016-10-13	Abdominal wall (subcutaneous)	left	No	No	Yes	2016-10-13	2018-04-09	Pazopanib	Targeted therapy	2016-12-02	Yes	SD
CPCT02180005T	HMF001589	HMF001589A	0.94	female	1954	2019-01-16	Ovary					2394	2016-11-23	abdominal wall (subcutaneous)	abdominal wall	Yes	No	Yes	2016-11-25	2017-04-28	Doxorubicin	Chemotherapy	2017-02-13	Yes	SD
CPCT02180007T	HMF001775	HMF001775A	0.61	female	1935	2016-12-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-24	omentum cake	omentum cake right	No	No	Yes	2016-12-09	2016-12-16	Paclitaxel	Chemotherapy	null	null	null
CPCT02180009T	HMF003274	HMF003274A	0.72	female	1939	2020-11-20	Unknown	CUP	Carcinoma			305	2016-12-08	Lymph node	supraclaviculair left	No	No	Yes	2016-12-21	2017-01-04	Tamoxifen	Hormonal therapy	null	null	null
CPCT02180012T	HMF000767	HMF000767A	0.73	male	1949	2017-01-05	Skin		Melanoma			8923	2016-12-28	Lymph node	axillary right	No	No	null	null	null	null	null	null	null	null
CPCT02180015T	HMF001018	HMF001018A	0.24	male	1942	2017-02-05	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2017-01-19	Intra-abdominal	Region above belly button	No	No	Yes	2017-01-26	2017-02-05	Vincristine/Rituximab/Doxorubicin	Multiple therapy	null	null	null
CPCT02180020T	HMF003521	HMF003521A	0.67	male	1944	2017-03-30	Pancreas					1793	2017-03-09	omentum	omentum lesion right	No	No	Yes	2017-03-22	2017-03-29	Gemcitabine	Chemotherapy	null	null	null
CPCT02180022T	HMF001953	HMF001953A	0.46	male	1962	2017-12-17	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-03-16	Muscle dorsum	Paravertebral T 12 right	No	No	Yes	2017-04-18	2017-10-12	Axitinib/Avelumab/Avelumab/Axitinib	Multiple therapy	2017-05-29	Yes	PR
CPCT02180023T	HMF000540	HMF000540A	0.5	female	1942	2017-06-16	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-04-04	Liver	liver	No	No	Yes	2017-06-01	2017-06-16	Cisplatin/Pemetrexed	Chemotherapy	2017-06-12	Yes	PD
CPCT02180025T	HMF002504	HMF002504A	0.25	female	1938	2018-07-03	Ovary					2394	2017-05-08	Lymph node	retroperitoneaal	Yes	No	Yes	2017-05-29	2017-09-13	Carboplatin/Gemcitabine	Chemotherapy	2017-07-27	Yes	SD
CPCT02180028T	HMF003064	HMF003064A	0.91	female	1950	2020-10-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-11	Omental cake	Omental cake	Yes	Yes	Yes	2017-05-23	2019-03-14	Letrozole/Ribociclib	Multiple therapy	2017-08-11	Yes	PR
CPCT02180029T	HMF002523	HMF002523A	0.93	female	1952	2020-10-11	Pancreas					1793	2017-05-22	Liver	Left liver lobe metastasis	No	No	Yes	2017-05-22	2017-10-23	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2017-07-10	Yes	SD
CPCT02180030T	HMF003563	HMF003563A	0.52	female	1954	2018-02-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-17	Liver	Lateral right	No	Yes	Yes	2017-06-12	2017-08-25	Letrozole/Ribociclib	Multiple therapy	2017-08-31	Yes	PD
CPCT02180031T	HMF000927	HMF000927A	0.51	male	1955	2017-10-22	Liver		Carcinoma	Hepatocellular carcinoma		684	2017-05-23	Liver	Right side	No	No	null	null	null	null	null	null	null	null
CPCT02180032T	HMF000561	HMF000561A	0.53	male	1978	2018-07-31	Unknown		Melanoma			1909	2017-05-31	Liver	Right lateral	No	No	null	null	null	null	null	null	null	null
CPCT02180033T	HMF000631	HMF000631A	0.32	male	1953	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-06-07	Lymph node	Supra clavicular	No	No	Yes	2017-06-21	2018-07-02	Axitinib/Avelumab	Multiple therapy	2017-07-31	Yes	SD
CPCT02180037T	HMF002851	HMF002851A	0.98	male	1937	2022-12-21	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2017-07-18	Bone	Mass dorsal Sacrum	Yes	No	Yes	2017-07-28	2017-12-26	Rituximab/Chlorambucil/Etoposide/Lomustine	Multiple therapy	2018-02-05	Yes	PR
CPCT02180038T	HMF002221	HMF002221A	0.51	female	1939	2017-10-19	Pancreas					1793	2017-07-19	Liver	Left	No	No	Yes	2017-08-15	2017-09-08	Gemcitabine	Chemotherapy	null	null	null
CPCT02180041T	HMF001901	HMF001901A	0.42	female	1960	2018-05-25	Esophagus		Neuroendocrine tumor			5784,169	2017-07-24	Oesophagus	Tumormass in oesophagus	Yes	No	Yes	2017-08-02	2017-11-17	Etoposide/Carboplatin	Chemotherapy	2017-10-11	Yes	PR
CPCT02180042T	HMF003713	HMF003713A	0.46	female	1972	2017-12-05	Colorectum					9256	2017-08-30	Liver	cq Metastasis adenocarcinoma	Yes	No	Yes	2017-08-30	2017-10-25	Panitumumab	Targeted therapy	2017-11-03	Yes	PD
CPCT02180043T	HMF003019	HMF003019A	0.9	male	1964	null	Lymphoid tissue		Non-Hodgkin lymphoma	Diffuse large B-cell lymphoma		0050745	2017-09-12	Primary	Abdomen	No	No	Yes	2017-09-20	2018-02-14	Cyclophosphamide/Rituximab/Doxorubicin/Vincristine/Lenalidomide	Multiple therapy	2017-11-16	Yes	PR
CPCT02180045T	HMF000747	HMF000747A	0.34	male	1946	2018-09-08	Colorectum					9256	2017-10-09	Thoracic wall (subcutaneous)	Left	Yes	Yes	Yes	2017-10-19	2017-12-10	Fluorouracil/Irinotecan/Leucovorin	Multiple therapy	2017-12-07	Yes	SD
CPCT02180048T	HMF003729	HMF003729A	0.21	male	1937	2018-01-07	Colorectum					9256	2017-11-23	Liver	Liver (no further specification)	No	No	Yes	2017-12-21	2017-12-29	Capecitabine/Bevacizumab	Multiple therapy	null	null	null
CPCT02180049T	HMF000390	HMF000390A	0.77	female	1975	2020-03-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-28	Lymph node	High left axilliary	Yes	Yes	Yes	2017-12-05	2019-07-10	Letrozole	Hormonal therapy	2018-02-21	Yes	PR
CPCT02180050T	HMF001802	HMF001802A	0.26	female	1963	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-11-28	Primary	Mass behind left nipple	No	No	Yes	2017-12-01	2018-11-19	Paclitaxel/Pertuzumab/Trastuzumab/Carboplatin	Multiple therapy	2018-01-23	Yes	CR
CPCT02180051T	HMF002654	HMF002654A	0.68	female	1958	2019-09-11	Ovary		Carcinoma	High-grade serous carcinoma		0050933	2017-12-12	Omentum	null	No	No	Yes	2018-01-05	2018-06-29	Paclitaxel/Carboplatin	Chemotherapy	2018-02-12	Yes	PR
CPCT02180052T	HMF000101	HMF000101A	0.72	female	1941	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-19	Liver	Right	No	Yes	Yes	2017-12-28	2019-03-28	Letrozole	Hormonal therapy	2018-05-14	Yes	SD
CPCT02180053T	HMF001945	HMF001945B	0.55	female	1983	2018-05-27	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-28	Breast	Right side	Yes	No	Yes	2017-12-29	2018-03-27	Cyclophosphamide/Carboplatin	Chemotherapy	2018-02-19	Yes	PD
CPCT02180054T	HMF000695	HMF000695A	0.64	male	1953	2018-06-05	Esophagus					5041	2018-01-09	Liver	Right lobe	No	No	Yes	2018-02-01	2018-05-22	Oxaliplatin/Fluorouracil/Leucovorin	Multiple therapy	2018-03-26	Yes	SD
CPCT02180055T	HMF001686	HMF001686A	0.33	male	1955	2019-05-23	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-01-18	Lung	Right	No	No	Yes	2018-01-30	2018-06-15	Pazopanib	Targeted therapy	2018-04-17	Yes	PR
CPCT02180057T	HMF000867	HMF000867A	0.81	female	1954	2019-11-08	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-22	Liver	Right lobe	Yes	No	Yes	2018-02-09	2018-09-08	Capecitabine	Chemotherapy	2018-04-09	Yes	PR
CPCT02180064T	HMF002867	HMF002867A	0.57	female	1955	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-04-09	back (subcutaneous)	left dorsal	No	No	Yes	2018-04-16	2019-05-16	Pazopanib	Targeted therapy	2018-10-15	Yes	PR
CPCT02180067T	HMF003359	HMF003359A	0.34	male	1964	2020-09-12	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-05-03	Kidney	Left kidney	No	No	Yes	2018-05-04	2018-11-16	Pazopanib	Targeted therapy	2018-08-08	Yes	SD
CPCT02180068T	HMF003651	HMF003651A	0.65	male	1938	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-05-04	Spleen/Pancreas	Caudal spleen	No	No	Yes	2018-05-31	2018-09-13	Cetuximab/Cyclophosphamide/Vincristine/Doxorubicin	Multiple therapy	2018-07-27	Yes	PR
CPCT02180069T	HMF001036	HMF001036B	0.48	female	1979	2019-05-29	Unknown	CUP	Carcinoma	Adenocarcinoma		299	2018-05-15	Liver	Segment 3	No	No	Yes	2018-05-15	2018-07-02	Carboplatin/Paclitaxel	Chemotherapy	2018-07-18	Yes	PD
CPCT02180070T	HMF000035	HMF000035A	0.72	female	1960	2022-06-01	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-01	Lymph node	axilla right parasternal	Yes	No	Yes	2018-06-13	2018-09-05	Letrozole	Hormonal therapy	2018-09-03	Yes	PD
CPCT02180072T	HMF000664	HMF000664A	0.29	female	1956	2019-12-08	Colorectum					9256	2018-06-22	Liver	segment VII	Yes	No	Yes	2018-06-26	2019-01-03	Capecitabine/Bevacizumab	Multiple therapy	2018-08-24	Yes	SD
CPCT02180076T	HMF003788	HMF003788A	0.33	male	1956	2022-06-30	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-10-19	Liver	Right liver segment	No	Yes	Yes	2018-10-30	2021-11-01	Pazopanib	Targeted therapy	2019-01-08	Yes	PR
CPCT02180077T	HMF002058	HMF002058A	0.69	female	1947	2019-03-20	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	Yes	Yes	Yes	2018-11-02	2019-02-05	Fulvestrant/Palbociclib	Multiple therapy	2019-01-30	Yes	PD
CPCT02180078T	HMF004114	HMF004114A	0.35	female	1953	2020-07-31	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-03-11	Bone	os ilium right	No	No	Yes	2019-05-10	2019-06-07	Pazopanib	Targeted therapy	2019-06-06	Yes	PR
CPCT02190001T	HMF003646	HMF003646A	0.43	male	1963	2016-11-04	Pancreas					1793	2016-09-02	Liver	right liver lobe	No	No	null	null	null	null	null	null	null	null
CPCT02190002T	HMF003213	HMF003213A	0.26	female	1950	2018-03-29	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-10-06	parasternaal subcutaneous, soft tissue	parasternal right side	No	Yes	Yes	2016-10-26	2017-04-07	Doxorubicin/Cyclophosphamide/Anastrozole	Multiple therapy	2016-12-22	Yes	PR
CPCT02190004T	HMF002861	HMF002861A	0.82	female	1940	2017-02-03	Colorectum					9256	2016-12-29	Liver	right liver lobe	No	No	null	null	null	null	null	null	null	null
CPCT02190006T	HMF002786	HMF002786A	0.83	male	1947	2017-02-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-02-01	Liver	right	No	No	null	null	null	null	null	null	null	null
CPCT02190009T	HMF000360	HMF000360A	0.67	female	1948	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-02-16	Liver	unknown	Yes	Yes	Yes	2017-03-10	2018-06-06	Docetaxel/Pertuzumab/Trastuzumab/Tamoxifen	Multiple therapy	2017-04-12	Yes	PR
CPCT02190010T	HMF002014	HMF002014A	0.75	female	1949	2017-04-16	Unknown	CUP	Carcinoma			305	2017-02-16	Primary	mediastinum	No	No	null	null	null	null	null	null	null	null
CPCT02190012T	HMF002090	HMF002090A	0.32	male	1944	2018-03-17	Unknown	CUP	Carcinoma			305	2017-03-06	Liver	high subcapsulair	No	No	Yes	2017-03-24	2017-06-30	Gemcitabine/Nab-paclitaxel	Chemotherapy	2017-06-06	Yes	SD
CPCT02190013T	HMF003312	HMF003312A	0.98	male	1955	2017-08-25	Lung		Carcinoma	Small cell carcinoma		5409	2017-04-12	Liver	unknown	No	No	Yes	2017-04-25	2017-07-23	Etoposide/Cisplatin/Carboplatin	Chemotherapy	2017-06-14	Yes	PR
CPCT02190014T	HMF003425	HMF003425A	0.29	male	1954	2017-11-16	Liver		Carcinoma	Hepatocellular carcinoma		684	2017-04-14	Liver	caudal in right live lobe	No	No	Yes	2017-05-02	2017-08-03	Sorafenib	Targeted therapy	2017-07-24	Yes	PD
CPCT02190017T	HMF001577	HMF001577A	0.58	male	1961	2018-05-02	Colorectum					9256	2018-03-29	Liver	left liver lobe	Yes	No	Yes	2017-09-26	2018-01-02	Panitumumab	Targeted therapy	null	null	null
CPCT02190019T	HMF000708	HMF000708A	0.55	female	1940	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-19	Lymph node	left axilla	Yes	Yes	Yes	2017-09-29	2018-07-06	Exemestane	Hormonal therapy	2017-12-21	Yes	SD
CPCT02190020T	HMF000164	HMF000164A	0.66	male	1959	2017-12-11	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-09-28	Lung	left upper lobe	No	No	Yes	2017-11-09	2017-11-09	Carboplatin	Chemotherapy	null	null	null
CPCT02190023T	HMF001859	HMF001859A	0.51	female	1935	2017-12-13	Colorectum					9256	2017-10-12	abdominal wall (subcutaneous)	subcutaneous	No	No	null	null	null	null	null	null	null	null
CPCT02190024T	HMF003055	HMF003055A	0.5	female	1953	2018-04-09	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-11-09	Primary	left breast, recidive, is not the primary tumor	Yes	Yes	Yes	2017-11-14	2017-12-29	Vinorelbine	Chemotherapy	2018-02-21	Yes	PD
CPCT02190027T	HMF003492	HMF003492A	0.71	female	1937	2018-07-08	Colorectum					9256	2017-12-04	Liver	segment 6	No	No	Yes	2018-01-03	2018-05-23	Bevacizumab/Capecitabine/Gimeracil/Oteracil/Fluorouracil	Multiple therapy	2018-02-12	Yes	SD
CPCT02190029T	HMF001519	HMF001519B	0.5	female	1949	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-15	Primary	lung right middle lobe	No	No	Yes	2018-02-22	2018-03-15	Cisplatin/Gemcitabine/Carboplatin	Chemotherapy	2018-04-03	Yes	PD
CPCT02190030T	HMF000721	HMF000721A	0.3	male	1953	null	Bile duct		Carcinoma			4947	2018-01-17	Liver	left liver lobe	No	No	null	null	null	null	null	null	null	null
CPCT02190033T	HMF001595	HMF001595A	0.48	male	1939	2018-03-26	Stomach		Carcinoma			5517	2018-02-21	Liver	liver, no details available	No	No	null	null	null	null	null	null	null	null
CPCT02190037T	HMF000441	HMF000441A	0.77	male	1945	2021-10-27	Colorectum					9256	2018-03-29	Liver	dorsal	No	No	Yes	2018-04-09	2020-04-20	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-06-05	Yes	PR
CPCT02190039T	HMF003199	HMF003199A	0.32	male	1943	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-01	Liver	segment 5	Yes	Yes	Yes	2018-06-04	2018-08-10	Carboplatin/Paclitaxel	Chemotherapy	2018-07-09	Yes	SD
CPCT02190040T	HMF003557	HMF003557A	0.82	male	1948	2018-08-20	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-14	Lung	left upperlobe	No	No	Yes	2018-06-20	2018-07-18	Pemetrexed/Cisplatin	Chemotherapy	null	null	null
CPCT02190041T	HMF001807	HMF001807A	0.53	male	1960	null	Pancreas					1793	2018-05-15	Lymph node	supraclavicular, left side	No	No	Yes	2018-05-18	2018-07-13	Gemcitabine/Nab-paclitaxel	Chemotherapy	2018-07-25	Yes	SD
CPCT02190043T	HMF003749	HMF003749A	0.34	female	1957	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-18	Lymph node	neck	Yes	No	Yes	2018-06-15	2018-10-19	Pembrolizumab	Immunotherapy	2018-08-09	Yes	PD
CPCT02190044T	HMF001744	HMF001744B	0.79	female	1958	null	Bone/Soft tissue	Endometrium	Endometrial stromal sarcoma			4226,1115	2018-05-18	abdominal wall (subcutaneous)	subcutaneous	No	No	null	null	null	null	null	null	null	null
CPCT02190045T	HMF000777	HMF000777A	0.75	male	1946	2019-01-31	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-30	Liver	liver	No	No	Yes	2018-06-25	2018-08-13	Pemetrexed/Cisplatin	Chemotherapy	2018-08-02	Yes	SD
CPCT02190049T	HMF001252	HMF001252A	0.74	female	1963	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-02	Liver	segment 4b	Yes	No	Yes	2018-07-06	2019-03-08	Capecitabine	Chemotherapy	2018-09-26	Yes	SD
CPCT02190050T	HMF002899	HMF002899A	0.61	female	1948	2019-04-02	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-07-20	Liver	segment 4	No	No	Yes	2018-07-26	2018-08-24	Pazopanib	Targeted therapy	2018-09-20	Yes	SD
CPCT02190051T	HMF002044	HMF002044A	0.44	female	1973	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	Yes	Yes	Yes	2018-11-12	2019-05-13	Everolimus/Exemestane	Multiple therapy	2019-03-11	Yes	PR
CPCT02190052T	HMF004379	HMF004379A	0.36	female	1947	null	Lung		Carcinoma	Non-small cell carcinoma		3908	null	null	null	No	No	Yes	2019-01-07	2019-02-25	Afatinib	Targeted therapy	2019-03-05	Yes	SD
CPCT02190054T	HMF003821	HMF003821A	0.79	male	1948	null	Prostate					10283	2019-03-05	Lymph node	para-aortal	Yes	Yes	Yes	2019-03-12	2019-05-10	Abiraterone	Hormonal therapy	2019-05-08	Yes	PD
CPCT02190055T	HMF004175	HMF004175A	0.45	male	1947	2019-06-25	Kidney		Carcinoma	Renal cell carcinoma		4450	null	null	null	No	No	Yes	2019-04-10	2019-06-06	Pazopanib	Targeted therapy	null	null	null
CPCT02190058T	HMF005937	HMF005937A	0.29	female	1980	2022-10-26	Pancreas					1793	2022-01-07	Peritoneum	omentum	No	No	Yes	2022-01-10	2022-06-27	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2022-04-20	Yes	SD
CPCT02200005T	HMF004012	HMF004012A	0.59	female	1971	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-08	Primary	mamma right side	Yes	No	Yes	2019-02-13	2020-05-20	Fulvestrant/Palbociclib	Multiple therapy	2020-05-06	No	PD
CPCT02200007T	HMF004135	HMF004135A	0.35	female	1972	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-04-25	Liver	segment 5	Yes	No	Yes	2019-04-26	2019-07-09	Tamoxifen	Hormonal therapy	2019-07-05	Yes	PD
CPCT02200008T	HMF004497	HMF004497A	0.23	male	1966	null	Pancreas					1793	2020-02-06	Liver	unk	No	No	Yes	2020-02-14	2020-08-12	Leucovorin/Fluorouracil/Irinotecan/Oxaliplatin	Multiple therapy	2020-04-06	Yes	PD
CPCT02200009T	HMF004639	HMF004639A	0.41	male	1961	null	Pancreas					1793	2020-03-12	Liver	unk	No	No	Yes	2020-04-07	2020-10-23	Oxaliplatin/Leucovorin/Irinotecan/Fluorouracil	Multiple therapy	2020-05-27	Yes	SD
CPCT02200012T	HMF005629	HMF005629A	0.35	female	1961	2022-05-17	Pancreas					1793	2021-07-26	Liver	liver	No	No	Yes	2021-08-24	2022-02-07	Oxaliplatin/Leucovorin/Irinotecan/Fluorouracil	Multiple therapy	2021-10-22	Yes	SD
CPCT02210001T	HMF002884	HMF002884A	0.22	male	1961	null	Colorectum					9256	2016-11-02	peritoneale	omentum	Yes	No	Yes	2016-11-07	2017-01-17	Fluorouracil/Leucovorin/Irinotecan	Multiple therapy	2017-01-23	Yes	Clinical progression
CPCT02210003T	HMF000202	HMF000202A	0.65	male	1935	null	Colorectum					9256	2016-10-28	Liver	segment 4	Yes	No	Yes	2016-10-31	2016-12-23	Panitumumab	Targeted therapy	2017-02-21	Yes	PD
CPCT02210004T	HMF003008	HMF003008A	0.29	female	1963	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-30	Liver	right	Yes	Yes	Yes	2017-02-23	2017-04-14	Cyclophosphamide	Chemotherapy	null	null	null
CPCT02210007T	HMF002864	HMF002864B	0.69	male	1947	null	Colorectum					9256	2017-05-12	Lung	right side dorsobasal	Yes	Yes	Yes	2017-05-25	2017-07-20	Trifluridine	Chemotherapy	2017-08-29	Yes	PD
CPCT02210008T	HMF001051	HMF001051A	0.41	male	1942	null	Colorectum					9256	2017-01-04	Liver	NA	Yes	No	Yes	2017-01-11	2017-01-12	Fluorouracil/Leucovorin/Irinotecan	Multiple therapy	null	null	null
CPCT02210009T	HMF001762	HMF001762A	0.34	male	1953	null	Colorectum					9256	2017-01-18	Liver	segment 4B	Yes	Yes	Yes	2017-01-31	2017-05-18	Oxaliplatin/Capecitabine	Chemotherapy	2017-04-11	Yes	SD
CPCT02210010T	HMF003391	HMF003391A	0.42	female	1959	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-01-20	Primary	breast	Yes	Yes	Yes	2017-04-13	2017-06-28	Palbociclib/Fulvestrant	Multiple therapy	2017-06-26	Yes	PD
CPCT02210011T	HMF000388	HMF000388A	0.34	male	1960	null	Colorectum					9256	2017-02-03	Liver	NA	Yes	No	Yes	2017-02-07	2017-07-12	Fluorouracil/Leucovorin/Irinotecan	Multiple therapy	2017-04-12	Yes	PR
CPCT02210012T	HMF003388	HMF003388A	0.23	female	1947	2017-04-01	Colorectum					9256	2017-02-03	Liver	intercostaal right	Yes	No	Yes	2017-02-09	2017-02-19	Oxaliplatin/Capecitabine	Chemotherapy	null	null	null
CPCT02210014T	HMF003804	HMF003804A	0.54	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-10	Liver	right lobe	Yes	Yes	Yes	2017-03-20	2017-09-04	Paclitaxel	Chemotherapy	2017-05-30	Yes	SD
CPCT02210016T	HMF003345	HMF003345A	0.48	male	1957	null	Pancreas					1793	2017-05-12	colon	colon	Yes	No	Yes	2017-05-18	2017-11-04	Fluorouracil/Irinotecan/Oxaliplatin/Leucovorin	Multiple therapy	2017-08-01	Yes	PR
CPCT02210017T	HMF002268	HMF002268A	0.43	female	1957	2017-11-15	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-24	Liver	left side	Yes	No	Yes	2017-05-29	2017-07-24	Anastrozole/Palbociclib	Multiple therapy	2017-07-28	Yes	PD
CPCT02210020T	HMF001042	HMF001042A	0.83	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-07	Liver	segment 8-4	Yes	No	Yes	2017-07-08	2018-06-15	Capecitabine	Chemotherapy	2017-08-15	Yes	PR
CPCT02210023T	HMF001513	HMF001513A	0.39	male	1939	2017-10-13	Colorectum					9256	2017-08-09	Liver	left lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02210024T	HMF001944	HMF001944A	0.3	female	1962	2018-04-26	Colorectum					9256	2017-08-16	Liver	left	Yes	No	Yes	2017-08-31	2017-11-23	Panitumumab	Targeted therapy	2017-11-20	Yes	PD
CPCT02210025T	HMF003294	HMF003294A	0.57	male	1957	2017-10-04	Stomach					10534	2017-08-16	Liver	segment 5	Yes	No	Yes	2017-08-25	2017-09-01	Trastuzumab/Leucovorin/Oxaliplatin/Fluorouracil	Multiple therapy	2017-09-01	Yes	PD
CPCT02210026T	HMF000489	HMF000489A	0.7	male	1949	2018-06-19	Prostate					10283	2017-08-23	Lymph node	right supraclavicular	Yes	Yes	Yes	2017-08-30	2018-03-07	Cabazitaxel	Chemotherapy	2017-10-20	Yes	SD
CPCT02210027T	HMF000402	HMF000402A	0.59	female	1957	2018-01-31	Colorectum					9256	2017-09-13	Liver	not specified	Yes	No	Yes	2017-09-29	2017-12-12	Trifluridine	Chemotherapy	2017-11-30	Yes	PD
CPCT02210028T	HMF000903	HMF000903A	0.63	female	1967	2018-04-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-30	Liver	right lobe	Yes	Yes	Yes	2017-09-04	2017-10-23	Vinorelbine	Chemotherapy	null	null	null
CPCT02210029T	HMF002284	HMF002284A	0.25	male	1954	2017-12-13	Colorectum					9256	2017-08-31	Liver	not specified	Yes	No	null	null	null	null	null	null	null	null
CPCT02210031T	HMF000801	HMF000801A	0.22	male	1960	2017-12-23	Pancreas					1793	2017-09-06	major duodenal papilla	major duodenal papilla	No	No	Yes	2017-09-13	2017-10-30	Leucovorin/Fluorouracil/Irinotecan/Oxaliplatin	Multiple therapy	2017-10-26	Yes	PD
CPCT02210033T	HMF000500	HMF000500B	0.54	male	1962	2019-01-05	Esophagus					5041	2017-10-06	Liver	right	No	No	Yes	2017-10-13	2018-02-23	Capecitabine/Oxaliplatin	Chemotherapy	2017-12-11	Yes	PR
CPCT02210034T	HMF002241	HMF002241B	0.38	female	1955	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-13	Liver	segment 4b	Yes	No	Yes	2017-10-18	2018-03-09	Doxorubicin/Cyclophosphamide	Chemotherapy	2018-01-12	Yes	PR
CPCT02210035T	HMF000989	HMF000989A	0.56	female	1947	2017-12-11	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-17	skin	trunk dorsal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02210036T	HMF003045	HMF003045A	0.37	female	1957	null	Pancreas					1793	2017-11-08	Liver	segment 8	Yes	No	null	null	null	null	null	null	null	null
CPCT02210037T	HMF000179	HMF000179B	0.71	female	1960	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-08	Bone	iliac, right side	Yes	Yes	Yes	2017-11-28	2018-01-26	Letrozole/Ribociclib	Multiple therapy	2018-01-24	Yes	PD
CPCT02210041T	HMF000287	HMF000287A	0.22	male	1935	2018-07-13	Colorectum					9256	2017-12-11	Primary	colon	Yes	Yes	Yes	2018-01-24	2018-07-13	Panitumumab	Targeted therapy	2018-03-01	Yes	PD
CPCT02210042T	HMF002032	HMF002032A	0.23	female	1953	2018-07-14	Small intestine	Duodenum	Carcinoma			10021,305	2018-01-19	Liver	left	Yes	No	Yes	2018-01-20	2018-04-16	Capecitabine	Chemotherapy	2018-04-09	Yes	SD
CPCT02210043T	HMF002665	HMF002665A	0.86	male	1945	null	Prostate					10283	2018-01-19	Liver	segment 4	Yes	No	null	null	null	null	null	null	null	null
CPCT02210044T	HMF000797	HMF000797A	0.83	female	1959	null	Breast		Carcinoma			3459	2018-02-07	Lymph node	supraclavicular right	Yes	Yes	Yes	2018-02-14	2018-06-04	Doxorubicin/Cyclophosphamide	Chemotherapy	2018-06-01	Yes	PD
CPCT02210045T	HMF001663	HMF001663B	0.42	male	1946	2018-09-10	Esophagus					5041	2018-02-16	Lymph node	left supraclavicular	Yes	No	Yes	2018-02-28	2018-04-03	Trastuzumab/Paclitaxel	Multiple therapy	2018-03-29	Yes	PD
CPCT02210046T	HMF002078	HMF002078A	0.57	female	1962	null	Ovary					2394	2018-02-28	Peritoneum	Upper abdominal right para median	Yes	No	Yes	2018-03-06	2018-07-06	Paclitaxel/Bevacizumab	Multiple therapy	2018-06-04	Yes	SD
CPCT02210048T	HMF001512	HMF001512A	0.3	male	1959	null	Colorectum					9256	2018-02-28	Liver	left lobe	No	No	Yes	2018-03-02	2019-01-17	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-04-30	Yes	SD
CPCT02210050T	HMF001156	HMF001156A	0.7	male	1942	null	Colorectum					9256	2018-03-07	Liver	segment 3	No	No	Yes	2018-03-19	2018-11-30	Capecitabine	Chemotherapy	2018-05-14	Yes	SD
CPCT02210053T	HMF003325	HMF003325A	0.8	female	1966	2018-05-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-21	Liver	left lobe	Yes	Yes	Yes	2018-03-23	2018-04-20	Anastrozole/Capecitabine/Leuprorelin/Trastuzumab	Multiple therapy	null	null	null
CPCT02210054T	HMF000237	HMF000237A	0.4	female	1953	null	Pancreas					1793	2018-03-28	Lung	right sub pleural	Yes	Yes	Yes	2018-04-23	2018-07-20	Leucovorin/Fluorouracil/Irinotecan/Oxaliplatin	Multiple therapy	2018-06-05	Yes	SD
CPCT02210056T	HMF001747	HMF001747A	0.46	female	1953	2018-08-04	Uterus	Endometrium				1380	2018-04-04	Lymph node	left supraclavicular	No	No	Yes	2018-04-20	2018-06-22	Carboplatin/Paclitaxel	Chemotherapy	2018-06-18	Yes	PD
CPCT02210059T	HMF000054	HMF000054B	0.62	female	1954	2018-12-19	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-18	Liver	left	Yes	Yes	Yes	2018-04-23	2018-08-24	Eribulin	Chemotherapy	2018-07-09	Yes	SD
CPCT02210065T	HMF003412	HMF003412A	0.39	female	1947	null	Ovary					2394	2018-06-20	vagina	top vagina	Yes	No	Yes	2018-07-17	2018-10-18	Carboplatin	Chemotherapy	2018-09-19	Yes	SD
CPCT02210066T	HMF001863	HMF001863A	0.57	female	1967	null	Ovary					2394	2018-06-01	omentum	omentum	Yes	No	Yes	2018-06-05	2018-09-24	Carboplatin	Chemotherapy	2018-10-08	Yes	PR
CPCT02210067T	HMF001823	HMF001823A	0.25	male	1954	null	Esophagus					5041	2018-06-13	Liver	right lobe	No	No	Yes	2018-06-26	2018-12-14	Capecitabine/Oxaliplatin/Trastuzumab	Multiple therapy	2018-09-10	Yes	SD
CPCT02210068T	HMF000563	HMF000563A	0.46	female	1950	2018-11-12	Pancreas					1793	2018-06-13	Liver	right lobe	Yes	Yes	Yes	2018-06-29	2018-10-01	Paclitaxel/Gemcitabine	Chemotherapy	2018-08-24	Yes	SD
CPCT02210069T	HMF001427	HMF001427A	0.69	female	1945	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-15	Peritoneum	lower abdomen mesenterial (peritoneal)	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02210070T	HMF000461	HMF000461A	0.58	male	1951	2018-11-25	Colorectum					9256	2018-06-27	Liver	Segment 8-4	Yes	Yes	Yes	2018-06-29	2018-09-20	Trifluridine	Chemotherapy	2018-09-17	Yes	PD
CPCT02210071T	HMF002197	HMF002197A	0.79	female	1957	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-04	Liver	right	Yes	Yes	Yes	2018-07-05	2018-09-27	Capecitabine	Chemotherapy	2018-09-24	Yes	PD
CPCT02210073T	HMF000179	HMF000179A	0.91	female	1960	2019-04-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-20	Bone	scapula right side	Yes	Yes	Yes	2018-08-13	2018-10-15	Capecitabine	Chemotherapy	2018-10-09	Yes	PR
CPCT02210074T	HMF002026	HMF002026A	0.36	male	1961	2019-06-07	Prostate					10283	2018-10-24	Lymph node	axillar left	Yes	Yes	Yes	2018-11-11	2018-12-21	Enzalutamide	Hormonal therapy	2018-12-20	Yes	PD
CPCT02210075T	HMF000482	HMF000482A	0.34	male	1946	null	Prostate					10283	2018-12-10	Primary	prostate	Yes	No	Yes	2019-01-02	2019-10-04	Abiraterone	Hormonal therapy	2019-09-30	Yes	PD
CPCT02210076T	HMF004101	HMF004101A	0.85	female	1944	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-12-19	Pleural fluid	left thoracic wall	Yes	Yes	Yes	2018-12-22	2019-03-01	Megestrol	Hormonal therapy	2019-02-11	Yes	PD
CPCT02210077T	HMF004117	HMF004117A	0.54	male	1949	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2019-01-02	abdominal	mass abdominal wall (soft tissue)	Yes	Yes	Yes	2019-01-14	2019-04-30	Pembrolizumab	Immunotherapy	2019-04-23	Yes	PD
CPCT02210082T	HMF003851	HMF003851A	0.55	female	1964	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-03-20	Liver	right intercostal	Yes	Yes	Yes	2019-03-21	2019-06-06	Everolimus/Exemestane	Multiple therapy	2019-05-24	Yes	PD
CPCT02210083T	HMF004356	HMF004356A	0.23	male	1951	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-05-15	Lymph node	next to vena jugularis and carotis communis	Yes	Yes	Yes	2019-05-24	2019-07-25	Everolimus/Lenvatinib	Targeted therapy	2019-07-19	Yes	PD
CPCT02210085T	HMF003985	HMF003985A	0.5	male	1964	null	Prostate					10283	2019-06-07	Lymph node	left groin	Yes	No	Yes	2019-06-12	2020-03-05	Abiraterone	Hormonal therapy	2019-12-16	Yes	PD
CPCT02220001T	HMF002175	HMF002175A	0.86	female	1938	2017-08-15	Skin		Melanoma			8923	2016-11-16	Cutaneous	right flank	No	Yes	Yes	2016-12-02	2017-03-10	Dacarbazine	Chemotherapy	2017-01-25	Yes	Clinical progression
CPCT02220002T	HMF001215	HMF001215A	0.26	female	1951	2017-02-21	Uterus	Endometrium				1380	2016-12-21	Lymph node	axiila right side	Yes	Yes	Yes	2016-12-02	2017-01-13	Doxorubicin	Chemotherapy	2017-01-23	Yes	PD
CPCT02220006T	HMF000311	HMF000311A	0.67	female	1955	2017-01-14	Ovary					2394	2017-01-04	cutane	left shoulder	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02220007T	HMF000717	HMF000717A	0.41	male	1956	2017-12-10	Esophagus					5041	2017-01-25	Bone	right knee	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02220008T	HMF001779	HMF001779A	0.65	female	1966	2018-03-20	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-22	Bone	pelvic	Yes	Yes	Yes	2017-05-10	2017-06-27	Vinorelbine	Chemotherapy	null	null	null
CPCT02220009T	HMF000365	HMF000365A	0.32	male	1943	2017-07-04	Colorectum					9256	2017-03-08	Lung	thoracal	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02220014T	HMF002733	HMF002733A	0.67	male	1948	2017-12-14	Skin		Melanoma			8923	2017-05-03	Lymph node	groin left side	Yes	No	Yes	2017-06-27	2017-10-10	Dacarbazine	Chemotherapy	2017-10-23	Yes	PD
CPCT02220015T	HMF002460	HMF002460A	0.66	male	1961	2017-09-13	Colorectum					9256	null	null	null	Yes	No	Yes	2017-05-26	2017-07-06	Irinotecan	Chemotherapy	2017-07-20	Yes	PD
CPCT02220019T	HMF001875	HMF001875A	0.81	female	1964	2017-06-30	Colorectum	Caecum				1521,9256	2017-06-08	Liver	liver	Yes	No	null	null	null	null	null	null	null	null
CPCT02220020T	HMF001346	HMF001346A	0.54	male	1944	2019-05-20	Colorectum	Colon sigmoideum				12192	2017-06-08	Liver	ventral left liver lobe	Yes	No	Yes	2017-06-14	2017-11-15	Panitumumab	Targeted therapy	2017-08-30	Yes	PD
CPCT02220022T	HMF003606	HMF003606A	0.67	male	1959	2017-10-08	Colorectum	Colon sigmoideum				12192	2017-06-21	Liver	segment 6	Yes	No	Yes	2017-06-28	2017-07-26	Irinotecan	Chemotherapy	2017-07-28	Yes	PD
CPCT02220023T	HMF000698	HMF000698A	0.33	male	1945	2019-03-05	Colorectum	Colon sigmoideum				12192	2017-06-28	Bone	parasternal right side	Yes	Yes	Yes	2017-12-08	2018-03-23	Irinotecan	Chemotherapy	2018-01-31	Yes	SD
CPCT02220024T	HMF000089	HMF000089A	0.33	male	1962	2018-01-12	Colorectum					9256	2017-07-12	cutane	sacraal	Yes	Yes	Yes	2017-07-13	2017-10-04	Panitumumab	Targeted therapy	2017-09-27	Yes	PD
CPCT02220025T	HMF000720	HMF000720A	0.49	male	1946	2019-08-06	Colorectum					9256	2017-08-25	Liver	unknown	Yes	No	Yes	2017-08-31	2018-06-21	Panitumumab	Targeted therapy	2017-10-31	Yes	PR
CPCT02220026T	HMF002824	HMF002824B	0.58	female	1952	null	Breast		Carcinoma	Triple negative		0060081	2017-09-06	Lymph node	neck supracla left side	Yes	Yes	Yes	2017-10-06	2018-03-16	Gemcitabine	Chemotherapy	2017-11-29	Yes	SD
CPCT02220027T	HMF003470	HMF003470A	0.49	female	1959	2018-02-11	Colorectum	Rectum				1993	2017-09-18	Liver	left liver lobe	Yes	Yes	Yes	2017-09-20	2018-01-03	Irinotecan	Chemotherapy	2017-11-13	Yes	SD
CPCT02220029T	HMF001223	HMF001223C	0.35	female	1944	2019-04-24	Breast		Carcinoma	Triple negative		0060081	2017-11-08	Lymph node	nek left side	Yes	Yes	Yes	2017-11-09	2018-01-08	Vinorelbine	Chemotherapy	2018-01-02	Yes	SD
CPCT02220030T	HMF001506	HMF001506A	0.81	male	1947	2018-03-20	Prostate					10283	2017-11-15	presternal / subcutaneous	at the height of the haert	Yes	Yes	Yes	2017-11-23	2018-01-18	Abiraterone	Hormonal therapy	null	null	null
CPCT02220032T	HMF001028	HMF001028A	0.95	female	1964	2018-03-30	Small intestine	Duodenum				10021	2017-12-27	Liver	left liver lobe	Yes	No	Yes	2018-01-05	2018-03-09	Irinotecan/Fluorouracil	Chemotherapy	null	null	null
CPCT02220037T	HMF000084	HMF000084A	0.35	male	1948	2018-06-18	Esophagus					5041	2018-02-14	omental	left side	Yes	Yes	Yes	2018-02-15	2018-03-08	Oxaliplatin/Capecitabine	Chemotherapy	2018-04-03	Yes	SD
CPCT02220038T	HMF001954	HMF001954A	0.7	male	1962	2018-12-08	Bone marrow		Multiple myeloma		Morbus Kahler	9538	2018-02-21	muscle	gastrocnemius right side	Yes	Yes	Yes	2018-02-13	2018-08-22	Cyclophosphamide	Chemotherapy	2018-05-09	Yes	PR
CPCT02220041T	HMF000417	HMF000417A	0.44	female	1951	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-03-01	omental	paracolic left side	Yes	No	Yes	2018-03-08	2018-11-22	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	2018-05-02	Yes	SD
CPCT02220043T	HMF002877	HMF002877B	0.65	male	1950	2019-08-19	null	null	null	null	null	null	2018-03-05	abdominal subcuteneous	intra-abdominal	Yes	No	Yes	2018-03-07	2018-06-20	Oxaliplatin	Chemotherapy	2018-05-03	Yes	SD
CPCT02220044T	HMF001924	HMF001924A	0.56	female	1947	2019-02-09	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-12	Liver	right liver lobe	Yes	Yes	Yes	2018-03-13	2018-12-06	Capecitabine	Chemotherapy	2018-05-09	Yes	SD
CPCT02220045T	HMF003292	HMF003292A	0.64	female	1944	null	Ovary					2394	2018-03-12	Lymph node	supraclavicular	No	No	Yes	2018-04-03	2018-09-11	Paclitaxel/Carboplatin	Chemotherapy	2018-05-29	Yes	PR
CPCT02220047T	HMF002917	HMF002917A	0.66	female	1958	2018-11-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-16	Liver	right liver lobe	Yes	Yes	Yes	2018-04-17	2018-08-21	Eribulin	Chemotherapy	2018-05-23	Yes	SD
CPCT02220050T	HMF000219	HMF000219A	0.4	female	1965	null	Colorectum	Rectum	Melanoma			1992	2018-05-01	Lymph node	left groin	Yes	Yes	Yes	2018-05-07	2018-06-18	Ipilimumab	Immunotherapy	2018-07-02	Yes	SD
CPCT02220053T	HMF002481	HMF002481A	0.72	female	1956	2018-09-16	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-23	Liver	left liver lobe	Yes	Yes	Yes	2018-05-25	2018-08-16	Capecitabine	Chemotherapy	2018-08-13	Yes	PD
CPCT02220056T	HMF002437	HMF002437A	0.31	male	1958	2019-03-21	Esophagus					5041	2018-06-11	scalp	pari?to-occipitaal	No	No	null	null	null	null	null	null	null	null
CPCT02220057T	HMF000765	HMF000765A	0.8	female	1957	2019-07-17	Skin		Melanoma			8923	2018-06-20	subcutane	scalp	No	Yes	Yes	2018-07-02	2018-09-20	Ipilimumab/Nivolumab	Immunotherapy	2018-10-01	Yes	PD
CPCT02220059T	HMF003360	HMF003360A	0.27	male	1959	2018-11-03	Colorectum					9256	2018-08-14	Liver	right liverlobe at the left side	Yes	No	null	null	null	null	null	null	null	null
CPCT02220060T	HMF000793	HMF000793A	0.79	female	1968	2018-12-24	Breast		Carcinoma	Triple negative		0060081	2018-08-31	Primary	mamma right side	Yes	No	Yes	2018-08-31	2018-10-18	Gemcitabine/Carboplatin	Chemotherapy	2018-10-31	Yes	PD
CPCT02220061T	HMF004222	HMF004222A	0.64	female	1951	2019-10-30	Pancreas					1793	2018-11-07	Liver	segmetal 4	Yes	No	Yes	2018-11-28	2018-12-29	Capecitabine	Chemotherapy	2019-01-07	Yes	PD
CPCT02220063T	HMF000992	HMF000992A	0.46	female	1959	2020-01-15	Breast		Carcinoma	Triple negative		0060081	2018-11-13	Lymph node	left mamma	Yes	Yes	Yes	2018-11-16	2019-01-18	Gemcitabine/Carboplatin	Chemotherapy	2019-01-21	Yes	PD
CPCT02220064T	HMF002310	HMF002310A	0.82	male	1952	2018-11-30	Prostate					10283	2018-11-16	Liver	right liver lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02220067T	HMF004209	HMF004209A	0.63	male	1955	2019-12-07	Colorectum					9256	2019-03-25	Liver	right side	Yes	Yes	Yes	2019-04-02	2019-06-19	Trifluridine	Chemotherapy	2019-06-12	Yes	PD
CPCT02220071T	HMF004054	HMF004054A	0.74	female	1951	2021-02-06	Uterus	Endometrium				1380	2019-03-19	Lymph node	abdominal wall	Yes	Yes	Yes	2019-03-22	2019-05-03	Paclitaxel/Carboplatin	Chemotherapy	2019-05-22	Yes	PR
CPCT02220075T	HMF004266	HMF004266A	0.2	male	1957	2020-05-16	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-04-15	Liver	right liver lobe	Yes	No	Yes	2019-04-15	2019-04-15	Nivolumab	Immunotherapy	2019-05-20	Yes	PD
CPCT02220076T	HMF004185	HMF004185A	0.88	female	1954	null	Colorectum					9256	2019-04-15	Liver	left lobe	Yes	No	Yes	2019-04-24	2020-03-06	Capecitabine/Oxaliplatin/Bevacizumab/Bevacizumab	Multiple therapy	2019-07-01	Yes	PR
CPCT02220077T	HMF003895	HMF003895A	0.35	male	1950	2020-12-01	Colorectum					9256	2019-04-18	Liver	anterior	Yes	Yes	Yes	2019-04-23	2019-09-24	Irinotecan	Chemotherapy	2019-06-12	Yes	SD
CPCT02220079T	HMF004231	HMF004231A	0.3	female	1953	2019-08-09	Ovary					2394	2019-05-13	abdominal subcuteneous	abdominal wall	Yes	No	Yes	2019-05-24	2019-07-18	Gemcitabine	Chemotherapy	2019-05-29	Yes	SD
CPCT02230001T	HMF000051	HMF000051A	0.21	female	1939	2017-04-03	Pancreas					1793	2016-11-14	Liver	right liver lobe	No	No	Yes	2016-11-28	2016-12-13	Gemcitabine/Nab-paclitaxel	Chemotherapy	null	null	null
CPCT02230002T	HMF002539	HMF002539A	0.34	female	1942	2017-04-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-07	Lymph node	neck	Yes	Yes	Yes	2016-12-23	2017-01-20	Paclitaxel/Bevacizumab	Multiple therapy	null	null	null
CPCT02230003T	HMF000136	HMF000136A	0.74	female	1950	2017-04-13	Colorectum					9256	2016-12-20	Liver	unknown	No	No	Yes	2017-01-12	2017-02-10	Oxaliplatin/Capecitabine	Chemotherapy	null	null	null
CPCT02230004T	HMF000585	HMF000585A	0.32	male	1936	2018-11-19	Bile duct		Carcinoma			4947	2017-01-03	Liver	left lobe	No	No	Yes	2017-01-06	2017-05-10	Cisplatin/Gemcitabine	Chemotherapy	2017-03-14	Yes	SD
CPCT02230005T	HMF001601	HMF001601A	0.23	male	1960	2017-11-01	Colorectum					9256	2017-01-09	Primary	rectum	No	No	Yes	2017-01-18	2017-07-06	Oxaliplatin/Capecitabine	Chemotherapy	2017-03-14	Yes	SD
CPCT02230006T	HMF002739	HMF002739A	0.41	female	1960	2017-06-01	Colorectum					9256	2017-01-19	Liver	unknown	No	No	Yes	2017-01-27	2017-04-14	Capecitabine/Oxaliplatin	Chemotherapy	2017-03-20	Yes	SD
CPCT02230011T	HMF001674	HMF001674A	0.71	female	1948	2017-09-23	Colorectum					9256	2017-02-07	Liver	T17-3332	No	No	null	null	null	null	null	null	null	null
CPCT02230013T	HMF002376	HMF002376A	0.85	male	1945	2017-11-13	Lung		Carcinoma	Small cell carcinoma		5409	2017-03-08	Lung	right underwriting	No	No	Yes	2017-03-21	2017-05-30	Carboplatin/Etoposide	Chemotherapy	2017-06-15	Yes	PR
CPCT02230014T	HMF003792	HMF003792A	0.61	female	1954	2019-07-01	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-16	Liver	left liverlob	Yes	No	Yes	2017-04-03	2017-08-28	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02230015T	HMF001591	HMF001591A	0.52	female	1940	2017-06-16	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-03-23	Liver	unknown	No	No	Yes	2017-04-01	2017-06-16	Pazopanib/Pazopanib	Targeted therapy	null	null	null
CPCT02230016T	HMF002526	HMF002526A	0.56	female	1976	2019-12-27	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-24	Liver	unknown	Yes	Yes	Yes	2017-04-04	2018-01-29	Capecitabine	Chemotherapy	2017-06-23	Yes	SD
CPCT02230017T	HMF000911	HMF000911A	0.81	male	1952	2017-05-12	Lung		Carcinoma	Small cell carcinoma		5409	2017-04-10	Liver	null	No	No	null	null	null	null	null	null	null	null
CPCT02230021T	HMF001727	HMF001727A	0.72	female	1967	2018-10-13	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-05-15	Liver	right liverlob	Yes	Yes	Yes	2017-06-01	2018-01-09	Trastuzumab	Targeted therapy	2017-07-19	Yes	SD
CPCT02230022T	HMF001491	HMF001491A	0.42	female	1985	2018-03-28	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-08-30	Lung	left lung	Yes	No	Yes	2017-09-12	2018-01-03	Trastuzumab/Vinorelbine	Multiple therapy	2018-01-10	Yes	PD
CPCT02230023T	HMF003344	HMF003344A	0.61	male	1947	2019-01-18	Colorectum					9256	2017-06-09	cutaneous	right groin	Yes	Yes	Yes	2017-07-11	2017-10-19	Oxaliplatin/Fluorouracil	Chemotherapy	2017-10-05	Yes	PR
CPCT02230024T	HMF002451	HMF002451A	0.73	female	1950	2017-09-28	Colorectum					9256	2017-06-08	Liver	left liver lob	Yes	Yes	Yes	2017-06-24	2017-07-19	Capecitabine	Chemotherapy	2017-08-07	Yes	PD
CPCT02230025T	HMF003154	HMF003154A	0.44	female	1972	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-06-26	Primary	left breast	Yes	No	Yes	2017-07-04	2018-07-31	Trastuzumab/Capecitabine/Letrozole	Multiple therapy	2017-09-21	Yes	SD
CPCT02230027T	HMF000400	HMF000400A	0.59	male	1938	2018-05-27	Colorectum					9256	2017-06-30	Liver	right lob	Yes	Yes	Yes	2017-07-31	2018-02-07	Irinotecan	Chemotherapy	2017-10-23	Yes	SD
CPCT02230028T	HMF002495	HMF002495A	0.74	female	1965	2018-09-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-03	Liver	unknown	Yes	Yes	Yes	2017-07-04	2017-11-07	Capecitabine	Chemotherapy	2017-09-07	Yes	PR
CPCT02230029T	HMF003559	HMF003559A	0.43	male	1948	2017-07-19	Esophagus					5041	2017-07-07	Liver	liver	No	Yes	Yes	2017-07-10	2017-07-19	Oxaliplatin/Capecitabine	Chemotherapy	null	null	null
CPCT02230030T	HMF002528	HMF002528A	0.77	male	1946	2017-10-14	Esophagus					5041	2017-07-13	Liver	right lobe	Yes	Yes	Yes	2017-07-14	2017-09-08	Irinotecan	Chemotherapy	2017-09-04	Yes	SD
CPCT02230033T	HMF002718	HMF002718A	0.31	male	1961	2018-02-06	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-07-14	Liver	unknown	No	No	Yes	2017-07-24	2017-11-08	Pazopanib	Targeted therapy	2017-09-22	Yes	SD
CPCT02230034T	HMF001862	HMF001862A	0.23	male	1948	2018-04-02	Esophagus					5041	2017-07-18	Lymph node	left site of the neck	No	No	Yes	2017-08-08	2017-12-06	Capecitabine/Oxaliplatin	Chemotherapy	2017-10-04	Yes	SD
CPCT02230035T	HMF002334	HMF002334A	0.45	female	1948	2017-11-21	Pancreas					1793	2017-07-19	intra-abdominal	ovarium	Yes	No	Yes	2017-07-21	2017-09-16	Capecitabine	Chemotherapy	2017-09-20	Yes	PD
CPCT02230036T	HMF002325	HMF002325A	0.49	female	1946	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-24	Peritoneum	unknown	Yes	No	Yes	2017-08-18	2017-12-15	Doxorubicin/Cyclophosphamide	Chemotherapy	2018-01-03	Yes	SD
CPCT02230039T	HMF003523	HMF003523A	0.54	male	1951	null	Esophagus					5041	2017-08-04	Liver	unknown	No	No	Yes	2017-08-24	null	Oxaliplatin/Capecitabine	Chemotherapy	2017-10-20	Yes	PR
CPCT02230042T	HMF000946	HMF000946A	0.26	male	1982	null	Stomach					10534	2017-08-31	Lymph node	neck	No	No	Yes	2017-09-04	2018-01-16	Capecitabine/Oxaliplatin	Chemotherapy	2017-11-13	Yes	SD
CPCT02230043T	HMF002919	HMF002919A	0.73	male	1961	2017-10-16	Pancreas		Carcinoma	Neuroendocrine carcinoma		1798,1800	2017-08-21	Lymph node	neck	No	No	Yes	2017-08-29	2017-10-10	Gemcitabine/Carboplatin	Chemotherapy	2017-10-12	Yes	PD
CPCT02230044T	HMF003092	HMF003092A	0.63	female	1978	2021-04-06	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-21	Liver	unknown	No	No	Yes	2017-08-31	2021-03-10	Doxorubicin/Cyclophosphamide/Letrozole/Fulvestrant/Ribociclib/Capecitabine/Paclitaxel/Vinorelbine	Multiple therapy	2017-10-26	Yes	SD
CPCT02230047T	HMF000953	HMF000953A	0.58	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-31	Liver	right lob	Yes	Yes	Yes	2017-09-06	2018-10-10	Letrozole/Ribociclib	Multiple therapy	2018-01-08	Yes	SD
CPCT02230049T	HMF000885	HMF000885A	0.83	female	1957	2017-11-19	Unknown	CUP	Carcinoma			305	2017-09-14	Liver	unknown	No	No	null	null	null	null	null	null	null	null
CPCT02230050T	HMF003560	HMF003560A	0.42	female	1947	2018-03-06	Ovary					2394	2017-09-14	Lymph node	supraclavicular left site	Yes	No	Yes	2017-10-02	2018-01-15	Carboplatin	Chemotherapy	2017-11-27	Yes	SD
CPCT02230051T	HMF000772	HMF000772A	0.81	male	1956	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2017-09-15	peritoneum	pancreas	No	No	Yes	2017-10-30	2018-02-12	Rituximab/Cyclophosphamide/Vincristine	Multiple therapy	2017-12-18	Yes	PR
CPCT02230053T	HMF002804	HMF002804A	0.24	female	1964	2018-07-05	Colorectum					9256	2017-09-19	colon	ascendens	No	No	Yes	2017-09-25	2018-01-24	Leucovorin/Fluorouracil/Oxaliplatin/Irinotecan	Multiple therapy	2017-11-15	Yes	SD
CPCT02230055T	HMF000821	HMF000821A	0.43	male	1943	2019-03-07	Colorectum					9256	2017-09-20	Liver	left lob	No	No	Yes	2017-11-01	2017-12-28	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-11-03	Yes	SD
CPCT02230056T	HMF000236	HMF000236A	0.73	male	1952	2017-11-19	Urothelial tract	Bladder				11054	2017-09-21	Lymph node	axillar left side	Yes	No	Yes	2017-10-04	2017-10-04	Gemcitabine/Cisplatin	Chemotherapy	null	null	null
CPCT02230067T	HMF002059	HMF002059A	0.78	female	1948	2019-02-21	Colorectum					9256	2017-11-10	Liver	right site	No	No	null	null	null	null	null	null	null	null
CPCT02230068T	HMF001532	HMF001532A	0.38	female	1953	2018-01-28	Esophagus					5041	2017-11-10	oesophagus	distal	No	No	Yes	2017-11-23	2017-12-07	Capecitabine/Oxaliplatin	Chemotherapy	null	null	null
CPCT02230070T	HMF000858	HMF000858A	0.65	male	1956	2018-07-07	Esophagus					5041	2018-02-09	Lymph node	intraclaviculair	Yes	Yes	Yes	2017-12-08	2018-02-04	Oxaliplatin/Capecitabine	Chemotherapy	2018-02-07	Yes	PD
CPCT02230071T	HMF003511	HMF003511A	0.22	female	1959	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-20	Liver	unknown	Yes	Yes	Yes	2017-12-19	2018-06-12	Doxorubicin/Cyclophosphamide/Fluorouracil	Chemotherapy	2018-02-08	Yes	SD
CPCT02230073T	HMF000742	HMF000742A	0.41	male	1955	2018-02-05	Colorectum					9256	2017-11-16	Peritoneum	unknown	Yes	No	Yes	2017-11-21	2017-12-02	Trifluridine	Chemotherapy	null	null	null
CPCT02230074T	HMF003105	HMF003105A	0.79	female	1965	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-21	Liver	rigt lob	Yes	Yes	Yes	2017-11-27	2019-05-15	Doxorubicin/Cyclophosphamide/Docetaxel/Letrozole	Multiple therapy	2018-01-22	Yes	SD
CPCT02230075T	HMF001479	HMF001479A	0.23	female	1945	2018-01-03	Bile duct		Carcinoma			4947	2017-11-22	Liver	unknown	No	No	null	null	null	null	null	null	null	null
CPCT02230077T	HMF003195	HMF003195A	0.78	female	1963	2018-07-11	Colorectum					9256	2017-12-21	Liver	Central	Yes	Yes	Yes	2017-12-22	2018-02-16	Panitumumab	Targeted therapy	2018-02-19	Yes	PD
CPCT02230078T	HMF003725	HMF003725A	0.46	male	1949	2021-02-28	Colorectum					9256	2017-12-14	abdominal wall (subcutaneous)	right site	No	Yes	null	null	null	null	null	null	null	null
CPCT02230079T	HMF001203	HMF001203A	0.62	male	1944	2018-01-27	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-12-15	Lymph node	inguinaal lilicaal	No	No	null	null	null	null	null	null	null	null
CPCT02230080T	HMF002430	HMF002430A	0.22	male	1950	2018-03-20	Stomach					10534	2017-12-21	stomach	unknown	No	No	Yes	2018-01-08	2018-01-22	Capecitabine/Oxaliplatin	Chemotherapy	null	null	null
CPCT02230082T	HMF002404	HMF002404A	0.77	female	1945	2019-08-18	Ovary					2394	2018-01-16	Peritoneum	unknown	No	No	Yes	2018-01-30	2018-05-22	Carboplatin	Chemotherapy	2018-06-05	Yes	SD
CPCT02230086T	HMF002693	HMF002693A	0.44	female	1940	2018-11-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-01-22	Lymph node	neck	No	No	null	null	null	null	null	null	null	null
CPCT02230087T	HMF003539	HMF003539A	0.79	male	1939	null	Colorectum					9256	2018-02-06	Liver	intrahepatic close to gall bladder	No	No	Yes	2018-02-17	2018-10-05	Capecitabine	Chemotherapy	2018-04-17	Yes	SD
CPCT02230088T	HMF003739	HMF003739A	0.91	female	1951	2018-03-05	Unknown					162	2018-02-08	soft tissue	anterolateraal left hip	No	No	Yes	2018-02-26	2018-03-05	Paclitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02230089T	HMF002952	HMF002952A	0.33	female	1966	2018-04-20	Breast		Carcinoma	Triple negative		0060081	2018-02-27	skin/ subcutaneous	thoracal, left side	Yes	Yes	Yes	2018-02-27	2018-02-27	Carboplatin	Chemotherapy	null	null	null
CPCT02230090T	HMF001695	HMF001695A	0.57	female	1969	2019-06-07	Colorectum					9256	2018-02-19	Lymph node	neck left	No	No	Yes	2018-03-23	2018-07-27	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-05-18	Yes	PR
CPCT02230091T	HMF000864	HMF000864A	0.68	male	1938	2018-04-24	Prostate					10283	2018-04-03	Lymph node	inginual left	Yes	No	null	null	null	null	null	null	null	null
CPCT02230093T	HMF001621	HMF001621A	0.28	female	1950	2018-06-30	Gallbladder					3121	2018-02-26	Peritoneum	metastasis	Yes	No	Yes	2018-03-07	2018-05-01	Capecitabine	Chemotherapy	2018-05-02	Yes	PD
CPCT02230095T	HMF001064	HMF001064A	0.88	female	1958	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-05	omentale soft tissue	deposit belly left site	Yes	Yes	Yes	2018-03-26	2019-03-25	Letrozole/Palbociclib	Multiple therapy	2018-08-23	Yes	PR
CPCT02230096T	HMF002797	HMF002797A	0.54	male	1952	2018-05-29	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-03-20	Lymph node	neck	No	No	Yes	2018-03-24	2018-05-22	Sunitinib	Targeted therapy	null	null	null
CPCT02230097T	HMF000393	HMF000393A	0.22	male	1949	2019-10-13	Esophagus					5041	2018-03-09	Liver	intercostal	No	No	Yes	2018-03-20	2018-09-03	Capecitabine/Cisplatin/Trastuzumab	Multiple therapy	2018-05-14	Yes	PR
CPCT02230098T	HMF002002	HMF002002A	0.69	male	1956	2018-04-06	Mesothelium		Malignant mesothelioma			1790,0050686	2018-03-20	Peritoneum	left belly half	No	No	Yes	2018-03-28	2018-03-28	Cisplatin/Pemetrexed	Chemotherapy	null	null	null
CPCT02230099T	HMF003447	HMF003447A	0.53	female	1946	2018-08-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-22	Liver	not specified	Yes	No	Yes	2018-03-30	2018-06-15	Paclitaxel	Chemotherapy	2018-07-06	Yes	PR
CPCT02230101T	HMF001504	HMF001504A	0.2	female	1962	2019-03-29	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2018-03-30	Lymph node	right armpit	Yes	Yes	Yes	2018-04-10	2019-02-26	Trastuzumab	Targeted therapy	2018-06-11	Yes	CR
CPCT02230102T	HMF001986	HMF001986A	0.9	male	1961	null	Prostate					10283	2018-04-06	Lymph node	supraclavicular left side	No	No	Yes	2018-04-17	2018-07-31	Docetaxel	Chemotherapy	2018-06-12	Yes	PR
CPCT02230105T	HMF000658	HMF000658A	0.63	female	1966	2019-05-06	Adrenal gland	Adrenal medulla	Pheochromocytoma	Malignant pheochromocytoma		0080347	2018-04-09	Lymph node	supraclavicular left side	No	No	null	null	null	null	null	null	null	null
CPCT02230106T	HMF001664	HMF001664A	0.34	male	1963	2020-01-13	Esophagus					5041	2018-04-11	Liver	left lobe	Yes	Yes	Yes	2018-05-15	2018-12-31	Cisplatin/Capecitabine/Trastuzumab	Multiple therapy	2018-07-16	Yes	SD
CPCT02230107T	HMF002497	HMF002497A	0.4	female	1970	2018-05-25	Stomach					10534	2018-04-30	ovarium	metastasis	No	No	null	null	null	null	null	null	null	null
CPCT02230108T	HMF000181	HMF000181A	0.74	male	1960	2019-07-09	Prostate					10283	2018-04-18	Liver	right liver lob	Yes	No	Yes	2018-05-07	2018-06-18	Docetaxel	Chemotherapy	2018-07-13	Yes	PD
CPCT02230110T	HMF001947	HMF001947A	0.79	female	1963	2019-08-01	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-03	Liver	left lob	Yes	Yes	Yes	2018-05-15	2018-09-18	Capecitabine	Chemotherapy	null	null	null
CPCT02230111T	HMF002550	HMF002550A	0.59	female	1951	2019-06-04	Ovary					2394	2018-04-30	Lymph node	ovarium	Yes	No	Yes	2018-05-03	2019-02-07	Gemcitabine/Bevacizumab/Carboplatin	Multiple therapy	2018-06-27	Yes	PR
CPCT02230113T	HMF002819	HMF002819A	0.82	male	1955	null	Small intestine		Neuroendocrine tumor			10154,169	null	null	null	No	No	Yes	2018-07-01	null	Octreotide	Hormonal therapy	2020-07-08	Yes	SD
CPCT02230115T	HMF003710	HMF003710A	0.23	female	1960	2018-07-14	Gallbladder					3121	2018-05-28	omental cake	right lower abdomen	No	No	Yes	2018-06-12	2018-06-19	Cisplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02230117T	HMF001599	HMF001599A	0.86	male	1950	2019-04-12	Colorectum					9256	2018-06-19	Liver	null	No	No	Yes	2018-07-03	2018-12-03	Capecitabine/Oxaliplatin	Chemotherapy	2018-10-29	Yes	PR
CPCT02230118T	HMF001055	HMF001055A	0.56	female	1946	2019-05-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-11-21	Liver	segment 6/7	Yes	Yes	Yes	2018-12-04	2019-02-26	Letrozole/Palbociclib	Multiple therapy	2019-02-18	Yes	PD
CPCT02230120T	HMF004244	HMF004244A	0.36	female	1964	2020-12-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-12-20	Liver	right lobe	No	No	Yes	2018-12-20	2019-07-03	Letrozole	Hormonal therapy	2019-03-18	Yes	PR
CPCT02230124T	HMF003817	HMF003817A	0.8	female	1948	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-05	Liver	segment 4a/4b	Yes	Yes	Yes	2019-02-12	2019-11-14	Doxorubicin/Cyclophosphamide	Chemotherapy	2019-04-10	Yes	PR
CPCT02230125T	HMF003938	HMF003938A	0.66	female	1965	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-28	Liver	S7	Yes	Yes	Yes	2019-03-12	2019-08-29	Palbociclib/Fulvestrant	Multiple therapy	2019-05-28	Yes	SD
CPCT02230126T	HMF004104	HMF004104A	0.27	female	1956	2019-02-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-15	Liver	right lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02230128T	HMF000953	HMF000953B	0.62	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-05-29	Liver	segment 2	Yes	Yes	Yes	2019-06-06	2020-07-01	Everolimus/Exemestane	Multiple therapy	2019-08-21	Yes	SD
CPCT02230130T	HMF005223	HMF005223A	0.36	female	1959	2021-01-26	Pancreas					1793	2020-12-18	subcutaneous	upper belly	No	No	Yes	2021-01-05	2021-01-25	Oxaliplatin/Fluorouracil/Irinotecan	Chemotherapy	null	null	null
CPCT02240001T	HMF002988	HMF002988A	0.57	female	1951	null	Breast		Carcinoma	Triple negative		0060081	2016-11-17	Liver	leftside	No	No	Yes	2016-12-06	2017-03-17	Capecitabine	Chemotherapy	2017-02-20	Yes	PD
CPCT02240003T	HMF001496	HMF001496A	0.43	female	1937	2017-04-23	Breast		Carcinoma	Triple negative		0060081	2017-01-25	axillair	right	No	Yes	Yes	2017-02-09	2017-03-31	Doxorubicin	Chemotherapy	2017-03-31	Yes	PD
CPCT02240005T	HMF000150	HMF000150A	0.4	female	1947	2018-01-06	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-24	Lymph node	right axillair	Yes	No	Yes	2017-05-24	2017-07-26	Capecitabine	Chemotherapy	2017-07-20	Yes	PD
CPCT02240007T	HMF000042	HMF000042A	0.23	female	1974	2018-07-10	Colorectum					9256	2017-07-14	Liver	right	Yes	No	Yes	2017-07-18	2017-12-19	Capecitabine/Oxaliplatin/Gimeracil/Oteracil/Fluorouracil	Chemotherapy	2017-10-02	Yes	PR
CPCT02240008T	HMF000235	HMF000235A	0.53	female	1979	2018-06-09	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-14	Lymph node	right	Yes	Yes	Yes	2017-07-19	2018-02-20	Palbociclib/Exemestane	Multiple therapy	2017-10-09	Yes	CR
CPCT02240010T	HMF000850	HMF000850A	0.54	male	1955	null	Colorectum					9256	2017-11-08	Liver	leftlobe	No	Yes	Yes	2017-11-28	null	Fluorouracil/Oxaliplatin/Leucovorin/Cetuximab/Panitumumab	Multiple therapy	2018-02-09	Yes	PR
CPCT02240011T	HMF002638	HMF002638A	0.35	female	1977	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-09	Liver	right	Yes	Yes	Yes	2018-02-19	2018-10-23	Paclitaxel	Chemotherapy	2018-05-16	Yes	PR
CPCT02240012T	HMF001342	HMF001342A	0.66	female	1981	null	Colorectum					9256	2018-03-06	Liver	right	Yes	No	Yes	2018-03-14	null	Panitumumab/Fluorouracil/Oxaliplatin	Multiple therapy	2018-06-08	Yes	SD
CPCT02240013T	HMF002477	HMF002477A	0.73	female	1974	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-26	CNS	cerebellair left	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02250001T	HMF002382	HMF002382A	0.32	female	1942	2018-03-26	Pancreas					1793	2017-09-07	Liver	left liver lobe	No	No	Yes	2017-09-15	2018-01-12	Gemcitabine	Chemotherapy	2017-11-20	Yes	PR
CPCT02250002T	HMF003193	HMF003193A	0.25	female	1959	2018-06-13	Pancreas					1793	2017-11-08	Liver	right lobe	No	No	Yes	2017-11-16	2018-03-03	Oxaliplatin/Irinotecan/Fluorouracil	Chemotherapy	2017-12-20	Yes	SD
CPCT02250004T	HMF001300	HMF001300A	0.43	male	1958	2019-09-16	Esophagus					5041	2017-12-12	Primary	oesophagus	No	No	Yes	2017-12-19	2018-04-23	Epirubicin/Oxaliplatin/Capecitabine	Chemotherapy	2018-02-06	Yes	PR
CPCT02250005T	HMF000572	HMF000572A	0.89	female	1952	2018-04-28	Colorectum					9256	2018-01-04	Liver	central	No	No	Yes	2018-01-24	2018-01-26	Etoposide/Cisplatin	Chemotherapy	2018-02-06	Yes	PD
CPCT02250006T	HMF001483	HMF001483A	0.43	male	1942	2019-03-07	Pancreas					1793	2018-01-11	Liver	left lobe	No	No	Yes	2018-01-25	2018-08-15	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil/Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2018-03-16	Yes	SD
CPCT02250007T	HMF001128	HMF001128A	0.66	female	1959	2018-04-05	Breast		Carcinoma	Triple negative		0060081	2018-03-01	Liver	left lobe	Yes	No	Yes	2018-03-05	2018-03-28	Capecitabine	Chemotherapy	2018-03-28	Yes	PD
CPCT02250009T	HMF003459	HMF003459A	0.58	female	1964	2018-11-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-05	Liver	left lobe	Yes	Yes	Yes	2018-04-05	2018-08-20	Capecitabine	Chemotherapy	2018-05-29	Yes	SD
CPCT02250010T	HMF000766	HMF000766A	0.59	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-26	Lymph node	axillair right	Yes	No	Yes	2018-04-26	2018-08-10	Paclitaxel	Chemotherapy	2018-07-04	Yes	PR
CPCT02250011T	HMF001550	HMF001550A	0.36	female	1941	null	Colorectum					9256	2018-06-28	subcutaneous	abdominal wall	No	No	Yes	2018-07-05	2018-09-21	Capecitabine/Bevacizumab	Multiple therapy	2018-08-23	Yes	SD
CPCT02260001T	HMF000548	HMF000548A	0.86	male	1949	2017-08-31	Prostate					10283	2017-06-20	Lymph node	paravertebral mass	Yes	Yes	Yes	2017-06-23	2017-06-23	Paclitaxel	Chemotherapy	null	null	null
CPCT02260008T	HMF000130	HMF000130A	0.83	female	1978	2018-06-07	Breast		Carcinoma	Triple negative		0060081	2017-09-07	Liver	left lobe liver	Yes	Yes	Yes	2017-09-14	2017-11-16	Capecitabine	Chemotherapy	2017-11-09	Yes	PD
CPCT02260012T	HMF003768	HMF003768A	0.37	male	1961	null	Pancreas					1793	2017-11-09	Peritoneum	right subhepatic omentum	No	No	Yes	2017-11-16	2019-03-19	Fluorouracil/Leucovorin/Irinotecan/Oxaliplatin	Multiple therapy	2017-12-21	Yes	SD
CPCT02260015T	HMF001665	HMF001665A	0.56	female	1950	null	Uterus	Cervix				4362	2018-01-25	Lymph node	right groin	Yes	Yes	Yes	2018-01-29	2018-05-23	Doxorubicin	Chemotherapy	2018-03-27	Yes	PD
CPCT02260016T	HMF000526	HMF000526A	0.58	male	1948	2018-07-08	Prostate					10283	2018-02-06	Liver	right liver lobe	Yes	No	Yes	2018-02-13	2018-03-13	Cisplatin/Gemcitabine	Chemotherapy	2018-03-21	Yes	PD
CPCT02260017T	HMF002982	HMF002982A	0.72	female	1931	2018-07-02	Uterus	Endometrium				1380	2018-02-20	abdominal wall (subcutaneous)	abdomen	Yes	No	Yes	2018-02-20	2018-04-17	Doxorubicin	Chemotherapy	2018-04-13	Yes	PD
CPCT02260021T	HMF001896	HMF001896A	0.32	female	1969	2019-06-02	Bile duct		Carcinoma			4947	2018-04-24	Liver	border between left and right liver lobe	No	No	Yes	2018-05-09	2018-11-14	Cisplatin/Gemcitabine	Chemotherapy	2018-06-08	Yes	SD
CPCT02260022T	HMF000494	HMF000494A	0.57	male	1963	2018-10-23	Colorectum					9256	2018-04-26	Liver	left liver lobe	Yes	No	Yes	2018-04-30	2018-09-08	Bevacizumab/Irinotecan	Multiple therapy	2018-06-27	Yes	PR
CPCT02260028T	HMF003928	HMF003928A	0.51	female	1965	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-04-11	Liver	liver metastasis	Yes	Yes	Yes	2019-04-08	2019-10-08	Exemestane	Hormonal therapy	2019-09-30	Yes	SD
CPCT02260029T	HMF003988	HMF003988A	0.95	female	1946	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-05-28	Primary	lateral upper quadrant breast right	Yes	No	Yes	2019-06-05	2019-07-10	Tamoxifen	Hormonal therapy	null	null	null
CPCT02260039T	HMF005835	HMF005835A	0.39	female	1953	null	Pancreas					1793	null	null	null	No	No	Yes	2021-11-16	2022-02-24	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2022-01-03	Yes	SD
CPCT02260040T	HMF005901	HMF005901A	0.65	male	1956	2021-12-20	Pancreas					1793	2021-12-06	Liver	Liver	No	No	Yes	2021-12-07	2021-12-07	Irinotecan/Fluorouracil/Oxaliplatin/Leucovorin	Multiple therapy	null	null	null
CPCT02270001T	HMF001796	HMF001796B	0.49	male	1949	2018-04-12	Colorectum					9256	2017-05-16	Liver	Segment 5/6	Yes	Yes	Yes	2017-05-19	2017-08-10	Panitumumab	Targeted therapy	2017-07-07	Yes	SD
CPCT02270003T	HMF002485	HMF002485A	0.25	male	1946	2018-02-26	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-07-10	Intra abdominal retro peritoneal	Mass between musculus psoas and musculus quadratus lumborum left	No	Yes	Yes	2017-07-13	2017-11-02	Gemcitabine/Carboplatin	Chemotherapy	2017-09-11	Yes	SD
CPCT02270006T	HMF000768	HMF000768A	0.78	female	1963	2018-08-17	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-22	Lymph node	axilla left	Yes	Yes	Yes	2017-09-25	2018-03-19	Palbociclib/Fulvestrant	Multiple therapy	2017-12-06	Yes	SD
CPCT02270007T	HMF002114	HMF002114A	0.47	female	1965	2018-09-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-03	Liver	Left lobe	Yes	No	Yes	2017-10-06	2018-02-02	Paclitaxel/Bevacizumab	Multiple therapy	2017-11-28	Yes	SD
CPCT02270008T	HMF000657	HMF000657A	0.2	female	1968	2017-10-13	Breast		Carcinoma	Triple negative		0060081	2017-10-09	Lymph node	Neck	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02270018T	HMF001998	HMF001998A	0.28	female	1958	2018-08-04	Colorectum					9256	2018-02-01	Liver	intercostal	Yes	No	Yes	2018-02-02	2018-03-24	Trifluridine	Chemotherapy	2018-04-05	Yes	PD
CPCT02270021T	HMF000100	HMF000100A	0.35	female	1953	2020-07-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-12	Liver	left lobe	Yes	No	Yes	2018-02-21	2018-11-11	Letrozole/Palbociclib	Multiple therapy	2018-05-18	Yes	SD
CPCT02270022T	HMF002159	HMF002159A	0.56	male	1952	2019-06-25	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-02-08	Lung	left lower lobe	Yes	No	Yes	2018-02-15	2018-05-04	Docetaxel	Chemotherapy	2018-04-06	Yes	SD
CPCT02270023T	HMF002161	HMF002161A	0.78	female	1951	2019-06-17	Ovary					2394	2018-02-13	Soft tissue mass ovarial	left paravertebral abdomen	Yes	No	Yes	2018-02-16	2018-07-10	Carboplatin	Chemotherapy	2018-05-07	Yes	SD
CPCT02270026T	HMF003649	HMF003649A	0.3	male	1958	2018-11-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-26	Adrenal gland	Right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02270028T	HMF000221	HMF000221A	0.8	female	1958	2020-12-12	Breast		Carcinoma	Triple negative		0060081	2018-03-19	Soft tissue mass sternum	pre sternal / thoracal	Yes	Yes	Yes	2018-03-20	2019-01-03	Vinorelbine	Chemotherapy	2018-06-01	Yes	SD
CPCT02270029T	HMF003147	HMF003147A	0.46	female	1960	2018-06-02	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-20	connective tissue mass pelvix	Left above pelvic comb	Yes	Yes	Yes	2018-03-23	2018-05-03	Gemcitabine	Chemotherapy	2018-05-14	Yes	PD
CPCT02270030T	HMF003104	HMF003104A	0.73	female	1959	2018-08-06	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-22	Liver	Right liver lobe	Yes	Yes	Yes	2018-03-23	2018-04-12	Capecitabine	Chemotherapy	2018-05-09	Yes	PD
CPCT02270031T	HMF003042	HMF003042A	0.63	female	1944	2018-12-23	Ovary					2394	2018-04-06	Peritoneum	unknown	Yes	Yes	Yes	2018-04-23	2018-09-25	Bevacizumab/Doxorubicin	Multiple therapy	2018-06-12	Yes	SD
CPCT02270036T	HMF002499	HMF002499A	0.59	male	1940	2019-06-10	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-14	Lung	Right upper lobe	Yes	Yes	Yes	2018-06-22	2018-08-25	Docetaxel	Chemotherapy	2018-07-27	Yes	SD
CPCT02270041T	HMF000675	HMF000675A	0.22	female	1937	2019-04-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-07	Liver	segment V	Yes	No	Yes	2018-11-09	2018-12-07	Nivolumab	Immunotherapy	2018-12-17	Yes	PD
CPCT02270043T	HMF003384	HMF003384A	0.61	female	1943	2019-10-31	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-29	Lung	intrapulmonary lesion left	Yes	No	Yes	2018-12-05	2019-03-30	Nivolumab	Immunotherapy	2019-01-16	Yes	SD
CPCT02270045T	HMF004107	HMF004107A	0.55	female	1945	2019-02-20	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-31	Liver	right liver lobe ventral	Yes	No	Yes	2019-01-04	2019-01-05	Nivolumab	Immunotherapy	2019-01-14	Yes	PD
CPCT02270046T	HMF004180	HMF004180A	0.65	female	1950	2019-10-01	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-28	Lung	trachae	Yes	Yes	Yes	2019-03-12	2019-04-20	Nivolumab	Immunotherapy	2019-05-06	Yes	PD
CPCT02270047T	HMF004148	HMF004148A	0.92	female	1946	2019-05-15	Lung		Carcinoma	Small cell carcinoma		5409	2019-03-28	skin/subcutaneous	left caudal back	No	No	Yes	2019-04-04	2019-05-15	Etoposide/Carboplatin/Etoposide	Chemotherapy	null	null	null
CPCT02290001T	HMF001103	HMF001103A	0.58	female	1974	2018-04-24	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2016-12-02	Lymph node	supraclavicular right	Yes	Yes	Yes	2016-12-07	2017-05-24	Docetaxel/Trastuzumab/Pertuzumab/Trastuzumab	Multiple therapy	2017-02-02	Yes	PR
CPCT02290003T	HMF000266	HMF000266A	0.72	female	1937	2017-02-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-12-12	Liver	liver NOS	Yes	Yes	Yes	2016-12-07	2017-02-08	Everolimus/Exemestane	Multiple therapy	null	null	null
CPCT02290006T	HMF002505	HMF002505A	0.82	male	1967	2018-02-01	Prostate					10283	2017-01-25	Liver	left lobe	Yes	Yes	Yes	2017-02-20	2017-11-15	Cabazitaxel/Carboplatin	Chemotherapy	2017-04-20	Yes	SD
CPCT02290008T	HMF000193	HMF000193A	0.62	female	1970	2019-05-22	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	No	No	Yes	2017-03-22	2018-06-15	Paclitaxel/Tamoxifen	Multiple therapy	2017-06-13	Yes	PR
CPCT02290011T	HMF002887	HMF002887A	0.21	female	1961	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-02	Primary	left mamma	Yes	No	Yes	2017-06-09	2020-01-06	Anastrozole	Hormonal therapy	2020-01-02	Yes	PD
CPCT02290013T	HMF003377	HMF003377A	0.55	male	1940	null	Bone marrow		Multiple myeloma			9538	2017-08-14	Bone	unknown	No	No	null	null	null	null	null	null	null	null
CPCT02290016T	HMF000229	HMF000229A	0.52	male	1946	2018-06-27	Colorectum					9256	2017-09-27	Liver	right liver lobe	No	Yes	Yes	2017-10-12	2018-02-20	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-03-01	Yes	PD
CPCT02290017T	HMF003352	HMF003352A	0.45	female	1947	2020-06-28	Colorectum					9256	2017-10-02	Peritoneum	peritoneale laesie	No	No	Yes	2017-10-13	2018-06-22	Bevacizumab/Capecitabine/Oxaliplatin	Multiple therapy	2017-12-13	Yes	PR
CPCT02290018T	HMF000116	HMF000116A	0.38	female	1964	2020-03-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-09	Liver	right liver lobe	Yes	Yes	Yes	2017-10-23	2020-03-02	Fulvestrant/Palbociclib	Multiple therapy	null	null	null
CPCT02290028T	HMF001788	HMF001788A	0.93	female	1965	2020-04-16	Ovary					2394	2018-01-12	Primary	ovarium	Yes	No	Yes	2018-01-22	2018-07-03	Bevacizumab/Gemcitabine/Carboplatin	Multiple therapy	2018-04-16	Yes	SD
CPCT02290030T	HMF000915	HMF000915A	0.21	female	1975	2019-08-25	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-02-14	Liver	liver segment 5	Yes	Yes	Yes	2018-02-26	2018-11-09	Docetaxel/Trastuzumab/Pertuzumab/Letrozole	Multiple therapy	2018-04-24	Yes	SD
CPCT02290031T	HMF002710	HMF002710A	0.5	male	1955	2018-11-09	Prostate					10283	2018-02-26	Peritoneum	cavum rectovesicale	Yes	No	Yes	2018-02-28	2018-06-07	Cabazitaxel	Chemotherapy	2018-06-04	Yes	PD
CPCT02290032T	HMF003404	HMF003404A	0.62	male	1965	null	Colorectum					9256	2018-03-07	Liver	segment 4	Yes	No	Yes	2018-03-30	2019-04-18	Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2018-05-22	Yes	PR
CPCT02290033T	HMF002843	HMF002843A	0.21	male	1945	2018-07-13	Head and neck	Oropharynx				8557,11934	2018-03-07	skin/subcutaneous	skin submandibular	No	Yes	Yes	2018-03-14	2018-06-21	Cetuximab/Carboplatin	Multiple therapy	2018-07-04	No	Clinical progression
CPCT02290035T	HMF000370	HMF000370A	0.61	female	1964	2018-09-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-14	Liver	ventral	Yes	Yes	Yes	2018-03-28	2018-07-04	Paclitaxel	Chemotherapy	null	null	null
CPCT02290037T	HMF001340	HMF001340A	0.71	female	1951	2018-05-13	Breast		Carcinoma	Triple negative		0060081	2018-03-26	Primary	left breast	Yes	No	Yes	2018-03-27	2018-04-05	Capecitabine	Chemotherapy	null	null	null
CPCT02290038T	HMF000635	HMF000635A	0.58	male	1950	2019-02-26	Prostate					10283	2018-04-06	Liver	right lobe	Yes	Yes	Yes	2018-04-16	2018-07-06	Docetaxel	Chemotherapy	2018-07-23	Yes	PD
CPCT02290039T	HMF000055	HMF000055B	0.9	male	1952	2018-09-18	Unknown					162	2018-04-04	Liver	segment 4	Yes	Yes	Yes	2018-04-19	2018-05-30	Cisplatin/Etoposide	Chemotherapy	2018-05-28	Yes	PD
CPCT02290040T	HMF001339	HMF001339A	0.36	female	1969	2018-08-04	Breast		Carcinoma	Triple negative		0060081	2018-04-06	Lymph node	neck	Yes	Yes	Yes	2018-04-20	2018-07-06	Capecitabine	Chemotherapy	2018-06-07	Yes	SD
CPCT02290041T	HMF000483	HMF000483A	0.68	female	1936	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-04-16	Bone	femur	No	No	Yes	2018-04-27	2018-11-15	Doxorubicin/Cyclophosphamide/Vincristine/Rituximab	Multiple therapy	null	null	null
CPCT02290044T	HMF003262	HMF003262A	0.71	male	1968	2021-01-19	Colorectum					9256	2018-05-07	Liver	segment 6/7	No	Yes	Yes	2018-05-25	2019-09-12	Oxaliplatin/Bevacizumab/Capecitabine	Multiple therapy	2018-07-20	Yes	SD
CPCT02290045T	HMF000944	HMF000944A	0.28	male	1948	2019-06-09	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-05-17	Lymph node	cervical	No	No	Yes	2018-07-05	2019-03-14	Pazopanib	Targeted therapy	null	null	null
CPCT02290046T	HMF001931	HMF001931A	0.75	female	1953	2018-06-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-24	Liver	liver nos	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02290048T	HMF000935	HMF000935A	0.45	female	1972	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-04	Bone	femur	Yes	Yes	Yes	2018-07-18	2023-01-15	Letrozole/Leuprorelin	Multiple therapy	2019-08-14	Yes	SD
CPCT02290050T	HMF000260	HMF000260A	0.86	male	1941	2019-01-22	Prostate					10283	2018-06-06	Liver	liver	No	Yes	Yes	2018-06-19	2018-08-28	Etoposide/Carboplatin	Chemotherapy	2018-09-24	Yes	PR
CPCT02290051T	HMF000033	HMF000033A	0.68	male	1951	null	Pancreas		Neuroendocrine tumor			1793,169	2018-06-06	Liver	liver	No	No	Yes	2018-09-05	2019-09-04	Lanreotide	Hormonal therapy	2019-08-16	Yes	PD
CPCT02290052T	HMF002951	HMF002951A	0.66	female	1958	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-11	Lymph node	supraclavicular	Yes	Yes	Yes	2018-06-22	null	Letrozole/Cyclophosphamide/Docetaxel/Letrozole	Multiple therapy	2018-09-26	Yes	SD
CPCT02290053T	HMF000660	HMF000660A	0.74	male	1979	null	Pancreas		Neuroendocrine tumor			1793,169	2018-06-19	Liver	left lobe	No	No	Yes	2018-08-01	2022-09-01	Octreotide	Hormonal therapy	2019-02-12	Yes	SD
CPCT02290054T	HMF003794	HMF003794A	0.55	male	1970	2018-07-24	Unknown	CUP				162	2018-06-13	Liver	segment 4b	No	No	Yes	2018-06-20	2018-07-24	Oxaliplatin/Leucovorin/Fluorouracil	Multiple therapy	null	null	null
CPCT02290055T	HMF003542	HMF003542A	0.46	male	1955	2018-07-31	Hepatobiliary system	Liver and Bile duct	Carcinoma	Combined hepatocellular carcinoma-cholangiocarcinoma		686,4947	2018-06-22	Liver	left lobe	No	No	null	null	null	null	null	null	null	null
CPCT02290056T	HMF001193	HMF001193A	0.57	female	1950	2018-08-19	Bile duct		Carcinoma			4947	2018-06-26	Liver	NOS	No	No	Yes	2018-06-29	2018-08-19	Cisplatin/Gemcitabine	Chemotherapy	null	null	null
CPCT02290057T	HMF000773	HMF000773A	0.86	female	1963	2019-08-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-16	subcutaneous	sternum	Yes	No	Yes	2018-07-16	2019-02-13	Fulvestrant	Hormonal therapy	2018-10-11	Yes	SD
CPCT02290061T	HMF003868	HMF003868A	0.37	male	1957	null	Skin		Melanoma			8923	2019-02-18	Lymph node	right armpit	No	No	Yes	2019-03-05	2019-05-06	Ipilimumab/Nivolumab	Immunotherapy	2019-05-24	Yes	PR
CPCT02290064T	HMF005630	HMF005630A	0.49	male	1942	2022-03-22	Pancreas					1793	2021-03-17	Liver	segment 4	No	No	Yes	2021-04-02	2021-09-07	Irinotecan/Leucovorin/Fluorouracil/Oxaliplatin	Multiple therapy	2021-06-23	Yes	SD
CPCT02290065T	HMF005631	HMF005631A	0.29	female	1973	2021-10-30	Pancreas					1793	2021-04-13	Liver	left lobe	No	No	Yes	2021-04-26	2021-09-14	Oxaliplatin/Irinotecan/Fluorouracil	Chemotherapy	2021-08-04	Yes	SD
CPCT02300001T	HMF000908	HMF000908A	0.45	female	1955	2019-05-06	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2016-11-29	Bone	pelvis	Yes	No	Yes	2016-12-02	2018-07-31	Docetaxel/Anastrozole	Multiple therapy	2017-01-30	Yes	SD
CPCT02300002T	HMF003143	HMF003143A	0.64	male	1955	2017-05-05	Prostate					10283	2016-12-16	Lymph node	para iliacaal	No	No	Yes	2017-01-12	2017-02-23	Docetaxel	Chemotherapy	2017-03-13	Yes	PD
CPCT02300004T	HMF001816	HMF001816A	0.83	female	1938	2017-05-16	Unknown	CUP	Carcinoma			305	2016-12-20	Bone	rib right high thoracic	Yes	Yes	Yes	2016-12-29	2017-04-01	Anastrozole	Hormonal therapy	null	null	null
CPCT02300005T	HMF003780	HMF003780A	0.75	female	1963	2020-01-27	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-05	Primary	breast	Yes	No	Yes	2017-01-19	2017-03-22	Capecitabine	Chemotherapy	2017-03-20	Yes	SD
CPCT02300006T	HMF001710	HMF001710A	0.24	female	1938	2017-05-31	Gallbladder					3121	2017-01-23	gall bladder	gall bladder	No	No	Yes	2017-01-26	2017-03-15	Gemcitabine/Cisplatin	Chemotherapy	2017-03-23	Yes	SD
CPCT02300008T	HMF001536	HMF001536A	0.82	female	1944	2017-10-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-02-20	subcutane	UK	Yes	No	Yes	2017-03-07	2017-05-24	Capecitabine	Chemotherapy	2017-03-16	Yes	PD
CPCT02300009T	HMF000170	HMF000170A	0.62	female	1950	2020-04-20	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-03-15	Bone	ileum	Yes	Yes	Yes	2017-03-28	2018-11-02	Anastrozole	Hormonal therapy	2017-06-16	Yes	SD
CPCT02300010T	HMF000799	HMF000799A	0.33	female	1961	2017-09-04	Colorectum					9256	2017-03-30	Primary	colon	No	No	Yes	2017-05-30	2017-06-16	Oxaliplatin/Leucovorin/Fluorouracil	Multiple therapy	2017-08-03	Yes	PR
CPCT02300011T	HMF003626	HMF003626A	0.43	female	1965	2019-05-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-04-21	Bone	sacrum	Yes	Yes	Yes	2017-05-16	2017-11-14	Capecitabine	Chemotherapy	2017-07-27	Yes	SD
CPCT02300014T	HMF003296	HMF003296A	0.48	female	1938	2020-03-13	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-02	Bone	sacrum right	Yes	No	Yes	2017-05-16	2018-07-03	Letrozole	Hormonal therapy	null	null	null
CPCT02300015T	HMF001149	HMF001149A	0.58	male	1952	2018-05-16	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-05-30	Liver	liver	No	No	Yes	2017-06-23	2017-11-01	Cisplatin/Pemetrexed	Chemotherapy	2017-09-25	Yes	SD
CPCT02300016T	HMF000965	HMF000965A	0.85	female	1961	2018-02-16	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-21	Lymph node	axilla right	Yes	Yes	Yes	2017-06-29	2018-02-16	Fulvestrant/Palbociclib	Multiple therapy	2017-10-23	Yes	SD
CPCT02300017T	HMF000467	HMF000467A	0.57	male	1937	2017-07-17	Colorectum					9256	2017-06-22	Primary	sigmoid	No	No	null	null	null	null	null	null	null	null
CPCT02300018T	HMF003738	HMF003738A	0.66	female	1966	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-06-23	Bone	os ileum sacro iliacaal right	Yes	Yes	Yes	2017-07-06	2019-06-26	Anastrozole/Palbociclib	Multiple therapy	2017-10-02	Yes	PR
CPCT02300021T	HMF001580	HMF001580A	0.21	female	1949	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-08-21	Lymph node	axilla right	Yes	No	Yes	2017-08-30	2018-04-20	Palbociclib/Fulvestrant	Multiple therapy	2017-12-28	Yes	PR
CPCT02300023T	HMF000432	HMF000432A	0.29	female	1946	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2017-08-28	Lymph node	inguinal right	No	No	Yes	2017-09-18	2018-02-13	Vincristine/Doxorubicin/Cyclophosphamide/Rituximab/Methotrexate	Multiple therapy	2017-11-16	Yes	PR
CPCT02300026T	HMF003031	HMF003031A	0.83	female	1955	2019-11-21	Ovary					2394	2017-11-10	Peritoneum	abdominall wall	Yes	No	Yes	2017-11-22	2018-01-17	Doxorubicin	Chemotherapy	2018-02-09	Yes	PD
CPCT02300027T	HMF001870	HMF001870A	0.41	male	1951	2018-02-01	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-11-10	Bone	scapula	No	No	Yes	2017-11-17	2018-01-11	Pazopanib	Targeted therapy	2018-01-18	Yes	SD
CPCT02300028T	HMF003102	HMF003102A	0.34	female	1951	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-08	Bone	vertebral body thoracal 12	Yes	Yes	Yes	2017-12-19	null	Anastrozole/Palbociclib	Multiple therapy	null	null	null
CPCT02300029T	HMF002947	HMF002947A	0.37	female	1971	2018-07-06	Bile duct		Carcinoma			4947	2017-12-15	Liver	liver	No	No	Yes	2018-01-03	2018-02-14	Cisplatin/Gemcitabine	Chemotherapy	2018-03-01	Yes	PD
CPCT02300030T	HMF002051	HMF002051A	0.23	male	1950	2018-05-20	Unknown	CUP	Carcinoma			305	2018-01-09	Liver	right liver lobe	No	No	Yes	2018-01-31	2018-03-14	Irinotecan/Oxaliplatin/Fluorouracil	Chemotherapy	2018-03-30	Yes	PR
CPCT02300031T	HMF002121	HMF002121A	0.31	male	1961	2018-05-30	Esophagus					5041	2018-01-09	Liver	right liver lobe	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02300032T	HMF003389	HMF003389A	0.7	female	1969	2019-09-11	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-01-11	Bone	rib	No	No	Yes	2018-02-13	2019-09-11	Docetaxel/Trastuzumab/Pertuzumab/Tamoxifen	Multiple therapy	2018-04-11	Yes	PR
CPCT02300033T	HMF000555	HMF000555A	0.79	female	1962	null	Colorectum					9256	2018-01-18	Primary	colon descendens	No	No	Yes	2018-02-13	2018-05-29	Capecitabine/Oxaliplatin	Chemotherapy	2018-04-10	Yes	SD
CPCT02300036T	HMF002833	HMF002833A	0.95	male	1940	2018-03-04	Unknown		Carcinoma	Small cell carcinoma		0050685	2018-02-16	Liver	right lobe	No	No	Yes	2018-02-22	2018-02-24	Etoposide/Carboplatin	Chemotherapy	null	null	null
CPCT02300038T	HMF001819	HMF001819A	0.96	female	1938	2020-02-27	Lymphoid tissue		Non-Hodgkin lymphoma	B-cell lymphoma		707	2018-03-15	Lymph node	around the aorta; lymphnode	No	No	Yes	2018-03-30	2018-08-30	Doxorubicin/Cyclophosphamide/Vincristine/Rituximab	Multiple therapy	2018-05-29	Yes	PR
CPCT02300039T	HMF002987	HMF002987A	0.58	male	1970	2018-04-28	Esophagus					5041	2018-03-23	Primary	esophagus	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02300040T	HMF002252	HMF002252A	0.61	female	1972	2021-04-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-05	Bone	os ileum	Yes	Yes	Yes	2018-04-11	2018-06-12	Anastrozole/Palbociclib	Multiple therapy	2018-08-08	Yes	PD
CPCT02300042T	HMF001903	HMF001903A	0.28	male	1971	null	Skin		Carcinoma	Basal cell carcinoma		2513	2018-04-18	Lymph node	infraclavicular right side	No	No	null	null	null	null	null	null	null	null
CPCT02300043T	HMF000848	HMF000848A	0.36	female	1978	2018-11-07	Breast		Carcinoma	Triple negative		0060081	2018-04-25	Liver	right lobe	Yes	Yes	Yes	2018-05-17	2018-07-05	Carboplatin	Chemotherapy	2018-07-18	Yes	PD
CPCT02300046T	HMF001411	HMF001411A	0.62	male	1944	2018-09-10	Prostate					10283	2018-06-01	Liver	segment 8	Yes	Yes	Yes	2018-06-08	2018-08-09	Abiraterone	Hormonal therapy	null	null	null
CPCT02300048T	HMF001968	HMF001968A	0.63	male	1958	2022-08-13	Colorectum					9256	2018-07-03	intra abdominal	intra abdominal	Yes	No	Yes	2018-07-19	2018-09-19	Capecitabine/Irinotecan/Bevacizumab	Multiple therapy	2018-09-12	Yes	SD
CPCT02300049T	HMF001630	HMF001630A	0.23	female	1948	2018-10-09	Ovary					2394	2018-06-14	Liver	segment 5	Yes	No	Yes	2018-07-23	2018-09-04	Capecitabine/Oxaliplatin	Chemotherapy	2018-09-19	Yes	PD
CPCT02300050T	HMF003007	HMF003007A	0.51	male	1957	2019-01-10	Stomach					10534	2018-06-18	Liver	leasion left liver lobe	Yes	No	Yes	2018-06-26	2018-07-24	Oxaliplatin/Fluorouracil	Chemotherapy	2018-07-30	Yes	PD
CPCT02300052T	HMF003910	HMF003910A	0.51	male	1948	null	Prostate					10283	2019-05-09	Bone	os ileum	Yes	No	Yes	2019-06-03	null	Enzalutamide	Hormonal therapy	null	null	null
CPCT02310003T	HMF003625	HMF003625A	0.69	female	1941	2017-11-21	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-06	Liver	liver	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02310007T	HMF002283	HMF002283A	0.64	male	1944	2018-03-05	Colorectum					9256	2018-01-26	Liver	Right liver lobe	No	No	null	null	null	null	null	null	null	null
CPCT02310008T	HMF002971	HMF002971A	0.31	male	1948	null	Prostate					10283	2018-01-29	Liver	Upper right lobe	Yes	Yes	Yes	2018-02-08	2018-08-01	Docetaxel/Cyproterone	Multiple therapy	2018-04-10	Yes	PD
CPCT02310011T	HMF003448	HMF003448A	0.65	female	1938	2019-12-05	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-03-09	Liver	left lobe	Yes	Yes	Yes	2018-04-18	2019-02-28	Anastrozole/Trastuzumab	Multiple therapy	2018-06-22	Yes	SD
CPCT02310012T	HMF003288	HMF003288A	0.78	female	1943	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-03-16	Liver	Right lobe	No	No	Yes	2018-04-06	2018-09-07	Rituximab/Cyclophosphamide/Doxorubicin/Vincristine	Multiple therapy	2018-06-11	Yes	PR
CPCT02310013T	HMF001404	HMF001404A	0.62	female	1957	2018-07-27	Colorectum					9256	2018-04-16	Liver	Left liver lobe	No	No	null	null	null	null	null	null	null	null
CPCT02310016T	HMF002875	HMF002875A	0.71	female	1980	2018-06-30	Stomach					10534	2018-05-25	Liver	Right lobe	No	No	Yes	2018-06-01	2018-06-29	Oxaliplatin/Fluorouracil	Chemotherapy	2018-06-27	Yes	PD
CPCT02310017T	HMF000920	HMF000920A	1.0	male	1942	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2018-06-01	Lymph node	Right neck	No	No	Yes	2018-06-20	2018-07-10	Rituximab/Cyclophosphamide/Doxorubicin/Vincristine	Multiple therapy	2018-10-15	Yes	CR
CPCT02310018T	HMF002435	HMF002435A	0.84	female	1965	2019-03-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-29	Liver	Right liver lobe	Yes	No	Yes	2018-08-03	2018-09-20	Paclitaxel	Chemotherapy	2018-09-19	Yes	PD
CPCT02310019T	HMF000082	HMF000082A	0.77	female	1956	2019-09-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-07-06	Lymph node	Right armpit	Yes	Yes	Yes	2018-07-18	2018-09-12	Fulvestrant/Palbociclib	Multiple therapy	null	null	null
CPCT02310021T	HMF003238	HMF003238A	0.61	female	1946	2019-11-20	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-11-08	Adrenal gland	Left	Yes	No	Yes	2018-11-29	2019-06-27	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	2019-01-28	Yes	PR
CPCT02310022T	HMF003306	HMF003306A	0.28	female	1963	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-11-26	Bone	crista	Yes	No	Yes	2018-12-10	2020-03-25	Fulvestrant/Palbociclib	Multiple therapy	null	null	null
CPCT02320002T	HMF000282	HMF000282A	0.65	male	1945	2018-07-04	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	2018-03-12	Liver	segment 6	No	Yes	Yes	2018-03-14	2018-06-13	Gemcitabine/Carboplatin	Chemotherapy	2018-04-30	Yes	SD
CPCT02320003T	HMF000504	HMF000504A	0.44	female	1946	2020-11-28	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-15	Lymph node	supraclaviculair right	Yes	Yes	Yes	2018-03-31	2020-06-04	Palbociclib/Letrozole	Multiple therapy	2018-06-25	Yes	PR
CPCT02320005T	HMF002976	HMF002976A	0.55	male	1943	2018-10-07	Colorectum					9256	2018-05-22	Liver	right lobe	Yes	No	Yes	2018-05-28	2018-07-10	Panitumumab	Targeted therapy	2018-07-10	Yes	PD
CPCT02320008T	HMF003981	HMF003981A	0.49	female	1955	2021-12-15	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-15	Bone	os sacrum	null	null	Yes	2019-03-18	2019-07-01	Everolimus	Targeted therapy	null	null	null
CPCT02320011T	HMF004831	HMF004831A	0.57	female	1962	2020-12-21	Pancreas					1793	2020-07-31	Liver	right lobe	No	No	Yes	2020-08-07	2020-11-23	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2020-09-25	Yes	PD
CPCT02330006T	HMF003347	HMF003347A	0.24	female	1948	null	Pancreas					1793	2016-11-08	Liver	left liver segment	No	No	Yes	2016-11-23	2017-05-17	Gemcitabine	Chemotherapy	2017-01-12	Yes	SD
CPCT02330007T	HMF001105	HMF001105A	0.33	female	1940	2016-12-17	Colorectum	Colon sigmoideum				12192	2016-11-22	abdominal wall, intramusculair	distal	Yes	No	Yes	2016-11-28	2016-11-28	Irinotecan	Chemotherapy	2016-12-12	Yes	PD
CPCT02330009T	HMF003133	HMF003133A	0.47	female	1946	null	Colorectum					9256	2016-11-29	Liver	right liver lob	No	No	Yes	2016-12-06	2018-03-02	Bevacizumab/Oxaliplatin/Capecitabine	Multiple therapy	2017-02-09	Yes	SD
CPCT02330015T	HMF000691	HMF000691A	0.77	female	1935	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-01-11	Lymph node	inguinal	No	Yes	Yes	2017-01-25	2017-05-17	Gemcitabine/Carboplatin	Chemotherapy	2017-03-23	Yes	PR
CPCT02330016T	HMF003158	HMF003158A	0.49	male	1946	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2017-01-23	Lung	dorsal lesion in the left chest wall at the height of costa 8	No	No	Yes	2017-02-10	2017-07-12	Rituximab/Cyclophosphamide/Doxorubicin/Vincristine/Rituximab	Multiple therapy	2017-04-10	Yes	PR
CPCT02330017T	HMF003071	HMF003071A	0.67	female	1958	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-01-24	Liver	left liver segment	Yes	Yes	Yes	2017-01-27	2017-04-25	Letrozole	Hormonal therapy	2017-04-19	Yes	PD
CPCT02330021T	HMF000064	HMF000064A	0.48	female	1964	null	Ovary					2394	2017-03-08	peritonial lesion	abdomen	No	No	Yes	2017-03-16	2017-06-15	Carboplatin/Paclitaxel	Chemotherapy	2017-04-19	Yes	SD
CPCT02330023T	HMF001617	HMF001617A	0.26	female	1950	null	Ovary					2394	2017-03-22	Lymph node	right axilla	Yes	No	Yes	2017-04-10	2017-09-28	Carboplatin/Paclitaxel/Letrozole	Multiple therapy	2017-06-06	Yes	SD
CPCT02330024T	HMF000533	HMF000533A	0.41	male	1948	null	Colorectum					9256	2017-04-19	Liver	right liver lob	Yes	No	Yes	2017-04-24	2017-10-26	Capecitabine/Bevacizumab/Oxaliplatin	Multiple therapy	2017-06-23	Yes	SD
CPCT02330025T	HMF001242	HMF001242A	0.56	female	1943	null	Colorectum					9256	2017-04-19	subcutane laesion	left flank	Yes	Yes	Yes	2017-04-25	2018-08-08	Capecitabine/Irinotecan	Chemotherapy	2017-07-11	Yes	PR
CPCT02330027T	HMF000802	HMF000802A	0.58	female	1956	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-05-09	Lung	parasternally right	Yes	No	Yes	2017-05-10	2017-11-27	Capecitabine	Chemotherapy	2017-07-19	Yes	SD
CPCT02330029T	HMF002916	HMF002916A	0.69	male	1960	null	Prostate					10283	2017-05-10	Lymph node	supraclaviculair	Yes	Yes	Yes	2017-06-13	2018-01-04	Cabazitaxel	Chemotherapy	2017-08-09	Yes	PR
CPCT02330032T	HMF003614	HMF003614A	0.66	female	1973	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-05-15	left mamma	left mamma	Yes	Yes	Yes	2017-05-23	2018-09-10	Letrozole	Hormonal therapy	2017-07-19	Yes	SD
CPCT02330033T	HMF002215	HMF002215A	0.42	female	1971	null	Esophagus					5041	2017-05-24	Liver	left liver lob	No	No	Yes	2017-06-07	2018-03-21	Capecitabine/Oxaliplatin/Trastuzumab	Multiple therapy	2017-08-02	Yes	PR
CPCT02330034T	HMF003534	HMF003534A	0.6	female	1947	null	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2017-05-31	Liver	right liver lob	No	No	Yes	2017-07-18	2017-10-05	Carboplatin/Gemcitabine	Chemotherapy	2017-09-12	Yes	PR
CPCT02330035T	HMF003401	HMF003401A	0.65	female	1965	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-06-02	Liver	right liver lob	Yes	Yes	Yes	2017-06-14	2017-10-04	Trastuzumab	Targeted therapy	2017-08-14	Yes	SD
CPCT02330036T	HMF003696	HMF003696A	0.27	male	1950	null	Colorectum					9256	2017-06-07	Lung	right upper lob	Yes	No	Yes	2017-06-12	2018-01-10	Trifluridine	Chemotherapy	2017-08-22	Yes	SD
CPCT02330041T	HMF001184	HMF001184B	0.42	male	1953	null	Colorectum					9256	2017-07-25	Lung	ROK	Yes	Yes	Yes	2017-07-31	2018-04-22	Trifluridine	Chemotherapy	2017-09-19	Yes	SD
CPCT02330042T	HMF002904	HMF002904A	0.43	female	1941	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-27	Lung	paravertebral left	Yes	Yes	Yes	2017-08-03	2020-12-21	Anastrozole	Hormonal therapy	2017-10-25	Yes	PR
CPCT02330043T	HMF000547	HMF000547A	0.85	male	1958	null	Colorectum					9256	2018-05-09	Lung	right under lob	Yes	No	Yes	2018-05-14	2019-02-01	Trifluridine	Chemotherapy	2018-08-13	Yes	SD
CPCT02330044T	HMF002186	HMF002186A	0.77	male	1955	null	Prostate					10283	2017-08-10	Lung	ROK	Yes	Yes	Yes	2017-08-17	2017-11-30	Carboplatin	Chemotherapy	2017-10-12	Yes	SD
CPCT02330045T	HMF000211	HMF000211A	0.66	female	1960	null	Colorectum					9256	2017-08-03	Liver	segment 3	Yes	No	Yes	2017-08-04	2017-09-29	Trifluridine	Chemotherapy	2017-09-27	Yes	PD
CPCT02330046T	HMF002895	HMF002895A	0.46	female	1948	null	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2017-08-01	peritoneal deposition	the medianline, under the left liver lob	No	No	Yes	2017-08-07	2017-11-29	Gemcitabine/Carboplatin	Chemotherapy	2017-09-07	Yes	PR
CPCT02330047T	HMF001843	HMF001843A	0.86	female	1952	null	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-08-10	abdominal wall, intramusculair	lesion left abdominal wall	No	No	Yes	2017-10-20	null	Pazopanib	Targeted therapy	2018-02-12	Yes	SD
CPCT02330049T	HMF001432	HMF001432B	0.68	male	1952	null	Colorectum					9256	2017-09-18	Liver	segment 8	Yes	Yes	Yes	2017-09-22	2017-11-17	Trifluridine	Chemotherapy	2017-11-10	Yes	PD
CPCT02330051T	HMF001255	HMF001255A	0.35	male	1945	null	Colorectum					9256	2017-09-29	Liver	segment 6	Yes	No	Yes	2017-10-05	2018-10-22	Irinotecan	Chemotherapy	2017-12-19	Yes	SD
CPCT02330052T	HMF002741	HMF002741A	0.56	female	1944	null	Colorectum					9256	2017-10-12	Liver	segment 2	Yes	No	Yes	2017-10-16	2019-06-01	Trifluridine	Chemotherapy	2018-01-02	Yes	SD
CPCT02330053T	HMF000587	HMF000587A	0.62	female	1955	null	Colorectum					9256	2017-10-09	Liver	ND	No	No	Yes	2017-10-18	2018-05-08	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-12-13	Yes	SD
CPCT02330058T	HMF000387	HMF000387A	0.91	male	1959	null	Nervous system		Glioma	Glioblastoma multiforme		3068	2017-10-30	brain	left frontal	Yes	Yes	Yes	2018-01-08	2018-03-21	Lomustine	Chemotherapy	null	null	null
CPCT02330059T	HMF000726	HMF000726C	0.48	male	1964	null	Gastroesophageal	Esophago-gastric junction	Carcinoma			0080374,305	2017-10-27	Liver	segment 5	Yes	Yes	Yes	2017-10-30	2018-04-17	Paclitaxel/Ramucirumab	Multiple therapy	2017-12-14	Yes	SD
CPCT02330061T	HMF001017	HMF001017A	0.45	female	1967	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-27	Liver	right side of the liver	Yes	Yes	Yes	2017-11-01	2018-01-04	Doxorubicin/Cyclophosphamide	Chemotherapy	2018-01-18	Yes	PD
CPCT02330063T	HMF002282	HMF002282A	0.72	female	1943	2017-12-17	Stomach					10534	2017-10-24	Liver	right liver lob	No	No	Yes	2017-12-07	2017-12-07	Fluorouracil/Trastuzumab/Leucovorin	Multiple therapy	2017-12-12	Yes	PD
CPCT02330066T	HMF001084	HMF001084A	0.43	female	1961	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2017-11-02	Lymph node	peritoneal	Yes	Yes	Yes	2017-11-17	2019-03-22	Paclitaxel/Trastuzumab	Multiple therapy	2018-01-08	Yes	SD
CPCT02330067T	HMF000968	HMF000968A	0.72	female	1956	2018-02-08	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-13	adnex	right adnex	Yes	No	null	null	null	null	null	null	null	null
CPCT02330070T	HMF002502	HMF002502A	0.9	female	1956	null	Colorectum					9256	2017-11-09	Liver	point of the liver right	Yes	No	Yes	2017-11-15	2018-01-23	Trifluridine	Chemotherapy	2018-01-12	Yes	SD
CPCT02330071T	HMF001033	HMF001033A	0.53	female	1964	2018-05-20	Breast		Carcinoma	Triple negative		0060081	2017-11-20	Liver	left liver lob	Yes	No	Yes	2018-01-30	2018-03-20	Vinorelbine	Chemotherapy	2018-03-23	Yes	PD
CPCT02330072T	HMF001081	HMF001081A	0.2	male	1945	null	Esophagus					5041	2018-03-30	Liver	right liver lob	Yes	No	Yes	2018-03-30	2019-01-08	Paclitaxel/Ramucirumab	Multiple therapy	2018-05-31	Yes	PR
CPCT02330073T	HMF003151	HMF003151A	0.59	female	1962	null	Colorectum					9256	2017-11-23	Liver	not decribed in radiology report	No	No	Yes	2017-12-13	2018-09-19	Fluorouracil/Irinotecan/Oxaliplatin/Bevacizumab	Multiple therapy	2018-02-06	Yes	SD
CPCT02330074T	HMF000641	HMF000641B	0.47	female	1973	null	Anus					14110	2017-11-24	muscle	erectur spinae right	Yes	Yes	Yes	2017-12-04	2018-04-01	Cisplatin/Capecitabine	Chemotherapy	2018-02-02	Yes	CR
CPCT02330075T	HMF002043	HMF002043A	0.87	female	1951	2018-08-20	Uterus	Endometrium				1380	2018-06-06	Peritoneum	left under in the abdomen	Yes	Yes	Yes	2018-06-06	2018-08-10	Anastrozole/Doxorubicin	Multiple therapy	null	null	null
CPCT02330076T	HMF000964	HMF000964A	0.47	female	1952	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-16	Lung	paravertebral and basal in the right under lob	Yes	Yes	Yes	2018-02-06	2018-12-06	Palbociclib/Fulvestrant	Multiple therapy	2018-06-04	Yes	SD
CPCT02330078T	HMF001301	HMF001301A	0.66	male	1944	null	Colorectum	Colon sigmoideum				12192	2018-01-02	Liver	segment 5/6	Yes	No	Yes	2018-01-09	2018-03-13	Irinotecan	Chemotherapy	2018-03-06	Yes	PD
CPCT02330080T	HMF000306	HMF000306A	0.84	female	1969	null	Colorectum					9256	2018-01-08	Liver	ventral side of gall bladder bed	No	No	Yes	2018-01-18	2018-04-20	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	null	null	null
CPCT02330082T	HMF002275	HMF002275A	0.34	male	1966	null	Bile duct		Carcinoma			4947	2018-01-09	Liver	UK	No	No	Yes	2018-01-12	2018-06-13	Cisplatin/Gemcitabine	Chemotherapy	2018-03-26	Yes	SD
CPCT02330084T	HMF003013	HMF003013A	0.54	female	1944	null	Ovary					2394	2018-01-12	omental cake	omentum	Yes	No	Yes	2018-02-02	2018-06-20	Topotecan	Chemotherapy	2018-03-22	Yes	SD
CPCT02330085T	HMF002292	HMF002292A	0.39	male	1943	null	Colorectum					9256	2018-01-15	Liver	right liver lob	Yes	No	Yes	2018-01-26	2018-04-25	Trifluridine	Chemotherapy	2018-04-20	Yes	SD
CPCT02330089T	HMF002907	HMF002907A	0.92	male	1949	null	Colorectum					9256	2018-01-24	Liver	left liver lob	No	No	Yes	2018-02-07	2019-07-09	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-04-20	Yes	SD
CPCT02330092T	HMF001234	HMF001234A	0.73	male	1944	null	Colorectum					9256	2018-01-26	Liver	unknown	Yes	No	Yes	2018-02-07	2018-03-21	Irinotecan	Chemotherapy	2018-04-03	Yes	PD
CPCT02330094T	HMF002408	HMF002408A	0.69	male	1950	null	Esophagus					5041	2018-02-02	Liver	right liver lob	Yes	Yes	Yes	2018-02-06	2018-10-04	Capecitabine/Oxaliplatin/Capecitabine	Chemotherapy	2018-04-04	Yes	PR
CPCT02330095T	HMF003437	HMF003437A	0.54	male	1947	null	Colorectum					9256	2018-02-05	Liver	left liver lob	No	No	Yes	2018-02-26	2018-06-08	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-04-26	Yes	SD
CPCT02330098T	HMF000859	HMF000859A	0.27	female	1959	null	Colorectum					9256	2018-02-23	Liver	segment 2 en 3	Yes	No	Yes	2018-02-26	2018-04-08	Trifluridine	Chemotherapy	2018-04-16	Yes	SD
CPCT02330099T	HMF000685	HMF000685A	0.68	male	1939	null	Prostate					10283	2018-02-23	Lymph node	axillair right	Yes	Yes	Yes	2018-03-03	2018-05-11	Abiraterone	Hormonal therapy	null	null	null
CPCT02330102T	HMF002224	HMF002224A	0.34	male	1940	null	Colorectum					9256	2018-06-11	Liver	segment 6	Yes	Yes	Yes	2018-03-06	2018-05-22	Trifluridine	Chemotherapy	2018-05-30	Yes	PD
CPCT02330103T	HMF003791	HMF003791A	0.23	male	1947	2018-07-17	Urothelial tract	Pyelum	Carcinoma	Urothelial carcinoma		5974	2018-03-02	Lymph node	neck	No	No	Yes	2018-03-22	2018-06-15	Cisplatin/Gemcitabine	Chemotherapy	2018-05-11	Yes	PR
CPCT02330111T	HMF000436	HMF000436A	0.58	male	1950	null	Colorectum					9256	2018-04-19	Liver	right liver lob	No	No	Yes	2018-05-02	2019-07-09	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-06-27	Yes	SD
CPCT02330112T	HMF000469	HMF000469A	0.8	female	1946	2018-05-12	Colorectum					9256	2018-04-23	Liver	left liver lob, ventral side	No	No	null	null	null	null	null	null	null	null
CPCT02330117T	HMF000770	HMF000770A	0.39	female	1970	2018-07-26	Vulva					1245	2018-05-18	skin	right upper arm	No	Yes	Yes	2018-05-24	2018-07-17	Paclitaxel/Carboplatin	Chemotherapy	2018-07-17	Yes	PD
CPCT02330122T	HMF002927	HMF002927A	0.92	female	1937	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-20	Liver	right liver lob	Yes	No	null	null	null	null	null	null	null	null
CPCT02330123T	HMF001178	HMF001178A	0.86	male	1941	null	Lung					1324	2018-06-28	Liver	right liver lob	Yes	No	Yes	2018-07-03	2018-07-24	Docetaxel	Chemotherapy	2018-08-09	Yes	PR
CPCT02330124T	HMF002575	HMF002575A	0.51	male	1955	2018-11-20	Esophagus					5041	2018-07-05	Liver	left liver lob	No	Yes	Yes	2018-08-23	2018-11-06	Oxaliplatin/Fluorouracil	Chemotherapy	2018-10-01	Yes	SD
CPCT02330125T	HMF003639	HMF003639A	0.6	male	1938	null	Prostate					10283	2018-08-02	Penis	Penis	Yes	Yes	Yes	2018-08-30	2018-11-01	Docetaxel	Chemotherapy	null	null	null
CPCT02330128T	HMF003393	HMF003393A	0.76	male	1957	2019-01-21	Head and neck	Oropharynx				8557,11934	2018-11-12	Lymph node	left neck gland	Yes	Yes	Yes	2018-12-05	2019-01-03	Nivolumab	Immunotherapy	null	null	null
CPCT02330129T	HMF001991	HMF001991A	0.79	male	1952	null	Prostate					10283	2018-11-29	Lymph node	neck, cervical left	Yes	No	Yes	2018-11-30	2019-03-22	Enzalutamide	Hormonal therapy	null	null	null
CPCT02330130T	HMF000759	HMF000759A	0.74	male	1961	null	Prostate					10283	2018-12-17	Lymph node	supra claviculair caudal	Yes	Yes	Yes	2018-12-19	2019-07-30	Abiraterone	Hormonal therapy	2019-02-19	Yes	PR
CPCT02330131T	HMF003221	HMF003221A	0.53	male	1948	null	Colorectum					9256	2018-12-20	Liver	right liver lob	Yes	Yes	Yes	2019-01-14	2019-06-10	Panitumumab	Targeted therapy	2019-03-24	Yes	SD
CPCT02330132T	HMF004252	HMF004252A	0.54	female	1979	null	Esophagus					5041	2019-01-22	Liver	hypo-echogene/hetero-echogene mass	Yes	Yes	Yes	2019-02-01	2019-02-15	Paclitaxel/Ramucirumab	Multiple therapy	2019-02-19	Yes	PD
CPCT02330133T	HMF004069	HMF004069A	0.32	female	1953	null	Head and neck	Oropharynx				8557,11934	2019-01-31	Primary	nasopharynx	Yes	Yes	Yes	2019-02-05	2019-03-19	Nivolumab	Immunotherapy	2019-03-25	Yes	PD
CPCT02330135T	HMF004496	HMF004496A	0.29	female	1949	null	Pancreas					1793	2020-03-09	Lung	anterior in middle lob	No	No	Yes	2020-03-17	2020-09-15	Fluorouracil/Irinotecan/Oxaliplatin/Leucovorin	Multiple therapy	2020-06-10	Yes	SD
CPCT02330138T	HMF005050	HMF005050A	0.71	female	1943	2020-09-08	Pancreas					1793	2020-08-19	Peritoneum	peritoneum	No	No	Yes	2020-08-28	2020-08-28	Fluorouracil/Oxaliplatin/Leucovorin/Irinotecan	Multiple therapy	null	null	null
CPCT02330139T	HMF005051	HMF005051A	0.49	male	1941	null	Pancreas					1793	2020-08-27	Liver	segment 8	Yes	Yes	Yes	2020-09-08	2021-02-09	Oxaliplatin/Leucovorin/Irinotecan/Fluorouracil	Multiple therapy	2020-10-28	Yes	SD
CPCT02330143T	HMF005632	HMF005632A	0.66	female	1951	null	Pancreas					1793	2021-02-25	Liver	segment 6	No	No	Yes	2021-03-16	2021-09-07	Oxaliplatin/Leucovorin/Irinotecan/Fluorouracil	Multiple therapy	2021-05-18	Yes	SD
CPCT02330149T	HMF005734	HMF005734A	0.5	male	1943	2022-02-26	Pancreas					1793	2021-09-07	Liver	left liver lob	No	No	Yes	2021-10-05	2021-10-05	Leucovorin/Fluorouracil/Irinotecan/Oxaliplatin	Multiple therapy	null	null	null
CPCT02340001T	HMF003442	HMF003442A	0.44	male	1945	null	Skin		Melanoma			8923	2017-02-03	Lymph node	axila	No	No	Yes	2017-02-08	2017-06-28	Nivolumab	Immunotherapy	2017-04-12	Yes	SD
CPCT02340006T	HMF000234	HMF000234A	0.82	female	1942	null	Colorectum					9256	2017-03-31	Liver	right lob	No	No	null	null	null	null	null	null	null	null
CPCT02340008T	HMF000955	HMF000955A	0.44	male	1956	2018-02-24	Unknown	CUP	Carcinoma			305	2017-04-26	subcutis	Back	No	No	Yes	2017-05-08	2017-09-11	Gemcitabine/Cisplatin	Chemotherapy	2017-07-10	Yes	SD
CPCT02340008TII	HMF000955	HMF000955B	0.21	male	1956	2018-02-24	Unknown	CUP	Carcinoma			305	2017-12-12	skin	back	No	No	Yes	2017-05-08	2017-09-11	Gemcitabine/Cisplatin	Chemotherapy	2017-07-10	Yes	SD
CPCT02340010T	HMF000442	HMF000442C	0.86	male	1966	2019-08-11	Unknown	CUP	Carcinoma			305	2017-05-24	Liver	right lob	Yes	Yes	Yes	2017-05-29	2017-09-18	Carboplatin/Paclitaxel	Chemotherapy	2017-07-28	Yes	PR
CPCT02340011T	HMF000433	HMF000433A	0.83	male	1969	2017-11-07	Esophagus					5041	2017-05-29	Lymph node	supraclaviculair	Yes	No	Yes	2017-06-02	2017-07-21	Irinotecan	Chemotherapy	2017-07-21	Yes	PD
CPCT02340012T	HMF000240	HMF000240A	0.8	male	1958	2017-06-11	Esophagus					5041	2017-05-31	Liver	right lob (segment 7)	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02340014T	HMF000096	HMF000096B	0.4	female	1975	2018-04-13	Colorectum					9256	2017-10-10	Liver	Right liver lobe	Yes	No	Yes	2017-10-19	2017-12-01	Trifluridine	Chemotherapy	2017-12-01	Yes	PD
CPCT02340017T	HMF003383	HMF003383A	0.48	male	1956	null	Colorectum					9256	2017-08-03	Lymph node	right groin	Yes	Yes	Yes	2017-08-04	2017-12-29	Irinotecan	Chemotherapy	2017-10-19	Yes	SD
CPCT02340018T	HMF001511	HMF001511A	0.94	female	1964	2018-08-11	Bone/Soft tissue	Uterus	Sarcoma			363,1115	2017-08-15	Peritoneum	kidney	No	Yes	Yes	2017-08-16	2017-12-05	Paclitaxel/Carboplatin	Chemotherapy	2017-12-18	Yes	PR
CPCT02340019T	HMF000182	HMF000182A	0.61	male	1953	2018-02-27	Esophagus					5041	2017-08-16	Liver	left lob	Yes	Yes	Yes	2017-08-25	2018-01-05	Capecitabine/Oxaliplatin	Chemotherapy	2017-10-20	Yes	Non-CR/Non-PD
CPCT02340020T	HMF001199	HMF001199A	0.9	male	1961	null	Bone/Soft tissue		Synovial sarcoma			5485,1115	2017-08-22	subcutaneous	tumormass chestwall	No	No	Yes	2017-09-04	2017-12-18	Doxorubicin	Chemotherapy	2017-10-25	Yes	Non-CR/Non-PD
CPCT02340024T	HMF000596	HMF000596B	0.31	male	1949	null	Colorectum					9256	2017-09-18	Liver	unk	Yes	No	Yes	2017-10-02	2017-11-10	Trifluridine	Chemotherapy	2017-11-13	Yes	PD
CPCT02340025T	HMF003287	HMF003287A	0.78	female	1967	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-14	Liver	left lob	Yes	No	Yes	2017-09-28	2017-12-20	Fulvestrant/Palbociclib	Multiple therapy	2017-12-15	Yes	PD
CPCT02340026T	HMF001045	HMF001045B	0.69	male	1942	2018-03-10	Bone/Soft tissue	Small intestine	Leiomyosarcoma			10154,1967,1115	2017-09-21	Liver	left lobe	Yes	No	Yes	2017-09-30	2017-11-09	Pazopanib	Targeted therapy	2017-11-20	Yes	PD
CPCT02340030T	HMF002723	HMF002723B	0.38	female	1954	null	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2017-10-05	nasal cavity	nasal cavity	Yes	No	null	null	null	null	null	null	null	null
CPCT02340031T	HMF001227	HMF001227A	0.73	male	1962	2017-10-31	Lymphoid tissue		Non-Hodgkin lymphoma			0060060	2017-10-06	Lymph node	supraclavicular left	Yes	No	null	null	null	null	null	null	null	null
CPCT02340032T	HMF001305	HMF001305A	0.54	female	1954	null	Ovary					2394	2017-10-17	Peritoneum	peritoneum	Yes	No	Yes	2017-10-19	2018-10-25	Gemcitabine/Carboplatin/Bevacizumab	Multiple therapy	2017-12-21	Yes	SD
CPCT02340034T	HMF000281	HMF000281A	0.43	male	1967	2018-06-15	Esophagus					5041	2017-10-19	Bone	pelvis left	Yes	Yes	Yes	2018-02-07	2018-04-30	Irinotecan	Chemotherapy	2018-03-28	Yes	SD
CPCT02340036T	HMF002148	HMF002148B	0.46	male	1985	2018-04-06	Colorectum					9256	2017-10-23	Lymph node	supraclavicular	Yes	No	Yes	2017-10-26	2018-01-22	Irinotecan/Panitumumab	Multiple therapy	2017-12-05	Yes	PD
CPCT02340037T	HMF001521	HMF001521A	0.27	female	1941	2018-03-29	Breast		Carcinoma	Triple negative		0060081	2017-10-24	Bone	thorax	No	Yes	Yes	2018-01-11	2018-01-28	Capecitabine	Chemotherapy	null	null	null
CPCT02340038T	HMF003279	HMF003279A	0.71	male	1951	null	Prostate					10283	2017-10-26	Lymph node	upper arm right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02340040T	HMF000313	HMF000313A	0.35	male	1970	null	Skin		Melanoma			8923	2017-11-09	Liver	segment 6	No	No	Yes	2017-11-15	2019-11-29	Ipilimumab/Nivolumab	Immunotherapy	2018-01-30	Yes	PR
CPCT02340041T	HMF002818	HMF002818B	0.75	male	1939	2019-02-07	Esophagus					5041	2017-11-10	Liver	left lobe	Yes	Yes	Yes	2017-12-12	2018-04-06	Oxaliplatin/Capecitabine	Chemotherapy	2018-02-13	Yes	SD
CPCT02340042T	HMF001906	HMF001906A	0.61	female	1942	2017-11-30	Ovary					2394	2017-11-14	Peritoneum	next to the abdominal wall left paramediaan just below level of the navel	Yes	No	Yes	2017-11-20	2017-11-20	Cabazitaxel/Paclitaxel	Chemotherapy	null	null	null
CPCT02340045T	HMF001756	HMF001756A	0.53	male	1969	2018-01-16	Colorectum	Colon sigmoideum				12192	2017-11-23	Liver	left lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02340048T	HMF002769	HMF002769A	0.68	male	1945	2018-12-27	Colorectum	Colon sigmoideum				12192	2017-12-07	Liver	left lobe	Yes	No	Yes	2017-12-15	2018-01-26	Irinotecan	Chemotherapy	2018-02-02	Yes	PD
CPCT02340049T	HMF001619	HMF001619A	0.84	female	1971	2018-03-07	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-06	Lymph node	right axilla	Yes	Yes	Yes	2017-12-15	2018-02-02	Letrozole/Anastrozole	Hormonal therapy	null	null	null
CPCT02340050T	HMF002622	HMF002622A	0.79	male	1947	2018-08-25	Anus	Perianal	Melanoma			14145	2017-12-14	Liver	right lobe	No	No	Yes	2017-12-15	2018-02-16	Dacarbazine	Chemotherapy	2018-02-12	Yes	PD
CPCT02340055T	HMF001133	HMF001133A	0.28	male	1947	2019-02-10	Prostate					10283	2017-12-28	Lymph node	inguinal right	Yes	Yes	Yes	2017-12-29	2018-08-03	Cabazitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02340056T	HMF002712	HMF002712A	0.8	male	1943	2018-08-23	Prostate					10283	2018-01-03	Bone	crista	Yes	Yes	Yes	2018-01-22	2018-03-19	Cabazitaxel/Carboplatin	Chemotherapy	null	null	null
CPCT02340057T	HMF002409	HMF002409A	0.29	female	1946	2019-05-07	Colorectum	Flexura hepatica				260	2018-01-18	Peritoneum	behind rib cartilage	Yes	No	Yes	2018-01-19	2018-07-01	Capecitabine	Chemotherapy	2018-03-19	Yes	Non-CR/Non-PD
CPCT02340058T	HMF000218	HMF000218A	0.71	female	1970	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-25	Liver	left lobe	Yes	Yes	Yes	2018-01-29	2018-07-09	Capecitabine	Chemotherapy	2018-04-23	Yes	SD
CPCT02340060T	HMF000567	HMF000567A	0.32	female	1963	2018-02-21	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2018-01-19	Bone	lesion buttock left	Yes	Yes	Yes	2018-01-29	2018-01-29	Doxorubicin/Cyclophosphamide	Chemotherapy	2018-02-18	Yes	PD
CPCT02340066T	HMF002980	HMF002980B	0.66	female	1943	2019-12-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-25	skin	mamma left	Yes	Yes	Yes	2018-01-25	2018-07-19	Paclitaxel/Tamoxifen	Multiple therapy	2018-04-16	Yes	SD
CPCT02340067T	HMF002936	HMF002936A	0.89	male	1936	2018-08-03	Skin		Melanoma			8923	2018-02-07	Liver	liver	Yes	No	null	null	null	null	null	null	null	null
CPCT02340068T	HMF003016	HMF003016A	0.33	female	1947	2019-01-28	Uterus	Endometrium				1380	2018-02-05	Liver	segment 4	Yes	No	Yes	2018-04-17	2018-08-01	Paclitaxel/Carboplatin	Chemotherapy	2018-06-13	Yes	PR
CPCT02340070T	HMF000568	HMF000568A	0.26	male	1961	2018-05-11	Esophagus					5041	2018-02-02	Lymph node	supraclavicular	No	No	Yes	2018-02-13	2018-03-09	Docetaxel/Oxaliplatin/Capecitabine	Chemotherapy	2018-04-03	Yes	PD
CPCT02340073T	HMF002353	HMF002353A	0.25	male	1970	2019-01-03	Esophagus					5041	2018-02-07	Lymph node	para aortal	No	No	Yes	2018-02-16	2018-06-05	Docetaxel/Oxaliplatin/Capecitabine	Chemotherapy	2018-04-11	Yes	SD
CPCT02340074T	HMF001993	HMF001993A	0.65	male	1948	2018-06-26	Colorectum	Rectum				1993	2018-02-22	Liver	unknown	Yes	Yes	Yes	2018-02-28	2018-03-28	Panitumumab	Targeted therapy	2018-04-20	Yes	PD
CPCT02340075T	HMF000659	HMF000659A	0.65	male	1942	2018-03-08	Small intestine	Duodenum				10021	2018-02-12	subcutaneous nodus	abdominal wall	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02340077T	HMF000451	HMF000451A	0.34	male	1949	2018-09-03	Esophagus					5041	2018-02-16	Liver	right lobe	No	No	Yes	2018-02-21	2018-06-21	Capecitabine/Oxaliplatin	Chemotherapy	2018-04-19	Yes	Non-CR/Non-PD
CPCT02340078T	HMF000263	HMF000263A	0.93	male	1961	null	Bone/Soft tissue	Perianal	Gastrointestinal stromal tumor			9253	2018-02-19	Liver	left lobe	No	No	Yes	2018-02-22	null	Imatinib	Targeted therapy	2018-05-14	Yes	SD
CPCT02340080T	HMF002714	HMF002714A	0.34	female	1960	2018-12-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-01	Peritoneum	lower abdomen left	Yes	Yes	Yes	2018-03-06	2018-04-03	Doxorubicin (liposomal)	Chemotherapy	null	null	null
CPCT02340081T	HMF003254	HMF003254A	0.75	male	1974	null	Skin		Carcinoma	Merkel cell carcinoma		3965	2018-03-06	Lymph node	axilla right	No	Yes	Yes	2018-03-20	2018-07-27	Etoposide/Cisplatin	Chemotherapy	2018-05-04	Yes	Clinical progression
CPCT02340083T	HMF000580	HMF000580A	0.63	female	1946	2018-07-01	Skin		Melanoma			8923	2018-03-13	Lymph node	inguinal left	Yes	No	Yes	2018-03-14	2018-06-14	Dacarbazine	Chemotherapy	2018-05-09	Yes	SD
CPCT02340084T	HMF003191	HMF003191A	0.54	female	1952	2019-03-10	Unknown					162	2018-04-05	Lymph node	head/neck	No	No	Yes	2018-04-10	2018-08-08	Carboplatin/Gemcitabine	Chemotherapy	2018-06-20	Yes	PR
CPCT02340086T	HMF001325	HMF001325A	0.85	male	1943	2018-06-04	Prostate					10283	2018-04-06	Liver	unknown	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02340088T	HMF002149	HMF002149A	0.71	female	1955	2018-07-20	Unknown		Carcinoma	Carcinosarcoma		4236	2018-04-12	Liver	right lobe	Yes	No	Yes	2018-04-13	2018-05-04	Doxorubicin	Chemotherapy	2018-05-18	Yes	PD
CPCT02340090T	HMF001760	HMF001760A	0.66	male	1945	null	Penis	Glans penis	Carcinoma	Squamous cell carcinoma		11839,5518	2018-04-24	subcutaneous	abdomen	No	Yes	null	null	null	null	null	null	null	null
CPCT02340095T	HMF003371	HMF003371A	0.92	male	1945	2018-05-24	Colorectum					9256	2018-05-09	Liver	unknown	No	No	null	null	null	null	null	null	null	null
CPCT02340097T	HMF003583	HMF003583A	0.62	male	1967	null	Skin		Melanoma			8923	2018-06-21	Lymph node	infraclavicular	No	No	Yes	2018-06-22	2019-02-07	Dabrafenib/Trametinib/Ipilimumab/Nivolumab	Multiple therapy	2018-08-06	Yes	PR
CPCT02340098T	HMF002287	HMF002287A	0.43	male	1949	2019-12-10	Skin		Melanoma			8923	2018-06-22	Lymph node	inguinal left	No	No	Yes	2018-07-03	2019-07-18	Nivolumab	Immunotherapy	2018-09-05	Yes	SD
CPCT02340100T	HMF000267	HMF000267A	0.36	male	1945	null	Skin		Melanoma			8923	2018-07-23	Bone	os ilium right	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02340102T	HMF000450	HMF000450A	0.38	male	1946	null	Skin		Melanoma			8923	2018-07-27	Lymph node	axilla left	No	No	Yes	2018-08-02	2018-09-14	Pembrolizumab	Immunotherapy	null	null	null
CPCT02340106T	HMF000305	HMF000305A	0.75	male	1950	2019-04-18	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-11-06	Peritoneum	midline above navel	Yes	No	Yes	2018-11-08	2018-11-20	Regorafenib	Targeted therapy	2018-11-20	Yes	PD
CPCT02340107T	HMF004198	HMF004198A	0.28	male	1947	2019-03-30	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-01-17	subcutaneos	back	Yes	Yes	Yes	2019-01-25	2019-01-25	Nivolumab	Immunotherapy	null	null	null
CPCT02340108T	HMF004349	HMF004349A	0.3	male	1965	2020-06-21	Prostate					10283	2018-12-19	Primary	prostate	Yes	No	Yes	2019-01-02	2019-07-25	Abiraterone	Hormonal therapy	null	null	null
CPCT02340110T	HMF003837	HMF003837A	0.54	female	1955	2019-07-21	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2019-02-21	Lung	left under lobe	Yes	Yes	Yes	2019-03-04	2019-07-06	Everolimus/Exemestane	Multiple therapy	2019-05-09	Yes	PD
CPCT02340112T	HMF004129	HMF004129A	0.56	female	1947	2020-02-05	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-03-28	Liver	segm 4	Yes	Yes	Yes	2019-04-24	2020-01-29	Fulvestrant/Palbociclib	Multiple therapy	2019-07-16	Yes	SD
CPCT02340115T	HMF003926	HMF003926A	0.3	male	1951	2019-08-25	Skin		Melanoma			8923	2019-05-23	subcutaneous	neck/scapula right	Yes	Yes	Yes	2019-05-24	2019-06-28	Dabrafenib/Trametinib	Targeted therapy	2019-06-28	Yes	PD
CPCT02350002T	HMF000667	HMF000667A	0.49	male	1970	2019-02-01	Colorectum					9256	2018-03-22	Liver	Left segment 3	Yes	No	Yes	2018-03-27	2018-10-12	Fluorouracil/Leucovorin/Irinotecan/Panitumumab	Multiple therapy	2018-05-17	Yes	SD
CPCT02350003T	HMF001361	HMF001361A	0.35	male	1962	2018-05-16	Prostate					10283	2018-03-23	Liver	Segment V	Yes	No	Yes	2018-03-31	2018-04-20	Carboplatin	Chemotherapy	2018-04-24	Yes	PD
CPCT02350007T	HMF002701	HMF002701A	0.56	female	1938	2019-05-14	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-06	Lymph node	neck right side	Yes	Yes	Yes	2018-06-11	2019-04-18	Paclitaxel/Capecitabine	Chemotherapy	null	null	null
CPCT02350008T	HMF000261	HMF000261A	0.59	female	1959	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-08	mamma right	mamma right	Yes	Yes	Yes	2018-05-31	2018-09-14	Capecitabine	Chemotherapy	2018-08-08	Yes	PR
CPCT02350009T	HMF001256	HMF001256A	0.86	female	1947	2018-09-09	Colorectum					9256	2018-06-18	partly instramuscular and partly subcutaneous	belly button	Yes	Yes	Yes	2018-07-10	2018-07-10	Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	null	null	null
CPCT02350014T	HMF000248	HMF000248A	0.52	male	1963	2019-11-10	Liver		Carcinoma	Hepatocellular carcinoma		684	2018-10-12	Liver	liver tumor	No	No	Yes	2018-10-15	2019-10-07	Sorafenib	Targeted therapy	2019-01-22	Yes	SD
CPCT02350020T	HMF003838	HMF003838A	0.85	male	1949	null	Prostate					10283	2019-04-11	Lymph node	para-aortal	Yes	No	Yes	2019-04-18	2021-03-16	Abemaciclib/placebo JPCM trial/Abiraterone	Multiple therapy	2019-06-11	Yes	SD
CPCT02350021T	HMF004227	HMF004227A	0.48	female	1963	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2019-04-12	Liver	segment II	Yes	Yes	Yes	2019-05-06	null	Pertuzumab/Trastuzumab/Docetaxel	Multiple therapy	2019-07-01	Yes	PR
CPCT02350027T	HMF005052	HMF005052A	0.25	male	1969	2021-12-12	Pancreas					1793	2020-09-21	Liver	segment 3	No	No	Yes	2020-09-25	2021-02-19	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2020-11-17	Yes	SD
CPCT02350029T	HMF005226	HMF005226A	0.47	female	1951	2021-06-08	Pancreas					1793	2021-02-19	Liver	segment VIII	No	No	Yes	2021-02-24	2021-04-07	Oxaliplatin/Irinotecan/Fluorouracil/Leucovorin	Multiple therapy	2021-04-13	Yes	PD
CPCT02350032T	HMF005635	HMF005635A	0.39	male	1954	null	Pancreas					1793	2021-03-30	Primary	Pancreas	No	No	Yes	2021-04-12	2021-10-08	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2021-06-02	Yes	SD
CPCT02360007T	HMF001797	HMF001797A	0.41	male	1955	2017-12-03	Kidney		Carcinoma	Renal cell carcinoma		4450	2017-11-03	soft tissue left sacral lesion which is probably a metastasis of the Grawitz tumor	sacrum	No	No	null	null	null	null	null	null	null	null
CPCT02360008T	HMF001841	HMF001841A	0.67	female	1980	2018-08-07	Breast		Carcinoma	Triple negative		0060081	2017-11-29	Lung	left upper lobe	Yes	Yes	Yes	2017-12-13	2018-03-27	Gemcitabine/Carboplatin	Chemotherapy	2018-02-13	Yes	PR
CPCT02360009T	HMF001196	HMF001196A	0.51	female	1963	2018-10-05	Ovary					2394	2018-01-15	Liver	right lob	Yes	No	Yes	2018-01-23	2018-09-17	Paclitaxel/Carboplatin/Bevacizumab	Multiple therapy	2018-03-21	Yes	PR
CPCT02360011T	HMF000025	HMF000025A	0.4	female	1962	2018-06-25	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-25	Liver	null	Yes	No	Yes	2018-02-09	2018-03-30	Carboplatin/Gemcitabine	Chemotherapy	2018-04-18	Yes	PD
CPCT02360012T	HMF001330	HMF001330A	0.69	female	1953	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-15	skin	right breast	Yes	No	Yes	2018-02-15	2019-01-17	Palbociclib/Fulvestrant	Multiple therapy	2018-07-26	Yes	PR
CPCT02360014T	HMF003186	HMF003186A	0.89	male	1946	2019-07-26	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-03-05	Lymph node	neck	No	No	Yes	2018-03-16	2018-08-14	Gemcitabine/Cisplatin	Chemotherapy	2018-06-07	Yes	CR
CPCT02360015T	HMF003319	HMF003319A	0.58	female	1962	2018-07-10	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-15	Liver	lower edge right lob	Yes	No	null	null	null	null	null	null	null	null
CPCT02360017T	HMF003513	HMF003513A	0.74	female	1969	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-20	Liver	left lob	Yes	Yes	Yes	2018-03-26	2018-12-11	Paclitaxel/Bevacizumab/Anastrozole	Multiple therapy	2018-06-20	Yes	PR
CPCT02360018T	HMF003678	HMF003678A	0.62	female	1950	2018-08-25	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-04	Lymph node	neck, left	Yes	Yes	Yes	2018-04-18	2018-07-04	Paclitaxel/Bevacizumab	Multiple therapy	null	null	null
CPCT02360022T	HMF000737	HMF000737A	0.97	female	1964	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-05	Liver	seg. 2	Yes	Yes	Yes	2018-06-29	2023-02-22	Palbociclib/Anastrozole	Multiple therapy	2018-09-25	Yes	SD
CPCT02370001T	HMF000112	HMF000112B	0.62	male	1945	2018-01-01	Colorectum					9256	2017-03-14	Liver	caudaal segment 6	Yes	Yes	Yes	2017-03-17	2017-08-25	Irinotecan/Cetuximab	Multiple therapy	2017-06-06	Yes	PD
CPCT02370002T	HMF002782	HMF002782A	0.82	male	1948	2018-01-03	Colorectum					9256	2017-03-22	Liver	liver	No	No	Yes	2017-04-04	2017-10-09	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-05-30	Yes	SD
CPCT02370002TII	HMF002782	HMF002782B	0.74	male	1948	2018-01-03	Colorectum					9256	2017-10-11	Liver	liver	No	No	Yes	2017-04-04	2017-10-09	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2017-05-30	Yes	SD
CPCT02370003T	HMF001745	HMF001745A	0.7	female	1962	null	Breast		Carcinoma	Triple negative		0060081	2017-04-04	Liver	segment 6	Yes	Yes	Yes	2017-05-03	2017-06-14	Epirubicin	Chemotherapy	2017-06-19	Yes	PD
CPCT02370005T	HMF000779	HMF000779A	0.62	female	1943	2018-07-12	Colorectum					9256	2017-07-18	Liver	location not specified	No	No	Yes	2017-07-31	2017-08-31	Oxaliplatin/Capecitabine/Bevacizumab/Fluorouracil/Leucovorin	Multiple therapy	2017-09-26	Yes	SD
CPCT02370006T	HMF002285	HMF002285A	0.73	female	1982	2020-01-24	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-21	Liver	not otherwise specified	Yes	Yes	Yes	2017-08-07	2019-09-24	Palbociclib/Letrozole	Multiple therapy	2017-12-04	Yes	SD
CPCT02370008T	HMF001471	HMF001471A	0.69	female	1958	2019-08-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-26	Liver	left lob	Yes	Yes	Yes	2017-09-30	2018-09-26	Capecitabine	Chemotherapy	2017-11-27	Yes	SD
CPCT02370010T	HMF000158	HMF000158B	0.76	female	1946	null	Uterus	Endometrium				1380	2017-10-26	Peritoneum	omental cake	Yes	Yes	Yes	2017-10-27	2018-02-23	Carboplatin	Chemotherapy	2018-01-02	Yes	PR
CPCT02370012T	HMF003277	HMF003277A	0.42	female	1954	2018-07-24	Colorectum					9256	2017-11-22	Liver	right lobe	Yes	No	Yes	2017-11-28	2018-02-21	Irinotecan	Chemotherapy	2018-01-03	Yes	PD
CPCT02370013TII	HMF000205	HMF000205A	0.95	male	1946	2018-06-27	Prostate					10283	2018-03-21	Lymph node	axillair	Yes	No	Yes	2018-01-04	2018-02-15	Cabazitaxel	Chemotherapy	null	null	null
CPCT02370015T	HMF001139	HMF001139A	0.2	female	1955	2018-02-18	Bile duct		Carcinoma			4947	2017-12-21	Liver	not specified	No	Yes	Yes	2018-01-10	2018-01-17	Gemcitabine/Cisplatin	Chemotherapy	null	null	null
CPCT02370016T	HMF003165	HMF003165A	0.8	female	1955	2018-03-27	Thyroid gland					1781	2017-12-22	intra-abdominal	left	Yes	No	Yes	2017-12-28	2018-02-01	Doxorubicin	Chemotherapy	2018-02-16	Yes	PD
CPCT02370019T	HMF003010	HMF003010A	0.4	female	1937	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-07	Lung	lower lobe right	No	No	null	null	null	null	null	null	null	null
CPCT02370020T	HMF002933	HMF002933A	0.5	female	1957	2018-09-06	Colorectum					9256	2018-02-27	Liver	left lobe	Yes	No	Yes	2018-03-06	2018-05-01	Trifluridine	Chemotherapy	2018-05-22	Yes	PD
CPCT02370022T	HMF000707	HMF000707A	0.73	female	1954	2018-07-05	Colorectum					9256	2018-02-28	Liver	left lobe	Yes	No	Yes	2018-03-08	2018-04-19	Irinotecan	Chemotherapy	2018-05-01	Yes	PD
CPCT02370024T	HMF001228	HMF001228A	0.65	female	1950	2018-04-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-21	Liver	right	Yes	Yes	Yes	2018-04-09	2018-04-18	Carboplatin	Chemotherapy	null	null	null
CPCT02370025T	HMF001778	HMF001778A	0.34	female	1955	null	Breast		Carcinoma	Triple negative		0060081	2018-03-27	Liver	left lobe	Yes	Yes	Yes	2018-04-10	2018-08-07	Carboplatin	Chemotherapy	2018-06-04	Yes	PR
CPCT02370026T	HMF000422	HMF000422A	0.81	female	1948	null	Ovary					2394	2018-04-04	Liver	central	Yes	No	Yes	2018-04-24	2020-01-14	Tamoxifen	Hormonal therapy	2019-02-27	Yes	PD
CPCT02370027T	HMF001570	HMF001570A	0.42	male	1940	2018-11-08	Prostate					10283	2018-04-10	Liver	liver	Yes	Yes	Yes	2018-04-19	2018-07-10	Enzalutamide/Goserelin/Goserelin	Multiple therapy	2018-07-04	Yes	PD
CPCT02370030T	HMF000970	HMF000970A	0.74	female	1953	2018-07-08	Pancreas					1793	2018-04-18	Liver	lateral right lobe	No	No	null	null	null	null	null	null	null	null
CPCT02370031T	HMF000931	HMF000931A	0.43	male	1948	2018-10-02	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-04-19	skin	above left hip	No	No	Yes	2018-06-06	2018-07-13	Carboplatin/Etoposide	Chemotherapy	null	null	null
CPCT02370034T	HMF000052	HMF000052A	0.3	female	1946	2018-06-02	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-16	Primary	lung	No	No	null	null	null	null	null	null	null	null
CPCT02370036T	HMF002538	HMF002538A	0.77	male	1968	2019-08-21	Colorectum					9256	2018-06-20	Lymph node	supraclaviculair left	Yes	No	Yes	2018-07-02	2018-12-31	Irinotecan	Chemotherapy	2018-09-27	Yes	PD
CPCT02370037T	HMF000379	HMF000379A	0.5	female	1981	2019-04-08	Colorectum					9256	2018-08-08	Liver	segment 4a/b	Yes	Yes	Yes	2018-08-10	2018-08-20	Capecitabine	Chemotherapy	null	null	null
CPCT02380002T	HMF001499	HMF001499A	0.25	male	1947	2017-11-06	Colorectum					9256	2017-03-29	Liver	segment 4	No	No	Yes	2017-04-13	2017-09-22	Oxaliplatin/Capecitabine/Bevacizumab	Multiple therapy	2017-06-09	Yes	PD
CPCT02380005T	HMF003757	HMF003757A	0.43	male	1952	null	Colorectum	Colon transversum				261	2017-05-10	Liver	lower left lobe	Yes	No	Yes	2017-05-10	2017-08-14	Trifluridine/Trifluridine	Chemotherapy	2017-08-10	Yes	PD
CPCT02380006T	HMF001574	HMF001574A	0.66	male	1947	2017-10-27	Unknown	CUP	Carcinoma			305	2017-05-08	Liver	unknown	No	No	Yes	2017-06-02	2017-06-24	Pemetrexed/Carboplatin	Chemotherapy	2017-07-10	Yes	PD
CPCT02380007T	HMF000582	HMF000582A	0.61	male	1978	2017-08-15	Unknown	CUP	Carcinoma		Probably kidney	305	2017-05-12	Kidney	left	No	No	Yes	2017-05-22	2017-07-06	Cisplatin/Etoposide	Chemotherapy	2017-07-17	Yes	SD
CPCT02380008T	HMF002475	HMF002475A	0.56	male	1946	2017-08-27	Unknown	CUP	Carcinoma			305	2017-05-29	Liver	central	No	No	Yes	2017-06-13	2017-08-08	Cisplatin/Gemcitabine	Chemotherapy	2017-08-17	Yes	PD
CPCT02380009T	HMF003142	HMF003142A	0.33	male	1949	null	Prostate					10283	2017-06-07	Lymph node	left inguinal	Yes	Yes	Yes	2017-06-20	2017-10-18	Docetaxel	Chemotherapy	null	null	null
CPCT02380010T	HMF001964	HMF001964A	0.73	female	1962	2018-03-03	Small intestine		Neuroendocrine tumor			10154,169	2017-11-15	Lymph node	glandular package in aorta	Yes	No	Yes	2017-11-20	2018-01-03	Paclitaxel/Carboplatin	Chemotherapy	2018-01-16	Yes	PD
CPCT02380011T	HMF001649	HMF001649A	0.79	male	1947	2017-12-09	Colorectum					9256	2017-09-15	Liver	segment 4B	Yes	No	Yes	2017-10-09	2017-11-21	Panitumumab	Targeted therapy	2017-11-24	Yes	PD
CPCT02380013T	HMF001908	HMF001908A	0.84	male	1985	null	Unknown	CUP	Carcinoma			305	2017-07-21	Liver	left lobe	Yes	Yes	Yes	2017-08-09	2018-09-20	Doxorubicin/Olaratumab	Multiple therapy	null	null	null
CPCT02380014T	HMF002672	HMF002672A	0.64	male	1952	2017-08-31	Prostate					10283	2017-07-26	psoas	right site	Yes	Yes	Yes	2017-07-27	2017-08-16	Abiraterone	Hormonal therapy	null	null	null
CPCT02380015T	HMF002111	HMF002111A	0.54	female	1940	null	Colorectum	Rectum				1993	2017-07-28	Lung	right lower lobe	No	No	Yes	2017-08-16	2019-05-23	Capecitabine/Oxaliplatin/Bevacizumab/Bevacizumab	Multiple therapy	null	null	null
CPCT02380016T	HMF000104	HMF000104A	0.23	female	1956	null	Colorectum	Rectum				1993	2017-08-10	Lung	left bronchus/left under lobe	Yes	Yes	Yes	2017-08-14	2018-05-19	Panitumumab	Targeted therapy	2017-11-15	Yes	PR
CPCT02380018T	HMF001752	HMF001752A	0.73	male	1944	2018-02-26	Unknown				Possibly high GI-tract	162	2017-09-13	pericardiale laesie	pericardiale laesie	Yes	No	Yes	2017-09-22	2018-01-26	Capecitabine	Chemotherapy	2017-11-21	Yes	PD
CPCT02380020T	HMF003796	HMF003796A	0.68	female	1962	null	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-09-21	Lymph node	right axilla	Yes	No	Yes	2017-09-22	2018-03-02	Capecitabine/Doxorubicin	Chemotherapy	2017-11-07	Yes	SD
CPCT02380021T	HMF003663	HMF003663A	0.6	male	1955	2018-04-29	Esophagus					5041	2017-09-25	abdominal wall (subcutaneous)	subcutaneous lesion in the anterior abdominal wall left paramediaan.	Yes	Yes	Yes	2017-09-28	2018-01-12	Paclitaxel/Ramucirumab	Multiple therapy	2018-01-02	Yes	PD
CPCT02380023T	HMF001198	HMF001198A	0.47	male	1954	2019-01-31	Colorectum					9256	2017-09-18	Liver	segment 6	Yes	Yes	Yes	2017-09-20	2017-11-02	Irinotecan	Chemotherapy	2017-11-15	Yes	PD
CPCT02380024T	HMF002470	HMF002470A	0.75	female	1968	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-10-06	Liver	left liver lobe	Yes	No	Yes	2017-12-04	2018-04-18	Paclitaxel	Chemotherapy	2018-02-19	Yes	SD
CPCT02380026T	HMF003573	HMF003573A	0.61	female	1964	2018-04-28	Breast		Carcinoma	ER-negative/HER2-positive		0060076,0060079	2017-11-29	Lung	right lower lobe	Yes	No	Yes	2017-11-30	2018-03-16	Trastuzumab/Capecitabine	Multiple therapy	2018-01-29	Yes	PD
CPCT02380029T	HMF000573	HMF000573A	0.4	female	1945	null	Unknown	CUP	Carcinoma			305	2017-11-06	caudaal below liver	laesie caudaal belowliver	Yes	Yes	null	null	null	null	null	null	null	null
CPCT02380030T	HMF000146	HMF000146A	0.5	male	1972	2019-10-04	Esophagus					5041	2017-11-14	Primary	oesophagus	No	No	Yes	2017-11-21	2018-09-14	Capecitabine/Oxaliplatin	Chemotherapy	2018-01-17	Yes	PR
CPCT02380033T	HMF000542	HMF000542A	0.52	male	1942	null	Pancreas					1793	2017-12-15	Liver	segment 2/4	Yes	No	Yes	2017-12-19	2018-10-16	Oxaliplatin/Irinotecan/Leucovorin/Fluorouracil	Multiple therapy	2018-02-12	Yes	SD
CPCT02380034T	HMF000143	HMF000143A	0.76	female	1958	2018-03-31	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-29	Liver	segment 5	Yes	No	Yes	2018-02-14	2018-03-26	Vinorelbine/Capecitabine	Chemotherapy	null	null	null
CPCT02380035T	HMF002615	HMF002615A	0.58	female	1971	2018-03-04	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-12-27	Lymph node	axillair right	Yes	No	Yes	2017-12-29	2018-02-03	Capecitabine/Carboplatin	Chemotherapy	null	null	null
CPCT02380036T	HMF000598	HMF000598A	0.49	female	1967	2019-03-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-17	Liver	right lobe	Yes	Yes	Yes	2018-01-18	2018-02-13	Eribulin	Chemotherapy	2018-02-20	Yes	PD
CPCT02380037T	HMF002037	HMF002037A	0.77	female	1975	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-01-17	Liver	central in liver	Yes	Yes	Yes	2018-01-18	2018-09-01	Capecitabine	Chemotherapy	2018-03-15	Yes	SD
CPCT02380039T	HMF002915	HMF002915A	0.68	female	1960	2018-02-08	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-22	Liver	left upper lobe craniaal	Yes	Yes	Yes	2018-01-23	2018-01-24	Vinorelbine	Chemotherapy	null	null	null
CPCT02380040T	HMF001500	HMF001500A	0.64	female	1958	2018-05-04	Colorectum	Colon sigmoideum				12192	2018-03-30	Liver	left liver lobe	Yes	No	null	null	null	null	null	null	null	null
CPCT02380044T	HMF002859	HMF002859A	0.55	female	1988	null	Uterus	Cervix				4362	2018-04-03	right peritoneal towards small basin	right peritoneal towards small pelvis	Yes	Yes	Yes	2018-04-09	2018-05-23	Carboplatin/Paclitaxel	Chemotherapy	2018-06-11	Yes	PD
CPCT02380045T	HMF002104	HMF002104A	0.29	male	1946	2018-06-06	Gastrointestinal tract		Carcinoma			0050922	2018-04-19	Lymph node	lymph node neck	No	No	Yes	2018-05-04	2018-05-25	Oxaliplatin/Capecitabine	Chemotherapy	null	null	null
CPCT02380047T	HMF002656	HMF002656A	0.69	female	1962	null	Colorectum					9256	2018-05-14	Liver	segment 4b	Yes	No	Yes	2018-05-15	2018-08-20	Trifluridine/Trifluridine	Chemotherapy	2018-08-16	Yes	PD
CPCT02380049T	HMF001949	HMF001949A	0.68	female	1958	null	Ovary					2394	2018-06-11	lesion median in the lower abdomen.	lesion median in the lower abdomen.	Yes	No	Yes	2018-06-15	2018-10-13	Carboplatin/Paclitaxel	Chemotherapy	2018-08-13	Yes	SD
CPCT02380050T	HMF002019	HMF002019A	0.6	male	1951	2018-07-19	Pancreas					1793	2018-06-15	Liver	liver transition segment 2-3	No	No	Yes	2018-06-27	2018-07-13	Oxaliplatin/Fluorouracil/Irinotecan/Leucovorin	Multiple therapy	null	null	null
CPCT02380051T	HMF003201	HMF003201A	0.9	female	1984	2019-02-25	Bone/Soft tissue		Rhabdomyosarcoma			3247,1115	2018-06-15	large mass Starting from the uterus.	large mass Starting from the uterus.	No	No	Yes	2018-06-22	2018-10-31	Epirubicin/Vindesine/Ifosfamide/Doxorubicin	Chemotherapy	2018-09-10	Yes	PR
CPCT02380052T	HMF004131	HMF004131A	0.69	female	1970	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-03-22	Liver	segment 4-5	Yes	No	Yes	2019-03-22	2020-01-28	Palbociclib/Fulvestrant	Multiple therapy	2019-05-24	Yes	PD
CPCT02380054T	HMF004935	HMF004935A	0.38	male	1977	null	Pancreas					1793	2020-05-18	Liver	right liver lobe	No	No	Yes	2020-05-26	2021-04-08	Oxaliplatin/Fluorouracil/Irinotecan	Chemotherapy	2020-08-14	Yes	SD
CPCT02390001T	HMF002761	HMF002761A	0.72	female	1974	2019-11-18	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-04-13	Primary	left mamma	No	No	Yes	2017-04-24	2017-06-22	Letrozole	Hormonal therapy	2017-06-15	Yes	PD
CPCT02390002T	HMF000438	HMF000438A	0.27	male	1953	2019-04-22	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-06-06	Lymph node	right arm pit	Yes	Yes	Yes	2017-06-08	2017-08-16	Carboplatin/Paclitaxel/Bevacizumab	Multiple therapy	2017-07-13	Yes	SD
CPCT02390003T	HMF003566	HMF003566A	0.28	male	1949	2019-06-29	Lung		Carcinoma	Small cell carcinoma		5409	2017-07-06	Liver	subcapsulaire lesion caudaal right liver lobe	Yes	No	Yes	2017-07-07	2017-09-26	Topotecan	Chemotherapy	2017-09-22	Yes	PD
CPCT02390005T	HMF001187	HMF001187B	0.52	female	1953	2018-01-12	Lung		Carcinoma	Small cell carcinoma		5409	2017-09-14	Lymph node	left inguinal	No	No	Yes	2017-09-15	2017-10-10	Cisplatin/Pemetrexed	Chemotherapy	2017-10-24	Yes	PD
CPCT02390006T	HMF003514	HMF003514A	0.71	male	1952	2018-06-16	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-10-11	Lymph node	supraclavicular right	Yes	Yes	Yes	2017-10-11	2018-01-04	Carboplatin/Gemcitabine	Chemotherapy	2017-11-24	Yes	SD
CPCT02390007T	HMF000023	HMF000023A	0.53	male	1953	2018-12-10	Colorectum					9256	2017-11-20	Liver	segment 6	Yes	Yes	Yes	2017-11-23	2018-11-07	Panitumumab/Panitumumab	Targeted therapy	2018-02-01	Yes	PR
CPCT02390008T	HMF001794	HMF001794A	0.86	female	1948	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-11-20	Liver	left liver lobe	Yes	Yes	Yes	2018-01-08	2018-05-14	Paclitaxel	Chemotherapy	2018-03-27	Yes	SD
CPCT02390010T	HMF001900	HMF001900A	0.27	female	1966	2018-06-21	Breast		Carcinoma	Triple negative		0060081	2017-12-27	Lymph node	supraclaviculair	Yes	Yes	Yes	2018-01-03	2018-03-08	Capecitabine	Chemotherapy	2018-02-22	Yes	PD
CPCT02390011T	HMF002792	HMF002792A	0.86	female	1958	null	Lung		Carcinoma	Small cell carcinoma		5409	2018-01-08	Lung	right lower lobe	Yes	Yes	Yes	2018-01-09	2018-04-03	Topotecan	Chemotherapy	2018-02-12	Yes	SD
CPCT02390015T	HMF002822	HMF002822A	0.59	female	1965	2018-05-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-01-24	Lymph node	neck right side	Yes	Yes	Yes	2018-01-26	2018-03-02	Paclitaxel	Chemotherapy	2018-04-19	Yes	PD
CPCT02390017T	HMF000468	HMF000468A	0.61	male	1947	2018-06-22	Colorectum					9256	2018-01-31	Liver	segment 4	Yes	No	Yes	2018-02-01	2018-03-29	Panitumumab	Targeted therapy	2018-03-28	Yes	PD
CPCT02390020T	HMF000302	HMF000302A	0.59	male	1971	null	Lung		Carcinoma	Small cell carcinoma		5409	2018-02-16	Liver	caudal left lobe	No	No	Yes	2018-02-16	2018-05-28	Etoposide/Cisplatin	Chemotherapy	2018-06-11	Yes	PR
CPCT02390021T	HMF001628	HMF001628A	0.81	female	1939	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-02-15	Bone	caudal of xifo?d	Yes	No	Yes	2018-02-21	2018-06-22	Fluorouracil/Epirubicin/Cyclophosphamide	Chemotherapy	2018-04-23	Yes	PR
CPCT02390022T	HMF001121	HMF001121A	0.81	male	1960	2018-12-30	Colorectum					9256	2018-04-09	sigmoid	sigmoid	No	No	Yes	2018-05-15	2018-10-08	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-07-04	Yes	SD
CPCT02390026T	HMF000168	HMF000168A	0.42	male	1968	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-03	Lymph node	supraclaviculair	No	No	Yes	2018-07-10	2018-10-15	Capmatinib	Targeted therapy	2018-08-21	Yes	PR
CPCT02390027T	HMF003472	HMF003472A	0.29	male	1945	null	Colorectum					9256	2018-05-16	Lymph node	inguinalis right	No	No	Yes	2018-06-05	2018-11-05	Capecitabine/Oxaliplatin/Bevacizumab	Multiple therapy	2018-08-02	Yes	PR
CPCT02390029T	HMF002265	HMF002265A	0.88	female	1965	2018-07-10	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-05-30	Liver	left liver lobe	Yes	Yes	Yes	2018-06-01	2018-07-04	Capecitabine/Bevacizumab	Multiple therapy	2018-07-06	Yes	SD
CPCT02390030T	HMF002977	HMF002977A	0.25	female	1968	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-04	Bone	presternal	No	No	Yes	2018-06-07	2020-06-11	Pembrolizumab	Immunotherapy	2018-07-13	Yes	PR
CPCT02390032T	HMF002271	HMF002271A	0.24	male	1939	2018-06-19	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-07	Lymph node	supraclaviculair	No	No	null	null	null	null	null	null	null	null
CPCT02390033T	HMF003235	HMF003235A	0.83	male	1962	2018-08-02	Colorectum					9256	2018-06-14	Liver	right hemi liver	No	No	Yes	2018-06-26	2018-07-21	Capecitabine/Oxaliplatin	Chemotherapy	2018-07-23	Yes	PD
CPCT02390034T	HMF001279	HMF001279A	0.79	female	1959	2018-11-22	Colorectum					9256	2018-06-20	Lymph node	supraclavicular	Yes	No	Yes	2018-06-22	2018-08-17	Irinotecan/Cetuximab	Multiple therapy	2018-08-15	Yes	PD
CPCT02390035T	HMF002088	HMF002088A	0.73	female	1973	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-11-09	mammae	right mammae	No	No	Yes	2018-11-15	2019-09-02	Letrozole/Palbociclib	Multiple therapy	2019-01-29	Yes	SD
CPCT02390037T	HMF004234	HMF004234A	0.66	male	1940	2019-04-03	Prostate					10283	2019-01-08	Bone	os ileum right	Yes	No	Yes	2019-01-09	2019-04-03	Abiraterone	Hormonal therapy	null	null	null
CPCT02390038T	HMF004081	HMF004081A	0.44	female	1942	2019-12-12	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-01-29	Lymph node	right axilla	No	No	Yes	2019-01-30	2019-12-09	Letrozole	Hormonal therapy	2019-05-01	Yes	SD
CPCT02390040T	HMF004287	HMF004287A	0.61	female	1974	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-21	Lymph node	axillary lymphnode	No	No	Yes	2019-04-01	null	Letrozole/Palbociclib	Multiple therapy	2019-07-01	Yes	SD
CPCT02390043T	HMF003810	HMF003810A	0.72	female	1962	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-04-25	Lymph node	axilla right	No	No	Yes	2019-04-25	2020-04-23	Letrozole	Hormonal therapy	2019-07-10	Yes	PR
CPCT02390044T	HMF003990	HMF003990A	0.57	male	1941	2020-02-10	Prostate					10283	2019-07-18	Bone	os ileum	Yes	Yes	Yes	2019-07-18	2019-10-14	Abiraterone	Hormonal therapy	2019-10-09	Yes	SD
CPCT02400002T	HMF001320	HMF001320A	0.49	male	1959	2017-10-29	Esophagus					5041	2017-05-01	Liver	lateroventral caudal right liver lobe	No	No	Yes	2017-05-26	2017-09-19	Trastuzumab/Capecitabine/Oxaliplatin	Multiple therapy	2017-08-01	Yes	PD
CPCT02410001T	HMF000045	HMF000045A	0.49	female	1952	2019-10-02	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-07-14	Bone	os pubis	Yes	No	Yes	2017-07-25	2017-09-05	Docetaxel	Chemotherapy	null	null	null
CPCT02410004T	HMF002841	HMF002841A	0.36	female	1952	2020-05-01	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-03-08	Lymph node	lymph node in lower part of the neck to the left	Yes	No	Yes	2018-03-12	2019-07-15	Fulvestrant/Palbociclib	Multiple therapy	2018-06-05	Yes	CR
CPCT02410006T	HMF000257	HMF000257A	0.27	female	1939	2018-12-31	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-12	skin/subcutaneous	subcutis left dorsolateraal	No	No	null	null	null	null	null	null	null	null
CPCT02410008T	HMF001010	HMF001010A	0.25	female	1958	null	Colorectum					9256	2018-06-18	Liver	left liver lobe	No	No	Yes	2018-07-03	2019-01-08	Bevacizumab/Fluorouracil/Irinotecan/Leucovorin/Oxaliplatin	Multiple therapy	2018-08-31	Yes	SD
CPCT02410009T	HMF002225	HMF002225A	0.34	female	1958	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-06-19	Liver	left liver lobe	Yes	Yes	Yes	2018-07-03	2019-03-21	Capecitabine	Chemotherapy	2018-09-03	Yes	SD
CPCT02410013T	HMF001281	HMF001281A	0.38	male	1960	2019-01-19	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-07-04	Primary	left upper lung lobe	No	No	null	null	null	null	null	null	null	null
CPCT02410017T	HMF003975	HMF003975A	0.61	female	1950	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-02-21	Liver	caudally right liver lobe.	Yes	Yes	Yes	2019-03-03	2019-08-08	Palbociclib/Anastrozole	Multiple therapy	2019-05-23	Yes	SD
CPCT02410018T	HMF003820	HMF003820A	0.49	female	1965	2019-12-17	Lung		Carcinoma	Small cell carcinoma		5409	2019-03-28	Liver	left liver lobe	No	No	Yes	2019-04-15	2019-08-19	Carboplatin/Etoposide/Atezolizumab	Multiple therapy	2019-05-20	Yes	PR
CPCT02410019T	HMF004188	HMF004188A	0.33	male	1967	2019-11-29	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-04-18	Bone	femoral, left	No	No	Yes	2019-06-03	2019-08-12	Cisplatin/Pemetrexed	Chemotherapy	2019-07-09	Yes	SD
CPCT02410023T	HMF005636	HMF005636A	0.46	male	1971	2021-10-19	Pancreas					1793	2021-03-25	Liver	left liver lobe	No	No	Yes	2021-04-07	2021-08-19	Oxaliplatin/Irinotecan/Fluorouracil	Chemotherapy	2021-05-28	Yes	SD
CPCT02440001T	HMF002869	HMF002869A	0.28	female	1948	2018-07-17	Colorectum					9256	2017-10-10	Peritoneum	high mesenterial	Yes	Yes	Yes	2017-11-10	2018-01-04	Capecitabine/Oxaliplatin	Chemotherapy	2018-01-08	Yes	SD
CPCT02440003T	HMF000794	HMF000794A	0.75	male	1972	2019-01-26	Lung		Neuroendocrine tumor			1324,169	2017-11-07	Liver	liver metastase	No	No	Yes	2018-02-06	2018-04-11	Everolimus	Targeted therapy	null	null	null
CPCT02440009T	HMF003630	HMF003630A	0.2	female	1964	2018-06-10	Pancreas					1793	2018-02-20	Liver	right lobe liver	Yes	No	Yes	2018-03-16	2018-05-04	Gemcitabine/Paclitaxel/Sonidegib	Multiple therapy	2018-05-04	Yes	PD
CPCT02440010T	HMF003475	HMF003475B	0.41	male	1959	2018-08-15	Stomach					10534	2018-03-06	Liver	right liver lobe	Yes	No	Yes	2018-03-09	2018-04-13	Irinotecan	Chemotherapy	2018-04-16	Yes	PD
CPCT02440012T	HMF003761	HMF003761A	0.37	male	1940	2019-12-24	Kidney		Carcinoma	Renal cell carcinoma		4450	2018-04-26	Bone	costa left	No	No	Yes	2018-05-09	2019-05-25	Sunitinib	Targeted therapy	2018-08-14	Yes	PR
CPCT02440014T	HMF002011	HMF002011B	0.58	male	1952	2019-08-14	Esophagus					5041	2018-06-05	Liver	laesie segment 2	Yes	Yes	Yes	2018-06-15	2018-07-05	Trastuzumab/Docetaxel	Multiple therapy	2018-07-23	Yes	PD
CPCT02440016T	HMF003308	HMF003308A	0.35	female	1953	2018-12-13	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-07-09	Primary	bladder	Yes	No	Yes	2018-08-02	2018-09-28	Pembrolizumab	Immunotherapy	2018-09-28	Yes	PD
CPCT02440017T	HMF000053	HMF000053A	0.5	male	1946	null	Prostate					10283	2018-08-28	Lymph node	inguinal region	Yes	Yes	Yes	2018-09-10	2019-08-20	Enzalutamide	Hormonal therapy	null	null	null
CPCT02440018T	HMF001669	HMF001669A	0.51	female	1941	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-10-16	Lymph node	suptaclavicular	Yes	Yes	Yes	2018-11-01	2020-07-03	Palbociclib/Exemestane/Fulvestrant	Multiple therapy	2018-12-13	Yes	SD
CPCT02440020T	HMF003865	HMF003865A	0.63	male	1947	2019-01-03	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-12-11	Liver	right liver lob	Yes	No	null	null	null	null	null	null	null	null
CPCT02440021T	HMF003935	HMF003935A	0.51	female	1936	2021-01-08	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-01-08	Liver	subcapsular right site	Yes	Yes	Yes	2019-01-16	2019-05-08	Fulvestrant	Hormonal therapy	null	null	null
CPCT02440023T	HMF004233	HMF004233A	0.44	male	1945	2021-01-29	Kidney		Carcinoma	Renal cell carcinoma		4450	2019-02-08	Kidney	lower pole right kidney	No	No	Yes	2019-02-15	2020-05-25	Pazopanib	Targeted therapy	2019-04-30	Yes	SD
CPCT02440024T	HMF004051	HMF004051A	0.91	female	1952	2020-08-14	Small intestine	Duodenum	Carcinoma			10021,305	2019-02-26	Liver	metastase segment 8	Yes	No	null	null	null	null	null	null	null	null
CPCT02440027T	HMF005001	HMF005001A	0.51	male	1953	null	Pancreas					1793	2020-04-03	Lung	nodus right lower lobe	No	No	Yes	2020-04-16	2020-09-24	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2020-06-05	Yes	SD
CPCT02440028T	HMF004837	HMF004837A	0.31	female	1951	2020-12-19	Pancreas					1793	2020-06-18	Liver	liver lob left	No	No	Yes	2020-06-25	2020-12-03	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2020-07-24	Yes	SD
CPCT02440030T	HMF005053	HMF005053A	0.46	female	1956	2020-11-28	Pancreas					1793	2020-08-04	Liver	lesion right liver	No	No	Yes	2020-08-13	2020-08-14	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2020-10-14	Yes	PD
CPCT02440033T	HMF005228	HMF005228A	0.42	male	1960	2021-06-25	Pancreas					1793	2020-12-03	Liver	leasion right site	No	No	Yes	2020-12-10	2021-03-21	Fluorouracil/Irinotecan/Oxaliplatin	Chemotherapy	2021-02-26	Yes	PD
CPCT02440037T	HMF005637	HMF005637A	0.65	female	1952	null	Pancreas					1793	2021-08-17	Liver	left liver lobe	No	No	Yes	2021-08-30	2021-10-12	Irinotecan/Fluorouracil/Oxaliplatin	Chemotherapy	2021-10-27	Yes	PD
CPCT02440038T	HMF005837	HMF005837A	0.32	female	1957	2022-03-17	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2021-09-27	Primary	left kidney	Yes	No	Yes	2021-10-06	2022-01-06	Pembrolizumab	Immunotherapy	2021-10-27	Yes	PD
CPCT02450002T	HMF003708	HMF003708A	0.64	female	1962	2018-04-09	Uterus	Cervix				4362	2017-09-20	cervix	cervix	Yes	Yes	Yes	2017-10-13	2017-12-01	Vinorelbine	Chemotherapy	2017-12-07	Yes	SD
CPCT02450003T	HMF000730	HMF000730A	0.89	female	1942	2018-06-03	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2017-09-21	Liver	liver	Yes	Yes	Yes	2017-09-25	2017-11-20	Paclitaxel	Chemotherapy	2017-11-21	Yes	SD
CPCT02450004T	HMF002395	HMF002395A	0.5	male	1974	2019-10-31	Colorectum					9256	2017-10-02	Liver	central	No	No	Yes	2017-10-05	2018-09-27	Bevacizumab/Capecitabine/Oxaliplatin	Multiple therapy	2017-12-04	Yes	SD
CPCT02450007T	HMF000511	HMF000511A	0.57	female	1964	null	Ovary					2394	2017-11-21	Peritoneum	peritoneum	Yes	No	Yes	2017-11-22	2018-01-24	Carboplatin/Paclitaxel	Chemotherapy	2017-12-21	Yes	SD
CPCT02450008T	HMF002806	HMF002806A	0.52	female	1940	2019-03-27	Unknown				Probably tractus genitalis	162	2017-11-20	vaginal	vaginal	No	No	Yes	2017-12-13	2019-03-27	Paclitaxel/Carboplatin/Melphalan	Chemotherapy	2018-01-22	Yes	SD
CPCT02450013T	HMF002720	HMF002720A	0.91	female	1958	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-04-03	Liver	Left lobe	No	No	Yes	2018-04-10	2018-08-07	Paclitaxel	Chemotherapy	2018-05-31	Yes	SD
CPCT02450014T	HMF002760	HMF002760A	1.0	male	1960	2018-06-18	Stomach					10534	2018-04-30	Liver	Left lobe	No	No	Yes	2018-04-24	2018-06-18	Oxaliplatin/Capecitabine/Trastuzumab	Multiple therapy	null	null	null
CPCT02450016T	HMF001130	HMF001130A	0.81	female	1951	2019-10-25	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-09-26	Skin	Scalp	Yes	No	Yes	2018-10-08	2019-10-11	Fulvestrant/Palbociclib	Multiple therapy	2018-12-13	Yes	SD
CPCT02460002T	HMF003030	HMF003030A	0.68	male	1968	2018-12-07	Colorectum					9256	2018-07-26	Liver	right liver lobe	Yes	No	Yes	2018-07-30	2018-11-03	Trifluridine	Chemotherapy	2018-10-29	Yes	PD
CPCT02460004T	HMF003464	HMF003464A	0.54	female	1966	null	Breast		Carcinoma	ER-positive/HER2-positive		0060075,0060079	2018-11-01	Liver	right liver lobe	Yes	No	Yes	2018-11-08	null	Trastuzumab/Letrozole/Capecitabine/Vinorelbine/Fulvestrant	Multiple therapy	2019-01-30	Yes	PD
CPCT02460005T	HMF004174	HMF004174A	0.92	female	1988	2019-06-04	Breast		Carcinoma	Triple negative		0060081	2019-01-02	Liver	left liver lobe	Yes	Yes	Yes	2019-01-07	2019-05-06	Carboplatin	Chemotherapy	null	null	null
CPCT02460006T	HMF003882	HMF003882A	0.66	female	1968	2019-03-23	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2019-01-31	Liver	ventral in segment four of the left liver lobe	Yes	Yes	Yes	2019-02-06	2019-03-23	Gemcitabine	Chemotherapy	null	null	null
CPCT02470001T	HMF001352	HMF001352A	0.38	female	1931	2019-12-26	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	2018-12-07	Liver	left lobe (near ligament falciforme)	Yes	Yes	null	null	null	null	null	null	null	null
DRUP01010001T	HMF003674	HMF003674A	0.44	female	1970	2017-01-28	Bone/Soft tissue		Follicular dendritic cell sarcoma			6262	2016-08-26	null	abdominal wall right lower abdomen	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010007T	HMF001458	HMF001458B	0.33	male	1953	2018-08-31	Colorectum	Colon sigmoideum	Carcinoma			12192,1520	2016-11-09	Liver	segment 5	YES	No	YES	2016-11-11	2017-09-08	Pertuzumab/Trastuzumab	Targeted therapy	2017-01-07	YES	PR
DRUP01010010T	HMF003486	HMF003486A	0.24	male	1948	2017-02-09	Lung		Carcinoma	Non-small cell carcinoma		3908	2016-11-22	Lung	subpleural longnodus right	YES	No	null	null	null	null	null	null	null	null
DRUP01010012T	HMF001334	HMF001334A	0.54	female	1967	2017-07-22	Breast		Carcinoma			3459	2016-12-23	null	unknown	YES	Yes	YES	2016-12-23	2017-02-27	Olaparib	Targeted therapy	2017-02-24	YES	PD
DRUP01010013T	HMF000841	HMF000841A	0.75	female	1975	2017-07-08	Unknown	CUP	Carcinoma	Adenocarcinoma		299	2017-01-03	Liver	segment 3	NO	No	null	null	null	null	null	null	null	null
DRUP01010016T	HMF000058	HMF000058A	0.21	female	1961	2017-07-19	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-02-17	Lung	right upper lobe	YES	No	null	null	null	null	null	null	null	null
DRUP01010017T	HMF001883	HMF001883A	0.35	female	1966	2017-07-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-02-24	Lymph node	supraclavicular left	YES	No	null	null	null	null	null	null	null	null
DRUP01010018T	HMF001099	HMF001099A	0.55	male	1943	2022-09-27	Colorectum		Carcinoma			0080199	2017-03-15	null	mass paramedial left	YES	No	YES	2017-03-16	2019-04-25	Nivolumab	Immunotherapy	2017-05-03	YES	SD
DRUP01010019T	HMF000963	HMF000963A	0.36	male	1951	2017-08-31	Bile duct		Carcinoma			4947	2017-04-05	Liver	segment 5/8	YES	No	null	null	null	null	null	null	null	null
DRUP01010020T	HMF003575	HMF003575A	0.66	female	1960	null	Urothelial tract	Urethra	Carcinoma	Urothelial carcinoma		734,2671	null	null	null	YES	No	YES	2017-04-28	null	Nivolumab	Immunotherapy	2017-06-30	YES	PR
DRUP01010022T	HMF003505	HMF003505A	0.26	female	1975	null	Uterus	Cervix	Carcinoma	Squamous cell carcinoma		3744	2017-05-09	null	mass left para-aortal	YES	Yes	YES	2017-05-10	2022-02-11	Nivolumab	Immunotherapy	null	null	null
DRUP01010023T	HMF000463	HMF000463A	0.48	female	1967	2018-03-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-05-09	Kidney	lower pool right kidney	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010024T	HMF000026	HMF000026B	0.27	female	1973	2018-09-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-06-01	Primary	mass right upper lobe	YES	No	YES	2017-06-12	2017-10-03	Pertuzumab/Trastuzumab	Targeted therapy	2017-08-03	YES	SD
DRUP01010024TII	HMF000026	HMF000026A	0.61	female	1973	2018-09-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-20	Lung	dorsal in right upper lobe	YES	No	YES	2017-06-12	2017-10-03	Pertuzumab/Trastuzumab	Targeted therapy	2017-08-03	YES	SD
DRUP01010025T	HMF001651	HMF001651A	0.31	female	1945	null	Colorectum		Carcinoma			0080199	2017-06-23	Liver	segment 8	YES	No	YES	2017-06-23	null	Nivolumab	Immunotherapy	2017-08-11	YES	PR
DRUP01010034T	HMF001558	HMF001558A	0.24	male	1971	2022-01-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-07-28	Lymph node	axilla left	YES	No	null	null	null	null	null	null	null	null
DRUP01010035T	HMF000780	HMF000780A	0.52	female	1994	null	Head and neck	Salivary gland	Carcinoma	Adenoid cystic carcinoma		4866,1542	2017-08-08	Liver	segment 6	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010036T	HMF002923	HMF002923A	0.46	male	1945	2018-07-29	Mesothelium	Pleura	Malignant mesothelioma			7474,1790	2017-08-17	Primary	plaural mass right craniodorsal	YES	No	null	null	null	null	null	null	null	null
DRUP01010037T	HMF001880	HMF001880A	0.9	female	1945	2018-10-03	Breast		Carcinoma			3459	2017-08-21	null	subcutaneous thorax wall lateral	YES	Yes	YES	2017-08-25	2018-02-08	Nivolumab	Immunotherapy	2017-10-17	YES	PR
DRUP01010040T	HMF000615	HMF000615A	0.88	male	1963	2019-02-15	Prostate					10283	2017-10-11	Lymph node	aortic caval lymphadenopathy	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010041T	HMF000020	HMF000020A	0.5	male	1954	2018-08-17	Colorectum		Carcinoma			0080199	2017-10-05	Liver	segment 6	YES	No	null	null	null	null	null	null	null	null
DRUP01010044T	HMF001458	HMF001458A	0.35	male	1953	2018-08-31	Colorectum		Carcinoma			0080199	2017-10-06	Liver	segment 7	YES	No	null	null	null	null	null	null	null	null
DRUP01010047T	HMF000872	HMF000872B	0.56	male	1948	2022-02-03	Colorectum		Carcinoma			0080199	2017-10-16	Liver	primair mass lower abdomen right	NO	Yes	YES	2017-10-17	2018-05-02	Nivolumab	Immunotherapy	2017-12-05	YES	SD
DRUP01010047TII	HMF000872	HMF000872A	0.37	male	1948	2022-02-03	Colorectum		Carcinoma			0080199	null	null	null	NO	Yes	YES	2017-10-17	2018-05-02	Nivolumab	Immunotherapy	2017-12-05	YES	SD
DRUP01010049T	HMF002864	HMF002864A	0.79	male	1947	2018-05-27	Colorectum		Carcinoma			0080199	2017-11-02	Lung	mass right lower lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010051TII	HMF002724	HMF002724B	0.52	female	1945	2021-07-21	Colorectum		Carcinoma			0080199	null	null	null	YES	No	YES	2017-10-26	2019-10-18	Nivolumab	Immunotherapy	2017-12-14	YES	SD
DRUP01010053T	HMF001068	HMF001068A	0.97	male	1970	2018-07-13	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-10-30	Peritoneum	mesenterium	YES	No	null	null	null	null	null	null	null	null
DRUP01010054T	HMF003785	HMF003785A	0.39	female	1962	2017-12-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-10-27	null	right flank	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010057T	HMF002109	HMF002109A	0.93	male	1954	2019-02-09	Thymus					3277	null	null	null	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010058T	HMF002400	HMF002400A	0.95	male	1944	2017-11-30	Lung		Carcinoma	Small cell carcinoma		5409	2017-11-03	Lung	paramediastinal left	YES	Yes	YES	2017-11-02	2017-11-03	Pembrolizumab	Immunotherapy	null	null	null
DRUP01010059T	HMF003654	HMF003654A	0.44	female	1944	2018-02-19	Colorectum		Carcinoma			0080199	null	null	null	YES	No	YES	2017-11-16	2017-12-29	Nivolumab	Immunotherapy	2018-01-03	YES	SD
DRUP01010065T	HMF000411	HMF000411A	0.67	female	1944	2018-01-21	Breast		Carcinoma			3459	2017-12-08	Liver	segment 5/6	YES	Yes	YES	2017-12-14	2018-01-04	Pembrolizumab	Immunotherapy	null	null	null
DRUP01010066T	HMF000666	HMF000666A	0.37	female	1958	2018-09-11	Lung		Carcinoma	Small cell carcinoma		5409	2017-12-12	Lung	Right upper lobe	YES	Yes	YES	2017-12-19	2018-01-30	Pembrolizumab	Immunotherapy	2018-01-29	YES	SD
DRUP01010078T	HMF003689	HMF003689A	0.39	male	1970	2018-04-23	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-02-28	Lymph node	right axilla	YES	No	null	null	null	null	null	null	null	null
DRUP01010084T	HMF003082	HMF003082A	0.84	female	1945	2019-08-09	Ovary		Carcinoma			4001	2018-04-18	Liver	segment 2	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010086T	HMF000835	HMF000835A	0.84	female	1946	2018-10-08	Lung		Carcinoma	Small cell carcinoma		5409	2018-05-15	null	Mamma right	YES	Yes	YES	2018-05-18	2018-07-09	Pembrolizumab	Immunotherapy	2018-07-18	YES	PD
DRUP01010088T	HMF000065	HMF000065A	0.73	female	1949	2018-09-18	Uterus	Endometrium	Carcinoma			2871	2018-06-07	Lung	mass dorsobasal right lower lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010090T	HMF002883	HMF002883A	0.37	female	1943	2018-09-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-06-08	Primary	Thoracic wall dorsal left	YES	No	null	null	null	null	null	null	null	null
DRUP01010091T	HMF001423	HMF001423A	0.31	female	1978	2019-09-16	Breast		Carcinoma			3459	null	null	null	YES	No	YES	2018-06-20	2018-12-31	Pembrolizumab	Immunotherapy	2018-08-16	YES	PD
DRUP01010095T	HMF001561	HMF001561A	0.68	female	1981	2019-06-04	Bile duct		Carcinoma			4947	2018-08-08	null	subcutaneous left abdomen	YES	No	null	null	null	null	null	null	null	null
DRUP01010096T	HMF003228	HMF003228A	0.44	male	1948	2019-08-10	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-08-08	Lung	pleural mass left dorsal	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010097T	HMF001925	HMF001925A	0.73	male	1941	2020-03-19	Prostate		Carcinoma			10286	2018-08-15	Liver	segment 5	YES	Yes	YES	2018-08-16	2020-01-02	Olaparib	Targeted therapy	2018-10-05	YES	SD
DRUP01010099T	HMF001036	HMF001036A	0.61	female	1978	2019-05-29	Unknown	CUP	Carcinoma	Adenocarcinoma		299	2018-08-15	Liver	segment 5	YES	No	null	null	null	null	null	null	null	null
DRUP01010101T	HMF000506	HMF000506A	0.59	male	1951	2018-11-10	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-18	Liver	Segment 6	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010102T	HMF000690	HMF000690A	0.9	male	1940	2018-12-13	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-09-17	Lymph node	neck level 4 right	YES	No	null	null	null	null	null	null	null	null
DRUP01010104T	HMF003605	HMF003605A	0.49	female	1964	2020-12-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-01	Lung	main broncus right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010106T	HMF002028	HMF002028A	0.26	female	1976	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-19	Lymph node	level 5 right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010108T	HMF002349	HMF002349A	0.49	male	1961	2019-06-18	Esophagus		Carcinoma			1107	2018-11-13	Peritoneum	NOS	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010109T	HMF002398	HMF002398B	0.37	female	1971	2019-12-06	Bile duct		Carcinoma			4947	2018-11-12	Liver	segment 4	YES	No	YES	2018-11-12	2018-11-27	Palbociclib	Targeted therapy	null	null	null
DRUP01010110T	HMF002420	HMF002420A	0.23	female	1940	2019-12-06	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-29	Lung	right upper lobe	NO	Yes	null	null	null	null	null	null	null	null
DRUP01010111T	HMF000669	HMF000669A	0.37	female	1940	2019-01-13	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-11-28	null	right	NO	No	null	null	null	null	null	null	null	null
DRUP01010113T	HMF001952	HMF001952A	0.68	male	1949	2018-12-27	Bile duct		Carcinoma			4947	2018-11-30	Liver	near gall bladder bed	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010116T	HMF000018	HMF000018B	0.45	female	1951	2019-09-01	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-21	Lymph node	supraclavicular right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010122T	HMF004000	HMF004000A	0.48	female	1946	2021-07-01	Colorectum		Carcinoma			0080199	2019-02-01	null	right flank	YES	No	YES	2019-02-15	2021-03-26	Durvalumab	Immunotherapy	2019-04-12	YES	PR
DRUP01010123T	HMF004249	HMF004249A	0.51	male	1948	null	Small intestine		Carcinoma			4907	2019-01-11	Primary	small bowel	YES	No	YES	2019-02-19	null	Durvalumab	Immunotherapy	null	null	null
DRUP01010124T	HMF005978	HMF005978A	0.23	male	1948	2021-08-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-02-28	Primary	Right upper lobe	NO	Yes	null	null	null	null	null	null	null	null
DRUP01010132T	HMF001138	HMF001138B	0.77	female	1969	null	Breast		Carcinoma			3459	2019-06-25	Lymph node	axilla right	YES	Yes	YES	2019-06-27	2019-10-09	Pembrolizumab	Immunotherapy	2019-08-27	YES	PR
DRUP01010148T	HMF003839	HMF003839B	0.73	female	1976	2020-01-10	Breast		Carcinoma			3459	2019-08-28	Lymph node	axilla right	YES	Yes	YES	2019-09-05	2019-12-27	Durvalumab	Immunotherapy	2019-10-24	YES	PD
DRUP01010149T	HMF004779	HMF004779A	0.21	female	1961	2020-08-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-08-23	Lung	lateral right lower lobe	YES	No	YES	2019-09-10	2019-12-16	Pertuzumab/Trastuzumab	Targeted therapy	2019-11-07	YES	SD
DRUP01010157T	HMF006550	HMF006550A	0.63	male	1974	2019-11-26	Bronchus		Carcinoma	Adenoid cystic carcinoma		3904,0080202	2019-09-27	Lung	left lower lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010173T	HMF004302	HMF004302B	0.6	male	1958	2020-02-07	Bone/Soft tissue		Osteosarcoma			3347	2019-12-11	Primary	left thoracic wall	YES	Yes	null	null	null	null	null	null	null	null
DRUP01010186T	HMF004635	HMF004635B	0.68	female	1949	2020-04-28	Colorectum		Carcinoma			0080199	2020-02-07	Liver	segment 2-3	YES	Yes	YES	2020-02-11	2020-03-06	Pembrolizumab	Immunotherapy	2020-04-06	YES	PD
DRUP01010209T	HMF004810	HMF004810A	0.7	female	1964	null	Colorectum		Carcinoma			0080199	2020-04-21	Peritoneum	left upper abdomen	YES	Yes	YES	2020-04-24	null	Nivolumab	Immunotherapy	null	null	null
DRUP01010211T	HMF004616	HMF004616B	0.2	male	1968	null	Colorectum		Carcinoma			0080199	2020-04-22	null	abdominal wall in scar	YES	No	YES	2020-04-29	null	Durvalumab	Immunotherapy	null	null	null
DRUP01010212T	HMF004509	HMF004509B	0.42	male	1963	null	Bile duct	Intrahepatic	Carcinoma			4928	2020-05-15	null	upper abdomen	NO	No	YES	2020-05-29	null	Nivolumab	Immunotherapy	null	null	null
DRUP01010219T	HMF005054	HMF005054A	0.53	male	1969	null	Colorectum		Carcinoma			0080199	2020-05-29	Lymph node	mediastinum	YES	Yes	YES	2020-06-09	null	Nivolumab	Immunotherapy	null	null	null
DRUP01010220T	HMF005055	HMF005055A	0.32	male	1951	2021-08-26	Colorectum		Carcinoma			0080199	2020-08-04	Lung	left lower lobe	YES	No	YES	2020-08-07	2020-10-02	Nivolumab	Immunotherapy	2020-09-30	YES	PR
DRUP01010223T	HMF005056	HMF005056A	0.34	female	1956	null	Small intestine		Carcinoma			4907	2020-06-11	Lymph node	mesentery	YES	No	YES	2020-06-15	null	Nivolumab	Immunotherapy	null	null	null
DRUP01010224T	HMF004550	HMF004550B	0.72	female	1970	2021-05-06	Breast		Carcinoma			3459	2020-06-09	Liver	right	YES	Yes	YES	2020-06-12	2020-07-24	Pembrolizumab	Immunotherapy	2020-08-06	YES	PD
DRUP01010230T	HMF004887	HMF004887A	0.23	female	1959	2020-11-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-07-03	Primary	left upper lobe	YES	Yes	YES	2020-07-08	2020-09-29	Pertuzumab/Trastuzumab	Targeted therapy	2020-09-06	YES	SD
DRUP01010246T	HMF005057	HMF005057A	0.85	female	1952	null	Colorectum		Carcinoma			0080199	2020-09-23	Primary	colon anastomose	YES	No	YES	2020-09-30	null	Nivolumab	Immunotherapy	null	null	null
DRUP01010247T	HMF005005	HMF005005B	0.51	male	1959	2020-12-15	Lung		Carcinoma	Small cell carcinoma		5409	2020-09-18	Liver	segment 5	YES	Yes	YES	2020-09-24	2020-11-06	Pembrolizumab	Immunotherapy	2020-11-18	YES	PD
DRUP01010249T	HMF004851	HMF004851B	0.38	female	1955	2020-11-13	Ovary		Carcinoma			4001	2020-09-16	Liver	segment 3	YES	No	YES	2020-09-23	2020-10-15	Pembrolizumab	Immunotherapy	null	null	null
DRUP01010258T	HMF004794	HMF004794B	0.53	female	1954	2020-12-21	Urothelial tract	Urachus	Carcinoma			5958	2020-10-23	Primary	abdominal wall/ventral bladder	YES	No	YES	2020-10-28	2020-11-17	Pembrolizumab	Immunotherapy	null	null	null
DRUP01010262T	HMF005128	HMF005128B	0.72	female	1965	2021-06-28	Breast		Carcinoma			3459	2020-10-28	Lymph node	right supraclavicular	YES	Yes	YES	2020-10-30	2021-02-08	Pembrolizumab	Immunotherapy	2020-12-28	YES	PR
DRUP01010268T	HMF001540	HMF001540B	0.67	female	1950	2021-02-23	Breast		Carcinoma			3459	2020-11-24	Primary	right breast cranial to the nipple	YES	Yes	YES	2020-12-01	2021-02-02	Pembrolizumab	Immunotherapy	2021-01-19	YES	iUPD
DRUP01010276T	HMF005532	HMF005532B	0.39	female	1950	2022-07-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-12-23	Bone	L1	NO	No	null	null	null	null	null	null	null	null
DRUP01010277T	HMF005229	HMF005229A	0.46	female	1936	2022-02-25	Colorectum		Carcinoma			0080199	2020-12-31	Primary	terminal ileum	YES	No	YES	2021-01-05	2022-01-25	Nivolumab	Immunotherapy	2021-03-02	YES	iUPD
DRUP01010288T	HMF005230	HMF005230A	0.74	female	1939	null	Colorectum		Carcinoma			0080199	2021-01-29	Primary	flexura hepatica	YES	No	YES	2021-02-05	null	Nivolumab	Immunotherapy	null	null	null
DRUP01010289T	HMF005231	HMF005231A	0.78	male	1935	2021-05-18	Esophagus		Carcinoma			1107	2021-02-05	Liver	segment 8	YES	Yes	YES	2021-02-11	2021-03-25	Nivolumab	Immunotherapy	2021-04-02	YES	PD
DRUP01010290T	HMF005903	HMF005903A	0.23	male	1955	2021-09-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2021-02-04	Primary	Left upper lobe	NO	Yes	null	null	null	null	null	null	null	null
DRUP01010295T	HMF006551	HMF006551A	0.93	female	1979	2022-08-24	Bile duct		Carcinoma			4947	2021-03-09	Lymph node	groin left	YES	No	null	null	null	null	null	null	null	null
DRUP01010296T	HMF005639	HMF005639A	0.54	male	1981	null	Colorectum		Carcinoma			0080199	2021-03-23	Primary	colon transversum	YES	No	YES	2021-03-29	null	Nivolumab	Immunotherapy	null	null	null
DRUP01010320T	HMF005328	HMF005328B	0.68	male	1973	2021-11-23	Colorectum		Carcinoma			0080199	2021-06-10	Liver	segment 4b	YES	No	null	null	null	null	null	null	null	null
DRUP01010340T	HMF005979	HMF005979A	0.24	female	1955	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2021-09-17	Lung	left upper lobe	YES	No	null	null	null	null	null	null	null	null
DRUP01020004T	HMF001680	HMF001680A	0.64	female	null	2020-08-07	Ovary		Carcinoma			4001	2017-07-24	null	left	NO	No	null	null	null	null	null	null	null	null
DRUP01020006T	HMF001266	HMF001266A	0.76	male	1933	2017-09-05	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-08-22	Lymph node	lung	NO	Yes	null	null	null	null	null	null	null	null
DRUP01020022T	HMF003293	HMF003293A	0.92	male	1950	2019-08-28	Thyroid gland		Carcinoma			3963	2017-12-19	Lymph node	axillary right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01020026T	HMF000613	HMF000613A	0.8	female	1951	2023-08-01	Ovary		Carcinoma			4001	2018-02-13	null	null	YES	No	null	null	null	null	null	null	null	null
DRUP01020027T	HMF002443	HMF002443A	0.67	male	1969	2018-03-22	Esophagus		Carcinoma			1107	2018-02-22	Liver	null	YES	Yes	null	null	null	null	null	null	null	null
DRUP01020033T	HMF001131	HMF001131A	0.5	female	1963	null	Colorectum		Carcinoma			0080199	null	null	null	null	null	null	null	null	null	null	null	null	null
DRUP01020043T	HMF003878	HMF003878A	0.27	female	1956	2019-03-03	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-08	Bone	os ilium right	YES	No	YES	2019-01-09	2019-01-30	Pertuzumab/Trastuzumab	Targeted therapy	2019-02-18	YES	SD
DRUP01020076T	HMF005232	HMF005232A	0.48	male	1976	2021-10-13	Small intestine	Ampulla of vater	Carcinoma			4932	2020-12-04	Liver	liver central	YES	No	YES	2020-12-07	2021-01-18	Nivolumab	Immunotherapy	2021-01-27	YES	PD
DRUP01020096T	HMF005735	HMF005735A	0.66	female	1955	null	Uterus	Endometrium	Carcinoma			2871	2021-08-02	Primary	top of vagina	YES	No	YES	2021-08-03	2021-11-23	Nivolumab	Immunotherapy	2021-09-28	YES	PR
DRUP01020112T	HMF005838	HMF005838A	0.86	male	1982	2023-03-29	Uterus		Carcinoma	Carcinosarcoma		6171	2021-11-29	null	nodus left thorax	YES	No	YES	2021-12-07	2022-03-01	Nivolumab	Immunotherapy	2022-01-31	YES	PD
DRUP01030002T	HMF002012	HMF002012A	0.78	female	1962	null	Uterus	Cervix	Carcinoma	Squamous cell carcinoma		3744	2016-12-22	null	subcutaneous	YES	Yes	null	null	null	null	null	null	null	null
DRUP01030004T	HMF000316	HMF000316A	0.48	female	1964	2017-06-22	Head and neck	Hypopharynx				8533,11934	2017-04-11	Lymph node	Skin	YES	Yes	null	null	null	null	null	null	null	null
DRUP01030012T	HMF001233	HMF001233A	0.53	male	1955	2018-08-29	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-04-19	Liver	ventral left liver lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01030013T	HMF000498	HMF000498A	0.28	female	1967	2019-02-10	Uterus	Endometrium	Carcinoma	Clear cell adenocarcinoma		5299	2018-03-02	Lymph node	axilla right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01030015T	HMF003265	HMF003265A	0.7	female	1952	2018-07-23	Anus		Carcinoma			4908	2018-03-22	Liver	right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01030024T	HMF000966	HMF000966A	0.21	female	1944	2019-01-19	Bile duct		Carcinoma			4947	2018-08-29	Liver	right liver lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01030046T	HMF004447	HMF004447A	0.44	female	1958	2024-01-16	Small intestine	Duodenum	Carcinoma			10021,305	2019-11-14	Liver	segment 3	YES	No	YES	2019-11-18	2021-10-15	Nivolumab	Immunotherapy	2020-01-09	YES	PR
DRUP01030053T	HMF005959	HMF005959A	0.91	female	1961	2020-11-08	Ovary		Sex-cord stromal tumor	Granulosa cell tumor		2999,2394	2020-06-25	Peritoneum	peritoneal lateral of right kidney	YES	Yes	YES	2020-07-01	2020-08-04	Pembrolizumab	Immunotherapy	2020-08-26	YES	PD
DRUP01030070T	HMF005234	HMF005234A	0.39	female	1956	2024-01-11	Pancreas		Carcinoma			4905	2021-02-24	Peritoneum	right hemi-abdomen	YES	No	YES	2021-02-26	2022-01-07	Nivolumab	Immunotherapy	2021-04-20	YES	iCR
DRUP01040009T	HMF000991	HMF000991B	0.87	female	1944	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-12-11	Bone	sacrum left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01040010T	HMF004017	HMF004017A	0.2	female	1948	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-17	Lung	right upper lobe	NO	No	null	null	null	null	null	null	null	null
DRUP01040028T	HMF003951	HMF003951C	0.5	female	1972	2021-06-05	Breast		Carcinoma			3459	2020-11-19	Liver	segment 3	YES	No	YES	2020-11-20	2021-04-26	Pembrolizumab	Immunotherapy	2021-01-22	YES	SD
DRUP01050001T	HMF001371	HMF001371A	0.43	male	1973	2018-02-19	Colorectum	Rectum	Carcinoma			1993,305	2016-10-27	Liver	liver	YES	Yes	YES	2016-11-02	2017-09-27	Nivolumab	Immunotherapy	2016-12-14	YES	SD
DRUP01050002T	HMF003387	HMF003387A	0.62	male	1950	2018-01-06	Colorectum		Carcinoma			0080199	null	null	null	YES	No	YES	2017-02-15	2017-11-08	Nivolumab	Immunotherapy	2017-02-23	YES	SD
DRUP01050003T	HMF000729	HMF000729A	0.96	male	1984	2017-08-30	Nervous system	Brain	Glioma	Glioblastoma multiforme		3068	2017-01-18	Primary	Brain left	YES	Yes	YES	2017-01-26	2017-05-02	Nivolumab	Immunotherapy	2017-03-16	YES	PD
DRUP01050008T	HMF002436	HMF002436A	0.7	male	1946	2018-08-08	Head and neck	Nasal cavity				10811,11934	2017-05-19	Primary	ethmoiden left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01050012T	HMF002361	HMF002361A	0.35	female	1960	2018-04-19	Colorectum		Carcinoma			0080199	2017-10-30	null	metastasis in scar	YES	No	YES	2017-11-01	2017-11-20	Olaparib	Targeted therapy	2017-11-30	YES	PD
DRUP01050016T	HMF002908	HMF002908A	0.83	male	1940	2018-04-04	Esophagus		Carcinoma			1107	2017-11-28	Liver	left lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01050017T	HMF000694	HMF000694A	0.58	female	1965	2023-11-10	Small intestine		Carcinoma			4907	2017-11-29	null	Central abdomen	YES	No	YES	2017-11-29	2018-11-28	Nivolumab	Immunotherapy	2018-01-22	YES	PR
DRUP01050018T	HMF000323	HMF000323A	0.55	female	1955	2018-09-25	Breast		Carcinoma			3459	2017-12-07	Lung	Paravertebral RUL	YES	No	YES	2017-12-12	2018-01-24	Pembrolizumab	Immunotherapy	2018-02-07	YES	PD
DRUP01050019T	HMF000342	HMF000342A	0.38	female	1959	2018-04-20	Breast		Carcinoma			3459	2018-02-14	Liver	Not specified	YES	Yes	null	null	null	null	null	null	null	null
DRUP01050020T	HMF000376	HMF000376A	0.83	male	1947	2018-10-10	Prostate		Carcinoma			10286	2018-02-13	null	posterior pararenal right kidney	YES	Yes	null	null	null	null	null	null	null	null
DRUP01050021T	HMF002166	HMF002166A	0.55	male	1933	null	Bone/Soft tissue	Skin	Sarcoma			2687	2018-02-14	Adrenal gland	left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01050023T	HMF002163	HMF002163A	0.35	male	1966	2018-06-18	Urothelial tract	Bladder				11054	2018-03-20	null	Abdominal Wall	YES	Yes	null	null	null	null	null	null	null	null
DRUP01050025T	HMF000628	HMF000628A	0.58	male	1944	2018-05-30	Colorectum		Carcinoma			0080199	2018-04-04	Lung	basal right	YES	No	null	null	null	null	null	null	null	null
DRUP01050026T	HMF002441	HMF002441A	0.51	female	1971	2018-05-26	Colorectum		Carcinoma			0080199	2018-04-11	Lymph node	Inguinal lymph node left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01050029T	HMF000019	HMF000019A	0.21	female	1941	2018-06-06	Ovary		Carcinoma			4001	2018-05-14	Peritoneum	supra umbilicaal	YES	No	YES	2018-05-14	2018-06-04	Olaparib	Targeted therapy	2018-05-17	YES	PD
DRUP01050030T	HMF002634	HMF002634A	0.43	male	1959	2018-07-09	Esophagus		Carcinoma			1107	2018-06-08	Primary	Oesophagus	YES	No	null	null	null	null	null	null	null	null
DRUP01050031T	HMF000628	HMF000628B	0.68	male	1944	2019-02-28	Colorectum		Carcinoma			0080199	2018-06-21	Lung	right basal	YES	No	null	null	null	null	null	null	null	null
DRUP01050033T	HMF000811	HMF000811A	0.53	male	1946	2020-01-25	Esophagus		Carcinoma			1107	2018-08-29	Lymph node	Supraclaviculair left	YES	No	YES	2018-08-29	2019-02-20	Pembrolizumab	Immunotherapy	2018-10-24	YES	SD
DRUP01050035T	HMF001659	HMF001659A	0.54	female	1954	2018-11-21	Gallbladder		Carcinoma			4948	2018-09-20	Liver	segment II	YES	No	YES	2018-09-20	2018-11-15	Pembrolizumab	Immunotherapy	2018-11-18	YES	PD
DRUP01050040T	HMF001460	HMF001460A	0.56	male	1969	2020-08-31	Pancreas		Neuroendocrine tumor			1793,169	2018-10-11	Liver	behind the rib (not otherwise specified)	YES	No	null	null	null	null	null	null	null	null
DRUP01050048T	HMF004705	HMF004705A	0.66	male	1943	null	Bile duct		Carcinoma			4947	2019-07-19	Primary	liver	YES	No	YES	2019-07-19	null	Durvalumab	Immunotherapy	2019-09-06	YES	SD
DRUP01050049T	HMF004300	HMF004300B	0.74	male	1957	2020-10-04	Prostate		Carcinoma			10286	2019-09-11	Lymph node	Level IV supraclaviculair left	YES	No	YES	2019-09-17	2020-02-04	Durvalumab	Immunotherapy	2019-11-05	YES	PD
DRUP01050051T	HMF005642	HMF005642A	0.61	male	1955	2020-09-16	Thyroid gland		Carcinoma	Anaplastic carcinoma		0080522	2019-10-09	null	behind sternotomy scar	YES	Yes	null	null	null	null	null	null	null	null
DRUP01050065T	HMF005235	HMF005235A	0.24	female	1943	2022-07-17	Colorectum		Carcinoma			0080199	2020-10-23	null	Mesenterial mass	YES	Yes	YES	2020-10-27	2021-04-26	Nivolumab	Immunotherapy	2020-12-17	YES	SD
DRUP01050070T	HMF005236	HMF005236A	0.51	female	1946	null	Esophagus		Carcinoma			1107	2020-12-29	Adrenal gland	right	YES	Yes	YES	2020-12-30	null	Nivolumab	Immunotherapy	null	null	null
DRUP01050073T	HMF005238	HMF005238A	0.42	male	1940	2021-02-08	Stomach		Carcinoma			5517	2021-02-04	Liver	Hilus	YES	No	YES	2021-02-05	2021-02-05	Nivolumab	Immunotherapy	null	null	null
DRUP01060018T	HMF000809	HMF000809A	0.46	male	1975	2018-10-16	Skin		Carcinoma			3451	2018-02-15	Lymph node	axilla right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01060019T	HMF000809	HMF000809B	0.56	male	1975	2018-10-16	Skin		Carcinoma			3451	2018-04-30	Lymph node	Axilla right	YES	Yes	YES	2018-06-04	2018-09-17	Pembrolizumab	Immunotherapy	2018-07-30	YES	PD
DRUP01060021T	HMF002723	HMF002723A	0.78	female	1954	2019-12-06	Skin		Carcinoma	Basal cell carcinoma		2513	2018-06-05	Primary	nose	YES	No	null	null	null	null	null	null	null	null
DRUP01060025T	HMF000158	HMF000158A	0.72	female	1946	2019-09-20	Uterus	Endometrium	Carcinoma			2871	2018-08-07	Peritoneum	omentum	YES	Yes	null	null	null	null	null	null	null	null
DRUP01060026T	HMF002013	HMF002013A	0.34	male	1971	2020-07-31	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-10-30	Lung	left upper lobe	YES	Yes	YES	2018-10-31	2019-05-08	Pertuzumab/Trastuzumab	Targeted therapy	2018-12-10	YES	SD
DRUP01060027T	HMF003432	HMF003432A	0.62	female	1964	2019-10-18	Uterus	Endometrium	Carcinoma			2871	2018-11-19	Liver	left lobe liver	YES	Yes	YES	2018-11-21	2019-05-14	Olaparib	Targeted therapy	2019-01-21	YES	PR
DRUP01060028T	HMF000158	HMF000158C	0.86	female	1946	2019-09-20	Uterus	Endometrium	Carcinoma			2871	2019-02-25	Peritoneum	ventral stomach wall	YES	Yes	YES	2019-02-28	2019-05-02	Pembrolizumab	Immunotherapy	2019-04-11	YES	SD
DRUP01060029T	HMF004759	HMF004759A	0.31	male	1951	2020-04-26	Colorectum	Colon	Carcinoma			1520	2019-10-28	Adrenal gland	right	YES	No	YES	2019-11-05	2020-02-04	Nivolumab	Immunotherapy	2019-12-24	YES	SD
DRUP01060042T	HMF005905	HMF005905A	0.52	female	1948	null	Uterus	Endometrium	Carcinoma			2871	2021-11-04	Lymph node	suptraclaviculair left	NO	Yes	YES	2021-11-12	null	Nivolumab	Immunotherapy	null	null	null
DRUP01060044T	HMF005188	HMF005188B	0.31	female	1958	2023-03-28	Unknown	CUP	Carcinoma	Squamous cell carcinoma		1749	2021-10-29	null	lesion intercostal left 1-2 retropectoral	NO	Yes	YES	2021-11-12	2022-02-25	Nivolumab	Immunotherapy	2021-12-27	YES	non iCR/non iPD
DRUP01060047T	HMF005906	HMF005906A	0.31	female	1959	2022-01-01	Uterus	Endometrium	Carcinoma			2871	2021-12-03	null	retroperitoneal mass	YES	No	YES	2021-12-09	2021-12-09	Nivolumab	Immunotherapy	2021-12-28	YES	iSD
DRUP01060048T	HMF006004	HMF006004A	0.72	female	1944	2022-03-17	Uterus	Endometrium	Carcinoma	Carcinosarcoma		6171,4236	2021-12-08	Peritoneum	abdomen right side	YES	Yes	YES	2021-12-16	2022-02-17	Nivolumab	Immunotherapy	2022-02-11	YES	SD
DRUP01060052T	HMF006374	HMF006374A	0.63	male	1945	2023-11-30	Colorectum	Rectum	Carcinoma			1993,305	2022-03-09	Liver	right side liver	YES	Yes	YES	2022-03-14	2022-11-24	Pertuzumab/Trastuzumab	Targeted therapy	2022-05-13	YES	PR
DRUP01070001T	HMF002628	HMF002628A	0.32	female	1949	2022-11-14	Colorectum	Colon	Carcinoma	Adenocarcinoma		234,0050861	2016-11-25	Lymph node	Para iliac right	YES	No	YES	2016-11-28	2018-11-12	Nivolumab	Immunotherapy	2017-01-16	YES	PR
DRUP01070003T	HMF002513	HMF002513A	0.22	male	1939	2017-12-14	Head and neck	Parotid gland	Carcinoma	Salivary duct carcinoma		9036,1542	2016-12-21	null	skin left shoulder /back	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070005T	HMF001044	HMF001044A	0.66	male	1974	2017-07-18	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-02-02	null	abdominal wall	YES	No	null	null	null	null	null	null	null	null
DRUP01070006T	HMF001600	HMF001600A	0.23	male	1968	2017-10-12	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-02-03	Liver	null	YES	No	null	null	null	null	null	null	null	null
DRUP01070008T	HMF000458	HMF000458A	0.69	male	1958	2023-04-19	Prostate					10283	2017-02-28	Adrenal gland	left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070010T	HMF000715	HMF000715A	0.66	male	1945	null	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-03-09	null	behind bladder	YES	No	null	null	null	null	null	null	null	null
DRUP01070015T	HMF000191	HMF000191A	0.22	male	1950	2020-01-30	Prostate					10283	2017-06-13	null	presacral	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070016T	HMF000472	HMF000472A	0.7	female	1966	2020-08-15	Head and neck	Salivary gland	Carcinoma	Adenoid cystic carcinoma		4866,1542	2017-05-31	Primary	sinus sphenoidalis	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070017T	HMF002810	HMF002810A	0.33	female	1954	2017-11-03	Colorectum		Carcinoma			0080199	2017-06-01	Liver	right lobe	YES	No	YES	2017-06-07	2017-08-07	Olaparib	Targeted therapy	2017-07-31	YES	PD
DRUP01070020T	HMF000881	HMF000881A	0.73	male	1949	2019-04-02	Prostate					10283	2017-09-05	Liver	left lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070022T	HMF001685	HMF001685A	0.33	male	1942	2018-04-15	Head and neck	Salivary gland	Carcinoma	Salivary duct carcinoma		0050904,1542	2017-10-05	Lymph node	left axilla	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070024T	HMF001101	HMF001101A	0.51	female	1963	2019-02-06	Uterus	Cervix	Carcinoma			2893	2017-10-19	Lymph node	right scapular	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070026T	HMF000501	HMF000501A	0.49	male	1963	2018-10-29	Prostate		Carcinoma			10286	2017-11-09	Lymph node	supraclavicular left	YES	No	null	null	null	null	null	null	null	null
DRUP01070026TII	HMF000501	HMF000501B	0.48	male	1963	2018-10-29	Prostate		Carcinoma			10286	null	null	null	YES	No	null	null	null	null	null	null	null	null
DRUP01070028T	HMF000551	HMF000551A	0.78	male	1950	2020-10-25	Prostate		Carcinoma			10286	2018-01-15	Lymph node	supraclavicular right	YES	No	null	null	null	null	null	null	null	null
DRUP01070028TII	HMF000551	HMF000551C	0.93	male	1950	2020-10-25	Prostate		Carcinoma			10286	null	null	null	YES	No	null	null	null	null	null	null	null	null
DRUP01070029T	HMF001647	HMF001647A	0.41	male	1987	2018-12-29	Bone/Soft tissue		Inflammatory myofibroblastic tumor			0050905,1115	2017-10-09	Primary	right acetabulum	NO	No	null	null	null	null	null	null	null	null
DRUP01070030T	HMF003552	HMF003552A	0.3	female	1958	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-11-23	Lung	left upper lobe	YES	No	YES	2017-11-27	2018-05-14	Pertuzumab/Trastuzumab	Targeted therapy	2018-01-23	YES	SD
DRUP01070031T	HMF002034	HMF002034A	0.87	male	1949	2019-07-20	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-11-30	null	back musculature, right side	YES	No	null	null	null	null	null	null	null	null
DRUP01070036T	HMF000832	HMF000832A	0.76	male	1939	2018-04-16	Prostate		Carcinoma			10286	2018-02-13	Lymph node	para aortal right	YES	Yes	YES	2018-02-13	2018-03-15	Olaparib	Targeted therapy	2018-04-04	YES	PD
DRUP01070038T	HMF003658	HMF003658A	0.6	male	1939	2018-06-05	Prostate		Carcinoma			10286	2018-01-25	Liver	right lobe caudal	YES	Yes	YES	2018-01-25	2018-04-05	Nivolumab	Immunotherapy	2018-03-15	YES	PD
DRUP01070039T	HMF001249	HMF001249A	0.31	male	1948	2018-08-17	Unknown	CUP	Carcinoma	Adenocarcinoma		299	2018-01-18	Lymph node	axillaire left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070042T	HMF001596	HMF001596A	0.53	male	1947	2018-05-27	Prostate		Carcinoma			10286	2018-04-12	Liver	right liver lobe	YES	Yes	YES	2018-04-18	2018-04-18	Pembrolizumab	Immunotherapy	null	null	null
DRUP01070046T	HMF002732	HMF002732A	0.24	male	1968	2018-08-15	Urothelial tract		Carcinoma	Urothelial carcinoma		3996,2671	2018-05-29	Lymph node	inguinal	YES	No	null	null	null	null	null	null	null	null
DRUP01070048T	HMF000754	HMF000754A	0.43	female	1943	2018-11-28	Urothelial tract	Bladder	Carcinoma	Urothelial carcinoma		4006	2018-05-25	Lymph node	neck	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070051T	HMF000949	HMF000949A	0.85	female	1974	2021-11-11	Head and neck	Salivary gland	Carcinoma	Mucoepidermoid carcinoma		4531,1542	2018-07-18	Lymph node	neck	NO	Yes	null	null	null	null	null	null	null	null
DRUP01070052T	HMF000391	HMF000391A	0.87	male	1938	2020-04-16	Prostate		Carcinoma			10286	2018-08-30	Lymph node	para iliac mass left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070055T	HMF000805	HMF000805A	0.22	male	1948	2021-07-06	Prostate		Carcinoma			10286	2018-08-29	Lymph node	supraclavicular left	YES	Yes	YES	2018-09-24	2019-07-05	Olaparib	Targeted therapy	2018-11-14	YES	SD
DRUP01070057T	HMF001378	HMF001378A	0.35	male	1945	2020-12-11	Prostate		Carcinoma			10286	2018-09-19	Lymph node	armpit	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070063T	HMF001550	HMF001550B	0.49	female	1941	null	Colorectum	Colon	Carcinoma			1520	2018-12-11	null	abdominal wall right	YES	No	YES	2018-12-12	2019-01-31	Pembrolizumab	Immunotherapy	2019-02-13	YES	PD
DRUP01070070T	HMF001891	HMF001891B	0.81	male	1947	2019-09-13	Prostate		Carcinoma			10286	2019-07-04	Liver	liver segment 2/3	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070071T	HMF000429	HMF000429B	0.44	male	1963	2020-07-16	Prostate		Carcinoma			10286	2019-01-24	Lymph node	lymph node package right intra-abdominal	YES	No	YES	2019-01-25	2019-10-07	Olaparib	Targeted therapy	2019-03-19	YES	PR
DRUP01070085T	HMF004717	HMF004717A	0.35	male	1938	2019-10-16	Stomach		Carcinoma			5517	null	null	null	YES	No	YES	2019-09-04	2019-10-03	Durvalumab	Immunotherapy	2019-10-09	YES	PD
DRUP01070110T	HMF003866	HMF003866B	0.97	male	1960	2020-07-16	Prostate		Carcinoma			10286	2020-03-31	Lung	pleura	YES	No	YES	2020-03-31	2020-05-13	Nivolumab	Immunotherapy	2020-05-22	YES	PD
DRUP01070119T	HMF004597	HMF004597A	0.47	male	1940	2020-05-18	Pancreas					1793	2020-01-02	Lung	left upper lobe	NO	Yes	YES	2020-01-06	2020-02-03	Durvalumab	Immunotherapy	2020-02-25	YES	PD
DRUP01070126T	HMF004691	HMF004691A	0.62	female	1940	2020-08-03	Colorectum	Colon sigmoideum	Carcinoma			12192,1520	2020-02-06	Liver	segment 4	YES	No	YES	2020-02-10	2020-03-12	Nivolumab	Immunotherapy	2020-04-02	YES	PD
DRUP01070198T	HMF005645	HMF005645A	0.49	male	1940	2023-03-15	Unknown	CUP	Carcinoma	Large cell carcinoma		4552	2021-04-15	Bone	thorax wall	NO	Yes	YES	2021-04-15	2022-02-16	Nivolumab	Immunotherapy	2021-06-03	YES	SD
DRUP01070199T	HMF006477	HMF006477A	0.8	female	1956	2023-01-24	Thyroid gland		Carcinoma			3963	2021-04-13	Lymph node	axillar	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070222T	HMF005737	HMF005737A	0.82	male	1940	null	Prostate		Carcinoma			10286	2021-08-13	Lymph node	Left axilla	YES	Yes	YES	2021-08-16	2023-08-15	Nivolumab	Immunotherapy	2021-10-05	YES	SD
DRUP01070253T	HMF006395	HMF006395A	0.58	female	1960	2022-11-16	Uterus	Endometrium	Carcinoma			2871	2022-03-29	Primary	mass small pelvis left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01070260T	HMF006396	HMF006396A	0.74	female	1953	2023-03-16	Uterus	Endometrium	Carcinoma			2871	2022-09-08	Peritoneum	peritoneum	YES	No	null	null	null	null	null	null	null	null
DRUP01070264T	HMF006479	HMF006479A	0.66	female	1958	null	Ovary		Carcinoma			4001	2022-10-18	Lymph node	inguinal left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01080004T	HMF000579	HMF000579A	0.66	female	1952	2018-03-11	Breast		Carcinoma			3459	2017-09-15	null	right upper arm	YES	Yes	null	null	null	null	null	null	null	null
DRUP01080005T	HMF000154	HMF000154A	0.8	male	1957	2018-01-01	Unknown	CUP	Carcinoma	Neuroendocrine carcinoma		1800	2017-09-28	Liver	left liver lobe	YES	No	null	null	null	null	null	null	null	null
DRUP01080008T	HMF001362	HMF001362A	0.36	female	1947	2018-03-14	Uterus	Endometrium	Carcinoma			2871	2017-11-24	Lung	right upper lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01080009T	HMF000693	HMF000693A	0.63	female	1963	2018-11-06	Breast		Carcinoma			3459	2017-11-14	Lymph node	axillar left	YES	Yes	YES	2017-11-16	2018-02-07	Pembrolizumab	Immunotherapy	2018-01-10	YES	SD
DRUP01080012T	HMF001343	HMF001343A	0.66	female	1962	2018-06-04	Bone/Soft tissue		Sarcoma			1115	2018-03-14	Bone	left arm	YES	No	null	null	null	null	null	null	null	null
DRUP01080014T	HMF003240	HMF003240A	0.42	female	1949	null	Uterus	Endometrium	Carcinoma			2871	2018-04-26	Primary	endometrium	YES	Yes	YES	2018-05-03	2018-05-03	Pembrolizumab	Immunotherapy	2018-05-20	YES	PD
DRUP01080021T	HMF000594	HMF000594A	0.5	female	1943	null	Skin		Carcinoma	Basal cell carcinoma		2513	2018-11-01	Primary	skin scapula left	YES	No	null	null	null	null	null	null	null	null
DRUP01080022T	HMF001195	HMF001195A	0.2	male	1946	null	Skin		Carcinoma	Squamous cell carcinoma		3151	2018-11-16	Primary	cutan lesion right shoulder	YES	Yes	YES	2018-12-07	2021-07-02	Pembrolizumab	Immunotherapy	2019-02-01	YES	PR
DRUP01080024T	HMF002727	HMF002727B	0.27	male	1942	2020-05-08	Bile duct		Carcinoma			4947	2018-12-27	Liver	right hemi liver	YES	No	YES	2018-12-21	2019-04-16	Palbociclib	Targeted therapy	2019-02-14	YES	PR
DRUP01080025T	HMF002321	HMF002321B	0.88	female	1943	2019-02-21	Skin		Melanoma			8923	2019-01-25	Lymph node	inguinal right	YES	No	YES	2019-01-25	2019-02-15	Palbociclib	Targeted therapy	null	null	null
DRUP01080027T	HMF005940	HMF005940A	0.72	male	1943	2020-02-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-16	Lymph node	supraclavicular right side	NO	No	null	null	null	null	null	null	null	null
DRUP01080031T	HMF004754	HMF004754A	0.59	male	1958	2019-09-21	Bile duct		Carcinoma			4947	2019-07-02	Liver	left hemi liver	YES	No	YES	2019-07-02	2019-07-30	Durvalumab	Immunotherapy	2019-08-20	YES	PD
DRUP01080039T	HMF001982	HMF001982C	0.27	female	1983	2020-03-03	Breast		Carcinoma			3459	2019-10-29	Liver	right liver lobe	YES	Yes	YES	2019-10-29	2019-11-19	Pembrolizumab	Immunotherapy	2019-11-29	YES	PD
DRUP01080046T	HMF006005	HMF006005A	0.38	female	1946	2020-11-12	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-03-13	null	lateral thorax wall left side	NO	No	null	null	null	null	null	null	null	null
DRUP01080048T	HMF006555	HMF006555A	1.0	male	1954	2023-06-16	Skin	Upper limb	Carcinoma	Papillary adenocarcinoma		3451,3112	2020-06-16	null	pectoral	YES	No	null	null	null	null	null	null	null	null
DRUP01080058T	HMF005646	HMF005646A	0.51	female	1959	2023-02-24	Stomach		Carcinoma			5517	2021-03-30	Primary	soft tissue abdomen	YES	No	YES	2021-03-30	2022-02-08	Nivolumab	Immunotherapy	2021-05-18	YES	PR
DRUP01080059T	HMF005981	HMF005981A	0.25	male	1945	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2021-05-20	Lymph node	supraclavicular right	NO	No	null	null	null	null	null	null	null	null
DRUP01080060T	HMF005982	HMF005982A	0.2	female	1942	2021-08-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2021-06-22	Lung	right upper lobe	NO	No	null	null	null	null	null	null	null	null
DRUP01080064T	HMF005907	HMF005907A	0.48	male	1937	2022-03-02	Colorectum	Colon	Carcinoma			1520	2021-11-11	Liver	liver	YES	No	YES	2021-11-19	2022-01-25	Nivolumab	Immunotherapy	2022-01-18	YES	SD
DRUP01080073T	HMF006252	HMF006252A	0.56	female	1991	null	Colorectum		Carcinoma			0080199	2022-08-04	Liver	segment 6,7	YES	No	null	null	null	null	null	null	null	null
DRUP01080074T	HMF006397	HMF006397A	0.33	male	1957	2022-11-17	Colorectum	Colon	Carcinoma			1520	2022-08-11	Liver	segment 4	YES	Yes	YES	2022-08-11	2022-09-20	Pertuzumab/Trastuzumab	Targeted therapy	2022-10-04	YES	PD
DRUP01090001T	HMF001082	HMF001082A	0.78	male	1963	2017-08-07	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2017-03-28	Liver	right	YES	No	null	null	null	null	null	null	null	null
DRUP01090003T	HMF002551	HMF002551A	0.6	male	1960	2018-01-29	Colorectum	Colon	Carcinoma			1520	2017-08-15	null	ventral	YES	Yes	YES	2017-08-15	2017-09-11	Nivolumab	Immunotherapy	2017-09-25	YES	ND
DRUP01090004T	HMF001251	HMF001251A	0.93	male	1971	2017-12-08	Thyroid gland		Carcinoma			3963	2017-09-19	Liver	central leasion segment 4	YES	Yes	null	null	null	null	null	null	null	null
DRUP01090005T	HMF002752	HMF002752A	0.68	female	1951	2018-11-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2017-09-22	Liver	right leasion	YES	No	null	null	null	null	null	null	null	null
DRUP01090008T	HMF002107	HMF002107A	0.64	male	1958	2018-03-08	Colorectum	Colon sigmoideum	Carcinoma			12192,1520	2017-11-29	Lymph node	left iliacale	YES	Yes	null	null	null	null	null	null	null	null
DRUP01090009T	HMF003369	HMF003369A	0.46	female	1975	2018-06-01	Colorectum	Rectum	Carcinoma			1993,305	2017-12-12	Liver	right lobe	YES	Yes	YES	2017-12-13	2018-04-19	Pertuzumab/Trastuzumab	Targeted therapy	2018-02-06	YES	SD
DRUP01090011T	HMF002708	HMF002708A	0.75	female	1966	2018-04-17	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-01-16	null	abdominal mass	YES	No	null	null	null	null	null	null	null	null
DRUP01090012T	HMF001038	HMF001038A	0.92	male	1948	2018-03-29	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-02-14	Bone	sacrum right	YES	No	null	null	null	null	null	null	null	null
DRUP01090014T	HMF000056	HMF000056A	0.67	male	1997	2020-09-03	Bone/Soft tissue		Osteosarcoma			3347	2018-07-20	Bone	femur left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01090015T	HMF002103	HMF002103A	0.27	male	1967	2020-04-26	Eye		Melanoma			1752,1909	2018-03-27	null	belly/abdomen	YES	No	null	null	null	null	null	null	null	null
DRUP01090017T	HMF003475	HMF003475A	0.78	male	1959	2018-08-15	Stomach		Carcinoma			5517	2018-05-02	Liver	liver	YES	No	null	null	null	null	null	null	null	null
DRUP01090019T	HMF002247	HMF002247A	0.26	female	1961	2018-09-03	Vulva		Carcinoma	Squamous cell carcinoma		2101	2018-05-02	null	vulva	YES	Yes	null	null	null	null	null	null	null	null
DRUP01090022T	HMF001285	HMF001285A	0.37	male	1948	2018-10-12	Pancreas					1793	2018-09-18	Liver	liver	YES	No	YES	2018-09-19	2018-09-26	Olaparib	Targeted therapy	null	null	null
DRUP01090023T	HMF001097	HMF001097A	0.61	male	1956	2019-02-18	Colorectum	Colon	Carcinoma			1520	2018-10-23	Liver	liver right lobe	YES	No	YES	2018-10-29	2018-12-17	Palbociclib	Targeted therapy	2018-12-17	YES	PD
DRUP01090026T	HMF004151	HMF004151A	0.85	male	1953	2020-11-11	Thyroid gland		Carcinoma	Papillary carcinoma		3969	2019-02-05	Lymph node	neck left	YES	No	null	null	null	null	null	null	null	null
DRUP01090055T	HMF005647	HMF005647A	0.71	female	1965	2023-10-25	Uterus	Endometrium	Carcinoma			2871	2021-03-02	Lymph node	groin	YES	Yes	YES	2021-03-02	2022-02-10	Nivolumab	Immunotherapy	2021-04-19	YES	PR
DRUP01090074T	HMF006375	HMF006375A	0.65	female	1948	null	Colorectum	Colon	Carcinoma			1520	2022-05-31	Liver	right lobe	YES	No	YES	2022-06-03	null	Pertuzumab/Trastuzumab	Targeted therapy	null	null	null
DRUP01090078T	HMF006426	HMF006426A	0.36	male	1949	2023-01-10	Lung		Carcinoma			3905	2022-10-04	null	back right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01100003T	HMF000977	HMF000977A	0.72	female	1972	2018-07-02	Bone/Soft tissue	Uterus	Leiomyosarcoma			363,1967,1115	2017-11-13	null	abdomen	YES	No	YES	2017-11-21	2018-03-07	Pembrolizumab	Immunotherapy	2018-01-19	YES	SD
DRUP01100007T	HMF003321	HMF003321A	0.68	female	1947	2019-02-11	Uterus	Endometrium	Carcinoma			2871	2018-09-13	null	vagina	YES	Yes	null	null	null	null	null	null	null	null
DRUP01100013T	HMF004569	HMF004569A	0.5	male	1950	2023-09-01	Colorectum	Colon	Carcinoma			1520	2019-12-09	Primary	Colon	YES	No	YES	2019-12-20	2020-01-17	Nivolumab	Immunotherapy	2020-02-03	YES	PR
DRUP01100015T	HMF004860	HMF004860A	0.58	female	1946	null	Colorectum	Flexura hepatica	Carcinoma			260	2020-06-15	Primary	duodenum	YES	No	YES	2020-06-30	null	Nivolumab	Immunotherapy	2020-08-21	YES	SD
DRUP01110002T	HMF003198	HMF003198A	0.85	female	1930	2017-12-05	Uterus	Endometrium	Carcinoma			2871	2017-11-17	null	Right	YES	Yes	YES	2017-11-24	2017-11-24	Nivolumab	Immunotherapy	null	null	null
DRUP01110005T	HMF000984	HMF000984A	0.76	female	1960	2018-06-24	Breast		Carcinoma			3459	2018-04-04	Liver	R. lobe	YES	Yes	YES	2018-04-11	2018-05-24	Pembrolizumab	Immunotherapy	2018-06-05	YES	PD
DRUP01110007T	HMF001698	HMF001698B	0.59	female	1973	2019-05-19	Breast		Carcinoma			3459	2019-01-17	Liver	Right liverlobe	YES	Yes	YES	2019-01-23	2019-04-17	Pembrolizumab	Immunotherapy	2019-03-14	YES	PD
DRUP01110015T	HMF005058	HMF005058A	0.52	male	1964	2023-12-02	Colorectum	Colon	Carcinoma			1520	2020-09-17	Lymph node	inguinal Left	YES	No	YES	2020-10-07	2022-12-02	Nivolumab	Immunotherapy	null	null	null
DRUP01110020T	HMF005648	HMF005648A	0.66	male	1951	2021-07-14	Prostate		Carcinoma			10286	2021-03-30	Lymph node	iliac right	YES	Yes	YES	2021-04-16	2021-06-11	Nivolumab	Immunotherapy	2021-06-02	YES	SD
DRUP01110027T	HMF005732	HMF005732B	0.42	male	1968	2022-08-10	Colorectum	Colon	Carcinoma			1520	2021-12-29	Liver	nos	YES	Yes	null	null	null	null	null	null	null	null
DRUP01110028T	HMF006006	HMF006006A	0.28	female	1936	2022-05-20	Uterus	Endometrium	Carcinoma			2871	2022-01-18	null	Right lower abdomen	YES	No	null	null	null	null	null	null	null	null
DRUP01120001T	HMF001461	HMF001461A	0.82	female	1956	2019-04-14	Breast		Carcinoma			3459	2018-09-25	Liver	left	YES	Yes	YES	2018-10-01	2019-01-21	Pembrolizumab	Immunotherapy	2018-12-18	YES	SD
DRUP01120007T	HMF004562	HMF004562A	0.53	null	null	2023-01-16	Colorectum		Carcinoma			0080199	2019-12-03	Bone	paravertebral low thoracal	YES	Yes	YES	2019-12-12	2021-12-28	Nivolumab	Immunotherapy	2020-02-03	YES	non CR/non PD
DRUP01120010T	HMF005059	HMF005059A	0.72	male	1986	2020-10-29	Colorectum	Colon	Carcinoma			1520	2020-09-03	Liver	left	NO	No	YES	2020-09-04	2020-10-15	Nivolumab	Immunotherapy	null	null	null
DRUP01120011T	HMF002801	HMF002801B	0.56	null	null	2020-12-18	Breast		Carcinoma			3459	2020-09-22	Liver	LEFT	YES	Yes	YES	2020-09-28	2020-11-09	Pembrolizumab	Immunotherapy	2020-11-10	YES	PD
DRUP01120015T	HMF005649	HMF005649A	0.89	female	1964	null	Uterus	Endometrium	Carcinoma			2871	2021-05-26	Liver	seg. IVa	YES	Yes	YES	2021-06-14	2021-07-26	Nivolumab	Immunotherapy	2021-08-05	YES	PD
DRUP01130008T	HMF004579	HMF004579A	0.72	female	1942	2020-02-02	Colorectum	Colon ascendens	Carcinoma			218,1520	2020-01-07	null	flexura hepatica	YES	No	YES	2020-01-07	2020-01-07	Nivolumab	Immunotherapy	null	null	null
DRUP01130009T	HMF004406	HMF004406A	0.73	female	1953	2020-02-11	Uterus	Endometrium	Carcinoma			2871	2020-01-20	Peritoneum	paramedian left	YES	Yes	YES	2020-01-20	2020-01-20	Nivolumab	Immunotherapy	null	null	null
DRUP01130012T	HMF004590	HMF004590A	0.42	male	1944	2020-07-04	Colorectum	Colon	Carcinoma			1520	2020-02-27	Liver	Segment 3 caudal	YES	No	YES	2020-03-02	2020-04-29	Nivolumab	Immunotherapy	null	null	null
DRUP01140001T	HMF000826	HMF000826A	0.72	male	1957	2017-01-26	Prostate		Carcinoma			10286	2016-12-05	Lymph node	para-aorthaal	YES	Yes	null	null	null	null	null	null	null	null
DRUP01140002T	HMF001592	HMF001592A	0.91	male	1960	2017-06-01	Prostate					10283	2017-02-28	Lymph node	subclavicular	YES	Yes	YES	2017-03-01	2017-04-25	Olaparib	Targeted therapy	2017-04-24	YES	PD
DRUP01140003T	HMF002858	HMF002858A	0.62	female	1947	2018-01-20	Ovary		Carcinoma			4001	2017-01-30	null	omentum	YES	No	null	null	null	null	null	null	null	null
DRUP01140005T	HMF000840	HMF000840A	0.66	male	1950	2018-03-02	Prostate		Carcinoma			10286	2017-12-19	Liver	left lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01140006T	HMF000296	HMF000296A	0.96	female	1956	2018-08-12	Lung		Carcinoma	Small cell carcinoma		5409	2018-06-18	null	epigastrio	YES	Yes	YES	2018-06-22	2018-07-13	Pembrolizumab	Immunotherapy	2018-08-06	YES	PD
DRUP01160001T	HMF001379	HMF001379A	0.46	male	1957	2019-07-18	Colorectum	Rectum	Carcinoma			1993,305	2018-07-09	null	Sacral	YES	Yes	YES	2018-07-23	2019-01-14	Pembrolizumab	Immunotherapy	2018-09-17	YES	PD
DRUP01170001T	HMF002788	HMF002788A	0.64	male	1972	2020-06-21	Thymus		Neuroendocrine tumor			3277,169	2018-05-22	null	interpulmonal	YES	Yes	null	null	null	null	null	null	null	null
DRUP01170003T	HMF001889	HMF001889A	0.26	female	1981	null	Bile duct		Carcinoma			4947	2018-07-18	Liver	left liver lobe	YES	No	YES	2018-07-27	2023-03-13	Olaparib	Targeted therapy	2018-09-10	YES	SD
DRUP01170009T	HMF006053	HMF006053A	0.2	male	1952	2022-04-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2021-11-04	Primary	RBK	NO	Yes	null	null	null	null	null	null	null	null
DRUP01170012T	HMF006498	HMF006498A	0.43	female	1948	2023-03-06	Lung		Carcinoma	Non-small cell carcinoma		3908	2022-07-05	Lymph node	neck	YES	No	null	null	null	null	null	null	null	null
DRUP01180001T	HMF001945	HMF001945A	0.74	female	1983	2018-05-27	Breast		Carcinoma			3459	2018-05-02	Primary	mamma right	YES	No	YES	2018-05-08	2018-05-08	Pembrolizumab	Immunotherapy	null	null	null
DRUP01190001T	HMF001421	HMF001421A	0.39	male	1960	2018-09-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-08-29	Lung	right	YES	No	null	null	null	null	null	null	null	null
DRUP01190005T	HMF004982	HMF004982A	0.69	female	1944	2023-03-27	Colorectum		Carcinoma			0080199	2020-08-06	Lymph node	supraclavicular	YES	No	YES	2020-08-14	2022-01-28	Nivolumab	Immunotherapy	2020-10-07	YES	SD
DRUP01210002T	HMF001663	HMF001663A	0.37	male	1946	2018-09-10	Stomach		Carcinoma			5517	2018-04-18	Lymph node	supraclaviculair	YES	No	YES	2018-04-26	2018-08-09	Pembrolizumab	Immunotherapy	2018-06-25	YES	PD
DRUP01210003T	HMF000500	HMF000500A	0.33	male	1962	2019-01-05	Esophagus		Carcinoma			1107	2018-06-13	Liver	segment 5	YES	No	null	null	null	null	null	null	null	null
DRUP01210004T	HMF002241	HMF002241A	0.52	female	1955	2019-06-13	Breast		Carcinoma			3459	2018-08-24	Liver	segment 8	YES	No	null	null	null	null	null	null	null	null
DRUP01210005T	HMF000054	HMF000054A	0.5	female	1954	2018-12-19	Breast		Carcinoma			3459	2018-09-12	Liver	segment 2	YES	Yes	YES	2018-09-17	2018-10-08	Pembrolizumab	Immunotherapy	2018-10-31	YES	PD
DRUP01210006T	HMF001863	HMF001863B	0.54	female	1967	2019-08-19	Ovary		Carcinoma			4001	2019-01-02	null	abdominal wall	YES	No	null	null	null	null	null	null	null	null
DRUP01210008T	HMF004117	HMF004117B	0.5	male	1949	2020-04-13	Urothelial tract		Carcinoma	Urothelial carcinoma		3996,2671	2019-06-05	Lymph node	abdominal wall	YES	Yes	null	null	null	null	null	null	null	null
DRUP01210014T	HMF005000	HMF005000A	0.64	male	1942	2021-11-20	Colorectum	Colon	Carcinoma			1520	2020-06-19	Liver	left side	YES	No	YES	2020-07-02	2021-06-09	Nivolumab	Immunotherapy	2020-08-06	YES	iSD
DRUP01210016T	HMF005242	HMF005242A	0.33	male	null	2022-02-22	Prostate		Carcinoma			10286	2020-11-03	Primary	unknown	YES	No	YES	2020-11-13	2021-04-30	Nivolumab	Immunotherapy	2020-12-29	YES	iPR
DRUP01210018T	HMF005650	HMF005650A	0.56	female	null	2021-12-29	Uterus	Endometrium	Carcinoma			2871	2021-04-30	null	under right side	YES	No	YES	2021-05-10	2021-06-22	Nivolumab	Immunotherapy	2021-07-01	YES	iUPD
DRUP01220001T	HMF001223	HMF001223A	0.31	female	1944	2019-04-24	Breast		Carcinoma			3459	2018-02-22	Lymph node	neck left side	YES	Yes	null	null	null	null	null	null	null	null
DRUP01220002T	HMF002824	HMF002824A	0.61	female	1952	2021-02-17	Breast		Carcinoma			3459	2018-05-14	Lymph node	neck	YES	Yes	YES	2018-05-14	2019-03-25	Pembrolizumab	Immunotherapy	2018-07-10	YES	SD
DRUP01220004T	HMF002877	HMF002877A	0.22	male	1950	2019-08-19	Small intestine		Carcinoma			4907	2018-09-14	null	abdominal wall	YES	No	YES	2018-09-20	2018-10-24	Pembrolizumab	Immunotherapy	2018-11-22	YES	PD
DRUP01220005T	HMF001735	HMF001735A	0.92	female	1967	2019-04-21	Uterus	Cervix	Carcinoma	Squamous cell carcinoma		3744	null	null	null	YES	No	null	null	null	null	null	null	null	null
DRUP01220006T	HMF001924	HMF001924B	0.45	female	1947	2019-02-09	Breast		Carcinoma			3459	2018-12-27	Liver	right side	YES	Yes	YES	2019-01-02	2019-01-02	Pembrolizumab	Immunotherapy	2019-01-18	YES	PD
DRUP01220007T	HMF002877	HMF002877C	0.59	male	1950	2019-08-19	Small intestine		Carcinoma			4907	2019-02-07	Peritoneum	abdominal wall	YES	No	YES	2019-02-19	2019-04-09	Palbociclib	Targeted therapy	2019-04-09	YES	PD
DRUP01220008T	HMF004007	HMF004007B	0.22	female	1957	2019-07-28	Small intestine		Carcinoma			4907	2019-03-28	null	epigastric	YES	No	null	null	null	null	null	null	null	null
DRUP01220012T	HMF004783	HMF004783A	0.57	female	1947	2020-06-07	Colorectum	Colon	Carcinoma			1520	2020-02-17	null	left and right side labia	YES	Yes	YES	2020-02-25	2020-05-05	Nivolumab	Immunotherapy	2020-05-15	YES	PD
DRUP01220015T	HMF005061	HMF005061A	0.44	female	1965	2024-01-11	Colorectum	Colon sigmoideum	Carcinoma			12192,1520	2020-07-16	Primary	sigmoidal	YES	No	YES	2020-07-20	2022-06-20	Nivolumab	Immunotherapy	2020-09-01	YES	PR
DRUP01220016T	HMF005243	HMF005243A	0.66	female	1950	2021-07-12	Colorectum	Caecum	Carcinoma			1519,0080199	2020-11-17	Liver	left liver lobe	YES	No	YES	2020-11-23	2021-02-15	Nivolumab	Immunotherapy	2021-01-15	YES	PD
DRUP01220019T	HMF005244	HMF005244A	0.38	female	1952	2021-03-18	Colorectum	Colon	Carcinoma			1520	2021-01-12	Peritoneum	retroperitoneal	YES	No	YES	2021-01-15	2021-02-26	Nivolumab	Immunotherapy	2021-03-03	YES	PD
DRUP01220020T	HMF005651	HMF005651A	0.59	male	1967	2021-07-13	Small intestine		Carcinoma			4907	2021-03-23	Liver	ventral liverlesions	NO	No	YES	2021-03-29	2021-06-28	Nivolumab	Immunotherapy	2021-05-25	YES	PD
DRUP01230001T	HMF000269	HMF000269A	0.79	female	1942	2018-05-22	Unknown	CUP	Carcinoma	Squamous cell carcinoma		1749	2018-02-23	null	Axilla left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01230002T	HMF001055	HMF001055B	0.52	female	1946	2019-05-21	Breast		Carcinoma			3459	2019-03-15	Liver	right	YES	No	YES	2019-03-22	2019-05-02	Pembrolizumab	Immunotherapy	2019-05-15	YES	PD
DRUP01230004T	HMF004147	HMF004147A	0.71	male	1943	null	Colorectum	Colon	Carcinoma			1520	2019-04-23	Lymph node	inguinal right	YES	No	YES	2019-04-23	null	Durvalumab	Immunotherapy	null	null	null
DRUP01230005T	HMF004747	HMF004747A	0.32	female	1969	2019-10-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-07-08	Lung	Left endobrochial from carina	YES	Yes	YES	2019-07-15	2019-08-28	Pertuzumab/Trastuzumab	Targeted therapy	2019-09-10	YES	PD
DRUP01230010T	HMF005840	HMF005840A	0.59	female	1969	2023-06-23	Uterus	Endometrium	Carcinoma			2871	2021-09-21	Lymph node	para-iliacaal	YES	No	YES	2021-09-29	2022-02-16	Nivolumab	Immunotherapy	2021-11-16	YES	iPR
DRUP01230011T	HMF006054	HMF006054A	0.9	male	1956	2022-07-16	Prostate		Carcinoma			10286	2022-02-03	Lymph node	neck left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01260010T	HMF006427	HMF006427A	0.51	female	1973	2022-11-30	Breast		Carcinoma	Adenocarcinoma		3458	2022-07-07	Liver	region against gallbladder	YES	Yes	null	null	null	null	null	null	null	null
DRUP01270001T	HMF001796	HMF001796A	0.41	male	1949	2018-04-12	Colorectum		Carcinoma			0080199	2017-11-10	Liver	liver	YES	No	null	null	null	null	null	null	null	null
DRUP01270003T	HMF002643	HMF002643A	0.53	female	1973	2018-07-06	Uterus	Cervix	Carcinoma			2893	2018-05-22	Liver	liver	YES	Yes	YES	2018-05-25	2018-06-22	Pembrolizumab	Immunotherapy	2018-06-04	YES	PD
DRUP01270004T	HMF002308	HMF002308A	0.45	male	1945	2018-08-09	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-05-29	Lung	left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01270007T	HMF000675	HMF000675B	0.3	female	1937	2019-04-14	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-01-28	Liver	left liverlobe	YES	No	YES	2019-01-30	2019-03-27	Pertuzumab/Trastuzumab	Targeted therapy	2019-03-28	YES	PD
DRUP01290001T	HMF000055	HMF000055A	0.89	male	1952	2018-09-18	Esophagus		Carcinoma	Neuroendocrine carcinoma		1107	2018-07-02	Liver	largest livermetastasis, right	YES	Yes	null	null	null	null	null	null	null	null
DRUP01290005T	HMF005247	HMF005247A	0.41	male	1959	2023-12-15	Colorectum	Caecum	Carcinoma			1519,0080199	2020-11-18	null	right	YES	Yes	YES	2020-11-27	2022-11-25	Nivolumab	Immunotherapy	null	null	null
DRUP01300001T	HMF005841	HMF005841A	0.55	female	1942	2023-06-20	Bile duct		Carcinoma			4947	2021-10-19	Liver	null	NO	No	YES	2021-10-21	2022-04-08	Nivolumab	Immunotherapy	2021-12-14	YES	SD
DRUP01300002T	HMF005842	HMF005842A	0.59	female	1951	2022-07-30	Stomach		Carcinoma			5517	2021-10-13	Liver	unknown	YES	No	YES	2021-10-22	2021-12-10	Nivolumab	Immunotherapy	2021-12-15	YES	PD
DRUP01310001T	HMF005803	HMF005803B	0.58	female	1969	2022-08-29	Bile duct		Carcinoma			4947	2022-04-08	Liver	left liver lobe	YES	No	null	null	null	null	null	null	null	null
DRUP01330002T	HMF001432	HMF001432A	0.64	male	1952	2018-01-25	Colorectum	Rectum	Carcinoma			1993,305	2017-12-15	Liver	right lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01330005T	HMF000726	HMF000726A	0.48	male	1964	2019-11-10	Stomach		Carcinoma			5517	2018-05-17	Liver	right lobe	YES	Yes	null	null	null	null	null	null	null	null
DRUP01330008T	HMF001184	HMF001184A	0.7	male	1953	2018-10-27	Colorectum	Rectum	Carcinoma			1993,305	2018-05-09	Lung	right site	YES	Yes	null	null	null	null	null	null	null	null
DRUP01330013T	HMF000726	HMF000726B	0.29	male	1964	2018-11-10	Esophagus		Carcinoma			1107	2018-08-10	Liver	segment VI	YES	Yes	null	null	null	null	null	null	null	null
DRUP01330016T	HMF000641	HMF000641A	0.75	female	1973	2021-01-05	Anus		Carcinoma			4908	2018-12-03	Bone	Pelvis	YES	Yes	null	null	null	null	null	null	null	null
DRUP01330018T	HMF001084	HMF001084B	0.69	female	1961	2020-06-01	Breast		Carcinoma			3459	2019-03-28	null	left	YES	Yes	YES	2019-04-11	2019-05-23	Pembrolizumab	Immunotherapy	2019-05-13	YES	PD
DRUP01330020T	HMF000964	HMF000964B	0.84	female	1952	2019-12-04	Breast		Carcinoma			3459	2019-08-30	Liver	segment 2	YES	Yes	YES	2019-09-03	2019-10-29	Durvalumab	Immunotherapy	2019-10-23	YES	PD
DRUP01330025T	HMF005652	HMF005652A	0.82	female	1951	2024-02-19	Colorectum	Colon	Carcinoma			1520	2021-03-24	Bone	Chest wall, costa 11 right paramedian	YES	Yes	YES	2021-04-01	2021-05-27	Nivolumab	Immunotherapy	2021-05-14	YES	PR
DRUP01330026T	HMF005653	HMF005653A	0.38	male	1945	2023-12-04	Colorectum	Colon	Carcinoma			1520	2021-05-18	Lymph node	axillary leftside	YES	No	YES	2021-05-19	2022-09-21	Nivolumab	Immunotherapy	2021-07-08	YES	SD
DRUP01340001T	HMF000596	HMF000596A	0.47	male	1949	2018-01-14	Colorectum	Caecum	Carcinoma			1519,0080199	2017-11-21	Liver	unknown	YES	No	null	null	null	null	null	null	null	null
DRUP01340002T	HMF001045	HMF001045A	0.52	male	1942	2018-03-10	Bone/Soft tissue	Small intestine	Leiomyosarcoma			10154,1967,1115	2017-11-29	Liver	left lob	YES	No	null	null	null	null	null	null	null	null
DRUP01340003T	HMF000096	HMF000096A	0.59	female	1975	2018-04-13	Colorectum	Colon	Carcinoma			1520	2017-12-12	Liver	right lob	YES	No	null	null	null	null	null	null	null	null
DRUP01340004T	HMF002232	HMF002232A	0.43	female	1957	2018-02-16	Colorectum	Colon	Carcinoma			1520	2017-12-18	Liver	left lob	YES	No	null	null	null	null	null	null	null	null
DRUP01340006T	HMF002148	HMF002148A	0.63	male	1985	2018-04-06	Colorectum	Colon	Carcinoma			1520	2018-01-23	Lymph node	supraclavicular left	YES	Yes	null	null	null	null	null	null	null	null
DRUP01340010T	HMF001152	HMF001152A	0.78	female	1979	2018-05-10	Lung		Carcinoma	Non-small cell carcinoma		3908	2018-03-30	Lymph node	mediastinal	YES	No	null	null	null	null	null	null	null	null
DRUP01340014T	HMF003016	HMF003016B	0.21	female	1947	2019-01-28	Uterus	Endometrium	Carcinoma			2871	2018-12-21	Liver	right lob	YES	No	null	null	null	null	null	null	null	null
DRUP01340015T	HMF000305	HMF000305B	0.93	male	1950	2019-04-18	Bone/Soft tissue		Gastrointestinal stromal tumor			9253	2018-12-28	null	upper abdomen	YES	No	null	null	null	null	null	null	null	null
DRUP01340016T	HMF003962	HMF003962A	0.54	male	1963	2020-02-12	Colorectum	Colon	Carcinoma			1520	2019-03-01	Liver	left	YES	No	YES	2019-03-13	2019-07-30	Durvalumab	Immunotherapy	2019-05-03	YES	SD
DRUP01340017T	HMF004031	HMF004031A	0.44	female	1969	null	Colorectum	Colon	Carcinoma			1520	null	null	null	YES	Yes	YES	2019-03-08	null	Durvalumab	Immunotherapy	2019-04-26	YES	PR
DRUP01340028T	HMF004951	HMF004951B	0.42	male	1965	2021-11-13	Bile duct	Extrahepatic	Carcinoma			4682	2020-10-09	Liver	segment6	YES	No	null	null	null	null	null	null	null	null
DRUP01340051T	HMF006399	HMF006399A	0.67	female	1976	2022-08-23	Breast		Carcinoma			3459	2022-06-01	Liver	segment 8	YES	Yes	null	null	null	null	null	null	null	null
DRUP01350003T	HMF000261	HMF000261B	0.59	female	1959	null	Breast		Carcinoma		lobular carcinoma	3459	2020-09-11	Lymph node	neck left	YES	Yes	YES	2020-09-23	null	Pembrolizumab	Immunotherapy	null	null	null
DRUP01350004T	HMF005062	HMF005062A	0.61	male	1951	2020-12-24	Prostate		Carcinoma			10286	2020-09-30	Bone	os ilium right	YES	Yes	YES	2020-10-01	2020-11-12	Nivolumab	Immunotherapy	2020-11-23	YES	ND
DRUP01360007T	HMF005248	HMF005248A	0.2	male	null	2023-08-12	Unknown	CUP	Carcinoma	Adenocarcinoma		299	2020-12-08	null	abdomen	NO	No	YES	2020-12-11	2022-06-24	Nivolumab	Immunotherapy	2021-02-01	YES	PR
DRUP01380010T	HMF005249	HMF005249A	0.65	male	null	2021-06-01	Stomach		Carcinoma			5517	2021-03-03	null	stomach	YES	Yes	YES	2021-03-05	2021-05-07	Nivolumab	Immunotherapy	null	null	null
DRUP01390008T	HMF005740	HMF005740A	0.47	female	1944	null	Colorectum	Caecum	Carcinoma	Neuroendocrine carcinoma		1519,1800,0080199	2021-10-06	null	peritoneal lesion left	NO	No	YES	2021-10-14	null	Nivolumab	Immunotherapy	null	null	null
DRUP01440001T	HMF002011	HMF002011A	0.77	male	1952	2019-08-14	Esophagus		Carcinoma			1107	2018-08-14	Liver	segment 2	YES	Yes	null	null	null	null	null	null	null	null
DRUP01440008T	HMF004956	HMF004956A	0.31	female	1948	2020-06-16	Colorectum	Colon	Carcinoma			1520	2020-05-22	Peritoneum	retroperitoneum	YES	No	YES	2020-05-29	2020-05-29	Nivolumab	Immunotherapy	null	null	null
DRUP01440009T	HMF005064	HMF005064A	0.75	male	1943	2023-05-23	Colorectum	Colon	Carcinoma			1520	2020-07-09	Lymph node	axilla	YES	No	YES	2020-07-10	2022-07-15	Nivolumab	Immunotherapy	2020-09-01	YES	SD
DRUP01440011T	HMF005655	HMF005655A	0.2	female	1956	2023-04-12	Bile duct		Carcinoma			4947	2021-03-16	Liver	segment VI	YES	No	YES	2021-03-19	2023-03-17	Nivolumab	Immunotherapy	2021-05-10	YES	SD
GAYA01200001T	HMF006324	HMF006324A	0.5	null	null	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	null	null	null	null	null	null	null	null	null	null
GAYA01210001T	HMF006348	HMF006348A	0.44	null	null	null	Breast		Carcinoma	ER-positive/HER2-negative		0060075,0060080	null	null	null	null	null	null	null	null	null	null	null	null	null
OMIC01130103T	HMF006177	HMF006177A	0.42	null	null	null	Esophagus		Carcinoma	Squamous cell carcinoma		3748	null	null	null	null	null	null	null	null	null	null	null	null	null
OMIC01130104T	HMF006178	HMF006178A	0.54	null	null	null	Esophagus		Carcinoma	Squamous cell carcinoma		3748	null	null	null	null	null	null	null	null	null	null	null	null	null
OMIC01130105T	HMF006202	HMF006202A	0.81	null	null	null	Esophagus		Carcinoma	Squamous cell carcinoma		3748	null	null	null	null	null	null	null	null	null	null	null	null	null
OMIC01130107T	HMF006203	HMF006203A	0.23	null	null	null	Esophagus		Carcinoma	Squamous cell carcinoma		3748	null	null	null	null	null	null	null	null	null	null	null	null	null
OMIC01130108T	HMF006204	HMF006204A	0.37	null	null	null	Esophagus		Carcinoma	Squamous cell carcinoma		3748	null	null	null	null	null	null	null	null	null	null	null	null	null
OMIC01130109T	HMF006205	HMF006205A	0.31	null	null	null	Esophagus		Carcinoma	Squamous cell carcinoma		3748	null	null	null	null	null	null	null	null	null	null	null	null	null
WIDE01010005T	HMF003934	HMF003934A	0.56	female	1955	2021-01-12	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-08-30	long links	long	Yes	No	Yes	2019-09-10	2020-05-20	Paclitaxel/Bevacizumab	Multiple therapy	null	null	null
WIDE01010026T	HMF004066	HMF004066A	0.33	female	1946	2021-09-22	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-13	bijnier	bijnier	Yes	Yes	Yes	2018-03-02	2019-08-05	null	null	2019-07-22	null	CLINICAL_BENEFIT
WIDE01010057T	HMF004089	HMF004089A	0.24	female	1948	2020-02-04	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-05-28	lever	lever neoplasie	No	No	Yes	2018-10-18	2019-06-21	Erlotinib	Targeted therapy	null	null	null
WIDE01010058T	HMF003961	HMF003961A	0.3	female	1956	2020-12-19	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-06-05	lever	lever neoplasie	Yes	Yes	Yes	2018-10-11	2019-06-05	null	null	null	null	null
WIDE01010079T	HMF003857	HMF003857A	0.25	male	1948	2020-11-02	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-06-12	rib rechts	bot	Yes	No	Yes	2019-06-26	2019-11-21	Trastuzumab	Targeted therapy	null	null	null
WIDE01010115T	HMF004305	HMF004305A	0.47	female	1946	2021-07-25	Lung		Carcinoma	Non-small cell carcinoma		3908	null	null	null	No	No	Yes	2019-09-11	2020-10-07	Osimertinib	Targeted therapy	null	null	null
WIDE01010130T	HMF004213	HMF004213A	0.4	female	1972	2020-07-07	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-07-17	lever	lever neoplasie	Yes	No	Yes	2019-08-29	2020-06-04	Osimertinib	Targeted therapy	2019-09-18	null	CLINICAL_BENEFIT
WIDE01010130TII	HMF004213	HMF004213B	0.2	female	1972	2020-07-07	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-02-26	lever	lever neoplasie	Yes	No	Yes	2019-08-29	2020-06-04	Osimertinib	Targeted therapy	2019-09-18	null	CLINICAL_BENEFIT
WIDE01010134T	HMF004052	HMF004052A	0.74	female	1938	2020-10-31	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-07-16	lever	lever neoplasie	Yes	Yes	Yes	2020-05-25	2020-10-19	Osimertinib	Targeted therapy	null	null	null
WIDE01010151T	HMF004178	HMF004178A	0.89	male	1944	2020-04-16	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-07-30	lever	lever neoplasie	Yes	Yes	Yes	2019-03-19	2019-08-14	null	null	null	null	null
WIDE01010176T	HMF004182	HMF004182A	0.69	female	1953	2019-10-15	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-08-16	spier tegen scapula	weke delen	No	No	Yes	2018-11-26	2019-08-23	Erlotinib	Targeted therapy	2019-09-12	null	PD
WIDE01010192T	HMF003880	HMF003880A	0.2	female	1960	2022-07-20	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-08-27	processus transversus L3 rechts	bot	Yes	Yes	Yes	2019-09-18	2020-03-09	Atezolizumab/Bevacizumab	Multiple therapy	null	null	null
WIDE01010193T	HMF004137	HMF004137A	0.54	female	1943	2020-02-05	Lung		Carcinoma	Non-small cell carcinoma		3908	null	null	null	No	No	Yes	2019-09-24	2020-01-31	Osimertinib	Targeted therapy	null	null	null
WIDE01010241T	HMF003927	HMF003927A	0.6	female	1958	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-09-20	oksel rechts	lymfeklier	Yes	No	Yes	2019-09-02	2019-10-11	Osimertinib	Targeted therapy	null	null	null
WIDE01010307T	HMF003950	HMF003950A	0.58	female	1948	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-10-15	os ilium	bot	Yes	Yes	Yes	2019-08-21	2021-04-12	Osimertinib	Targeted therapy	null	null	null
WIDE01010316T	HMF004470	HMF004470A	0.5	female	1951	2022-02-18	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-10-18	rib 7	bot	Yes	No	Yes	2020-11-10	2021-11-05	null	null	null	null	null
WIDE01010368T	HMF004541	HMF004541A	0.31	male	1972	2020-04-24	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-11-22	thoraxwand	weke delen	Yes	Yes	Yes	2019-08-21	2020-04-14	Osimertinib	Targeted therapy	null	null	null
WIDE01010399T	HMF004631	HMF004631A	0.26	female	1944	2022-04-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-11-26	thoraxwand	weke delen	Yes	No	Yes	2019-09-10	2019-12-09	Osimertinib	Targeted therapy	2022-04-30	null	STOP_TREATMENT;DEATH
WIDE01010403T	HMF004505	HMF004505A	0.37	female	1952	2020-03-22	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-12-03	lever	lever neoplasie	Yes	No	Yes	2018-07-16	2019-12-17	Pemetrexed	Chemotherapy	2020-01-24	null	PD
WIDE01010419T	HMF004481	HMF004481A	0.21	female	1941	2022-08-16	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-12-03	oksel links	lymfklier	Yes	Yes	Yes	2019-12-16	2020-03-13	Pemetrexed, Carboplatin	Chemotherapy	null	null	null
WIDE01010427T	HMF002477	HMF002477B	0.21	female	1974	2021-06-05	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-12-17	long rechts	long	Yes	No	Yes	2019-09-12	2021-04-09	Osimertinib	Targeted therapy	null	null	null
WIDE01010474T	HMF004545	HMF004545B	0.43	female	1952	2021-05-19	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-01-07	lever	lever neoplasie	Yes	No	Yes	2019-09-05	2021-03-30	Osimertinib	Targeted therapy	null	null	null
WIDE01010480T	HMF004558	HMF004558A	0.38	female	1937	2020-11-18	Lung		Carcinoma	Non-small cell carcinoma		3908	2019-12-27	long rechts	long	Yes	No	Yes	2019-09-02	2019-12-30	Osimertinib	Targeted therapy	2020-01-29	null	SD
WIDE01010501T	HMF004755	HMF004755A	0.38	female	1944	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-01-07	mediastinum	lymfklier	Yes	Yes	Yes	2019-05-07	2020-05-27	Erlotinib	Targeted therapy	null	null	null
WIDE01010558T	HMF004489	HMF004489A	0.21	female	1949	2020-03-06	Lung		Carcinoma	Non-small cell carcinoma		3908	null	null	null	No	No	Yes	2019-11-22	2020-02-17	Dabrafenib/Trametinib	Targeted therapy	null	null	null
WIDE01010611T	HMF002337	HMF002337B	0.42	male	1945	2020-12-21	Prostate					10283	2020-02-20	oksel rechts	lymfklier	No	No	Yes	2020-04-01	2020-04-29	Abiraterone	Hormonal therapy	2020-09-09	null	PD
WIDE01010626T	HMF004948	HMF004948A	0.33	female	1952	2020-06-27	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-03-10	bijnier	bijnier	Yes	No	Yes	2019-12-13	2020-06-15	Osimertinib	Targeted therapy	null	null	null
WIDE01010656T	HMF004636	HMF004636A	0.48	male	1959	2020-10-28	Lung		Carcinoma	Non-small cell carcinoma		3908	null	null	null	Yes	No	Yes	2019-09-19	2020-10-12	Osimertinib	Targeted therapy	2020-10-28	null	STOP_TREATMENT;DEATH
WIDE01010667T	HMF004533	HMF004533A	0.28	female	1964	2022-02-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-03-10	oksel links	lymfklier	Yes	No	Yes	2020-07-07	2020-07-28	Bevacizumab	Targeted therapy	null	null	null
WIDE01010675T	HMF004491	HMF004491A	0.38	female	1965	2021-07-17	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-03-12	bot	bot	Yes	Yes	Yes	2019-09-10	2021-02-25	Osimertinib	Targeted therapy	null	null	null
WIDE01010685T	HMF004488	HMF004488A	0.59	male	1982	2020-06-28	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-03-20	lever	lever neoplasie	Yes	Yes	Yes	2019-10-09	2020-06-11	Osimertinib	Targeted therapy	null	null	null
WIDE01010708T	HMF004728	HMF004728A	0.61	female	1955	2021-10-21	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-04-09	lever	lever neoplasie	No	No	Yes	2019-12-19	2020-04-09	Osimertinib	Targeted therapy	null	null	null
WIDE01010764T	HMF004928	HMF004928A	0.43	female	1968	2021-04-01	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-05-01	long rechts	long	Yes	Yes	Yes	2020-06-03	2020-06-23	Trastuzumab	Targeted therapy	2020-07-14	null	SD
WIDE01010767T	HMF004825	HMF004825A	0.28	female	1951	2021-06-07	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-05-12	lever	lever neoplasie	Yes	No	Yes	2020-05-25	2021-03-29	Osimertinib	Targeted therapy	null	null	null
WIDE01010791T	HMF004908	HMF004908A	0.33	female	1955	null	Lung		Carcinoma	Non-small cell carcinoma		3908	null	null	null	Yes	Yes	Yes	2020-05-27	2021-07-08	Osimertinib	Targeted therapy	null	null	null
WIDE01010792T	HMF004955	HMF004955A	0.41	female	1956	2021-06-26	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-05-26	long links	long	Yes	No	Yes	2019-09-17	2021-04-12	Osimertinib	Targeted therapy	null	null	null
WIDE01010793T	HMF004990	HMF004990A	0.6	female	1962	2021-01-08	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-03	weke delen	weke delen	Yes	Yes	Yes	2019-11-25	2020-10-05	Osimertinib	Targeted therapy	null	null	null
WIDE01010798T	HMF004826	HMF004826A	0.22	female	1954	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-05-28	long links	long	Yes	No	Yes	2019-08-21	2021-03-17	Osimertinib	Targeted therapy	null	null	null
WIDE01010811T	HMF004814	HMF004814A	0.28	male	1947	null	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-05-29	long links	long	No	No	Yes	2020-05-29	2021-06-28	Osimertinib	Targeted therapy	null	null	null
WIDE01010814T	HMF005013	HMF005013A	0.3	female	1950	2020-07-08	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-11	long rechts	long	No	No	Yes	2020-03-02	2020-06-24	Osimertinib	Targeted therapy	2020-07-08	null	STOP_TREATMENT;DEATH
WIDE01010817T	HMF004849	HMF004849A	0.26	female	1966	2020-07-09	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-04	long rechts	long	Yes	Yes	null	null	null	null	null	null	null	null
WIDE01010831T	HMF004900	HMF004900A	0.42	female	1975	2021-09-18	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-10	lever	lever neoplasie	No	No	Yes	2020-06-10	2021-04-21	Osimertinib	Targeted therapy	null	null	null
WIDE01010833T	HMF004795	HMF004795A	0.5	male	1971	2021-04-30	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-18	long rechts	long	Yes	No	Yes	2020-06-18	2020-09-10	Osimertinib	Targeted therapy	null	null	null
WIDE01010835T	HMF005034	HMF005034A	0.75	male	1945	2020-10-09	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-11	bot	bot	Yes	Yes	Yes	2019-09-04	2020-06-29	Osimertinib	Targeted therapy	2020-10-09	null	STOP_TREATMENT;DEATH
WIDE01010837T	HMF004845	HMF004845A	0.48	female	1961	2022-07-11	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-12	lever	lever neoplasie	Yes	No	Yes	2020-04-20	2020-07-31	Carboplatin	Chemotherapy	null	null	null
WIDE01010840T	HMF004839	HMF004839A	0.41	male	1953	2022-04-23	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-18	long links	long	No	No	Yes	2020-11-20	2021-01-21	Paclitaxel/Bevacizumab/Carboplatin	Multiple therapy	2021-03-19	null	PD
WIDE01010846T	HMF004964	HMF004964A	0.29	female	1958	2021-08-19	Lung		Carcinoma	Non-small cell carcinoma		3908	2020-06-18	pleura	pleura	Yes	No	Yes	2019-09-27	2021-07-15	Osimertinib	Targeted therapy	null	null	null
